...1	sampleID	cancer_type	age_diagnosis	gender	race	pathologic_stage	clinical_stage	histological_type	histological_grade	initial_pathologic_dx_year	menopause_status	birth_days_to	vital_status	tumor_status	last_contact_days_to	death_days_to	cause_of_death	new_tumor_event_type	new_tumor_event_site	new_tumor_event_dx_days_to	treatment_outcome_first_course	OS	OS.time	DSS	DSS.time	DFI	DFI.time	PFI	PFI.time	age_at_last_followup_years	disease_duration_years	age_group_diagnosis	stage_group
505	TCGA-3C-AAAU	BRCA	55	FEMALE	WHITE	Stage X	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20211	Alive	WITH TUMOR	4047	548	[Not Available]	Distant Metastasis	Lung	1808	[Not Available]	0	4047	0	4047	1	1808	1	1808	66.41	11.08	50-59	other
506	TCGA-3C-AALI	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18538	Alive	TUMOR FREE	4005	548	[Not Available]	NA	NA	364	[Not Available]	0	4005	0	4005	0	4005	0	4005	61.72	10.97	50-59	Stage 2
507	TCGA-3C-AALJ	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22848	Alive	TUMOR FREE	1474	548	[Not Available]	NA	NA	364	[Not Available]	0	1474	0	1474	0	1474	0	1474	66.59	4.04	60-69	Stage 2
508	TCGA-3C-AALK	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	[Unknown]	-19074	Alive	TUMOR FREE	1448	548	[Not Available]	NA	NA	364	[Not Available]	0	1448	0	1448	0	720	0	1448	56.19	3.96	50-59	Stage 1
509	TCGA-4H-AAAK	BRCA	50	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18371	Alive	TUMOR FREE	348	548	[Not Available]	NA	NA	364	[Not Available]	0	348	0	348	0	348	0	348	51.25	0.95	50-59	Stage 3
510	TCGA-5L-AAT0	BRCA	42	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15393	Alive	TUMOR FREE	1477	548	[Not Available]	NA	NA	364	[Not Available]	0	1477	0	1477	0	720	0	1477	46.19	4.04	40-49	Stage 2
511	TCGA-5L-AAT1	BRCA	63	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23225	Alive	WITH TUMOR	1471	548	[Not Available]	NA	NA	364	[Not Available]	0	1471	0	1471	0	720	0	1471	67.61	4.03	60-69	Stage 4
512	TCGA-5T-A9QA	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2013	[Unknown]	-19031	Alive	TUMOR FREE	303	548	[Not Available]	NA	NA	364	[Not Available]	0	303	0	303	0	720	0	303	52.93	0.83	50-59	Stage 2
513	TCGA-A1-A0SB	BRCA	70	FEMALE	WHITE	Stage I	[Not Applicable]	Other, specify	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25833	Alive	TUMOR FREE	259	548	[Not Available]	NA	NA	364	[Not Available]	0	259	0	259	0	259	0	259	71.44	0.71	70-79	Stage 1
514	TCGA-A1-A0SD	BRCA	59	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	[Not Available]	-21793	Alive	TUMOR FREE	437	548	[Not Available]	NA	NA	364	[Not Available]	0	437	0	437	0	437	0	437	60.86	1.2	50-59	Stage 2
515	TCGA-A1-A0SE	BRCA	56	FEMALE	WHITE	Stage I	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20717	Alive	TUMOR FREE	1321	548	[Not Available]	NA	NA	364	[Not Available]	0	1321	0	1321	0	1321	0	1321	60.34	3.62	50-59	Stage 1
516	TCGA-A1-A0SF	BRCA	54	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19731	Alive	TUMOR FREE	1463	548	[Not Available]	NA	NA	364	[Not Available]	0	1463	0	1463	0	1463	0	1463	58.03	4.01	50-59	Stage 2
517	TCGA-A1-A0SG	BRCA	61	FEMALE	WHITE	Stage IIB	[Not Applicable]	Other, specify	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22380	Alive	TUMOR FREE	434	548	[Not Available]	NA	NA	364	[Not Available]	0	434	0	434	0	434	0	434	62.46	1.19	60-69	Stage 2
518	TCGA-A1-A0SH	BRCA	39	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14595	Alive	TUMOR FREE	1437	548	[Not Available]	NA	NA	364	[Not Available]	0	1437	0	1437	0	1437	0	1437	43.89	3.93	30-39	Stage 2
519	TCGA-A1-A0SI	BRCA	52	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	[Not Available]	-19250	Alive	TUMOR FREE	635	548	[Not Available]	NA	NA	364	[Not Available]	0	635	0	635	0	635	0	635	54.44	1.74	50-59	Stage 2
520	TCGA-A1-A0SJ	BRCA	39	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	[Not Available]	-14383	Alive	TUMOR FREE	416	548	[Not Available]	NA	NA	364	[Not Available]	0	416	0	416	0	416	0	416	40.52	1.14	30-39	Stage 3
521	TCGA-A1-A0SK	BRCA	54	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2007	Indeterminate (neither Pre or Postmenopausal)	-20048	Dead	WITH TUMOR	766	967	[Not Available]	NA	NA	364	[Not Available]	1	967	1	967	0	720	1	967	57.54	2.65	50-59	Stage 2
522	TCGA-A1-A0SM	BRCA	77	MALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	[Not Available]	-28198	Alive	TUMOR FREE	242	548	[Not Available]	NA	NA	364	[Not Available]	0	242	0	242	0	242	0	242	77.86	0.66	70-79	Stage 2
523	TCGA-A1-A0SN	BRCA	50	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18401	Alive	TUMOR FREE	1196	548	[Not Available]	NA	NA	364	[Not Available]	0	1196	0	1196	0	1196	0	1196	53.65	3.27	50-59	Stage 2
524	TCGA-A1-A0SO	BRCA	67	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24826	Alive	TUMOR FREE	852	548	[Not Available]	NA	NA	364	[Not Available]	0	852	0	852	0	852	0	852	70.3	2.33	60-69	Stage 2
525	TCGA-A1-A0SP	BRCA	40	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	[Not Available]	-14954	Alive	TUMOR FREE	584	548	[Not Available]	NA	NA	364	[Not Available]	0	584	0	584	0	584	0	584	42.54	1.6	40-49	Stage 2
526	TCGA-A1-A0SQ	BRCA	45	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16458	Alive	TUMOR FREE	554	548	[Not Available]	NA	NA	364	[Not Available]	0	554	0	554	0	554	0	554	46.58	1.52	40-49	Stage 2
527	TCGA-A2-A04N	BRCA	66	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24155	Alive	TUMOR FREE	4354	548	[Not Available]	NA	NA	364	[Not Available]	0	4354	0	4354	0	4354	0	4354	78.05	11.92	60-69	Stage 1
528	TCGA-A2-A04P	BRCA	36	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13238	Dead	WITH TUMOR	766	548	[Not Available]	Distant Metastasis	Bone	102	[Not Available]	1	548	1	548	0	720	1	102	37.74	1.5	30-39	Stage 3
529	TCGA-A2-A04Q	BRCA	48	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17660	Alive	TUMOR FREE	2385	548	[Not Available]	NA	NA	364	[Not Available]	0	2385	0	2385	0	2385	0	2385	54.88	6.53	40-49	Stage 1
530	TCGA-A2-A04R	BRCA	36	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13483	Alive	TUMOR FREE	3709	548	[Not Available]	NA	NA	364	[Not Available]	0	3709	0	3709	0	3709	0	3709	47.07	10.15	30-39	Stage 1
531	TCGA-A2-A04T	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22707	Alive	TUMOR FREE	2246	548	[Not Available]	NA	NA	364	[Not Available]	0	2246	0	2246	0	2246	0	2246	68.32	6.15	60-69	Stage 2
532	TCGA-A2-A04U	BRCA	47	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Peri (6-12 months since last menstrual period)	-17474	Alive	TUMOR FREE	2654	548	[Not Available]	NA	NA	364	[Not Available]	0	2654	0	2654	0	2654	0	2654	55.11	7.27	40-49	Stage 2
533	TCGA-A2-A04V	BRCA	39	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14250	Dead	WITH TUMOR	766	1920	[Not Available]	NA	NA	1470	[Not Available]	1	1920	1	1920	1	1470	1	1470	44.27	5.26	30-39	Stage 2
534	TCGA-A2-A04W	BRCA	50	FEMALE	WHITE	Stage IIB	[Not Applicable]	Other, specify	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18345	Alive	TUMOR FREE	3102	548	[Not Available]	NA	NA	364	[Not Available]	0	3102	0	3102	0	3102	0	3102	58.72	8.49	50-59	Stage 2
535	TCGA-A2-A04X	BRCA	34	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12642	Alive	TUMOR FREE	1686	548	[Not Available]	NA	NA	364	[Not Available]	0	1686	0	1686	0	1686	0	1686	39.23	4.62	30-39	Stage 2
536	TCGA-A2-A04Y	BRCA	53	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19533	Alive	TUMOR FREE	1099	548	[Not Available]	NA	NA	364	[Not Available]	0	1099	0	1099	0	1099	0	1099	56.49	3.01	50-59	Stage 2
537	TCGA-A2-A0CK	BRCA	60	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22094	Alive	TUMOR FREE	4159	548	[Not Available]	New Primary Tumor	Other, specify	1364	[Not Available]	0	4159	0	4159	1	1364	1	1364	71.88	11.39	60-69	Stage 3
538	TCGA-A2-A0CL	BRCA	37	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13556	Alive	TUMOR FREE	3015	548	[Not Available]	NA	NA	364	[Not Available]	0	3015	0	3015	0	720	0	3015	45.37	8.25	30-39	Stage 3
539	TCGA-A2-A0CM	BRCA	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14969	Dead	WITH TUMOR	766	754	[Not Available]	NA	NA	382	[Not Available]	1	754	1	754	1	382	1	382	43.05	2.06	40-49	Stage 2
540	TCGA-A2-A0CO	BRCA	85	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31404	Dead	TUMOR FREE	766	3492	[Not Available]	NA	NA	364	[Not Available]	1	3492	0	3492	0	720	0	3492	95.54	9.56	>=80	Stage 2
541	TCGA-A2-A0CP	BRCA	60	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22133	Alive	TUMOR FREE	2813	548	[Not Available]	NA	NA	364	[Not Available]	0	2813	0	2813	0	2813	0	2813	68.3	7.7	60-69	Stage 1
542	TCGA-A2-A0CQ	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22810	Alive	TUMOR FREE	2695	548	[Not Available]	NA	NA	364	[Not Available]	0	2695	0	2695	0	2695	0	2695	69.83	7.38	60-69	Stage 1
543	TCGA-A2-A0CR	BRCA	54	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20075	Alive	TUMOR FREE	3283	548	[Not Available]	NA	NA	364	[Not Available]	0	3283	0	3283	0	720	0	3283	63.95	8.99	50-59	Stage 2
544	TCGA-A2-A0CS	BRCA	73	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26817	Dead	TUMOR FREE	766	2348	[Not Available]	NA	NA	364	[Not Available]	1	2348	0	2348	0	720	0	2348	79.85	6.43	70-79	Stage 4
545	TCGA-A2-A0CT	BRCA	71	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25959	Alive	TUMOR FREE	2289	548	[Not Available]	NA	NA	364	[Not Available]	0	2289	0	2289	0	2289	0	2289	77.34	6.27	70-79	Stage 2
546	TCGA-A2-A0CU	BRCA	73	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26823	Dead	TUMOR FREE	766	158	[Not Available]	NA	NA	364	[Not Available]	1	158	0	158	0	720	0	158	73.87	0.43	70-79	Stage 2
547	TCGA-A2-A0CV	BRCA	41	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15289	Alive	TUMOR FREE	3011	548	[Not Available]	NA	NA	364	[Not Available]	0	3011	0	3011	0	3011	0	3011	50.1	8.24	40-49	Stage 2
548	TCGA-A2-A0CW	BRCA	67	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24541	Alive	TUMOR FREE	3283	548	[Not Available]	NA	NA	364	[Not Available]	0	3283	0	3283	0	3283	0	3283	76.18	8.99	60-69	Stage 2
549	TCGA-A2-A0CX	BRCA	52	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19152	Alive	TUMOR FREE	1728	548	[Not Available]	NA	NA	364	[Not Available]	0	1728	0	1728	0	1728	0	1728	57.17	4.73	50-59	Stage 2
550	TCGA-A2-A0CY	BRCA	63	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23229	Alive	TUMOR FREE	1673	548	[Not Available]	NA	NA	364	[Not Available]	0	1673	0	1673	0	1673	0	1673	68.18	4.58	60-69	Stage 2
551	TCGA-A2-A0CZ	BRCA	46	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Peri (6-12 months since last menstrual period)	-17026	Alive	TUMOR FREE	1616	548	[Not Available]	NA	NA	364	[Not Available]	0	1616	0	1616	0	720	0	1616	51.04	4.42	40-49	Stage 2
552	TCGA-A2-A0D0	BRCA	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22115	Alive	TUMOR FREE	2048	548	[Not Available]	NA	NA	364	[Not Available]	0	2048	0	2048	0	2048	0	2048	66.15	5.61	60-69	Stage 2
553	TCGA-A2-A0D1	BRCA	76	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28084	Alive	TUMOR FREE	1051	548	[Not Available]	NA	NA	364	[Not Available]	0	1051	0	1051	0	1051	0	1051	79.77	2.88	70-79	Stage 2
554	TCGA-A2-A0D2	BRCA	45	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16623	Alive	TUMOR FREE	1027	548	[Not Available]	NA	NA	364	[Not Available]	0	1027	0	1027	0	1027	0	1027	48.32	2.81	40-49	Stage 2
555	TCGA-A2-A0D3	BRCA	42	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15524	Alive	TUMOR FREE	1873	548	[Not Available]	NA	NA	364	[Not Available]	0	1873	0	1873	0	1873	0	1873	47.63	5.13	40-49	Stage 1
556	TCGA-A2-A0D4	BRCA	37	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13805	Alive	TUMOR FREE	767	548	[Not Available]	NA	NA	364	[Not Available]	0	767	0	767	0	767	0	767	39.9	2.1	30-39	Stage 2
557	TCGA-A2-A0EM	BRCA	73	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26845	Alive	TUMOR FREE	3094	548	[Not Available]	NA	NA	364	[Not Available]	0	3094	0	3094	0	3094	0	3094	81.97	8.47	70-79	Stage 1
558	TCGA-A2-A0EN	BRCA	70	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25771	Alive	TUMOR FREE	4088	548	[Not Available]	NA	NA	364	[Not Available]	0	4088	0	4088	0	4088	0	4088	81.75	11.19	70-79	Stage 2
559	TCGA-A2-A0EO	BRCA	54	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Peri (6-12 months since last menstrual period)	-19880	Alive	TUMOR FREE	2442	548	[Not Available]	NA	NA	364	[Not Available]	0	2442	0	2442	0	720	0	2442	61.11	6.69	50-59	Stage 1
560	TCGA-A2-A0EP	BRCA	56	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20585	Alive	TUMOR FREE	3603	548	[Not Available]	NA	NA	364	[Not Available]	0	3603	0	3603	0	3603	0	3603	66.22	9.86	50-59	Stage 1
561	TCGA-A2-A0EQ	BRCA	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23543	Alive	TUMOR FREE	2426	548	[Not Available]	NA	NA	364	[Not Available]	0	2426	0	2426	0	2426	0	2426	71.1	6.64	60-69	Stage 2
562	TCGA-A2-A0ER	BRCA	63	FEMALE	WHITE	Stage IB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23021	Alive	TUMOR FREE	2263	548	[Not Available]	NA	NA	364	[Not Available]	0	2263	0	2263	0	2263	0	2263	69.22	6.2	60-69	Stage 1
563	TCGA-A2-A0ES	BRCA	52	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19160	Alive	TUMOR FREE	2190	548	[Not Available]	NA	NA	364	[Not Available]	0	2190	0	2190	0	2190	0	2190	58.45	6	50-59	Stage 2
564	TCGA-A2-A0ET	BRCA	58	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21464	Alive	TUMOR FREE	1066	548	[Not Available]	NA	NA	364	[Not Available]	0	1066	0	1066	0	1066	0	1066	61.68	2.92	50-59	Stage 3
565	TCGA-A2-A0EU	BRCA	79	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29144	Alive	TUMOR FREE	1043	548	[Not Available]	NA	NA	364	[Not Available]	0	1043	0	1043	0	1043	0	1043	82.65	2.86	70-79	Stage 1
566	TCGA-A2-A0EV	BRCA	80	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29285	Alive	TUMOR FREE	968	548	[Not Available]	NA	NA	364	[Not Available]	0	968	0	968	0	968	0	968	82.83	2.65	>=80	Stage 1
567	TCGA-A2-A0EW	BRCA	53	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19413	Dead	WITH TUMOR	766	1884	[Not Available]	Distant Metastasis	Bone	1353	[Not Available]	1	1884	1	1884	0	720	1	1353	58.31	5.16	50-59	Stage 3
568	TCGA-A2-A0EX	BRCA	46	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16858	Alive	TUMOR FREE	752	548	[Not Available]	NA	NA	364	[Not Available]	0	752	0	752	0	752	0	752	48.21	2.06	40-49	Stage 2
569	TCGA-A2-A0EY	BRCA	62	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22872	Alive	TUMOR FREE	1925	548	[Not Available]	NA	NA	364	[Not Available]	0	1925	0	1925	0	1925	0	1925	67.89	5.27	60-69	Stage 2
570	TCGA-A2-A0ST	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22922	Alive	WITH TUMOR	3017	548	[Not Available]	NA	NA	364	[Not Available]	0	3017	0	3017	0	3017	0	3017	71.02	8.26	60-69	Stage 2
571	TCGA-A2-A0SU	BRCA	66	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24219	Alive	TUMOR FREE	1662	548	[Not Available]	NA	NA	364	[Not Available]	0	1662	0	1662	0	1662	0	1662	70.86	4.55	60-69	Stage 2
572	TCGA-A2-A0SV	BRCA	63	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23126	Dead	WITH TUMOR	766	825	[Not Available]	NA	NA	364	[Not Available]	1	825	1	825	0	720	1	825	65.57	2.26	60-69	Stage 4
573	TCGA-A2-A0SW	BRCA	82	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30085	Dead	WITH TUMOR	766	1365	[Not Available]	NA	NA	653	[Not Available]	1	1365	1	1365	0	720	1	653	86.11	3.74	>=80	Stage 4
574	TCGA-A2-A0SX	BRCA	48	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17774	Alive	WITH TUMOR	1534	548	[Not Available]	NA	NA	1239	[Not Available]	0	1534	0	1534	1	1239	1	1239	52.86	4.2	40-49	Stage 1
575	TCGA-A2-A0SY	BRCA	62	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22928	Alive	TUMOR FREE	1347	548	[Not Available]	NA	NA	364	[Not Available]	0	1347	0	1347	0	1347	0	1347	66.46	3.69	60-69	Stage 3
576	TCGA-A2-A0T0	BRCA	59	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21575	Alive	TUMOR FREE	533	548	[Not Available]	NA	NA	364	[Not Available]	0	533	0	533	0	533	0	533	60.53	1.46	50-59	Stage 2
577	TCGA-A2-A0T1	BRCA	55	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20227	Alive	TUMOR FREE	521	548	[Not Available]	NA	NA	364	[Not Available]	0	521	0	521	0	521	0	521	56.8	1.43	50-59	Stage 3
578	TCGA-A2-A0T2	BRCA	66	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24235	Dead	WITH TUMOR	766	255	[Not Available]	NA	NA	364	[Not Available]	1	255	1	255	0	720	1	255	67.05	0.7	60-69	Stage 4
579	TCGA-A2-A0T3	BRCA	37	FEMALE	WHITE	Stage IB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13680	Alive	TUMOR FREE	1516	548	[Not Available]	NA	NA	364	[Not Available]	0	1516	0	1516	0	1516	0	1516	41.6	4.15	30-39	Stage 1
580	TCGA-A2-A0T4	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22849	Alive	TUMOR FREE	624	548	[Not Available]	NA	NA	364	[Not Available]	0	624	0	624	0	624	0	624	64.27	1.71	60-69	Stage 2
581	TCGA-A2-A0T5	BRCA	39	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14503	Alive	TUMOR FREE	531	548	[Not Available]	NA	NA	364	[Not Available]	0	531	0	531	0	531	0	531	41.16	1.45	30-39	Stage 2
582	TCGA-A2-A0T6	BRCA	50	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18334	Alive	TUMOR FREE	575	548	[Not Available]	NA	NA	364	[Not Available]	0	575	0	575	0	575	0	575	51.77	1.57	50-59	Stage 2
583	TCGA-A2-A0T7	BRCA	51	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18756	Alive	TUMOR FREE	631	548	[Not Available]	NA	NA	364	[Not Available]	0	631	0	631	0	631	0	631	53.08	1.73	50-59	Stage 2
584	TCGA-A2-A0YC	BRCA	59	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21685	Alive	WITH TUMOR	990	548	[Not Available]	Locoregional Disease	NA	756	[Not Available]	0	990	0	990	0	720	1	756	62.08	2.71	50-59	Stage 2
585	TCGA-A2-A0YD	BRCA	63	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23021	Alive	TUMOR FREE	769	548	[Not Available]	NA	NA	364	[Not Available]	0	769	0	769	0	769	0	769	65.13	2.11	60-69	Stage 2
586	TCGA-A2-A0YE	BRCA	48	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17727	Alive	TUMOR FREE	554	548	[Not Available]	NA	NA	364	[Not Available]	0	554	0	554	0	554	0	554	50.05	1.52	40-49	Stage 2
587	TCGA-A2-A0YF	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24660	Alive	TUMOR FREE	1535	548	[Not Available]	NA	NA	364	[Not Available]	0	1535	0	1535	0	1535	0	1535	71.72	4.2	60-69	Stage 1
588	TCGA-A2-A0YG	BRCA	63	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23058	Alive	TUMOR FREE	666	548	[Not Available]	NA	NA	364	[Not Available]	0	666	0	666	0	666	0	666	64.95	1.82	60-69	Stage 3
589	TCGA-A2-A0YH	BRCA	53	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19596	Alive	TUMOR FREE	659	548	[Not Available]	NA	NA	364	[Not Available]	0	659	0	659	0	659	0	659	55.46	1.8	50-59	Stage 3
590	TCGA-A2-A0YI	BRCA	62	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22961	Alive	TUMOR FREE	1505	548	[Not Available]	NA	NA	364	[Not Available]	0	1505	0	1505	0	1505	0	1505	66.98	4.12	60-69	Stage 1
591	TCGA-A2-A0YJ	BRCA	39	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14448	Alive	WITH TUMOR	566	548	[Not Available]	Distant Metastasis	Other, specify	559	[Not Available]	0	566	0	566	1	559	1	559	41.11	1.55	30-39	Stage 3
592	TCGA-A2-A0YK	BRCA	61	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22625	Alive	TUMOR FREE	588	548	[Not Available]	NA	NA	364	[Not Available]	0	588	0	588	0	720	0	588	63.55	1.61	60-69	Stage 2
593	TCGA-A2-A0YL	BRCA	48	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17702	Alive	TUMOR FREE	1474	548	[Not Available]	NA	NA	364	[Not Available]	0	1474	0	1474	0	1474	0	1474	52.5	4.04	40-49	Stage 3
594	TCGA-A2-A0YM	BRCA	67	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24831	Alive	TUMOR FREE	965	548	[Not Available]	NA	NA	364	[Not Available]	0	965	0	965	0	965	0	965	70.63	2.64	60-69	Stage 2
595	TCGA-A2-A0YT	BRCA	56	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20482	Dead	TUMOR FREE	766	723	[Not Available]	NA	NA	364	[Not Available]	1	723	0	723	0	723	0	723	58.06	1.98	50-59	Stage 3
596	TCGA-A2-A1FV	BRCA	74	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27287	Alive	TUMOR FREE	714	548	[Not Available]	NA	NA	364	[Not Available]	0	714	0	714	0	714	0	714	76.66	1.95	70-79	Stage 2
597	TCGA-A2-A1FW	BRCA	62	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22779	Alive	TUMOR FREE	528	548	[Not Available]	NA	NA	364	[Not Available]	0	528	0	528	0	528	0	528	63.81	1.45	60-69	Stage 3
598	TCGA-A2-A1FX	BRCA	61	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22344	Alive	TUMOR FREE	1847	548	[Not Available]	NA	NA	364	[Not Available]	0	1847	0	1847	0	1847	0	1847	66.23	5.06	60-69	Stage 3
599	TCGA-A2-A1FZ	BRCA	63	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23055	Alive	TUMOR FREE	683	548	[Not Available]	NA	NA	364	[Not Available]	0	683	0	683	0	683	0	683	64.99	1.87	60-69	Stage 2
600	TCGA-A2-A1G0	BRCA	49	FEMALE	WHITE	Stage IIB	[Not Applicable]	Other, specify	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18002	Alive	TUMOR FREE	616	548	[Not Available]	NA	NA	364	[Not Available]	0	616	0	616	0	616	0	616	50.97	1.69	40-49	Stage 2
601	TCGA-A2-A1G1	BRCA	85	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31223	Alive	TUMOR FREE	584	548	[Not Available]	NA	NA	364	[Not Available]	0	584	0	584	0	584	0	584	87.08	1.6	>=80	Stage 2
602	TCGA-A2-A1G4	BRCA	71	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25966	Alive	TUMOR FREE	595	548	[Not Available]	NA	NA	364	[Not Available]	0	595	0	595	0	595	0	595	72.72	1.63	70-79	Stage 3
603	TCGA-A2-A1G6	BRCA	50	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18514	Alive	TUMOR FREE	501	548	[Not Available]	NA	NA	364	[Not Available]	0	501	0	501	0	501	0	501	52.06	1.37	50-59	Stage 3
604	TCGA-A2-A259	BRCA	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25666	Alive	TUMOR FREE	1596	548	[Not Available]	NA	NA	364	[Not Available]	0	1596	0	1596	0	720	0	1596	74.64	4.37	70-79	Stage 1
605	TCGA-A2-A25A	BRCA	44	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16084	Alive	TUMOR FREE	3276	548	[Not Available]	NA	NA	364	[Not Available]	0	3276	0	3276	0	3276	0	3276	53	8.97	40-49	Stage 2
606	TCGA-A2-A25B	BRCA	39	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14454	Alive	WITH TUMOR	1291	548	[Not Available]	Distant Metastasis	Bone	1290	[Not Available]	0	1291	0	1291	0	720	1	1290	43.11	3.53	30-39	Stage 2
607	TCGA-A2-A25C	BRCA	50	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18508	Alive	TUMOR FREE	523	548	[Not Available]	NA	NA	364	[Not Available]	0	523	0	523	0	523	0	523	52.1	1.43	50-59	Stage 2
608	TCGA-A2-A25D	BRCA	90	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Alive	TUMOR FREE	552	548	[Not Available]	NA	NA	364	[Not Available]	0	552	0	552	0	720	0	552	91.51	1.51	>=80	Stage 3
609	TCGA-A2-A25E	BRCA	34	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12601	Alive	TUMOR FREE	3204	548	[Not Available]	Locoregional Recurrence	Other, specify	2989	[Not Available]	0	3204	0	3204	1	2989	1	2989	43.27	8.77	30-39	Stage 3
610	TCGA-A2-A25F	BRCA	66	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24319	Alive	TUMOR FREE	322	548	[Not Available]	NA	NA	364	[Not Available]	0	322	0	322	0	322	0	322	67.46	0.88	60-69	Stage 2
611	TCGA-A2-A3KC	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20401	Alive	TUMOR FREE	1102	548	[Not Available]	NA	NA	364	[Not Available]	0	1102	0	1102	0	1102	0	1102	58.87	3.02	50-59	Stage 2
612	TCGA-A2-A3KD	BRCA	47	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17372	Alive	TUMOR FREE	1206	548	[Not Available]	NA	NA	364	[Not Available]	0	1206	0	1206	0	720	0	1206	50.86	3.3	40-49	Stage 3
613	TCGA-A2-A3XS	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23000	Dead	WITH TUMOR	766	1032	[Not Available]	Distant Metastasis	Lung	682	[Not Available]	1	1032	1	1032	1	682	1	682	65.8	2.83	60-69	Stage 3
614	TCGA-A2-A3XT	BRCA	45	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16649	Alive	TUMOR FREE	2770	548	[Not Available]	NA	NA	364	[Not Available]	0	2770	0	2770	0	2770	0	2770	53.17	7.58	40-49	Stage 2
615	TCGA-A2-A3XU	BRCA	35	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-13046	Dead	WITH TUMOR	766	912	[Not Available]	Distant Metastasis	Bone	574	[Not Available]	1	912	1	912	1	574	1	574	38.21	2.5	30-39	Stage 2
616	TCGA-A2-A3XV	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16971	Alive	TUMOR FREE	996	548	[Not Available]	NA	NA	364	[Not Available]	0	996	0	996	0	996	0	996	49.19	2.73	40-49	Stage 2
617	TCGA-A2-A3XW	BRCA	42	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15670	Alive	TUMOR FREE	1712	548	[Not Available]	NA	NA	364	[Not Available]	0	1712	0	1712	0	1712	0	1712	47.59	4.69	40-49	Stage 2
618	TCGA-A2-A3XX	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17981	Dead	TUMOR FREE	766	1439	[Not Available]	NA	NA	364	[Not Available]	1	1439	0	1439	0	1439	0	1439	53.17	3.94	40-49	Stage 2
619	TCGA-A2-A3XY	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18059	Dead	WITH TUMOR	766	1093	[Not Available]	Distant Metastasis	Lung	802	[Not Available]	1	1093	1	1093	1	802	1	802	52.44	2.99	40-49	Stage 2
620	TCGA-A2-A3XZ	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16978	Alive	TUMOR FREE	1532	548	[Not Available]	NA	NA	364	[Not Available]	0	1532	0	1532	0	1532	0	1532	50.68	4.19	40-49	Stage 1
621	TCGA-A2-A3Y0	BRCA	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21024	Alive	TUMOR FREE	1546	548	[Not Available]	NA	NA	364	[Not Available]	0	1546	0	1546	0	720	0	1546	61.79	4.23	50-59	Stage 2
622	TCGA-A2-A4RW	BRCA	49	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18060	Alive	TUMOR FREE	222	548	[Not Available]	NA	NA	364	[Not Available]	0	222	0	222	0	222	0	222	50.05	0.61	40-49	Stage 3
623	TCGA-A2-A4RX	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Metaplastic Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24779	Alive	TUMOR FREE	742	548	[Not Available]	NA	NA	364	[Not Available]	0	742	0	742	0	742	0	742	69.87	2.03	60-69	Stage 2
624	TCGA-A2-A4RY	BRCA	46	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17157	Alive	TUMOR FREE	648	548	[Not Available]	NA	NA	364	[Not Available]	0	648	0	648	0	648	0	648	48.75	1.77	40-49	Stage 3
625	TCGA-A2-A4S0	BRCA	77	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28416	Alive	TUMOR FREE	706	548	[Not Available]	NA	NA	364	[Not Available]	0	706	0	706	0	706	0	706	79.73	1.93	70-79	Stage 2
626	TCGA-A2-A4S1	BRCA	66	FEMALE	WHITE	Stage IIA	[Not Applicable]	Metaplastic Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24353	Alive	TUMOR FREE	820	548	[Not Available]	NA	NA	364	[Not Available]	0	820	0	820	0	820	0	820	68.92	2.25	60-69	Stage 2
627	TCGA-A2-A4S2	BRCA	62	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22936	Alive	TUMOR FREE	643	548	[Not Available]	NA	NA	364	[Not Available]	0	643	0	643	0	643	0	643	64.56	1.76	60-69	Stage 3
628	TCGA-A2-A4S3	BRCA	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21762	Alive	TUMOR FREE	666	548	[Not Available]	NA	NA	364	[Not Available]	0	666	0	666	0	666	0	666	61.4	1.82	50-59	Stage 2
629	TCGA-A7-A0CD	BRCA	66	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Indeterminate (neither Pre or Postmenopausal)	-24242	Alive	TUMOR FREE	1165	548	[Not Available]	NA	NA	364	[Not Available]	0	1165	0	1165	0	1165	0	1165	69.56	3.19	60-69	Stage 1
630	TCGA-A7-A0CE	BRCA	57	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Indeterminate (neither Pre or Postmenopausal)	-20863	Alive	TUMOR FREE	1074	548	[Not Available]	NA	NA	364	[Not Available]	0	1074	0	1074	0	1074	0	1074	60.06	2.94	50-59	Stage 2
631	TCGA-A7-A0CG	BRCA	78	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28596	Alive	TUMOR FREE	1043	548	[Not Available]	NA	NA	364	[Not Available]	0	1043	0	1043	0	720	0	1043	81.15	2.86	70-79	Stage 2
632	TCGA-A7-A0CH	BRCA	79	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29104	Alive	TUMOR FREE	1079	548	[Not Available]	NA	NA	364	[Not Available]	0	1079	0	1079	0	1079	0	1079	82.64	2.95	70-79	Stage 2
633	TCGA-A7-A0CJ	BRCA	57	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21014	Alive	TUMOR FREE	931	548	[Not Available]	NA	NA	364	[Not Available]	0	931	0	931	0	720	0	931	60.08	2.55	50-59	Stage 2
634	TCGA-A7-A0D9	BRCA	37	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13836	Alive	TUMOR FREE	1139	548	[Not Available]	NA	NA	364	[Not Available]	0	1139	0	1139	0	1139	0	1139	41	3.12	30-39	Stage 2
635	TCGA-A7-A0DA	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22708	Alive	TUMOR FREE	1085	548	[Not Available]	NA	NA	364	[Not Available]	0	1085	0	1085	0	1085	0	1085	65.14	2.97	60-69	Stage 2
636	TCGA-A7-A0DB	BRCA	56	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20570	Alive	TUMOR FREE	1007	548	[Not Available]	NA	NA	364	[Not Available]	0	1007	0	1007	0	720	0	1007	59.07	2.76	50-59	Stage 2
637	TCGA-A7-A0DC	BRCA	63	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23294	Alive	TUMOR FREE	906	548	[Not Available]	NA	NA	364	[Not Available]	0	906	0	906	0	906	0	906	66.26	2.48	60-69	Stage 1
638	TCGA-A7-A13D	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17070	Alive	TUMOR FREE	965	548	[Not Available]	NA	NA	364	[Not Available]	0	965	0	965	0	965	0	965	49.38	2.64	40-49	Stage 2
639	TCGA-A7-A13E	BRCA	62	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22690	Dead	WITH TUMOR	766	614	[Not Available]	Distant Metastasis	Other, specify	556	[Not Available]	1	614	1	614	1	556	1	556	63.8	1.68	60-69	Stage 2
640	TCGA-A7-A13F	BRCA	44	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16363	Alive	TUMOR FREE	765	548	[Not Available]	NA	NA	364	[Not Available]	0	765	0	765	0	765	0	765	46.89	2.09	40-49	Stage 3
641	TCGA-A7-A13G	BRCA	79	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28969	Alive	TUMOR FREE	718	548	[Not Available]	New Primary Tumor	Other, specify	586	[Not Available]	0	718	0	718	0	718	1	586	81.28	1.97	70-79	Stage 2
642	TCGA-A7-A13H	BRCA	61	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22643	Alive	TUMOR FREE	899	548	[Not Available]	New Primary Tumor	Other, specify	795	[Not Available]	0	899	0	899	0	899	1	795	64.45	2.46	60-69	Stage 2
643	TCGA-A7-A26E	BRCA	71	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26274	Alive	TUMOR FREE	954	548	[Not Available]	NA	NA	364	[Not Available]	0	954	0	954	0	954	0	954	74.55	2.61	70-79	Stage 3
644	TCGA-A7-A26F	BRCA	55	FEMALE	WHITE	Stage IA	[Not Applicable]	Other, specify	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20210	Alive	TUMOR FREE	738	548	[Not Available]	NA	NA	364	[Not Available]	0	738	0	738	0	738	0	738	57.35	2.02	50-59	Stage 1
645	TCGA-A7-A26G	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18362	Alive	TUMOR FREE	722	548	[Not Available]	NA	NA	364	[Not Available]	0	722	0	722	0	722	0	722	52.25	1.98	50-59	Stage 2
646	TCGA-A7-A26H	BRCA	72	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26423	Alive	WITH TUMOR	724	548	[Not Available]	Distant Metastasis	Liver	291	[Not Available]	0	724	0	724	1	291	1	291	74.32	1.98	70-79	Stage 2
647	TCGA-A7-A26I	BRCA	65	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23948	Alive	TUMOR FREE	661	548	[Not Available]	NA	NA	364	[Not Available]	0	661	0	661	0	661	0	661	67.38	1.81	60-69	Stage 2
648	TCGA-A7-A26J	BRCA	49	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17930	Alive	TUMOR FREE	627	548	[Not Available]	NA	NA	364	[Not Available]	0	627	0	627	0	627	0	627	50.81	1.72	40-49	Stage 2
649	TCGA-A7-A2KD	BRCA	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19563	Alive	TUMOR FREE	679	548	[Not Available]	NA	NA	364	[Not Available]	0	679	0	679	0	679	0	679	55.42	1.86	50-59	Stage 3
650	TCGA-A7-A3IY	BRCA	71	FEMALE	WHITE	Stage I	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26042	Alive	TUMOR FREE	345	548	[Not Available]	NA	NA	364	[Not Available]	0	345	0	345	0	345	0	345	72.24	0.94	70-79	Stage 1
651	TCGA-A7-A3IZ	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22997	Alive	TUMOR FREE	322	548	[Not Available]	NA	NA	364	[Not Available]	0	322	0	322	0	322	0	322	63.84	0.88	60-69	Stage 2
652	TCGA-A7-A3J0	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22672	Alive	TUMOR FREE	313	548	[Not Available]	NA	NA	364	[Not Available]	0	313	0	313	0	313	0	313	62.93	0.86	60-69	Stage 2
653	TCGA-A7-A3J1	BRCA	63	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23209	Alive	TUMOR FREE	343	548	[Not Available]	NA	NA	364	[Not Available]	0	343	0	343	0	343	0	343	64.48	0.94	60-69	Stage 1
654	TCGA-A7-A3RF	BRCA	79	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29184	Alive	WITH TUMOR	408	548	[Not Available]	Distant Metastasis	Bone	174	[Not Available]	0	408	0	408	1	174	1	174	81.02	1.12	70-79	Stage 2
655	TCGA-A7-A425	BRCA	70	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25678	Alive	WITH TUMOR	447	548	[Not Available]	Locoregional Recurrence	Other, specify	419	[Not Available]	0	447	0	447	1	419	1	419	71.53	1.22	70-79	Stage 3
656	TCGA-A7-A426	BRCA	50	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18296	Alive	TUMOR FREE	364	548	[Not Available]	NA	NA	364	[Not Available]	0	364	0	364	0	364	0	364	51.09	1	50-59	Stage 3
657	TCGA-A7-A4SA	BRCA	40	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14906	Alive	TUMOR FREE	454	548	[Not Available]	NA	NA	364	[Not Available]	0	454	0	454	0	454	0	454	42.05	1.24	40-49	Stage 2
658	TCGA-A7-A4SB	BRCA	56	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20539	Alive	TUMOR FREE	418	548	[Not Available]	NA	NA	364	[Not Available]	0	418	0	418	0	418	0	418	57.38	1.14	50-59	Stage 3
659	TCGA-A7-A4SC	BRCA	62	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23008	Alive	TUMOR FREE	446	548	[Not Available]	NA	NA	364	[Not Available]	0	446	0	446	0	446	0	446	64.21	1.22	60-69	Stage 2
660	TCGA-A7-A4SD	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19131	Alive	TUMOR FREE	441	548	[Not Available]	NA	NA	364	[Not Available]	0	441	0	441	0	441	0	441	53.59	1.21	50-59	Stage 2
661	TCGA-A7-A4SE	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20080	Alive	TUMOR FREE	644	548	[Not Available]	NA	NA	364	[Not Available]	0	644	0	644	0	644	0	644	56.74	1.76	50-59	Stage 2
662	TCGA-A7-A4SF	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19985	Alive	TUMOR FREE	545	548	[Not Available]	NA	NA	364	[Not Available]	0	545	0	545	0	720	0	545	56.21	1.49	50-59	Stage 2
663	TCGA-A7-A56D	BRCA	84	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30783	Alive	TUMOR FREE	448	548	[Not Available]	NA	NA	364	[Not Available]	0	448	0	448	0	448	0	448	85.51	1.23	>=80	Stage 2
664	TCGA-A7-A5ZV	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Carcinoma NOS	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22966	Alive	TUMOR FREE	368	548	[Not Available]	NA	NA	364	[Not Available]	0	368	0	368	0	368	0	368	63.89	1.01	60-69	Stage 2
665	TCGA-A7-A5ZW	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Peri (6-12 months since last menstrual period)	-17529	Alive	TUMOR FREE	326	548	[Not Available]	NA	NA	364	[Not Available]	0	326	0	326	0	326	0	326	48.88	0.89	40-49	Stage 2
666	TCGA-A7-A5ZX	BRCA	48	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17683	Alive	TUMOR FREE	336	548	[Not Available]	NA	NA	364	[Not Available]	0	336	0	336	0	720	0	336	49.33	0.92	40-49	Stage 3
667	TCGA-A7-A6VV	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Peri (6-12 months since last menstrual period)	-18695	Alive	TUMOR FREE	313	548	[Not Available]	NA	NA	364	[Not Available]	0	313	0	313	0	313	0	313	52.04	0.86	50-59	Stage 2
668	TCGA-A7-A6VW	BRCA	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17539	Alive	TUMOR FREE	285	548	[Not Available]	NA	NA	364	[Not Available]	0	285	0	285	0	720	0	285	48.8	0.78	40-49	Stage 2
669	TCGA-A7-A6VX	BRCA	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25066	Alive	TUMOR FREE	317	548	[Not Available]	NA	NA	364	[Not Available]	0	317	0	317	0	317	0	317	69.49	0.87	60-69	Stage 2
670	TCGA-A7-A6VY	BRCA	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17640	Alive	TUMOR FREE	266	548	[Not Available]	NA	NA	364	[Not Available]	0	266	0	266	0	266	0	266	49.02	0.73	40-49	Stage 2
671	TCGA-A8-A06N	BRCA	66	FEMALE	[Not Available]	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24288	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	66.5	0	60-69	Stage 3
672	TCGA-A8-A06O	BRCA	60	FEMALE	[Not Available]	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22157	Alive	TUMOR FREE	396	548	[Not Available]	NA	NA	364	[Not Available]	0	396	0	396	0	396	0	396	61.75	1.08	60-69	Stage 1
673	TCGA-A8-A06P	BRCA	63	FEMALE	[Not Available]	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23011	Alive	TUMOR FREE	396	548	[Not Available]	NA	NA	364	[Not Available]	0	396	0	396	0	396	0	396	64.08	1.08	60-69	Stage 3
674	TCGA-A8-A06Q	BRCA	63	FEMALE	[Not Available]	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23164	Alive	TUMOR FREE	31	548	[Not Available]	NA	NA	364	[Not Available]	0	31	0	31	0	31	0	31	63.5	0.08	60-69	Stage 3
675	TCGA-A8-A06R	BRCA	69	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25477	Alive	TUMOR FREE	547	548	[Not Available]	NA	NA	364	[Not Available]	0	547	0	547	0	547	0	547	71.25	1.5	60-69	Stage 2
676	TCGA-A8-A06T	BRCA	75	FEMALE	[Not Available]	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27393	Alive	TUMOR FREE	1614	548	[Not Available]	NA	NA	364	[Not Available]	0	1614	0	1614	0	1614	0	1614	79.42	4.42	70-79	Stage 3
677	TCGA-A8-A06U	BRCA	80	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29525	Dead	TUMOR FREE	766	883	[Not Available]	NA	NA	364	[Not Available]	1	883	0	883	0	883	0	883	83.25	2.42	>=80	Stage 2
678	TCGA-A8-A06X	BRCA	77	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28338	Dead	TUMOR FREE	766	943	[Not Available]	NA	NA	364	[Not Available]	1	943	0	943	0	943	0	943	80.17	2.58	70-79	Stage 2
679	TCGA-A8-A06Y	BRCA	66	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24442	Alive	TUMOR FREE	791	548	[Not Available]	NA	NA	791	[Not Available]	0	791	0	791	1	791	1	791	69.08	2.17	60-69	Stage 2
680	TCGA-A8-A06Z	BRCA	84	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30984	Alive	TUMOR FREE	31	548	[Not Available]	NA	NA	364	[Not Available]	0	31	0	31	0	720	0	31	84.91	0.08	>=80	Stage 2
681	TCGA-A8-A075	BRCA	42	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15369	Alive	TUMOR FREE	518	548	[Not Available]	NA	NA	364	[Not Available]	0	518	0	518	0	518	0	518	43.5	1.42	40-49	Stage 2
682	TCGA-A8-A076	BRCA	66	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24230	Alive	TUMOR FREE	1642	548	[Not Available]	NA	NA	364	[Not Available]	0	1642	0	1642	0	1642	0	1642	70.83	4.5	60-69	Stage 2
683	TCGA-A8-A079	BRCA	69	FEMALE	[Not Available]	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25294	Alive	TUMOR FREE	274	548	[Not Available]	NA	NA	364	[Not Available]	0	274	0	274	0	274	0	274	70	0.75	60-69	Stage 3
684	TCGA-A8-A07B	BRCA	69	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25475	Alive	TUMOR FREE	1308	548	[Not Available]	NA	NA	364	[Not Available]	0	1308	0	1308	0	1308	0	1308	73.33	3.58	60-69	Stage 2
685	TCGA-A8-A07C	BRCA	57	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20820	Alive	TUMOR FREE	1034	548	[Not Available]	NA	NA	364	[Not Available]	0	1034	0	1034	0	1034	0	1034	59.83	2.83	50-59	Stage 2
686	TCGA-A8-A07E	BRCA	81	FEMALE	[Not Available]	Stage X	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29800	Alive	TUMOR FREE	608	548	[Not Available]	NA	NA	364	[Not Available]	0	608	0	608	0	608	0	608	83.25	1.66	>=80	other
687	TCGA-A8-A07F	BRCA	65	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23742	Alive	TUMOR FREE	577	548	[Not Available]	NA	NA	364	[Not Available]	0	577	0	577	0	577	0	577	66.58	1.58	60-69	Stage 2
688	TCGA-A8-A07G	BRCA	65	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23926	Alive	TUMOR FREE	577	548	[Not Available]	NA	NA	364	[Not Available]	0	577	0	577	0	577	0	577	67.09	1.58	60-69	Stage 2
689	TCGA-A8-A07I	BRCA	69	FEMALE	[Not Available]	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25263	Alive	TUMOR FREE	426	548	[Not Available]	NA	NA	364	[Not Available]	0	426	0	426	0	426	0	426	70.33	1.17	60-69	Stage 3
690	TCGA-A8-A07J	BRCA	35	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12965	Alive	TUMOR FREE	365	548	[Not Available]	NA	NA	364	[Not Available]	0	365	0	365	0	365	0	365	36.5	1	30-39	Stage 2
691	TCGA-A8-A07L	BRCA	58	FEMALE	[Not Available]	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21428	Alive	TUMOR FREE	975	548	[Not Available]	NA	NA	364	[Not Available]	0	975	0	975	0	975	0	975	61.34	2.67	50-59	Stage 3
692	TCGA-A8-A07O	BRCA	51	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18870	Alive	TUMOR FREE	304	548	[Not Available]	NA	NA	364	[Not Available]	0	304	0	304	0	304	0	304	52.5	0.83	50-59	Stage 2
693	TCGA-A8-A07P	BRCA	68	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24929	Alive	TUMOR FREE	334	548	[Not Available]	NA	NA	364	[Not Available]	0	334	0	334	0	334	0	334	69.17	0.91	60-69	Stage 2
694	TCGA-A8-A07R	BRCA	80	FEMALE	[Not Available]	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	[Not Available]	-29251	Alive	TUMOR FREE	273	548	[Not Available]	NA	NA	364	[Not Available]	0	273	0	273	0	720	0	273	80.83	0.75	>=80	Stage 3
695	TCGA-A8-A07S	BRCA	73	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26998	Alive	WITH TUMOR	243	548	[Not Available]	NA	NA	364	[Not Available]	0	243	0	243	0	720	0	243	74.58	0.67	70-79	Stage 2
696	TCGA-A8-A07U	BRCA	66	FEMALE	[Not Available]	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24411	Alive	TUMOR FREE	760	548	[Not Available]	NA	NA	364	[Not Available]	0	760	0	760	0	760	0	760	68.91	2.08	60-69	Stage 3
697	TCGA-A8-A07W	BRCA	76	FEMALE	[Not Available]	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27942	Alive	WITH TUMOR	304	548	[Not Available]	NA	NA	364	[Not Available]	0	304	0	304	0	720	0	304	77.33	0.83	70-79	Stage 4
698	TCGA-A8-A07Z	BRCA	85	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31351	Alive	TUMOR FREE	1371	548	[Not Available]	NA	NA	364	[Not Available]	0	1371	0	1371	0	1371	0	1371	89.59	3.75	>=80	Stage 2
699	TCGA-A8-A081	BRCA	80	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29555	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	80.92	0	>=80	Stage 2
700	TCGA-A8-A082	BRCA	58	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21338	Alive	TUMOR FREE	549	548	[Not Available]	NA	NA	364	[Not Available]	0	549	0	549	0	549	0	549	59.92	1.5	50-59	Stage 2
701	TCGA-A8-A083	BRCA	67	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24746	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	67.75	0	60-69	Stage 2
702	TCGA-A8-A084	BRCA	81	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29858	Alive	WITH TUMOR	458	548	[Not Available]	NA	NA	364	[Not Available]	0	458	0	458	0	720	0	458	83	1.25	>=80	Stage 2
703	TCGA-A8-A085	BRCA	44	MALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	[Not Available]	-16377	Alive	TUMOR FREE	1124	548	[Not Available]	NA	NA	364	[Not Available]	0	1124	0	1124	0	1124	0	1124	47.92	3.08	40-49	Stage 2
704	TCGA-A8-A086	BRCA	59	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21731	Alive	TUMOR FREE	396	548	[Not Available]	NA	NA	364	[Not Available]	0	396	0	396	0	396	0	396	60.58	1.08	50-59	Stage 2
705	TCGA-A8-A08A	BRCA	89	FEMALE	[Not Available]	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32750	Alive	TUMOR FREE	30	548	[Not Available]	NA	NA	364	[Not Available]	0	30	0	30	0	30	0	30	89.75	0.08	>=80	Stage 1
706	TCGA-A8-A08B	BRCA	52	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19114	Alive	TUMOR FREE	1156	548	[Not Available]	NA	NA	364	[Not Available]	0	1156	0	1156	0	1156	0	1156	55.5	3.16	50-59	Stage 2
707	TCGA-A8-A08C	BRCA	65	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24017	Alive	TUMOR FREE	881	548	[Not Available]	NA	NA	364	[Not Available]	0	881	0	881	0	881	0	881	68.17	2.41	60-69	Stage 2
708	TCGA-A8-A08F	BRCA	59	FEMALE	[Not Available]	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21641	Alive	TUMOR FREE	1004	548	[Not Available]	NA	NA	364	[Not Available]	0	1004	0	1004	0	1004	0	1004	62	2.75	50-59	Stage 3
709	TCGA-A8-A08G	BRCA	41	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14976	Alive	TUMOR FREE	607	548	[Not Available]	NA	NA	364	[Not Available]	0	607	0	607	0	607	0	607	42.66	1.66	40-49	Stage 2
710	TCGA-A8-A08H	BRCA	66	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24137	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	66.08	0	60-69	Stage 2
711	TCGA-A8-A08I	BRCA	53	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19389	Alive	TUMOR FREE	365	548	[Not Available]	NA	NA	364	[Not Available]	0	365	0	365	0	365	0	365	54.08	1	50-59	Stage 2
712	TCGA-A8-A08J	BRCA	52	FEMALE	[Not Available]	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19266	Dead	WITH TUMOR	766	1127	[Not Available]	NA	NA	364	[Not Available]	1	1127	1	1127	0	720	1	1127	55.83	3.09	50-59	Stage 4
713	TCGA-A8-A08L	BRCA	89	FEMALE	[Not Available]	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32842	Dead	TUMOR FREE	766	304	[Not Available]	NA	NA	364	[Not Available]	1	304	0	304	0	304	0	304	90.75	0.83	>=80	Stage 3
714	TCGA-A8-A08O	BRCA	45	FEMALE	[Not Available]	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16681	Alive	WITH TUMOR	943	548	[Not Available]	NA	NA	762	[Not Available]	0	943	0	943	0	720	1	762	48.25	2.58	40-49	Stage 4
715	TCGA-A8-A08P	BRCA	70	FEMALE	[Not Available]	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25598	Alive	TUMOR FREE	943	548	[Not Available]	NA	NA	364	[Not Available]	0	943	0	943	0	943	0	943	72.67	2.58	70-79	Stage 3
716	TCGA-A8-A08R	BRCA	52	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19298	Alive	TUMOR FREE	30	548	[Not Available]	NA	NA	364	[Not Available]	0	30	0	30	0	30	0	30	52.92	0.08	50-59	Stage 2
717	TCGA-A8-A08S	BRCA	71	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25994	Alive	TUMOR FREE	1004	548	[Not Available]	NA	NA	364	[Not Available]	0	1004	0	1004	0	1004	0	1004	73.92	2.75	70-79	Stage 2
718	TCGA-A8-A08T	BRCA	64	FEMALE	[Not Available]	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23560	Dead	WITH TUMOR	766	3409	[Not Available]	NA	NA	2557	[Not Available]	1	3409	1	3409	0	720	1	2557	73.84	9.33	60-69	Stage 4
719	TCGA-A8-A08X	BRCA	43	FEMALE	[Not Available]	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15705	Alive	TUMOR FREE	1308	548	[Not Available]	NA	NA	366	[Not Available]	0	1308	0	1308	1	366	1	366	46.58	3.58	40-49	Stage 3
720	TCGA-A8-A08Z	BRCA	76	FEMALE	[Not Available]	[Discrepancy]	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28003	Alive	TUMOR FREE	1217	548	[Not Available]	NA	NA	364	[Not Available]	0	1217	0	1217	0	1217	0	1217	80	3.33	70-79	other
721	TCGA-A8-A090	BRCA	74	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27121	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	74.25	0	70-79	Stage 2
722	TCGA-A8-A091	BRCA	61	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22554	Alive	TUMOR FREE	1004	548	[Not Available]	NA	NA	243	[Not Available]	0	1004	0	1004	1	243	1	243	64.5	2.75	60-69	Stage 2
723	TCGA-A8-A092	BRCA	48	FEMALE	[Not Available]	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17807	Alive	TUMOR FREE	942	548	[Not Available]	NA	NA	364	[Not Available]	0	942	0	942	0	942	0	942	51.33	2.58	40-49	Stage 3
724	TCGA-A8-A093	BRCA	61	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22373	Alive	TUMOR FREE	546	548	[Not Available]	NA	NA	364	[Not Available]	0	546	0	546	0	546	0	546	62.75	1.49	60-69	Stage 2
725	TCGA-A8-A094	BRCA	75	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27729	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	75.92	0	70-79	Stage 2
726	TCGA-A8-A095	BRCA	45	FEMALE	[Not Available]	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16742	Alive	TUMOR FREE	1277	548	[Not Available]	NA	NA	364	[Not Available]	0	1277	0	1277	0	1277	0	1277	49.33	3.5	40-49	Stage 1
727	TCGA-A8-A096	BRCA	73	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26723	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	73.16	0	70-79	Stage 2
728	TCGA-A8-A097	BRCA	65	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23741	Alive	TUMOR FREE	365	548	[Not Available]	NA	NA	364	[Not Available]	0	365	0	365	0	365	0	365	66	1	60-69	Stage 2
729	TCGA-A8-A099	BRCA	76	FEMALE	[Not Available]	Stage X	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28063	Alive	TUMOR FREE	304	548	[Not Available]	NA	NA	364	[Not Available]	0	304	0	304	0	720	0	304	77.66	0.83	70-79	other
730	TCGA-A8-A09A	BRCA	40	FEMALE	[Not Available]	Stage X	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14883	Alive	WITH TUMOR	304	548	[Not Available]	NA	NA	364	[Not Available]	0	304	0	304	0	720	0	304	41.58	0.83	40-49	other
731	TCGA-A8-A09B	BRCA	58	FEMALE	[Not Available]	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21520	Alive	TUMOR FREE	365	548	[Not Available]	NA	NA	364	[Not Available]	0	365	0	365	0	365	0	365	59.92	1	50-59	Stage 3
732	TCGA-A8-A09C	BRCA	69	FEMALE	[Not Available]	Stage X	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25355	Alive	TUMOR FREE	31	548	[Not Available]	NA	NA	364	[Not Available]	0	31	0	31	0	720	0	31	69.5	0.08	60-69	other
733	TCGA-A8-A09D	BRCA	47	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17440	Alive	TUMOR FREE	1522	548	[Not Available]	NA	NA	364	[Not Available]	0	1522	0	1522	0	1522	0	1522	51.92	4.17	40-49	Stage 2
734	TCGA-A8-A09E	BRCA	73	FEMALE	[Not Available]	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26724	Alive	WITH TUMOR	1492	548	[Not Available]	NA	NA	364	[Not Available]	0	1492	0	1492	0	720	0	1492	77.25	4.08	70-79	Stage 3
735	TCGA-A8-A09G	BRCA	79	FEMALE	[Not Available]	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29006	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	79.41	0	70-79	Stage 3
736	TCGA-A8-A09I	BRCA	84	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30711	Alive	TUMOR FREE	1371	548	[Not Available]	NA	NA	364	[Not Available]	0	1371	0	1371	0	1371	0	1371	87.84	3.75	>=80	Stage 2
737	TCGA-A8-A09K	BRCA	68	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24960	Alive	TUMOR FREE	912	548	[Not Available]	NA	NA	364	[Not Available]	0	912	0	912	0	912	0	912	70.83	2.5	60-69	Stage 2
738	TCGA-A8-A09M	BRCA	75	FEMALE	[Not Available]	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27455	Alive	TUMOR FREE	1006	548	[Not Available]	NA	NA	364	[Not Available]	0	1006	0	1006	0	1006	0	1006	77.92	2.75	70-79	Stage 3
739	TCGA-A8-A09N	BRCA	57	FEMALE	[Not Available]	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21002	Alive	TUMOR FREE	31	548	[Not Available]	NA	NA	364	[Not Available]	0	31	0	31	0	31	0	31	57.59	0.08	50-59	Stage 3
740	TCGA-A8-A09Q	BRCA	83	FEMALE	[Not Available]	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30528	Alive	WITH TUMOR	761	548	[Not Available]	NA	NA	364	[Not Available]	0	761	0	761	0	720	0	761	85.66	2.08	>=80	Stage 3
741	TCGA-A8-A09R	BRCA	82	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30196	Alive	TUMOR FREE	273	548	[Not Available]	NA	NA	364	[Not Available]	0	273	0	273	0	273	0	273	83.42	0.75	>=80	Stage 2
742	TCGA-A8-A09T	BRCA	68	FEMALE	[Not Available]	[Discrepancy]	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25110	Alive	TUMOR FREE	579	548	[Not Available]	NA	NA	364	[Not Available]	0	579	0	579	0	579	0	579	70.33	1.59	60-69	other
743	TCGA-A8-A09V	BRCA	51	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18628	Alive	TUMOR FREE	457	548	[Not Available]	NA	NA	364	[Not Available]	0	457	0	457	0	457	0	457	52.25	1.25	50-59	Stage 2
744	TCGA-A8-A09W	BRCA	70	FEMALE	[Not Available]	Stage IIIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25659	Alive	TUMOR FREE	30	548	[Not Available]	NA	NA	364	[Not Available]	0	30	0	30	0	720	0	30	70.33	0.08	70-79	Stage 3
745	TCGA-A8-A09X	BRCA	62	FEMALE	[Not Available]	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22858	Dead	TUMOR FREE	766	426	[Not Available]	NA	NA	364	[Not Available]	1	426	0	426	0	720	0	426	63.75	1.17	60-69	Stage 3
746	TCGA-A8-A09Z	BRCA	83	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30590	Alive	WITH TUMOR	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	720	0	0	83.75	0	>=80	Stage 2
747	TCGA-A8-A0A1	BRCA	84	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30742	Alive	TUMOR FREE	365	548	[Not Available]	NA	NA	364	[Not Available]	0	365	0	365	0	365	0	365	85.17	1	>=80	Stage 2
748	TCGA-A8-A0A2	BRCA	66	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24380	Alive	TUMOR FREE	579	548	[Not Available]	NA	NA	364	[Not Available]	0	579	0	579	0	579	0	579	68.33	1.59	60-69	Stage 2
749	TCGA-A8-A0A4	BRCA	73	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26693	Alive	TUMOR FREE	396	548	[Not Available]	NA	NA	364	[Not Available]	0	396	0	396	0	396	0	396	74.17	1.08	70-79	Stage 2
750	TCGA-A8-A0A6	BRCA	64	FEMALE	[Not Available]	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23404	Alive	TUMOR FREE	640	548	[Not Available]	NA	NA	364	[Not Available]	0	640	0	640	0	640	0	640	65.83	1.75	60-69	Stage 3
751	TCGA-A8-A0A7	BRCA	57	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20940	Alive	TUMOR FREE	30	548	[Not Available]	NA	NA	364	[Not Available]	0	30	0	30	0	30	0	30	57.41	0.08	50-59	Stage 2
752	TCGA-A8-A0A9	BRCA	80	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29370	Alive	TUMOR FREE	822	548	[Not Available]	NA	NA	364	[Not Available]	0	822	0	822	0	822	0	822	82.66	2.25	>=80	Stage 2
753	TCGA-A8-A0AB	BRCA	54	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19814	Alive	TUMOR FREE	518	548	[Not Available]	NA	NA	364	[Not Available]	0	518	0	518	0	518	0	518	55.67	1.42	50-59	Stage 2
754	TCGA-A8-A0AD	BRCA	83	FEMALE	[Not Available]	Stage I	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30407	Alive	TUMOR FREE	1157	548	[Not Available]	NA	NA	364	[Not Available]	0	1157	0	1157	0	1157	0	1157	86.42	3.17	>=80	Stage 1
755	TCGA-AC-A23C	BRCA	62	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22751	Alive	TUMOR FREE	585	548	[Not Available]	NA	NA	364	[Not Available]	0	585	0	585	0	585	0	585	63.89	1.6	60-69	Stage 2
756	TCGA-AC-A23E	BRCA	50	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	[Not Available]	-18500	Alive	TUMOR FREE	698	548	[Not Available]	NA	NA	364	[Not Available]	0	698	0	698	0	698	0	698	52.56	1.91	50-59	Stage 2
757	TCGA-AC-A23G	BRCA	76	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27934	Alive	TUMOR FREE	2248	548	[Not Available]	NA	NA	364	[Not Available]	0	2248	0	2248	0	2248	0	2248	82.63	6.15	70-79	Stage 2
758	TCGA-AC-A23H	BRCA	90	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32873	Dead	WITH TUMOR	766	174	[Not Available]	NA	NA	364	[Not Available]	1	174	1	174	0	720	1	174	90.48	0.48	>=80	Stage 2
759	TCGA-AC-A2B8	BRCA	84	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31003	Alive	TUMOR FREE	677	548	[Not Available]	New Primary Tumor	Other, specify	654	[Not Available]	0	677	0	677	0	677	1	654	86.74	1.85	>=80	Stage 2
760	TCGA-AC-A2BK	BRCA	78	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28625	Alive	TUMOR FREE	2222	548	[Not Available]	NA	NA	364	[Not Available]	0	2222	0	2222	0	2222	0	2222	84.45	6.08	70-79	Stage 3
761	TCGA-AC-A2BM	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	[Not Available]	-15212	Alive	TUMOR FREE	3022	548	[Not Available]	NA	NA	364	[Not Available]	0	3022	0	3022	0	3022	0	3022	49.92	8.27	40-49	Stage 2
762	TCGA-AC-A2FB	BRCA	65	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	[Not Available]	-23851	Alive	TUMOR FREE	1234	548	[Not Available]	NA	NA	364	[Not Available]	0	1234	0	1234	0	1234	0	1234	68.68	3.38	60-69	Stage 2
763	TCGA-AC-A2FE	BRCA	62	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22746	Dead	WITH TUMOR	766	2636	[Not Available]	Distant Metastasis	Bone	766	[Not Available]	1	2636	1	2636	1	766	1	766	69.49	7.22	60-69	Stage 3
764	TCGA-AC-A2FF	BRCA	40	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	[Not Available]	-22222	Alive	TUMOR FREE	2759	548	[Not Available]	NA	NA	364	[Not Available]	0	2759	0	2759	0	2759	0	2759	68.39	7.55	40-49	Stage 2
765	TCGA-AC-A2FG	BRCA	79	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29211	Alive	TUMOR FREE	1853	548	[Not Available]	NA	NA	364	[Not Available]	0	1853	0	1853	0	1853	0	1853	85.05	5.07	70-79	Stage 2
766	TCGA-AC-A2FK	BRCA	45	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	[Not Available]	-16627	Alive	TUMOR FREE	2650	548	[Not Available]	NA	NA	364	[Not Available]	0	2650	0	2650	0	2650	0	2650	52.78	7.26	40-49	Stage 3
767	TCGA-AC-A2FM	BRCA	87	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31805	Dead	WITH TUMOR	766	792	[Not Available]	Distant Metastasis	Other, specify	780	[Not Available]	1	792	1	792	1	780	1	780	89.25	2.17	>=80	Stage 2
768	TCGA-AC-A2FO	BRCA	65	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23928	Alive	TUMOR FREE	2255	548	[Not Available]	NA	NA	364	[Not Available]	0	2255	0	2255	0	2255	0	2255	71.69	6.17	60-69	Stage 2
769	TCGA-AC-A2QH	BRCA	58	FEMALE	WHITE	Stage IIB	[Not Applicable]	Metaplastic Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21488	Alive	TUMOR FREE	1005	548	[Not Available]	NA	NA	364	[Not Available]	0	1005	0	1005	0	1005	0	1005	61.58	2.75	50-59	Stage 2
770	TCGA-AC-A2QI	BRCA	76	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27865	Alive	TUMOR FREE	588	548	[Not Available]	NA	NA	364	[Not Available]	0	588	0	588	0	588	0	588	77.9	1.61	70-79	Stage 3
771	TCGA-AC-A2QJ	BRCA	48	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Metaplastic Carcinoma	[Not Available]	2011	Peri (6-12 months since last menstrual period)	-17569	Dead	WITH TUMOR	766	446	[Not Available]	Distant Metastasis	Bone	237	[Not Available]	1	446	1	446	1	237	1	237	49.32	1.22	40-49	Stage 3
772	TCGA-AC-A3BB	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	[Not Available]	-16983	Alive	TUMOR FREE	987	548	[Not Available]	NA	NA	364	[Not Available]	0	987	0	987	0	987	0	987	49.2	2.7	40-49	Stage 3
773	TCGA-AC-A3EH	BRCA	79	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29014	Dead	TUMOR FREE	766	197	[Not Available]	NA	NA	364	[Not Available]	1	197	0	197	0	197	0	197	79.98	0.54	70-79	Stage 3
774	TCGA-AC-A3HN	BRCA	87	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32061	Alive	TUMOR FREE	496	548	[Not Available]	NA	NA	364	[Not Available]	0	496	0	496	0	496	0	496	89.14	1.36	>=80	Stage 2
775	TCGA-AC-A3OD	BRCA	68	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25186	Alive	TUMOR FREE	451	548	[Not Available]	NA	NA	364	[Not Available]	0	451	0	451	0	451	0	451	70.19	1.23	60-69	Stage 2
776	TCGA-AC-A3QP	BRCA	79	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29113	Alive	TUMOR FREE	675	548	[Not Available]	NA	NA	364	[Not Available]	0	675	0	675	0	675	0	675	81.56	1.85	70-79	Stage 2
777	TCGA-AC-A3QQ	BRCA	54	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Peri (6-12 months since last menstrual period)	-19723	Alive	TUMOR FREE	734	548	[Not Available]	NA	NA	364	[Not Available]	0	734	0	734	0	720	0	734	56.01	2.01	50-59	Stage 1
778	TCGA-AC-A3TM	BRCA	50	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Peri (6-12 months since last menstrual period)	-18535	Alive	TUMOR FREE	762	548	[Not Available]	NA	NA	364	[Not Available]	0	762	0	762	0	762	0	762	52.83	2.09	50-59	Stage 3
779	TCGA-AC-A3TN	BRCA	75	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27421	Alive	TUMOR FREE	456	548	[Not Available]	NA	NA	364	[Not Available]	0	456	0	456	0	456	0	456	76.32	1.25	70-79	Stage 2
780	TCGA-AC-A3W5	BRCA	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	[Not Evaluated]	-24029	Alive	TUMOR FREE	504	548	[Not Available]	NA	NA	364	[Not Available]	0	504	0	504	0	720	0	504	67.17	1.38	60-69	Stage 2
781	TCGA-AC-A3W6	BRCA	90	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Alive	TUMOR FREE	602	548	[Not Available]	NA	NA	364	[Not Available]	0	602	0	602	0	602	0	602	91.65	1.65	>=80	Stage 3
782	TCGA-AC-A3W7	BRCA	66	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24327	Alive	TUMOR FREE	471	548	[Not Available]	NA	NA	364	[Not Available]	0	471	0	471	0	471	0	471	67.89	1.29	60-69	Stage 2
783	TCGA-AC-A3YI	BRCA	74	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27143	Alive	TUMOR FREE	707	548	[Not Available]	NA	NA	364	[Not Available]	0	707	0	707	0	707	0	707	76.25	1.94	70-79	Stage 3
784	TCGA-AC-A3YJ	BRCA	66	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24439	Alive	TUMOR FREE	754	548	[Not Available]	NA	NA	364	[Not Available]	0	754	0	754	0	754	0	754	68.97	2.06	60-69	Stage 2
785	TCGA-AC-A4ZE	BRCA	63	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23284	Alive	TUMOR FREE	890	548	[Not Available]	NA	NA	364	[Not Available]	0	890	0	890	0	890	0	890	66.18	2.44	60-69	Stage 2
786	TCGA-AC-A5EH	BRCA	76	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	[Not Available]	-27964	Alive	TUMOR FREE	511	548	[Not Available]	NA	NA	364	[Not Available]	0	511	0	511	0	511	0	511	77.96	1.4	70-79	Stage 2
787	TCGA-AC-A5EI	BRCA	88	FEMALE	WHITE	Stage IB	[Not Applicable]	Other, specify	[Not Available]	2012	[Not Available]	-32375	Alive	TUMOR FREE	442	548	[Not Available]	NA	NA	364	[Not Available]	0	442	0	442	0	442	0	442	89.85	1.21	>=80	Stage 1
788	TCGA-AC-A5XS	BRCA	74	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	[Not Available]	-27160	Alive	TUMOR FREE	588	548	[Not Available]	NA	NA	364	[Not Available]	0	588	0	588	0	588	0	588	75.97	1.61	70-79	Stage 2
789	TCGA-AC-A5XU	BRCA	74	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	[Not Available]	-27191	Alive	TUMOR FREE	455	548	[Not Available]	NA	NA	364	[Not Available]	0	455	0	455	0	455	0	455	75.69	1.25	70-79	Stage 2
790	TCGA-AC-A62V	BRCA	58	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	[Not Evaluated]	-21389	Dead	WITH TUMOR	766	348	[Not Available]	NA	NA	364	[Not Available]	1	348	1	348	0	720	1	348	59.51	0.95	50-59	Stage 4
791	TCGA-AC-A62X	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26627	Alive	TUMOR FREE	417	548	[Not Available]	NA	NA	364	[Not Available]	0	417	0	417	0	417	0	417	74.04	1.14	70-79	Stage 2
792	TCGA-AC-A62Y	BRCA	79	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28876	Alive	TUMOR FREE	530	548	[Not Available]	NA	NA	364	[Not Available]	0	530	0	530	0	720	0	530	80.51	1.45	70-79	Stage 2
793	TCGA-AC-A6IV	BRCA	47	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	[Not Available]	-17521	Alive	TUMOR FREE	568	548	[Not Available]	NA	NA	364	[Not Available]	0	568	0	568	0	568	0	568	49.52	1.56	40-49	Stage 2
794	TCGA-AC-A6IW	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26896	Alive	TUMOR FREE	413	548	[Not Available]	NA	NA	364	[Not Available]	0	413	0	413	0	413	0	413	74.77	1.13	70-79	Stage 2
795	TCGA-AC-A6IX	BRCA	49	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	Peri (6-12 months since last menstrual period)	-17969	Alive	TUMOR FREE	373	548	[Not Available]	NA	NA	364	[Not Available]	0	373	0	373	0	373	0	373	50.22	1.02	40-49	Stage 3
796	TCGA-AC-A6NO	BRCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	[Unknown]	-15996	Alive	TUMOR FREE	51	548	[Not Available]	NA	NA	364	[Not Available]	0	51	0	51	0	51	0	51	43.93	0.14	40-49	Stage 2
797	TCGA-AC-A7VB	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	[Unknown]	-18806	Alive	TUMOR FREE	250	548	[Not Available]	NA	NA	364	[Not Available]	0	250	0	250	0	250	0	250	52.17	0.68	50-59	Stage 2
798	TCGA-AC-A7VC	BRCA	56	FEMALE	WHITE	Stage IIB	[Not Applicable]	Metaplastic Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20479	Alive	TUMOR FREE	1	548	[Not Available]	NA	NA	364	[Not Available]	0	1	0	1	0	1	0	1	56.07	0	50-59	Stage 2
799	TCGA-AC-A8OP	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26550	Alive	TUMOR FREE	614	548	[Not Available]	NA	NA	364	[Not Available]	0	614	0	614	0	614	0	614	74.37	1.68	70-79	Stage 1
800	TCGA-AC-A8OQ	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26535	Alive	TUMOR FREE	34	548	[Not Available]	NA	NA	364	[Not Available]	0	34	0	34	0	34	0	34	72.74	0.09	70-79	Stage 2
801	TCGA-AC-A8OR	BRCA	75	FEMALE	WHITE	Stage IA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27605	Alive	TUMOR FREE	40	548	[Not Available]	NA	NA	364	[Not Available]	0	40	0	40	0	40	0	40	75.69	0.11	70-79	Stage 1
802	TCGA-AC-A8OS	BRCA	71	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26248	Alive	TUMOR FREE	70	548	[Not Available]	NA	NA	364	[Not Available]	0	70	0	70	0	70	0	70	72.05	0.19	70-79	Stage 2
803	TCGA-AN-A03X	BRCA	74	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27163	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	74.4	0.03	70-79	Stage 2
804	TCGA-AN-A03Y	BRCA	66	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24232	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	66.37	0.03	60-69	Stage 2
805	TCGA-AN-A041	BRCA	29	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10812	Alive	TUMOR FREE	7	548	[Not Available]	NA	NA	364	[Not Available]	0	7	0	7	0	7	0	7	29.62	0.02	18-29	Stage 2
806	TCGA-AN-A046	BRCA	68	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25158	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	68.91	0.03	60-69	Stage 2
807	TCGA-AN-A049	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22710	Alive	TUMOR FREE	19	548	[Not Available]	NA	NA	364	[Not Available]	0	19	0	19	0	720	0	19	62.23	0.05	60-69	Stage 2
808	TCGA-AN-A04A	BRCA	36	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Peri (6-12 months since last menstrual period)	-13445	Alive	TUMOR FREE	90	548	[Not Available]	NA	NA	364	[Not Available]	0	90	0	90	0	720	0	90	37.06	0.25	30-39	Stage 3
809	TCGA-AN-A04C	BRCA	51	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18851	Alive	TUMOR FREE	54	548	[Not Available]	NA	NA	364	[Not Available]	0	54	0	54	0	720	0	54	51.76	0.15	50-59	Stage 2
810	TCGA-AN-A04D	BRCA	58	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21426	Alive	TUMOR FREE	52	548	[Not Available]	NA	NA	364	[Not Available]	0	52	0	52	0	720	0	52	58.8	0.14	50-59	Stage 2
811	TCGA-AN-A0AJ	BRCA	79	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29131	Alive	TUMOR FREE	303	548	[Not Available]	NA	NA	364	[Not Available]	0	303	0	303	0	303	0	303	80.59	0.83	70-79	Stage 2
812	TCGA-AN-A0AK	BRCA	76	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27977	Alive	TUMOR FREE	224	548	[Not Available]	NA	NA	364	[Not Available]	0	224	0	224	0	224	0	224	77.21	0.61	70-79	Stage 2
813	TCGA-AN-A0AL	BRCA	41	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15286	Alive	TUMOR FREE	227	548	[Not Available]	NA	NA	364	[Not Available]	0	227	0	227	0	227	0	227	42.47	0.62	40-49	Stage 3
814	TCGA-AN-A0AM	BRCA	56	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20713	Alive	TUMOR FREE	5	548	[Not Available]	NA	NA	364	[Not Available]	0	5	0	5	0	5	0	5	56.72	0.01	50-59	Stage 2
815	TCGA-AN-A0AR	BRCA	55	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20152	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	55.2	0.03	50-59	Stage 2
816	TCGA-AN-A0AS	BRCA	70	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25658	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	70.28	0.03	70-79	Stage 3
817	TCGA-AN-A0AT	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22798	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	62.44	0.03	60-69	Stage 2
818	TCGA-AN-A0FD	BRCA	71	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26007	Alive	TUMOR FREE	196	548	[Not Available]	NA	NA	364	[Not Available]	0	196	0	196	0	196	0	196	71.74	0.54	70-79	Stage 2
819	TCGA-AN-A0FF	BRCA	32	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11929	Alive	TUMOR FREE	172	548	[Not Available]	NA	NA	364	[Not Available]	0	172	0	172	0	172	0	172	33.13	0.47	30-39	Stage 1
820	TCGA-AN-A0FJ	BRCA	59	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-21910	Alive	TUMOR FREE	242	548	[Not Available]	NA	NA	364	[Not Available]	0	242	0	242	0	720	0	242	60.65	0.66	50-59	Stage 4
821	TCGA-AN-A0FK	BRCA	88	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32462	Alive	TUMOR FREE	213	548	[Not Available]	NA	NA	364	[Not Available]	0	213	0	213	0	213	0	213	89.46	0.58	>=80	Stage 3
822	TCGA-AN-A0FL	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22805	Alive	TUMOR FREE	231	548	[Not Available]	NA	NA	364	[Not Available]	0	231	0	231	0	231	0	231	63.07	0.63	60-69	Stage 2
823	TCGA-AN-A0FN	BRCA	61	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22629	Alive	TUMOR FREE	218	548	[Not Available]	NA	NA	364	[Not Available]	0	218	0	218	0	218	0	218	62.55	0.6	60-69	Stage 1
824	TCGA-AN-A0FS	BRCA	55	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-20352	Alive	TUMOR FREE	210	548	[Not Available]	NA	NA	364	[Not Available]	0	210	0	210	0	210	0	210	56.3	0.57	50-59	Stage 1
825	TCGA-AN-A0FT	BRCA	63	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23300	Alive	TUMOR FREE	214	548	[Not Available]	NA	NA	364	[Not Available]	0	214	0	214	0	214	0	214	64.38	0.59	60-69	Stage 2
826	TCGA-AN-A0FV	BRCA	58	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21479	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	58.83	0.03	50-59	Stage 2
827	TCGA-AN-A0FW	BRCA	67	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24692	Alive	TUMOR FREE	11	548	[Not Available]	NA	NA	364	[Not Available]	0	11	0	11	0	11	0	11	67.63	0.03	60-69	Stage 3
828	TCGA-AN-A0FX	BRCA	52	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19309	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	52.89	0.03	50-59	Stage 2
829	TCGA-AN-A0FY	BRCA	55	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20347	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	55.73	0.03	50-59	Stage 1
830	TCGA-AN-A0FZ	BRCA	45	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16533	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	45.29	0.03	40-49	Stage 3
831	TCGA-AN-A0G0	BRCA	56	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20504	Alive	TUMOR FREE	16	548	[Not Available]	NA	NA	364	[Not Available]	0	16	0	16	0	16	0	16	56.18	0.04	50-59	Stage 2
832	TCGA-AN-A0XL	BRCA	61	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22341	Alive	TUMOR FREE	163	548	[Not Available]	NA	NA	364	[Not Available]	0	163	0	163	0	163	0	163	61.61	0.45	60-69	Stage 2
833	TCGA-AN-A0XN	BRCA	68	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25029	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	68.55	0.03	60-69	Stage 3
834	TCGA-AN-A0XO	BRCA	59	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21640	Alive	TUMOR FREE	375	548	[Not Available]	NA	NA	364	[Not Available]	0	375	0	375	0	375	0	375	60.27	1.03	50-59	Stage 3
835	TCGA-AN-A0XP	BRCA	69	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25305	Alive	TUMOR FREE	9	548	[Not Available]	NA	NA	364	[Not Available]	0	9	0	9	0	9	0	9	69.31	0.02	60-69	Stage 3
836	TCGA-AN-A0XR	BRCA	55	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20381	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	55.83	0.03	50-59	Stage 3
837	TCGA-AN-A0XS	BRCA	63	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23358	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	63.98	0.03	60-69	Stage 3
838	TCGA-AN-A0XT	BRCA	54	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19794	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	54.22	0.03	50-59	Stage 3
839	TCGA-AN-A0XU	BRCA	54	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20052	Alive	TUMOR FREE	10	548	[Not Available]	NA	NA	364	[Not Available]	0	10	0	10	0	10	0	10	54.93	0.03	50-59	Stage 2
840	TCGA-AN-A0XV	BRCA	67	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24779	Alive	TUMOR FREE	162	548	[Not Available]	NA	NA	364	[Not Available]	0	162	0	162	0	162	0	162	68.28	0.44	60-69	Stage 3
841	TCGA-AN-A0XW	BRCA	36	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13208	Alive	TUMOR FREE	170	548	[Not Available]	NA	NA	364	[Not Available]	0	170	0	170	0	170	0	170	36.63	0.47	30-39	Stage 3
842	TCGA-AO-A03L	BRCA	34	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12443	Alive	TUMOR FREE	2442	548	[Not Available]	NA	NA	364	[Not Available]	0	2442	0	2442	0	2442	0	2442	40.75	6.69	30-39	Stage 3
843	TCGA-AO-A03M	BRCA	29	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10616	Alive	TUMOR FREE	1866	548	[Not Available]	NA	NA	364	[Not Available]	0	1866	0	1866	0	1866	0	1866	34.17	5.11	18-29	Stage 1
844	TCGA-AO-A03N	BRCA	59	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21816	Alive	WITH TUMOR	2031	548	[Not Available]	Locoregional Disease	NA	1645	[Not Available]	0	2031	0	2031	1	1645	1	1645	65.29	5.56	50-59	Stage 2
845	TCGA-AO-A03O	BRCA	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25362	Dead	TUMOR FREE	766	2483	[Not Available]	NA	NA	364	[Not Available]	1	2483	0	2483	0	2483	0	2483	76.24	6.8	60-69	Stage 2
846	TCGA-AO-A03P	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19724	Dead	WITH TUMOR	766	2911	[Not Available]	Distant Metastasis	Liver	1922	[Not Available]	1	2911	1	2911	0	720	1	1922	61.97	7.97	50-59	Stage 2
847	TCGA-AO-A03R	BRCA	57	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20930	Alive	TUMOR FREE	2091	548	[Not Available]	NA	NA	364	[Not Available]	0	2091	0	2091	0	2091	0	2091	63.03	5.72	50-59	Stage 2
848	TCGA-AO-A03T	BRCA	42	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15540	Alive	TUMOR FREE	2124	548	[Not Available]	NA	NA	364	[Not Available]	0	2124	0	2124	0	2124	0	2124	48.36	5.82	40-49	Stage 2
849	TCGA-AO-A03U	BRCA	31	FEMALE	WHITE	Stage I	[Not Applicable]	Other, specify	[Not Available]	2001	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11354	Dead	TUMOR FREE	766	1793	[Not Available]	New Primary Tumor	Lung	1614	[Not Available]	1	1793	0	1793	0	1793	1	1614	35.99	4.91	30-39	Stage 1
850	TCGA-AO-A03V	BRCA	41	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Peri (6-12 months since last menstrual period)	-15284	Alive	TUMOR FREE	1351	548	[Not Available]	NA	NA	364	[Not Available]	0	1351	0	1351	0	1351	0	1351	45.54	3.7	40-49	Stage 1
851	TCGA-AO-A0J2	BRCA	41	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15324	Alive	TUMOR FREE	997	548	[Not Available]	NA	NA	364	[Not Available]	0	997	0	997	0	997	0	997	44.68	2.73	40-49	Stage 1
852	TCGA-AO-A0J3	BRCA	67	FEMALE	WHITE	Stage IIB	[Not Applicable]	Other, specify	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24519	Alive	TUMOR FREE	651	548	[Not Available]	NA	NA	364	[Not Available]	0	651	0	651	0	651	0	651	68.91	1.78	60-69	Stage 2
853	TCGA-AO-A0J4	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15052	Alive	TUMOR FREE	1587	548	[Not Available]	NA	NA	364	[Not Available]	0	1587	0	1587	0	1587	0	1587	45.56	4.34	40-49	Stage 1
854	TCGA-AO-A0J5	BRCA	48	FEMALE	WHITE	Stage IV	[Not Applicable]	Other, specify	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17815	Dead	WITH TUMOR	766	792	[Not Available]	NA	NA	364	[Not Available]	1	792	1	792	0	720	1	792	50.94	2.17	40-49	Stage 4
855	TCGA-AO-A0J6	BRCA	61	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22462	Alive	TUMOR FREE	1140	548	[Not Available]	NA	NA	364	[Not Available]	0	1140	0	1140	0	1140	0	1140	64.62	3.12	60-69	Stage 2
856	TCGA-AO-A0J7	BRCA	71	FEMALE	WHITE	Stage IIB	[Not Applicable]	Other, specify	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26281	Alive	TUMOR FREE	618	548	[Not Available]	NA	NA	364	[Not Available]	0	618	0	618	0	618	0	618	73.65	1.69	70-79	Stage 2
857	TCGA-AO-A0J8	BRCA	61	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22284	Alive	TUMOR FREE	680	548	[Not Available]	NA	NA	364	[Not Available]	0	680	0	680	0	680	0	680	62.87	1.86	60-69	Stage 2
858	TCGA-AO-A0J9	BRCA	61	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22642	Alive	WITH TUMOR	1613	548	[Not Available]	Distant Metastasis	Bone	1066	[Not Available]	0	1613	0	1613	1	1066	1	1066	66.41	4.42	60-69	Stage 3
859	TCGA-AO-A0JA	BRCA	36	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13307	Alive	WITH TUMOR	655	548	[Not Available]	Distant Metastasis	Bone	143	[Not Available]	0	655	0	655	1	143	1	143	38.23	1.79	30-39	Stage 3
860	TCGA-AO-A0JB	BRCA	50	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18561	Alive	TUMOR FREE	1542	548	[Not Available]	NA	NA	364	[Not Available]	0	1542	0	1542	0	1542	0	1542	55.04	4.22	50-59	Stage 3
861	TCGA-AO-A0JC	BRCA	64	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23404	Alive	TUMOR FREE	1547	548	[Not Available]	NA	NA	364	[Not Available]	0	1547	0	1547	0	1547	0	1547	68.31	4.24	60-69	Stage 2
862	TCGA-AO-A0JD	BRCA	59	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21831	Alive	TUMOR FREE	2190	548	[Not Available]	NA	NA	364	[Not Available]	0	2190	0	2190	0	2190	0	2190	65.77	6	50-59	Stage 3
863	TCGA-AO-A0JE	BRCA	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19516	Alive	TUMOR FREE	2335	548	[Not Available]	NA	NA	364	[Not Available]	0	2335	0	2335	0	720	0	2335	59.82	6.39	50-59	Stage 3
864	TCGA-AO-A0JF	BRCA	68	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24923	Alive	TUMOR FREE	1980	548	[Not Available]	NA	NA	364	[Not Available]	0	1980	0	1980	0	1980	0	1980	73.66	5.42	60-69	Stage 2
865	TCGA-AO-A0JG	BRCA	49	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Other, specify	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18021	Alive	TUMOR FREE	798	548	[Not Available]	NA	NA	364	[Not Available]	0	798	0	798	0	720	0	798	51.52	2.18	40-49	Stage 3
866	TCGA-AO-A0JI	BRCA	56	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20694	Alive	TUMOR FREE	1528	548	[Not Available]	NA	NA	364	[Not Available]	0	1528	0	1528	0	1528	0	1528	60.84	4.18	50-59	Stage 2
867	TCGA-AO-A0JJ	BRCA	54	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19758	Alive	TUMOR FREE	1887	548	[Not Available]	NA	NA	364	[Not Available]	0	1887	0	1887	0	1887	0	1887	59.26	5.17	50-59	Stage 2
868	TCGA-AO-A0JL	BRCA	59	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21895	Alive	TUMOR FREE	1683	548	[Not Available]	NA	NA	364	[Not Available]	0	1683	0	1683	0	1683	0	1683	64.55	4.61	50-59	Stage 3
869	TCGA-AO-A0JM	BRCA	40	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14653	Alive	TUMOR FREE	2184	548	[Not Available]	NA	NA	364	[Not Available]	0	2184	0	2184	0	2184	0	2184	46.1	5.98	40-49	Stage 2
870	TCGA-AO-A124	BRCA	38	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14174	Alive	TUMOR FREE	3506	548	[Not Available]	NA	NA	364	[Not Available]	0	3506	0	3506	0	3506	0	3506	48.41	9.6	30-39	Stage 2
871	TCGA-AO-A125	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26466	Alive	TUMOR FREE	3456	548	[Not Available]	NA	NA	364	[Not Available]	0	3456	0	3456	0	3456	0	3456	81.92	9.46	70-79	Stage 2
872	TCGA-AO-A126	BRCA	39	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14264	Alive	TUMOR FREE	3307	548	[Not Available]	Locoregional Disease	NA	267	[Not Available]	0	3307	0	3307	1	267	1	267	48.11	9.05	30-39	Stage 2
873	TCGA-AO-A128	BRCA	61	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22340	Alive	TUMOR FREE	3248	548	[Not Available]	NA	NA	364	[Not Available]	0	3248	0	3248	0	3248	0	3248	70.06	8.89	60-69	Stage 2
874	TCGA-AO-A129	BRCA	29	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10898	Alive	TUMOR FREE	3286	548	[Not Available]	NA	NA	364	[Not Available]	0	3286	0	3286	0	3286	0	3286	38.83	9	18-29	Stage 2
875	TCGA-AO-A12A	BRCA	47	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17420	Alive	TUMOR FREE	3112	548	[Not Available]	NA	NA	364	[Not Available]	0	3112	0	3112	0	720	0	3112	56.21	8.52	40-49	Stage 2
876	TCGA-AO-A12B	BRCA	63	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23150	Alive	TUMOR FREE	2989	548	[Not Available]	NA	NA	364	[Not Available]	0	2989	0	2989	0	2989	0	2989	71.56	8.18	60-69	Stage 2
877	TCGA-AO-A12C	BRCA	42	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15469	Alive	TUMOR FREE	2372	548	[Not Available]	NA	NA	364	[Not Available]	0	2372	0	2372	0	2372	0	2372	48.85	6.49	40-49	Stage 2
878	TCGA-AO-A12D	BRCA	43	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15774	Alive	TUMOR FREE	2515	548	[Not Available]	NA	NA	364	[Not Available]	0	2515	0	2515	0	2515	0	2515	50.07	6.89	40-49	Stage 2
879	TCGA-AO-A12E	BRCA	51	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18721	Alive	TUMOR FREE	2142	548	[Not Available]	NA	NA	364	[Not Available]	0	2142	0	2142	0	2142	0	2142	57.12	5.86	50-59	Stage 2
880	TCGA-AO-A12F	BRCA	36	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13409	Alive	TUMOR FREE	1842	548	[Not Available]	NA	NA	364	[Not Available]	0	1842	0	1842	0	1842	0	1842	41.75	5.04	30-39	Stage 2
881	TCGA-AO-A12G	BRCA	75	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27705	Alive	TUMOR FREE	1639	548	[Not Available]	NA	NA	364	[Not Available]	0	1639	0	1639	0	1639	0	1639	80.34	4.49	70-79	Stage 2
882	TCGA-AO-A12H	BRCA	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-25515	Alive	TUMOR FREE	1234	548	[Not Available]	NA	NA	364	[Not Available]	0	1234	0	1234	0	1234	0	1234	73.23	3.38	60-69	Stage 2
883	TCGA-AO-A1KO	BRCA	46	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16817	Alive	TUMOR FREE	622	548	[Not Available]	NA	NA	364	[Not Available]	0	622	0	622	0	622	0	622	47.75	1.7	40-49	Stage 2
884	TCGA-AO-A1KP	BRCA	77	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28247	Alive	TUMOR FREE	2953	548	[Not Available]	NA	NA	364	[Not Available]	0	2953	0	2953	0	2953	0	2953	85.42	8.08	70-79	Stage 2
885	TCGA-AO-A1KQ	BRCA	84	MALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	[Not Available]	-30859	Alive	TUMOR FREE	1882	548	[Not Available]	NA	NA	364	[Not Available]	0	1882	0	1882	0	1882	0	1882	89.64	5.15	>=80	Stage 3
886	TCGA-AO-A1KR	BRCA	51	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18900	Alive	TUMOR FREE	2513	548	[Not Available]	NA	NA	364	[Not Available]	0	2513	0	2513	0	2513	0	2513	58.63	6.88	50-59	Stage 2
887	TCGA-AO-A1KS	BRCA	69	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25230	Alive	TUMOR FREE	350	548	[Not Available]	NA	NA	364	[Not Available]	0	350	0	350	0	350	0	350	70.03	0.96	60-69	Stage 2
888	TCGA-AO-A1KT	BRCA	78	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28660	Alive	TUMOR FREE	541	548	[Not Available]	NA	NA	364	[Not Available]	0	541	0	541	0	541	0	541	79.95	1.48	70-79	Stage 2
889	TCGA-AQ-A04H	BRCA	61	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22539	Alive	TUMOR FREE	754	548	[Not Available]	NA	NA	364	[Not Available]	0	754	0	754	0	754	0	754	63.77	2.06	60-69	Stage 3
890	TCGA-AQ-A04J	BRCA	45	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16615	Alive	TUMOR FREE	819	548	[Not Available]	NA	NA	364	[Not Available]	0	819	0	819	0	819	0	819	47.73	2.24	40-49	Stage 2
891	TCGA-AQ-A04L	BRCA	48	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2001	Peri (6-12 months since last menstrual period)	-17759	Alive	TUMOR FREE	3957	548	[Not Available]	NA	NA	364	[Not Available]	0	3957	0	3957	0	3957	0	3957	59.46	10.83	40-49	Stage 2
892	TCGA-AQ-A0Y5	BRCA	70	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25793	Dead	TUMOR FREE	766	172	[Not Available]	NA	NA	364	[Not Available]	1	172	0	172	0	172	0	172	71.09	0.47	70-79	Stage 3
893	TCGA-AQ-A1H2	BRCA	84	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30958	Alive	TUMOR FREE	475	548	[Not Available]	NA	NA	364	[Not Available]	0	475	0	475	0	475	0	475	86.06	1.3	>=80	Stage 3
894	TCGA-AQ-A1H3	BRCA	49	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18177	Alive	TUMOR FREE	989	548	[Not Available]	NA	NA	364	[Not Available]	0	989	0	989	0	989	0	989	52.47	2.71	40-49	Stage 3
895	TCGA-AQ-A54N	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18741	Alive	TUMOR FREE	78	548	[Not Available]	NA	NA	364	[Not Available]	0	78	0	78	0	78	0	78	51.52	0.21	50-59	Stage 2
896	TCGA-AQ-A54O	BRCA	51	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	[Not Available]	-18694	Alive	TUMOR FREE	1001	548	[Not Available]	NA	NA	364	[Not Available]	0	1001	0	1001	0	1001	0	1001	53.92	2.74	50-59	Stage 2
897	TCGA-AQ-A7U7	BRCA	55	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20239	Dead	TUMOR FREE	766	584	[Not Available]	NA	NA	364	[Not Available]	1	584	0	584	0	584	0	584	57.01	1.6	50-59	Stage 3
898	TCGA-AR-A0TP	BRCA	43	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15812	Alive	TUMOR FREE	4275	548	[Not Available]	NA	NA	364	[Not Available]	0	4275	0	4275	0	4275	0	4275	55	11.7	40-49	Stage 2
899	TCGA-AR-A0TQ	BRCA	27	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9873	Alive	TUMOR FREE	2991	548	[Not Available]	NA	NA	364	[Not Available]	0	2991	0	2991	0	2991	0	2991	35.22	8.19	18-29	Stage 3
900	TCGA-AR-A0TR	BRCA	68	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25190	Dead	TUMOR FREE	766	160	[Not Available]	NA	NA	364	[Not Available]	1	160	0	160	0	160	0	160	69.4	0.44	60-69	Stage 2
901	TCGA-AR-A0TS	BRCA	46	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17141	Alive	TUMOR FREE	2558	548	[Not Available]	NA	NA	364	[Not Available]	0	2558	0	2558	0	2558	0	2558	53.93	7	40-49	Stage 2
902	TCGA-AR-A0TT	BRCA	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19679	Alive	TUMOR FREE	3316	548	[Not Available]	NA	NA	364	[Not Available]	0	3316	0	3316	0	3316	0	3316	62.96	9.08	50-59	Stage 3
903	TCGA-AR-A0TU	BRCA	35	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13039	Alive	TUMOR FREE	709	548	[Not Available]	NA	NA	364	[Not Available]	0	709	0	709	0	709	0	709	37.64	1.94	30-39	Stage 2
904	TCGA-AR-A0TV	BRCA	66	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24279	Alive	TUMOR FREE	2288	548	[Not Available]	NA	NA	364	[Not Available]	0	2288	0	2288	0	2288	0	2288	72.74	6.26	60-69	Stage 2
905	TCGA-AR-A0TW	BRCA	50	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18263	Alive	TUMOR FREE	3009	548	[Not Available]	NA	NA	739	[Not Available]	0	3009	0	3009	1	739	1	739	58.24	8.24	50-59	Stage 3
906	TCGA-AR-A0TX	BRCA	64	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23653	Alive	TUMOR FREE	1972	548	[Not Available]	NA	NA	364	[Not Available]	0	1972	0	1972	0	1972	0	1972	70.16	5.4	60-69	Stage 2
907	TCGA-AR-A0TY	BRCA	54	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19836	Dead	WITH TUMOR	766	1699	[Not Available]	Distant Metastasis	Bone	544	[Not Available]	1	1699	1	1699	1	544	1	544	58.96	4.65	50-59	Stage 2
908	TCGA-AR-A0TZ	BRCA	43	FEMALE	WHITE	[Discrepancy]	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15720	Dead	TUMOR FREE	766	3262	[Not Available]	Distant Metastasis	Bone	1313	[Not Available]	1	3262	0	3262	1	1313	1	1313	51.97	8.93	40-49	other
909	TCGA-AR-A0U0	BRCA	73	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26993	Alive	TUMOR FREE	1988	548	[Not Available]	NA	NA	364	[Not Available]	0	1988	0	1988	0	1988	0	1988	79.35	5.44	70-79	Stage 2
910	TCGA-AR-A0U1	BRCA	36	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13467	Alive	TUMOR FREE	4052	548	[Not Available]	NA	NA	364	[Not Available]	0	4052	0	4052	0	4052	0	4052	47.96	11.09	30-39	Stage 2
911	TCGA-AR-A0U2	BRCA	47	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17390	Dead	WITH TUMOR	766	2551	[Not Available]	Distant Metastasis	Bone	1609	[Not Available]	1	2551	1	2551	1	1609	1	1609	54.6	6.98	40-49	Stage 3
912	TCGA-AR-A0U3	BRCA	59	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21755	Alive	TUMOR FREE	4080	548	[Not Available]	NA	NA	364	[Not Available]	0	4080	0	4080	0	4080	0	4080	70.73	11.17	50-59	Stage 2
913	TCGA-AR-A0U4	BRCA	54	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19729	Alive	TUMOR FREE	3261	548	[Not Available]	NA	NA	364	[Not Available]	0	3261	0	3261	0	3261	0	3261	62.94	8.93	50-59	Stage 2
914	TCGA-AR-A1AH	BRCA	51	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18991	Alive	TUMOR FREE	3807	548	[Not Available]	New Primary Tumor	Other, specify	1136	[Not Available]	0	3807	0	3807	0	3807	1	1136	62.42	10.42	50-59	Stage 2
915	TCGA-AR-A1AI	BRCA	47	FEMALE	WHITE	Stage IIA	[Not Applicable]	Medullary Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17229	Alive	TUMOR FREE	3296	548	[Not Available]	New Primary Tumor	Other, specify	588	[Not Available]	0	3296	0	3296	1	588	1	588	56.19	9.02	40-49	Stage 2
916	TCGA-AR-A1AJ	BRCA	83	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30489	Alive	TUMOR FREE	3072	548	[Not Available]	NA	NA	364	[Not Available]	0	3072	0	3072	0	3072	0	3072	91.89	8.41	>=80	Stage 1
917	TCGA-AR-A1AK	BRCA	70	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25825	Alive	TUMOR FREE	3159	548	[Not Available]	NA	NA	364	[Not Available]	0	3159	0	3159	0	3159	0	3159	79.35	8.65	70-79	Stage 1
918	TCGA-AR-A1AL	BRCA	60	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22023	Alive	TUMOR FREE	2971	548	[Not Available]	NA	NA	364	[Not Available]	0	2971	0	2971	0	2971	0	2971	68.43	8.13	60-69	Stage 3
919	TCGA-AR-A1AM	BRCA	52	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19123	Alive	TUMOR FREE	2991	548	[Not Available]	NA	NA	364	[Not Available]	0	2991	0	2991	0	2991	0	2991	60.54	8.19	50-59	Stage 3
920	TCGA-AR-A1AN	BRCA	46	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16974	Alive	TUMOR FREE	2920	548	[Not Available]	NA	NA	364	[Not Available]	0	2920	0	2920	0	2920	0	2920	54.47	7.99	40-49	Stage 2
921	TCGA-AR-A1AO	BRCA	47	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17332	Alive	TUMOR FREE	2618	548	[Not Available]	NA	NA	364	[Not Available]	0	2618	0	2618	0	2618	0	2618	54.62	7.17	40-49	Stage 2
922	TCGA-AR-A1AP	BRCA	80	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29406	Alive	TUMOR FREE	2856	548	[Not Available]	NA	NA	364	[Not Available]	0	2856	0	2856	0	2856	0	2856	88.33	7.82	>=80	Stage 1
923	TCGA-AR-A1AQ	BRCA	49	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18109	Alive	TUMOR FREE	3021	548	[Not Available]	NA	NA	364	[Not Available]	0	3021	0	3021	0	3021	0	3021	57.85	8.27	40-49	Stage 2
924	TCGA-AR-A1AR	BRCA	50	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18482	Dead	WITH TUMOR	766	524	[Not Available]	New Primary Tumor	Other, specify	268	[Not Available]	1	524	1	524	1	268	1	268	52.04	1.43	50-59	Stage 3
925	TCGA-AR-A1AS	BRCA	54	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20028	Alive	TUMOR FREE	1150	548	[Not Available]	NA	NA	364	[Not Available]	0	1150	0	1150	0	1150	0	1150	57.98	3.15	50-59	Stage 2
926	TCGA-AR-A1AT	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22942	Dead	TUMOR FREE	766	1272	[Not Available]	NA	NA	364	[Not Available]	1	1272	0	1272	0	1272	0	1272	66.29	3.48	60-69	Stage 2
927	TCGA-AR-A1AU	BRCA	39	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14564	Alive	TUMOR FREE	2868	548	[Not Available]	NA	NA	364	[Not Available]	0	2868	0	2868	0	2868	0	2868	47.73	7.85	30-39	Stage 3
928	TCGA-AR-A1AV	BRCA	68	MALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	[Not Available]	-24875	Alive	TUMOR FREE	1864	548	[Not Available]	NA	NA	364	[Not Available]	0	1864	0	1864	0	1864	0	1864	73.21	5.1	60-69	Stage 2
929	TCGA-AR-A1AW	BRCA	65	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23855	Alive	TUMOR FREE	2632	548	[Not Available]	NA	NA	364	[Not Available]	0	2632	0	2632	0	2632	0	2632	72.52	7.21	60-69	Stage 2
930	TCGA-AR-A1AX	BRCA	64	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23507	Alive	TUMOR FREE	2629	548	[Not Available]	NA	NA	364	[Not Available]	0	2629	0	2629	0	2629	0	2629	71.56	7.2	60-69	Stage 1
931	TCGA-AR-A1AY	BRCA	65	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23927	Alive	TUMOR FREE	1026	548	[Not Available]	NA	NA	364	[Not Available]	0	1026	0	1026	0	1026	0	1026	68.32	2.81	60-69	Stage 1
932	TCGA-AR-A24H	BRCA	65	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24046	Alive	TUMOR FREE	4894	548	[Not Available]	NA	NA	364	[Not Available]	0	4894	0	4894	0	4894	0	4894	79.23	13.4	60-69	Stage 2
933	TCGA-AR-A24K	BRCA	46	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16961	Alive	TUMOR FREE	1548	548	[Not Available]	NA	NA	364	[Not Available]	0	1548	0	1548	0	1548	0	1548	50.67	4.24	40-49	Stage 2
934	TCGA-AR-A24L	BRCA	26	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-9706	Dead	WITH TUMOR	766	2866	[Not Available]	Locoregional Disease	NA	1414	[Not Available]	1	2866	1	2866	1	1414	1	1414	34.42	7.85	18-29	Stage 2
935	TCGA-AR-A24M	BRCA	38	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14119	Alive	TUMOR FREE	3660	548	[Not Available]	NA	NA	364	[Not Available]	0	3660	0	3660	0	3660	0	3660	48.68	10.02	30-39	Stage 3
936	TCGA-AR-A24N	BRCA	54	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Peri (6-12 months since last menstrual period)	-19989	Alive	TUMOR FREE	3035	548	[Not Available]	NA	NA	364	[Not Available]	0	3035	0	3035	0	3035	0	3035	63.04	8.31	50-59	Stage 1
937	TCGA-AR-A24O	BRCA	43	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15977	Alive	WITH TUMOR	3607	548	[Not Available]	NA	NA	2561	[Not Available]	0	3607	0	3607	1	2561	1	2561	53.62	9.88	40-49	Stage 3
938	TCGA-AR-A24P	BRCA	47	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17490	Alive	TUMOR FREE	84	548	[Not Available]	NA	NA	364	[Not Available]	0	84	0	84	0	84	0	84	48.11	0.23	40-49	Stage 1
939	TCGA-AR-A24Q	BRCA	49	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18084	Alive	TUMOR FREE	3172	548	[Not Available]	NA	NA	364	[Not Available]	0	3172	0	3172	0	3172	0	3172	58.2	8.68	40-49	Stage 2
940	TCGA-AR-A24R	BRCA	45	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16642	Alive	TUMOR FREE	3430	548	[Not Available]	NA	NA	364	[Not Available]	0	3430	0	3430	0	3430	0	3430	54.95	9.39	40-49	Stage 3
941	TCGA-AR-A24S	BRCA	61	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22587	Alive	TUMOR FREE	2976	548	[Not Available]	NA	NA	364	[Not Available]	0	2976	0	2976	0	2976	0	2976	69.99	8.15	60-69	Stage 1
942	TCGA-AR-A24T	BRCA	46	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17135	Alive	TUMOR FREE	3202	548	[Not Available]	NA	NA	364	[Not Available]	0	3202	0	3202	0	3202	0	3202	55.68	8.77	40-49	Stage 3
943	TCGA-AR-A24U	BRCA	47	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17523	Alive	TUMOR FREE	3128	548	[Not Available]	NA	NA	364	[Not Available]	0	3128	0	3128	0	3128	0	3128	56.54	8.56	40-49	Stage 2
944	TCGA-AR-A24V	BRCA	52	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Peri (6-12 months since last menstrual period)	-19027	Alive	TUMOR FREE	3203	548	[Not Available]	NA	NA	364	[Not Available]	0	3203	0	3203	0	3203	0	3203	60.86	8.77	50-59	Stage 2
945	TCGA-AR-A24W	BRCA	55	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20123	Alive	TUMOR FREE	1550	548	[Not Available]	NA	NA	364	[Not Available]	0	1550	0	1550	0	1550	0	1550	59.34	4.24	50-59	Stage 2
946	TCGA-AR-A24X	BRCA	52	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19030	Alive	TUMOR FREE	3004	548	[Not Available]	NA	NA	364	[Not Available]	0	3004	0	3004	0	3004	0	3004	60.33	8.22	50-59	Stage 2
947	TCGA-AR-A24Z	BRCA	57	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20900	Alive	TUMOR FREE	3001	548	[Not Available]	NA	NA	364	[Not Available]	0	3001	0	3001	0	3001	0	3001	65.44	8.22	50-59	Stage 2
948	TCGA-AR-A250	BRCA	58	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21309	Alive	TUMOR FREE	2707	548	[Not Available]	NA	NA	364	[Not Available]	0	2707	0	2707	0	2707	0	2707	65.75	7.41	50-59	Stage 2
949	TCGA-AR-A251	BRCA	51	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18771	Alive	TUMOR FREE	3030	548	[Not Available]	NA	NA	364	[Not Available]	0	3030	0	3030	0	3030	0	3030	59.69	8.3	50-59	Stage 3
950	TCGA-AR-A252	BRCA	50	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18611	Alive	TUMOR FREE	2838	548	[Not Available]	NA	NA	364	[Not Available]	0	2838	0	2838	0	2838	0	2838	58.72	7.77	50-59	Stage 1
951	TCGA-AR-A254	BRCA	50	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18270	Alive	TUMOR FREE	2605	548	[Not Available]	NA	NA	364	[Not Available]	0	2605	0	2605	0	2605	0	2605	57.15	7.13	50-59	Stage 3
952	TCGA-AR-A255	BRCA	62	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22809	Alive	TUMOR FREE	2161	548	[Not Available]	NA	NA	364	[Not Available]	0	2161	0	2161	0	2161	0	2161	68.36	5.92	60-69	Stage 1
953	TCGA-AR-A256	BRCA	45	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2001	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16642	Dead	TUMOR FREE	766	2854	[Not Available]	Locoregional Disease	NA	1640	[Not Available]	1	2854	0	2854	1	1640	1	1640	53.38	7.81	40-49	Stage 2
954	TCGA-AR-A2LE	BRCA	69	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25499	Alive	TUMOR FREE	5062	548	[Not Available]	New Primary Tumor	Other, specify	4203	[Not Available]	0	5062	0	5062	0	5062	1	4203	83.67	13.86	60-69	Stage 1
955	TCGA-AR-A2LH	BRCA	55	FEMALE	WHITE	Stage III	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20288	Dead	TUMOR FREE	766	616	[Not Available]	Distant Metastasis	Bone	434	[Not Available]	1	616	0	616	1	434	1	434	57.23	1.69	50-59	Stage 3
956	TCGA-AR-A2LJ	BRCA	40	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14723	Alive	TUMOR FREE	2632	548	[Not Available]	NA	NA	364	[Not Available]	0	2632	0	2632	0	2632	0	2632	47.52	7.21	40-49	Stage 3
957	TCGA-AR-A2LK	BRCA	62	FEMALE	WHITE	Stage III	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22800	Dead	TUMOR FREE	766	1649	[Not Available]	Distant Metastasis	Bone	1304	[Not Available]	1	1649	0	1649	1	1304	1	1304	66.94	4.51	60-69	Stage 3
958	TCGA-AR-A2LL	BRCA	70	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25747	Alive	TUMOR FREE	2012	548	[Not Available]	NA	NA	364	[Not Available]	0	2012	0	2012	0	2012	0	2012	76	5.51	70-79	Stage 2
959	TCGA-AR-A2LM	BRCA	49	FEMALE	WHITE	Stage II	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18053	Alive	TUMOR FREE	1935	548	[Not Available]	NA	NA	364	[Not Available]	0	1935	0	1935	0	1935	0	1935	54.72	5.3	40-49	Stage 2
960	TCGA-AR-A2LN	BRCA	65	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23992	Alive	TUMOR FREE	1161	548	[Not Available]	NA	NA	364	[Not Available]	0	1161	0	1161	0	1161	0	1161	68.87	3.18	60-69	Stage 2
961	TCGA-AR-A2LO	BRCA	46	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17080	Alive	TUMOR FREE	1198	548	[Not Available]	NA	NA	364	[Not Available]	0	1198	0	1198	0	1198	0	1198	50.04	3.28	40-49	Stage 2
962	TCGA-AR-A2LQ	BRCA	59	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21865	Alive	TUMOR FREE	1233	548	[Not Available]	NA	NA	364	[Not Available]	0	1233	0	1233	0	1233	0	1233	63.24	3.38	50-59	Stage 2
963	TCGA-AR-A2LR	BRCA	49	FEMALE	WHITE	Stage I	[Not Applicable]	Metaplastic Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18214	Alive	TUMOR FREE	1742	548	[Not Available]	NA	NA	364	[Not Available]	0	1742	0	1742	0	1742	0	1742	54.64	4.77	40-49	Stage 1
964	TCGA-AR-A5QM	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22780	Alive	TUMOR FREE	2231	548	[Not Available]	New Primary Tumor	Other, specify	968	[Not Available]	0	2231	0	2231	0	720	1	968	68.48	6.11	60-69	Stage 2
965	TCGA-AR-A5QN	BRCA	68	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25089	Alive	TUMOR FREE	1013	548	[Not Available]	NA	NA	364	[Not Available]	0	1013	0	1013	0	720	0	1013	71.46	2.77	60-69	Stage 3
966	TCGA-AR-A5QP	BRCA	54	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19805	Alive	TUMOR FREE	1185	548	[Not Available]	NA	NA	364	[Not Available]	0	1185	0	1185	0	720	0	1185	57.47	3.24	50-59	Stage 2
967	TCGA-AR-A5QQ	BRCA	68	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Other, specify	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24841	Dead	WITH TUMOR	766	322	[Not Available]	Distant Metastasis	Lung	301	[Not Available]	1	322	1	322	0	720	1	301	68.89	0.88	60-69	Stage 3
968	TCGA-B6-A0I1	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26902	Dead	TUMOR FREE	766	2361	[Not Available]	Distant Metastasis	Lung	1120	[Not Available]	1	2361	0	2361	1	1120	1	1120	80.12	6.46	70-79	Stage 2
969	TCGA-B6-A0I2	BRCA	45	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1995	Indeterminate (neither Pre or Postmenopausal)	-16702	Alive	TUMOR FREE	4361	548	[Not Available]	NA	NA	364	[Not Available]	0	4361	0	4361	0	720	0	4361	57.67	11.94	40-49	Stage 1
970	TCGA-B6-A0I5	BRCA	49	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1988	Indeterminate (neither Pre or Postmenopausal)	-18038	Alive	TUMOR FREE	8556	548	[Not Available]	NA	NA	364	[Not Available]	0	8556	0	8556	0	8556	0	8556	72.81	23.43	40-49	Stage 2
971	TCGA-B6-A0I6	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1990	Indeterminate (neither Pre or Postmenopausal)	-18014	Dead	WITH TUMOR	766	991	[Not Available]	Distant Metastasis	Other, specify	859	[Not Available]	1	991	1	991	1	859	1	859	52.03	2.71	40-49	Stage 2
972	TCGA-B6-A0I8	BRCA	46	FEMALE	WHITE	Stage X	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1992	Indeterminate (neither Pre or Postmenopausal)	-17073	Dead	WITH TUMOR	766	749	[Not Available]	Locoregional Disease	Other, specify	746	[Not Available]	1	749	1	749	0	720	1	746	48.79	2.05	40-49	other
973	TCGA-B6-A0I9	BRCA	62	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1992	Indeterminate (neither Pre or Postmenopausal)	-22798	Dead	WITH TUMOR	766	362	[Not Available]	NA	NA	364	[Not Available]	1	362	1	362	0	720	1	362	63.41	0.99	60-69	Stage 4
974	TCGA-B6-A0IA	BRCA	51	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	1992	Indeterminate (neither Pre or Postmenopausal)	-18748	Alive	TUMOR FREE	8391	548	[Not Available]	NA	NA	364	[Not Available]	0	8391	0	8391	0	8391	0	8391	74.3	22.97	50-59	Stage 2
975	TCGA-B6-A0IB	BRCA	64	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1992	Indeterminate (neither Pre or Postmenopausal)	-23646	Dead	WITH TUMOR	766	3941	[Not Available]	Distant Metastasis	Other, specify	2717	[Not Available]	1	3941	1	3941	0	720	1	2717	75.53	10.79	60-69	Stage 4
976	TCGA-B6-A0IC	BRCA	90	FEMALE	WHITE	Stage X	[Not Applicable]	Other, specify	[Not Available]	1992	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Dead	TUMOR FREE	766	1542	[Not Available]	NA	NA	364	[Not Available]	1	1542	0	1542	0	1542	0	1542	94.22	4.22	>=80	other
977	TCGA-B6-A0IE	BRCA	38	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	1995	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13982	Dead	WITH TUMOR	766	1993	[Not Available]	Distant Metastasis	Bone	834	[Not Available]	1	1993	1	1993	1	834	1	834	43.74	5.46	30-39	Stage 3
978	TCGA-B6-A0IG	BRCA	50	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1994	Indeterminate (neither Pre or Postmenopausal)	-18433	Dead	WITH TUMOR	766	4456	[Not Available]	NA	NA	364	[Not Available]	1	4456	1	4456	0	720	1	4456	62.67	12.2	50-59	Stage 2
979	TCGA-B6-A0IH	BRCA	81	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29907	Dead	TUMOR FREE	766	3418	[Not Available]	NA	NA	364	[Not Available]	1	3418	0	3418	0	3418	0	3418	91.24	9.36	>=80	Stage 3
980	TCGA-B6-A0IJ	BRCA	42	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1995	Indeterminate (neither Pre or Postmenopausal)	-15625	Alive	TUMOR FREE	7106	548	[Not Available]	NA	NA	364	[Not Available]	0	7106	0	7106	0	7106	0	7106	62.23	19.46	40-49	Stage 2
981	TCGA-B6-A0IK	BRCA	63	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1994	Indeterminate (neither Pre or Postmenopausal)	-23150	Dead	WITH TUMOR	766	571	[Not Available]	Distant Metastasis	Brain	489	[Not Available]	1	571	1	571	1	489	1	489	64.94	1.56	60-69	Stage 3
982	TCGA-B6-A0IM	BRCA	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Other, specify	[Not Available]	1997	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27557	Dead	TUMOR FREE	766	3873	[Not Available]	NA	NA	364	[Not Available]	1	3873	0	3873	0	3873	0	3873	86.05	10.6	70-79	Stage 2
983	TCGA-B6-A0IN	BRCA	45	FEMALE	WHITE	Stage X	[Not Applicable]	Other, specify	[Not Available]	1996	Indeterminate (neither Pre or Postmenopausal)	-16705	Dead	WITH TUMOR	766	2573	[Not Available]	Distant Metastasis	Other, specify	1412	[Not Available]	1	2573	1	2573	1	1412	1	1412	52.78	7.04	40-49	other
984	TCGA-B6-A0IO	BRCA	66	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2001	Indeterminate (neither Pre or Postmenopausal)	-24322	Alive	TUMOR FREE	5042	548	[Not Available]	NA	NA	364	[Not Available]	0	5042	0	5042	0	5042	0	5042	80.39	13.8	60-69	Stage 2
985	TCGA-B6-A0IP	BRCA	74	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	1997	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27047	Dead	TUMOR FREE	766	3926	[Not Available]	NA	NA	364	[Not Available]	1	3926	0	3926	0	3926	0	3926	84.8	10.75	70-79	Stage 1
986	TCGA-B6-A0IQ	BRCA	40	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1996	Indeterminate (neither Pre or Postmenopausal)	-14669	Alive	TUMOR FREE	4285	548	[Not Available]	NA	NA	364	[Not Available]	0	4285	0	4285	0	4285	0	4285	51.89	11.73	40-49	Stage 3
987	TCGA-B6-A0RE	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage X	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1989	Indeterminate (neither Pre or Postmenopausal)	-22449	Alive	TUMOR FREE	7777	548	[Not Available]	NA	NA	364	[Not Available]	0	7777	0	7777	0	7777	0	7777	82.75	21.29	60-69	other
988	TCGA-B6-A0RG	BRCA	26	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1991	Indeterminate (neither Pre or Postmenopausal)	-9840	Alive	TUMOR FREE	2082	548	[Not Available]	NA	NA	364	[Not Available]	0	2082	0	2082	0	2082	0	2082	32.64	5.7	18-29	Stage 2
989	TCGA-B6-A0RH	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1991	Indeterminate (neither Pre or Postmenopausal)	-18759	Dead	TUMOR FREE	766	6456	[Not Available]	Locoregional Disease	Other, specify	2165	[Not Available]	1	6456	0	6456	1	2165	1	2165	69.03	17.68	50-59	Stage 2
990	TCGA-B6-A0RI	BRCA	44	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1992	Indeterminate (neither Pre or Postmenopausal)	-16138	Alive	WITH TUMOR	7126	548	[Not Available]	Locoregional Disease	Other, specify	1100	[Not Available]	0	7126	0	7126	1	1100	1	1100	63.69	19.51	40-49	Stage 3
991	TCGA-B6-A0RL	BRCA	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1993	[Not Available]	-22238	Dead	TUMOR FREE	766	2469	[Not Available]	NA	NA	364	[Not Available]	1	2469	0	2469	0	2469	0	2469	67.64	6.76	60-69	Stage 2
992	TCGA-B6-A0RM	BRCA	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage X	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1993	Indeterminate (neither Pre or Postmenopausal)	-21047	Dead	TUMOR FREE	766	2373	[Not Available]	NA	NA	364	[Not Available]	1	2373	0	2373	0	720	0	2373	64.12	6.5	50-59	other
993	TCGA-B6-A0RN	BRCA	60	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1993	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22077	Alive	TUMOR FREE	8008	548	[Not Available]	NA	NA	364	[Not Available]	0	8008	0	8008	0	8008	0	8008	82.37	21.92	60-69	Stage 1
994	TCGA-B6-A0RO	BRCA	71	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1993	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26269	Alive	TUMOR FREE	4929	548	[Not Available]	NA	NA	364	[Not Available]	0	4929	0	4929	0	4929	0	4929	85.42	13.49	70-79	Stage 3
995	TCGA-B6-A0RP	BRCA	73	FEMALE	WHITE	[Discrepancy]	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	1994	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26941	Dead	WITH TUMOR	766	3126	[Not Available]	Distant Metastasis	Bone	2787	[Not Available]	1	3126	1	3126	1	2787	1	2787	82.32	8.56	70-79	other
996	TCGA-B6-A0RQ	BRCA	68	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	1994	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25010	Dead	TUMOR FREE	766	4267	[Not Available]	NA	NA	364	[Not Available]	1	4267	0	4267	0	4267	0	4267	80.16	11.68	60-69	Stage 2
997	TCGA-B6-A0RS	BRCA	38	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1988	Indeterminate (neither Pre or Postmenopausal)	-14134	Dead	WITH TUMOR	766	3063	[Not Available]	New Primary Tumor	Other, specify	2041	[Not Available]	1	3063	1	3063	1	2041	1	2041	47.08	8.39	30-39	Stage 2
998	TCGA-B6-A0RT	BRCA	39	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1996	Indeterminate (neither Pre or Postmenopausal)	-14374	Alive	TUMOR FREE	2721	548	[Not Available]	NA	NA	364	[Not Available]	0	2721	0	2721	0	720	0	2721	46.8	7.45	30-39	Stage 3
999	TCGA-B6-A0RU	BRCA	40	FEMALE	WHITE	Stage IA	[Not Applicable]	Other, specify	[Not Available]	1990	Indeterminate (neither Pre or Postmenopausal)	-14920	Alive	TUMOR FREE	8605	548	[Not Available]	New Primary Tumor	Other, specify	3076	[Not Available]	0	8605	0	8605	1	3076	1	3076	64.41	23.56	40-49	Stage 1
1000	TCGA-B6-A0RV	BRCA	42	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	1996	Indeterminate (neither Pre or Postmenopausal)	-15507	Alive	TUMOR FREE	5156	548	[Not Available]	NA	NA	364	[Not Available]	0	5156	0	5156	0	5156	0	5156	56.57	14.12	40-49	Stage 3
1001	TCGA-B6-A0WS	BRCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage X	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1996	Indeterminate (neither Pre or Postmenopausal)	-21230	Dead	TUMOR FREE	766	2965	[Not Available]	NA	NA	364	[Not Available]	1	2965	0	2965	0	720	0	2965	66.24	8.12	50-59	other
1002	TCGA-B6-A0WT	BRCA	61	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22362	Alive	TUMOR FREE	5739	548	[Not Available]	New Primary Tumor	Other, specify	3862	[Not Available]	0	5739	0	5739	1	3862	1	3862	76.94	15.71	60-69	Stage 2
1003	TCGA-B6-A0WV	BRCA	67	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24803	Dead	TUMOR FREE	766	2417	[Not Available]	NA	NA	364	[Not Available]	1	2417	0	2417	0	2417	0	2417	74.52	6.62	60-69	Stage 2
1004	TCGA-B6-A0WW	BRCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage X	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1997	Indeterminate (neither Pre or Postmenopausal)	-21479	Dead	WITH TUMOR	766	558	[Not Available]	Distant Metastasis	Liver	447	[Not Available]	1	558	1	558	1	447	1	447	60.33	1.53	50-59	other
1005	TCGA-B6-A0WX	BRCA	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Other, specify	[Not Available]	1998	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14784	Dead	WITH TUMOR	766	639	[Not Available]	Distant Metastasis	Bone	563	[Not Available]	1	639	1	639	1	563	1	563	42.23	1.75	40-49	Stage 3
1006	TCGA-B6-A0WY	BRCA	40	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1996	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14778	Dead	WITH TUMOR	766	3461	[Not Available]	Distant Metastasis	Bone	2011	[Not Available]	1	3461	1	3461	1	2011	1	2011	49.94	9.48	40-49	Stage 3
1007	TCGA-B6-A0WZ	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1996	Indeterminate (neither Pre or Postmenopausal)	-18584	Alive	TUMOR FREE	6292	548	[Not Available]	New Primary Tumor	Bone	5117	[Not Available]	0	6292	0	6292	0	6292	1	5117	68.11	17.23	50-59	Stage 2
1008	TCGA-B6-A0X0	BRCA	54	FEMALE	WHITE	Stage I	[Not Applicable]	Other, specify	[Not Available]	1996	Indeterminate (neither Pre or Postmenopausal)	-19802	Dead	TUMOR FREE	766	3945	[Not Available]	NA	NA	364	[Not Available]	1	3945	0	3945	0	3945	0	3945	65.02	10.8	50-59	Stage 1
1009	TCGA-B6-A0X1	BRCA	48	FEMALE	WHITE	[Discrepancy]	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1994	Indeterminate (neither Pre or Postmenopausal)	-17624	Dead	TUMOR FREE	766	7455	[Not Available]	Distant Metastasis	Brain	490	[Not Available]	1	7455	0	7455	1	490	1	490	68.66	20.41	40-49	other
1010	TCGA-B6-A0X4	BRCA	62	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22688	Dead	WITH TUMOR	766	860	[Not Available]	Distant Metastasis	Bone	716	[Not Available]	1	860	1	860	1	716	1	716	64.47	2.35	60-69	Stage 2
1011	TCGA-B6-A0X5	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22380	Dead	WITH TUMOR	766	2097	[Not Available]	Distant Metastasis	Other, specify	1343	[Not Available]	1	2097	1	2097	1	1343	1	1343	67.01	5.74	60-69	Stage 2
1012	TCGA-B6-A0X7	BRCA	62	FEMALE	WHITE	Stage X	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	1994	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22723	Dead	TUMOR FREE	766	1781	[Not Available]	New Primary Tumor	Other, specify	1104	[Not Available]	1	1781	0	1781	0	720	1	1104	67.09	4.88	60-69	other
1013	TCGA-B6-A1KC	BRCA	67	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24791	Alive	TUMOR FREE	1326	548	[Not Available]	NA	NA	364	[Not Available]	0	1326	0	1326	0	1326	0	1326	71.5	3.63	60-69	Stage 2
1014	TCGA-B6-A1KF	BRCA	68	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24891	Alive	TUMOR FREE	3088	548	[Not Available]	NA	NA	364	[Not Available]	0	3088	0	3088	0	3088	0	3088	76.6	8.45	60-69	Stage 2
1015	TCGA-B6-A1KI	BRCA	63	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23031	Alive	TUMOR FREE	2236	548	[Not Available]	NA	NA	364	[Not Available]	0	2236	0	2236	0	2236	0	2236	69.18	6.12	60-69	Stage 1
1016	TCGA-B6-A1KN	BRCA	57	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21183	Alive	TUMOR FREE	4233	548	[Not Available]	NA	NA	364	[Not Available]	0	4233	0	4233	0	4233	0	4233	69.59	11.59	50-59	Stage 3
1017	TCGA-B6-A2IU	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	1998	Indeterminate (neither Pre or Postmenopausal)	-22905	Alive	WITH TUMOR	5176	548	[Not Available]	New Primary Tumor	Other, specify	4224	[Not Available]	0	5176	0	5176	0	5176	1	4224	76.88	14.17	60-69	Stage 2
1018	TCGA-B6-A3ZX	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2007	[Unknown]	-18434	Dead	WITH TUMOR	766	1152	[Not Available]	Distant Metastasis	Bone	994	[Not Available]	1	1152	1	1152	0	720	1	994	53.62	3.15	50-59	Stage 4
1019	TCGA-B6-A400	BRCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	[Unknown]	-16022	Alive	TUMOR FREE	215	548	[Not Available]	NA	NA	364	[Not Available]	0	215	0	215	0	215	0	215	44.45	0.59	40-49	Stage 3
1020	TCGA-B6-A401	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	[Unknown]	-17438	Alive	TUMOR FREE	2596	548	[Not Available]	NA	NA	364	[Not Available]	0	2596	0	2596	0	2596	0	2596	54.85	7.11	40-49	Stage 2
1021	TCGA-B6-A402	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	[Unknown]	-17314	Alive	WITH TUMOR	2281	548	[Not Available]	Locoregional Recurrence	Other, specify	1516	[Not Available]	0	2281	0	2281	1	1516	1	1516	53.65	6.25	40-49	Stage 1
1022	TCGA-B6-A408	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2008	[Unknown]	-20102	Alive	TUMOR FREE	2072	548	[Not Available]	NA	NA	364	[Not Available]	0	2072	0	2072	0	2072	0	2072	60.71	5.67	50-59	Stage 3
1023	TCGA-B6-A409	BRCA	44	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16178	Dead	WITH TUMOR	766	573	[Not Available]	Distant Metastasis	Lung	456	[Not Available]	1	573	1	573	1	456	1	456	45.86	1.57	40-49	Stage 3
1024	TCGA-B6-A40B	BRCA	76	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27811	Alive	TUMOR FREE	3152	548	[Not Available]	NA	NA	364	[Not Available]	0	3152	0	3152	0	3152	0	3152	84.77	8.63	70-79	Stage 1
1025	TCGA-B6-A40C	BRCA	51	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2005	[Unknown]	-18852	Alive	TUMOR FREE	2164	548	[Not Available]	NA	NA	364	[Not Available]	0	2164	0	2164	0	2164	0	2164	57.54	5.92	50-59	Stage 2
1026	TCGA-BH-A0AU	BRCA	45	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16688	Alive	TUMOR FREE	1914	548	[Not Available]	NA	NA	364	[Not Available]	0	1914	0	1914	0	1914	0	1914	50.93	5.24	40-49	Stage 2
1027	TCGA-BH-A0AV	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	[Not Available]	-19314	Alive	TUMOR FREE	1820	548	[Not Available]	NA	NA	364	[Not Available]	0	1820	0	1820	0	1820	0	1820	57.86	4.98	50-59	Stage 1
1028	TCGA-BH-A0AW	BRCA	56	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20468	Alive	TUMOR FREE	622	548	[Not Available]	NA	NA	364	[Not Available]	0	622	0	622	0	622	0	622	57.74	1.7	50-59	Stage 2
1029	TCGA-BH-A0AY	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22703	Alive	TUMOR FREE	777	548	[Not Available]	NA	NA	364	[Not Available]	0	777	0	777	0	777	0	777	64.28	2.13	60-69	Stage 2
1030	TCGA-BH-A0AZ	BRCA	47	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17465	Alive	TUMOR FREE	1919	548	[Not Available]	NA	NA	364	[Not Available]	0	1919	0	1919	0	1919	0	1919	53.07	5.25	40-49	Stage 3
1031	TCGA-BH-A0B0	BRCA	56	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Peri (6-12 months since last menstrual period)	-20776	Alive	TUMOR FREE	2477	548	[Not Available]	NA	NA	364	[Not Available]	0	2477	0	2477	0	2477	0	2477	63.66	6.78	50-59	Stage 1
1032	TCGA-BH-A0B1	BRCA	66	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24315	Alive	TUMOR FREE	1148	548	[Not Available]	NA	NA	364	[Not Available]	0	1148	0	1148	0	1148	0	1148	69.71	3.14	60-69	Stage 2
1033	TCGA-BH-A0B3	BRCA	53	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19479	Alive	TUMOR FREE	1203	548	[Not Available]	NA	NA	364	[Not Available]	0	1203	0	1203	0	1203	0	1203	56.62	3.29	50-59	Stage 2
1034	TCGA-BH-A0B4	BRCA	65	MALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	[Not Available]	-23980	Alive	TUMOR FREE	1191	548	[Not Available]	NA	NA	364	[Not Available]	0	1191	0	1191	0	1191	0	1191	68.91	3.26	60-69	Stage 3
1035	TCGA-BH-A0B5	BRCA	40	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14920	Alive	TUMOR FREE	2136	548	[Not Available]	NA	NA	364	[Not Available]	0	2136	0	2136	0	720	0	2136	46.7	5.85	40-49	Stage 3
1036	TCGA-BH-A0B6	BRCA	47	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	[Not Available]	-17346	Alive	TUMOR FREE	2483	548	[Not Available]	NA	NA	364	[Not Available]	0	2483	0	2483	0	2483	0	2483	54.29	6.8	40-49	Stage 1
1037	TCGA-BH-A0B7	BRCA	42	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15593	Alive	TUMOR FREE	2559	548	[Not Available]	NA	NA	364	[Not Available]	0	2559	0	2559	0	2559	0	2559	49.7	7.01	40-49	Stage 2
1038	TCGA-BH-A0B8	BRCA	64	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23380	Alive	TUMOR FREE	1569	548	[Not Available]	NA	NA	364	[Not Available]	0	1569	0	1569	0	1569	0	1569	68.31	4.3	60-69	Stage 1
1039	TCGA-BH-A0B9	BRCA	44	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16310	Alive	TUMOR FREE	1572	548	[Not Available]	NA	NA	364	[Not Available]	0	1572	0	1572	0	1572	0	1572	48.96	4.3	40-49	Stage 1
1040	TCGA-BH-A0BA	BRCA	51	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18839	Alive	TUMOR FREE	1132	548	[Not Available]	NA	NA	364	[Not Available]	0	1132	0	1132	0	1132	0	1132	54.68	3.1	50-59	Stage 3
1041	TCGA-BH-A0BC	BRCA	60	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21949	Alive	TUMOR FREE	974	548	[Not Available]	NA	NA	364	[Not Available]	0	974	0	974	0	974	0	974	62.76	2.67	60-69	Stage 3
1042	TCGA-BH-A0BD	BRCA	47	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17275	Alive	TUMOR FREE	554	548	[Not Available]	NA	NA	364	[Not Available]	0	554	0	554	0	554	0	554	48.81	1.52	40-49	Stage 2
1043	TCGA-BH-A0BF	BRCA	56	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20691	Dead	TUMOR FREE	766	1324	[Not Available]	NA	NA	364	[Not Available]	1	1324	0	1324	0	1324	0	1324	60.27	3.62	50-59	Stage 2
1044	TCGA-BH-A0BG	BRCA	73	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26988	Alive	TUMOR FREE	1871	548	[Not Available]	NA	NA	364	[Not Available]	0	1871	0	1871	0	1871	0	1871	79.01	5.12	70-79	Stage 1
1045	TCGA-BH-A0BJ	BRCA	41	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15027	Alive	TUMOR FREE	660	548	[Not Available]	NA	NA	364	[Not Available]	0	660	0	660	0	660	0	660	42.95	1.81	40-49	Stage 2
1046	TCGA-BH-A0BL	BRCA	35	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12841	Alive	TUMOR FREE	2278	548	[Not Available]	NA	NA	364	[Not Available]	0	2278	0	2278	0	2278	0	2278	41.39	6.24	30-39	Stage 1
1047	TCGA-BH-A0BM	BRCA	54	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20049	Alive	TUMOR FREE	1876	548	[Not Available]	NA	NA	364	[Not Available]	0	1876	0	1876	0	1876	0	1876	60.03	5.14	50-59	Stage 2
1048	TCGA-BH-A0BO	BRCA	54	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19767	Alive	TUMOR FREE	2197	548	[Not Available]	NA	NA	364	[Not Available]	0	2197	0	2197	0	2197	0	2197	60.13	6.02	50-59	Stage 1
1049	TCGA-BH-A0BP	BRCA	76	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27917	Dead	TUMOR FREE	766	2296	[Not Available]	NA	NA	364	[Not Available]	1	2296	0	2296	0	2296	0	2296	82.72	6.29	70-79	Stage 1
1050	TCGA-BH-A0BQ	BRCA	39	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14494	Alive	TUMOR FREE	2255	548	[Not Available]	Locoregional Recurrence	Other, specify	1709	[Not Available]	0	2255	0	2255	1	1709	1	1709	45.86	6.17	30-39	Stage 1
1051	TCGA-BH-A0BR	BRCA	59	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21622	Alive	TUMOR FREE	2330	548	[Not Available]	NA	NA	364	[Not Available]	0	2330	0	2330	0	2330	0	2330	65.58	6.38	50-59	Stage 1
1052	TCGA-BH-A0BS	BRCA	55	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20374	Alive	TUMOR FREE	2612	548	[Not Available]	NA	NA	364	[Not Available]	0	2612	0	2612	0	2612	0	2612	62.93	7.15	50-59	Stage 3
1053	TCGA-BH-A0BT	BRCA	56	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	[Not Available]	-20625	Alive	TUMOR FREE	2365	548	[Not Available]	NA	NA	364	[Not Available]	0	2365	0	2365	0	2365	0	2365	62.94	6.48	50-59	Stage 2
1054	TCGA-BH-A0BV	BRCA	78	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28699	Alive	TUMOR FREE	1519	548	[Not Available]	NA	NA	364	[Not Available]	0	1519	0	1519	0	1519	0	1519	82.73	4.16	70-79	Stage 2
1055	TCGA-BH-A0BW	BRCA	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25974	Alive	TUMOR FREE	2371	548	[Not Available]	NA	NA	364	[Not Available]	0	2371	0	2371	0	2371	0	2371	77.6	6.49	70-79	Stage 1
1056	TCGA-BH-A0BZ	BRCA	59	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21856	Alive	TUMOR FREE	2255	548	[Not Available]	NA	NA	364	[Not Available]	0	2255	0	2255	0	2255	0	2255	66.01	6.17	50-59	Stage 3
1057	TCGA-BH-A0C0	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23006	Alive	TUMOR FREE	1270	548	[Not Available]	NA	NA	364	[Not Available]	0	1270	0	1270	0	1270	0	1270	66.46	3.48	60-69	Stage 2
1058	TCGA-BH-A0C1	BRCA	61	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22377	Dead	WITH TUMOR	766	1411	[Not Available]	Distant Metastasis	Bone	1123	[Not Available]	1	1411	1	1411	1	1123	1	1123	65.13	3.86	60-69	Stage 3
1059	TCGA-BH-A0C3	BRCA	47	FEMALE	WHITE	Stage I	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17221	Alive	WITH TUMOR	2709	548	[Not Available]	Distant Metastasis	Bone	2674	[Not Available]	0	2709	0	2709	1	2674	1	2674	54.57	7.42	40-49	Stage 1
1060	TCGA-BH-A0C7	BRCA	48	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Peri (6-12 months since last menstrual period)	-17871	Alive	TUMOR FREE	2767	548	[Not Available]	NA	NA	364	[Not Available]	0	2767	0	2767	0	2767	0	2767	56.5	7.58	40-49	Stage 2
1061	TCGA-BH-A0DD	BRCA	58	MALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	[Not Available]	-21386	Alive	TUMOR FREE	2486	548	[Not Available]	NA	NA	364	[Not Available]	0	2486	0	2486	0	2486	0	2486	65.36	6.81	50-59	Stage 2
1062	TCGA-BH-A0DE	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22656	Alive	TUMOR FREE	2372	548	[Not Available]	NA	NA	364	[Not Available]	0	2372	0	2372	0	2372	0	2372	68.52	6.49	60-69	Stage 2
1063	TCGA-BH-A0DG	BRCA	30	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11204	Alive	TUMOR FREE	2041	548	[Not Available]	NA	NA	364	[Not Available]	0	2041	0	2041	0	2041	0	2041	36.26	5.59	30-39	Stage 2
1064	TCGA-BH-A0DH	BRCA	63	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23366	Alive	TUMOR FREE	1156	548	[Not Available]	NA	NA	364	[Not Available]	0	1156	0	1156	0	1156	0	1156	67.14	3.16	60-69	Stage 2
1065	TCGA-BH-A0DI	BRCA	63	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23327	Alive	TUMOR FREE	912	548	[Not Available]	NA	NA	364	[Not Available]	0	912	0	912	0	912	0	912	66.36	2.5	60-69	Stage 2
1066	TCGA-BH-A0DK	BRCA	49	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18237	Alive	TUMOR FREE	423	548	[Not Available]	NA	NA	364	[Not Available]	0	423	0	423	0	423	0	423	51.09	1.16	40-49	Stage 2
1067	TCGA-BH-A0DL	BRCA	64	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23628	Alive	TUMOR FREE	2381	548	[Not Available]	NA	NA	364	[Not Available]	0	2381	0	2381	0	2381	0	2381	71.21	6.52	60-69	Stage 2
1068	TCGA-BH-A0DO	BRCA	78	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28529	Alive	TUMOR FREE	1644	548	[Not Available]	NA	NA	364	[Not Available]	0	1644	0	1644	0	1644	0	1644	82.61	4.5	70-79	Stage 1
1069	TCGA-BH-A0DP	BRCA	60	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22199	Alive	TUMOR FREE	476	548	[Not Available]	NA	NA	364	[Not Available]	0	476	0	476	0	476	0	476	62.08	1.3	60-69	Stage 2
1070	TCGA-BH-A0DQ	BRCA	42	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15533	Alive	TUMOR FREE	98	548	[Not Available]	NA	NA	364	[Not Available]	0	98	0	98	0	98	0	98	42.8	0.27	40-49	Stage 2
1071	TCGA-BH-A0DS	BRCA	71	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25944	Alive	TUMOR FREE	78	548	[Not Available]	NA	NA	364	[Not Available]	0	78	0	78	0	78	0	78	71.24	0.21	70-79	Stage 3
1072	TCGA-BH-A0DT	BRCA	41	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15078	Alive	TUMOR FREE	2403	548	[Not Available]	NA	NA	364	[Not Available]	0	2403	0	2403	0	2403	0	2403	47.86	6.58	40-49	Stage 2
1073	TCGA-BH-A0DV	BRCA	54	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Peri (6-12 months since last menstrual period)	-19781	Alive	TUMOR FREE	2064	548	[Not Available]	NA	NA	364	[Not Available]	0	2064	0	2064	0	2064	0	2064	59.81	5.65	50-59	Stage 3
1074	TCGA-BH-A0DX	BRCA	62	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22833	Alive	TUMOR FREE	2156	548	[Not Available]	NA	NA	364	[Not Available]	0	2156	0	2156	0	2156	0	2156	68.42	5.9	60-69	Stage 1
1075	TCGA-BH-A0DZ	BRCA	43	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15980	Alive	TUMOR FREE	495	548	[Not Available]	NA	NA	364	[Not Available]	0	495	0	495	0	495	0	495	45.11	1.36	40-49	Stage 2
1076	TCGA-BH-A0E0	BRCA	38	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14175	Alive	TUMOR FREE	134	548	[Not Available]	NA	NA	364	[Not Available]	0	134	0	134	0	134	0	134	39.18	0.37	30-39	Stage 3
1077	TCGA-BH-A0E1	BRCA	52	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Peri (6-12 months since last menstrual period)	-19192	Alive	TUMOR FREE	477	548	[Not Available]	NA	NA	364	[Not Available]	0	477	0	477	0	477	0	477	53.85	1.31	50-59	Stage 2
1078	TCGA-BH-A0E2	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18152	Alive	TUMOR FREE	435	548	[Not Available]	NA	NA	364	[Not Available]	0	435	0	435	0	435	0	435	50.89	1.19	40-49	Stage 3
1079	TCGA-BH-A0E6	BRCA	69	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25408	Alive	TUMOR FREE	293	548	[Not Available]	NA	NA	364	[Not Available]	0	293	0	293	0	293	0	293	70.37	0.8	60-69	Stage 1
1080	TCGA-BH-A0E7	BRCA	79	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29115	Alive	TUMOR FREE	1363	548	[Not Available]	NA	NA	364	[Not Available]	0	1363	0	1363	0	1363	0	1363	83.44	3.73	70-79	Stage 2
1081	TCGA-BH-A0E9	BRCA	53	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19415	Alive	TUMOR FREE	2489	548	[Not Available]	NA	NA	364	[Not Available]	0	2489	0	2489	0	2489	0	2489	59.97	6.81	50-59	Stage 2
1082	TCGA-BH-A0EA	BRCA	72	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26548	Dead	TUMOR FREE	766	991	[Not Available]	NA	NA	364	[Not Available]	1	991	0	991	0	991	0	991	75.4	2.71	70-79	Stage 2
1083	TCGA-BH-A0EB	BRCA	69	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25259	Alive	TUMOR FREE	745	548	[Not Available]	NA	NA	364	[Not Available]	0	745	0	745	0	745	0	745	71.2	2.04	60-69	Stage 1
1084	TCGA-BH-A0EE	BRCA	68	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24850	Alive	TUMOR FREE	943	548	[Not Available]	NA	NA	364	[Not Available]	0	943	0	943	0	943	0	943	70.62	2.58	60-69	Stage 2
1085	TCGA-BH-A0EI	BRCA	51	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Peri (6-12 months since last menstrual period)	-18741	Alive	TUMOR FREE	1926	548	[Not Available]	NA	NA	364	[Not Available]	0	1926	0	1926	0	1926	0	1926	56.58	5.27	50-59	Stage 2
1086	TCGA-BH-A0GY	BRCA	67	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24493	Alive	TUMOR FREE	923	548	[Not Available]	NA	NA	364	[Not Available]	0	923	0	923	0	923	0	923	69.59	2.53	60-69	Stage 2
1087	TCGA-BH-A0GZ	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22714	Alive	TUMOR FREE	328	548	[Not Available]	NA	NA	364	[Not Available]	0	328	0	328	0	328	0	328	63.09	0.9	60-69	Stage 2
1088	TCGA-BH-A0H0	BRCA	69	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25223	Alive	TUMOR FREE	461	548	[Not Available]	NA	NA	364	[Not Available]	0	461	0	461	0	461	0	461	70.32	1.26	60-69	Stage 1
1089	TCGA-BH-A0H3	BRCA	46	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17152	Alive	TUMOR FREE	1928	548	[Not Available]	NA	NA	364	[Not Available]	0	1928	0	1928	0	1928	0	1928	52.24	5.28	40-49	Stage 1
1090	TCGA-BH-A0H5	BRCA	45	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16719	Alive	TUMOR FREE	1620	548	[Not Available]	NA	NA	364	[Not Available]	0	1620	0	1620	0	1620	0	1620	50.21	4.44	40-49	Stage 1
1091	TCGA-BH-A0H6	BRCA	82	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30125	Alive	TUMOR FREE	747	548	[Not Available]	NA	NA	364	[Not Available]	0	747	0	747	0	747	0	747	84.52	2.05	>=80	Stage 1
1092	TCGA-BH-A0H7	BRCA	65	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23972	Alive	TUMOR FREE	702	548	[Not Available]	NA	NA	364	[Not Available]	0	702	0	702	0	702	0	702	67.55	1.92	60-69	Stage 3
1093	TCGA-BH-A0H9	BRCA	69	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25289	Alive	TUMOR FREE	1247	548	[Not Available]	NA	NA	364	[Not Available]	0	1247	0	1247	0	1247	0	1247	72.65	3.41	60-69	Stage 2
1094	TCGA-BH-A0HA	BRCA	31	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11379	Alive	TUMOR FREE	1611	548	[Not Available]	NA	NA	364	[Not Available]	0	1611	0	1611	0	1611	0	1611	35.56	4.41	30-39	Stage 1
1095	TCGA-BH-A0HB	BRCA	55	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20448	Alive	TUMOR FREE	806	548	[Not Available]	NA	NA	364	[Not Available]	0	806	0	806	0	806	0	806	58.19	2.21	50-59	Stage 1
1096	TCGA-BH-A0HF	BRCA	77	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28233	Alive	TUMOR FREE	727	548	[Not Available]	NA	NA	364	[Not Available]	0	727	0	727	0	727	0	727	79.29	1.99	70-79	Stage 1
1097	TCGA-BH-A0HI	BRCA	78	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28644	Alive	TUMOR FREE	620	548	[Not Available]	NA	NA	364	[Not Available]	0	620	0	620	0	620	0	620	80.12	1.7	70-79	Stage 1
1098	TCGA-BH-A0HK	BRCA	81	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29751	Alive	TUMOR FREE	178	548	[Not Available]	NA	NA	364	[Not Available]	0	178	0	178	0	178	0	178	81.94	0.49	>=80	Stage 2
1099	TCGA-BH-A0HL	BRCA	56	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20804	Alive	TUMOR FREE	72	548	[Not Available]	NA	NA	364	[Not Available]	0	72	0	72	0	72	0	72	57.16	0.2	50-59	Stage 2
1100	TCGA-BH-A0HN	BRCA	67	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24731	Alive	TUMOR FREE	516	548	[Not Available]	NA	NA	364	[Not Available]	0	516	0	516	0	516	0	516	69.12	1.41	60-69	Stage 1
1101	TCGA-BH-A0HO	BRCA	48	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17710	Alive	TUMOR FREE	76	548	[Not Available]	NA	NA	364	[Not Available]	0	76	0	76	0	76	0	76	48.7	0.21	40-49	Stage 2
1102	TCGA-BH-A0HP	BRCA	65	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23883	Alive	TUMOR FREE	414	548	[Not Available]	NA	NA	364	[Not Available]	0	414	0	414	0	414	0	414	66.52	1.13	60-69	Stage 3
1103	TCGA-BH-A0HQ	BRCA	56	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20719	Alive	TUMOR FREE	1121	548	[Not Available]	NA	NA	364	[Not Available]	0	1121	0	1121	0	1121	0	1121	59.79	3.07	50-59	Stage 2
1104	TCGA-BH-A0HU	BRCA	52	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Peri (6-12 months since last menstrual period)	-19216	Alive	TUMOR FREE	392	548	[Not Available]	NA	NA	364	[Not Available]	0	392	0	392	0	392	0	392	53.68	1.07	50-59	Stage 1
1105	TCGA-BH-A0HW	BRCA	62	FEMALE	ASIAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22962	Alive	TUMOR FREE	1561	548	[Not Available]	NA	NA	364	[Not Available]	0	1561	0	1561	0	1561	0	1561	67.14	4.27	60-69	Stage 1
1106	TCGA-BH-A0HX	BRCA	54	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19900	Alive	TUMOR FREE	829	548	[Not Available]	NA	NA	364	[Not Available]	0	829	0	829	0	829	0	829	56.75	2.27	50-59	Stage 2
1107	TCGA-BH-A0HY	BRCA	60	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22179	Alive	TUMOR FREE	1545	548	[Not Available]	NA	NA	364	[Not Available]	0	1545	0	1545	0	1545	0	1545	64.95	4.23	60-69	Stage 1
1108	TCGA-BH-A0RX	BRCA	59	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21857	Alive	TUMOR FREE	170	548	[Not Available]	NA	NA	364	[Not Available]	0	170	0	170	0	170	0	170	60.31	0.47	50-59	Stage 2
1109	TCGA-BH-A0W3	BRCA	58	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Indeterminate (neither Pre or Postmenopausal)	-21369	Alive	TUMOR FREE	728	548	[Not Available]	NA	NA	364	[Not Available]	0	728	0	728	0	720	0	728	60.5	1.99	50-59	Stage 2
1110	TCGA-BH-A0W4	BRCA	46	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	[Not Available]	-16911	Alive	TUMOR FREE	759	548	[Not Available]	NA	NA	364	[Not Available]	0	759	0	759	0	720	0	759	48.38	2.08	40-49	Stage 2
1111	TCGA-BH-A0W5	BRCA	77	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	[Not Available]	-28304	Alive	TUMOR FREE	1288	548	[Not Available]	NA	NA	364	[Not Available]	0	1288	0	1288	0	1288	0	1288	81.02	3.53	70-79	Stage 2
1112	TCGA-BH-A0W7	BRCA	49	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	[Not Available]	-17996	Alive	TUMOR FREE	1363	548	[Not Available]	NA	NA	364	[Not Available]	0	1363	0	1363	0	1363	0	1363	53	3.73	40-49	Stage 1
1113	TCGA-BH-A0WA	BRCA	82	FEMALE	WHITE	Stage I	[Not Applicable]	[Not Available]	[Not Available]	2008	[Not Available]	-30025	Alive	TUMOR FREE	701	548	[Not Available]	NA	NA	364	[Not Available]	0	701	0	701	0	701	0	701	84.12	1.92	>=80	Stage 1
1114	TCGA-BH-A18F	BRCA	50	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-18594	Alive	TUMOR FREE	1001	548	[Not Available]	NA	NA	364	[Not Available]	0	1001	0	1001	0	1001	0	1001	53.65	2.74	50-59	Stage 2
1115	TCGA-BH-A18G	BRCA	81	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29820	Alive	TUMOR FREE	149	548	[Not Available]	NA	NA	364	[Not Available]	0	149	0	149	0	149	0	149	82.05	0.41	>=80	Stage 1
1116	TCGA-BH-A18H	BRCA	63	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23065	Alive	TUMOR FREE	652	548	[Not Available]	NA	NA	364	[Not Available]	0	652	0	652	0	652	0	652	64.93	1.79	60-69	Stage 1
1117	TCGA-BH-A18I	BRCA	53	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19489	Alive	TUMOR FREE	1093	548	[Not Available]	NA	NA	364	[Not Available]	0	1093	0	1093	0	1093	0	1093	56.35	2.99	50-59	Stage 2
1118	TCGA-BH-A18J	BRCA	56	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2000	[Not Available]	-20678	Dead	WITH TUMOR	766	612	[Not Available]	NA	NA	364	[Not Available]	1	612	1	612	0	720	1	612	58.29	1.68	50-59	Stage 4
1119	TCGA-BH-A18K	BRCA	46	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1999	[Not Available]	-16824	Dead	WITH TUMOR	766	2763	[Not Available]	NA	NA	364	[Not Available]	1	2763	1	2763	0	720	1	2763	53.63	7.56	40-49	Stage 1
1120	TCGA-BH-A18L	BRCA	50	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	[Not Available]	-18519	Dead	TUMOR FREE	766	811	[Not Available]	NA	NA	364	[Not Available]	1	811	0	811	0	811	0	811	52.92	2.22	50-59	Stage 3
1121	TCGA-BH-A18M	BRCA	39	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2001	[Not Available]	-14532	Dead	TUMOR FREE	766	2207	[Not Available]	NA	NA	364	[Not Available]	1	2207	0	2207	0	2207	0	2207	45.83	6.04	30-39	Stage 3
1122	TCGA-BH-A18N	BRCA	88	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2001	[Not Available]	-32404	Dead	TUMOR FREE	766	1148	[Not Available]	NA	NA	364	[Not Available]	1	1148	0	1148	0	1148	0	1148	91.86	3.14	>=80	Stage 2
1123	TCGA-BH-A18P	BRCA	60	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	[Not Available]	-22222	Dead	WITH TUMOR	766	921	[Not Available]	NA	NA	364	[Not Available]	1	921	1	921	0	720	1	921	63.36	2.52	60-69	Stage 1
1124	TCGA-BH-A18Q	BRCA	56	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2001	[Not Available]	-20675	Dead	TUMOR FREE	766	1692	[Not Available]	NA	NA	364	[Not Available]	1	1692	0	1692	0	1692	0	1692	61.24	4.63	50-59	Stage 2
1125	TCGA-BH-A18R	BRCA	50	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2001	[Not Available]	-18524	Dead	TUMOR FREE	766	1142	[Not Available]	NA	NA	364	[Not Available]	1	1142	0	1142	0	1142	0	1142	53.84	3.13	50-59	Stage 2
1126	TCGA-BH-A18S	BRCA	79	FEMALE	WHITE	Stage I	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28974	Dead	TUMOR FREE	766	2009	[Not Available]	NA	NA	364	[Not Available]	1	2009	0	2009	0	2009	0	2009	84.83	5.5	70-79	Stage 1
1127	TCGA-BH-A18T	BRCA	70	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25674	Dead	WITH TUMOR	766	224	[Not Available]	NA	NA	364	[Not Available]	1	224	1	224	0	720	1	224	70.9	0.61	70-79	Stage 2
1128	TCGA-BH-A18U	BRCA	72	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26426	Dead	TUMOR FREE	766	1563	[Not Available]	NA	NA	364	[Not Available]	1	1563	0	1563	0	1563	0	1563	76.63	4.28	70-79	Stage 3
1129	TCGA-BH-A18V	BRCA	48	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2001	[Not Available]	-17682	Dead	TUMOR FREE	766	1556	[Not Available]	NA	NA	364	[Not Available]	1	1556	0	1556	0	1556	0	1556	52.67	4.26	40-49	Stage 2
1130	TCGA-BH-A1EN	BRCA	78	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28724	Dead	TUMOR FREE	766	2127	[Not Available]	NA	NA	364	[Not Available]	1	2127	0	2127	0	2127	0	2127	84.47	5.82	70-79	Stage 2
1131	TCGA-BH-A1EO	BRCA	68	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25136	Dead	TUMOR FREE	766	2798	[Not Available]	NA	NA	364	[Not Available]	1	2798	0	2798	0	720	0	2798	76.48	7.66	60-69	Stage 2
1132	TCGA-BH-A1ES	BRCA	35	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1999	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13138	Dead	WITH TUMOR	766	3462	[Not Available]	NA	NA	364	[Not Available]	1	3462	1	3462	0	720	1	3462	45.45	9.48	30-39	Stage 2
1133	TCGA-BH-A1ET	BRCA	55	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1999	[Not Available]	-20425	Dead	TUMOR FREE	766	2520	[Not Available]	NA	NA	364	[Not Available]	1	2520	0	2520	0	720	0	2520	62.82	6.9	50-59	Stage 1
1134	TCGA-BH-A1EU	BRCA	83	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30339	Dead	TUMOR FREE	766	1286	[Not Available]	NA	NA	364	[Not Available]	1	1286	0	1286	0	720	0	1286	86.58	3.52	>=80	Stage 1
1135	TCGA-BH-A1EV	BRCA	45	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1999	[Not Available]	-16504	Dead	WITH TUMOR	766	365	[Not Available]	NA	NA	364	[Not Available]	1	365	1	365	0	720	1	365	46.18	1	40-49	Stage 3
1136	TCGA-BH-A1EW	BRCA	38	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1999	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14090	Dead	WITH TUMOR	766	1694	[Not Available]	NA	NA	364	[Not Available]	1	1694	1	1694	0	720	1	1694	43.21	4.64	30-39	Stage 2
1137	TCGA-BH-A1EX	BRCA	67	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24544	Dead	WITH TUMOR	766	1508	[Not Available]	NA	NA	364	[Not Available]	1	1508	1	1508	0	720	1	1508	71.33	4.13	60-69	Stage 2
1138	TCGA-BH-A1EY	BRCA	79	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28940	Dead	WITH TUMOR	766	538	[Not Available]	Distant Metastasis	Lung	396	[Not Available]	1	538	1	538	0	720	1	396	80.71	1.47	70-79	Stage 2
1139	TCGA-BH-A1F0	BRCA	80	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29335	Dead	WITH TUMOR	766	785	[Not Available]	NA	NA	364	[Not Available]	1	785	1	785	0	720	1	785	82.46	2.15	>=80	Stage 2
1140	TCGA-BH-A1F2	BRCA	53	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1999	[Not Available]	-19701	Dead	TUMOR FREE	766	959	[Not Available]	NA	NA	364	[Not Available]	1	959	0	959	0	720	0	959	56.56	2.63	50-59	Stage 3
1141	TCGA-BH-A1F5	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2002	[Not Available]	-22842	Dead	TUMOR FREE	766	2712	[Not Available]	NA	NA	364	[Not Available]	1	2712	0	2712	0	720	0	2712	69.96	7.43	60-69	Stage 2
1142	TCGA-BH-A1F6	BRCA	51	FEMALE	WHITE	[Not Available]	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1996	[Not Available]	-18691	Dead	TUMOR FREE	766	2965	[Not Available]	NA	NA	364	[Not Available]	1	2965	0	2965	0	720	0	2965	59.29	8.12	50-59	other
1143	TCGA-BH-A1F8	BRCA	90	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32871	Dead	WITH TUMOR	766	763	[Not Available]	NA	NA	364	[Not Available]	1	763	1	763	0	720	1	763	92.08	2.09	>=80	Stage 3
1144	TCGA-BH-A1FB	BRCA	60	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21933	Dead	WITH TUMOR	766	3669	[Not Available]	NA	NA	364	[Not Available]	1	3669	1	3669	0	720	1	3669	70.09	10.05	60-69	Stage 2
1145	TCGA-BH-A1FC	BRCA	78	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Medullary Carcinoma	[Not Available]	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28706	Dead	TUMOR FREE	766	3472	[Not Available]	NA	NA	364	[Not Available]	1	3472	0	3472	0	720	0	3472	88.1	9.51	70-79	Stage 2
1146	TCGA-BH-A1FD	BRCA	68	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24940	Dead	WITH TUMOR	766	1009	[Not Available]	NA	NA	364	[Not Available]	1	1009	1	1009	0	720	1	1009	71.04	2.76	60-69	Stage 1
1147	TCGA-BH-A1FE	BRCA	31	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	[Not Available]	-11650	Dead	WITH TUMOR	766	2273	[Not Available]	NA	NA	364	[Not Available]	1	2273	1	2273	0	720	1	2273	38.12	6.22	30-39	Stage 2
1148	TCGA-BH-A1FG	BRCA	88	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32295	Dead	TUMOR FREE	766	3736	[Not Available]	NA	NA	364	[Not Available]	1	3736	0	3736	0	720	0	3736	98.65	10.23	>=80	Stage 1
1149	TCGA-BH-A1FH	BRCA	47	FEMALE	WHITE	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	[Not Available]	-17172	Dead	WITH TUMOR	766	1034	[Not Available]	NA	NA	364	[Not Available]	1	1034	1	1034	0	720	1	1034	49.85	2.83	40-49	Stage 4
1150	TCGA-BH-A1FJ	BRCA	66	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	[Not Available]	-24262	Dead	TUMOR FREE	766	1927	[Not Available]	NA	NA	364	[Not Available]	1	1927	0	1927	0	720	0	1927	71.7	5.28	60-69	Stage 3
1151	TCGA-BH-A1FL	BRCA	69	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	[Not Available]	-25558	Dead	WITH TUMOR	766	1673	[Not Available]	NA	NA	364	[Not Available]	1	1673	1	1673	0	720	1	1673	74.55	4.58	60-69	Stage 2
1152	TCGA-BH-A1FM	BRCA	44	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1998	[Not Available]	-16289	Dead	TUMOR FREE	766	1388	[Not Available]	NA	NA	364	[Not Available]	1	1388	0	1388	0	720	0	1388	48.4	3.8	40-49	Stage 3
1153	TCGA-BH-A1FN	BRCA	34	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1997	[Not Available]	-12525	Dead	WITH TUMOR	766	2192	[Not Available]	NA	NA	364	[Not Available]	1	2192	1	2192	0	720	1	2192	40.29	6	30-39	Stage 2
1154	TCGA-BH-A1FR	BRCA	73	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Other, specify	[Not Available]	1997	[Not Available]	-26684	Dead	WITH TUMOR	766	1642	[Not Available]	NA	NA	364	[Not Available]	1	1642	1	1642	0	720	1	1642	77.55	4.5	70-79	Stage 3
1155	TCGA-BH-A1FU	BRCA	44	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1997	[Not Available]	-16174	Dead	WITH TUMOR	766	1688	[Not Available]	NA	NA	364	[Not Available]	1	1688	1	1688	0	720	1	1688	48.9	4.62	40-49	Stage 1
1156	TCGA-BH-A201	BRCA	64	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23423	Alive	TUMOR FREE	856	548	[Not Available]	NA	NA	364	[Not Available]	0	856	0	856	0	720	0	856	66.47	2.34	60-69	Stage 1
1157	TCGA-BH-A202	BRCA	60	FEMALE	WHITE	Stage II	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22052	Alive	TUMOR FREE	795	548	[Not Available]	NA	NA	364	[Not Available]	0	795	0	795	0	720	0	795	62.55	2.18	60-69	Stage 2
1158	TCGA-BH-A203	BRCA	78	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28609	Dead	WITH TUMOR	766	1174	[Not Available]	NA	NA	364	[Not Available]	1	1174	1	1174	0	720	1	1174	81.54	3.21	70-79	Stage 2
1159	TCGA-BH-A204	BRCA	80	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29529	Dead	TUMOR FREE	766	2534	[Not Available]	NA	NA	364	[Not Available]	1	2534	0	2534	0	720	0	2534	87.78	6.94	>=80	Stage 2
1160	TCGA-BH-A208	BRCA	48	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1995	[Not Available]	-17715	Dead	TUMOR FREE	766	1759	[Not Available]	NA	NA	364	[Not Available]	1	1759	0	1759	0	720	0	1759	53.32	4.82	40-49	Stage 2
1161	TCGA-BH-A209	BRCA	77	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Medullary Carcinoma	[Not Available]	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28403	Dead	TUMOR FREE	766	3959	[Not Available]	NA	NA	364	[Not Available]	1	3959	0	3959	0	720	0	3959	88.6	10.84	70-79	Stage 1
1162	TCGA-BH-A28O	BRCA	50	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	[Not Available]	-18501	Alive	TUMOR FREE	1120	548	[Not Available]	NA	NA	364	[Not Available]	0	1120	0	1120	0	1120	0	1120	53.72	3.07	50-59	Stage 3
1163	TCGA-BH-A28Q	BRCA	46	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16882	Alive	TUMOR FREE	1119	548	[Not Available]	NA	NA	364	[Not Available]	0	1119	0	1119	0	720	0	1119	49.28	3.06	40-49	Stage 2
1164	TCGA-BH-A2L8	BRCA	45	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16658	Alive	TUMOR FREE	612	548	[Not Available]	NA	NA	364	[Not Available]	0	612	0	612	0	612	0	612	47.28	1.68	40-49	Stage 2
1165	TCGA-BH-A42T	BRCA	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27731	Dead	TUMOR FREE	766	320	[Not Available]	NA	NA	364	[Not Available]	1	320	0	320	0	320	0	320	76.8	0.88	70-79	Stage 2
1166	TCGA-BH-A42U	BRCA	80	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29330	Alive	TUMOR FREE	3364	548	[Not Available]	NA	NA	364	[Not Available]	0	3364	0	3364	0	3364	0	3364	89.51	9.21	>=80	Stage 2
1167	TCGA-BH-A42V	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15158	Alive	TUMOR FREE	635	548	[Not Available]	NA	NA	364	[Not Available]	0	635	0	635	0	635	0	635	43.24	1.74	40-49	Stage 1
1168	TCGA-BH-A5IZ	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18927	Alive	TUMOR FREE	567	548	[Not Available]	NA	NA	364	[Not Available]	0	567	0	567	0	567	0	567	53.37	1.55	50-59	Stage 2
1169	TCGA-BH-A5J0	BRCA	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23072	Alive	TUMOR FREE	715	548	[Not Available]	NA	NA	364	[Not Available]	0	715	0	715	0	715	0	715	65.13	1.96	60-69	Stage 1
1170	TCGA-BH-A6R8	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	[Unknown]	-16829	Alive	TUMOR FREE	293	548	[Not Available]	NA	NA	364	[Not Available]	0	293	0	293	0	293	0	293	46.88	0.8	40-49	Stage 2
1171	TCGA-BH-A6R9	BRCA	61	FEMALE	WHITE	Stage IIA	[Not Applicable]	Metaplastic Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22325	Alive	TUMOR FREE	160	548	[Not Available]	NA	NA	364	[Not Available]	0	160	0	160	0	160	0	160	61.56	0.44	60-69	Stage 2
1172	TCGA-BH-A8FY	BRCA	87	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31932	Dead	TUMOR FREE	766	295	[Not Available]	NA	NA	364	[Not Available]	1	295	0	295	0	295	0	295	88.23	0.81	>=80	Stage 1
1173	TCGA-BH-A8FZ	BRCA	58	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21343	Alive	TUMOR FREE	574	548	[Not Available]	NA	NA	364	[Not Available]	0	574	0	574	0	574	0	574	60.01	1.57	50-59	Stage 1
1174	TCGA-BH-A8G0	BRCA	54	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Peri (6-12 months since last menstrual period)	-19975	Alive	TUMOR FREE	662	548	[Not Available]	NA	NA	364	[Not Available]	0	662	0	662	0	662	0	662	56.5	1.81	50-59	Stage 2
1175	TCGA-BH-AB28	BRCA	53	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	[Unknown]	-19570	Alive	TUMOR FREE	287	548	[Not Available]	NA	NA	364	[Not Available]	0	287	0	287	0	287	0	287	54.37	0.79	50-59	Stage 3
1176	TCGA-C8-A12K	BRCA	80	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29463	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	80.67	0	>=80	Stage 2
1177	TCGA-C8-A12L	BRCA	67	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24710	Alive	TUMOR FREE	363	548	[Not Available]	NA	NA	364	[Not Available]	0	363	0	363	0	363	0	363	68.65	0.99	60-69	Stage 2
1178	TCGA-C8-A12M	BRCA	70	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25811	Alive	TUMOR FREE	358	548	[Not Available]	NA	NA	364	[Not Available]	0	358	0	358	0	358	0	358	71.65	0.98	70-79	Stage 2
1179	TCGA-C8-A12N	BRCA	58	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21428	Alive	TUMOR FREE	358	548	[Not Available]	NA	NA	364	[Not Available]	0	358	0	358	0	358	0	358	59.65	0.98	50-59	Stage 2
1180	TCGA-C8-A12O	BRCA	50	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18506	Alive	TUMOR FREE	385	548	[Not Available]	NA	NA	364	[Not Available]	0	385	0	385	0	385	0	385	51.72	1.05	50-59	Stage 2
1181	TCGA-C8-A12P	BRCA	55	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20332	Alive	TUMOR FREE	358	548	[Not Available]	NA	NA	364	[Not Available]	0	358	0	358	0	358	0	358	56.65	0.98	50-59	Stage 2
1182	TCGA-C8-A12Q	BRCA	78	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28733	Dead	WITH TUMOR	766	385	[Not Available]	NA	NA	364	[Not Available]	1	385	1	385	0	720	1	385	79.72	1.05	70-79	Stage 3
1183	TCGA-C8-A12T	BRCA	43	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-22222	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	60.84	0	40-49	Stage 2
1184	TCGA-C8-A12U	BRCA	46	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17045	Alive	TUMOR FREE	385	548	[Not Available]	NA	NA	364	[Not Available]	0	385	0	385	0	385	0	385	47.72	1.05	40-49	Stage 2
1185	TCGA-C8-A12V	BRCA	55	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20346	Alive	TUMOR FREE	385	548	[Not Available]	NA	NA	364	[Not Available]	0	385	0	385	0	720	0	385	56.76	1.05	50-59	Stage 2
1186	TCGA-C8-A12W	BRCA	49	FEMALE	ASIAN	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18140	Alive	TUMOR FREE	385	548	[Not Available]	NA	NA	364	[Not Available]	0	385	0	385	0	385	0	385	50.72	1.05	40-49	Stage 3
1187	TCGA-C8-A12X	BRCA	62	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22889	Alive	TUMOR FREE	385	548	[Not Available]	NA	NA	364	[Not Available]	0	385	0	385	0	385	0	385	63.72	1.05	60-69	Stage 2
1188	TCGA-C8-A12Y	BRCA	44	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-22222	Alive	TUMOR FREE	1476	548	[Not Available]	NA	NA	364	[Not Available]	0	1476	0	1476	0	1476	0	1476	64.88	4.04	40-49	Stage 2
1189	TCGA-C8-A12Z	BRCA	45	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-16508	Alive	TUMOR FREE	382	548	[Not Available]	NA	NA	364	[Not Available]	0	382	0	382	0	382	0	382	46.24	1.05	40-49	Stage 2
1190	TCGA-C8-A130	BRCA	52	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-19117	Alive	TUMOR FREE	370	548	[Not Available]	NA	NA	364	[Not Available]	0	370	0	370	0	370	0	370	53.35	1.01	50-59	Stage 3
1191	TCGA-C8-A131	BRCA	82	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29966	Alive	TUMOR FREE	411	548	[Not Available]	NA	NA	364	[Not Available]	0	411	0	411	0	411	0	411	83.17	1.13	>=80	Stage 3
1192	TCGA-C8-A132	BRCA	56	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20471	Alive	TUMOR FREE	383	548	[Not Available]	NA	NA	364	[Not Available]	0	383	0	383	0	383	0	383	57.1	1.05	50-59	Stage 2
1193	TCGA-C8-A133	BRCA	65	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Other, specify	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23922	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	0	0	0	65.49	0	60-69	Stage 3
1194	TCGA-C8-A134	BRCA	52	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-19010	Alive	TUMOR FREE	383	548	[Not Available]	NA	NA	364	[Not Available]	0	383	0	383	0	383	0	383	53.1	1.05	50-59	Stage 2
1195	TCGA-C8-A135	BRCA	64	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23667	Alive	TUMOR FREE	393	548	[Not Available]	NA	NA	364	[Not Available]	0	393	0	393	0	393	0	393	65.87	1.08	60-69	Stage 2
1196	TCGA-C8-A137	BRCA	34	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12729	Alive	WITH TUMOR	379	548	[Not Available]	Locoregional Recurrence	NA	136	[Not Available]	0	379	0	379	1	136	1	136	35.89	1.04	30-39	Stage 2
1197	TCGA-C8-A138	BRCA	54	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20053	Alive	TUMOR FREE	380	548	[Not Available]	NA	NA	364	[Not Available]	0	380	0	380	0	380	0	380	55.94	1.04	50-59	Stage 3
1198	TCGA-C8-A1HE	BRCA	59	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	375	548	[Not Available]	NA	NA	364	[Not Available]	0	375	0	375	0	375	0	375	61.87	1.03	50-59	Stage 2
1199	TCGA-C8-A1HF	BRCA	48	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-22222	Alive	TUMOR FREE	332	548	[Not Available]	NA	NA	364	[Not Available]	0	332	0	332	0	332	0	332	61.75	0.91	40-49	Stage 2
1200	TCGA-C8-A1HG	BRCA	50	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-22222	Alive	TUMOR FREE	345	548	[Not Available]	NA	NA	364	[Not Available]	0	345	0	345	0	345	0	345	61.79	0.94	50-59	Stage 2
1201	TCGA-C8-A1HI	BRCA	40	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-22222	Alive	TUMOR FREE	343	548	[Not Available]	NA	NA	364	[Not Available]	0	343	0	343	0	343	0	343	61.78	0.94	40-49	Stage 3
1202	TCGA-C8-A1HJ	BRCA	53	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-19629	Alive	TUMOR FREE	5	548	[Not Available]	NA	NA	364	[Not Available]	0	5	0	5	0	5	0	5	53.75	0.01	50-59	Stage 2
1203	TCGA-C8-A1HK	BRCA	53	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-22222	Alive	TUMOR FREE	366	548	[Not Available]	NA	NA	364	[Not Available]	0	366	0	366	0	366	0	366	61.84	1	50-59	Stage 2
1204	TCGA-C8-A1HL	BRCA	38	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Other, specify	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-22222	Alive	TUMOR FREE	317	548	[Not Available]	NA	NA	364	[Not Available]	0	317	0	317	0	317	0	317	61.71	0.87	30-39	Stage 3
1205	TCGA-C8-A1HM	BRCA	74	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27063	Alive	TUMOR FREE	375	548	[Not Available]	NA	NA	364	[Not Available]	0	375	0	375	0	375	0	375	75.12	1.03	70-79	Stage 2
1206	TCGA-C8-A1HN	BRCA	56	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20712	Alive	TUMOR FREE	394	548	[Not Available]	NA	NA	364	[Not Available]	0	394	0	394	0	394	0	394	57.79	1.08	50-59	Stage 2
1207	TCGA-C8-A1HO	BRCA	34	FEMALE	ASIAN	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12715	Alive	TUMOR FREE	375	548	[Not Available]	NA	NA	364	[Not Available]	0	375	0	375	0	375	0	375	35.84	1.03	30-39	Stage 3
1208	TCGA-C8-A26V	BRCA	47	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-17468	Alive	TUMOR FREE	616	548	[Not Available]	NA	NA	364	[Not Available]	0	616	0	616	0	616	0	616	49.51	1.69	40-49	Stage 3
1209	TCGA-C8-A26W	BRCA	58	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21391	Alive	TUMOR FREE	381	548	[Not Available]	NA	NA	364	[Not Available]	0	381	0	381	0	381	0	381	59.61	1.04	50-59	Stage 2
1210	TCGA-C8-A26X	BRCA	58	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21463	Alive	TUMOR FREE	376	548	[Not Available]	NA	NA	364	[Not Available]	0	376	0	376	0	376	0	376	59.79	1.03	50-59	Stage 2
1211	TCGA-C8-A26Y	BRCA	90	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Alive	TUMOR FREE	394	548	[Not Available]	NA	NA	364	[Not Available]	0	394	0	394	0	394	0	394	91.08	1.08	>=80	Stage 2
1212	TCGA-C8-A26Z	BRCA	59	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	470	548	[Not Available]	NA	NA	364	[Not Available]	0	470	0	470	0	470	0	470	62.13	1.29	50-59	Stage 2
1213	TCGA-C8-A273	BRCA	29	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-22222	Alive	TUMOR FREE	513	548	[Not Available]	NA	NA	364	[Not Available]	0	513	0	513	0	513	0	513	62.25	1.4	18-29	Stage 2
1214	TCGA-C8-A274	BRCA	63	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23337	Alive	TUMOR FREE	508	548	[Not Available]	NA	NA	364	[Not Available]	0	508	0	508	0	508	0	508	65.28	1.39	60-69	Stage 2
1215	TCGA-C8-A275	BRCA	56	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20774	Alive	TUMOR FREE	1	548	[Not Available]	NA	NA	364	[Not Available]	0	1	0	1	0	1	0	1	56.88	0	50-59	Stage 2
1216	TCGA-C8-A278	BRCA	61	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22598	Alive	TUMOR FREE	297	548	[Not Available]	NA	NA	364	[Not Available]	0	297	0	297	0	297	0	297	62.68	0.81	60-69	Stage 3
1217	TCGA-C8-A27A	BRCA	48	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-17779	Alive	TUMOR FREE	747	548	[Not Available]	NA	NA	364	[Not Available]	0	747	0	747	0	747	0	747	50.72	2.05	40-49	Stage 2
1218	TCGA-C8-A27B	BRCA	48	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Peri (6-12 months since last menstrual period)	-17763	Alive	TUMOR FREE	439	548	[Not Available]	NA	NA	364	[Not Available]	0	439	0	439	0	439	0	439	49.83	1.2	40-49	Stage 2
1219	TCGA-C8-A3M7	BRCA	60	FEMALE	ASIAN	Stage IIIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22096	Dead	WITH TUMOR	766	1034	[Not Available]	Locoregional Recurrence	NA	1034	[Not Available]	1	1034	1	1034	1	1034	1	1034	63.33	2.83	60-69	Stage 3
1220	TCGA-C8-A3M8	BRCA	68	FEMALE	ASIAN	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24877	Alive	TUMOR FREE	394	548	[Not Available]	NA	NA	364	[Not Available]	0	394	0	394	0	394	0	394	69.19	1.08	60-69	Stage 1
1221	TCGA-C8-A8HP	BRCA	59	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Metaplastic Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21613	Alive	TUMOR FREE	396	548	[Not Available]	NA	NA	364	[Not Available]	0	396	0	396	0	396	0	396	60.26	1.08	50-59	Stage 3
1222	TCGA-C8-A8HQ	BRCA	53	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19432	Alive	TUMOR FREE	380	548	[Not Available]	NA	NA	364	[Not Available]	0	380	0	380	0	380	0	380	54.24	1.04	50-59	Stage 2
1223	TCGA-C8-A8HR	BRCA	49	FEMALE	ASIAN	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	Peri (6-12 months since last menstrual period)	-17921	Alive	TUMOR FREE	408	548	[Not Available]	NA	NA	364	[Not Available]	0	408	0	408	0	408	0	408	50.18	1.12	40-49	Stage 3
1224	TCGA-C8-A9FZ	BRCA	49	FEMALE	WHITE	Stage IIB	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18038	Alive	TUMOR FREE	592	548	[Not Available]	NA	NA	364	[Not Available]	0	592	0	592	0	592	0	592	51.01	1.62	40-49	Stage 2
1225	TCGA-D8-A13Y	BRCA	52	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19028	Alive	TUMOR FREE	1728	548	[Not Available]	NA	NA	364	[Not Available]	0	1728	0	1728	0	1728	0	1728	56.83	4.73	50-59	Stage 1
1226	TCGA-D8-A13Z	BRCA	51	FEMALE	WHITE	[Not Available]	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18942	Alive	TUMOR FREE	635	548	[Not Available]	NA	NA	364	[Not Available]	0	635	0	635	0	635	0	635	53.6	1.74	50-59	other
1227	TCGA-D8-A140	BRCA	62	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22900	Alive	TUMOR FREE	403	548	[Not Available]	NA	NA	364	[Not Available]	0	403	0	403	0	403	0	403	63.8	1.1	60-69	Stage 2
1228	TCGA-D8-A141	BRCA	40	FEMALE	WHITE	[Not Available]	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Indeterminate (neither Pre or Postmenopausal)	-14626	Alive	TUMOR FREE	626	548	[Not Available]	NA	NA	364	[Not Available]	0	626	0	626	0	626	0	626	41.76	1.71	40-49	other
1229	TCGA-D8-A142	BRCA	74	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27313	Alive	TUMOR FREE	425	548	[Not Available]	NA	NA	364	[Not Available]	0	425	0	425	0	425	0	425	75.94	1.16	70-79	Stage 2
1230	TCGA-D8-A143	BRCA	51	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18984	Alive	TUMOR FREE	431	548	[Not Available]	NA	NA	364	[Not Available]	0	431	0	431	0	431	0	431	53.16	1.18	50-59	Stage 2
1231	TCGA-D8-A145	BRCA	80	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29280	Alive	TUMOR FREE	410	548	[Not Available]	NA	NA	364	[Not Available]	0	410	0	410	0	410	0	410	81.29	1.12	>=80	Stage 2
1232	TCGA-D8-A146	BRCA	57	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20861	Alive	TUMOR FREE	643	548	[Not Available]	NA	NA	364	[Not Available]	0	643	0	643	0	643	0	643	58.87	1.76	50-59	Stage 2
1233	TCGA-D8-A147	BRCA	45	FEMALE	WHITE	[Not Available]	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Indeterminate (neither Pre or Postmenopausal)	-16736	Alive	TUMOR FREE	584	548	[Not Available]	NA	NA	364	[Not Available]	0	584	0	584	0	584	0	584	47.42	1.6	40-49	other
1234	TCGA-D8-A1J8	BRCA	77	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28444	Alive	TUMOR FREE	431	548	[Not Available]	NA	NA	364	[Not Available]	0	431	0	431	0	431	0	431	79.06	1.18	70-79	Stage 2
1235	TCGA-D8-A1J9	BRCA	48	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17879	Alive	TUMOR FREE	532	548	[Not Available]	NA	NA	364	[Not Available]	0	532	0	532	0	532	0	532	50.41	1.46	40-49	Stage 1
1236	TCGA-D8-A1JA	BRCA	60	FEMALE	WHITE	[Not Available]	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21918	Alive	WITH TUMOR	502	548	[Not Available]	Locoregional Disease	NA	431	[Not Available]	0	502	0	502	1	431	1	431	61.38	1.37	60-69	other
1237	TCGA-D8-A1JB	BRCA	54	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19822	Alive	TUMOR FREE	1688	548	[Not Available]	NA	NA	364	[Not Available]	0	1688	0	1688	0	1688	0	1688	58.89	4.62	50-59	Stage 2
1238	TCGA-D8-A1JC	BRCA	59	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21898	Alive	TUMOR FREE	480	548	[Not Available]	NA	NA	364	[Not Available]	0	480	0	480	0	480	0	480	61.27	1.31	50-59	Stage 3
1239	TCGA-D8-A1JD	BRCA	41	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15166	Alive	TUMOR FREE	552	548	[Not Available]	NA	NA	364	[Not Available]	0	552	0	552	0	552	0	552	43.03	1.51	40-49	Stage 2
1240	TCGA-D8-A1JE	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22683	Alive	TUMOR FREE	575	548	[Not Available]	NA	NA	364	[Not Available]	0	575	0	575	0	575	0	575	63.68	1.57	60-69	Stage 2
1241	TCGA-D8-A1JF	BRCA	79	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29199	Alive	TUMOR FREE	366	548	[Not Available]	NA	NA	364	[Not Available]	0	366	0	366	0	366	0	366	80.94	1	70-79	Stage 3
1242	TCGA-D8-A1JG	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22878	Alive	TUMOR FREE	1612	548	[Not Available]	NA	NA	364	[Not Available]	0	1612	0	1612	0	1612	0	1612	67.05	4.41	60-69	Stage 2
1243	TCGA-D8-A1JH	BRCA	56	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20497	Alive	TUMOR FREE	426	548	[Not Available]	NA	NA	364	[Not Available]	0	426	0	426	0	426	0	426	57.28	1.17	50-59	Stage 1
1244	TCGA-D8-A1JI	BRCA	54	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20072	Alive	TUMOR FREE	577	548	[Not Available]	NA	NA	364	[Not Available]	0	577	0	577	0	577	0	577	56.53	1.58	50-59	Stage 2
1245	TCGA-D8-A1JJ	BRCA	54	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19966	Alive	TUMOR FREE	611	548	[Not Available]	NA	NA	364	[Not Available]	0	611	0	611	0	611	0	611	56.34	1.67	50-59	Stage 2
1246	TCGA-D8-A1JK	BRCA	90	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Alive	TUMOR FREE	612	548	[Not Available]	NA	NA	364	[Not Available]	0	612	0	612	0	612	0	612	91.67	1.68	>=80	Stage 2
1247	TCGA-D8-A1JL	BRCA	72	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26484	Alive	TUMOR FREE	611	548	[Not Available]	NA	NA	364	[Not Available]	0	611	0	611	0	611	0	611	74.18	1.67	70-79	Stage 2
1248	TCGA-D8-A1JM	BRCA	59	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21602	Alive	TUMOR FREE	590	548	[Not Available]	NA	NA	364	[Not Available]	0	590	0	590	0	590	0	590	60.76	1.62	50-59	Stage 2
1249	TCGA-D8-A1JN	BRCA	80	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29331	Alive	TUMOR FREE	620	548	[Not Available]	NA	NA	364	[Not Available]	0	620	0	620	0	620	0	620	82	1.7	>=80	Stage 3
1250	TCGA-D8-A1JP	BRCA	73	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26862	Alive	TUMOR FREE	639	548	[Not Available]	NA	NA	364	[Not Available]	0	639	0	639	0	639	0	639	75.29	1.75	70-79	Stage 1
1251	TCGA-D8-A1JS	BRCA	77	FEMALE	WHITE	Stage IA	[Not Applicable]	Other, specify	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28178	Alive	TUMOR FREE	371	548	[Not Available]	NA	NA	364	[Not Available]	0	371	0	371	0	371	0	371	78.16	1.02	70-79	Stage 1
1252	TCGA-D8-A1JT	BRCA	70	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25677	Alive	TUMOR FREE	405	548	[Not Available]	NA	NA	364	[Not Available]	0	405	0	405	0	405	0	405	71.41	1.11	70-79	Stage 2
1253	TCGA-D8-A1JU	BRCA	51	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18733	Alive	TUMOR FREE	447	548	[Not Available]	NA	NA	364	[Not Available]	0	447	0	447	0	447	0	447	52.51	1.22	50-59	Stage 1
1254	TCGA-D8-A1X5	BRCA	81	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29734	Alive	TUMOR FREE	565	548	[Not Available]	NA	NA	364	[Not Available]	0	565	0	565	0	565	0	565	82.95	1.55	>=80	Stage 3
1255	TCGA-D8-A1X6	BRCA	80	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29256	Alive	TUMOR FREE	541	548	[Not Available]	NA	NA	364	[Not Available]	0	541	0	541	0	541	0	541	81.58	1.48	>=80	Stage 3
1256	TCGA-D8-A1X7	BRCA	40	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14858	Alive	TUMOR FREE	509	548	[Not Available]	NA	NA	364	[Not Available]	0	509	0	509	0	509	0	509	42.07	1.39	40-49	Stage 2
1257	TCGA-D8-A1X8	BRCA	62	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22995	Alive	TUMOR FREE	783	548	[Not Available]	NA	NA	364	[Not Available]	0	783	0	783	0	783	0	783	65.1	2.14	60-69	Stage 3
1258	TCGA-D8-A1X9	BRCA	66	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24417	Alive	TUMOR FREE	727	548	[Not Available]	NA	NA	364	[Not Available]	0	727	0	727	0	720	0	727	68.84	1.99	60-69	Stage 2
1259	TCGA-D8-A1XA	BRCA	64	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23387	Alive	TUMOR FREE	839	548	[Not Available]	NA	NA	364	[Not Available]	0	839	0	839	0	839	0	839	66.33	2.3	60-69	Stage 1
1260	TCGA-D8-A1XB	BRCA	62	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22976	Alive	TUMOR FREE	552	548	[Not Available]	NA	NA	364	[Not Available]	0	552	0	552	0	552	0	552	64.42	1.51	60-69	Stage 2
1261	TCGA-D8-A1XC	BRCA	85	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31220	Dead	WITH TUMOR	766	377	[Not Available]	NA	NA	364	[Not Available]	1	377	1	377	0	720	1	377	86.51	1.03	>=80	Stage 3
1262	TCGA-D8-A1XD	BRCA	36	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13510	Alive	TUMOR FREE	522	548	[Not Available]	NA	NA	364	[Not Available]	0	522	0	522	0	522	0	522	38.42	1.43	30-39	Stage 3
1263	TCGA-D8-A1XF	BRCA	45	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16787	Alive	TUMOR FREE	463	548	[Not Available]	NA	NA	364	[Not Available]	0	463	0	463	0	720	0	463	47.23	1.27	40-49	Stage 2
1264	TCGA-D8-A1XG	BRCA	86	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31748	Alive	TUMOR FREE	448	548	[Not Available]	NA	NA	364	[Not Available]	0	448	0	448	0	448	0	448	88.15	1.23	>=80	Stage 3
1265	TCGA-D8-A1XJ	BRCA	76	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Other, specify	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27967	Alive	TUMOR FREE	664	548	[Not Available]	NA	NA	364	[Not Available]	0	664	0	664	0	664	0	664	78.39	1.82	70-79	Stage 3
1266	TCGA-D8-A1XK	BRCA	55	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20092	Alive	TUMOR FREE	441	548	[Not Available]	NA	NA	364	[Not Available]	0	441	0	441	0	441	0	441	56.22	1.21	50-59	Stage 2
1267	TCGA-D8-A1XL	BRCA	34	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12668	Alive	TUMOR FREE	606	548	[Not Available]	NA	NA	364	[Not Available]	0	606	0	606	0	606	0	606	36.34	1.66	30-39	Stage 2
1268	TCGA-D8-A1XM	BRCA	57	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21056	Alive	TUMOR FREE	538	548	[Not Available]	NA	NA	364	[Not Available]	0	538	0	538	0	538	0	538	59.12	1.47	50-59	Stage 1
1269	TCGA-D8-A1XO	BRCA	56	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20606	Alive	TUMOR FREE	1682	548	[Not Available]	NA	NA	364	[Not Available]	0	1682	0	1682	0	1682	0	1682	61.02	4.61	50-59	Stage 2
1270	TCGA-D8-A1XQ	BRCA	69	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25345	Alive	TUMOR FREE	499	548	[Not Available]	NA	NA	364	[Not Available]	0	499	0	499	0	499	0	499	70.76	1.37	60-69	Stage 2
1271	TCGA-D8-A1XR	BRCA	56	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20488	Alive	TUMOR FREE	482	548	[Not Available]	NA	NA	364	[Not Available]	0	482	0	482	0	482	0	482	57.41	1.32	50-59	Stage 2
1272	TCGA-D8-A1XS	BRCA	48	MALE	WHITE	Stage IIIC	[Not Applicable]	Other, specify	[Not Available]	2010	[Not Available]	-17708	Alive	TUMOR FREE	496	548	[Not Available]	NA	NA	364	[Not Available]	0	496	0	496	0	496	0	496	49.84	1.36	40-49	Stage 3
1273	TCGA-D8-A1XT	BRCA	61	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22448	Alive	TUMOR FREE	506	548	[Not Available]	NA	NA	364	[Not Available]	0	506	0	506	0	506	0	506	62.84	1.39	60-69	Stage 2
1274	TCGA-D8-A1XU	BRCA	56	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20715	Alive	TUMOR FREE	395	548	[Not Available]	NA	NA	364	[Not Available]	0	395	0	395	0	395	0	395	57.8	1.08	50-59	Stage 1
1275	TCGA-D8-A1XV	BRCA	84	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30830	Alive	TUMOR FREE	461	548	[Not Available]	NA	NA	364	[Not Available]	0	461	0	461	0	461	0	461	85.67	1.26	>=80	Stage 2
1276	TCGA-D8-A1XW	BRCA	53	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19478	Alive	TUMOR FREE	1309	548	[Not Available]	NA	NA	364	[Not Available]	0	1309	0	1309	0	1309	0	1309	56.91	3.58	50-59	Stage 2
1277	TCGA-D8-A1XY	BRCA	74	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27106	Alive	TUMOR FREE	503	548	[Not Available]	NA	NA	364	[Not Available]	0	503	0	503	0	720	0	503	75.59	1.38	70-79	Stage 2
1278	TCGA-D8-A1XZ	BRCA	81	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29916	Alive	TUMOR FREE	466	548	[Not Available]	NA	NA	364	[Not Available]	0	466	0	466	0	466	0	466	83.18	1.28	>=80	Stage 3
1279	TCGA-D8-A1Y0	BRCA	65	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24083	Alive	TUMOR FREE	472	548	[Not Available]	NA	NA	364	[Not Available]	0	472	0	472	0	720	0	472	67.23	1.29	60-69	Stage 3
1280	TCGA-D8-A1Y1	BRCA	80	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29474	Dead	WITH TUMOR	766	302	[Not Available]	NA	NA	364	[Not Available]	1	302	1	302	0	720	1	302	81.52	0.83	>=80	Stage 3
1281	TCGA-D8-A1Y2	BRCA	71	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26021	Alive	TUMOR FREE	433	548	[Not Available]	NA	NA	364	[Not Available]	0	433	0	433	0	433	0	433	72.43	1.19	70-79	Stage 2
1282	TCGA-D8-A1Y3	BRCA	61	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22317	Alive	TUMOR FREE	430	548	[Not Available]	NA	NA	364	[Not Available]	0	430	0	430	0	430	0	430	62.28	1.18	60-69	Stage 3
1283	TCGA-D8-A27E	BRCA	66	FEMALE	WHITE	Stage IA	[Not Applicable]	Other, specify	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24315	Alive	TUMOR FREE	530	548	[Not Available]	NA	NA	364	[Not Available]	0	530	0	530	0	530	0	530	68.02	1.45	60-69	Stage 1
1284	TCGA-D8-A27F	BRCA	40	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14731	Alive	TUMOR FREE	488	548	[Not Available]	NA	NA	364	[Not Available]	0	488	0	488	0	488	0	488	41.67	1.34	40-49	Stage 2
1285	TCGA-D8-A27G	BRCA	75	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27521	Alive	TUMOR FREE	409	548	[Not Available]	NA	NA	364	[Not Available]	0	409	0	409	0	409	0	409	76.47	1.12	70-79	Stage 2
1286	TCGA-D8-A27H	BRCA	72	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26588	Alive	TUMOR FREE	397	548	[Not Available]	NA	NA	364	[Not Available]	0	397	0	397	0	397	0	397	73.88	1.09	70-79	Stage 2
1287	TCGA-D8-A27I	BRCA	58	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21327	Alive	TUMOR FREE	439	548	[Not Available]	NA	NA	364	[Not Available]	0	439	0	439	0	439	0	439	59.59	1.2	50-59	Stage 3
1288	TCGA-D8-A27K	BRCA	47	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17426	Alive	TUMOR FREE	1461	548	[Not Available]	NA	NA	364	[Not Available]	0	1461	0	1461	0	1461	0	1461	51.71	4	40-49	Stage 2
1289	TCGA-D8-A27L	BRCA	49	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18025	Alive	TUMOR FREE	499	548	[Not Available]	NA	NA	364	[Not Available]	0	499	0	499	0	499	0	499	50.72	1.37	40-49	Stage 3
1290	TCGA-D8-A27M	BRCA	59	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21910	Alive	TUMOR FREE	410	548	[Not Available]	NA	NA	364	[Not Available]	0	410	0	410	0	410	0	410	61.11	1.12	50-59	Stage 1
1291	TCGA-D8-A27N	BRCA	36	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13243	Alive	TUMOR FREE	519	548	[Not Available]	NA	NA	364	[Not Available]	0	519	0	519	0	519	0	519	37.68	1.42	30-39	Stage 3
1292	TCGA-D8-A27P	BRCA	64	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23576	Alive	TUMOR FREE	49	548	[Not Available]	NA	NA	364	[Not Available]	0	49	0	49	0	49	0	49	64.68	0.13	60-69	Stage 1
1293	TCGA-D8-A27R	BRCA	41	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15122	Alive	TUMOR FREE	307	548	[Not Available]	NA	NA	364	[Not Available]	0	307	0	307	0	307	0	307	42.24	0.84	40-49	Stage 3
1294	TCGA-D8-A27T	BRCA	53	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19591	Alive	TUMOR FREE	398	548	[Not Available]	NA	NA	364	[Not Available]	0	398	0	398	0	398	0	398	54.73	1.09	50-59	Stage 3
1295	TCGA-D8-A27V	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22958	Alive	TUMOR FREE	381	548	[Not Available]	NA	NA	364	[Not Available]	0	381	0	381	0	381	0	381	63.9	1.04	60-69	Stage 2
1296	TCGA-D8-A27W	BRCA	55	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20173	Alive	TUMOR FREE	373	548	[Not Available]	NA	NA	364	[Not Available]	0	373	0	373	0	373	0	373	56.25	1.02	50-59	Stage 3
1297	TCGA-D8-A3Z5	BRCA	54	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19846	Alive	TUMOR FREE	1015	548	[Not Available]	NA	NA	364	[Not Available]	0	1015	0	1015	0	1015	0	1015	57.11	2.78	50-59	Stage 3
1298	TCGA-D8-A3Z6	BRCA	56	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20629	Alive	TUMOR FREE	563	548	[Not Available]	NA	NA	364	[Not Available]	0	563	0	563	0	563	0	563	58.02	1.54	50-59	Stage 3
1299	TCGA-D8-A4Z1	BRCA	68	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25097	Alive	TUMOR FREE	659	548	[Not Available]	NA	NA	364	[Not Available]	0	659	0	659	0	659	0	659	70.52	1.8	60-69	Stage 1
1300	TCGA-D8-A73U	BRCA	88	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32208	Alive	WITH TUMOR	492	548	[Not Available]	NA	NA	364	[Not Available]	0	492	0	492	0	492	0	492	89.53	1.35	>=80	Stage 2
1301	TCGA-D8-A73W	BRCA	79	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29125	Dead	WITH TUMOR	766	385	[Not Available]	Distant Metastasis	Lung	21	[Not Available]	1	385	1	385	1	21	1	21	80.79	1.05	70-79	Stage 3
1302	TCGA-D8-A73X	BRCA	53	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19607	Alive	TUMOR FREE	767	548	[Not Available]	NA	NA	364	[Not Available]	0	767	0	767	0	767	0	767	55.78	2.1	50-59	Stage 2
1303	TCGA-E2-A105	BRCA	79	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28855	Alive	TUMOR FREE	1308	548	[Not Available]	NA	NA	364	[Not Available]	0	1308	0	1308	0	1308	0	1308	82.58	3.58	70-79	Stage 2
1304	TCGA-E2-A106	BRCA	34	FEMALE	ASIAN	Stage IB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12528	Alive	TUMOR FREE	2541	548	[Not Available]	NA	NA	364	[Not Available]	0	2541	0	2541	0	2541	0	2541	41.26	6.96	30-39	Stage 1
1305	TCGA-E2-A107	BRCA	54	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20065	Alive	TUMOR FREE	1047	548	[Not Available]	NA	NA	364	[Not Available]	0	1047	0	1047	0	1047	0	1047	57.8	2.87	50-59	Stage 3
1306	TCGA-E2-A108	BRCA	64	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23530	Alive	WITH TUMOR	837	548	[Not Available]	NA	NA	364	[Not Available]	0	837	0	837	0	837	0	837	66.71	2.29	60-69	Stage 3
1307	TCGA-E2-A109	BRCA	64	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23521	Alive	TUMOR FREE	1417	548	[Not Available]	NA	NA	364	[Not Available]	0	1417	0	1417	0	1417	0	1417	68.28	3.88	60-69	Stage 2
1308	TCGA-E2-A10A	BRCA	41	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15085	Alive	WITH TUMOR	1229	548	[Not Available]	Distant Metastasis	Bone	75	[Not Available]	0	1229	0	1229	1	75	1	75	44.67	3.36	40-49	Stage 2
1309	TCGA-E2-A10B	BRCA	67	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24577	Alive	TUMOR FREE	1141	548	[Not Available]	New Primary Tumor	Lung	195	[Not Available]	0	1141	0	1141	0	720	1	195	70.41	3.12	60-69	Stage 2
1310	TCGA-E2-A10C	BRCA	54	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19849	Alive	TUMOR FREE	1220	548	[Not Available]	NA	NA	364	[Not Available]	0	1220	0	1220	0	1220	0	1220	57.68	3.34	50-59	Stage 2
1311	TCGA-E2-A10E	BRCA	64	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23684	Alive	TUMOR FREE	865	548	[Not Available]	NA	NA	364	[Not Available]	0	865	0	865	0	865	0	865	67.21	2.37	60-69	Stage 2
1312	TCGA-E2-A10F	BRCA	47	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17257	Alive	TUMOR FREE	878	548	[Not Available]	NA	NA	364	[Not Available]	0	878	0	878	0	878	0	878	49.65	2.4	40-49	Stage 2
1313	TCGA-E2-A14N	BRCA	37	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13743	Alive	TUMOR FREE	1434	548	[Not Available]	NA	NA	364	[Not Available]	0	1434	0	1434	0	1434	0	1434	41.55	3.93	30-39	Stage 2
1314	TCGA-E2-A14O	BRCA	76	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27837	Alive	TUMOR FREE	1359	548	[Not Available]	NA	NA	364	[Not Available]	0	1359	0	1359	0	1359	0	1359	79.93	3.72	70-79	Stage 3
1315	TCGA-E2-A14P	BRCA	79	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28923	Alive	TUMOR FREE	1246	548	[Not Available]	NA	NA	364	[Not Available]	0	1246	0	1246	0	1246	0	1246	82.6	3.41	70-79	Stage 3
1316	TCGA-E2-A14Q	BRCA	50	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18507	Alive	TUMOR FREE	1163	548	[Not Available]	NA	NA	364	[Not Available]	0	1163	0	1163	0	1163	0	1163	53.85	3.18	50-59	Stage 2
1317	TCGA-E2-A14R	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22686	Alive	TUMOR FREE	1174	548	[Not Available]	New Primary Tumor	Other, specify	971	[Not Available]	0	1174	0	1174	0	1174	1	971	65.33	3.21	60-69	Stage 2
1318	TCGA-E2-A14S	BRCA	65	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23878	Alive	TUMOR FREE	1009	548	[Not Available]	NA	NA	364	[Not Available]	0	1009	0	1009	0	1009	0	1009	68.14	2.76	60-69	Stage 1
1319	TCGA-E2-A14T	BRCA	52	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19237	Alive	TUMOR FREE	2311	548	[Not Available]	NA	NA	364	[Not Available]	0	2311	0	2311	0	2311	0	2311	59	6.33	50-59	Stage 2
1320	TCGA-E2-A14U	BRCA	74	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27389	Alive	TUMOR FREE	1318	548	[Not Available]	NA	NA	364	[Not Available]	0	1318	0	1318	0	1318	0	1318	78.6	3.61	70-79	Stage 1
1321	TCGA-E2-A14V	BRCA	53	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19643	Alive	TUMOR FREE	1042	548	[Not Available]	NA	NA	364	[Not Available]	0	1042	0	1042	0	1042	0	1042	56.63	2.85	50-59	Stage 2
1322	TCGA-E2-A14W	BRCA	78	MALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	[Not Available]	-28664	Alive	TUMOR FREE	974	548	[Not Available]	NA	NA	364	[Not Available]	0	974	0	974	0	974	0	974	81.14	2.67	70-79	Stage 2
1323	TCGA-E2-A14X	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20105	Alive	TUMOR FREE	972	548	[Not Available]	NA	NA	364	[Not Available]	0	972	0	972	0	972	0	972	57.71	2.66	50-59	Stage 3
1324	TCGA-E2-A14Y	BRCA	35	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13004	Alive	TUMOR FREE	2109	548	[Not Available]	NA	NA	364	[Not Available]	0	2109	0	2109	0	2109	0	2109	41.38	5.77	30-39	Stage 2
1325	TCGA-E2-A14Z	BRCA	64	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23682	Dead	WITH TUMOR	766	563	[Not Available]	Distant Metastasis	Bone	188	[Not Available]	1	563	1	563	1	188	1	188	66.38	1.54	60-69	Stage 1
1326	TCGA-E2-A150	BRCA	48	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17580	Alive	TUMOR FREE	1935	548	[Not Available]	NA	NA	364	[Not Available]	0	1935	0	1935	0	1935	0	1935	53.43	5.3	40-49	Stage 2
1327	TCGA-E2-A152	BRCA	56	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20705	Alive	TUMOR FREE	2128	548	[Not Available]	Distant Metastasis	Liver	54	[Not Available]	0	2128	0	2128	1	54	1	54	62.51	5.83	50-59	Stage 1
1328	TCGA-E2-A153	BRCA	51	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18875	Alive	TUMOR FREE	707	548	[Not Available]	NA	NA	364	[Not Available]	0	707	0	707	0	707	0	707	53.61	1.94	50-59	Stage 2
1329	TCGA-E2-A154	BRCA	68	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24999	Alive	TUMOR FREE	591	548	[Not Available]	NA	NA	364	[Not Available]	0	591	0	591	0	591	0	591	70.06	1.62	60-69	Stage 1
1330	TCGA-E2-A155	BRCA	58	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21348	Alive	TUMOR FREE	640	548	[Not Available]	NA	NA	364	[Not Available]	0	640	0	640	0	640	0	640	60.2	1.75	50-59	Stage 2
1331	TCGA-E2-A156	BRCA	61	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22422	Alive	TUMOR FREE	726	548	[Not Available]	NA	NA	364	[Not Available]	0	726	0	726	0	726	0	726	63.38	1.99	60-69	Stage 1
1332	TCGA-E2-A158	BRCA	43	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15903	Alive	TUMOR FREE	450	548	[Not Available]	NA	NA	364	[Not Available]	0	450	0	450	0	450	0	450	44.77	1.23	40-49	Stage 2
1333	TCGA-E2-A159	BRCA	50	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18621	Alive	TUMOR FREE	762	548	[Not Available]	NA	NA	364	[Not Available]	0	762	0	762	0	762	0	762	53.07	2.09	50-59	Stage 2
1334	TCGA-E2-A15A	BRCA	45	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16750	Alive	TUMOR FREE	710	548	[Not Available]	NA	NA	364	[Not Available]	0	710	0	710	0	710	0	710	47.8	1.94	40-49	Stage 3
1335	TCGA-E2-A15C	BRCA	61	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22583	Alive	TUMOR FREE	694	548	[Not Available]	NA	NA	364	[Not Available]	0	694	0	694	0	694	0	694	63.73	1.9	60-69	Stage 1
1336	TCGA-E2-A15D	BRCA	47	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17224	Alive	TUMOR FREE	526	548	[Not Available]	NA	NA	364	[Not Available]	0	526	0	526	0	526	0	526	48.6	1.44	40-49	Stage 2
1337	TCGA-E2-A15E	BRCA	40	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14894	Alive	TUMOR FREE	630	548	[Not Available]	NA	NA	364	[Not Available]	0	630	0	630	0	630	0	630	42.5	1.72	40-49	Stage 2
1338	TCGA-E2-A15F	BRCA	64	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23660	Alive	TUMOR FREE	658	548	[Not Available]	NA	NA	364	[Not Available]	0	658	0	658	0	658	0	658	66.58	1.8	60-69	Stage 1
1339	TCGA-E2-A15G	BRCA	76	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28013	Alive	TUMOR FREE	554	548	[Not Available]	NA	NA	364	[Not Available]	0	554	0	554	0	554	0	554	78.21	1.52	70-79	Stage 2
1340	TCGA-E2-A15H	BRCA	38	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13985	Alive	TUMOR FREE	393	548	[Not Available]	NA	NA	364	[Not Available]	0	393	0	393	0	393	0	393	39.36	1.08	30-39	Stage 2
1341	TCGA-E2-A15I	BRCA	44	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16163	Alive	TUMOR FREE	1692	548	[Not Available]	NA	NA	364	[Not Available]	0	1692	0	1692	0	1692	0	1692	48.88	4.63	40-49	Stage 2
1342	TCGA-E2-A15J	BRCA	51	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18771	Alive	TUMOR FREE	1640	548	[Not Available]	NA	NA	364	[Not Available]	0	1640	0	1640	0	1640	0	1640	55.88	4.49	50-59	Stage 1
1343	TCGA-E2-A15K	BRCA	58	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21514	Alive	TUMOR FREE	275	548	[Not Available]	NA	NA	364	[Not Available]	0	275	0	275	0	275	0	275	59.66	0.75	50-59	Stage 2
1344	TCGA-E2-A15L	BRCA	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23845	Alive	TUMOR FREE	626	548	[Not Available]	NA	NA	364	[Not Available]	0	626	0	626	0	626	0	626	67	1.71	60-69	Stage 2
1345	TCGA-E2-A15M	BRCA	66	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24266	Dead	TUMOR FREE	766	336	[Not Available]	NA	NA	364	[Not Available]	1	336	0	336	0	336	0	336	67.36	0.92	60-69	Stage 2
1346	TCGA-E2-A15O	BRCA	89	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32583	Alive	TUMOR FREE	1545	548	[Not Available]	Locoregional Recurrence	NA	1210	[Not Available]	0	1545	0	1545	1	1210	1	1210	93.44	4.23	>=80	Stage 1
1347	TCGA-E2-A15P	BRCA	61	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22524	Alive	TUMOR FREE	595	548	[Not Available]	NA	NA	364	[Not Available]	0	595	0	595	0	595	0	595	63.3	1.63	60-69	Stage 1
1348	TCGA-E2-A15R	BRCA	64	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23570	Alive	TUMOR FREE	1732	548	[Not Available]	NA	NA	364	[Not Available]	0	1732	0	1732	0	1732	0	1732	69.27	4.74	60-69	Stage 2
1349	TCGA-E2-A15S	BRCA	34	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-12671	Alive	TUMOR FREE	428	548	[Not Available]	NA	NA	364	[Not Available]	0	428	0	428	0	428	0	428	35.86	1.17	30-39	Stage 2
1350	TCGA-E2-A15T	BRCA	65	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24054	Alive	TUMOR FREE	1563	548	[Not Available]	NA	NA	364	[Not Available]	0	1563	0	1563	0	1563	0	1563	70.14	4.28	60-69	Stage 2
1351	TCGA-E2-A1AZ	BRCA	63	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23230	Alive	TUMOR FREE	2329	548	[Not Available]	NA	NA	364	[Not Available]	0	2329	0	2329	0	2329	0	2329	69.98	6.38	60-69	Stage 2
1352	TCGA-E2-A1B0	BRCA	50	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18346	Alive	TUMOR FREE	1631	548	[Not Available]	NA	NA	364	[Not Available]	0	1631	0	1631	0	1631	0	1631	54.69	4.47	50-59	Stage 3
1353	TCGA-E2-A1B1	BRCA	45	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16603	Alive	TUMOR FREE	2653	548	[Not Available]	NA	NA	364	[Not Available]	0	2653	0	2653	0	2653	0	2653	52.72	7.26	40-49	Stage 2
1354	TCGA-E2-A1B4	BRCA	74	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27241	Dead	TUMOR FREE	766	1004	[Not Available]	NA	NA	364	[Not Available]	1	1004	0	1004	0	1004	0	1004	77.33	2.75	70-79	Stage 3
1355	TCGA-E2-A1B5	BRCA	46	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17039	Alive	TUMOR FREE	984	548	[Not Available]	NA	NA	364	[Not Available]	0	984	0	984	0	984	0	984	49.34	2.69	40-49	Stage 2
1356	TCGA-E2-A1B6	BRCA	44	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16370	Alive	TUMOR FREE	867	548	[Not Available]	NA	NA	364	[Not Available]	0	867	0	867	0	867	0	867	47.19	2.37	40-49	Stage 2
1357	TCGA-E2-A1BC	BRCA	63	FEMALE	[Not Available]	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23168	Alive	TUMOR FREE	501	548	[Not Available]	NA	NA	364	[Not Available]	0	501	0	501	0	720	0	501	64.8	1.37	60-69	Stage 1
1358	TCGA-E2-A1BD	BRCA	53	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19627	Alive	TUMOR FREE	1133	548	[Not Available]	NA	NA	364	[Not Available]	0	1133	0	1133	0	1133	0	1133	56.84	3.1	50-59	Stage 2
1359	TCGA-E2-A1IE	BRCA	61	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22510	Alive	WITH TUMOR	2362	548	[Not Available]	Distant Metastasis	Liver	1810	[Not Available]	0	2362	0	2362	1	1810	1	1810	68.1	6.47	60-69	Stage 2
1360	TCGA-E2-A1IF	BRCA	74	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27341	Alive	TUMOR FREE	1138	548	[Not Available]	NA	NA	364	[Not Available]	0	1138	0	1138	0	1138	0	1138	77.97	3.12	70-79	Stage 1
1361	TCGA-E2-A1IG	BRCA	45	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16757	Alive	TUMOR FREE	2140	548	[Not Available]	NA	NA	364	[Not Available]	0	2140	0	2140	0	2140	0	2140	51.74	5.86	40-49	Stage 2
1362	TCGA-E2-A1IH	BRCA	80	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29444	Alive	TUMOR FREE	1026	548	[Not Available]	NA	NA	364	[Not Available]	0	1026	0	1026	0	1026	0	1026	83.42	2.81	>=80	Stage 1
1363	TCGA-E2-A1II	BRCA	51	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18788	Alive	TUMOR FREE	1025	548	[Not Available]	NA	NA	364	[Not Available]	0	1025	0	1025	0	1025	0	1025	54.25	2.81	50-59	Stage 1
1364	TCGA-E2-A1IJ	BRCA	57	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20956	Alive	TUMOR FREE	865	548	[Not Available]	NA	NA	364	[Not Available]	0	865	0	865	0	865	0	865	59.74	2.37	50-59	Stage 1
1365	TCGA-E2-A1IK	BRCA	71	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26052	Alive	TUMOR FREE	1800	548	[Not Available]	NA	NA	364	[Not Available]	0	1800	0	1800	0	1800	0	1800	76.25	4.93	70-79	Stage 2
1366	TCGA-E2-A1IL	BRCA	78	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28495	Alive	TUMOR FREE	118	548	[Not Available]	NA	NA	364	[Not Available]	0	118	0	118	0	118	0	118	78.34	0.32	70-79	Stage 2
1367	TCGA-E2-A1IN	BRCA	60	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22199	Alive	TUMOR FREE	675	548	[Not Available]	NA	NA	364	[Not Available]	0	675	0	675	0	675	0	675	62.63	1.85	60-69	Stage 1
1368	TCGA-E2-A1IO	BRCA	37	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13671	Alive	TUMOR FREE	1855	548	[Not Available]	NA	NA	364	[Not Available]	0	1855	0	1855	0	1855	0	1855	42.51	5.08	30-39	Stage 1
1369	TCGA-E2-A1IU	BRCA	60	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22279	Alive	TUMOR FREE	337	548	[Not Available]	NA	NA	364	[Not Available]	0	337	0	337	0	337	0	337	61.92	0.92	60-69	Stage 1
1370	TCGA-E2-A1L6	BRCA	44	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16403	Alive	TUMOR FREE	1648	548	[Not Available]	NA	NA	364	[Not Available]	0	1648	0	1648	0	1648	0	1648	49.42	4.51	40-49	Stage 2
1371	TCGA-E2-A1L7	BRCA	40	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14854	Alive	TUMOR FREE	1836	548	[Not Available]	New Primary Tumor	Other, specify	1619	[Not Available]	0	1836	0	1836	1	1619	1	1619	45.69	5.03	40-49	Stage 3
1372	TCGA-E2-A1L8	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19187	Alive	TUMOR FREE	2240	548	[Not Available]	NA	NA	364	[Not Available]	0	2240	0	2240	0	2240	0	2240	58.66	6.13	50-59	Stage 2
1373	TCGA-E2-A1L9	BRCA	40	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14868	Alive	TUMOR FREE	598	548	[Not Available]	NA	NA	364	[Not Available]	0	598	0	598	0	598	0	598	42.34	1.64	40-49	Stage 2
1374	TCGA-E2-A1LA	BRCA	59	FEMALE	[Not Available]	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21773	Alive	TUMOR FREE	748	548	[Not Available]	NA	NA	364	[Not Available]	0	748	0	748	0	748	0	748	61.66	2.05	50-59	Stage 2
1375	TCGA-E2-A1LB	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15283	Alive	TUMOR FREE	2306	548	[Not Available]	NA	NA	364	[Not Available]	0	2306	0	2306	0	2306	0	2306	48.16	6.31	40-49	Stage 2
1376	TCGA-E2-A1LE	BRCA	71	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26239	Dead	WITH TUMOR	766	879	[Not Available]	Distant Metastasis	Lung	361	[Not Available]	1	879	1	879	1	361	1	361	74.25	2.41	70-79	Stage 3
1377	TCGA-E2-A1LG	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Peri (6-12 months since last menstrual period)	-18492	Alive	TUMOR FREE	1523	548	[Not Available]	NA	NA	364	[Not Available]	0	1523	0	1523	0	1523	0	1523	54.8	4.17	50-59	Stage 2
1378	TCGA-E2-A1LH	BRCA	59	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21628	Alive	TUMOR FREE	3247	548	[Not Available]	NA	NA	364	[Not Available]	0	3247	0	3247	0	3247	0	3247	68.1	8.89	50-59	Stage 1
1379	TCGA-E2-A1LI	BRCA	57	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21064	Alive	TUMOR FREE	3121	548	[Not Available]	NA	NA	364	[Not Available]	0	3121	0	3121	0	720	0	3121	66.21	8.54	50-59	Stage 2
1380	TCGA-E2-A1LK	BRCA	84	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30757	Dead	WITH TUMOR	766	266	[Not Available]	Locoregional Disease	Other, specify	155	[Not Available]	1	266	1	266	1	155	1	155	84.94	0.73	>=80	Stage 3
1381	TCGA-E2-A1LL	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27028	Alive	WITH TUMOR	1309	548	[Not Available]	Distant Metastasis	Liver	1303	[Not Available]	0	1309	0	1309	1	1303	1	1303	77.58	3.58	70-79	Stage 3
1382	TCGA-E2-A1LS	BRCA	46	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16887	Alive	TUMOR FREE	1604	548	[Not Available]	NA	NA	364	[Not Available]	0	1604	0	1604	0	1604	0	1604	50.63	4.39	40-49	Stage 1
1383	TCGA-E2-A2P5	BRCA	78	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28621	Dead	WITH TUMOR	766	821	[Not Available]	Distant Metastasis	Bone	597	[Not Available]	1	821	1	821	1	597	1	597	80.61	2.25	70-79	Stage 3
1384	TCGA-E2-A2P6	BRCA	77	FEMALE	[Not Available]	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28411	Alive	TUMOR FREE	1051	548	[Not Available]	NA	NA	364	[Not Available]	0	1051	0	1051	0	1051	0	1051	80.66	2.88	70-79	Stage 2
1385	TCGA-E2-A3DX	BRCA	43	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15969	Alive	TUMOR FREE	1325	548	[Not Available]	NA	NA	364	[Not Available]	0	1325	0	1325	0	720	0	1325	47.35	3.63	40-49	Stage 3
1386	TCGA-E2-A56Z	BRCA	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25282	Alive	TUMOR FREE	252	548	[Not Available]	NA	NA	364	[Not Available]	0	252	0	252	0	252	0	252	69.91	0.69	60-69	Stage 2
1387	TCGA-E2-A570	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17456	Alive	TUMOR FREE	931	548	[Not Available]	NA	NA	364	[Not Available]	0	931	0	931	0	931	0	931	50.34	2.55	40-49	Stage 1
1388	TCGA-E2-A572	BRCA	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26399	Alive	TUMOR FREE	1208	548	[Not Available]	NA	NA	364	[Not Available]	0	1208	0	1208	0	1208	0	1208	75.58	3.31	70-79	Stage 3
1389	TCGA-E2-A573	BRCA	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Peri (6-12 months since last menstrual period)	-17689	Alive	TUMOR FREE	1062	548	[Not Available]	NA	NA	364	[Not Available]	0	1062	0	1062	0	1062	0	1062	51.34	2.91	40-49	Stage 1
1390	TCGA-E2-A574	BRCA	44	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16195	Alive	TUMOR FREE	1179	548	[Not Available]	NA	NA	364	[Not Available]	0	1179	0	1179	0	1179	0	1179	47.57	3.23	40-49	Stage 2
1391	TCGA-E2-A576	BRCA	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25350	Alive	TUMOR FREE	1043	548	[Not Available]	NA	NA	364	[Not Available]	0	1043	0	1043	0	1043	0	1043	72.26	2.86	60-69	Stage 1
1392	TCGA-E2-A9RU	BRCA	90	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32873	Alive	TUMOR FREE	538	548	[Not Available]	NA	NA	364	[Not Available]	0	538	0	538	0	538	0	538	91.47	1.47	>=80	Stage 3
1393	TCGA-E9-A1N3	BRCA	70	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25714	Alive	TUMOR FREE	1059	548	[Not Available]	NA	NA	364	[Not Available]	0	1059	0	1059	0	1059	0	1059	73.3	2.9	70-79	Stage 3
1394	TCGA-E9-A1N4	BRCA	41	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15055	Alive	TUMOR FREE	1000	548	[Not Available]	NA	NA	364	[Not Available]	0	1000	0	1000	0	1000	0	1000	43.96	2.74	40-49	Stage 3
1395	TCGA-E9-A1N5	BRCA	45	FEMALE	WHITE	Stage IIB	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16736	Alive	TUMOR FREE	1120	548	[Not Available]	NA	NA	364	[Not Available]	0	1120	0	1120	0	1120	0	1120	48.89	3.07	40-49	Stage 2
1396	TCGA-E9-A1N6	BRCA	52	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19327	Dead	WITH TUMOR	766	678	[Not Available]	Distant Metastasis	Bone	443	[Not Available]	1	678	1	678	1	443	1	443	54.77	1.86	50-59	Stage 2
1397	TCGA-E9-A1N8	BRCA	48	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17652	Alive	TUMOR FREE	1039	548	[Not Available]	NA	NA	364	[Not Available]	0	1039	0	1039	0	1039	0	1039	51.17	2.84	40-49	Stage 2
1398	TCGA-E9-A1N9	BRCA	58	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21228	Alive	TUMOR FREE	1101	548	[Not Available]	NA	NA	364	[Not Available]	0	1101	0	1101	0	1101	0	1101	61.13	3.01	50-59	Stage 2
1399	TCGA-E9-A1NA	BRCA	58	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21397	Alive	TUMOR FREE	1112	548	[Not Available]	NA	NA	364	[Not Available]	0	1112	0	1112	0	1112	0	1112	61.63	3.04	50-59	Stage 2
1400	TCGA-E9-A1NC	BRCA	61	FEMALE	WHITE	Stage IIB	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22355	Alive	TUMOR FREE	1203	548	[Not Available]	NA	NA	364	[Not Available]	0	1203	0	1203	0	1203	0	1203	64.5	3.29	60-69	Stage 2
1401	TCGA-E9-A1ND	BRCA	75	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27400	Alive	TUMOR FREE	1266	548	[Not Available]	NA	NA	364	[Not Available]	0	1266	0	1266	0	1266	0	1266	78.48	3.47	70-79	Stage 2
1402	TCGA-E9-A1NE	BRCA	28	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10564	Alive	TUMOR FREE	1088	548	[Not Available]	NA	NA	364	[Not Available]	0	1088	0	1088	0	1088	0	1088	31.9	2.98	18-29	Stage 2
1403	TCGA-E9-A1NF	BRCA	60	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21981	Dead	WITH TUMOR	766	1072	[Not Available]	Distant Metastasis	Lung	90	[Not Available]	1	1072	1	1072	1	90	1	90	63.12	2.93	60-69	Stage 2
1404	TCGA-E9-A1NG	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22896	Dead	TUMOR FREE	766	786	[Not Available]	NA	NA	364	[Not Available]	1	786	0	786	0	786	0	786	64.84	2.15	60-69	Stage 2
1405	TCGA-E9-A1NH	BRCA	71	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26221	Alive	TUMOR FREE	576	548	[Not Available]	NA	NA	364	[Not Available]	0	576	0	576	0	576	0	576	73.37	1.58	70-79	Stage 2
1406	TCGA-E9-A1NI	BRCA	51	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18985	Alive	TUMOR FREE	300	548	[Not Available]	NA	NA	364	[Not Available]	0	300	0	300	0	300	0	300	52.8	0.82	50-59	Stage 2
1407	TCGA-E9-A1QZ	BRCA	61	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22397	Alive	TUMOR FREE	755	548	[Not Available]	NA	NA	364	[Not Available]	0	755	0	755	0	755	0	755	63.39	2.07	60-69	Stage 2
1408	TCGA-E9-A1R0	BRCA	58	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21394	Alive	TUMOR FREE	860	548	[Not Available]	NA	NA	364	[Not Available]	0	860	0	860	0	720	0	860	60.93	2.35	50-59	Stage 2
1409	TCGA-E9-A1R2	BRCA	51	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18936	Alive	TUMOR FREE	1063	548	[Not Available]	NA	NA	364	[Not Available]	0	1063	0	1063	0	720	0	1063	54.75	2.91	50-59	Stage 3
1410	TCGA-E9-A1R3	BRCA	70	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25693	Alive	TUMOR FREE	78	548	[Not Available]	NA	NA	364	[Not Available]	0	78	0	78	0	78	0	78	70.56	0.21	70-79	Stage 3
1411	TCGA-E9-A1R4	BRCA	66	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24181	Alive	TUMOR FREE	186	548	[Not Available]	NA	NA	364	[Not Available]	0	186	0	186	0	186	0	186	66.71	0.51	60-69	Stage 1
1412	TCGA-E9-A1R5	BRCA	63	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23116	Alive	TUMOR FREE	92	548	[Not Available]	NA	NA	364	[Not Available]	0	92	0	92	0	92	0	92	63.54	0.25	60-69	Stage 1
1413	TCGA-E9-A1R6	BRCA	63	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23347	Alive	TUMOR FREE	339	548	[Not Available]	NA	NA	364	[Not Available]	0	339	0	339	0	339	0	339	64.85	0.93	60-69	Stage 2
1414	TCGA-E9-A1R7	BRCA	64	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23397	Alive	TUMOR FREE	1467	548	[Not Available]	NA	NA	364	[Not Available]	0	1467	0	1467	0	1467	0	1467	68.07	4.02	60-69	Stage 2
1415	TCGA-E9-A1RA	BRCA	48	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17699	Alive	TUMOR FREE	1369	548	[Not Available]	NA	NA	364	[Not Available]	0	1369	0	1369	0	1369	0	1369	52.21	3.75	40-49	Stage 1
1416	TCGA-E9-A1RB	BRCA	40	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14755	Dead	TUMOR FREE	766	976	[Not Available]	NA	NA	364	[Not Available]	1	976	0	976	0	976	0	976	43.07	2.67	40-49	Stage 2
1417	TCGA-E9-A1RC	BRCA	56	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20795	Alive	TUMOR FREE	1224	548	[Not Available]	NA	NA	364	[Not Available]	0	1224	0	1224	0	1224	0	1224	60.28	3.35	50-59	Stage 3
1418	TCGA-E9-A1RD	BRCA	67	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24719	Alive	TUMOR FREE	34	548	[Not Available]	NA	NA	364	[Not Available]	0	34	0	34	0	34	0	34	67.77	0.09	60-69	Stage 2
1419	TCGA-E9-A1RE	BRCA	74	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27392	Alive	TUMOR FREE	1419	548	[Not Available]	NA	NA	364	[Not Available]	0	1419	0	1419	0	1419	0	1419	78.88	3.89	70-79	Stage 3
1420	TCGA-E9-A1RF	BRCA	68	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25119	Alive	TUMOR FREE	200	548	[Not Available]	NA	NA	364	[Not Available]	0	200	0	200	0	200	0	200	69.32	0.55	60-69	Stage 3
1421	TCGA-E9-A1RG	BRCA	62	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22788	Alive	TUMOR FREE	647	548	[Not Available]	NA	NA	364	[Not Available]	0	647	0	647	0	647	0	647	64.16	1.77	60-69	Stage 3
1422	TCGA-E9-A1RH	BRCA	63	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23224	Alive	TUMOR FREE	1417	548	[Not Available]	NA	NA	364	[Not Available]	0	1417	0	1417	0	1417	0	1417	67.46	3.88	60-69	Stage 2
1423	TCGA-E9-A1RI	BRCA	43	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15942	Alive	TUMOR FREE	1449	548	[Not Available]	NA	NA	364	[Not Available]	0	1449	0	1449	0	1449	0	1449	47.61	3.97	40-49	Stage 3
1424	TCGA-E9-A226	BRCA	45	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16511	Dead	WITH TUMOR	766	1048	[Not Available]	Distant Metastasis	Bone	790	[Not Available]	1	1048	1	1048	1	790	1	790	48.07	2.87	40-49	Stage 3
1425	TCGA-E9-A227	BRCA	42	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15602	Alive	TUMOR FREE	975	548	[Not Available]	NA	NA	364	[Not Available]	0	975	0	975	0	975	0	975	45.39	2.67	40-49	Stage 2
1426	TCGA-E9-A228	BRCA	58	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21294	Alive	TUMOR FREE	1285	548	[Not Available]	NA	NA	364	[Not Available]	0	1285	0	1285	0	1285	0	1285	61.82	3.52	50-59	Stage 2
1427	TCGA-E9-A229	BRCA	37	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13817	Alive	TUMOR FREE	1148	548	[Not Available]	NA	NA	364	[Not Available]	0	1148	0	1148	0	1148	0	1148	40.97	3.14	30-39	Stage 1
1428	TCGA-E9-A22A	BRCA	74	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27288	Alive	TUMOR FREE	1189	548	[Not Available]	NA	NA	364	[Not Available]	0	1189	0	1189	0	1189	0	1189	77.97	3.26	70-79	Stage 2
1429	TCGA-E9-A22B	BRCA	71	FEMALE	WHITE	Stage IA	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26278	Alive	TUMOR FREE	1167	548	[Not Available]	NA	NA	364	[Not Available]	0	1167	0	1167	0	1167	0	1167	75.14	3.2	70-79	Stage 1
1430	TCGA-E9-A22D	BRCA	38	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14115	Alive	TUMOR FREE	1248	548	[Not Available]	NA	NA	364	[Not Available]	0	1248	0	1248	0	1248	0	1248	42.06	3.42	30-39	Stage 2
1431	TCGA-E9-A22E	BRCA	56	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20574	Alive	TUMOR FREE	1269	548	[Not Available]	NA	NA	364	[Not Available]	0	1269	0	1269	0	1269	0	1269	59.8	3.47	50-59	Stage 3
1432	TCGA-E9-A22G	BRCA	47	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17300	Alive	TUMOR FREE	1239	548	[Not Available]	NA	NA	364	[Not Available]	0	1239	0	1239	0	1239	0	1239	50.76	3.39	40-49	Stage 2
1433	TCGA-E9-A22H	BRCA	42	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15504	Alive	TUMOR FREE	1232	548	[Not Available]	NA	NA	364	[Not Available]	0	1232	0	1232	0	1232	0	1232	45.82	3.37	40-49	Stage 2
1434	TCGA-E9-A243	BRCA	52	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Peri (6-12 months since last menstrual period)	-19035	Alive	WITH TUMOR	612	548	[Not Available]	Distant Metastasis	Bone	305	[Not Available]	0	612	0	612	1	305	1	305	53.79	1.68	50-59	Stage 2
1435	TCGA-E9-A244	BRCA	54	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19778	Alive	TUMOR FREE	21	548	[Not Available]	NA	NA	364	[Not Available]	0	21	0	21	0	21	0	21	54.21	0.06	50-59	Stage 2
1436	TCGA-E9-A245	BRCA	47	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17363	Alive	TUMOR FREE	26	548	[Not Available]	NA	NA	364	[Not Available]	0	26	0	26	0	26	0	26	47.61	0.07	40-49	Stage 2
1437	TCGA-E9-A247	BRCA	59	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21562	Alive	TUMOR FREE	1186	548	[Not Available]	NA	NA	364	[Not Available]	0	1186	0	1186	0	1186	0	1186	62.28	3.25	50-59	Stage 1
1438	TCGA-E9-A248	BRCA	51	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Peri (6-12 months since last menstrual period)	-18684	Alive	TUMOR FREE	59	548	[Not Available]	NA	NA	364	[Not Available]	0	59	0	59	0	59	0	59	51.32	0.16	50-59	Stage 2
1439	TCGA-E9-A249	BRCA	45	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16689	Alive	TUMOR FREE	217	548	[Not Available]	NA	NA	364	[Not Available]	0	217	0	217	0	217	0	217	46.29	0.59	40-49	Stage 2
1440	TCGA-E9-A24A	BRCA	69	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25370	Alive	TUMOR FREE	747	548	[Not Available]	NA	NA	364	[Not Available]	0	747	0	747	0	747	0	747	71.5	2.05	60-69	Stage 2
1441	TCGA-E9-A295	BRCA	71	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25957	Alive	TUMOR FREE	375	548	[Not Available]	NA	NA	364	[Not Available]	0	375	0	375	0	375	0	375	72.09	1.03	70-79	Stage 2
1442	TCGA-E9-A2JS	BRCA	72	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26407	Dead	WITH TUMOR	766	904	[Not Available]	Distant Metastasis	Bone	524	[Not Available]	1	904	1	904	1	524	1	524	74.77	2.48	70-79	Stage 2
1443	TCGA-E9-A2JT	BRCA	63	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23318	Alive	TUMOR FREE	288	548	[Not Available]	NA	NA	364	[Not Available]	0	288	0	288	0	288	0	288	64.63	0.79	60-69	Stage 2
1444	TCGA-E9-A3HO	BRCA	49	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18046	Alive	TUMOR FREE	1158	548	[Not Available]	NA	NA	364	[Not Available]	0	1158	0	1158	0	1158	0	1158	52.58	3.17	40-49	Stage 2
1445	TCGA-E9-A3Q9	BRCA	78	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28715	Alive	TUMOR FREE	1001	548	[Not Available]	NA	NA	364	[Not Available]	0	1001	0	1001	0	1001	0	1001	81.36	2.74	70-79	Stage 3
1446	TCGA-E9-A3QA	BRCA	33	FEMALE	WHITE	Stage IIA	[Not Applicable]	Medullary Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12142	Alive	TUMOR FREE	918	548	[Not Available]	NA	NA	364	[Not Available]	0	918	0	918	0	918	0	918	35.76	2.51	30-39	Stage 2
1447	TCGA-E9-A3X8	BRCA	48	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17588	Alive	TUMOR FREE	926	548	[Not Available]	NA	NA	364	[Not Available]	0	926	0	926	0	926	0	926	50.69	2.54	40-49	Stage 2
1448	TCGA-E9-A54X	BRCA	85	FEMALE	WHITE	Stage IA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31173	Alive	TUMOR FREE	727	548	[Not Available]	NA	NA	364	[Not Available]	0	727	0	727	0	727	0	727	87.34	1.99	>=80	Stage 1
1449	TCGA-E9-A54Y	BRCA	63	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23057	Alive	TUMOR FREE	725	548	[Not Available]	NA	NA	364	[Not Available]	0	725	0	725	0	725	0	725	65.11	1.98	60-69	Stage 3
1450	TCGA-E9-A5FK	BRCA	60	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22199	Alive	TUMOR FREE	812	548	[Not Available]	NA	NA	364	[Not Available]	0	812	0	812	0	812	0	812	63	2.22	60-69	Stage 3
1451	TCGA-E9-A5FL	BRCA	65	FEMALE	WHITE	Stage IIB	[Not Applicable]	Metaplastic Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24053	Alive	TUMOR FREE	24	548	[Not Available]	NA	NA	364	[Not Available]	0	24	0	24	0	24	0	24	65.92	0.07	60-69	Stage 2
1452	TCGA-E9-A5UO	BRCA	41	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15050	Alive	TUMOR FREE	785	548	[Not Available]	NA	NA	364	[Not Available]	0	785	0	785	0	785	0	785	43.35	2.15	40-49	Stage 2
1453	TCGA-E9-A5UP	BRCA	63	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23371	Alive	TUMOR FREE	803	548	[Not Available]	NA	NA	364	[Not Available]	0	803	0	803	0	803	0	803	66.18	2.2	60-69	Stage 2
1454	TCGA-E9-A6HE	BRCA	45	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16697	Alive	TUMOR FREE	847	548	[Not Available]	NA	NA	364	[Not Available]	0	847	0	847	0	847	0	847	48.03	2.32	40-49	Stage 3
1455	TCGA-EW-A1IW	BRCA	80	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29529	Alive	TUMOR FREE	371	548	[Not Available]	NA	NA	364	[Not Available]	0	371	0	371	0	371	0	371	81.86	1.02	>=80	Stage 2
1456	TCGA-EW-A1IX	BRCA	48	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2008	Peri (6-12 months since last menstrual period)	-17597	Alive	TUMOR FREE	1208	548	[Not Available]	NA	NA	364	[Not Available]	0	1208	0	1208	0	1208	0	1208	51.49	3.31	40-49	Stage 2
1457	TCGA-EW-A1IY	BRCA	38	FEMALE	ASIAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14122	Alive	TUMOR FREE	258	548	[Not Available]	NA	NA	364	[Not Available]	0	258	0	258	0	258	0	258	39.37	0.71	30-39	Stage 1
1458	TCGA-EW-A1IZ	BRCA	53	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19706	Alive	TUMOR FREE	554	548	[Not Available]	NA	NA	364	[Not Available]	0	554	0	554	0	554	0	554	55.47	1.52	50-59	Stage 3
1459	TCGA-EW-A1J1	BRCA	38	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14122	Alive	TUMOR FREE	575	548	[Not Available]	NA	NA	364	[Not Available]	0	575	0	575	0	575	0	575	40.24	1.57	30-39	Stage 2
1460	TCGA-EW-A1J2	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	[Discrepancy]	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18558	Alive	TUMOR FREE	403	548	[Not Available]	NA	NA	364	[Not Available]	0	403	0	403	0	403	0	403	51.91	1.1	50-59	other
1461	TCGA-EW-A1J3	BRCA	61	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22332	Alive	TUMOR FREE	504	548	[Not Available]	NA	NA	364	[Not Available]	0	504	0	504	0	504	0	504	62.52	1.38	60-69	Stage 1
1462	TCGA-EW-A1J5	BRCA	59	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21559	Alive	TUMOR FREE	477	548	[Not Available]	NA	NA	364	[Not Available]	0	477	0	477	0	477	0	477	60.33	1.31	50-59	Stage 2
1463	TCGA-EW-A1J6	BRCA	70	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25830	Alive	TUMOR FREE	875	548	[Not Available]	NA	NA	364	[Not Available]	0	875	0	875	0	875	0	875	73.11	2.4	70-79	Stage 1
1464	TCGA-EW-A1OV	BRCA	56	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20764	Alive	TUMOR FREE	789	548	[Not Available]	NA	NA	364	[Not Available]	0	789	0	789	0	789	0	789	59.01	2.16	50-59	Stage 2
1465	TCGA-EW-A1OW	BRCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21465	Alive	TUMOR FREE	694	548	[Not Available]	NA	NA	364	[Not Available]	0	694	0	694	0	694	0	694	60.67	1.9	50-59	Stage 2
1466	TCGA-EW-A1OX	BRCA	43	FEMALE	WHITE	Stage IIA	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15837	Alive	TUMOR FREE	911	548	[Not Available]	NA	NA	364	[Not Available]	0	911	0	911	0	911	0	911	45.85	2.49	40-49	Stage 2
1467	TCGA-EW-A1OY	BRCA	63	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23266	Alive	TUMOR FREE	908	548	[Not Available]	NA	NA	364	[Not Available]	0	908	0	908	0	908	0	908	66.18	2.49	60-69	Stage 2
1468	TCGA-EW-A1OZ	BRCA	56	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20664	Alive	TUMOR FREE	1229	548	[Not Available]	NA	NA	364	[Not Available]	0	1229	0	1229	0	1229	0	1229	59.94	3.36	50-59	Stage 2
1469	TCGA-EW-A1P0	BRCA	55	FEMALE	WHITE	Stage IIB	[Not Applicable]	Other, specify	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20107	Alive	TUMOR FREE	1251	548	[Not Available]	Distant Metastasis	Other, specify	1094	[Not Available]	0	1251	0	1251	1	1094	1	1094	58.48	3.43	50-59	Stage 2
1470	TCGA-EW-A1P1	BRCA	68	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24923	Alive	TUMOR FREE	1210	548	[Not Available]	Distant Metastasis	Lung	1014	[Not Available]	0	1210	0	1210	1	1014	1	1014	71.55	3.31	60-69	Stage 3
1471	TCGA-EW-A1P3	BRCA	48	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17637	Alive	TUMOR FREE	1611	548	[Not Available]	NA	NA	364	[Not Available]	0	1611	0	1611	0	1611	0	1611	52.7	4.41	40-49	Stage 2
1472	TCGA-EW-A1P4	BRCA	43	FEMALE	WHITE	Stage IIA	[Not Applicable]	Medullary Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15989	Alive	TUMOR FREE	907	548	[Not Available]	NA	NA	364	[Not Available]	0	907	0	907	0	907	0	907	46.26	2.48	40-49	Stage 2
1473	TCGA-EW-A1P5	BRCA	77	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28177	Alive	TUMOR FREE	703	548	[Not Available]	NA	NA	364	[Not Available]	0	703	0	703	0	703	0	703	79.07	1.92	70-79	Stage 2
1474	TCGA-EW-A1P6	BRCA	64	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23485	Alive	TUMOR FREE	562	548	[Not Available]	NA	NA	364	[Not Available]	0	562	0	562	0	720	0	562	65.84	1.54	60-69	Stage 2
1475	TCGA-EW-A1P7	BRCA	59	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21750	Alive	WITH TUMOR	915	548	[Not Available]	Distant Metastasis	Other, specify	729	[Not Available]	0	915	0	915	1	729	1	729	62.05	2.51	50-59	Stage 2
1476	TCGA-EW-A1P8	BRCA	58	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21501	Dead	WITH TUMOR	766	239	[Not Available]	Distant Metastasis	Lung	207	[Not Available]	1	239	1	239	1	207	1	207	59.52	0.65	50-59	Stage 3
1477	TCGA-EW-A1PA	BRCA	59	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21837	Alive	TUMOR FREE	575	548	[Not Available]	NA	NA	364	[Not Available]	0	575	0	575	0	575	0	575	61.36	1.57	50-59	Stage 2
1478	TCGA-EW-A1PB	BRCA	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25770	Alive	TUMOR FREE	608	548	[Not Available]	NA	NA	364	[Not Available]	0	608	0	608	0	608	0	608	72.22	1.66	70-79	Stage 3
1479	TCGA-EW-A1PC	BRCA	66	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24434	Alive	TUMOR FREE	187	548	[Not Available]	NA	NA	364	[Not Available]	0	187	0	187	0	187	0	187	67.41	0.51	60-69	Stage 2
1480	TCGA-EW-A1PD	BRCA	61	MALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	[Not Available]	-22536	Alive	TUMOR FREE	424	548	[Not Available]	NA	NA	364	[Not Available]	0	424	0	424	0	424	0	424	62.86	1.16	60-69	Stage 2
1481	TCGA-EW-A1PE	BRCA	56	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20694	Alive	TUMOR FREE	320	548	[Not Available]	NA	NA	364	[Not Available]	0	320	0	320	0	320	0	320	57.53	0.88	50-59	Stage 2
1482	TCGA-EW-A1PF	BRCA	50	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18384	Alive	TUMOR FREE	439	548	[Not Available]	NA	NA	364	[Not Available]	0	439	0	439	0	439	0	439	51.53	1.2	50-59	Stage 1
1483	TCGA-EW-A1PG	BRCA	53	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19464	Alive	TUMOR FREE	1051	548	[Not Available]	NA	NA	364	[Not Available]	0	1051	0	1051	0	1051	0	1051	56.17	2.88	50-59	Stage 2
1484	TCGA-EW-A1PH	BRCA	52	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19073	Alive	TUMOR FREE	607	548	[Not Available]	NA	NA	364	[Not Available]	0	607	0	607	0	607	0	607	53.88	1.66	50-59	Stage 2
1485	TCGA-EW-A2FR	BRCA	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21628	Alive	TUMOR FREE	1673	548	[Not Available]	NA	NA	364	[Not Available]	0	1673	0	1673	0	1673	0	1673	63.79	4.58	50-59	Stage 3
1486	TCGA-EW-A2FS	BRCA	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15302	Alive	TUMOR FREE	1604	548	[Not Available]	NA	NA	364	[Not Available]	0	1604	0	1604	0	1604	0	1604	46.29	4.39	40-49	Stage 2
1487	TCGA-EW-A2FV	BRCA	39	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Other, specify	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14316	Alive	TUMOR FREE	788	548	[Not Available]	NA	NA	364	[Not Available]	0	788	0	788	0	788	0	788	41.35	2.16	30-39	Stage 3
1488	TCGA-EW-A2FW	BRCA	52	FEMALE	WHITE	Stage IIA	[Not Applicable]	Other, specify	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19085	Alive	TUMOR FREE	672	548	[Not Available]	NA	NA	364	[Not Available]	0	672	0	672	0	672	0	672	54.09	1.84	50-59	Stage 2
1489	TCGA-EW-A3E8	BRCA	60	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	[Not Evaluated]	-21922	Alive	TUMOR FREE	1035	548	[Not Available]	NA	NA	364	[Not Available]	0	1035	0	1035	0	1035	0	1035	62.85	2.83	60-69	Stage 2
1490	TCGA-EW-A3U0	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22520	Alive	TUMOR FREE	532	548	[Not Available]	NA	NA	364	[Not Available]	0	532	0	532	0	532	0	532	63.11	1.46	60-69	Stage 3
1491	TCGA-EW-A423	BRCA	75	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27627	Alive	TUMOR FREE	533	548	[Not Available]	NA	NA	364	[Not Available]	0	533	0	533	0	533	0	533	77.1	1.46	70-79	Stage 2
1492	TCGA-EW-A424	BRCA	51	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	[Not Evaluated]	-18850	Alive	TUMOR FREE	715	548	[Not Available]	NA	NA	364	[Not Available]	0	715	0	715	0	715	0	715	53.57	1.96	50-59	Stage 3
1493	TCGA-EW-A6S9	BRCA	34	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	[Not Available]	-12755	Alive	TUMOR FREE	463	548	[Not Available]	NA	NA	364	[Not Available]	0	463	0	463	0	720	0	463	36.19	1.27	30-39	Stage 2
1494	TCGA-EW-A6SA	BRCA	59	MALE	BLACK OR AFRICAN AMERICAN	Stage II	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	[Not Available]	-21623	Alive	TUMOR FREE	510	548	[Not Available]	NA	NA	364	[Not Available]	0	510	0	510	0	510	0	510	60.6	1.4	50-59	Stage 2
1495	TCGA-EW-A6SB	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	[Not Available]	-22844	Alive	TUMOR FREE	760	548	[Not Available]	NA	NA	364	[Not Available]	0	760	0	760	0	760	0	760	64.62	2.08	60-69	Stage 2
1496	TCGA-EW-A6SC	BRCA	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	[Not Available]	-21918	Alive	TUMOR FREE	952	548	[Not Available]	NA	NA	364	[Not Available]	0	952	0	952	0	952	0	952	62.61	2.61	60-69	Stage 2
1497	TCGA-EW-A6SD	BRCA	32	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	[Not Available]	-12006	Alive	TUMOR FREE	1010	548	[Not Available]	NA	NA	364	[Not Available]	0	1010	0	1010	0	1010	0	1010	35.64	2.77	30-39	Stage 2
1498	TCGA-GI-A2C8	BRCA	63	FEMALE	WHITE	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	[Not Available]	-23103	Alive	TUMOR FREE	225	548	[Not Available]	NA	NA	364	[Not Available]	0	225	0	225	0	225	0	225	63.87	0.62	60-69	Stage 3
1499	TCGA-GI-A2C9	BRCA	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21534	Alive	TUMOR FREE	3342	548	[Not Available]	NA	NA	364	[Not Available]	0	3342	0	3342	0	3342	0	3342	68.11	9.15	50-59	Stage 2
1500	TCGA-GM-A2D9	BRCA	69	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25490	Dead	WITH TUMOR	766	1812	[Not Available]	Distant Metastasis	Bone	536	[Not Available]	1	1812	1	1812	1	536	1	536	74.75	4.96	60-69	Stage 1
1501	TCGA-GM-A2DA	BRCA	46	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	1993	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16854	Dead	WITH TUMOR	766	6593	[Not Available]	Distant Metastasis	Bone	3014	[Not Available]	1	6593	1	6593	1	3014	1	3014	64.19	18.05	40-49	Stage 2
1502	TCGA-GM-A2DB	BRCA	62	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22883	Alive	TUMOR FREE	2406	548	[Not Available]	NA	NA	364	[Not Available]	0	2406	0	2406	0	2406	0	2406	69.24	6.59	60-69	Stage 2
1503	TCGA-GM-A2DC	BRCA	57	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21122	Alive	TUMOR FREE	2535	548	[Not Available]	NA	NA	364	[Not Available]	0	2535	0	2535	0	2535	0	2535	64.77	6.94	50-59	Stage 2
1504	TCGA-GM-A2DD	BRCA	53	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19415	Alive	TUMOR FREE	2282	548	[Not Available]	NA	NA	364	[Not Available]	0	2282	0	2282	0	2282	0	2282	59.4	6.25	50-59	Stage 1
1505	TCGA-GM-A2DF	BRCA	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19614	Alive	TUMOR FREE	2155	548	[Not Available]	NA	NA	364	[Not Available]	0	2155	0	2155	0	2155	0	2155	59.6	5.9	50-59	Stage 2
1506	TCGA-GM-A2DH	BRCA	58	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21344	Alive	TUMOR FREE	2193	548	[Not Available]	NA	NA	364	[Not Available]	0	2193	0	2193	0	2193	0	2193	64.44	6	50-59	Stage 1
1507	TCGA-GM-A2DI	BRCA	52	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19030	Alive	TUMOR FREE	2590	548	[Not Available]	NA	NA	364	[Not Available]	0	2590	0	2590	0	2590	0	2590	59.19	7.09	50-59	Stage 1
1508	TCGA-GM-A2DK	BRCA	58	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21198	Alive	TUMOR FREE	2645	548	[Not Available]	NA	NA	364	[Not Available]	0	2645	0	2645	0	2645	0	2645	65.28	7.24	50-59	Stage 1
1509	TCGA-GM-A2DL	BRCA	50	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2003	Peri (6-12 months since last menstrual period)	-18475	Alive	TUMOR FREE	3519	548	[Not Available]	NA	NA	364	[Not Available]	0	3519	0	3519	0	3519	0	3519	60.22	9.63	50-59	Stage 1
1510	TCGA-GM-A2DM	BRCA	57	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21160	Alive	TUMOR FREE	3226	548	[Not Available]	NA	NA	364	[Not Available]	0	3226	0	3226	0	3226	0	3226	66.77	8.83	50-59	Stage 2
1511	TCGA-GM-A2DN	BRCA	58	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21288	Alive	TUMOR FREE	3091	548	[Not Available]	NA	NA	364	[Not Available]	0	3091	0	3091	0	3091	0	3091	66.75	8.46	50-59	Stage 2
1512	TCGA-GM-A2DO	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19842	Alive	TUMOR FREE	2596	548	[Not Available]	NA	NA	364	[Not Available]	0	2596	0	2596	0	2596	0	2596	61.43	7.11	50-59	Stage 1
1513	TCGA-GM-A3NW	BRCA	63	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23041	Alive	TUMOR FREE	3361	548	[Not Available]	NA	NA	364	[Not Available]	0	3361	0	3361	0	3361	0	3361	72.28	9.2	60-69	Stage 2
1514	TCGA-GM-A3NY	BRCA	72	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26642	Alive	TUMOR FREE	1162	548	[Not Available]	NA	NA	364	[Not Available]	0	1162	0	1162	0	1162	0	1162	76.12	3.18	70-79	Stage 2
1515	TCGA-GM-A3XG	BRCA	46	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16948	Alive	TUMOR FREE	1330	548	[Not Available]	NA	NA	364	[Not Available]	0	1330	0	1330	0	1330	0	1330	50.04	3.64	40-49	Stage 3
1516	TCGA-GM-A3XL	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18171	Alive	TUMOR FREE	2108	548	[Not Available]	NA	NA	364	[Not Available]	0	2108	0	2108	0	2108	0	2108	55.52	5.77	40-49	Stage 2
1517	TCGA-GM-A3XN	BRCA	44	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16109	Alive	TUMOR FREE	2019	548	[Not Available]	NA	NA	364	[Not Available]	0	2019	0	2019	0	2019	0	2019	49.63	5.53	40-49	Stage 3
1518	TCGA-GM-A4E0	BRCA	67	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24788	Alive	TUMOR FREE	2191	548	[Not Available]	NA	NA	364	[Not Available]	0	2191	0	2191	0	2191	0	2191	73.86	6	60-69	Stage 3
1519	TCGA-GM-A5PV	BRCA	63	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23215	Alive	TUMOR FREE	412	548	[Not Available]	NA	NA	364	[Not Available]	0	412	0	412	0	412	0	412	64.69	1.13	60-69	Stage 2
1520	TCGA-GM-A5PX	BRCA	65	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23753	Alive	TUMOR FREE	551	548	[Not Available]	NA	NA	364	[Not Available]	0	551	0	551	0	551	0	551	66.54	1.51	60-69	Stage 2
1521	TCGA-HN-A2NL	BRCA	56	FEMALE	[Not Evaluated]	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20483	Alive	TUMOR FREE	79	548	[Not Available]	NA	NA	364	[Not Available]	0	79	0	79	0	79	0	79	56.3	0.22	50-59	Stage 2
1522	TCGA-HN-A2OB	BRCA	45	FEMALE	[Not Evaluated]	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16672	Dead	WITH TUMOR	766	1900	[Not Available]	Distant Metastasis	Bone	1543	[Not Available]	1	1900	1	1900	1	1543	1	1543	50.85	5.2	40-49	Stage 2
1523	TCGA-JL-A3YW	BRCA	49	FEMALE	ASIAN	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	360	548	[Not Available]	NA	NA	364	[Not Available]	0	360	0	360	0	360	0	360	61.83	0.99	40-49	Stage 2
1524	TCGA-JL-A3YX	BRCA	46	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	352	548	[Not Available]	NA	NA	364	[Not Available]	0	352	0	352	0	352	0	352	61.8	0.96	40-49	Stage 2
1525	TCGA-LD-A66U	BRCA	44	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	[Not Evaluated]	-16101	Alive	TUMOR FREE	646	548	[Not Available]	NA	NA	364	[Not Available]	0	646	0	646	0	646	0	646	45.85	1.77	40-49	Stage 2
1526	TCGA-LD-A74U	BRCA	79	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Other, specify	[Not Available]	2013	[Not Available]	-28981	Alive	WITH TUMOR	402	548	[Not Available]	NA	NA	364	[Not Available]	0	402	0	402	0	402	0	402	80.45	1.1	70-79	Stage 3
1527	TCGA-LD-A7W5	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19169	Alive	WITH TUMOR	216	548	[Not Available]	NA	NA	364	[Not Available]	0	216	0	216	0	720	0	216	53.07	0.59	50-59	Stage 3
1528	TCGA-LD-A7W6	BRCA	54	FEMALE	WHITE	Stage IIB	[Not Applicable]	Other, specify	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20077	Alive	TUMOR FREE	404	548	[Not Available]	NA	NA	364	[Not Available]	0	404	0	404	0	404	0	404	56.07	1.11	50-59	Stage 2
1529	TCGA-LD-A9QF	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26869	Alive	TUMOR FREE	323	548	[Not Available]	NA	NA	364	[Not Available]	0	323	0	323	0	323	0	323	74.45	0.88	70-79	Stage 1
1530	TCGA-LL-A440	BRCA	61	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22497	Alive	TUMOR FREE	759	548	[Not Available]	NA	NA	364	[Not Available]	0	759	0	759	0	759	0	759	63.67	2.08	60-69	Stage 1
1531	TCGA-LL-A441	BRCA	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22772	Alive	TUMOR FREE	996	548	[Not Available]	NA	NA	364	[Not Available]	0	996	0	996	0	996	0	996	65.07	2.73	60-69	Stage 1
1532	TCGA-LL-A442	BRCA	56	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20495	Alive	TUMOR FREE	889	548	[Not Available]	NA	NA	364	[Not Available]	0	889	0	889	0	889	0	889	58.55	2.43	50-59	Stage 2
1533	TCGA-LL-A50Y	BRCA	84	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30934	Alive	TUMOR FREE	762	548	[Not Available]	NA	NA	364	[Not Available]	0	762	0	762	0	762	0	762	86.78	2.09	>=80	Stage 2
1534	TCGA-LL-A5YL	BRCA	64	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23395	Alive	TUMOR FREE	519	548	[Not Available]	NA	NA	364	[Not Available]	0	519	0	519	0	519	0	519	65.47	1.42	60-69	Stage 2
1535	TCGA-LL-A5YM	BRCA	88	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32478	Alive	WITH TUMOR	466	548	[Not Available]	Locoregional Recurrence	Other, specify	258	[Not Available]	0	466	0	466	1	258	1	258	90.2	1.28	>=80	Stage 3
1536	TCGA-LL-A5YN	BRCA	46	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16884	Alive	TUMOR FREE	447	548	[Not Available]	NA	NA	364	[Not Available]	0	447	0	447	0	447	0	447	47.45	1.22	40-49	Stage 2
1537	TCGA-LL-A5YO	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18354	Alive	TUMOR FREE	440	548	[Not Available]	NA	NA	364	[Not Available]	0	440	0	440	0	440	0	440	51.46	1.2	50-59	Stage 1
1538	TCGA-LL-A5YP	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18041	Alive	TUMOR FREE	450	548	[Not Available]	NA	NA	364	[Not Available]	0	450	0	450	0	450	0	450	50.63	1.23	40-49	Stage 2
1539	TCGA-LL-A6FP	BRCA	90	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32873	Alive	TUMOR FREE	677	548	[Not Available]	NA	NA	364	[Not Available]	0	677	0	677	0	677	0	677	91.85	1.85	>=80	Stage 2
1540	TCGA-LL-A6FQ	BRCA	77	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28375	Alive	TUMOR FREE	80	548	[Not Available]	NA	NA	364	[Not Available]	0	80	0	80	0	80	0	80	77.91	0.22	70-79	Stage 3
1541	TCGA-LL-A6FR	BRCA	50	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18520	Alive	TUMOR FREE	489	548	[Not Available]	NA	NA	364	[Not Available]	0	489	0	489	0	489	0	489	52.04	1.34	50-59	Stage 2
1542	TCGA-LL-A73Y	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24647	Alive	TUMOR FREE	477	548	[Not Available]	NA	NA	364	[Not Available]	0	477	0	477	0	477	0	477	68.79	1.31	60-69	Stage 1
1543	TCGA-LL-A73Z	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20118	Dead	WITH TUMOR	766	227	[Not Available]	Distant Metastasis	Brain	192	[Not Available]	1	227	1	227	0	720	1	192	55.7	0.62	50-59	Stage 4
1544	TCGA-LL-A740	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22416	Alive	TUMOR FREE	441	548	[Not Available]	NA	NA	364	[Not Available]	0	441	0	441	0	441	0	441	62.58	1.21	60-69	Stage 1
1545	TCGA-LL-A7SZ	BRCA	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18161	Alive	TUMOR FREE	594	548	[Not Available]	NA	NA	364	[Not Available]	0	594	0	594	0	594	0	594	51.35	1.63	40-49	Stage 2
1546	TCGA-LL-A7T0	BRCA	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25867	Alive	TUMOR FREE	376	548	[Not Available]	NA	NA	364	[Not Available]	0	376	0	376	0	376	0	376	71.85	1.03	70-79	Stage 2
1547	TCGA-LL-A8F5	BRCA	61	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22544	Alive	TUMOR FREE	596	548	[Not Available]	NA	NA	364	[Not Available]	0	596	0	596	0	596	0	596	63.35	1.63	60-69	Stage 2
1548	TCGA-LL-A9Q3	BRCA	69	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25477	Alive	TUMOR FREE	532	548	[Not Available]	NA	NA	364	[Not Available]	0	532	0	532	0	532	0	532	71.21	1.46	60-69	Stage 3
1549	TCGA-LQ-A4E4	BRCA	73	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26883	Alive	WITH TUMOR	849	548	[Not Available]	Distant Metastasis	Bone	681	[Not Available]	0	849	0	849	0	720	1	681	75.93	2.32	70-79	Stage 3
1550	TCGA-MS-A51U	BRCA	44	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	[Not Available]	-16213	Alive	TUMOR FREE	681	548	[Not Available]	NA	NA	364	[Not Available]	0	681	0	681	0	681	0	681	46.25	1.86	40-49	Stage 2
1551	TCGA-OK-A5Q2	BRCA	59	FEMALE	[Not Evaluated]	Stage II	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	[Unknown]	-21555	Alive	TUMOR FREE	64	548	[Not Available]	NA	NA	364	[Not Available]	0	64	0	64	0	64	0	64	59.19	0.18	50-59	Stage 2
1552	TCGA-OL-A5D6	BRCA	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26052	Dead	TUMOR FREE	766	1104	[Not Available]	NA	NA	364	[Not Available]	1	1104	0	1104	0	1104	0	1104	74.35	3.02	70-79	Stage 2
1553	TCGA-OL-A5D7	BRCA	70	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25643	Alive	TUMOR FREE	1780	548	[Not Available]	NA	NA	364	[Not Available]	0	1780	0	1780	0	1780	0	1780	75.08	4.87	70-79	Stage 2
1554	TCGA-OL-A5D8	BRCA	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14853	Alive	TUMOR FREE	973	548	[Not Available]	NA	NA	364	[Not Available]	0	973	0	973	0	720	0	973	43.33	2.66	40-49	Stage 2
1555	TCGA-OL-A5DA	BRCA	61	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22411	Alive	TUMOR FREE	1783	548	[Not Available]	NA	NA	364	[Not Available]	0	1783	0	1783	0	1783	0	1783	66.24	4.88	60-69	Stage 2
1556	TCGA-OL-A5RU	BRCA	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23108	Alive	TUMOR FREE	1219	548	[Not Available]	NA	NA	364	[Not Available]	0	1219	0	1219	0	1219	0	1219	66.6	3.34	60-69	Stage 2
1557	TCGA-OL-A5RV	BRCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15820	Alive	TUMOR FREE	1062	548	[Not Available]	NA	NA	364	[Not Available]	0	1062	0	1062	0	1062	0	1062	46.22	2.91	40-49	Stage 3
1558	TCGA-OL-A5RW	BRCA	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14638	Alive	TUMOR FREE	1106	548	[Not Available]	NA	NA	364	[Not Available]	0	1106	0	1106	0	1106	0	1106	43.1	3.03	40-49	Stage 2
1559	TCGA-OL-A5RX	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18942	Alive	TUMOR FREE	878	548	[Not Available]	NA	NA	364	[Not Available]	0	878	0	878	0	878	0	878	54.26	2.4	50-59	Stage 1
1560	TCGA-OL-A5RY	BRCA	52	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19216	Alive	TUMOR FREE	752	548	[Not Available]	NA	NA	364	[Not Available]	0	752	0	752	0	752	0	752	54.67	2.06	50-59	Stage 2
1561	TCGA-OL-A5RZ	BRCA	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21038	Alive	TUMOR FREE	679	548	[Not Available]	NA	NA	364	[Not Available]	0	679	0	679	0	679	0	679	59.46	1.86	50-59	Stage 1
1562	TCGA-OL-A5S0	BRCA	66	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24139	Alive	TUMOR FREE	620	548	[Not Available]	NA	NA	364	[Not Available]	0	620	0	620	0	620	0	620	67.79	1.7	60-69	Stage 2
1563	TCGA-OL-A66H	BRCA	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB	[Not Applicable]	Mucinous Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	766	548	[Not Available]	NA	NA	364	[Not Available]	0	714	0	722	0	720	0	564	62.94	2.1	60-69	Stage 1
1564	TCGA-OL-A66I	BRCA	36	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2008	[Not Evaluated]	-13458	Alive	TUMOR FREE	714	548	[Not Available]	NA	NA	364	[Not Available]	0	714	0	714	0	714	0	714	38.8	1.95	30-39	Stage 2
1565	TCGA-OL-A66J	BRCA	80	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29345	Alive	TUMOR FREE	1996	548	[Not Available]	NA	NA	364	[Not Available]	0	1996	0	1996	0	1996	0	1996	85.81	5.46	>=80	Stage 1
1566	TCGA-OL-A66K	BRCA	72	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26299	Dead	TUMOR FREE	766	1275	[Not Available]	NA	NA	364	[Not Available]	1	1275	0	1275	0	1275	0	1275	75.49	3.49	70-79	Stage 2
1567	TCGA-OL-A66L	BRCA	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26186	Alive	TUMOR FREE	1301	548	[Not Available]	NA	NA	364	[Not Available]	0	1301	0	1301	0	1301	0	1301	75.26	3.56	70-79	Stage 1
1568	TCGA-OL-A66N	BRCA	59	FEMALE	WHITE	Stage IIIC	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21608	Alive	TUMOR FREE	792	548	[Not Available]	NA	NA	364	[Not Available]	0	792	0	792	0	792	0	792	61.33	2.17	50-59	Stage 3
1569	TCGA-OL-A66O	BRCA	39	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14272	Alive	TUMOR FREE	528	548	[Not Available]	NA	NA	364	[Not Available]	0	528	0	528	0	528	0	528	40.52	1.45	30-39	Stage 2
1570	TCGA-OL-A66P	BRCA	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	[Not Available]	-27489	Alive	TUMOR FREE	428	548	[Not Available]	NA	NA	364	[Not Available]	0	428	0	428	0	428	0	428	76.43	1.17	70-79	Stage 2
1571	TCGA-OL-A6VO	BRCA	43	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2012	[Unknown]	-15780	Alive	TUMOR FREE	858	548	[Not Available]	NA	NA	364	[Not Available]	0	858	0	858	0	858	0	858	45.55	2.35	40-49	Stage 1
1572	TCGA-OL-A6VQ	BRCA	49	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18151	Alive	TUMOR FREE	600	548	[Not Available]	NA	NA	364	[Not Available]	0	600	0	600	0	600	0	600	51.34	1.64	40-49	Stage 2
1573	TCGA-OL-A6VR	BRCA	48	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2011	[Unknown]	-17702	Alive	TUMOR FREE	1220	548	[Not Available]	NA	NA	364	[Not Available]	0	1220	0	1220	0	1220	0	1220	51.81	3.34	40-49	Stage 1
1574	TCGA-OL-A97C	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Other, specify	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24735	Alive	TUMOR FREE	271	548	[Not Available]	Distant Metastasis	Lung	275	[Not Available]	0	271	0	271	0	720	1	275	68.46	0.74	60-69	Stage 2
1575	TCGA-PE-A5DC	BRCA	72	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26514	Dead	TUMOR FREE	766	1430	[Not Available]	NA	NA	364	[Not Available]	1	1430	0	1430	0	720	0	1430	76.51	3.92	70-79	Stage 3
1576	TCGA-PE-A5DD	BRCA	64	FEMALE	ASIAN	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23686	Alive	TUMOR FREE	1953	548	[Not Available]	NA	NA	364	[Not Available]	0	1953	0	1953	0	1953	0	1953	70.2	5.35	60-69	Stage 2
1577	TCGA-PE-A5DE	BRCA	41	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15216	Alive	TUMOR FREE	2645	548	[Not Available]	NA	NA	364	[Not Available]	0	2645	0	2645	0	720	0	2645	48.9	7.24	40-49	Stage 2
1578	TCGA-PL-A8LV	BRCA	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	[Not Applicable]	Medullary Carcinoma	[Not Available]	2013	[Unknown]	-19746	Alive	WITH TUMOR	-7	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	720	0	0	54.04	-0.02	50-59	Stage 3
1579	TCGA-PL-A8LX	BRCA	35	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12840	Alive	WITH TUMOR	5	548	[Not Available]	NA	NA	364	[Not Available]	0	5	0	5	0	720	0	5	35.17	0.01	30-39	Stage 4
1580	TCGA-PL-A8LY	BRCA	30	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11199	Alive	WITH TUMOR	8	548	[Not Available]	NA	NA	364	[Not Available]	0	8	0	8	0	720	0	8	30.68	0.02	30-39	Stage 2
1581	TCGA-PL-A8LZ	BRCA	29	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10869	Alive	TUMOR FREE	302	548	[Not Available]	NA	NA	364	[Not Available]	0	302	0	302	0	720	0	302	30.58	0.83	18-29	Stage 3
1582	TCGA-S3-A6ZF	BRCA	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23650	Alive	TUMOR FREE	572	548	[Not Available]	NA	NA	364	[Not Available]	0	572	0	572	0	572	0	572	66.32	1.57	60-69	Stage 2
1583	TCGA-S3-A6ZG	BRCA	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Mixed Histology (please specify)	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26141	Alive	TUMOR FREE	562	548	[Not Available]	NA	NA	364	[Not Available]	0	562	0	562	0	562	0	562	73.11	1.54	70-79	Stage 2
1584	TCGA-S3-A6ZH	BRCA	29	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	[Unknown]	-10832	Alive	TUMOR FREE	641	548	[Not Available]	NA	NA	364	[Not Available]	0	641	0	641	0	641	0	641	31.41	1.75	18-29	Stage 3
1585	TCGA-S3-AA0Z	BRCA	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23314	Alive	TUMOR FREE	629	548	[Not Available]	NA	NA	364	[Not Available]	0	629	0	629	0	629	0	629	65.55	1.72	60-69	Stage 2
1586	TCGA-S3-AA10	BRCA	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24075	Alive	TUMOR FREE	586	548	[Not Available]	NA	NA	364	[Not Available]	0	586	0	586	0	586	0	586	67.52	1.6	60-69	Stage 2
1587	TCGA-S3-AA11	BRCA	67	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24813	Alive	TUMOR FREE	421	548	[Not Available]	NA	NA	364	[Not Available]	0	421	0	421	0	421	0	421	69.09	1.15	60-69	Stage 2
1588	TCGA-S3-AA12	BRCA	82	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30101	Alive	TUMOR FREE	574	548	[Not Available]	NA	NA	364	[Not Available]	0	574	0	574	0	574	0	574	83.98	1.57	>=80	Stage 3
1589	TCGA-S3-AA14	BRCA	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17352	Alive	TUMOR FREE	529	548	[Not Available]	NA	NA	364	[Not Available]	0	529	0	529	0	529	0	529	48.96	1.45	40-49	Stage 1
1590	TCGA-S3-AA15	BRCA	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18659	Alive	TUMOR FREE	525	548	[Not Available]	NA	NA	364	[Not Available]	0	525	0	525	0	525	0	525	52.52	1.44	50-59	Stage 2
1591	TCGA-S3-AA17	BRCA	64	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23642	Alive	TUMOR FREE	424	548	[Not Available]	NA	NA	364	[Not Available]	0	424	0	424	0	424	0	424	65.89	1.16	60-69	Stage 2
1592	TCGA-UL-AAZ6	BRCA	73	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26999	Alive	TUMOR FREE	518	548	[Not Available]	NA	NA	364	[Not Available]	0	518	0	518	0	720	0	518	75.34	1.42	70-79	Stage 2
1593	TCGA-UU-A93S	BRCA	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23278	Dead	WITH TUMOR	766	116	[Not Available]	NA	NA	364	[Not Available]	1	116	1	116	0	720	1	116	64.05	0.32	60-69	Stage 4
1594	TCGA-V7-A7HQ	BRCA	75	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27684	Alive	TUMOR FREE	2033	548	[Not Available]	NA	NA	364	[Not Available]	0	2033	0	2033	0	2033	0	2033	81.36	5.57	70-79	Stage 3
1595	TCGA-W8-A86G	BRCA	66	FEMALE	WHITE	Stage IIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24125	Alive	TUMOR FREE	347	548	[Not Available]	NA	NA	364	[Not Available]	0	347	0	347	0	347	0	347	67	0.95	60-69	Stage 2
1596	TCGA-WT-AB41	BRCA	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB	[Not Applicable]	Infiltrating Ductal Carcinoma	[Not Available]	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	1611	548	[Not Available]	NA	NA	364	[Not Available]	0	1611	0	1611	0	1611	0	1611	65.25	4.41	50-59	Stage 2
1597	TCGA-WT-AB44	BRCA	77	FEMALE	WHITE	Stage IA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	883	548	[Not Available]	NA	NA	364	[Not Available]	0	883	0	883	0	883	0	883	63.26	2.42	70-79	Stage 1
1598	TCGA-XX-A899	BRCA	46	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17022	Alive	TUMOR FREE	467	548	[Not Available]	NA	NA	364	[Not Available]	0	467	0	467	0	467	0	467	47.88	1.28	40-49	Stage 3
1599	TCGA-XX-A89A	BRCA	68	FEMALE	WHITE	Stage IIB	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25000	Alive	TUMOR FREE	488	548	[Not Available]	NA	NA	364	[Not Available]	0	488	0	488	0	488	0	488	69.78	1.34	60-69	Stage 2
1600	TCGA-Z7-A8R5	BRCA	61	FEMALE	WHITE	Stage IIIA	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22280	Alive	WITH TUMOR	3287	548	[Not Available]	Locoregional Recurrence	NA	181	[Not Available]	0	3287	0	3287	0	720	1	181	70	9	60-69	Stage 3
1601	TCGA-Z7-A8R6	BRCA	46	FEMALE	WHITE	Stage I	[Not Applicable]	Infiltrating Lobular Carcinoma	[Not Available]	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16955	Alive	TUMOR FREE	3256	548	[Not Available]	NA	NA	364	[Not Available]	0	3256	0	3256	0	3256	0	3256	55.33	8.91	40-49	Stage 1
2646	TCGA-02-0001	GBM	44	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-16179	Dead	WITH TUMOR	279	358	[Not Available]	Recurrence	[Not Applicable]	137	[Not Available]	1	358	1	358	0	720	1	137	45.28	0.98	40-49	other
2647	TCGA-02-0003	GBM	50	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-18341	Dead	WITH TUMOR	144	144	[Not Available]	Recurrence	[Not Applicable]	40	[Not Available]	1	144	1	144	0	720	1	40	50.61	0.39	50-59	other
2648	TCGA-02-0004	GBM	59	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-21617	Dead	WITH TUMOR	345	345	[Not Available]	Progression of Disease	[Not Applicable]	314	[Not Available]	1	345	1	345	0	720	1	314	60.13	0.94	50-59	other
2649	TCGA-02-0006	GBM	56	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-20516	Dead	WITH TUMOR	558	558	[Not Available]	Recurrence	[Not Applicable]	302	[Not Available]	1	558	1	558	0	720	1	302	57.7	1.53	50-59	other
2650	TCGA-02-0007	GBM	40	FEMALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2002	[Not Available]	-14806	Dead	WITH TUMOR	705	705	[Not Available]	Progression of Disease	[Not Applicable]	518	[Not Available]	1	705	1	705	0	720	1	518	42.47	1.93	40-49	other
2651	TCGA-02-0009	GBM	61	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-22457	Dead	WITH TUMOR	322	322	[Not Available]	Progression of Disease	[Not Applicable]	264	[Not Available]	1	322	1	322	0	720	1	264	62.37	0.88	60-69	other
2652	TCGA-02-0010	GBM	20	FEMALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2002	[Not Available]	-7452	Dead	WITH TUMOR	1077	1077	[Not Available]	Progression of Disease	[Not Applicable]	351	[Not Available]	1	1077	1	1077	0	720	1	351	23.35	2.95	18-29	other
2653	TCGA-02-0011	GBM	18	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-6926	Dead	WITH TUMOR	630	630	[Not Available]	Progression of Disease	[Not Applicable]	145	[Not Available]	1	630	1	630	0	720	1	145	20.69	1.72	18-29	other
2654	TCGA-02-0014	GBM	25	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-9369	Dead	WITH TUMOR	2512	2512	[Not Available]	Progression of Disease	[Not Applicable]	2243	[Not Available]	1	2512	1	2512	0	720	1	2243	32.53	6.88	18-29	other
2655	TCGA-02-0015	GBM	50	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-18404	Dead	WITH TUMOR	627	627	[Not Available]	Recurrence	[Not Applicable]	456	[Not Available]	1	627	1	627	0	720	1	456	52.1	1.72	50-59	other
2656	TCGA-02-0016	GBM	50	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-18271	Dead	WITH TUMOR	766	2648	[Not Available]	Recurrence	[Not Applicable]	1699	[Not Available]	1	2648	1	2648	0	720	1	1699	57.27	7.25	50-59	other
2657	TCGA-02-0021	GBM	43	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-16035	Dead	WITH TUMOR	2362	2362	[Not Available]	Progression of Disease	[Not Applicable]	255	[Not Available]	1	2362	1	2362	0	720	1	255	50.37	6.47	40-49	other
2658	TCGA-02-0023	GBM	38	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-14003	Dead	WITH TUMOR	612	612	[Not Available]	Progression of Disease	[Not Applicable]	435	[Not Available]	1	612	1	612	0	720	1	435	40.01	1.68	30-39	other
2659	TCGA-02-0024	GBM	35	MALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2000	[Not Available]	-13116	Dead	WITH TUMOR	1615	1615	[Not Available]	Recurrence	[Not Applicable]	1401	[Not Available]	1	1615	1	1615	0	720	1	1401	40.33	4.42	30-39	other
2660	TCGA-02-0025	GBM	47	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-17402	Dead	WITH TUMOR	1300	1300	[Not Available]	Progression of Disease	[Not Applicable]	656	[Not Available]	1	1300	1	1300	0	720	1	656	51.2	3.56	40-49	other
2661	TCGA-02-0026	GBM	27	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-10022	Dead	WITH TUMOR	748	748	[Not Available]	Progression of Disease	[Not Applicable]	462	[Not Available]	1	748	1	748	0	720	1	462	29.49	2.05	18-29	other
2662	TCGA-02-0027	GBM	33	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-12369	Dead	WITH TUMOR	315	370	[Not Available]	Progression of Disease	[Not Applicable]	257	[Not Available]	1	370	1	370	0	720	1	257	34.88	1.01	30-39	other
2663	TCGA-02-0028	GBM	39	MALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	1998	[Not Available]	-14304	Dead	WITH TUMOR	2755	2755	[Not Available]	Progression of Disease	[Not Applicable]	1921	[Not Available]	1	2755	1	2755	0	720	1	1921	46.7	7.54	30-39	other
2664	TCGA-02-0033	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-20070	Dead	WITH TUMOR	86	86	[Not Available]	Progression of Disease	[Not Applicable]	32	[Not Available]	1	86	1	86	0	720	1	32	55.18	0.24	50-59	other
2665	TCGA-02-0034	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-22166	Dead	WITH TUMOR	430	430	[Not Available]	Progression of Disease	[Not Applicable]	386	[Not Available]	1	430	1	430	0	720	1	386	61.86	1.18	60-69	other
2666	TCGA-02-0037	GBM	74	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-27063	Dead	WITH TUMOR	110	110	[Not Available]	Progression of Disease	[Not Applicable]	37	[Not Available]	1	110	1	110	0	720	1	37	74.4	0.3	70-79	other
2667	TCGA-02-0038	GBM	48	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-17749	Dead	WITH TUMOR	326	326	[Not Available]	Progression of Disease	[Not Applicable]	239	[Not Available]	1	326	1	326	0	720	1	239	49.49	0.89	40-49	other
2668	TCGA-02-0039	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-20065	Dead	WITH TUMOR	320	320	[Not Available]	Progression of Disease	[Not Applicable]	102	[Not Available]	1	320	1	320	0	720	1	102	55.81	0.88	50-59	other
2669	TCGA-02-0043	GBM	54	FEMALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2004	[Not Available]	-19882	Dead	WITH TUMOR	557	557	[Not Available]	Progression of Disease	[Not Applicable]	282	[Not Available]	1	557	1	557	0	720	1	282	55.96	1.52	50-59	other
2670	TCGA-02-0046	GBM	61	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-22417	Dead	WITH TUMOR	209	209	[Not Available]	Progression of Disease	[Not Applicable]	195	[Not Available]	1	209	1	209	0	720	1	195	61.95	0.57	60-69	other
2671	TCGA-02-0047	GBM	78	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-28759	Dead	WITH TUMOR	448	448	[Not Available]	Progression of Disease	[Not Applicable]	57	[Not Available]	1	448	1	448	0	720	1	57	79.96	1.23	70-79	other
2672	TCGA-02-0048	GBM	80	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-29299	Dead	TUMOR FREE	98	98	[Not Available]	Progression of Disease	[Not Applicable]	23	[Not Available]	1	98	0	98	0	720	1	23	80.48	0.27	>=80	other
2673	TCGA-02-0051	GBM	43	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-15983	Dead	WITH TUMOR	459	459	[Not Available]	Progression of Disease	[Not Applicable]	89	[Not Available]	1	459	1	459	0	720	1	89	45.02	1.26	40-49	other
2674	TCGA-02-0052	GBM	49	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-18061	Dead	WITH TUMOR	383	383	[Not Available]	Progression of Disease	[Not Applicable]	204	[Not Available]	1	383	1	383	0	720	1	204	50.5	1.05	40-49	other
2675	TCGA-02-0054	GBM	44	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-16224	Dead	WITH TUMOR	199	199	[Not Available]	Progression of Disease	[Not Applicable]	72	[Not Available]	1	199	1	199	0	720	1	72	44.96	0.54	40-49	other
2676	TCGA-02-0055	GBM	62	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-22798	Dead	WITH TUMOR	76	76	[Not Available]	Progression of Disease	[Not Applicable]	6	[Not Available]	1	76	1	76	0	720	1	6	62.63	0.21	60-69	other
2677	TCGA-02-0057	GBM	66	FEMALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2004	[Not Available]	-24140	Dead	WITH TUMOR	604	604	[Not Available]	Progression of Disease	[Not Applicable]	473	[Not Available]	1	604	1	604	0	720	1	473	67.75	1.65	60-69	other
2678	TCGA-02-0058	GBM	28	FEMALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2005	[Not Available]	-10517	Dead	WITH TUMOR	254	254	[Not Available]	Progression of Disease	[Not Applicable]	172	[Not Available]	1	254	1	254	0	720	1	172	29.49	0.7	18-29	other
2679	TCGA-02-0059	GBM	68	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-25097	Dead	WITH TUMOR	291	291	[Not Available]	Recurrence	[Not Applicable]	21	[Not Available]	1	291	1	291	0	720	1	21	69.51	0.8	60-69	other
2680	TCGA-02-0060	GBM	66	FEMALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-24151	Dead	WITH TUMOR	183	183	[Not Available]	Progression of Disease	[Not Applicable]	183	[Not Available]	1	183	1	183	0	720	1	183	66.62	0.5	60-69	other
2681	TCGA-02-0064	GBM	50	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-18280	Dead	WITH TUMOR	600	600	[Not Available]	Recurrence	[Not Applicable]	496	[Not Available]	1	600	1	600	0	720	1	496	51.69	1.64	50-59	other
2682	TCGA-02-0068	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-21160	Dead	WITH TUMOR	804	804	[Not Available]	Recurrence	[Not Applicable]	175	[Not Available]	1	804	1	804	0	720	1	175	60.13	2.2	50-59	other
2683	TCGA-02-0069	GBM	31	FEMALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-11668	Alive	WITH TUMOR	873	548	[Not Available]	Progression of Disease	[Not Applicable]	873	[Not Available]	0	873	0	873	0	720	1	873	34.34	2.39	30-39	other
2684	TCGA-02-0070	GBM	70	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-25916	Alive	WITH TUMOR	762	548	[Not Available]	Recurrence	[Not Applicable]	762	[Not Available]	0	762	0	762	0	720	1	762	73.04	2.09	70-79	other
2685	TCGA-02-0071	GBM	53	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-19425	Dead	WITH TUMOR	167	167	[Not Available]	Progression of Disease	[Not Applicable]	8	[Not Available]	1	167	1	167	0	720	1	8	53.64	0.46	50-59	other
2686	TCGA-02-0074	GBM	68	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-24906	Dead	WITH TUMOR	310	310	[Not Available]	Progression of Disease	[Not Applicable]	154	[Not Available]	1	310	1	310	0	720	1	154	69.04	0.85	60-69	other
2687	TCGA-02-0075	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-23205	Dead	WITH TUMOR	634	634	[Not Available]	Progression of Disease	[Not Applicable]	336	[Not Available]	1	634	1	634	0	720	1	336	65.27	1.74	60-69	other
2688	TCGA-02-0079	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-21173	Dead	WITH TUMOR	829	829	[Not Available]	Progression of Disease	[Not Applicable]	798	[Not Available]	1	829	1	829	0	720	1	798	60.24	2.27	50-59	other
2689	TCGA-02-0080	GBM	28	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-10310	Dead	WITH TUMOR	2729	2729	[Not Available]	Progression of Disease	[Not Applicable]	2339	[Not Available]	1	2729	1	2729	0	720	1	2339	35.7	7.47	18-29	other
2690	TCGA-02-0083	GBM	59	FEMALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2005	[Not Available]	-21626	Dead	WITH TUMOR	691	691	[Not Available]	Progression of Disease	[Not Applicable]	463	[Not Available]	1	691	1	691	0	720	1	463	61.1	1.89	50-59	other
2691	TCGA-02-0084	GBM	36	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-13263	Dead	TUMOR FREE	7	384	[Not Available]	NA	NA	364	[Not Available]	1	384	0	384	0	720	0	384	37.36	1.05	30-39	other
2692	TCGA-02-0085	GBM	63	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-23289	Dead	WITH TUMOR	1561	1561	[Not Available]	Progression of Disease	[Not Applicable]	976	[Not Available]	1	1561	1	1561	0	720	1	976	68.04	4.27	60-69	other
2693	TCGA-02-0086	GBM	45	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-16763	Dead	WITH TUMOR	268	268	[Not Available]	Progression of Disease	[Not Applicable]	97	[Not Available]	1	268	1	268	0	720	1	97	46.63	0.73	40-49	other
2694	TCGA-02-0087	GBM	27	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-10185	Alive	TUMOR FREE	1757	548	[Not Available]	Recurrence	[Not Applicable]	1757	[Not Available]	0	1757	0	1757	0	720	1	1757	32.7	4.81	18-29	other
2695	TCGA-02-0089	GBM	52	MALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2005	[Not Available]	-19233	Dead	WITH TUMOR	516	516	[Not Available]	Progression of Disease	[Not Applicable]	358	[Not Available]	1	516	1	516	0	720	1	358	54.07	1.41	50-59	other
2696	TCGA-02-0099	GBM	46	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-17080	Dead	WITH TUMOR	106	106	[Not Available]	NA	NA	364	[Not Available]	1	106	1	106	0	720	1	106	47.05	0.29	40-49	other
2697	TCGA-02-0102	GBM	42	MALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2004	[Not Available]	-15660	Dead	WITH TUMOR	822	822	[Not Available]	Progression of Disease	[Not Applicable]	450	[Not Available]	1	822	1	822	0	720	1	450	45.13	2.25	40-49	other
2698	TCGA-02-0104	GBM	29	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-10699	Dead	WITH TUMOR	1977	1977	[Not Available]	Recurrence	[Not Applicable]	1457	[Not Available]	1	1977	1	1977	0	720	1	1457	34.7	5.41	18-29	other
2699	TCGA-02-0106	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-19883	Dead	WITH TUMOR	355	355	[Not Available]	Recurrence	[Not Applicable]	196	[Not Available]	1	355	1	355	0	720	1	196	55.41	0.97	50-59	other
2700	TCGA-02-0107	GBM	56	MALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2004	[Not Available]	-20557	Dead	WITH TUMOR	537	537	[Not Available]	Recurrence	[Not Applicable]	146	[Not Available]	1	537	1	537	0	720	1	146	57.75	1.47	50-59	other
2701	TCGA-02-0111	GBM	56	MALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-20813	Dead	WITH TUMOR	705	705	[Not Available]	Progression of Disease	[Not Applicable]	74	[Not Available]	1	705	1	705	0	720	1	74	58.91	1.93	50-59	other
2702	TCGA-02-0113	GBM	43	FEMALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2001	[Not Available]	-15836	Alive	WITH TUMOR	2818	548	[Not Available]	Recurrence	[Not Applicable]	1560	[Not Available]	0	2818	0	2818	0	720	1	1560	51.07	7.72	40-49	other
2703	TCGA-02-0114	GBM	37	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	1998	[Not Available]	-13681	Dead	WITH TUMOR	3041	3041	[Not Available]	Recurrence	[Not Applicable]	2296	[Not Available]	1	3041	1	3041	0	720	1	2296	45.78	8.33	30-39	other
2704	TCGA-02-0115	GBM	52	MALE	ASIAN	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2006	[Not Available]	-19257	Dead	WITH TUMOR	476	476	[Not Available]	Progression of Disease	[Not Applicable]	91	[Not Available]	1	476	1	476	0	720	1	91	54.03	1.3	50-59	other
2705	TCGA-02-0116	GBM	51	MALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2003	[Not Available]	-18657	Dead	WITH TUMOR	1489	1489	[Not Available]	Progression of Disease	[Not Applicable]	1231	[Not Available]	1	1489	1	1489	0	720	1	1231	55.16	4.08	50-59	other
2706	TCGA-02-0258	GBM	36	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1989	[Not Available]	-13269	Dead	WITH TUMOR	503	503	[Not Available]	Recurrence	[Not Applicable]	503	[Not Available]	1	503	1	503	0	720	1	503	37.71	1.38	30-39	other
2707	TCGA-02-0260	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1989	[Not Available]	-19956	Dead	WITH TUMOR	515	515	[Not Available]	NA	NA	364	[Not Available]	1	515	1	515	0	720	1	515	56.05	1.41	50-59	other
2708	TCGA-02-0266	GBM	14	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1990	[Not Available]	-5303	Dead	WITH TUMOR	539	539	[Not Available]	Progression of Disease	[Not Applicable]	293	[Not Available]	1	539	1	539	0	720	1	293	15.99	1.48	<18	other
2709	TCGA-02-0269	GBM	68	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1990	[Not Available]	-25194	Dead	WITH TUMOR	327	327	[Not Available]	Progression of Disease	[Not Applicable]	99	[Not Available]	1	327	1	327	0	720	1	99	69.87	0.9	60-69	other
2710	TCGA-02-0271	GBM	26	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1990	[Not Available]	-9578	Dead	TUMOR FREE	440	440	[Not Available]	NA	NA	364	[Not Available]	1	440	0	440	0	720	0	440	27.43	1.2	18-29	other
2711	TCGA-02-0281	GBM	78	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1991	[Not Available]	-28696	Dead	WITH TUMOR	121	121	[Not Available]	NA	NA	364	[Not Available]	1	121	1	121	0	720	1	121	78.9	0.33	70-79	other
2712	TCGA-02-0285	GBM	50	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1991	[Not Available]	-18353	Dead	WITH TUMOR	422	422	[Not Available]	NA	NA	364	[Not Available]	1	422	1	422	0	720	1	422	51.4	1.16	50-59	other
2713	TCGA-02-0289	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1992	[Not Available]	-21031	Dead	WITH TUMOR	432	432	[Not Available]	Progression of Disease	[Not Applicable]	245	[Not Available]	1	432	1	432	0	720	1	245	58.76	1.18	50-59	other
2714	TCGA-02-0290	GBM	49	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1992	[Not Available]	-18066	Dead	WITH TUMOR	485	485	[Not Available]	Progression of Disease	[Not Applicable]	374	[Not Available]	1	485	1	485	0	720	1	374	50.79	1.33	40-49	other
2715	TCGA-02-0317	GBM	40	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1994	[Not Available]	-14636	Dead	WITH TUMOR	372	372	[Not Available]	Progression of Disease	[Not Applicable]	238	[Not Available]	1	372	1	372	0	720	1	238	41.09	1.02	40-49	other
2716	TCGA-02-0321	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-27125	Dead	WITH TUMOR	301	301	[Not Available]	Progression of Disease	[Not Applicable]	73	[Not Available]	1	301	1	301	0	720	1	73	75.09	0.82	70-79	other
2717	TCGA-02-0324	GBM	69	FEMALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-25352	Dead	WITH TUMOR	235	235	[Not Available]	Progression of Disease	[Not Applicable]	164	[Not Available]	1	235	1	235	0	720	1	164	70.05	0.64	60-69	other
2718	TCGA-02-0325	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-22598	Dead	WITH TUMOR	323	323	[Not Available]	Progression of Disease	[Not Applicable]	284	[Not Available]	1	323	1	323	0	720	1	284	62.75	0.88	60-69	other
2719	TCGA-02-0326	GBM	82	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-30160	Dead	WITH TUMOR	5	223	[Not Available]	Progression of Disease	[Not Applicable]	5	[Not Available]	1	223	1	223	0	720	1	5	83.18	0.61	>=80	other
2720	TCGA-02-0330	GBM	51	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-18654	Dead	WITH TUMOR	484	484	[Not Available]	Progression of Disease	[Not Applicable]	120	[Not Available]	1	484	1	484	0	720	1	120	52.4	1.33	50-59	other
2721	TCGA-02-0332	GBM	46	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-17021	Dead	WITH TUMOR	782	782	[Not Available]	Progression of Disease	[Not Applicable]	438	[Not Available]	1	782	1	782	0	720	1	438	48.74	2.14	40-49	other
2722	TCGA-02-0333	GBM	77	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-28449	Dead	WITH TUMOR	133	133	[Not Available]	Progression of Disease	[Not Applicable]	4	[Not Available]	1	133	1	133	0	720	1	4	78.25	0.36	70-79	other
2723	TCGA-02-0337	GBM	48	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-17643	Dead	WITH TUMOR	764	764	[Not Available]	Progression of Disease	[Not Applicable]	691	[Not Available]	1	764	1	764	0	720	1	691	50.4	2.09	40-49	other
2724	TCGA-02-0338	GBM	41	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-15231	Dead	WITH TUMOR	322	322	[Not Available]	Progression of Disease	[Not Applicable]	168	[Not Available]	1	322	1	322	0	720	1	168	42.58	0.88	40-49	other
2725	TCGA-02-0339	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-24524	Dead	WITH TUMOR	377	377	[Not Available]	Progression of Disease	[Not Applicable]	148	[Not Available]	1	377	1	377	0	720	1	148	68.18	1.03	60-69	other
2726	TCGA-02-0422	GBM	50	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-18368	Dead	WITH TUMOR	441	441	[Not Available]	Progression of Disease	[Not Applicable]	125	[Not Available]	1	441	1	441	0	720	1	125	51.5	1.21	50-59	other
2727	TCGA-02-0430	GBM	67	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-24641	Dead	WITH TUMOR	321	321	[Not Available]	NA	NA	364	[Not Available]	1	321	1	321	0	720	1	321	68.34	0.88	60-69	other
2728	TCGA-02-0432	GBM	36	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-13260	Dead	WITH TUMOR	1433	1433	[Not Available]	Progression of Disease	[Not Applicable]	1053	[Not Available]	1	1433	1	1433	0	720	1	1053	40.23	3.92	30-39	other
2729	TCGA-02-0439	GBM	70	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-25624	Dead	WITH TUMOR	20	20	[Not Available]	Progression of Disease	[Not Applicable]	13	[Not Available]	1	20	1	20	0	720	1	13	70.21	0.05	70-79	other
2730	TCGA-02-0440	GBM	62	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-22955	Dead	WITH TUMOR	345	345	[Not Available]	Progression of Disease	[Not Applicable]	212	[Not Available]	1	345	1	345	0	720	1	212	63.79	0.94	60-69	other
2731	TCGA-02-0446	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-22541	Dead	WITH TUMOR	282	282	[Not Available]	Recurrence	[Not Applicable]	15	[Not Available]	1	282	1	282	0	720	1	15	62.49	0.77	60-69	other
2732	TCGA-02-0451	GBM	62	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-22662	Dead	WITH TUMOR	493	493	[Not Available]	Recurrence	[Not Applicable]	428	[Not Available]	1	493	1	493	0	720	1	428	63.39	1.35	60-69	other
2733	TCGA-02-0456	GBM	67	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-24796	Dead	WITH TUMOR	102	102	[Not Available]	Recurrence	[Not Applicable]	12	[Not Available]	1	102	1	102	0	720	1	12	68.17	0.28	60-69	other
2734	TCGA-02-2466	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2007	[Not Available]	-22457	Dead	WITH TUMOR	511	511	[Not Available]	Progression of Disease	[Not Applicable]	128	[Not Available]	1	511	1	511	0	720	1	128	62.88	1.4	60-69	other
2735	TCGA-02-2470	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2007	[Not Available]	-21021	Dead	WITH TUMOR	393	393	[Not Available]	Progression of Disease	[Not Applicable]	183	[Not Available]	1	393	1	393	0	720	1	183	58.63	1.08	50-59	other
2736	TCGA-02-2483	GBM	43	MALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-15964	Alive	WITH TUMOR	466	548	[Not Available]	NA	NA	364	[Not Available]	0	466	0	466	0	720	0	466	44.98	1.28	40-49	other
2737	TCGA-02-2485	GBM	53	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-19494	Alive	WITH TUMOR	470	548	[Not Available]	Progression of Disease	[Not Applicable]	186	[Not Available]	0	470	0	470	0	720	1	186	54.66	1.29	50-59	other
2738	TCGA-02-2486	GBM	64	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-23394	Dead	WITH TUMOR	766	618	[Not Available]	NA	NA	364	[Not Available]	1	618	1	618	0	720	1	618	65.74	1.69	60-69	other
2739	TCGA-06-0119	GBM	81	FEMALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2005	[Not Available]	-29606	Dead	WITH TUMOR	766	82	[Not Available]	NA	NA	364	[Not Available]	1	82	1	82	0	720	1	82	81.28	0.22	>=80	other
2740	TCGA-06-0122	GBM	84	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-30968	Dead	TUMOR FREE	8	187	[Not Available]	NA	NA	364	[Not Available]	1	187	0	187	0	720	0	187	85.3	0.51	>=80	other
2741	TCGA-06-0124	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-24591	Dead	WITH TUMOR	123	620	[Not Available]	NA	NA	364	[Not Available]	1	620	1	620	0	720	1	620	69.02	1.7	60-69	other
2742	TCGA-06-0125	GBM	63	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-23343	Dead	WITH TUMOR	1439	1448	[Not Available]	Progression of Disease	[Not Applicable]	797	[Not Available]	1	1448	1	1448	0	720	1	797	67.87	3.96	60-69	other
2743	TCGA-06-0126	GBM	86	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-31627	Dead	TUMOR FREE	3	211	[Not Available]	NA	NA	364	[Unknown]	1	211	0	211	0	720	0	211	87.17	0.58	>=80	other
2744	TCGA-06-0127	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-24502	Dead	WITH TUMOR	109	121	[Not Available]	Progression of Disease	[Not Applicable]	91	[Not Available]	1	121	1	121	0	720	1	91	67.41	0.33	60-69	other
2745	TCGA-06-0128	GBM	66	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-24217	Dead	WITH TUMOR	691	691	[Not Available]	Progression of Disease	[Not Applicable]	190	[Not Available]	1	691	1	691	0	720	1	190	68.19	1.89	60-69	other
2746	TCGA-06-0129	GBM	30	MALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-11284	Dead	WITH TUMOR	989	1024	[Not Available]	Progression of Disease	[Not Applicable]	148	[Not Available]	1	1024	1	1024	0	720	1	148	33.7	2.8	30-39	other
2747	TCGA-06-0130	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-19812	Dead	WITH TUMOR	320	394	[Not Available]	Progression of Disease	[Not Applicable]	244	[Not Available]	1	394	1	394	0	720	1	244	55.32	1.08	50-59	other
2748	TCGA-06-0132	GBM	49	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-18125	Dead	WITH TUMOR	570	771	[Not Available]	Progression of Disease	[Not Applicable]	482	[Not Available]	1	771	1	771	0	720	1	482	51.73	2.11	40-49	other
2749	TCGA-06-0133	GBM	64	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-23402	Dead	WITH TUMOR	428	435	[Not Available]	Progression of Disease	[Not Applicable]	78	[Not Available]	1	435	1	435	0	720	1	78	65.26	1.19	60-69	other
2750	TCGA-06-0137	GBM	63	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-23273	Dead	WITH TUMOR	702	812	[Not Available]	Progression of Disease	[Not Applicable]	487	[Not Available]	1	812	1	812	0	720	1	487	65.94	2.22	60-69	other
2751	TCGA-06-0138	GBM	43	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-15736	Dead	WITH TUMOR	674	737	[Not Available]	Progression of Disease	[Not Applicable]	394	[Not Available]	1	737	1	737	0	720	1	394	45.1	2.02	40-49	other
2752	TCGA-06-0139	GBM	40	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-14729	Dead	WITH TUMOR	327	362	[Not Available]	Progression of Disease	[Not Applicable]	152	[Not Available]	1	362	1	362	0	720	1	152	41.32	0.99	40-49	other
2753	TCGA-06-0140	GBM	86	MALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2003	[Not Available]	-31566	Dead	WITH TUMOR	766	6	[Not Available]	NA	NA	364	[Not Available]	1	6	1	6	0	720	1	6	86.44	0.02	>=80	other
2754	TCGA-06-0141	GBM	62	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-22926	Dead	WITH TUMOR	280	313	[Not Available]	Progression of Disease	[Not Applicable]	145	[Not Available]	1	313	1	313	0	720	1	145	63.62	0.86	60-69	other
2755	TCGA-06-0142	GBM	81	MALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2002	[Not Available]	-29642	Dead	WITH TUMOR	766	67	[Not Available]	NA	NA	364	[Not Available]	1	67	1	67	0	720	1	67	81.34	0.18	>=80	other
2756	TCGA-06-0143	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-21386	Dead	WITH TUMOR	357	357	[Not Available]	Recurrence	[Not Applicable]	265	[Not Available]	1	357	1	357	0	720	1	265	59.53	0.98	50-59	other
2757	TCGA-06-0145	GBM	53	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-19661	Dead	WITH TUMOR	71	71	[Not Available]	NA	NA	364	[Not Available]	1	71	1	71	0	720	1	71	54.02	0.19	50-59	other
2758	TCGA-06-0146	GBM	33	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-12253	Dead	WITH TUMOR	611	611	[Not Available]	Progression of Disease	[Not Applicable]	530	[Not Available]	1	611	1	611	0	720	1	530	35.22	1.67	30-39	other
2759	TCGA-06-0147	GBM	51	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-18743	Dead	WITH TUMOR	508	541	[Not Available]	Progression of Disease	[Not Applicable]	92	[Not Available]	1	541	1	541	0	720	1	92	52.8	1.48	50-59	other
2760	TCGA-06-0148	GBM	76	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-27842	Dead	WITH TUMOR	298	307	[Not Available]	Progression of Disease	[Not Applicable]	189	[Not Available]	1	307	1	307	0	720	1	189	77.07	0.84	70-79	other
2761	TCGA-06-0149	GBM	74	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-27315	Dead	WITH TUMOR	239	262	[Not Available]	Progression of Disease	[Not Applicable]	204	[Not Available]	1	262	1	262	0	720	1	204	75.5	0.72	70-79	other
2762	TCGA-06-0150	GBM	45	MALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	1995	[Not Available]	-16442	Dead	WITH TUMOR	766	592	[Not Available]	NA	NA	364	[Not Available]	1	592	1	592	0	720	1	592	46.64	1.62	40-49	other
2763	TCGA-06-0151	GBM	32	FEMALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	1995	[Not Available]	-11956	Dead	WITH TUMOR	766	1417	[Not Available]	NA	NA	364	[Not Available]	1	1417	1	1417	0	720	1	1417	36.61	3.88	30-39	other
2764	TCGA-06-0152	GBM	68	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-24844	Dead	WITH TUMOR	359	375	[Not Available]	Progression of Disease	[Not Applicable]	299	[Not Available]	1	375	1	375	0	720	1	299	69.05	1.03	60-69	other
2765	TCGA-06-0154	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-20018	Dead	WITH TUMOR	389	424	[Not Available]	Progression of Disease	[Not Applicable]	208	[Not Available]	1	424	1	424	0	720	1	208	55.97	1.16	50-59	other
2766	TCGA-06-0155	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-22498	Dead	WITH TUMOR	263	318	[Not Available]	Progression of Disease	[Not Applicable]	256	[Not Available]	1	318	1	318	0	720	1	256	62.47	0.87	60-69	other
2767	TCGA-06-0156	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-20932	Dead	WITH TUMOR	164	178	[Not Available]	NA	NA	364	[Not Available]	1	178	1	178	0	720	1	178	57.8	0.49	50-59	other
2768	TCGA-06-0157	GBM	63	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-23128	Dead	WITH TUMOR	97	97	[Not Available]	NA	NA	364	[Not Available]	1	97	1	97	0	720	1	97	63.59	0.27	60-69	other
2769	TCGA-06-0158	GBM	73	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-26856	Dead	WITH TUMOR	166	329	[Not Available]	Progression of Disease	[Not Applicable]	90	[Not Available]	1	329	1	329	0	720	1	90	74.43	0.9	70-79	other
2770	TCGA-06-0159	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	1998	[Not Available]	-27368	Dead	WITH TUMOR	766	287	[Not Available]	NA	NA	364	[Unknown]	1	287	1	287	0	720	1	287	75.72	0.79	70-79	other
2771	TCGA-06-0160	GBM	56	FEMALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	1999	[Not Available]	-20684	Dead	WITH TUMOR	766	359	[Not Available]	NA	NA	364	[Discrepancy]	1	359	1	359	0	720	1	359	57.61	0.98	50-59	other
2772	TCGA-06-0162	GBM	47	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-17272	Dead	WITH TUMOR	78	104	[Not Available]	NA	NA	364	[Not Available]	1	104	1	104	0	720	1	104	47.57	0.28	40-49	other
2773	TCGA-06-0164	GBM	47	MALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-17510	Dead	WITH TUMOR	1730	1731	[Not Available]	Progression of Disease	[Not Applicable]	1428	[Not Available]	1	1731	1	1731	0	720	1	1428	52.68	4.74	40-49	other
2774	TCGA-06-0165	GBM	52	MALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2001	[Not Available]	-19198	Dead	WITH TUMOR	766	324	[Not Available]	NA	NA	364	[Unknown]	1	324	1	324	0	720	1	324	53.45	0.89	50-59	other
2775	TCGA-06-0166	GBM	51	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-18902	Dead	WITH TUMOR	161	178	[Not Available]	Progression of Disease	[Not Applicable]	66	[Not Available]	1	178	1	178	0	720	1	66	52.24	0.49	50-59	other
2776	TCGA-06-0167	GBM	44	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2001	[Not Available]	-16170	Dead	WITH TUMOR	766	347	[Not Available]	NA	NA	364	[Unknown]	1	347	1	347	0	720	1	347	45.22	0.95	40-49	other
2777	TCGA-06-0168	GBM	59	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-21776	Dead	WITH TUMOR	579	598	[Not Available]	Progression of Disease	[Not Applicable]	461	[Not Available]	1	598	1	598	0	720	1	461	61.26	1.64	50-59	other
2778	TCGA-06-0169	GBM	68	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-25127	Dead	WITH TUMOR	95	100	[Not Available]	Progression of Disease	[Not Applicable]	92	[Not Available]	1	100	1	100	0	720	1	92	69.07	0.27	60-69	other
2779	TCGA-06-0171	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-24085	Dead	WITH TUMOR	396	399	[Not Available]	Progression of Disease	[Not Applicable]	117	[Not Available]	1	399	1	399	0	720	1	117	67.03	1.09	60-69	other
2780	TCGA-06-0173	GBM	72	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-26549	Dead	WITH TUMOR	7	136	[Not Available]	NA	NA	364	[Not Available]	1	136	1	136	0	720	1	136	73.06	0.37	70-79	other
2781	TCGA-06-0174	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-19824	Dead	WITH TUMOR	67	98	[Not Available]	Progression of Disease	[Not Applicable]	47	[Not Available]	1	98	1	98	0	720	1	47	54.54	0.27	50-59	other
2782	TCGA-06-0175	GBM	69	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-25559	Dead	WITH TUMOR	83	123	[Not Available]	Progression of Disease	[Not Applicable]	39	[Not Available]	1	123	1	123	0	720	1	39	70.31	0.34	60-69	other
2783	TCGA-06-0176	GBM	34	MALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-12777	Alive	TUMOR FREE	2768	548	[Not Available]	Progression of Disease	[Not Applicable]	41	[Not Available]	0	2768	0	2768	0	720	1	41	42.56	7.58	30-39	other
2784	TCGA-06-0177	GBM	64	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-23498	Dead	WITH TUMOR	61	127	[Not Available]	NA	NA	364	[Not Available]	1	127	1	127	0	720	1	127	64.68	0.35	60-69	other
2785	TCGA-06-0178	GBM	38	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-14235	Dead	WITH TUMOR	766	2681	[Not Available]	Progression of Disease	[Not Applicable]	192	[Not Available]	1	2681	1	2681	0	720	1	192	46.31	7.34	30-39	other
2786	TCGA-06-0179	GBM	64	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-23450	Dead	WITH TUMOR	578	616	[Not Available]	Progression of Disease	[Not Applicable]	250	[Not Available]	1	616	1	616	0	720	1	250	65.89	1.69	60-69	other
2787	TCGA-06-0182	GBM	76	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-27964	Dead	WITH TUMOR	77	111	[Not Available]	NA	NA	364	[Not Available]	1	111	1	111	0	720	1	111	76.87	0.3	70-79	other
2788	TCGA-06-0184	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-23317	Dead	WITH TUMOR	766	2126	[Not Available]	NA	[Not Applicable]	1276	[Not Available]	1	2126	1	2126	0	720	1	1276	69.66	5.82	60-69	other
2789	TCGA-06-0185	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-19923	Alive	WITH TUMOR	2246	548	[Not Available]	Progression of Disease	[Not Applicable]	711	[Not Available]	0	2246	0	2246	0	720	1	711	60.7	6.15	50-59	other
2790	TCGA-06-0187	GBM	69	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-25318	Dead	WITH TUMOR	801	828	[Not Available]	Recurrence	[Not Applicable]	531	[Not Available]	1	828	1	828	0	720	1	531	71.58	2.27	60-69	other
2791	TCGA-06-0188	GBM	71	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-26080	Dead	WITH TUMOR	766	1356	[Not Available]	NA	[Not Applicable]	310	[Not Available]	1	1356	1	1356	0	720	1	310	75.12	3.71	70-79	other
2792	TCGA-06-0189	GBM	55	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-20297	Dead	WITH TUMOR	454	469	[Not Available]	NA	NA	364	[Not Available]	1	469	1	469	0	720	1	469	56.85	1.28	50-59	other
2793	TCGA-06-0190	GBM	62	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-22835	Dead	WITH TUMOR	313	317	[Not Available]	Progression of Disease	[Not Applicable]	88	[Not Available]	1	317	1	317	0	720	1	88	63.39	0.87	60-69	other
2794	TCGA-06-0192	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-21243	Dead	WITH TUMOR	766	1185	[Not Available]	Locoregional Disease	[Not Applicable]	648	[Not Available]	1	1185	1	1185	0	720	1	648	61.4	3.24	50-59	other
2795	TCGA-06-0194	GBM	37	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1994	[Not Available]	-13852	Dead	WITH TUMOR	142	142	[Not Available]	Progression of Disease	[Not Applicable]	125	[Not Available]	1	142	1	142	0	720	1	125	38.31	0.39	30-39	other
2796	TCGA-06-0195	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1994	[Not Available]	-23132	Dead	WITH TUMOR	214	225	[Not Available]	Progression of Disease	[Not Applicable]	147	[Not Available]	1	225	1	225	0	720	1	147	63.95	0.62	60-69	other
2797	TCGA-06-0197	GBM	65	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1994	[Not Available]	-24095	Dead	WITH TUMOR	79	169	[Not Available]	Progression of Disease	[Not Applicable]	47	[Not Available]	1	169	1	169	0	720	1	47	66.43	0.46	60-69	other
2798	TCGA-06-0201	GBM	51	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-18649	Dead	WITH TUMOR	12	12	[Not Available]	NA	NA	364	[Not Available]	1	12	1	12	0	720	1	12	51.09	0.03	50-59	other
2799	TCGA-06-0206	GBM	40	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-14937	Dead	WITH TUMOR	197	233	[Not Available]	Recurrence	[Not Applicable]	106	[Not Available]	1	233	1	233	0	720	1	106	41.53	0.64	40-49	other
2800	TCGA-06-0208	GBM	52	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-19108	Dead	WITH TUMOR	167	256	[Not Available]	Progression of Disease	[Not Applicable]	149	[Not Available]	1	256	1	256	0	720	1	149	53.02	0.7	50-59	other
2801	TCGA-06-0209	GBM	76	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-27877	Dead	WITH TUMOR	119	232	[Not Available]	NA	NA	364	[Not Available]	1	232	1	232	0	720	1	232	76.96	0.64	70-79	other
2802	TCGA-06-0210	GBM	72	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-26600	Dead	WITH TUMOR	151	225	[Not Available]	Progression of Disease	[Not Applicable]	67	[Not Available]	1	225	1	225	0	720	1	67	73.44	0.62	70-79	other
2803	TCGA-06-0211	GBM	47	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-17515	Dead	WITH TUMOR	360	360	[Not Available]	Progression of Disease	[Not Applicable]	53	[Not Available]	1	360	1	360	0	720	1	53	48.94	0.99	40-49	other
2804	TCGA-06-0213	GBM	55	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-20134	Dead	WITH TUMOR	6	16	[Not Available]	NA	NA	364	[Not Available]	1	16	1	16	0	720	1	16	55.17	0.04	50-59	other
2805	TCGA-06-0214	GBM	66	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-24187	Dead	WITH TUMOR	378	457	[Not Available]	Progression of Disease	[Not Applicable]	48	[Not Available]	1	457	1	457	0	720	1	48	67.47	1.25	60-69	other
2806	TCGA-06-0216	GBM	61	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-22524	Dead	WITH TUMOR	684	735	[Not Available]	Progression of Disease	[Not Applicable]	175	[Not Available]	1	735	1	735	0	720	1	175	63.68	2.01	60-69	other
2807	TCGA-06-0219	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-24488	Dead	WITH TUMOR	11	22	[Not Available]	NA	NA	364	[Not Available]	1	22	1	22	0	720	1	22	67.1	0.06	60-69	other
2808	TCGA-06-0221	GBM	31	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-11333	Dead	WITH TUMOR	548	603	[Not Available]	Progression of Disease	[Not Applicable]	260	[Not Available]	1	603	1	603	0	720	1	260	32.68	1.65	30-39	other
2809	TCGA-06-0237	GBM	75	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-27735	Dead	WITH TUMOR	315	415	[Not Available]	NA	NA	364	[Not Available]	1	415	1	415	0	720	1	415	77.07	1.14	70-79	other
2810	TCGA-06-0238	GBM	46	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-17037	Dead	WITH TUMOR	359	405	[Not Available]	Progression of Disease	[Not Applicable]	311	[Not Available]	1	405	1	405	0	720	1	311	47.75	1.11	40-49	other
2811	TCGA-06-0240	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2007	[Not Available]	-20937	Dead	WITH TUMOR	766	621	[Not Available]	NA	NA	364	[Unknown]	1	621	1	621	0	720	1	621	59.02	1.7	50-59	other
2812	TCGA-06-0241	GBM	65	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-24101	Dead	WITH TUMOR	766	1481	[Not Available]	Recurrence	[Not Applicable]	196	[Not Available]	1	1481	1	1481	0	720	1	196	70.04	4.05	60-69	other
2813	TCGA-06-0394	GBM	51	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1992	[Not Available]	-18913	Dead	WITH TUMOR	314	329	[Not Available]	Progression of Disease	[Not Applicable]	87	[Not Available]	1	329	1	329	0	720	1	87	52.68	0.9	50-59	other
2814	TCGA-06-0397	GBM	57	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1993	[Not Available]	-20845	Dead	WITH TUMOR	168	274	[Not Available]	NA	NA	364	[Not Available]	1	274	1	274	0	720	1	274	57.82	0.75	50-59	other
2815	TCGA-06-0402	GBM	71	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1993	[Not Available]	-26059	Dead	WITH TUMOR	8	8	[Not Available]	NA	NA	364	[Not Available]	1	8	1	8	0	720	1	8	71.37	0.02	70-79	other
2816	TCGA-06-0409	GBM	43	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1994	[Not Available]	-16023	Dead	WITH TUMOR	2145	2201	[Not Available]	Progression of Disease	[Not Applicable]	334	[Not Available]	1	2201	1	2201	0	720	1	334	49.89	6.03	40-49	other
2817	TCGA-06-0410	GBM	76	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-28084	Dead	WITH TUMOR	143	143	[Not Available]	NA	NA	364	[Not Available]	1	143	1	143	0	720	1	143	77.28	0.39	70-79	other
2818	TCGA-06-0412	GBM	56	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-20619	Dead	WITH TUMOR	245	291	[Not Available]	Progression of Disease	[Not Applicable]	130	[Not Available]	1	291	1	291	0	720	1	130	57.25	0.8	50-59	other
2819	TCGA-06-0413	GBM	77	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-28433	Dead	WITH TUMOR	5	96	[Not Available]	NA	NA	364	[Not Available]	1	96	1	96	0	720	1	96	78.11	0.26	70-79	other
2820	TCGA-06-0414	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-23215	Dead	TUMOR FREE	1065	1068	[Not Available]	Recurrence	[Not Applicable]	1013	[Not Available]	1	1068	0	1068	0	720	1	1013	66.48	2.92	60-69	other
2821	TCGA-06-0644	GBM	71	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-26247	Dead	WITH TUMOR	766	384	[Not Available]	Recurrence	[Not Applicable]	85	[Not Available]	1	384	1	384	0	720	1	85	72.91	1.05	70-79	other
2822	TCGA-06-0645	GBM	55	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-20449	Dead	WITH TUMOR	98	175	[Not Available]	NA	NA	364	[Not Available]	1	175	1	175	0	720	1	175	56.47	0.48	50-59	other
2823	TCGA-06-0646	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-22273	Dead	WITH TUMOR	136	175	[Not Available]	Progression of Disease	[Not Applicable]	90	[Not Available]	1	175	1	175	0	720	1	90	61.46	0.48	60-69	other
2824	TCGA-06-0648	GBM	77	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-28477	Dead	WITH TUMOR	294	298	[Not Available]	Progression of Disease	[Not Applicable]	202	[Not Available]	1	298	1	298	0	720	1	202	78.78	0.82	70-79	other
2825	TCGA-06-0649	GBM	73	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-26796	Dead	WITH TUMOR	62	64	[Not Available]	NA	NA	364	[Not Available]	1	64	1	64	0	720	1	64	73.54	0.18	70-79	other
2826	TCGA-06-0650	GBM	39	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-14560	Dead	WITH TUMOR	717	717	[Not Available]	Progression of Disease	[Not Applicable]	351	[Not Available]	1	717	1	717	0	720	1	351	41.83	1.96	30-39	other
2827	TCGA-06-0686	GBM	53	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-19503	Dead	WITH TUMOR	766	432	[Not Available]	Progression of Disease	[Not Applicable]	160	[Not Available]	1	432	1	432	0	720	1	160	54.58	1.18	50-59	other
2828	TCGA-06-0743	GBM	69	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-25434	Dead	WITH TUMOR	766	803	[Not Available]	Progression of Disease	[Not Applicable]	176	[Not Available]	1	803	1	803	0	720	1	176	71.83	2.2	60-69	other
2829	TCGA-06-0744	GBM	66	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-24471	Dead	WITH TUMOR	766	1426	[Not Available]	NA	[Not Applicable]	1277	[Not Available]	1	1426	1	1426	0	720	1	1277	70.9	3.9	60-69	other
2830	TCGA-06-0745	GBM	59	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-21884	Dead	WITH TUMOR	164	239	[Not Available]	Progression of Disease	[Not Applicable]	92	[Not Available]	1	239	1	239	0	720	1	92	60.57	0.65	50-59	other
2831	TCGA-06-0747	GBM	53	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-19657	Dead	WITH TUMOR	82	82	[Not Available]	NA	NA	364	[Not Available]	1	82	1	82	0	720	1	82	54.04	0.22	50-59	other
2832	TCGA-06-0749	GBM	50	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-18571	Dead	WITH TUMOR	66	82	[Not Available]	NA	NA	364	[Not Available]	1	82	1	82	0	720	1	82	51.07	0.22	50-59	other
2833	TCGA-06-0750	GBM	43	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-16018	Dead	WITH TUMOR	28	28	[Not Available]	NA	NA	364	[Not Available]	1	28	1	28	0	720	1	28	43.93	0.08	40-49	other
2834	TCGA-06-0875	GBM	61	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-22312	Alive	TUMOR FREE	1322	548	[Not Available]	Progression of Disease	[Not Applicable]	279	[Not Available]	0	1322	0	1322	0	720	1	279	64.71	3.62	60-69	other
2835	TCGA-06-0876	GBM	72	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-26372	Alive	WITH TUMOR	1405	548	[Not Available]	NA	[Not Applicable]	424	[Not Available]	0	1405	0	1405	0	720	1	424	76.05	3.85	70-79	other
2836	TCGA-06-0877	GBM	78	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-28760	Alive	WITH TUMOR	204	548	[Not Available]	NA	NA	364	[Not Available]	0	204	0	204	0	720	0	204	79.3	0.56	70-79	other
2837	TCGA-06-0878	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-27319	Alive	WITH TUMOR	218	548	[Not Available]	Recurrence	[Not Applicable]	66	[Not Available]	0	218	0	218	0	720	1	66	75.39	0.6	70-79	other
2838	TCGA-06-0879	GBM	52	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-19154	Dead	WITH TUMOR	766	1229	[Not Available]	Recurrence	[Not Applicable]	699	[Not Available]	1	1229	1	1229	0	720	1	699	55.81	3.36	50-59	other
2839	TCGA-06-0881	GBM	50	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-18278	Dead	WITH TUMOR	766	504	[Not Available]	Recurrence	[Not Applicable]	141	[Not Available]	1	504	1	504	0	720	1	141	51.42	1.38	50-59	other
2840	TCGA-06-0882	GBM	30	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-11112	Dead	WITH TUMOR	766	632	[Not Available]	Recurrence	[Not Applicable]	213	[Not Available]	1	632	1	632	0	720	1	213	32.15	1.73	30-39	other
2841	TCGA-06-0939	GBM	79	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-28893	Dead	WITH TUMOR	766	814	[Not Available]	Progression of Disease	[Not Applicable]	329	[Not Available]	1	814	1	814	0	720	1	329	81.33	2.23	70-79	other
2842	TCGA-06-1084	GBM	54	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-19899	Dead	WITH TUMOR	766	728	[Not Available]	Progression of Disease	[Not Applicable]	208	[Not Available]	1	728	1	728	0	720	1	208	56.47	1.99	50-59	other
2843	TCGA-06-1086	GBM	42	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-15645	Dead	WITH TUMOR	193	208	[Not Available]	NA	NA	364	[Not Available]	1	208	1	208	0	720	1	208	43.4	0.57	40-49	other
2844	TCGA-06-1087	GBM	75	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-27658	Dead	WITH TUMOR	109	123	[Not Available]	Recurrence	[Not Applicable]	109	[Not Available]	1	123	1	123	0	720	1	109	76.06	0.34	70-79	other
2845	TCGA-06-1800	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-22332	Dead	WITH TUMOR	815	815	[Not Available]	Recurrence	[Not Applicable]	750	[Not Available]	1	815	1	815	0	720	1	750	63.37	2.23	60-69	other
2846	TCGA-06-1801	GBM	56	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-20538	Dead	WITH TUMOR	766	360	[Not Available]	Recurrence	[Not Applicable]	232	[Not Available]	1	360	1	360	0	720	1	232	57.22	0.99	50-59	other
2847	TCGA-06-1802	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-22537	Dead	WITH TUMOR	766	466	[Not Available]	Recurrence	[Not Applicable]	81	[Not Available]	1	466	1	466	0	720	1	81	62.98	1.28	60-69	other
2848	TCGA-06-1804	GBM	81	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-29802	Dead	WITH TUMOR	414	414	[Not Available]	NA	NA	364	[Not Available]	1	414	1	414	0	720	1	414	82.73	1.13	>=80	other
2849	TCGA-06-1805	GBM	28	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-10542	Alive	TUMOR FREE	1031	548	[Not Available]	NA	NA	364	[Not Available]	0	1031	0	1031	0	720	0	1031	31.69	2.82	18-29	other
2850	TCGA-06-1806	GBM	47	MALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2009	[Not Available]	-17296	Dead	WITH TUMOR	766	466	[Not Available]	Progression of Disease	[Not Applicable]	256	Progressive Disease	1	466	1	466	0	720	1	256	48.63	1.28	40-49	other
2851	TCGA-06-2557	GBM	76	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-27980	Dead	WITH TUMOR	33	33	[Not Available]	NA	NA	364	[Not Available]	1	33	1	33	0	720	1	33	76.7	0.09	70-79	other
2852	TCGA-06-2558	GBM	75	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-27511	Dead	TUMOR FREE	23	380	[Not Available]	NA	NA	364	[Not Available]	1	380	0	380	0	720	0	380	76.36	1.04	70-79	other
2853	TCGA-06-2559	GBM	83	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-30580	Dead	WITH TUMOR	150	150	[Not Available]	NA	NA	364	[Not Available]	1	150	1	150	0	720	1	150	84.13	0.41	>=80	other
2854	TCGA-06-2561	GBM	53	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-19505	Dead	WITH TUMOR	766	537	[Not Available]	Recurrence	[Not Applicable]	78	[Not Available]	1	537	1	537	0	720	1	78	54.87	1.47	50-59	other
2855	TCGA-06-2562	GBM	81	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-29753	Dead	WITH TUMOR	766	382	[Not Available]	Progression of Disease	[Not Applicable]	151	[Not Available]	1	382	1	382	0	720	1	151	82.51	1.05	>=80	other
2856	TCGA-06-2563	GBM	72	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-26643	Alive	WITH TUMOR	932	548	[Not Available]	NA	[Not Applicable]	554	[Not Available]	0	932	0	932	0	720	1	554	75.5	2.55	70-79	other
2857	TCGA-06-2564	GBM	50	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-18435	Alive	WITH TUMOR	181	548	[Not Available]	NA	NA	364	[Not Available]	0	181	0	181	0	720	0	181	50.97	0.5	50-59	other
2858	TCGA-06-2565	GBM	59	MALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-21559	Dead	WITH TUMOR	766	506	[Not Available]	Progression of Disease	[Not Applicable]	178	[Not Available]	1	506	1	506	0	720	1	178	60.41	1.39	50-59	other
2859	TCGA-06-2566	GBM	23	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-8428	Dead	WITH TUMOR	182	182	[Not Available]	NA	NA	364	[Not Available]	1	182	1	182	0	720	1	182	23.57	0.5	18-29	other
2860	TCGA-06-2567	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-23759	Dead	WITH TUMOR	133	133	[Not Available]	NA	NA	364	[Not Available]	1	133	1	133	0	720	1	133	65.41	0.36	60-69	other
2861	TCGA-06-2569	GBM	24	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-8922	Alive	WITH TUMOR	13	548	[Not Available]	NA	NA	364	[Not Available]	0	13	0	13	0	720	0	13	24.46	0.04	18-29	other
2862	TCGA-06-2570	GBM	21	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-7936	Alive	TUMOR FREE	958	548	[Not Available]	NA	NA	364	[Not Available]	0	958	0	958	0	720	0	958	24.35	2.62	18-29	other
2863	TCGA-06-5408	GBM	54	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-20063	Dead	WITH TUMOR	342	357	[Not Available]	Progression of Disease	[Not Applicable]	158	[Not Available]	1	357	1	357	0	720	1	158	55.91	0.98	50-59	other
2864	TCGA-06-5410	GBM	72	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-26395	Dead	WITH TUMOR	108	108	[Not Available]	NA	NA	364	[Not Available]	1	108	1	108	0	720	1	108	72.56	0.3	70-79	other
2865	TCGA-06-5411	GBM	51	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-18832	Dead	WITH TUMOR	254	254	[Not Available]	Progression of Disease	[Not Applicable]	214	[Not Available]	1	254	1	254	0	720	1	214	52.25	0.7	50-59	other
2866	TCGA-06-5412	GBM	78	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-28762	Dead	WITH TUMOR	138	138	[Not Available]	Progression of Disease	[Not Applicable]	88	[Not Available]	1	138	1	138	0	720	1	88	79.12	0.38	70-79	other
2867	TCGA-06-5413	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-24477	Alive	WITH TUMOR	268	548	[Not Available]	Progression of Disease	[Not Applicable]	195	[Not Available]	0	268	0	268	0	720	1	195	67.75	0.73	60-69	other
2868	TCGA-06-5414	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-22527	Alive	WITH TUMOR	273	548	[Not Available]	Progression of Disease	[Not Applicable]	167	[Not Available]	0	273	0	273	0	720	1	167	62.42	0.75	60-69	other
2869	TCGA-06-5415	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-22213	Alive	WITH TUMOR	260	548	[Not Available]	NA	NA	364	[Not Available]	0	260	0	260	0	720	0	260	61.53	0.71	60-69	other
2870	TCGA-06-5416	GBM	23	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-8533	Alive	WITH TUMOR	204	548	[Not Available]	NA	NA	364	[Not Available]	0	204	0	204	0	720	0	204	23.92	0.56	18-29	other
2871	TCGA-06-5417	GBM	45	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-16572	Alive	WITH TUMOR	155	548	[Not Available]	NA	NA	364	[Not Available]	0	155	0	155	0	720	0	155	45.8	0.42	40-49	other
2872	TCGA-06-5418	GBM	75	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-27584	Dead	WITH TUMOR	83	83	[Not Available]	NA	NA	364	[Not Available]	1	83	1	83	0	720	1	83	75.75	0.23	70-79	other
2873	TCGA-06-5856	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-21232	Dead	WITH TUMOR	114	114	[Not Available]	NA	NA	364	[Not Available]	1	114	1	114	0	720	1	114	58.44	0.31	50-59	other
2874	TCGA-06-5858	GBM	45	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-16662	Alive	WITH TUMOR	187	548	[Not Available]	Progression of Disease	[Not Applicable]	97	[Not Available]	0	187	0	187	0	720	1	97	46.13	0.51	40-49	other
2875	TCGA-06-5859	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-23211	Alive	WITH TUMOR	139	548	[Not Available]	NA	NA	364	[Not Available]	0	139	0	139	0	720	0	139	63.93	0.38	60-69	other
2876	TCGA-06-6388	GBM	64	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-23519	Dead	WITH TUMOR	120	159	[Not Available]	Progression of Disease	[Not Applicable]	85	[Not Available]	1	159	1	159	0	720	1	85	64.83	0.44	60-69	other
2877	TCGA-06-6389	GBM	49	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-18248	Alive	WITH TUMOR	237	548	[Not Available]	NA	NA	364	[Not Available]	0	237	0	237	0	720	0	237	50.61	0.65	40-49	other
2878	TCGA-06-6390	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-21328	Dead	WITH TUMOR	164	164	[Not Available]	NA	NA	364	[Not Available]	1	164	1	164	0	720	1	164	58.84	0.45	50-59	other
2879	TCGA-06-6391	GBM	44	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-16206	Dead	WITH TUMOR	766	45	[Not Available]	NA	NA	364	[Not Available]	1	45	1	45	0	720	1	45	44.49	0.12	40-49	other
2880	TCGA-06-6693	GBM	64	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1993	[Not Available]	-23585	Dead	WITH TUMOR	15	3667	[Not Available]	NA	NA	364	[Not Available]	1	3667	1	3667	0	720	1	3667	74.61	10.04	60-69	other
2881	TCGA-06-6694	GBM	76	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1994	[Not Available]	-27909	Dead	WITH TUMOR	224	224	[Not Available]	NA	NA	364	[Not Available]	1	224	1	224	0	720	1	224	77.02	0.61	70-79	other
2882	TCGA-06-6695	GBM	64	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-23426	Alive	WITH TUMOR	253	548	[Not Available]	Progression of Disease	[Not Applicable]	133	[Not Available]	0	253	0	253	0	720	1	133	64.83	0.69	60-69	other
2883	TCGA-06-6697	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-23763	Alive	WITH TUMOR	391	548	[Not Available]	Progression of Disease	[Not Applicable]	306	[Not Available]	0	391	0	391	0	720	1	306	66.13	1.07	60-69	other
2884	TCGA-06-6698	GBM	53	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-19591	Alive	WITH TUMOR	145	548	[Not Available]	NA	NA	364	[Not Available]	0	145	0	145	0	720	0	145	54.03	0.4	50-59	other
2885	TCGA-06-6699	GBM	58	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-21190	Alive	WITH TUMOR	47	548	[Not Available]	NA	NA	364	[Not Available]	0	47	0	47	0	720	0	47	58.14	0.13	50-59	other
2886	TCGA-06-6700	GBM	76	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-27850	Alive	WITH TUMOR	145	548	[Not Available]	NA	NA	364	[Not Available]	0	145	0	145	0	720	0	145	76.65	0.4	70-79	other
2887	TCGA-06-6701	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-22051	Alive	WITH TUMOR	151	548	[Not Available]	NA	NA	364	[Not Available]	0	151	0	151	0	720	0	151	60.79	0.41	60-69	other
2888	TCGA-06-A5U0	GBM	21	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2012	[Not Available]	-7958	Alive	WITH TUMOR	815	548	[Not Available]	Progression of Disease	[Not Applicable]	100	Progressive Disease	0	815	0	815	0	720	1	100	24.02	2.23	18-29	other
2889	TCGA-06-A5U1	GBM	78	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2011	[Not Available]	-28545	Dead	WITH TUMOR	766	57	[Not Available]	NA	NA	364	Progressive Disease	1	57	1	57	0	720	1	57	78.31	0.16	70-79	other
2890	TCGA-06-A6S0	GBM	79	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2011	[Not Available]	-29037	Dead	WITH TUMOR	766	95	[Not Available]	NA	NA	364	Stable Disease	1	95	1	95	0	720	1	95	79.76	0.26	70-79	other
2891	TCGA-06-A6S1	GBM	53	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2012	[Not Available]	-19443	Dead	WITH TUMOR	766	78	[Not Available]	Progression of Disease	[Not Applicable]	46	Progressive Disease	1	78	1	78	0	720	1	46	53.45	0.21	50-59	other
2892	TCGA-06-A7TK	GBM	64	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2013	[Not Available]	-23674	Dead	WITH TUMOR	766	444	[Not Available]	Progression of Disease	[Not Applicable]	342	Progressive Disease	1	444	1	444	0	720	1	342	66.03	1.22	60-69	other
2893	TCGA-06-A7TL	GBM	30	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2013	[Not Available]	-11297	Alive	WITH TUMOR	539	548	[Not Available]	Progression of Disease	[Not Applicable]	188	Stable Disease	0	539	0	539	0	720	1	188	32.41	1.48	30-39	other
2894	TCGA-08-0244	GBM	62	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-22684	Dead	WITH TUMOR	690	690	[Not Available]	Recurrence	[Not Applicable]	484	[Not Available]	1	690	1	690	0	720	1	484	63.99	1.89	60-69	other
2895	TCGA-08-0245	GBM	31	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-11613	Dead	WITH TUMOR	1057	1151	[Not Available]	Progression of Disease	[Not Applicable]	463	[Not Available]	1	1151	1	1151	0	720	1	463	34.95	3.15	30-39	other
2896	TCGA-08-0246	GBM	57	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-20974	Dead	WITH TUMOR	119	127	[Not Available]	Progression of Disease	[Not Applicable]	103	[Not Available]	1	127	1	127	0	720	1	103	57.77	0.35	50-59	other
2897	TCGA-08-0344	GBM	66	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1992	[Not Available]	-24253	Dead	WITH TUMOR	3310	3524	[Not Available]	Recurrence	[Not Applicable]	1880	[Not Available]	1	3524	1	3524	0	720	1	1880	76.05	9.65	60-69	other
2898	TCGA-08-0345	GBM	71	FEMALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1992	[Not Available]	-25960	Dead	WITH TUMOR	53	53	[Not Available]	NA	NA	364	[Not Available]	1	53	1	53	0	720	1	53	71.22	0.15	70-79	other
2899	TCGA-08-0346	GBM	69	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1993	[Not Available]	-25409	Dead	WITH TUMOR	132	256	[Not Available]	Progression of Disease	[Not Applicable]	75	[Not Available]	1	256	1	256	0	720	1	75	70.27	0.7	60-69	other
2900	TCGA-08-0347	GBM	50	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1993	[Not Available]	-18384	Dead	WITH TUMOR	419	782	[Not Available]	Progression of Disease	[Not Applicable]	59	[Not Available]	1	782	1	782	0	720	1	59	52.47	2.14	50-59	other
2901	TCGA-08-0348	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-23373	Dead	WITH TUMOR	316	370	[Not Available]	Recurrence	[Not Applicable]	198	[Not Available]	1	370	1	370	0	720	1	198	65	1.01	60-69	other
2902	TCGA-08-0349	GBM	46	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-16964	Dead	WITH TUMOR	231	298	[Not Available]	Progression of Disease	[Not Applicable]	93	[Not Available]	1	298	1	298	0	720	1	93	47.26	0.82	40-49	other
2903	TCGA-08-0350	GBM	32	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-11905	Dead	WITH TUMOR	104	889	[Not Available]	Recurrence	[Not Applicable]	439	[Not Available]	1	889	1	889	0	720	1	439	35.03	2.43	30-39	other
2904	TCGA-08-0351	GBM	40	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-14838	Dead	WITH TUMOR	1637	1987	[Not Available]	Recurrence	[Not Applicable]	1542	[Not Available]	1	1987	1	1987	0	720	1	1542	46.06	5.44	40-49	other
2905	TCGA-08-0352	GBM	79	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-29106	Dead	WITH TUMOR	39	39	[Not Available]	NA	NA	364	[Not Available]	1	39	1	39	0	720	1	39	79.79	0.11	70-79	other
2906	TCGA-08-0353	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-21332	Dead	WITH TUMOR	195	256	[Not Available]	Progression of Disease	[Not Applicable]	164	[Not Available]	1	256	1	256	0	720	1	164	59.1	0.7	50-59	other
2907	TCGA-08-0354	GBM	52	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-19199	Dead	WITH TUMOR	458	546	[Not Available]	Progression of Disease	[Not Applicable]	253	[Not Available]	1	546	1	546	0	720	1	253	54.06	1.49	50-59	other
2908	TCGA-08-0355	GBM	30	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-11099	Dead	WITH TUMOR	685	747	[Not Available]	Recurrence	[Not Applicable]	519	[Not Available]	1	747	1	747	0	720	1	519	32.43	2.05	30-39	other
2909	TCGA-08-0356	GBM	59	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-21900	Dead	WITH TUMOR	447	946	[Not Available]	Recurrence	[Not Applicable]	447	[Not Available]	1	946	1	946	0	720	1	447	62.55	2.59	50-59	other
2910	TCGA-08-0357	GBM	49	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-18144	Dead	WITH TUMOR	1084	1143	[Not Available]	Recurrence	[Not Applicable]	155	[Not Available]	1	1143	1	1143	0	720	1	155	52.8	3.13	40-49	other
2911	TCGA-08-0358	GBM	50	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-18383	Dead	WITH TUMOR	594	678	[Not Available]	Recurrence	[Not Applicable]	264	[Not Available]	1	678	1	678	0	720	1	264	52.19	1.86	50-59	other
2912	TCGA-08-0359	GBM	59	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-21748	Dead	WITH TUMOR	29	103	[Not Available]	NA	NA	364	[Not Available]	1	103	1	103	0	720	1	103	59.82	0.28	50-59	other
2913	TCGA-08-0360	GBM	76	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-27895	Dead	WITH TUMOR	352	468	[Not Available]	Recurrence	[Not Applicable]	112	[Not Available]	1	468	1	468	0	720	1	112	77.65	1.28	70-79	other
2914	TCGA-08-0373	GBM	69	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1994	[Not Available]	-25274	Dead	WITH TUMOR	134	134	[Not Available]	NA	NA	364	[Not Available]	1	134	1	134	0	720	1	134	69.56	0.37	60-69	other
2915	TCGA-08-0375	GBM	51	FEMALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1994	[Not Available]	-18941	Dead	WITH TUMOR	279	372	[Not Available]	Recurrence	[Not Applicable]	161	[Not Available]	1	372	1	372	0	720	1	161	52.88	1.02	50-59	other
2916	TCGA-08-0380	GBM	74	FEMALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-27277	Dead	WITH TUMOR	330	454	[Not Available]	Progression of Disease	[Not Applicable]	151	[Not Available]	1	454	1	454	0	720	1	151	75.92	1.24	70-79	other
2917	TCGA-08-0385	GBM	71	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-26234	Dead	WITH TUMOR	31	82	[Not Available]	NA	NA	364	[Not Available]	1	82	1	82	0	720	1	82	72.05	0.22	70-79	other
2918	TCGA-08-0386	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-27053	Dead	WITH TUMOR	478	548	[Not Available]	Recurrence	[Not Applicable]	427	[Not Available]	1	548	1	548	0	720	1	427	75.57	1.5	70-79	other
2919	TCGA-08-0389	GBM	59	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-21638	Dead	WITH TUMOR	97	467	[Not Available]	NA	NA	364	[Not Available]	1	467	1	467	0	720	1	467	60.52	1.28	50-59	other
2920	TCGA-08-0390	GBM	69	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-25304	Dead	WITH TUMOR	322	425	[Not Available]	NA	NA	364	[Not Available]	1	425	1	425	0	720	1	425	70.44	1.16	60-69	other
2921	TCGA-08-0392	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-22056	Dead	WITH TUMOR	9	22	[Not Available]	NA	NA	364	[Not Available]	1	22	1	22	0	720	1	22	60.45	0.06	60-69	other
2922	TCGA-08-0509	GBM	63	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-23273	Dead	WITH TUMOR	17	382	[Not Available]	NA	NA	364	[Not Available]	1	382	1	382	0	720	1	382	64.76	1.05	60-69	other
2923	TCGA-08-0510	GBM	75	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-27675	Dead	WITH TUMOR	107	130	[Not Available]	Recurrence	[Not Applicable]	90	[Not Available]	1	130	1	130	0	720	1	90	76.13	0.36	70-79	other
2924	TCGA-08-0511	GBM	69	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-25300	Dead	WITH TUMOR	235	235	[Not Available]	NA	NA	364	[Not Available]	1	235	1	235	0	720	1	235	69.91	0.64	60-69	other
2925	TCGA-08-0512	GBM	48	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-17821	Dead	WITH TUMOR	358	1282	[Not Available]	Progression of Disease	[Not Applicable]	231	[Not Available]	1	1282	1	1282	0	720	1	231	52.3	3.51	40-49	other
2926	TCGA-08-0514	GBM	69	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-25457	Dead	WITH TUMOR	259	337	[Not Available]	NA	NA	364	[Not Available]	1	337	1	337	0	720	1	337	70.62	0.92	60-69	other
2927	TCGA-08-0516	GBM	14	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-5309	Dead	WITH TUMOR	561	596	[Not Available]	Progression of Disease	[Not Applicable]	40	[Not Available]	1	596	1	596	0	720	1	40	16.17	1.63	<18	other
2928	TCGA-08-0517	GBM	34	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-12771	Dead	WITH TUMOR	1770	1785	[Not Available]	Recurrence	[Not Applicable]	1024	[Not Available]	1	1785	1	1785	0	720	1	1024	39.85	4.89	30-39	other
2929	TCGA-08-0518	GBM	60	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-21995	Dead	WITH TUMOR	39	588	[Not Available]	Progression of Disease	[Not Applicable]	134	[Not Available]	1	588	1	588	0	720	1	134	61.83	1.61	60-69	other
2930	TCGA-08-0520	GBM	70	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-25766	Dead	WITH TUMOR	327	327	[Not Available]	Recurrence	[Not Applicable]	105	[Not Available]	1	327	1	327	0	720	1	105	71.44	0.9	70-79	other
2931	TCGA-08-0521	GBM	17	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-6377	Dead	WITH TUMOR	146	146	[Not Available]	Progression of Disease	[Not Applicable]	125	[Not Available]	1	146	1	146	0	720	1	125	17.86	0.4	<18	other
2932	TCGA-08-0522	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-22414	Dead	WITH TUMOR	555	635	[Not Available]	Progression of Disease	[Not Applicable]	266	[Not Available]	1	635	1	635	0	720	1	266	63.1	1.74	60-69	other
2933	TCGA-08-0524	GBM	17	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-6464	Dead	WITH TUMOR	199	221	[Not Available]	Progression of Disease	[Not Applicable]	61	[Not Available]	1	221	1	221	0	720	1	61	18.3	0.61	<18	other
2934	TCGA-08-0525	GBM	52	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-19013	Dead	WITH TUMOR	486	486	[Not Available]	Progression of Disease	[Not Applicable]	343	[Not Available]	1	486	1	486	0	720	1	343	53.39	1.33	50-59	other
2935	TCGA-08-0529	GBM	56	FEMALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-20556	Dead	WITH TUMOR	527	560	[Not Available]	Recurrence	[Not Applicable]	328	[Not Available]	1	560	1	560	0	720	1	328	57.81	1.53	50-59	other
2936	TCGA-08-0531	GBM	64	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-23482	Dead	WITH TUMOR	168	230	[Not Available]	NA	NA	364	[Not Available]	1	230	1	230	0	720	1	230	64.92	0.63	60-69	other
2937	TCGA-12-0615	GBM	78	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-28583	Dead	WITH TUMOR	426	467	[Not Available]	Progression of Disease	[Not Applicable]	160	[Not Available]	1	467	1	467	0	720	1	160	79.53	1.28	70-79	other
2938	TCGA-12-0616	GBM	36	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-13451	Dead	WITH TUMOR	439	448	[Not Available]	Progression of Disease	[Not Applicable]	398	[Not Available]	1	448	1	448	0	720	1	398	38.05	1.23	30-39	other
2939	TCGA-12-0618	GBM	49	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-18071	Dead	TUMOR FREE	50	395	[Not Available]	NA	NA	364	[Not Available]	1	395	0	395	0	720	0	395	50.56	1.08	40-49	other
2940	TCGA-12-0619	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-21920	Dead	WITH TUMOR	316	1062	[Not Available]	Progression of Disease	[Not Applicable]	203	[Not Available]	1	1062	1	1062	0	720	1	203	62.92	2.91	60-69	other
2941	TCGA-12-0620	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-21069	Dead	WITH TUMOR	181	318	[Not Available]	NA	NA	364	[Not Available]	1	318	1	318	0	720	1	318	58.55	0.87	50-59	other
2942	TCGA-12-0653	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-23952	Dead	WITH TUMOR	766	320	[Not Available]	Progression of Disease	[Not Applicable]	267	[Not Available]	1	320	1	320	0	720	1	267	66.45	0.88	60-69	other
2943	TCGA-12-0654	GBM	48	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-17625	Dead	WITH TUMOR	218	231	[Not Available]	Progression of Disease	[Not Applicable]	216	[Not Available]	1	231	1	231	0	720	1	216	48.89	0.63	40-49	other
2944	TCGA-12-0656	GBM	48	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-17865	Dead	WITH TUMOR	2005	2883	[Not Available]	Progression of Disease	[Not Applicable]	1467	[Not Available]	1	2883	1	2883	0	720	1	1467	56.8	7.89	40-49	other
2945	TCGA-12-0657	GBM	69	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-25413	Dead	WITH TUMOR	3	3	[Not Available]	NA	NA	364	[Not Available]	1	3	1	3	0	720	1	3	69.59	0.01	60-69	other
2946	TCGA-12-0662	GBM	51	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-18717	Dead	WITH TUMOR	1161	1161	[Not Available]	Progression of Disease	[Not Applicable]	600	[Not Available]	1	1161	1	1161	0	720	1	600	54.42	3.18	50-59	other
2947	TCGA-12-0670	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-22189	Dead	TUMOR FREE	790	790	[Not Available]	Progression of Disease	[Not Applicable]	379	[Not Available]	1	790	0	790	0	720	1	379	62.91	2.16	60-69	other
2948	TCGA-12-0688	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-27085	Dead	WITH TUMOR	734	811	[Not Available]	Progression of Disease	[Not Applicable]	228	[Not Available]	1	811	1	811	0	720	1	228	76.38	2.22	70-79	other
2949	TCGA-12-0691	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-23019	Dead	WITH TUMOR	186	369	[Not Available]	Progression of Disease	[Not Applicable]	98	[Not Available]	1	369	1	369	0	720	1	98	64.03	1.01	60-69	other
2950	TCGA-12-0692	GBM	75	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-27519	Dead	WITH TUMOR	80	111	[Not Available]	Progression of Disease	[Not Applicable]	35	[Not Available]	1	111	1	111	0	720	1	35	75.65	0.3	70-79	other
2951	TCGA-12-0703	GBM	46	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1996	[Not Available]	-17125	Dead	WITH TUMOR	551	620	[Not Available]	Progression of Disease	[Not Applicable]	208	[Not Available]	1	620	1	620	0	720	1	208	48.58	1.7	40-49	other
2952	TCGA-12-0707	GBM	55	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-20136	Dead	TUMOR FREE	0	864	[Not Available]	NA	NA	364	[Not Available]	1	864	0	864	0	720	0	864	57.49	2.37	50-59	other
2953	TCGA-12-0769	GBM	52	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-19171	Dead	WITH TUMOR	378	458	[Not Available]	Progression of Disease	[Not Applicable]	378	[Not Available]	1	458	1	458	0	720	1	378	53.74	1.25	50-59	other
2954	TCGA-12-0772	GBM	46	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-17019	Dead	WITH TUMOR	1615	1638	[Not Available]	Progression of Disease	[Not Applicable]	607	[Not Available]	1	1638	1	1638	0	720	1	607	51.08	4.48	40-49	other
2955	TCGA-12-0773	GBM	24	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-8849	Dead	WITH TUMOR	1311	1315	[Not Available]	Progression of Disease	[Not Applicable]	725	[Not Available]	1	1315	1	1315	0	720	1	725	27.83	3.6	18-29	other
2956	TCGA-12-0775	GBM	75	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-27565	Dead	WITH TUMOR	167	232	[Not Available]	Progression of Disease	[Not Applicable]	94	[Not Available]	1	232	1	232	0	720	1	94	76.1	0.64	70-79	other
2957	TCGA-12-0776	GBM	52	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-19228	Dead	WITH TUMOR	277	296	[Not Available]	Progression of Disease	[Not Applicable]	127	[Not Available]	1	296	1	296	0	720	1	127	53.45	0.81	50-59	other
2958	TCGA-12-0778	GBM	53	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-19460	Dead	WITH TUMOR	452	454	[Not Available]	Progression of Disease	[Not Applicable]	232	[Not Available]	1	454	1	454	0	720	1	232	54.52	1.24	50-59	other
2959	TCGA-12-0780	GBM	51	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-18646	Dead	WITH TUMOR	434	452	[Not Available]	Progression of Disease	[Not Applicable]	91	[Not Available]	1	452	1	452	0	720	1	91	52.29	1.24	50-59	other
2960	TCGA-12-0818	GBM	45	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1994	[Not Available]	-16666	Dead	TUMOR FREE	2791	2791	[Not Available]	NA	NA	364	[Not Available]	1	2791	0	2791	0	720	0	2791	53.27	7.64	40-49	other
2961	TCGA-12-0819	GBM	49	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1995	[Not Available]	-18160	Dead	WITH TUMOR	754	754	[Not Available]	Recurrence	[Not Applicable]	428	[Not Available]	1	754	1	754	0	720	1	428	51.78	2.06	40-49	other
2962	TCGA-12-0820	GBM	40	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1997	[Not Available]	-14878	Dead	WITH TUMOR	562	562	[Not Available]	Recurrence	[Not Applicable]	272	[Not Available]	1	562	1	562	0	720	1	272	42.27	1.54	40-49	other
2963	TCGA-12-0821	GBM	62	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-22949	Dead	WITH TUMOR	323	323	[Not Available]	Recurrence	[Not Applicable]	259	[Not Available]	1	323	1	323	0	720	1	259	63.72	0.88	60-69	other
2964	TCGA-12-0822	GBM	46	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-16803	Dead	WITH TUMOR	715	715	[Not Available]	Recurrence	[Not Applicable]	91	[Not Available]	1	715	1	715	0	720	1	91	47.96	1.96	40-49	other
2965	TCGA-12-0826	GBM	38	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-13887	Dead	TUMOR FREE	845	845	[Not Available]	NA	NA	364	[Not Available]	1	845	0	845	0	720	0	845	40.33	2.31	30-39	other
2966	TCGA-12-0827	GBM	38	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-14093	Dead	WITH TUMOR	1179	1179	[Not Available]	NA	NA	364	[Not Available]	1	1179	1	1179	0	720	1	1179	41.81	3.23	30-39	other
2967	TCGA-12-0828	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-20909	Dead	WITH TUMOR	272	272	[Not Available]	Progression of Disease	[Not Applicable]	13	[Not Available]	1	272	1	272	0	720	1	13	57.99	0.74	50-59	other
2968	TCGA-12-0829	GBM	75	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-27471	Dead	WITH TUMOR	626	626	[Not Available]	Recurrence	[Not Applicable]	473	[Not Available]	1	626	1	626	0	720	1	473	76.93	1.71	70-79	other
2969	TCGA-12-1088	GBM	53	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1989	[Not Available]	-19667	Dead	TUMOR FREE	3881	3881	[Not Available]	NA	NA	364	[Not Available]	1	3881	0	3881	0	720	0	3881	64.47	10.63	50-59	other
2970	TCGA-12-1089	GBM	64	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-23419	Dead	WITH TUMOR	177	177	[Not Available]	NA	NA	364	[Not Available]	1	177	1	177	0	720	1	177	64.6	0.48	60-69	other
2971	TCGA-12-1090	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-21377	Dead	WITH TUMOR	190	231	[Not Available]	NA	NA	364	[Not Available]	1	231	1	231	0	720	1	231	59.16	0.63	50-59	other
2972	TCGA-12-1091	GBM	10	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2001	[Not Available]	-3982	Dead	WITH TUMOR	929	1010	[Not Available]	Recurrence	[Not Applicable]	56	[Not Available]	1	1010	1	1010	0	720	1	56	13.67	2.77	<18	other
2973	TCGA-12-1092	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-21411	Dead	WITH TUMOR	658	661	[Not Available]	Recurrence	[Not Applicable]	637	[Not Available]	1	661	1	661	0	720	1	637	60.43	1.81	50-59	other
2974	TCGA-12-1093	GBM	66	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-24297	Dead	WITH TUMOR	364	486	[Not Available]	Recurrence	[Not Applicable]	322	[Not Available]	1	486	1	486	0	720	1	322	67.85	1.33	60-69	other
2975	TCGA-12-1094	GBM	56	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-20586	Dead	WITH TUMOR	346	372	[Not Available]	Recurrence	[Not Applicable]	186	[Not Available]	1	372	1	372	0	720	1	186	57.38	1.02	50-59	other
2976	TCGA-12-1095	GBM	65	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-23775	Dead	WITH TUMOR	482	482	[Not Available]	Progression of Disease	[Not Applicable]	96	[Not Available]	1	482	1	482	0	720	1	96	66.41	1.32	60-69	other
2977	TCGA-12-1096	GBM	55	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-20321	Dead	WITH TUMOR	766	277	[Not Available]	Recurrence	[Not Applicable]	270	[Not Available]	1	277	1	277	0	720	1	270	56.39	0.76	50-59	other
2978	TCGA-12-1097	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-22526	Dead	WITH TUMOR	442	442	[Not Available]	Progression of Disease	[Not Applicable]	166	[Not Available]	1	442	1	442	0	720	1	166	62.88	1.21	60-69	other
2979	TCGA-12-1098	GBM	75	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-27726	Dead	WITH TUMOR	121	121	[Not Available]	Recurrence	[Not Applicable]	93	[Not Available]	1	121	1	121	0	720	1	93	76.24	0.33	70-79	other
2980	TCGA-12-1099	GBM	68	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-25034	Dead	WITH TUMOR	104	126	[Not Available]	Recurrence	[Not Applicable]	62	[Not Available]	1	126	1	126	0	720	1	62	68.88	0.34	60-69	other
2981	TCGA-12-1597	GBM	62	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-22865	Dead	WITH TUMOR	427	675	[Not Available]	Progression of Disease	[Not Applicable]	180	[Not Available]	1	675	1	675	0	720	1	180	64.45	1.85	60-69	other
2982	TCGA-12-1598	GBM	75	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-27730	Dead	WITH TUMOR	287	476	[Not Available]	NA	NA	364	[Not Available]	1	476	1	476	0	720	1	476	77.22	1.3	70-79	other
2983	TCGA-12-1599	GBM	47	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-17432	Dead	WITH TUMOR	769	781	[Not Available]	Progression of Disease	[Not Applicable]	89	[Not Available]	1	781	1	781	0	720	1	89	49.86	2.14	40-49	other
2984	TCGA-12-1600	GBM	86	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-31419	Dead	WITH TUMOR	414	448	[Not Available]	Progression of Disease	[Not Applicable]	404	[Not Available]	1	448	1	448	0	720	1	404	87.25	1.23	>=80	other
2985	TCGA-12-1602	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-21492	Dead	WITH TUMOR	195	206	[Not Available]	Progression of Disease	[Not Applicable]	140	[Not Available]	1	206	1	206	0	720	1	140	59.41	0.56	50-59	other
2986	TCGA-12-3644	GBM	47	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-17468	Dead	WITH TUMOR	1807	1818	[Not Available]	Progression of Disease	[Not Applicable]	1142	[Not Available]	1	1818	1	1818	0	720	1	1142	52.8	4.98	40-49	other
2987	TCGA-12-3646	GBM	59	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-21855	Dead	WITH TUMOR	1315	1339	[Not Available]	Progression of Disease	[Not Applicable]	1315	[Not Available]	1	1339	1	1339	0	720	1	1315	63.5	3.67	50-59	other
2988	TCGA-12-3648	GBM	61	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-22463	Dead	WITH TUMOR	784	819	[Not Available]	Progression of Disease	[Not Applicable]	86	[Not Available]	1	819	1	819	0	720	1	86	63.74	2.24	60-69	other
2989	TCGA-12-3649	GBM	76	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-27846	Dead	WITH TUMOR	351	463	[Not Available]	Progression of Disease	[Not Applicable]	351	[Not Available]	1	463	1	463	0	720	1	351	77.51	1.27	70-79	other
2990	TCGA-12-3650	GBM	46	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-17138	Dead	WITH TUMOR	333	333	[Not Available]	Progression of Disease	[Not Applicable]	239	[Not Available]	1	333	1	333	0	720	1	239	47.83	0.91	40-49	other
2991	TCGA-12-3651	GBM	77	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-28277	Dead	WITH TUMOR	358	386	[Not Available]	Progression of Disease	[Not Applicable]	358	[Not Available]	1	386	1	386	0	720	1	358	78.48	1.06	70-79	other
2992	TCGA-12-3652	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-21920	Dead	WITH TUMOR	1050	1062	[Not Available]	Progression of Disease	[Not Applicable]	203	[Not Available]	1	1062	1	1062	0	720	1	203	62.92	2.91	60-69	other
2993	TCGA-12-3653	GBM	34	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-12529	Dead	WITH TUMOR	357	442	[Not Available]	Progression of Disease	[Not Applicable]	224	[Not Available]	1	442	1	442	0	720	1	224	35.51	1.21	30-39	other
2994	TCGA-12-5295	GBM	60	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-22161	Dead	WITH TUMOR	399	454	[Not Available]	Progression of Disease	[Not Applicable]	399	[Not Available]	1	454	1	454	0	720	1	399	61.92	1.24	60-69	other
2995	TCGA-12-5299	GBM	56	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-20463	Dead	WITH TUMOR	98	98	[Not Available]	NA	NA	364	[Not Available]	1	98	1	98	0	720	1	98	56.29	0.27	50-59	other
2996	TCGA-12-5301	GBM	59	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-21768	Dead	WITH TUMOR	62	62	[Not Available]	NA	NA	364	[Not Available]	1	62	1	62	0	720	1	62	59.77	0.17	50-59	other
2997	TCGA-14-0736	GBM	49	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-18219	Dead	WITH TUMOR	460	460	[Not Available]	Recurrence	[Not Applicable]	128	[Not Available]	1	460	1	460	0	720	1	128	51.14	1.26	40-49	other
2998	TCGA-14-0740	GBM	70	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-25627	Dead	WITH TUMOR	364	364	[Not Available]	NA	NA	364	[Not Available]	1	364	1	364	0	720	1	364	71.16	1	70-79	other
2999	TCGA-14-0781	GBM	49	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-17903	Dead	WITH TUMOR	29	29	[Not Available]	NA	NA	364	[Not Available]	1	29	1	29	0	720	1	29	49.1	0.08	40-49	other
3000	TCGA-14-0783	GBM	36	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2000	[Not Available]	-13159	Dead	WITH TUMOR	189	189	[Not Available]	NA	NA	364	[Not Available]	1	189	1	189	0	720	1	189	36.54	0.52	30-39	other
3001	TCGA-14-0786	GBM	50	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-18592	Dead	WITH TUMOR	701	701	[Not Available]	Recurrence	[Not Applicable]	127	[Not Available]	1	701	1	701	0	720	1	127	52.82	1.92	50-59	other
3002	TCGA-14-0787	GBM	69	MALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-25326	Dead	TUMOR FREE	68	68	[Not Available]	NA	NA	364	[Not Available]	1	68	0	68	0	720	0	68	69.52	0.19	60-69	other
3003	TCGA-14-0789	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-20050	Dead	TUMOR FREE	342	342	[Not Available]	Progression of Disease	[Not Applicable]	105	[Not Available]	1	342	0	342	0	720	1	105	55.83	0.94	50-59	other
3004	TCGA-14-0790	GBM	64	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-23674	Dead	WITH TUMOR	419	419	[Not Available]	NA	NA	364	[Not Available]	1	419	1	419	0	720	1	419	65.96	1.15	60-69	other
3005	TCGA-14-0812	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-24085	Dead	WITH TUMOR	99	99	[Not Available]	NA	NA	364	[Not Available]	1	99	1	99	0	720	1	99	66.21	0.27	60-69	other
3006	TCGA-14-0813	GBM	78	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-28582	Dead	TUMOR FREE	41	41	[Not Available]	NA	NA	364	[Not Available]	1	41	0	41	0	720	0	41	78.37	0.11	70-79	other
3007	TCGA-14-0817	GBM	69	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-25425	Dead	TUMOR FREE	164	164	[Not Available]	NA	NA	364	[Not Available]	1	164	0	164	0	720	0	164	70.06	0.45	60-69	other
3008	TCGA-14-0862	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-22179	Dead	WITH TUMOR	88	88	[Not Available]	NA	NA	364	[Not Available]	1	88	1	88	0	720	1	88	60.96	0.24	60-69	other
3009	TCGA-14-0865	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-24797	Dead	WITH TUMOR	502	502	[Not Available]	Progression of Disease	[Not Applicable]	215	[Not Available]	1	502	1	502	0	720	1	215	69.26	1.37	60-69	other
3010	TCGA-14-0866	GBM	55	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-20179	Dead	TUMOR FREE	801	801	[Not Available]	Recurrence	[Not Applicable]	97	[Not Available]	1	801	0	801	0	720	1	97	57.44	2.19	50-59	other
3011	TCGA-14-0867	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-24815	Dead	TUMOR FREE	62	62	[Not Available]	NA	NA	364	[Not Available]	1	62	0	62	0	720	0	62	68.11	0.17	60-69	other
3012	TCGA-14-0871	GBM	74	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-27387	Dead	TUMOR FREE	880	880	[Not Available]	NA	NA	364	[Not Available]	1	880	0	880	0	720	0	880	77.39	2.41	70-79	other
3013	TCGA-14-1034	GBM	60	FEMALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1999	[Not Available]	-22029	Dead	WITH TUMOR	485	485	[Not Available]	Progression of Disease	[Not Applicable]	282	[Not Available]	1	485	1	485	0	720	1	282	61.64	1.33	60-69	other
3014	TCGA-14-1037	GBM	66	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-24426	Dead	WITH TUMOR	587	587	[Not Available]	Recurrence	[Not Applicable]	326	[Not Available]	1	587	1	587	0	720	1	326	68.48	1.61	60-69	other
3015	TCGA-14-1043	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-22392	Dead	WITH TUMOR	24	24	[Not Available]	NA	NA	364	[Not Available]	1	24	1	24	0	720	1	24	61.37	0.07	60-69	other
3016	TCGA-14-1395	GBM	52	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-19237	Dead	WITH TUMOR	42	42	[Not Available]	NA	NA	364	[Not Available]	1	42	1	42	0	720	1	42	52.78	0.11	50-59	other
3017	TCGA-14-1396	GBM	78	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2003	[Not Available]	-28753	Dead	WITH TUMOR	34	34	[Not Available]	NA	NA	364	[Not Available]	1	34	1	34	0	720	1	34	78.81	0.09	70-79	other
3018	TCGA-14-1401	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-19921	Dead	WITH TUMOR	114	114	[Not Available]	NA	NA	364	[Not Available]	1	114	1	114	0	720	1	114	54.85	0.31	50-59	other
3019	TCGA-14-1402	GBM	58	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-21421	Dead	WITH TUMOR	975	975	[Not Available]	Progression of Disease	[Not Applicable]	333	[Not Available]	1	975	1	975	0	720	1	333	61.32	2.67	50-59	other
3020	TCGA-14-1450	GBM	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-20960	Alive	WITH TUMOR	1788	548	[Not Available]	Progression of Disease	[Not Applicable]	826	[Not Available]	0	1788	0	1788	0	720	1	826	62.28	4.9	50-59	other
3021	TCGA-14-1451	GBM	39	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-14401	Dead	WITH TUMOR	703	703	[Not Available]	Recurrence	[Not Applicable]	19	[Not Available]	1	703	1	703	0	720	1	19	41.35	1.92	30-39	other
3022	TCGA-14-1452	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-22106	Dead	WITH TUMOR	216	216	[Not Available]	Recurrence	[Not Applicable]	172	[Not Available]	1	216	1	216	0	720	1	172	61.11	0.59	60-69	other
3023	TCGA-14-1453	GBM	69	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-25297	Dead	WITH TUMOR	35	35	[Not Available]	NA	NA	364	[Not Available]	1	35	1	35	0	720	1	35	69.36	0.1	60-69	other
3024	TCGA-14-1454	GBM	54	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-19887	Dead	WITH TUMOR	918	918	[Not Available]	Recurrence	[Not Applicable]	291	[Not Available]	1	918	1	918	0	720	1	291	56.96	2.51	50-59	other
3025	TCGA-14-1455	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-22562	Dead	WITH TUMOR	28	28	[Not Available]	NA	NA	364	[Not Available]	1	28	1	28	0	720	1	28	61.85	0.08	60-69	other
3026	TCGA-14-1456	GBM	23	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-8710	Alive	WITH TUMOR	1246	548	[Not Available]	Progression of Disease	[Not Applicable]	98	[Not Available]	0	1246	0	1246	0	720	1	98	27.26	3.41	18-29	other
3027	TCGA-14-1458	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-19899	Dead	TUMOR FREE	187	203	[Not Available]	Recurrence	[Not Applicable]	81	[Not Available]	1	203	0	203	0	720	1	81	55.04	0.56	50-59	other
3028	TCGA-14-1459	GBM	63	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-23231	Dead	WITH TUMOR	378	378	[Not Available]	Progression of Disease	[Not Applicable]	275	[Not Available]	1	378	1	378	0	720	1	275	64.64	1.03	60-69	other
3029	TCGA-14-1794	GBM	59	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-21628	Dead	WITH TUMOR	30	30	[Not Available]	NA	NA	364	[Not Available]	1	30	1	30	0	720	1	30	59.3	0.08	50-59	other
3030	TCGA-14-1795	GBM	66	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-24375	Dead	WITH TUMOR	60	60	[Not Available]	NA	NA	364	[Not Available]	1	60	1	60	0	720	1	60	66.9	0.16	60-69	other
3031	TCGA-14-1821	GBM	31	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-11329	Dead	WITH TUMOR	541	541	[Not Available]	Recurrence	[Not Applicable]	331	[Not Available]	1	541	1	541	0	720	1	331	32.5	1.48	30-39	other
3032	TCGA-14-1823	GBM	58	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-21384	Dead	WITH TUMOR	543	543	[Not Available]	Recurrence	[Not Applicable]	140	[Not Available]	1	543	1	543	0	720	1	140	60.03	1.49	50-59	other
3033	TCGA-14-1825	GBM	70	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-25684	Dead	WITH TUMOR	766	232	[Not Available]	Progression of Disease	[Not Applicable]	82	[Not Available]	1	232	1	232	0	720	1	82	70.95	0.64	70-79	other
3034	TCGA-14-1827	GBM	51	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	1998	[Not Available]	-18828	Dead	TUMOR FREE	179	179	[Not Available]	NA	NA	364	[Not Available]	1	179	0	179	0	720	0	179	52.04	0.49	50-59	other
3035	TCGA-14-1829	GBM	57	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-20929	Alive	WITH TUMOR	218	548	[Not Available]	NA	NA	364	[Not Available]	0	218	0	218	0	720	0	218	57.9	0.6	50-59	other
3036	TCGA-14-2554	GBM	52	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2002	[Not Available]	-19090	Dead	WITH TUMOR	532	532	[Not Available]	NA	NA	364	[Not Available]	1	532	1	532	0	720	1	532	53.72	1.46	50-59	other
3037	TCGA-14-2555	GBM	44	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-16259	Alive	TUMOR FREE	242	548	[Not Available]	NA	NA	364	[Not Available]	0	242	0	242	0	720	0	242	45.18	0.66	40-49	other
3038	TCGA-14-3476	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-27172	Dead	TUMOR FREE	12	12	[Not Available]	Progression of Disease	[Not Applicable]	9	[Not Available]	1	12	0	12	0	720	1	9	74.43	0.03	70-79	other
3039	TCGA-14-3477	GBM	38	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-14082	Alive	WITH TUMOR	115	548	[Not Available]	NA	NA	364	[Not Available]	0	115	0	115	0	720	0	115	38.87	0.31	30-39	other
3040	TCGA-14-4157	GBM	40	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-14816	Alive	TUMOR FREE	104	548	[Not Available]	Progression of Disease	[Not Applicable]	96	[Not Available]	0	104	0	104	0	720	1	96	40.85	0.28	40-49	other
3041	TCGA-15-0742	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-24050	Dead	TUMOR FREE	766	419	[Not Available]	Progression of Disease	[Not Applicable]	232	[Not Available]	1	419	0	419	0	720	1	232	66.99	1.15	60-69	other
3042	TCGA-15-1444	GBM	21	MALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2004	[Not Available]	-7827	Dead	WITH TUMOR	766	1537	[Not Available]	Progression of Disease	[Not Applicable]	1550	Complete Remission/Response	1	1537	1	1537	1	1550	1	1550	25.64	4.21	18-29	other
3043	TCGA-15-1446	GBM	55	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-20355	Alive	WITH TUMOR	581	548	[Not Available]	Recurrence	[Not Applicable]	443	[Not Available]	0	581	0	581	0	720	1	443	57.32	1.59	50-59	other
3044	TCGA-15-1447	GBM	36	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-13326	Alive	WITH TUMOR	1618	548	[Not Available]	Recurrence	[Not Applicable]	340	[Not Available]	0	1618	0	1618	0	720	1	340	40.91	4.43	30-39	other
3045	TCGA-15-1449	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-23828	Dead	WITH TUMOR	766	404	[Not Available]	Recurrence	[Not Applicable]	74	[Not Available]	1	404	1	404	0	720	1	74	66.34	1.11	60-69	other
3046	TCGA-16-0846	GBM	85	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-31111	Dead	WITH TUMOR	119	119	[Not Available]	NA	NA	364	[Not Available]	1	119	1	119	0	720	1	119	85.5	0.33	>=80	other
3047	TCGA-16-0848	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-20848	Dead	WITH TUMOR	302	535	[Not Available]	Recurrence	[Not Applicable]	129	[Not Available]	1	535	1	535	0	720	1	129	58.54	1.46	50-59	other
3048	TCGA-16-0849	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-19939	Alive	TUMOR FREE	793	548	[Not Available]	NA	NA	364	[Not Available]	0	793	0	793	0	720	0	793	56.76	2.17	50-59	other
3049	TCGA-16-0850	GBM	52	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-19281	Dead	WITH TUMOR	496	498	[Not Available]	Recurrence	[Not Applicable]	83	[Not Available]	1	498	1	498	0	720	1	83	54.15	1.36	50-59	other
3050	TCGA-16-0861	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-23778	Alive	TUMOR FREE	131	548	[Not Available]	Recurrence	[Not Applicable]	94	[Not Available]	0	131	0	131	0	720	1	94	65.46	0.36	60-69	other
3051	TCGA-16-1045	GBM	49	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-18195	Dead	WITH TUMOR	883	883	[Not Available]	Recurrence	[Not Applicable]	654	[Not Available]	1	883	1	883	0	720	1	654	52.23	2.42	40-49	other
3052	TCGA-16-1047	GBM	66	FEMALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-24301	Dead	WITH TUMOR	25	139	[Not Available]	Progression of Disease	[Not Applicable]	25	[Not Available]	1	139	1	139	0	720	1	25	66.91	0.38	60-69	other
3053	TCGA-16-1055	GBM	48	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2004	[Not Available]	-17840	Dead	WITH TUMOR	301	313	[Not Available]	Recurrence	[Not Applicable]	288	[Not Available]	1	313	1	313	0	720	1	288	49.7	0.86	40-49	other
3054	TCGA-16-1056	GBM	55	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-20310	Dead	WITH TUMOR	406	426	[Not Available]	Recurrence	[Not Applicable]	239	[Not Available]	1	426	1	426	0	720	1	239	56.77	1.17	50-59	other
3055	TCGA-16-1060	GBM	70	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-25813	Dead	WITH TUMOR	111	278	[Not Available]	Progression of Disease	[Not Applicable]	111	[Not Available]	1	278	1	278	0	720	1	111	71.43	0.76	70-79	other
3056	TCGA-16-1062	GBM	57	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-21148	Dead	WITH TUMOR	556	646	[Not Available]	Progression of Disease	[Not Applicable]	518	[Not Available]	1	646	1	646	0	720	1	518	59.67	1.77	50-59	other
3057	TCGA-16-1063	GBM	72	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-26313	Dead	WITH TUMOR	425	425	[Not Available]	Progression of Disease	[Not Applicable]	369	[Not Available]	1	425	1	425	0	720	1	369	73.2	1.16	70-79	other
3058	TCGA-16-1460	GBM	36	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-13208	Alive	TUMOR FREE	195	548	[Not Available]	NA	NA	364	[Not Available]	0	195	0	195	0	720	0	195	36.7	0.53	30-39	other
3059	TCGA-19-0955	GBM	71	MALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-25974	Alive	TUMOR FREE	358	548	[Not Available]	NA	NA	364	[Not Available]	0	358	0	358	0	720	0	358	72.09	0.98	70-79	other
3060	TCGA-19-0957	GBM	48	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-17714	Dead	WITH TUMOR	666	666	[Not Available]	Recurrence	[Not Applicable]	50	[Not Available]	1	666	1	666	0	720	1	50	50.32	1.82	40-49	other
3061	TCGA-19-0960	GBM	83	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-30364	Alive	TUMOR FREE	262	548	[Not Available]	NA	NA	364	[Not Available]	0	262	0	262	0	720	0	262	83.85	0.72	>=80	other
3062	TCGA-19-0962	GBM	77	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-28382	Dead	TUMOR FREE	13	20	[Not Available]	NA	NA	364	[Not Available]	1	20	0	20	0	720	0	20	77.76	0.05	70-79	other
3063	TCGA-19-0963	GBM	61	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-22326	Dead	WITH TUMOR	434	434	[Not Available]	Recurrence	[Not Applicable]	310	[Not Available]	1	434	1	434	0	720	1	310	62.31	1.19	60-69	other
3064	TCGA-19-0964	GBM	70	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-25800	Alive	WITH TUMOR	103	548	[Not Available]	NA	NA	364	[Not Available]	0	103	0	103	0	720	0	103	70.92	0.28	70-79	other
3065	TCGA-19-1385	GBM	69	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-25459	Dead	WITH TUMOR	327	327	[Not Available]	Recurrence	[Not Applicable]	177	[Not Available]	1	327	1	327	0	720	1	177	70.6	0.9	60-69	other
3066	TCGA-19-1386	GBM	51	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-18678	Dead	WITH TUMOR	276	276	[Not Available]	Recurrence	[Not Applicable]	237	[Not Available]	1	276	1	276	0	720	1	237	51.89	0.76	50-59	other
3067	TCGA-19-1387	GBM	81	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-29892	Alive	WITH TUMOR	181	548	[Not Available]	Recurrence	[Not Applicable]	79	[Not Available]	0	181	0	181	0	720	1	79	82.34	0.5	>=80	other
3068	TCGA-19-1388	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-21368	Dead	WITH TUMOR	394	394	[Not Available]	Progression of Disease	[Not Applicable]	148	[Not Available]	1	394	1	394	0	720	1	148	59.58	1.08	50-59	other
3069	TCGA-19-1389	GBM	51	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-18659	Dead	WITH TUMOR	141	141	[Not Available]	Recurrence	[Not Applicable]	81	[Not Available]	1	141	1	141	0	720	1	81	51.47	0.39	50-59	other
3070	TCGA-19-1390	GBM	63	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-23063	Dead	TUMOR FREE	772	772	[Not Available]	NA	NA	364	[Not Available]	1	772	0	772	0	720	0	772	65.26	2.11	60-69	other
3071	TCGA-19-1392	GBM	72	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-26593	Dead	TUMOR FREE	106	111	[Not Available]	NA	NA	364	[Not Available]	1	111	0	111	0	720	0	111	73.11	0.3	70-79	other
3072	TCGA-19-1786	GBM	64	FEMALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-23568	Alive	TUMOR FREE	218	548	[Not Available]	NA	NA	364	[Not Available]	0	218	0	218	0	720	0	218	65.12	0.6	60-69	other
3073	TCGA-19-1787	GBM	48	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-17894	Dead	WITH TUMOR	385	385	[Not Available]	Recurrence	[Not Applicable]	308	[Not Available]	1	385	1	385	0	720	1	308	50.05	1.05	40-49	other
3074	TCGA-19-1788	GBM	39	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-14301	Dead	TUMOR FREE	112	112	[Not Available]	NA	NA	364	[Not Available]	1	112	0	112	0	720	0	112	39.46	0.31	30-39	other
3075	TCGA-19-1789	GBM	69	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-25282	Dead	TUMOR FREE	99	99	[Not Available]	NA	NA	364	[Not Available]	1	99	0	99	0	720	0	99	69.49	0.27	60-69	other
3076	TCGA-19-1790	GBM	56	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-20626	Dead	WITH TUMOR	154	154	[Not Available]	Progression of Disease	[Not Applicable]	88	[Not Available]	1	154	1	154	0	720	1	88	56.89	0.42	50-59	other
3077	TCGA-19-1791	GBM	82	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-30065	Alive	WITH TUMOR	4	548	[Not Available]	NA	NA	364	[Not Available]	0	4	0	4	0	720	0	4	82.32	0.01	>=80	other
3078	TCGA-19-2619	GBM	55	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-20159	Alive	WITH TUMOR	294	548	[Not Available]	Progression of Disease	[Not Applicable]	146	[Not Available]	0	294	0	294	0	720	1	146	56	0.8	50-59	other
3079	TCGA-19-2620	GBM	70	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-25665	Dead	TUMOR FREE	148	148	[Not Available]	NA	NA	364	[Not Available]	1	148	0	148	0	720	0	148	70.67	0.41	70-79	other
3080	TCGA-19-2621	GBM	83	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-30429	Dead	TUMOR FREE	33	33	[Not Available]	NA	NA	364	[Not Available]	1	33	0	33	0	720	0	33	83.4	0.09	>=80	other
3081	TCGA-19-2623	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-23835	Alive	TUMOR FREE	229	548	[Not Available]	NA	NA	364	[Not Available]	0	229	0	229	0	720	0	229	65.88	0.63	60-69	other
3082	TCGA-19-2624	GBM	51	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-18891	Dead	TUMOR FREE	5	5	[Not Available]	NA	NA	364	[Not Available]	1	5	0	5	0	720	0	5	51.73	0.01	50-59	other
3083	TCGA-19-2625	GBM	76	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-27930	Dead	TUMOR FREE	124	124	[Not Available]	NA	NA	364	[Not Available]	1	124	0	124	0	720	0	124	76.81	0.34	70-79	other
3084	TCGA-19-2629	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-22257	Dead	WITH TUMOR	501	737	[Not Available]	Progression of Disease	[Not Applicable]	145	[Not Available]	1	737	1	737	0	720	1	145	62.95	2.02	60-69	other
3085	TCGA-19-2631	GBM	74	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-27200	Dead	TUMOR FREE	213	213	[Not Available]	NA	NA	364	[Not Available]	1	213	0	213	0	720	0	213	75.05	0.58	70-79	other
3086	TCGA-19-4065	GBM	36	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-13257	Alive	WITH TUMOR	214	548	[Not Available]	Recurrence	[Not Applicable]	70	[Not Available]	0	214	0	214	0	720	1	70	36.88	0.59	30-39	other
3087	TCGA-19-4068	GBM	68	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-24945	Alive	TUMOR FREE	137	548	[Not Available]	NA	NA	364	[Not Available]	0	137	0	137	0	720	0	137	68.67	0.38	60-69	other
3088	TCGA-19-5947	GBM	47	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-17218	Dead	WITH TUMOR	202	202	[Not Available]	Progression of Disease	[Not Applicable]	43	[Not Available]	1	202	1	202	0	720	1	43	47.69	0.55	40-49	other
3089	TCGA-19-5950	GBM	52	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-19244	Dead	WITH TUMOR	766	523	[Not Available]	Recurrence	[Not Applicable]	294	Progressive Disease	1	523	1	523	0	720	1	294	54.12	1.43	50-59	other
3090	TCGA-19-5951	GBM	76	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-27995	Dead	WITH TUMOR	244	244	[Not Available]	NA	NA	364	[Not Available]	1	244	1	244	0	720	1	244	77.31	0.67	70-79	other
3091	TCGA-19-5952	GBM	62	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-22841	Dead	TUMOR FREE	567	575	[Not Available]	NA	NA	364	[Not Available]	1	575	0	575	0	720	0	575	64.11	1.57	60-69	other
3092	TCGA-19-5953	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-21204	Dead	WITH TUMOR	144	144	[Not Available]	Progression of Disease	[Not Applicable]	119	[Not Available]	1	144	1	144	0	720	1	119	58.45	0.39	50-59	other
3093	TCGA-19-5954	GBM	72	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-26355	Dead	WITH TUMOR	766	368	[Not Available]	NA	NA	364	Stable Disease	1	368	1	368	0	720	1	368	73.16	1.01	70-79	other
3094	TCGA-19-5955	GBM	83	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-30550	Dead	TUMOR FREE	54	54	[Not Available]	NA	NA	364	[Not Available]	1	54	0	54	0	720	0	54	83.79	0.15	>=80	other
3095	TCGA-19-5956	GBM	53	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-19591	Dead	WITH TUMOR	766	684	[Not Available]	Progression of Disease	[Not Applicable]	647	Stable Disease	1	684	1	684	0	720	1	647	55.51	1.87	50-59	other
3096	TCGA-19-5958	GBM	56	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-20466	Dead	WITH TUMOR	766	428	[Not Available]	Recurrence	[Not Applicable]	356	Progressive Disease	1	428	1	428	0	720	1	356	57.2	1.17	50-59	other
3097	TCGA-19-5959	GBM	77	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-28449	Dead	WITH TUMOR	766	511	[Not Available]	Recurrence	[Not Applicable]	119	Progressive Disease	1	511	1	511	0	720	1	119	79.29	1.4	70-79	other
3098	TCGA-19-5960	GBM	56	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-20641	Dead	WITH TUMOR	766	455	[Not Available]	Recurrence	[Not Applicable]	382	Stable Disease	1	455	1	455	0	720	1	382	57.76	1.25	50-59	other
3099	TCGA-19-A60I	GBM	39	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2012	[Not Available]	-14437	Alive	WITH TUMOR	541	548	[Not Available]	NA	NA	364	Stable Disease	0	541	0	541	0	720	0	541	41.01	1.48	30-39	other
3100	TCGA-19-A6J4	GBM	68	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2013	[Not Available]	-25058	Dead	WITH TUMOR	766	121	[Not Available]	NA	NA	364	[Unknown]	1	121	1	121	0	720	1	121	68.94	0.33	60-69	other
3101	TCGA-19-A6J5	GBM	40	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2012	[Not Available]	-14970	Alive	WITH TUMOR	868	548	[Not Available]	Progression of Disease	[Not Applicable]	784	Stable Disease	0	868	0	868	0	720	1	784	43.36	2.38	40-49	other
3102	TCGA-26-1438	GBM	36	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-13489	Alive	WITH TUMOR	305	548	[Not Available]	Progression of Disease	[Not Applicable]	158	[Not Available]	0	305	0	305	0	720	1	158	37.77	0.84	30-39	other
3103	TCGA-26-1439	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-23302	Dead	WITH TUMOR	766	422	[Not Available]	Progression of Disease	[Not Applicable]	284	[Not Available]	1	422	1	422	0	720	1	284	64.95	1.16	60-69	other
3104	TCGA-26-1440	GBM	48	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-17684	Alive	WITH TUMOR	296	548	[Not Available]	Recurrence	[Not Applicable]	233	[Not Available]	0	296	0	296	0	720	1	233	49.23	0.81	40-49	other
3105	TCGA-26-1442	GBM	43	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-15950	Alive	WITH TUMOR	953	548	[Not Available]	NA	NA	364	[Not Available]	0	953	0	953	0	720	0	953	46.28	2.61	40-49	other
3106	TCGA-26-1443	GBM	60	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-21990	Alive	WITH TUMOR	217	548	[Not Available]	Progression of Disease	[Not Applicable]	217	[Not Available]	0	217	0	217	0	720	1	217	60.8	0.59	60-69	other
3107	TCGA-26-1799	GBM	68	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-25171	Dead	WITH TUMOR	285	285	[Not Available]	Recurrence	[Not Applicable]	213	[Not Available]	1	285	1	285	0	720	1	213	69.69	0.78	60-69	other
3108	TCGA-26-5132	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-27196	Alive	TUMOR FREE	286	548	[Not Available]	NA	NA	364	[Not Available]	0	286	0	286	0	720	0	286	75.24	0.78	70-79	other
3109	TCGA-26-5133	GBM	59	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-21560	Alive	TUMOR FREE	452	548	[Not Available]	Progression of Disease	[Not Applicable]	370	[Not Available]	0	452	0	452	0	720	1	370	60.27	1.24	50-59	other
3110	TCGA-26-5134	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-27111	Alive	TUMOR FREE	167	548	[Not Available]	NA	NA	364	[Not Available]	0	167	0	167	0	720	0	167	74.68	0.46	70-79	other
3111	TCGA-26-5135	GBM	72	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-26490	Dead	TUMOR FREE	766	270	[Not Available]	NA	NA	364	[Unknown]	1	270	0	270	0	720	0	270	73.26	0.74	70-79	other
3112	TCGA-26-5136	GBM	78	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-28496	Dead	WITH TUMOR	766	577	[Not Available]	NA	NA	364	[Unknown]	1	577	1	577	0	720	1	577	79.6	1.58	70-79	other
3113	TCGA-26-5139	GBM	65	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-23782	Alive	WITH TUMOR	48	548	[Not Available]	NA	NA	364	[Not Available]	0	48	0	48	0	720	0	48	65.24	0.13	60-69	other
3114	TCGA-26-6173	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-21093	Alive	TUMOR FREE	241	548	[Not Available]	NA	NA	364	[Not Available]	0	241	0	241	0	720	0	241	58.41	0.66	50-59	other
3115	TCGA-26-6174	GBM	65	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-23884	Alive	TUMOR FREE	71	548	[Not Available]	NA	NA	364	[Not Available]	0	71	0	71	0	720	0	71	65.59	0.19	60-69	other
3116	TCGA-26-A7UX	GBM	47	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2013	[Not Available]	-17365	Alive	WITH TUMOR	588	548	[Not Available]	Recurrence	[Not Applicable]	407	Stable Disease	0	588	0	588	0	720	1	407	49.15	1.61	40-49	other
3117	TCGA-27-1830	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-21131	Dead	WITH TUMOR	146	154	[Not Available]	Recurrence	[Not Applicable]	124	[Not Available]	1	154	1	154	0	720	1	124	58.28	0.42	50-59	other
3118	TCGA-27-1831	GBM	66	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-24447	Dead	WITH TUMOR	505	505	[Not Available]	Progression of Disease	[Not Applicable]	144	[Not Available]	1	505	1	505	0	720	1	144	68.31	1.38	60-69	other
3119	TCGA-27-1832	GBM	59	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-21678	Dead	WITH TUMOR	0	300	[Not Available]	Progression of Disease	[Not Applicable]	176	[Not Available]	1	300	1	300	0	720	1	176	60.17	0.82	50-59	other
3120	TCGA-27-1833	GBM	67	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-24592	Dead	WITH TUMOR	555	737	[Not Available]	Recurrence	[Not Applicable]	469	[Not Available]	1	737	1	737	0	720	1	469	69.35	2.02	60-69	other
3121	TCGA-27-1834	GBM	56	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2006	[Not Available]	-20568	Dead	WITH TUMOR	1008	1233	[Not Available]	Recurrence	[Not Applicable]	335	[Not Available]	1	1233	1	1233	0	720	1	335	59.69	3.38	50-59	other
3122	TCGA-27-1835	GBM	53	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-19444	Dead	WITH TUMOR	648	648	[Not Available]	Progression of Disease	[Not Applicable]	157	[Not Available]	1	648	1	648	0	720	1	157	55.01	1.77	50-59	other
3123	TCGA-27-1836	GBM	33	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-12060	Dead	WITH TUMOR	766	914	[Not Available]	Progression of Disease	[Not Applicable]	172	[Not Available]	1	914	1	914	0	720	1	172	35.52	2.5	30-39	other
3124	TCGA-27-1837	GBM	36	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-13368	Dead	WITH TUMOR	427	427	[Not Available]	Progression of Disease	[Not Applicable]	136	[Not Available]	1	427	1	427	0	720	1	136	37.77	1.17	30-39	other
3125	TCGA-27-1838	GBM	59	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-21706	Dead	WITH TUMOR	350	350	[Not Available]	Progression of Disease	[Not Applicable]	119	[Not Available]	1	350	1	350	0	720	1	119	60.39	0.96	50-59	other
3126	TCGA-27-2518	GBM	52	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-19130	Dead	WITH TUMOR	753	753	[Not Available]	Progression of Disease	[Not Applicable]	539	[Not Available]	1	753	1	753	0	720	1	539	54.44	2.06	50-59	other
3127	TCGA-27-2519	GBM	48	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-17715	Dead	WITH TUMOR	766	550	[Not Available]	Progression of Disease	[Not Applicable]	256	[Not Available]	1	550	1	550	0	720	1	256	50.01	1.51	40-49	other
3128	TCGA-27-2521	GBM	34	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-12685	Dead	WITH TUMOR	766	510	[Not Available]	NA	NA	364	[Not Available]	1	510	1	510	0	720	1	510	36.13	1.4	30-39	other
3129	TCGA-27-2523	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-23034	Dead	WITH TUMOR	489	489	[Not Available]	Progression of Disease	[Not Applicable]	402	[Not Available]	1	489	1	489	0	720	1	402	64.4	1.34	60-69	other
3130	TCGA-27-2524	GBM	56	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-20555	Dead	WITH TUMOR	231	231	[Not Available]	NA	NA	364	[Not Available]	1	231	1	231	0	720	1	231	56.91	0.63	50-59	other
3131	TCGA-27-2526	GBM	79	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-28977	Dead	WITH TUMOR	87	87	[Not Available]	NA	NA	364	[Not Available]	1	87	1	87	0	720	1	87	79.57	0.24	70-79	other
3132	TCGA-27-2527	GBM	81	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-29619	Dead	WITH TUMOR	438	438	[Not Available]	NA	NA	364	[Not Available]	1	438	1	438	0	720	1	438	82.29	1.2	>=80	other
3133	TCGA-27-2528	GBM	62	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-22867	Dead	WITH TUMOR	480	480	[Not Available]	Progression of Disease	[Not Applicable]	72	[Not Available]	1	480	1	480	0	720	1	72	63.92	1.31	60-69	other
3134	TCGA-28-1745	GBM	76	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-27817	Alive	WITH TUMOR	345	548	[Not Available]	Progression of Disease	[Not Applicable]	317	[Not Available]	0	345	0	345	0	720	1	317	77.1	0.94	70-79	other
3135	TCGA-28-1746	GBM	77	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-28302	Alive	TUMOR FREE	6	548	[Not Available]	NA	NA	364	[Not Available]	0	6	0	6	0	720	0	6	77.5	0.02	70-79	other
3136	TCGA-28-1747	GBM	44	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-16301	Dead	TUMOR FREE	77	77	[Not Available]	NA	NA	364	[Not Available]	1	77	0	77	0	720	0	77	44.84	0.21	40-49	other
3137	TCGA-28-1749	GBM	73	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-26765	Alive	WITH TUMOR	280	548	[Not Available]	Progression of Disease	[Not Applicable]	280	[Not Available]	0	280	0	280	0	720	1	280	74.05	0.77	70-79	other
3138	TCGA-28-1750	GBM	40	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-14817	Alive	WITH TUMOR	254	548	[Not Available]	Progression of Disease	[Not Applicable]	116	[Not Available]	0	254	0	254	0	720	1	116	41.26	0.7	40-49	other
3139	TCGA-28-1751	GBM	61	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-22291	Alive	WITH TUMOR	232	548	[Not Available]	Progression of Disease	[Not Applicable]	219	[Not Available]	0	232	0	232	0	720	1	219	61.66	0.64	60-69	other
3140	TCGA-28-1752	GBM	42	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-15565	Alive	WITH TUMOR	258	548	[Not Available]	NA	NA	364	[Not Available]	0	258	0	258	0	720	0	258	43.32	0.71	40-49	other
3141	TCGA-28-1753	GBM	53	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-19366	Alive	WITH TUMOR	37	548	[Not Available]	NA	NA	364	[Not Available]	0	37	0	37	0	720	0	37	53.12	0.1	50-59	other
3142	TCGA-28-1755	GBM	52	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-19263	Dead	WITH TUMOR	47	47	[Not Available]	NA	NA	364	[Not Available]	1	47	1	47	0	720	1	47	52.87	0.13	50-59	other
3143	TCGA-28-1756	GBM	78	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-28649	Alive	TUMOR FREE	86	548	[Not Available]	NA	NA	364	[Not Available]	0	86	0	86	0	720	0	86	78.67	0.24	70-79	other
3144	TCGA-28-1757	GBM	71	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-26189	Alive	TUMOR FREE	4	548	[Not Available]	NA	NA	364	[Not Available]	0	4	0	4	0	720	0	4	71.71	0.01	70-79	other
3145	TCGA-28-1760	GBM	48	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-17758	Alive	WITH TUMOR	143	548	[Not Available]	Progression of Disease	[Not Applicable]	105	[Not Available]	0	143	0	143	0	720	1	105	49.01	0.39	40-49	other
3146	TCGA-28-2499	GBM	59	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-21838	Alive	TUMOR FREE	95	548	[Not Available]	NA	NA	364	[Not Available]	0	95	0	95	0	720	0	95	60.05	0.26	50-59	other
3147	TCGA-28-2502	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-23807	Alive	TUMOR FREE	20	548	[Not Available]	NA	NA	364	[Not Available]	0	20	0	20	0	720	0	20	65.23	0.05	60-69	other
3148	TCGA-28-2506	GBM	63	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-23292	Alive	WITH TUMOR	205	548	[Not Available]	Progression of Disease	[Not Applicable]	84	[Not Available]	0	205	0	205	0	720	1	84	64.33	0.56	60-69	other
3149	TCGA-28-2509	GBM	77	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-28240	Alive	TUMOR FREE	145	548	[Not Available]	NA	NA	364	[Not Available]	0	145	0	145	0	720	0	145	77.71	0.4	70-79	other
3150	TCGA-28-2512	GBM	37	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-13664	Dead	WITH TUMOR	343	343	[Not Available]	Progression of Disease	[Not Applicable]	193	[Not Available]	1	343	1	343	0	720	1	193	38.35	0.94	30-39	other
3151	TCGA-28-2513	GBM	69	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-25421	Alive	WITH TUMOR	222	548	[Not Available]	Progression of Disease	[Not Applicable]	75	[Not Available]	0	222	0	222	0	720	1	75	70.21	0.61	60-69	other
3152	TCGA-28-2514	GBM	45	MALE	ASIAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-16737	Alive	TUMOR FREE	160	548	[Not Available]	NA	NA	364	[Not Available]	0	160	0	160	0	720	0	160	46.26	0.44	40-49	other
3153	TCGA-28-5204	GBM	72	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-26490	Dead	WITH TUMOR	766	454	[Not Available]	NA	NA	364	[Not Available]	1	454	1	454	0	720	1	454	73.77	1.24	70-79	other
3154	TCGA-28-5207	GBM	71	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-25975	Dead	WITH TUMOR	275	343	[Not Available]	NA	NA	364	[Not Available]	1	343	1	343	0	720	1	343	72.05	0.94	70-79	other
3155	TCGA-28-5208	GBM	52	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-19053	Dead	WITH TUMOR	766	544	[Not Available]	NA	[Not Applicable]	148	Progressive Disease	1	544	1	544	0	720	1	148	53.65	1.49	50-59	other
3156	TCGA-28-5209	GBM	66	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-24362	Alive	TUMOR FREE	442	548	[Not Available]	NA	NA	364	[Not Available]	0	442	0	442	0	720	0	442	67.91	1.21	60-69	other
3157	TCGA-28-5211	GBM	42	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-15507	Alive	WITH TUMOR	358	548	[Not Available]	NA	[Not Applicable]	225	[Not Available]	0	358	0	358	0	720	1	225	43.44	0.98	40-49	other
3158	TCGA-28-5213	GBM	72	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-26491	Alive	WITH TUMOR	951	548	[Not Available]	NA	NA	364	[Not Applicable]	0	951	0	951	0	720	0	951	75.13	2.6	70-79	other
3159	TCGA-28-5214	GBM	53	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-19520	Dead	WITH TUMOR	766	713	[Not Available]	Locoregional Disease	[Not Applicable]	247	[Not Applicable]	1	713	1	713	0	720	1	247	55.39	1.95	50-59	other
3160	TCGA-28-5215	GBM	62	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-22686	Dead	WITH TUMOR	237	335	[Not Available]	NA	[Not Applicable]	164	[Not Available]	1	335	1	335	0	720	1	164	63.03	0.92	60-69	other
3161	TCGA-28-5216	GBM	52	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-19239	Alive	TUMOR FREE	415	548	[Not Available]	NA	NA	364	[Not Available]	0	415	0	415	0	720	0	415	53.81	1.14	50-59	other
3162	TCGA-28-5218	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-23096	Dead	TUMOR FREE	128	157	[Not Available]	NA	NA	364	[Not Available]	1	157	0	157	0	720	0	157	63.66	0.43	60-69	other
3163	TCGA-28-5219	GBM	47	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-17254	Alive	TUMOR FREE	690	548	[Not Available]	NA	[Not Applicable]	258	[Not Applicable]	0	690	0	690	0	720	1	258	49.13	1.89	40-49	other
3164	TCGA-28-5220	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-24622	Dead	WITH TUMOR	766	388	[Not Available]	NA	[Not Applicable]	262	[Not Applicable]	1	388	1	388	0	720	1	262	68.47	1.06	60-69	other
3165	TCGA-28-6450	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-22177	Dead	WITH TUMOR	165	165	[Not Available]	NA	NA	364	[Not Available]	1	165	1	165	0	720	1	165	61.17	0.45	60-69	other
3166	TCGA-32-1970	GBM	59	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-21613	Dead	WITH TUMOR	468	468	[Not Available]	Progression of Disease	[Not Applicable]	408	[Not Available]	1	468	1	468	0	720	1	408	60.45	1.28	50-59	other
3167	TCGA-32-1973	GBM	21	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-7756	Dead	WITH TUMOR	641	641	[Not Available]	Progression of Disease	[Not Applicable]	507	[Not Available]	1	641	1	641	0	720	1	507	22.99	1.75	18-29	other
3168	TCGA-32-1976	GBM	65	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-23798	Dead	TUMOR FREE	15	15	[Not Available]	NA	NA	364	[Not Available]	1	15	0	15	0	720	0	15	65.2	0.04	60-69	other
3169	TCGA-32-1977	GBM	63	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-23205	Alive	WITH TUMOR	3	548	[Not Available]	NA	NA	364	[Not Available]	0	3	0	3	0	720	0	3	63.54	0.01	60-69	other
3170	TCGA-32-1978	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-21054	Dead	WITH TUMOR	482	482	[Not Available]	NA	NA	364	[Not Available]	1	482	1	482	0	720	1	482	58.96	1.32	50-59	other
3171	TCGA-32-1979	GBM	69	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-25252	Dead	WITH TUMOR	593	593	[Not Available]	Progression of Disease	[Not Applicable]	265	[Not Available]	1	593	1	593	0	720	1	265	70.76	1.62	60-69	other
3172	TCGA-32-1980	GBM	72	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-26467	Dead	WITH TUMOR	36	36	[Not Available]	NA	NA	364	[Not Available]	1	36	1	36	0	720	1	36	72.56	0.1	70-79	other
3173	TCGA-32-1982	GBM	76	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-27764	Dead	WITH TUMOR	142	142	[Not Available]	NA	NA	364	[Not Available]	1	142	1	142	0	720	1	142	76.4	0.39	70-79	other
3174	TCGA-32-1986	GBM	68	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-25061	Dead	WITH TUMOR	386	386	[Not Available]	Progression of Disease	[Not Applicable]	233	[Not Available]	1	386	1	386	0	720	1	233	69.67	1.06	60-69	other
3175	TCGA-32-1987	GBM	49	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-18091	Dead	WITH TUMOR	452	452	[Not Available]	Recurrence	[Not Applicable]	68	[Not Available]	1	452	1	452	0	720	1	68	50.77	1.24	40-49	other
3176	TCGA-32-1991	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-22021	Dead	WITH TUMOR	515	515	[Not Available]	Recurrence	[Not Applicable]	345	[Not Available]	1	515	1	515	0	720	1	345	61.7	1.41	60-69	other
3177	TCGA-32-2491	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-23131	Dead	WITH TUMOR	372	372	[Not Available]	Recurrence	[Not Applicable]	70	[Not Available]	1	372	1	372	0	720	1	70	64.35	1.02	60-69	other
3178	TCGA-32-2494	GBM	58	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-21198	Dead	WITH TUMOR	632	632	[Not Available]	Progression of Disease	[Not Applicable]	488	[Not Available]	1	632	1	632	0	720	1	488	59.77	1.73	50-59	other
3179	TCGA-32-2495	GBM	59	FEMALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2008	[Not Available]	-21860	Dead	WITH TUMOR	457	457	[Not Available]	Recurrence	[Not Applicable]	252	[Not Available]	1	457	1	457	0	720	1	252	61.1	1.25	50-59	other
3180	TCGA-32-2615	GBM	62	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-22916	Dead	WITH TUMOR	485	485	[Not Available]	Progression of Disease	[Not Applicable]	131	[Not Available]	1	485	1	485	0	720	1	131	64.07	1.33	60-69	other
3181	TCGA-32-2616	GBM	48	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-17781	Dead	WITH TUMOR	224	224	[Not Available]	Progression of Disease	[Not Applicable]	182	[Not Available]	1	224	1	224	0	720	1	182	49.3	0.61	40-49	other
3182	TCGA-32-2632	GBM	80	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-29281	Dead	WITH TUMOR	766	269	[Not Available]	NA	NA	364	Progressive Disease	1	269	1	269	0	720	1	269	80.9	0.74	>=80	other
3183	TCGA-32-2634	GBM	82	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-29964	Alive	TUMOR FREE	693	548	[Not Available]	NA	NA	364	[Not Available]	0	693	0	693	0	720	0	693	83.93	1.9	>=80	other
3184	TCGA-32-2638	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-24658	Dead	WITH TUMOR	766	766	[Not Available]	NA	NA	364	[Not Available]	1	766	1	766	0	720	1	766	69.61	2.1	60-69	other
3185	TCGA-32-4208	GBM	25	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-9213	Alive	WITH TUMOR	643	548	[Not Available]	NA	NA	364	[Not Available]	0	643	0	643	0	720	0	643	26.98	1.76	18-29	other
3186	TCGA-32-4209	GBM	40	MALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2009	[Not Available]	-14903	Dead	WITH TUMOR	766	618	[Not Available]	Recurrence	[Not Applicable]	94	[Not Available]	1	618	1	618	0	720	1	94	42.49	1.69	40-49	other
3187	TCGA-32-4210	GBM	73	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-26768	Dead	WITH TUMOR	113	113	[Not Available]	NA	NA	364	[Not Available]	1	113	1	113	0	720	1	113	73.6	0.31	70-79	other
3188	TCGA-32-4211	GBM	56	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-20748	Dead	WITH TUMOR	383	383	[Not Available]	NA	NA	364	[Not Available]	1	383	1	383	0	720	1	383	57.85	1.05	50-59	other
3189	TCGA-32-4213	GBM	47	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-17237	Alive	WITH TUMOR	604	548	[Not Available]	Recurrence	[Not Applicable]	353	[Not Available]	0	604	0	604	0	720	1	353	48.85	1.65	40-49	other
3190	TCGA-32-4719	GBM	73	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-26691	Dead	WITH TUMOR	330	330	[Not Available]	NA	NA	364	[Not Available]	1	330	1	330	0	720	1	330	73.98	0.9	70-79	other
3191	TCGA-32-5222	GBM	66	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-24134	Dead	WITH TUMOR	766	585	[Not Available]	Progression of Disease	[Not Applicable]	118	[Not Available]	1	585	1	585	0	720	1	118	67.68	1.6	60-69	other
3192	TCGA-41-2571	GBM	89	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-32612	Dead	WITH TUMOR	26	26	[Not Available]	Progression of Disease	[Not Applicable]	26	[Not Available]	1	26	1	26	0	720	1	26	89.36	0.07	>=80	other
3193	TCGA-41-2572	GBM	67	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-24505	Dead	WITH TUMOR	406	406	[Not Available]	Progression of Disease	[Not Applicable]	122	[Not Available]	1	406	1	406	0	720	1	122	68.2	1.11	60-69	other
3194	TCGA-41-2573	GBM	59	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-21911	Alive	WITH TUMOR	272	548	[Not Available]	Progression of Disease	[Not Applicable]	167	[Not Available]	0	272	0	272	0	720	1	167	60.73	0.74	50-59	other
3195	TCGA-41-2575	GBM	75	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-27587	Dead	WITH TUMOR	290	290	[Not Available]	Progression of Disease	[Not Applicable]	131	[Not Available]	1	290	1	290	0	720	1	131	76.32	0.79	70-79	other
3196	TCGA-41-3392	GBM	88	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-32351	Dead	WITH TUMOR	30	30	[Not Available]	NA	NA	364	[Not Available]	1	30	1	30	0	720	1	30	88.65	0.08	>=80	other
3197	TCGA-41-3393	GBM	81	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-29904	Dead	WITH TUMOR	135	135	[Not Available]	NA	NA	364	[Not Available]	1	135	1	135	0	720	1	135	82.24	0.37	>=80	other
3198	TCGA-41-3915	GBM	48	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-17880	Dead	WITH TUMOR	766	360	[Not Available]	Locoregional Disease	[Not Applicable]	288	[Not Available]	1	360	1	360	0	720	1	288	49.94	0.99	40-49	other
3199	TCGA-41-4097	GBM	63	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-23107	Dead	WITH TUMOR	6	6	[Not Available]	NA	NA	364	[Not Available]	1	6	1	6	0	720	1	6	63.28	0.02	60-69	other
3200	TCGA-41-5651	GBM	59	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-21698	Dead	WITH TUMOR	766	460	[Not Available]	Progression of Disease	[Not Applicable]	210	[Not Available]	1	460	1	460	0	720	1	210	60.67	1.26	50-59	other
3201	TCGA-41-6646	GBM	73	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-26667	Dead	WITH TUMOR	766	379	[Not Available]	Progression of Disease	[Not Applicable]	200	[Not Available]	1	379	1	379	0	720	1	200	74.05	1.04	70-79	other
3202	TCGA-4W-AA9R	GBM	61	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2012	[Not Available]	-22317	Alive	TUMOR FREE	124	548	[Not Available]	NA	NA	364	Progressive Disease	0	124	0	124	0	720	0	124	61.44	0.34	60-69	other
3203	TCGA-4W-AA9S	GBM	69	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2013	[Not Available]	-25545	Alive	TUMOR FREE	44	548	[Not Available]	NA	NA	364	Stable Disease	0	44	0	44	0	720	0	44	70.06	0.12	60-69	other
3204	TCGA-4W-AA9T	GBM	54	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2012	[Not Available]	-19801	Alive	TUMOR FREE	778	548	[Not Available]	NA	[Not Applicable]	749	Progressive Disease	0	778	0	778	0	720	1	749	56.34	2.13	50-59	other
3205	TCGA-74-6573	GBM	67	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-24632	Dead	WITH TUMOR	766	105	[Not Available]	NA	NA	364	[Not Available]	1	105	1	105	0	720	1	105	67.73	0.29	60-69	other
3206	TCGA-74-6575	GBM	73	FEMALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-26827	Alive	WITH TUMOR	636	548	[Not Available]	NA	[Not Applicable]	93	[Not Available]	0	636	0	636	0	720	1	93	75.19	1.74	70-79	other
3207	TCGA-74-6577	GBM	51	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-18740	Alive	WITH TUMOR	132	548	[Not Available]	NA	[Not Applicable]	132	[Not Available]	0	132	0	132	0	720	1	132	51.67	0.36	50-59	other
3208	TCGA-74-6578	GBM	58	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-21464	Alive	WITH TUMOR	436	548	[Not Available]	NA	[Not Applicable]	222	[Not Available]	0	436	0	436	0	720	1	222	59.96	1.19	50-59	other
3209	TCGA-74-6581	GBM	77	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-28263	Alive	WITH TUMOR	250	548	[Not Available]	NA	NA	364	[Not Available]	0	250	0	250	0	720	0	250	78.06	0.68	70-79	other
3210	TCGA-74-6584	GBM	55	FEMALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-20232	Alive	WITH TUMOR	228	548	[Not Available]	NA	[Not Applicable]	91	[Not Available]	0	228	0	228	0	720	1	91	56.02	0.62	50-59	other
3211	TCGA-76-4925	GBM	76	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-28011	Dead	TUMOR FREE	146	146	[Not Available]	Progression of Disease	[Not Applicable]	88	[Not Available]	1	146	0	146	0	720	1	88	77.09	0.4	70-79	other
3212	TCGA-76-4926	GBM	68	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-25085	Dead	WITH TUMOR	138	138	[Not Available]	Progression of Disease	[Not Applicable]	34	[Not Available]	1	138	1	138	0	720	1	34	69.06	0.38	60-69	other
3213	TCGA-76-4927	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-21193	Dead	WITH TUMOR	535	535	[Not Available]	Progression of Disease	[Not Applicable]	416	[Not Available]	1	535	1	535	0	720	1	416	59.49	1.46	50-59	other
3214	TCGA-76-4928	GBM	85	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-31267	Dead	WITH TUMOR	94	94	[Not Available]	NA	NA	364	[Not Available]	1	94	1	94	0	720	1	94	85.86	0.26	>=80	other
3215	TCGA-76-4929	GBM	76	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-27831	Dead	WITH TUMOR	111	111	[Not Available]	NA	NA	364	[Not Available]	1	111	1	111	0	720	1	111	76.5	0.3	70-79	other
3216	TCGA-76-4931	GBM	70	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2005	[Not Available]	-25812	Dead	WITH TUMOR	279	279	[Not Available]	Progression of Disease	[Not Applicable]	112	[Not Available]	1	279	1	279	0	720	1	112	71.43	0.76	70-79	other
3217	TCGA-76-4932	GBM	50	FEMALE	WHITE	[Not Available]	[Not Applicable]	Treated primary GBM	[Not Available]	2006	[Not Available]	-18433	Dead	WITH TUMOR	1458	1458	[Not Available]	NA	NA	364	[Not Available]	1	1458	1	1458	0	720	1	1458	54.46	3.99	50-59	other
3218	TCGA-76-4934	GBM	66	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-24319	Dead	TUMOR FREE	77	77	[Not Available]	NA	NA	364	[Not Available]	1	77	0	77	0	720	0	77	66.79	0.21	60-69	other
3219	TCGA-76-4935	GBM	52	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-19231	Dead	TUMOR FREE	766	1121	[Not Available]	NA	NA	364	[Unknown]	1	1121	0	1121	0	720	0	1121	55.72	3.07	50-59	other
3220	TCGA-76-6191	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-20937	Dead	WITH TUMOR	508	508	[Not Available]	Progression of Disease	[Not Applicable]	323	[Not Available]	1	508	1	508	0	720	1	323	58.71	1.39	50-59	other
3221	TCGA-76-6192	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-27322	Dead	WITH TUMOR	100	100	[Not Available]	Progression of Disease	[Not Applicable]	76	[Not Available]	1	100	1	100	0	720	1	76	75.08	0.27	70-79	other
3222	TCGA-76-6193	GBM	78	MALE	[Not Available]	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-28742	Dead	TUMOR FREE	82	82	[Not Available]	Progression of Disease	[Not Applicable]	64	[Not Available]	1	82	0	82	0	720	1	64	78.92	0.22	70-79	other
3223	TCGA-76-6280	GBM	57	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-20931	Dead	WITH TUMOR	346	346	[Not Available]	Progression of Disease	[Not Applicable]	108	[Not Available]	1	346	1	346	0	720	1	108	58.25	0.95	50-59	other
3224	TCGA-76-6282	GBM	63	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2007	[Not Available]	-23323	Dead	WITH TUMOR	519	519	[Not Available]	Progression of Disease	[Not Applicable]	458	[Not Available]	1	519	1	519	0	720	1	458	65.28	1.42	60-69	other
3225	TCGA-76-6283	GBM	71	FEMALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2007	[Not Available]	-26002	Dead	WITH TUMOR	766	165	[Not Available]	NA	NA	364	[Not Available]	1	165	1	165	0	720	1	165	71.64	0.45	70-79	other
3226	TCGA-76-6285	GBM	64	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2008	[Not Available]	-23674	Dead	WITH TUMOR	254	254	[Not Available]	NA	NA	364	[Not Available]	1	254	1	254	0	720	1	254	65.51	0.7	60-69	other
3227	TCGA-76-6286	GBM	60	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-22173	Dead	WITH TUMOR	638	638	[Not Available]	Progression of Disease	[Not Applicable]	180	[Not Available]	1	638	1	638	0	720	1	180	62.45	1.75	60-69	other
3228	TCGA-76-6656	GBM	66	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-24265	Dead	TUMOR FREE	147	147	[Not Available]	NA	NA	364	[Not Available]	1	147	0	147	0	720	0	147	66.84	0.4	60-69	other
3229	TCGA-76-6657	GBM	74	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-27341	Dead	WITH TUMOR	153	153	[Not Available]	Progression of Disease	[Not Applicable]	135	[Not Available]	1	153	1	153	0	720	1	135	75.27	0.42	70-79	other
3230	TCGA-76-6660	GBM	73	MALE	WHITE	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2010	[Not Available]	-26913	Dead	WITH TUMOR	766	114	[Not Available]	NA	NA	364	[Not Available]	1	114	1	114	0	720	1	114	74	0.31	70-79	other
3231	TCGA-76-6661	GBM	54	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-19965	Dead	WITH TUMOR	766	727	[Not Available]	NA	NA	364	[Unknown]	1	727	1	727	0	720	1	727	56.65	1.99	50-59	other
3232	TCGA-76-6662	GBM	58	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-21511	Dead	WITH TUMOR	766	1048	[Not Available]	Progression of Disease	[Not Applicable]	205	[Not Available]	1	1048	1	1048	0	720	1	205	61.76	2.87	50-59	other
3233	TCGA-76-6663	GBM	44	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-16126	Dead	WITH TUMOR	766	567	[Not Available]	NA	NA	364	[Not Available]	1	567	1	567	0	720	1	567	45.7	1.55	40-49	other
3234	TCGA-76-6664	GBM	49	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2011	[Not Available]	-18054	Alive	WITH TUMOR	1101	548	[Not Available]	NA	NA	364	[Unknown]	0	1101	0	1101	0	720	0	1101	52.44	3.01	40-49	other
3235	TCGA-81-5910	GBM	64	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2009	[Not Available]	-23567	Dead	WITH TUMOR	766	49	[Not Available]	NA	NA	364	[Not Available]	1	49	1	49	0	720	1	49	64.66	0.13	60-69	other
3236	TCGA-81-5911	GBM	33	MALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-12292	Alive	WITH TUMOR	539	548	[Not Available]	Progression of Disease	[Not Applicable]	277	[Not Available]	0	539	0	539	0	720	1	277	35.13	1.48	30-39	other
3237	TCGA-87-5896	GBM	50	FEMALE	WHITE	[Not Available]	[Not Applicable]	Untreated primary (de novo) GBM	[Not Available]	2010	[Not Available]	-18391	Alive	TUMOR FREE	800	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	800	0	800	0	800	0	800	52.54	2.19	50-59	other
3238	TCGA-OX-A56R	GBM	68	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2012	[Not Available]	-25178	Dead	WITH TUMOR	766	180	[Not Available]	NA	NA	364	Partial Remission/Response	1	180	1	180	0	720	1	180	69.43	0.49	60-69	other
3239	TCGA-RR-A6KA	GBM	72	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2012	[Not Available]	-26582	Dead	WITH TUMOR	766	191	[Not Available]	NA	NA	364	Partial Remission/Response	1	191	1	191	0	720	1	191	73.3	0.52	70-79	other
3240	TCGA-RR-A6KB	GBM	51	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2007	[Not Available]	-18713	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Unknown]	0	0	0	0	0	720	0	0	51.23	0	50-59	other
3241	TCGA-RR-A6KC	GBM	55	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	[Not Applicable]	Glioblastoma Multiforme (GBM)	[Not Available]	2010	[Not Available]	-20302	Dead	TUMOR FREE	766	625	[Not Available]	Recurrence	[Not Applicable]	369	Complete Remission/Response	1	625	0	625	1	369	1	369	57.3	1.71	50-59	other
3242	TCGA-4P-AA8J	HNSC	66	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-24222	Alive	TUMOR FREE	102	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	102	0	102	0	720	0	102	66.6	0.28	60-69	Stage 4
3243	TCGA-BA-4074	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	[Not Available]	-25282	Dead	WITH TUMOR	766	462	[Not Available]	NA	Distant Metastasis	396	Complete Remission/Response	1	462	1	462	0	720	1	396	70.48	1.26	60-69	Stage 4
3244	TCGA-BA-4075	HNSC	49	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2004	[Not Available]	-17951	Dead	WITH TUMOR	766	283	[Not Available]	NA	Oral Cavity	236	Progressive Disease	1	283	1	283	0	720	1	236	49.92	0.77	40-49	Stage 3
3245	TCGA-BA-4076	HNSC	39	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2003	[Not Available]	-14405	Dead	WITH TUMOR	766	415	[Not Available]	NA	Larynx	286	Complete Remission/Response	1	415	1	415	0	720	1	286	40.57	1.14	30-39	other
3246	TCGA-BA-4077	HNSC	45	FEMALE	WHITE	Stage IVA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2003	[Not Available]	-16536	Dead	WITH TUMOR	766	1134	[Not Available]	NA	NA	364	Persistent Disease	1	1134	1	1134	0	720	1	1134	48.38	3.1	40-49	Stage 4
3247	TCGA-BA-4078	HNSC	83	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2003	[Not Available]	-30480	Dead	WITH TUMOR	766	276	[Not Available]	NA	NA	364	[Not Available]	1	276	1	276	0	720	1	276	84.21	0.76	>=80	other
3248	TCGA-BA-5149	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-17177	Dead	WITH TUMOR	766	806	[Not Available]	NA	Distant Metastasis	389	Complete Remission/Response	1	806	1	806	0	720	1	389	49.23	2.21	40-49	Stage 4
3249	TCGA-BA-5151	HNSC	72	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2010	[Not Available]	-26569	Alive	TUMOR FREE	722	548	[Not Available]	NA	NA	517	Complete Remission/Response	0	722	0	722	0	720	1	517	74.72	1.98	70-79	Stage 4
3250	TCGA-BA-5152	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-20783	Alive	TUMOR FREE	1288	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1288	0	1288	0	720	0	1288	60.43	3.53	50-59	Stage 4
3251	TCGA-BA-5153	HNSC	51	MALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2005	[Not Available]	-18743	Dead	WITH TUMOR	766	1762	[Not Available]	NA	Distant Metastasis	1522	Complete Remission/Response	1	1762	1	1762	1	1522	1	1522	56.14	4.82	50-59	other
3252	TCGA-BA-5555	HNSC	54	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-19956	Alive	TUMOR FREE	520	548	[Not Available]	NA	Oropharynx	248	Complete Remission/Response	0	520	0	520	0	720	1	248	56.06	1.42	50-59	Stage 4
3253	TCGA-BA-5556	HNSC	58	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-21444	Alive	TUMOR FREE	725	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	725	0	725	0	725	0	725	60.7	1.98	50-59	Stage 2
3254	TCGA-BA-5557	HNSC	41	FEMALE	[Not Available]	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-15247	Alive	TUMOR FREE	623	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	623	0	623	0	720	0	623	43.45	1.71	40-49	Stage 3
3255	TCGA-BA-5558	HNSC	65	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2006	[Not Available]	-23984	Alive	TUMOR FREE	1995	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1995	0	1995	0	720	0	1995	71.13	5.46	60-69	other
3256	TCGA-BA-5559	HNSC	71	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2006	[Not Available]	-26286	Dead	WITH TUMOR	766	2083	[Not Available]	NA	Oropharynx	1614	Complete Remission/Response	1	2083	1	2083	0	720	1	1614	77.67	5.7	70-79	other
3257	TCGA-BA-6868	HNSC	53	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-19608	Dead	WITH TUMOR	766	472	[Not Available]	NA	Distant Metastasis	344	Partial Remission/Response	1	472	1	472	0	720	1	344	54.98	1.29	50-59	other
3258	TCGA-BA-6869	HNSC	62	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-22765	Alive	TUMOR FREE	644	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	644	0	644	0	644	0	644	64.09	1.76	60-69	Stage 3
3259	TCGA-BA-6870	HNSC	60	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Available]	Stage IVC	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-22222	Dead	TUMOR FREE	766	451	[Not Available]	NA	NA	364	[Not Available]	1	451	0	451	0	720	0	451	62.08	1.23	60-69	other
3260	TCGA-BA-6871	HNSC	75	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-27708	Dead	WITH TUMOR	766	108	[Not Available]	NA	NA	364	Stable Disease	1	108	1	108	0	720	1	108	76.16	0.3	70-79	other
3261	TCGA-BA-6872	HNSC	47	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2004	[Not Available]	-17296	Dead	WITH TUMOR	766	384	[Not Available]	NA	NA	364	[Not Available]	1	384	1	384	0	720	1	384	48.41	1.05	40-49	other
3262	TCGA-BA-6873	HNSC	28	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-10512	Alive	WITH TUMOR	122	548	[Not Available]	NA	Oral Cavity	66	Progressive Disease	0	122	0	122	0	720	1	66	29.11	0.33	18-29	Stage 4
3263	TCGA-BA-7269	HNSC	61	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2010	[Not Available]	-22609	Alive	TUMOR FREE	1273	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1273	0	1273	0	1273	0	1273	65.39	3.49	60-69	Stage 3
3264	TCGA-BA-A4IF	HNSC	59	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-21635	Alive	TUMOR FREE	895	548	[Not Available]	New Primary Tumor	NA	463	Complete Remission/Response	0	895	0	895	0	720	1	463	61.68	2.45	50-59	other
3265	TCGA-BA-A4IG	HNSC	77	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-28402	Alive	TUMOR FREE	855	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	855	0	855	0	720	0	855	80.1	2.34	70-79	other
3266	TCGA-BA-A4IH	HNSC	57	MALE	WHITE	[Discrepancy]	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2012	[Not Available]	-21094	Alive	TUMOR FREE	622	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	622	0	622	0	720	0	622	59.46	1.7	50-59	other
3267	TCGA-BA-A4II	HNSC	46	MALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-17011	Alive	WITH TUMOR	918	548	[Not Available]	Locoregional Disease	Oral Cavity	197	Complete Remission/Response	0	918	0	918	1	197	1	197	49.09	2.51	40-49	Stage 2
3268	TCGA-BA-A6D8	HNSC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-21778	Alive	WITH TUMOR	850	548	[Not Available]	Distant Metastasis	Oral Cavity	849	Complete Remission/Response	0	850	0	850	0	720	1	849	61.95	2.33	50-59	Stage 4
3269	TCGA-BA-A6DA	HNSC	41	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-15004	Alive	TUMOR FREE	351	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	351	0	351	0	720	0	351	42.04	0.96	40-49	Stage 4
3270	TCGA-BA-A6DB	HNSC	24	FEMALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-8967	Alive	WITH TUMOR	216	548	[Not Available]	Locoregional Disease	Cervical Lymph Nodes	208	Complete Remission/Response	0	216	0	216	1	208	1	208	25.14	0.59	18-29	Stage 1
3271	TCGA-BA-A6DD	HNSC	44	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-16401	Dead	WITH TUMOR	766	173	[Not Available]	NA	Cervical Lymph Nodes	96	Progressive Disease	1	173	1	173	0	720	1	96	45.38	0.47	40-49	Stage 4
3272	TCGA-BA-A6DE	HNSC	70	FEMALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-25874	Alive	TUMOR FREE	440	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	440	0	440	0	440	0	440	72.04	1.2	70-79	Stage 2
3273	TCGA-BA-A6DF	HNSC	80	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-29283	Dead	TUMOR FREE	766	238	[Not Available]	NA	NA	364	Complete Remission/Response	1	238	0	238	0	720	0	238	80.82	0.65	>=80	Stage 4
3274	TCGA-BA-A6DG	HNSC	49	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-18052	Dead	WITH TUMOR	766	69	[Not Available]	NA	NA	364	Progressive Disease	1	69	1	69	0	720	1	69	49.61	0.19	40-49	other
3275	TCGA-BA-A6DI	HNSC	62	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-22857	Dead	WITH TUMOR	766	336	[Not Available]	NA	Larynx	266	Complete Remission/Response	1	336	1	336	1	266	1	266	63.5	0.92	60-69	other
3276	TCGA-BA-A6DJ	HNSC	62	MALE	ASIAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-22967	Dead	WITH TUMOR	766	407	[Not Available]	NA	Distant Metastasis	240	Complete Remission/Response	1	407	1	407	0	720	1	240	63.99	1.11	60-69	Stage 4
3277	TCGA-BA-A6DL	HNSC	59	MALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-21886	Alive	TUMOR FREE	623	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	623	0	623	0	623	0	623	61.63	1.71	50-59	other
3278	TCGA-BA-A8YP	HNSC	50	MALE	BLACK OR AFRICAN AMERICAN	Stage IVB	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-18355	Alive	TUMOR FREE	499	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	499	0	499	0	720	0	499	51.62	1.37	50-59	Stage 4
3279	TCGA-BB-4217	HNSC	68	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-25020	Alive	WITH TUMOR	187	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	187	0	187	0	720	0	187	69.01	0.51	60-69	Stage 4
3280	TCGA-BB-4223	HNSC	48	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	[Not Available]	-17608	Alive	TUMOR FREE	3221	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3221	0	3221	0	720	0	3221	57.03	8.82	40-49	Stage 4
3281	TCGA-BB-4224	HNSC	52	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2004	[Not Available]	-19119	Alive	WITH TUMOR	278	548	[Not Available]	NA	Oral Cavity	175	Progressive Disease	0	278	0	278	0	720	1	175	53.11	0.76	50-59	Stage 4
3282	TCGA-BB-4225	HNSC	73	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	[Not Available]	-26687	Alive	WITH TUMOR	146	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	146	0	146	0	720	0	146	73.46	0.4	70-79	other
3283	TCGA-BB-4227	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-24322	Alive	WITH TUMOR	134	548	[Not Available]	Locoregional Recurrence	Hypopharynx	85	Stable Disease	0	134	0	134	0	720	1	85	66.96	0.37	60-69	Stage 4
3284	TCGA-BB-4228	HNSC	50	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	GX	2010	[Not Available]	-18536	Alive	TUMOR FREE	559	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	559	0	559	0	559	0	559	52.28	1.53	50-59	Stage 3
3285	TCGA-BB-7861	HNSC	56	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	[Not Available]	2011	[Not Available]	-20563	Alive	TUMOR FREE	682	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	682	0	682	0	682	0	682	58.17	1.87	50-59	Stage 3
3286	TCGA-BB-7862	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-24823	Alive	TUMOR FREE	1117	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1117	0	1117	0	720	0	1117	71.02	3.06	60-69	Stage 4
3287	TCGA-BB-7863	HNSC	43	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-15899	Alive	TUMOR FREE	1025	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1025	0	1025	0	1025	0	1025	46.34	2.81	40-49	Stage 3
3288	TCGA-BB-7864	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-22317	Alive	TUMOR FREE	1527	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1527	0	1527	0	720	0	1527	65.28	4.18	60-69	Stage 4
3289	TCGA-BB-7866	HNSC	40	MALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	GX	2010	[Not Available]	-14810	Alive	TUMOR FREE	1368	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1368	0	1368	0	1368	0	1368	44.29	3.75	40-49	other
3290	TCGA-BB-7870	HNSC	58	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2009	[Not Available]	-21443	Alive	TUMOR FREE	2016	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2016	0	2016	0	720	0	2016	64.23	5.52	50-59	Stage 4
3291	TCGA-BB-7871	HNSC	64	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-23409	Alive	WITH TUMOR	750	548	[Not Available]	Distant Metastasis	Distant Metastasis	428	Complete Remission/Response	0	750	0	750	0	720	1	428	66.14	2.05	60-69	Stage 4
3292	TCGA-BB-7872	HNSC	63	MALE	ASIAN	Stage I	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-23185	Alive	TUMOR FREE	1168	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1168	0	1168	0	720	0	1168	66.67	3.2	60-69	Stage 1
3293	TCGA-BB-8596	HNSC	69	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2005	[Not Available]	-25408	Alive	TUMOR FREE	2161	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2161	0	2161	0	720	0	2161	75.48	5.92	60-69	Stage 4
3294	TCGA-BB-8601	HNSC	84	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-30721	Alive	WITH TUMOR	624	548	[Not Available]	Locoregional Disease	Oral Cavity	440	Progressive Disease	0	624	0	624	0	720	1	440	85.82	1.71	>=80	Stage 3
3295	TCGA-BB-A5HU	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-17502	Alive	TUMOR FREE	782	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	782	0	782	0	720	0	782	50.06	2.14	40-49	Stage 4
3296	TCGA-BB-A5HY	HNSC	64	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	[Not Available]	-23640	Dead	WITH TUMOR	766	321	[Not Available]	Distant Metastasis	Distant Metastasis	230	Complete Remission/Response	1	321	1	321	0	720	1	230	65.6	0.88	60-69	Stage 4
3297	TCGA-BB-A5HZ	HNSC	65	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-23906	Alive	WITH TUMOR	827	548	[Not Available]	Distant Metastasis	Distant Metastasis	438	Complete Remission/Response	0	827	0	827	0	720	1	438	67.72	2.26	60-69	Stage 4
3298	TCGA-BB-A6UM	HNSC	52	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	GX	2010	[Not Available]	-19194	Alive	TUMOR FREE	393	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	393	0	393	0	393	0	393	53.63	1.08	50-59	Stage 3
3299	TCGA-BB-A6UO	HNSC	61	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-22506	Dead	WITH TUMOR	766	268	[Not Available]	NA	Distant Metastasis	212	Complete Remission/Response	1	268	1	268	0	720	1	212	62.35	0.73	60-69	Stage 4
3300	TCGA-C9-A47Z	HNSC	72	FEMALE	ASIAN	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-26592	Dead	TUMOR FREE	766	191	[Not Available]	NA	NA	364	Complete Remission/Response	1	191	0	191	0	191	0	191	73.33	0.52	70-79	Stage 3
3301	TCGA-C9-A480	HNSC	45	FEMALE	ASIAN	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-16567	Alive	TUMOR FREE	386	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	386	0	386	0	386	0	386	46.41	1.06	40-49	Stage 3
3302	TCGA-CN-4722	HNSC	61	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2010	[Not Available]	-22299	Alive	TUMOR FREE	1483	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1483	0	1483	0	1483	0	1483	65.11	4.06	60-69	Stage 2
3303	TCGA-CN-4723	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-24815	Alive	TUMOR FREE	1699	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1699	0	1699	0	720	0	1699	72.59	4.65	60-69	Stage 4
3304	TCGA-CN-4725	HNSC	60	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-22171	Alive	TUMOR FREE	1157	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1157	0	1157	0	1157	0	1157	63.87	3.17	60-69	Stage 2
3305	TCGA-CN-4726	HNSC	68	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-25194	Dead	WITH TUMOR	766	142	[Not Available]	NA	Distant Metastasis	79	Progressive Disease	1	142	1	142	0	720	1	79	69.37	0.39	60-69	Stage 4
3306	TCGA-CN-4727	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-20748	Alive	TUMOR FREE	1560	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1560	0	1560	0	720	0	1560	61.08	4.27	50-59	Stage 4
3307	TCGA-CN-4728	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-20660	Alive	TUMOR FREE	1724	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1724	0	1724	0	720	0	1724	61.28	4.72	50-59	Stage 4
3308	TCGA-CN-4729	HNSC	73	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-26713	Alive	TUMOR FREE	392	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	392	0	392	0	720	0	392	74.21	1.07	70-79	Stage 3
3309	TCGA-CN-4730	HNSC	62	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-22828	Alive	TUMOR FREE	817	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	817	0	817	0	720	0	817	64.74	2.24	60-69	Stage 4
3310	TCGA-CN-4731	HNSC	63	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-23194	Dead	WITH TUMOR	766	998	[Not Available]	NA	Oral Cavity	243	Persistent Disease	1	998	1	998	0	720	1	243	66.23	2.73	60-69	Stage 4
3311	TCGA-CN-4733	HNSC	61	MALE	WHITE	Stage III	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-22561	Alive	TUMOR FREE	1586	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1586	0	1586	0	1586	0	1586	66.11	4.34	60-69	Stage 3
3312	TCGA-CN-4734	HNSC	70	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-25753	Alive	TUMOR FREE	1690	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1690	0	1690	0	1690	0	1690	75.13	4.63	70-79	Stage 2
3313	TCGA-CN-4735	HNSC	52	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-19107	Alive	TUMOR FREE	1737	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1737	0	1737	0	720	0	1737	57.07	4.76	50-59	Stage 4
3314	TCGA-CN-4736	HNSC	70	FEMALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-25683	Dead	WITH TUMOR	766	395	[Not Available]	NA	Cervical Lymph Nodes	209	Complete Remission/Response	1	395	1	395	1	209	1	209	71.4	1.08	70-79	Stage 2
3315	TCGA-CN-4737	HNSC	19	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-7301	Alive	TUMOR FREE	625	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	625	0	625	0	720	0	625	21.7	1.71	18-29	Stage 4
3316	TCGA-CN-4738	HNSC	53	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-19621	Dead	TUMOR FREE	766	436	[Not Available]	NA	NA	364	[Not Available]	1	436	0	436	0	720	0	436	54.91	1.19	50-59	Stage 4
3317	TCGA-CN-4739	HNSC	71	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-26081	Dead	WITH TUMOR	766	1394	[Not Available]	Locoregional Recurrence	Oropharynx	1302	Complete Remission/Response	1	1394	1	1394	0	720	1	1302	75.22	3.82	70-79	Stage 4
3318	TCGA-CN-4740	HNSC	79	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-29186	Dead	WITH TUMOR	766	839	[Not Available]	NA	NA	224	Complete Remission/Response	1	839	1	839	0	720	1	224	82.2	2.3	70-79	Stage 4
3319	TCGA-CN-4741	HNSC	75	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-27506	Alive	TUMOR FREE	2239	548	[Not Available]	Locoregional Recurrence	Cervical Lymph Nodes	1716	Complete Remission/Response	0	2239	0	2239	0	720	1	1716	81.44	6.13	70-79	Stage 4
3320	TCGA-CN-4742	HNSC	48	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-17793	Dead	WITH TUMOR	766	397	[Not Available]	NA	NA	364	Progressive Disease	1	397	1	397	0	720	1	397	49.8	1.09	40-49	Stage 4
3321	TCGA-CN-5355	HNSC	64	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-23670	Alive	TUMOR FREE	1278	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1278	0	1278	0	720	0	1278	68.3	3.5	60-69	Stage 4
3322	TCGA-CN-5356	HNSC	56	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-20540	Alive	TUMOR FREE	1409	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1409	0	1409	0	1409	0	1409	60.09	3.86	50-59	Stage 3
3323	TCGA-CN-5358	HNSC	60	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-22138	Dead	TUMOR FREE	766	261	[Not Available]	NA	Cervical Lymph Nodes	145	Complete Remission/Response	1	261	0	261	1	145	1	145	61.33	0.71	60-69	Stage 2
3324	TCGA-CN-5359	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-21858	Dead	WITH TUMOR	766	377	[Not Available]	NA	Distant Metastasis	356	Complete Remission/Response	1	377	1	377	0	720	1	356	60.88	1.03	50-59	Stage 4
3325	TCGA-CN-5360	HNSC	68	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-25034	Alive	TUMOR FREE	2169	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2169	0	2169	0	720	0	2169	74.48	5.94	60-69	Stage 4
3326	TCGA-CN-5361	HNSC	80	MALE	WHITE	Stage IVA	[Not Available]	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-29383	Dead	TUMOR FREE	766	2120	[Not Available]	New Primary Tumor	NA	2062	Complete Remission/Response	1	2120	0	2120	0	720	1	2062	86.25	5.8	>=80	Stage 4
3327	TCGA-CN-5363	HNSC	48	MALE	BLACK OR AFRICAN AMERICAN	Stage IVB	Stage IVB	Head & Neck Squamous Cell Carcinoma	G3	2007	[Not Available]	-17635	Dead	WITH TUMOR	766	253	[Not Available]	NA	Distant Metastasis	53	Complete Remission/Response	1	253	1	253	0	720	1	53	48.97	0.69	40-49	Stage 4
3328	TCGA-CN-5364	HNSC	55	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2006	[Not Available]	-20362	Dead	TUMOR FREE	766	493	[Not Available]	NA	NA	364	Complete Remission/Response	1	493	0	493	0	720	0	493	57.1	1.35	50-59	Stage 4
3329	TCGA-CN-5365	HNSC	38	MALE	WHITE	Stage IVB	Stage IVC	Head & Neck Squamous Cell Carcinoma	G2	2006	[Not Available]	-14190	Dead	WITH TUMOR	766	351	[Not Available]	NA	NA	364	Progressive Disease	1	351	1	351	0	720	1	351	39.81	0.96	30-39	Stage 4
3330	TCGA-CN-5366	HNSC	51	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2006	[Not Available]	-18904	Dead	WITH TUMOR	766	360	[Not Available]	NA	Cervical Lymph Nodes	276	Complete Remission/Response	1	360	1	360	0	720	1	276	52.74	0.99	50-59	Stage 4
3331	TCGA-CN-5367	HNSC	60	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2006	[Not Available]	-22246	Dead	TUMOR FREE	766	352	[Not Available]	NA	NA	364	Complete Remission/Response	1	352	0	352	0	720	0	352	61.87	0.96	60-69	Stage 4
3332	TCGA-CN-5369	HNSC	90	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2006	[Not Available]	-32871	Dead	TUMOR FREE	766	380	[Not Available]	NA	NA	364	Complete Remission/Response	1	380	0	380	0	720	0	380	91.04	1.04	>=80	Stage 4
3333	TCGA-CN-5370	HNSC	78	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2006	[Not Available]	-28549	Dead	WITH TUMOR	766	259	[Not Available]	NA	Oral Cavity	123	Complete Remission/Response	1	259	1	259	1	123	1	123	78.87	0.71	70-79	Stage 3
3334	TCGA-CN-5373	HNSC	55	FEMALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2010	[Not Available]	-20143	Alive	TUMOR FREE	1584	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1584	0	1584	0	1584	0	1584	59.49	4.34	50-59	Stage 1
3335	TCGA-CN-5374	HNSC	56	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007	[Not Available]	-20464	Dead	TUMOR FREE	766	1732	[Not Available]	NA	Distant Metastasis	1369	Complete Remission/Response	1	1732	0	1732	0	720	1	1369	60.77	4.74	50-59	Stage 4
3336	TCGA-CN-6010	HNSC	53	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-19475	Alive	TUMOR FREE	1523	548	[Not Available]	New Primary Tumor	NA	540	Complete Remission/Response	0	1523	0	1523	0	720	1	540	57.49	4.17	50-59	Stage 4
3337	TCGA-CN-6011	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-21016	Alive	TUMOR FREE	933	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	933	0	933	0	720	0	933	60.09	2.55	50-59	Stage 4
3338	TCGA-CN-6012	HNSC	66	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-24286	Alive	TUMOR FREE	1460	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1460	0	1460	0	720	0	1460	70.49	4	60-69	Stage 4
3339	TCGA-CN-6013	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-20703	Dead	WITH TUMOR	766	727	[Not Available]	NA	Distant Metastasis	323	Complete Remission/Response	1	727	1	727	0	720	1	323	58.67	1.99	50-59	Stage 4
3340	TCGA-CN-6016	HNSC	64	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-23664	Alive	TUMOR FREE	1443	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1443	0	1443	0	720	0	1443	68.74	3.95	60-69	Stage 4
3341	TCGA-CN-6017	HNSC	55	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-20358	Dead	TUMOR FREE	766	853	[Not Available]	NA	NA	364	Complete Remission/Response	1	853	0	853	0	720	0	853	58.07	2.34	50-59	Stage 4
3342	TCGA-CN-6018	HNSC	85	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-31242	Dead	TUMOR FREE	766	580	[Not Available]	NA	NA	364	Complete Remission/Response	1	580	0	580	0	720	0	580	87.12	1.59	>=80	Stage 4
3343	TCGA-CN-6019	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-22485	Alive	TUMOR FREE	1038	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1038	0	1038	0	720	0	1038	64.4	2.84	60-69	Stage 4
3344	TCGA-CN-6020	HNSC	58	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-21232	Dead	TUMOR FREE	766	205	[Not Available]	NA	NA	364	Complete Remission/Response	1	205	0	205	0	720	0	205	58.69	0.56	50-59	Stage 3
3345	TCGA-CN-6021	HNSC	63	FEMALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-23212	Dead	WITH TUMOR	766	276	[Not Available]	NA	NA	364	Progressive Disease	1	276	1	276	0	720	1	276	64.31	0.76	60-69	other
3346	TCGA-CN-6022	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-17971	Dead	WITH TUMOR	766	281	[Not Available]	NA	Cervical Lymph Nodes	101	Progressive Disease	1	281	1	281	0	720	1	101	49.97	0.77	40-49	Stage 4
3347	TCGA-CN-6023	HNSC	73	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2010	[Not Available]	-26769	Alive	TUMOR FREE	1584	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1584	0	1584	0	720	0	1584	77.63	4.34	70-79	Stage 4
3348	TCGA-CN-6024	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-24259	Dead	WITH TUMOR	766	337	[Not Available]	NA	Cervical Lymph Nodes	156	Progressive Disease	1	337	1	337	0	720	1	156	67.34	0.92	60-69	Stage 4
3349	TCGA-CN-6988	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-17308	Alive	TUMOR FREE	318	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	318	0	318	0	720	0	318	48.26	0.87	40-49	Stage 4
3350	TCGA-CN-6989	HNSC	64	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-23515	Dead	WITH TUMOR	766	980	[Not Available]	NA	NA	436	Complete Remission/Response	1	980	1	980	0	720	1	436	67.06	2.68	60-69	Stage 4
3351	TCGA-CN-6992	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-22598	Alive	TUMOR FREE	1066	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1066	0	1066	0	720	0	1066	64.79	2.92	60-69	Stage 4
3352	TCGA-CN-6994	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-24778	Alive	TUMOR FREE	1183	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1183	0	1183	0	720	0	1183	71.08	3.24	60-69	Stage 4
3353	TCGA-CN-6995	HNSC	78	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-28850	Dead	TUMOR FREE	766	112	[Not Available]	NA	NA	364	Complete Remission/Response	1	112	0	112	0	720	0	112	79.29	0.31	70-79	Stage 4
3354	TCGA-CN-6996	HNSC	58	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-21447	Dead	WITH TUMOR	766	530	[Not Available]	NA	Cervical Lymph Nodes	350	Complete Remission/Response	1	530	1	530	0	720	1	350	60.17	1.45	50-59	Stage 4
3355	TCGA-CN-6997	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-24298	Dead	TUMOR FREE	766	988	[Not Available]	NA	Distant Metastasis	279	Complete Remission/Response	1	988	0	988	0	720	1	279	69.23	2.7	60-69	Stage 4
3356	TCGA-CN-6998	HNSC	53	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-19447	Dead	WITH TUMOR	766	357	[Not Available]	NA	Oropharynx	244	Progressive Disease	1	357	1	357	0	720	1	244	54.22	0.98	50-59	Stage 4
3357	TCGA-CN-A497	HNSC	63	MALE	[Unknown]	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-23310	Alive	TUMOR FREE	1065	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1065	0	1065	0	720	0	1065	66.74	2.92	60-69	Stage 3
3358	TCGA-CN-A498	HNSC	61	FEMALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-22330	Dead	WITH TUMOR	766	773	[Not Available]	Locoregional Recurrence	Oral Cavity	186	Complete Remission/Response	1	773	1	773	1	186	1	186	63.25	2.12	60-69	Stage 3
3359	TCGA-CN-A499	HNSC	60	FEMALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-21971	Alive	TUMOR FREE	717	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	717	0	717	0	717	0	717	62.12	1.96	60-69	Stage 2
3360	TCGA-CN-A49A	HNSC	60	MALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-21995	Dead	WITH TUMOR	766	526	[Not Available]	Distant Metastasis	Distant Metastasis	344	Complete Remission/Response	1	526	1	526	0	720	1	344	61.66	1.44	60-69	Stage 4
3361	TCGA-CN-A49B	HNSC	71	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-26155	Alive	TUMOR FREE	904	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	904	0	904	0	904	0	904	74.08	2.48	70-79	Stage 3
3362	TCGA-CN-A49C	HNSC	67	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2012	[Not Available]	-24495	Alive	TUMOR FREE	645	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	645	0	645	0	720	0	645	68.83	1.77	60-69	other
3363	TCGA-CN-A63T	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-22201	Alive	TUMOR FREE	225	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	225	0	225	0	720	0	225	61.4	0.62	60-69	Stage 4
3364	TCGA-CN-A63U	HNSC	50	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-18272	Alive	TUMOR FREE	964	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	964	0	964	0	720	0	964	52.67	2.64	50-59	Stage 4
3365	TCGA-CN-A63V	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-21734	Alive	TUMOR FREE	679	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	679	0	679	0	720	0	679	61.36	1.86	50-59	Stage 4
3366	TCGA-CN-A63W	HNSC	48	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-17693	Dead	TUMOR FREE	766	377	[Not Available]	NA	NA	364	Complete Remission/Response	1	377	0	377	0	720	0	377	49.47	1.03	40-49	Stage 4
3367	TCGA-CN-A63Y	HNSC	46	MALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-17125	Alive	TUMOR FREE	504	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	504	0	504	0	504	0	504	48.27	1.38	40-49	Stage 2
3368	TCGA-CN-A640	HNSC	40	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-14758	Dead	TUMOR FREE	766	134	[Not Available]	NA	NA	364	Complete Remission/Response	1	134	0	134	0	720	0	134	40.77	0.37	40-49	Stage 4
3369	TCGA-CN-A641	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-17454	Alive	TUMOR FREE	367	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	367	0	367	0	720	0	367	48.79	1	40-49	Stage 4
3370	TCGA-CN-A642	HNSC	57	MALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	[Not Available]	-21011	Dead	WITH TUMOR	766	82	[Not Available]	NA	NA	364	Progressive Disease	1	82	1	82	0	720	1	82	57.75	0.22	50-59	Stage 4
3371	TCGA-CN-A6UY	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-20967	Alive	TUMOR FREE	713	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	713	0	713	0	720	0	713	59.36	1.95	50-59	Stage 4
3372	TCGA-CN-A6V1	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013	[Not Available]	-21730	Alive	TUMOR FREE	603	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	603	0	603	0	720	0	603	61.14	1.65	50-59	Stage 4
3373	TCGA-CN-A6V3	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	[Not Available]	-22397	Alive	TUMOR FREE	742	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	742	0	742	0	720	0	742	63.35	2.03	60-69	Stage 4
3374	TCGA-CN-A6V6	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013	[Not Available]	-21811	Alive	TUMOR FREE	635	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	635	0	635	0	720	0	635	61.45	1.74	50-59	Stage 4
3375	TCGA-CN-A6V7	HNSC	40	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013	[Not Available]	-14895	Alive	TUMOR FREE	594	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	594	0	594	0	720	0	594	42.41	1.63	40-49	Stage 4
3376	TCGA-CQ-5323	HNSC	82	MALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-30173	Alive	TUMOR FREE	1466	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1466	0	1466	0	1466	0	1466	86.62	4.01	>=80	Stage 1
3377	TCGA-CQ-5324	HNSC	59	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-21803	Alive	TUMOR FREE	1593	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1593	0	1593	0	720	0	1593	64.05	4.36	50-59	Stage 3
3378	TCGA-CQ-5325	HNSC	65	MALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-23833	Dead	WITH TUMOR	766	654	[Not Available]	NA	Oral Cavity	204	Complete Remission/Response	1	654	1	654	1	204	1	204	67.04	1.79	60-69	Stage 1
3379	TCGA-CQ-5326	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007	[Not Available]	-24473	Dead	WITH TUMOR	766	89	[Not Available]	NA	NA	364	Progressive Disease	1	89	1	89	0	720	1	89	67.25	0.24	60-69	Stage 4
3380	TCGA-CQ-5327	HNSC	61	FEMALE	ASIAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-22307	Alive	TUMOR FREE	1660	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1660	0	1660	0	720	0	1660	65.62	4.54	60-69	Stage 4
3381	TCGA-CQ-5329	HNSC	46	FEMALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-17028	Alive	TUMOR FREE	2143	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2143	0	2143	0	2143	0	2143	52.49	5.87	40-49	Stage 2
3382	TCGA-CQ-5330	HNSC	69	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-25255	Alive	TUMOR FREE	1897	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1897	0	1897	0	720	0	1897	74.34	5.19	60-69	Stage 4
3383	TCGA-CQ-5331	HNSC	73	FEMALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-26901	Alive	TUMOR FREE	1399	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1399	0	1399	0	720	0	1399	77.48	3.83	70-79	other
3384	TCGA-CQ-5332	HNSC	87	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-32032	Dead	TUMOR FREE	317	317	[Not Available]	NA	NA	364	[Not Available]	1	317	0	317	0	720	0	317	88.57	0.87	>=80	Stage 3
3385	TCGA-CQ-5333	HNSC	74	MALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-27110	Dead	WITH TUMOR	766	341	[Not Available]	NA	Oropharynx	176	Complete Remission/Response	1	341	1	341	1	176	1	176	75.16	0.93	70-79	Stage 2
3386	TCGA-CQ-5334	HNSC	87	MALE	WHITE	Stage IVA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-32024	Dead	WITH TUMOR	766	129	[Not Available]	NA	Oral Cavity	50	Progressive Disease	1	129	1	129	0	720	1	50	88.03	0.35	>=80	Stage 4
3387	TCGA-CQ-6218	HNSC	52	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-19096	Alive	TUMOR FREE	1253	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1253	0	1253	0	720	0	1253	55.71	3.43	50-59	Stage 4
3388	TCGA-CQ-6219	HNSC	50	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-18578	Dead	WITH TUMOR	766	479	[Not Available]	NA	Cervical Lymph Nodes	195	Complete Remission/Response	1	479	1	479	0	720	1	195	52.18	1.31	50-59	Stage 4
3389	TCGA-CQ-6220	HNSC	69	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-25366	Dead	TUMOR FREE	766	985	[Not Available]	NA	NA	364	Complete Remission/Response	1	985	0	985	0	985	0	985	72.15	2.7	60-69	Stage 3
3390	TCGA-CQ-6221	HNSC	79	MALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-29026	Alive	TUMOR FREE	1000	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1000	0	1000	0	1000	0	1000	82.21	2.74	70-79	Stage 2
3391	TCGA-CQ-6222	HNSC	63	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-23326	Alive	TUMOR FREE	2016	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2016	0	2016	0	720	0	2016	69.38	5.52	60-69	Stage 4
3392	TCGA-CQ-6223	HNSC	69	MALE	WHITE	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-25266	Alive	TUMOR FREE	1428	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1428	0	1428	0	720	0	1428	73.08	3.91	60-69	Stage 2
3393	TCGA-CQ-6224	HNSC	52	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2009	[Not Available]	-19051	Alive	TUMOR FREE	1721	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1721	0	1721	0	720	0	1721	56.87	4.71	50-59	Stage 4
3394	TCGA-CQ-6225	HNSC	65	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-23988	Dead	TUMOR FREE	766	403	[Not Available]	NA	Oral Cavity	180	Persistent Disease	1	403	0	403	0	720	1	180	66.78	1.1	60-69	Stage 3
3395	TCGA-CQ-6227	HNSC	77	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-28466	Dead	WITH TUMOR	766	129	[Not Available]	NA	NA	364	Progressive Disease	1	129	1	129	0	720	1	129	78.29	0.35	70-79	Stage 4
3396	TCGA-CQ-6228	HNSC	71	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-25942	Dead	TUMOR FREE	766	456	[Not Available]	NA	Distant Metastasis	273	Complete Remission/Response	1	456	0	456	0	720	1	273	72.27	1.25	70-79	Stage 4
3397	TCGA-CQ-6229	HNSC	61	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-22541	Alive	TUMOR FREE	1179	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1179	0	1179	0	1179	0	1179	64.94	3.23	60-69	Stage 2
3398	TCGA-CQ-7063	HNSC	59	FEMALE	WHITE	Stage I	[Not Available]	Head & Neck Squamous Cell Carcinoma	G1	2008	[Not Available]	-21723	Alive	TUMOR FREE	2133	548	[Not Available]	Locoregional Disease	Oral Cavity	1160	Complete Remission/Response	0	2133	0	2133	1	1160	1	1160	65.31	5.84	50-59	Stage 1
3399	TCGA-CQ-7064	HNSC	83	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-30640	Alive	TUMOR FREE	1973	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1973	0	1973	0	1973	0	1973	89.29	5.4	>=80	Stage 3
3400	TCGA-CQ-7065	HNSC	40	MALE	ASIAN	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-14676	Alive	TUMOR FREE	1628	548	[Not Available]	NA	Oral Cavity	230	Complete Remission/Response	0	1628	0	1628	1	230	1	230	44.64	4.46	40-49	Stage 2
3401	TCGA-CQ-7067	HNSC	75	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2009	[Not Available]	-27707	Alive	TUMOR FREE	509	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	509	0	509	0	509	0	509	77.25	1.39	70-79	Stage 1
3402	TCGA-CQ-7068	HNSC	80	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-29530	Alive	TUMOR FREE	1309	548	[Not Available]	New Primary Tumor	Oral Cavity	1148	Complete Remission/Response	0	1309	0	1309	0	1309	1	1148	84.43	3.58	>=80	Stage 2
3403	TCGA-CQ-7069	HNSC	77	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-28138	Alive	TUMOR FREE	1274	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1274	0	1274	0	1274	0	1274	80.53	3.49	70-79	Stage 2
3404	TCGA-CQ-7071	HNSC	76	FEMALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-27928	Alive	TUMOR FREE	1311	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1311	0	1311	0	720	0	1311	80.05	3.59	70-79	Stage 3
3405	TCGA-CQ-7072	HNSC	51	MALE	WHITE	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007	[Not Available]	-18841	Alive	TUMOR FREE	2359	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2359	0	2359	0	720	0	2359	58.04	6.46	50-59	Stage 2
3406	TCGA-CQ-A4C6	HNSC	63	MALE	ASIAN	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-23205	Alive	TUMOR FREE	1353	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1353	0	1353	0	1353	0	1353	67.24	3.7	60-69	Stage 2
3407	TCGA-CQ-A4C7	HNSC	88	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-32194	Dead	TUMOR FREE	766	353	[Not Available]	NA	Oral Cavity	207	Complete Remission/Response	1	353	0	353	1	207	1	207	89.11	0.97	>=80	Stage 3
3408	TCGA-CQ-A4C9	HNSC	56	MALE	[Not Evaluated]	Stage III	[Not Available]	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-20732	Alive	WITH TUMOR	707	548	[Not Available]	Locoregional Disease	Oral Cavity	287	Complete Remission/Response	0	707	0	707	1	287	1	287	58.7	1.94	50-59	Stage 3
3409	TCGA-CQ-A4CA	HNSC	60	MALE	[Not Evaluated]	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-22222	Alive	TUMOR FREE	766	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	714	0	722	0	720	0	564	62.94	2.1	60-69	Stage 2
3410	TCGA-CQ-A4CB	HNSC	59	MALE	[Not Evaluated]	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-21574	Alive	TUMOR FREE	893	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	893	0	893	0	893	0	893	61.51	2.44	50-59	Stage 3
3411	TCGA-CQ-A4CD	HNSC	69	MALE	WHITE	Stage IVA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-25497	Alive	TUMOR FREE	1022	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1022	0	1022	0	720	0	1022	72.61	2.8	60-69	Stage 4
3412	TCGA-CQ-A4CE	HNSC	76	FEMALE	[Not Evaluated]	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-27793	Alive	TUMOR FREE	897	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	897	0	897	0	897	0	897	78.55	2.46	70-79	Stage 2
3413	TCGA-CQ-A4CG	HNSC	78	FEMALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-28637	Dead	WITH TUMOR	766	430	[Not Available]	NA	Distant Metastasis	350	Complete Remission/Response	1	430	1	430	1	350	1	350	79.58	1.18	70-79	Stage 3
3414	TCGA-CQ-A4CH	HNSC	58	MALE	ASIAN	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-21455	Dead	WITH TUMOR	766	379	[Not Available]	NA	NA	210	Complete Remission/Response	1	379	1	379	0	720	1	210	59.78	1.04	50-59	Stage 2
3415	TCGA-CQ-A4CI	HNSC	73	MALE	WHITE	Stage III	[Not Available]	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2011	[Not Available]	-26664	Alive	WITH TUMOR	950	548	[Not Available]	NA	Distant Metastasis	517	Complete Remission/Response	0	950	0	950	1	517	1	517	75.6	2.6	70-79	Stage 3
3416	TCGA-CR-5243	HNSC	51	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	[Not Available]	-18812	Alive	TUMOR FREE	2562	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2562	0	2562	0	720	0	2562	58.52	7.01	50-59	other
3417	TCGA-CR-5247	HNSC	48	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2006	[Not Available]	-17810	Alive	TUMOR FREE	358	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	358	0	358	0	358	0	358	49.74	0.98	40-49	other
3418	TCGA-CR-5248	HNSC	53	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2006	[Not Available]	-19441	Alive	WITH TUMOR	1663	548	[Not Available]	NA	Cervical Lymph Nodes	936	Complete Remission/Response	0	1663	0	1663	0	720	1	936	57.78	4.55	50-59	other
3419	TCGA-CR-5249	HNSC	35	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	GX	2007	[Not Available]	-13047	Alive	TUMOR FREE	1152	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1152	0	1152	0	1152	0	1152	38.87	3.15	30-39	Stage 2
3420	TCGA-CR-5250	HNSC	71	MALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2009	[Not Available]	-26097	Alive	TUMOR FREE	799	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	799	0	799	0	799	0	799	73.64	2.19	70-79	Stage 2
3421	TCGA-CR-6467	HNSC	59	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2006	[Not Available]	-21689	Alive	TUMOR FREE	1777	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1777	0	1777	0	720	0	1777	64.25	4.87	50-59	Stage 3
3422	TCGA-CR-6470	HNSC	38	MALE	WHITE	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-14133	Alive	TUMOR FREE	1521	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1521	0	1521	0	720	0	1521	42.86	4.16	30-39	Stage 2
3423	TCGA-CR-6471	HNSC	58	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-21315	Dead	WITH TUMOR	766	1202	[Not Available]	NA	Oropharynx	498	Complete Remission/Response	1	1202	1	1202	0	720	1	498	61.65	3.29	50-59	Stage 4
3424	TCGA-CR-6472	HNSC	59	MALE	WHITE	[Not Available]	Stage IVB	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-21654	Alive	TUMOR FREE	1050	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1050	0	1050	0	720	0	1050	62.16	2.87	50-59	other
3425	TCGA-CR-6473	HNSC	68	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-24857	Alive	TUMOR FREE	1125	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1125	0	1125	0	720	0	1125	71.13	3.08	60-69	other
3426	TCGA-CR-6474	HNSC	51	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-18840	Dead	WITH TUMOR	766	564	[Not Available]	NA	Cervical Lymph Nodes	220	Complete Remission/Response	1	564	1	564	0	720	1	220	53.13	1.54	50-59	Stage 4
3427	TCGA-CR-6477	HNSC	56	FEMALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-20815	Alive	TUMOR FREE	514	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	514	0	514	0	720	0	514	58.4	1.41	50-59	other
3428	TCGA-CR-6478	HNSC	66	FEMALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-24244	Dead	TUMOR FREE	766	183	[Not Available]	NA	NA	364	Complete Remission/Response	1	183	0	183	0	720	0	183	66.88	0.5	60-69	other
3429	TCGA-CR-6480	HNSC	53	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-19472	Alive	TUMOR FREE	362	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	362	0	362	0	720	0	362	54.3	0.99	50-59	other
3430	TCGA-CR-6481	HNSC	47	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-17203	Alive	TUMOR FREE	311	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	311	0	311	0	720	0	311	47.95	0.85	40-49	other
3431	TCGA-CR-6482	HNSC	62	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-22741	Alive	TUMOR FREE	345	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	345	0	345	0	720	0	345	63.21	0.94	60-69	other
3432	TCGA-CR-6484	HNSC	67	FEMALE	ASIAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-24569	Alive	TUMOR FREE	354	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	354	0	354	0	720	0	354	68.24	0.97	60-69	Stage 4
3433	TCGA-CR-6487	HNSC	50	MALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-18331	Alive	TUMOR FREE	234	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	234	0	234	0	234	0	234	50.83	0.64	50-59	Stage 1
3434	TCGA-CR-6488	HNSC	68	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-25176	Alive	TUMOR FREE	379	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	379	0	379	0	379	0	379	69.97	1.04	60-69	Stage 2
3435	TCGA-CR-6491	HNSC	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-22125	Alive	WITH TUMOR	693	548	[Not Available]	New Primary Tumor	Distant Metastasis	499	Complete Remission/Response	0	693	0	693	0	720	1	499	62.47	1.9	60-69	Stage 4
3436	TCGA-CR-6492	HNSC	78	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-28600	Alive	TUMOR FREE	479	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	479	0	479	0	720	0	479	79.61	1.31	70-79	Stage 3
3437	TCGA-CR-6493	HNSC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-25432	Dead	WITH TUMOR	766	282	[Not Available]	Locoregional Recurrence	Oral Cavity	247	Complete Remission/Response	1	282	1	282	0	720	1	247	70.4	0.77	60-69	Stage 4
3438	TCGA-CR-7364	HNSC	66	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-24192	Alive	TUMOR FREE	1435	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1435	0	1435	0	1435	0	1435	70.16	3.93	60-69	Stage 3
3439	TCGA-CR-7365	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-22101	Alive	TUMOR FREE	1191	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1191	0	1191	0	720	0	1191	63.77	3.26	60-69	Stage 4
3440	TCGA-CR-7367	HNSC	52	MALE	WHITE	Stage IVA	Stage IVB	Head & Neck Squamous Cell Carcinoma	G1	2008	[Not Available]	-19116	Alive	TUMOR FREE	1440	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1440	0	1440	0	720	0	1440	56.28	3.94	50-59	Stage 4
3441	TCGA-CR-7368	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-19876	Alive	TUMOR FREE	1245	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1245	0	1245	0	720	0	1245	57.83	3.41	50-59	Stage 4
3442	TCGA-CR-7369	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-21897	Dead	TUMOR FREE	766	1090	[Not Available]	NA	NA	364	Complete Remission/Response	1	1090	0	1090	0	720	0	1090	62.93	2.98	50-59	Stage 4
3443	TCGA-CR-7370	HNSC	72	FEMALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-26468	Alive	TUMOR FREE	105	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	105	0	105	0	105	0	105	72.75	0.29	70-79	Stage 2
3444	TCGA-CR-7371	HNSC	45	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-16568	Dead	TUMOR FREE	766	94	[Not Available]	NA	NA	364	[Not Available]	1	94	0	94	0	720	0	94	45.62	0.26	40-49	Stage 3
3445	TCGA-CR-7372	HNSC	45	MALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2009	[Not Available]	-16610	Alive	TUMOR FREE	759	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	759	0	759	0	759	0	759	47.55	2.08	40-49	Stage 1
3446	TCGA-CR-7373	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-24448	Alive	TUMOR FREE	889	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	889	0	889	0	720	0	889	69.37	2.43	60-69	Stage 4
3447	TCGA-CR-7374	HNSC	67	FEMALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-24558	Alive	WITH TUMOR	30	548	[Not Available]	NA	NA	364	[Not Available]	0	30	0	30	0	720	0	30	67.32	0.08	60-69	Stage 2
3448	TCGA-CR-7376	HNSC	83	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-30670	Alive	TUMOR FREE	972	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	972	0	972	0	972	0	972	86.63	2.66	>=80	Stage 3
3449	TCGA-CR-7377	HNSC	58	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-21371	Dead	TUMOR FREE	766	279	[Not Available]	NA	NA	364	Complete Remission/Response	1	279	0	279	0	720	0	279	59.27	0.76	50-59	Stage 4
3450	TCGA-CR-7379	HNSC	78	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-28763	Alive	TUMOR FREE	1036	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1036	0	1036	0	720	0	1036	81.59	2.84	70-79	Stage 4
3451	TCGA-CR-7380	HNSC	58	MALE	WHITE	Stage IVB	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-21215	Dead	WITH TUMOR	766	606	[Not Available]	NA	Distant Metastasis	561	Complete Remission/Response	1	606	1	606	0	720	1	561	59.74	1.66	50-59	Stage 4
3452	TCGA-CR-7382	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-18078	Alive	TUMOR FREE	796	548	[Not Available]	NA	Oral Cavity	614	Complete Remission/Response	0	796	0	796	0	720	1	614	51.67	2.18	40-49	Stage 4
3453	TCGA-CR-7383	HNSC	79	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-29122	Dead	WITH TUMOR	766	521	[Not Available]	NA	Oropharynx	454	Complete Remission/Response	1	521	1	521	1	454	1	454	81.16	1.43	70-79	Stage 1
3454	TCGA-CR-7385	HNSC	42	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-15477	Alive	TUMOR FREE	997	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	997	0	997	0	720	0	997	45.1	2.73	40-49	other
3455	TCGA-CR-7386	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2008	[Not Available]	-25238	Alive	WITH TUMOR	1430	548	[Not Available]	NA	Distant Metastasis	1028	Complete Remission/Response	0	1430	0	1430	0	720	1	1028	73.01	3.92	60-69	Stage 4
3456	TCGA-CR-7388	HNSC	70	FEMALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-25728	Dead	WITH TUMOR	766	823	[Not Available]	NA	Cervical Lymph Nodes	334	Complete Remission/Response	1	823	1	823	0	720	1	334	72.69	2.25	70-79	other
3457	TCGA-CR-7389	HNSC	55	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-20169	Alive	TUMOR FREE	392	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	392	0	392	0	392	0	392	56.29	1.07	50-59	other
3458	TCGA-CR-7390	HNSC	67	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-24575	Alive	TUMOR FREE	1508	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1508	0	1508	0	720	0	1508	71.41	4.13	60-69	Stage 4
3459	TCGA-CR-7391	HNSC	36	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G1	2009	[Not Available]	-13508	Alive	TUMOR FREE	913	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	913	0	913	0	913	0	913	39.48	2.5	30-39	Stage 1
3460	TCGA-CR-7392	HNSC	67	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2009	[Not Available]	-24650	Alive	TUMOR FREE	1425	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1425	0	1425	0	720	0	1425	71.39	3.9	60-69	Stage 4
3461	TCGA-CR-7393	HNSC	26	MALE	WHITE	Stage III	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-9750	Alive	TUMOR FREE	993	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	993	0	993	0	993	0	993	29.41	2.72	18-29	Stage 3
3462	TCGA-CR-7394	HNSC	70	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-25581	Alive	TUMOR FREE	1346	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1346	0	1346	0	720	0	1346	73.72	3.69	70-79	Stage 4
3463	TCGA-CR-7395	HNSC	80	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-29527	Alive	TUMOR FREE	930	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	930	0	930	0	930	0	930	83.39	2.55	>=80	Stage 2
3464	TCGA-CR-7397	HNSC	44	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-16351	Alive	TUMOR FREE	754	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	754	0	754	0	720	0	754	46.83	2.06	40-49	Stage 4
3465	TCGA-CR-7398	HNSC	53	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-19468	Alive	TUMOR FREE	156	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	156	0	156	0	156	0	156	53.73	0.43	50-59	Stage 2
3466	TCGA-CR-7399	HNSC	60	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-22182	Alive	TUMOR FREE	181	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	181	0	181	0	720	0	181	61.23	0.5	60-69	Stage 4
3467	TCGA-CR-7401	HNSC	64	MALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-23420	Alive	TUMOR FREE	1077	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1077	0	1077	0	1077	0	1077	67.07	2.95	60-69	Stage 1
3468	TCGA-CR-7402	HNSC	68	MALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-25138	Alive	TUMOR FREE	911	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	911	0	911	0	911	0	911	71.32	2.49	60-69	other
3469	TCGA-CR-7404	HNSC	53	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-19532	Alive	WITH TUMOR	1472	548	[Not Available]	NA	Oropharynx	234	Complete Remission/Response	0	1472	0	1472	0	720	1	234	57.51	4.03	50-59	other
3470	TCGA-CV-5430	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	1999	[Not Available]	-22577	Alive	TUMOR FREE	4241	548	[Not Available]	NA	Distant Metastasis	783	Complete Remission/Response	0	4241	0	4241	0	720	1	783	73.42	11.61	60-69	Stage 4
3471	TCGA-CV-5431	HNSC	73	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-26953	Dead	TUMOR FREE	522	522	[Not Available]	NA	NA	364	Complete Remission/Response	1	522	0	522	0	720	0	522	75.22	1.43	70-79	Stage 4
3472	TCGA-CV-5432	HNSC	68	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-25006	Alive	TUMOR FREE	3930	548	[Not Available]	NA	NA	364	[Not Available]	0	3930	0	3930	0	720	0	3930	79.22	10.76	60-69	Stage 3
3473	TCGA-CV-5434	HNSC	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2000	[Not Available]	-22182	Dead	TUMOR FREE	3295	3314	[Not Available]	NA	Distant Metastasis	1859	Complete Remission/Response	1	3314	0	3314	0	720	1	1859	69.8	9.07	60-69	Stage 4
3474	TCGA-CV-5435	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-20926	Dead	WITH TUMOR	1438	2319	[Not Available]	NA	Distant Metastasis	284	[Not Available]	1	2319	1	2319	0	720	1	284	63.64	6.35	50-59	Stage 4
3475	TCGA-CV-5436	HNSC	65	MALE	[Not Available]	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2001	[Not Available]	-23923	Dead	WITH TUMOR	548	584	[Not Available]	NA	NA	364	Persistent Disease	1	584	1	584	0	720	1	584	67.1	1.6	60-69	Stage 4
3476	TCGA-CV-5439	HNSC	62	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2002	[Not Available]	-22686	Dead	WITH TUMOR	546	546	[Not Available]	NA	Oropharynx	211	[Not Available]	1	546	1	546	0	720	1	211	63.61	1.49	60-69	Stage 4
3477	TCGA-CV-5440	HNSC	52	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2002	[Not Available]	-19197	Alive	TUMOR FREE	3270	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3270	0	3270	0	720	0	3270	61.51	8.95	50-59	Stage 4
3478	TCGA-CV-5441	HNSC	58	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003	[Not Available]	-21305	Alive	TUMOR FREE	2886	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2886	0	2886	0	720	0	2886	66.23	7.9	50-59	Stage 4
3479	TCGA-CV-5442	HNSC	76	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2004	[Not Available]	-28040	Alive	TUMOR FREE	2327	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2327	0	2327	0	720	0	2327	83.14	6.37	70-79	Stage 4
3480	TCGA-CV-5443	HNSC	63	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2004	[Not Available]	-23287	Alive	TUMOR FREE	2784	548	[Not Available]	NA	NA	364	[Not Available]	0	2784	0	2784	0	720	0	2784	71.38	7.62	60-69	Stage 3
3481	TCGA-CV-5444	HNSC	64	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2004	[Not Available]	-23650	Alive	TUMOR FREE	2437	548	[Not Available]	NA	NA	364	[Not Available]	0	2437	0	2437	0	720	0	2437	71.42	6.67	60-69	Stage 4
3482	TCGA-CV-5966	HNSC	63	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2005	[Not Available]	-23119	Dead	TUMOR FREE	766	545	[Not Available]	NA	NA	364	Complete Remission/Response	1	545	0	545	0	720	0	545	64.79	1.49	60-69	Stage 4
3483	TCGA-CV-5970	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-21890	Dead	WITH TUMOR	406	406	[Not Available]	NA	NA	364	[Not Available]	1	406	1	406	0	720	1	406	61.04	1.11	50-59	Stage 4
3484	TCGA-CV-5971	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-22279	Alive	TUMOR FREE	701	548	[Not Available]	NA	NA	364	[Not Available]	0	701	0	701	0	720	0	701	62.92	1.92	60-69	Stage 4
3485	TCGA-CV-5973	HNSC	62	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2005	[Not Available]	-22771	Alive	TUMOR FREE	2641	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2641	0	2641	0	2641	0	2641	69.57	7.23	60-69	Stage 3
3486	TCGA-CV-5976	HNSC	50	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2006	[Not Available]	-18267	Alive	TUMOR FREE	1478	548	[Not Available]	NA	NA	364	[Not Available]	0	1478	0	1478	0	720	0	1478	54.06	4.05	50-59	Stage 4
3487	TCGA-CV-5977	HNSC	66	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-24115	Alive	TUMOR FREE	1840	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1840	0	1840	0	720	0	1840	71.06	5.04	60-69	Stage 4
3488	TCGA-CV-5978	HNSC	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVB	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-19480	Dead	WITH TUMOR	215	215	[Not Available]	NA	NA	364	[Not Available]	1	215	1	215	0	720	1	215	53.92	0.59	50-59	Stage 4
3489	TCGA-CV-5979	HNSC	26	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-9567	Alive	TUMOR FREE	1315	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1315	0	1315	0	720	0	1315	29.79	3.6	18-29	Stage 4
3490	TCGA-CV-6003	HNSC	50	FEMALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-18600	Alive	TUMOR FREE	1665	548	[Not Available]	NA	NA	364	[Not Available]	0	1665	0	1665	0	720	0	1665	55.48	4.56	50-59	Stage 3
3491	TCGA-CV-6433	HNSC	57	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-20855	Alive	WITH TUMOR	641	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	641	0	641	0	641	0	641	58.85	1.75	50-59	Stage 2
3492	TCGA-CV-6436	HNSC	62	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2007	[Not Available]	-22885	Alive	TUMOR FREE	1899	548	[Not Available]	NA	NA	364	[Not Available]	0	1899	0	1899	0	720	0	1899	67.85	5.2	60-69	Stage 4
3493	TCGA-CV-6441	HNSC	60	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-22025	Dead	WITH TUMOR	766	292	[Not Available]	Locoregional Recurrence	Oral Cavity	95	Progressive Disease	1	292	1	292	0	720	1	95	61.1	0.8	60-69	Stage 3
3494	TCGA-CV-6933	HNSC	53	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1998	[Not Available]	-19518	Dead	TUMOR FREE	766	2741	[Not Available]	NA	NA	364	[Not Available]	1	2741	0	2741	0	720	0	2741	60.94	7.5	50-59	Stage 3
3495	TCGA-CV-6934	HNSC	66	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1998	[Not Available]	-24180	Dead	WITH TUMOR	766	65	[Not Available]	NA	NA	364	Complete Remission/Response	1	65	1	65	0	720	1	65	66.38	0.18	60-69	Stage 4
3496	TCGA-CV-6935	HNSC	67	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	1999	[Not Available]	-24799	Dead	WITH TUMOR	766	295	[Not Available]	NA	NA	364	[Not Available]	1	295	1	295	0	720	1	295	68.7	0.81	60-69	Stage 4
3497	TCGA-CV-6936	HNSC	68	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2004	[Not Available]	-25020	Dead	WITH TUMOR	766	166	[Not Available]	Locoregional Recurrence	Oral Cavity	157	Progressive Disease	1	166	1	166	0	720	1	157	68.96	0.45	60-69	Stage 4
3498	TCGA-CV-6937	HNSC	71	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2003	[Not Available]	-26156	Dead	TUMOR FREE	766	624	[Not Available]	NA	NA	364	[Not Available]	1	624	0	624	0	720	0	624	73.32	1.71	70-79	Stage 2
3499	TCGA-CV-6938	HNSC	87	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	1996	[Not Available]	-31825	Dead	TUMOR FREE	766	144	[Not Available]	NA	NA	364	[Not Available]	1	144	0	144	0	720	0	144	87.53	0.39	>=80	Stage 2
3500	TCGA-CV-6939	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	1994	[Not Available]	-21947	Dead	WITH TUMOR	766	666	[Not Available]	NA	NA	364	[Not Available]	1	666	1	666	0	720	1	666	61.91	1.82	60-69	Stage 4
3501	TCGA-CV-6940	HNSC	80	FEMALE	WHITE	Stage III	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2002	[Not Available]	-29382	Dead	TUMOR FREE	766	804	[Not Available]	NA	NA	364	Complete Remission/Response	1	804	0	804	0	804	0	804	82.64	2.2	>=80	Stage 3
3502	TCGA-CV-6941	HNSC	51	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	[Not Available]	-18812	Dead	TUMOR FREE	766	342	[Not Available]	NA	NA	364	Complete Remission/Response	1	342	0	342	0	342	0	342	52.44	0.94	50-59	Stage 3
3503	TCGA-CV-6942	HNSC	73	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-26941	Alive	TUMOR FREE	4282	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	4282	0	4282	0	4282	0	4282	85.48	11.72	70-79	Stage 2
3504	TCGA-CV-6943	HNSC	74	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	[Not Available]	-27310	Dead	WITH TUMOR	766	602	[Not Available]	NA	NA	364	[Not Available]	1	602	1	602	0	720	1	602	76.42	1.65	70-79	Stage 3
3505	TCGA-CV-6945	HNSC	41	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1993	[Not Available]	-15158	Dead	WITH TUMOR	766	366	[Not Available]	NA	NA	364	[Not Available]	1	366	1	366	0	720	1	366	42.5	1	40-49	Stage 4
3506	TCGA-CV-6948	HNSC	79	FEMALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1994	[Not Available]	-29153	Dead	TUMOR FREE	766	1289	[Not Available]	NA	NA	364	[Not Available]	1	1289	0	1289	0	720	0	1289	83.35	3.53	70-79	Stage 4
3507	TCGA-CV-6950	HNSC	64	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1994	[Not Available]	-23549	Dead	WITH TUMOR	766	459	[Not Available]	Locoregional Recurrence	Oral Cavity	258	Complete Remission/Response	1	459	1	459	0	720	1	258	65.73	1.26	60-69	Stage 4
3508	TCGA-CV-6951	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1996	[Not Available]	-21166	Dead	WITH TUMOR	766	915	[Not Available]	NA	NA	364	[Not Available]	1	915	1	915	0	720	1	915	60.45	2.51	50-59	Stage 4
3509	TCGA-CV-6952	HNSC	65	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	1996	[Not Available]	-23892	Dead	TUMOR FREE	766	185	[Not Available]	NA	NA	364	[Not Available]	1	185	0	185	0	720	0	185	65.92	0.51	60-69	Stage 4
3510	TCGA-CV-6953	HNSC	80	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	1997	[Not Available]	-29465	Dead	WITH TUMOR	766	1641	[Not Available]	Locoregional Recurrence	Oral Cavity	1521	Complete Remission/Response	1	1641	1	1641	1	1521	1	1521	85.16	4.49	>=80	Stage 3
3511	TCGA-CV-6954	HNSC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1998	[Not Available]	-21557	Dead	TUMOR FREE	766	2002	[Not Available]	NA	NA	364	Complete Remission/Response	1	2002	0	2002	0	720	0	2002	64.5	5.48	50-59	Stage 4
3512	TCGA-CV-6955	HNSC	74	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-27261	Dead	WITH TUMOR	766	334	[Not Available]	NA	NA	364	[Not Available]	1	334	1	334	0	720	1	334	75.55	0.91	70-79	Stage 2
3513	TCGA-CV-6956	HNSC	67	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1993	[Not Available]	-24720	Dead	WITH TUMOR	766	217	[Not Available]	NA	NA	364	Complete Remission/Response	1	217	1	217	0	720	1	217	68.27	0.59	60-69	Stage 3
3514	TCGA-CV-6959	HNSC	48	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	[Not Available]	-17679	Dead	WITH TUMOR	766	256	[Not Available]	Locoregional Recurrence	NA	103	[Not Available]	1	256	1	256	0	720	1	103	49.1	0.7	40-49	Stage 3
3515	TCGA-CV-6960	HNSC	49	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	1999	[Not Available]	-18194	Dead	TUMOR FREE	766	862	[Not Available]	NA	NA	364	[Not Available]	1	862	0	862	0	720	0	862	52.17	2.36	40-49	Stage 3
3516	TCGA-CV-6961	HNSC	61	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	1999	[Not Available]	-22532	Dead	WITH TUMOR	766	76	[Not Available]	NA	NA	364	Complete Remission/Response	1	76	1	76	0	720	1	76	61.9	0.21	60-69	Stage 2
3517	TCGA-CV-6962	HNSC	65	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	[Not Available]	-24103	Dead	TUMOR FREE	766	126	[Not Available]	NA	NA	364	[Not Available]	1	126	0	126	0	720	0	126	66.34	0.34	60-69	Stage 4
3518	TCGA-CV-7089	HNSC	74	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2001	[Not Available]	-27149	Dead	TUMOR FREE	766	1972	[Not Available]	NA	NA	364	[Not Available]	1	1972	0	1972	0	720	0	1972	79.73	5.4	70-79	Stage 4
3519	TCGA-CV-7090	HNSC	39	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2001	[Not Available]	-14515	Alive	TUMOR FREE	5252	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	5252	0	5252	0	5252	0	5252	54.12	14.38	30-39	Stage 2
3520	TCGA-CV-7091	HNSC	54	MALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2001	[Not Available]	-19938	Alive	TUMOR FREE	3381	548	[Not Available]	NA	NA	364	[Not Available]	0	3381	0	3381	0	720	0	3381	63.84	9.26	50-59	Stage 1
3521	TCGA-CV-7095	HNSC	87	FEMALE	[Not Available]	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2001	[Not Available]	-32022	Dead	TUMOR FREE	766	572	[Not Available]	NA	NA	364	[Not Available]	1	572	0	572	0	720	0	572	89.24	1.57	>=80	Stage 2
3522	TCGA-CV-7097	HNSC	53	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2002	[Not Available]	-19382	Dead	WITH TUMOR	766	385	[Not Available]	NA	NA	364	[Not Available]	1	385	1	385	0	720	1	385	54.12	1.05	50-59	Stage 2
3523	TCGA-CV-7099	HNSC	85	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2002	[Not Available]	-31134	Dead	TUMOR FREE	766	243	[Not Available]	NA	NA	364	Complete Remission/Response	1	243	0	243	0	243	0	243	85.91	0.67	>=80	Stage 2
3524	TCGA-CV-7100	HNSC	66	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2001	[Not Available]	-24183	Dead	WITH TUMOR	766	274	[Not Available]	NA	NA	364	[Not Available]	1	274	1	274	0	720	1	274	66.96	0.75	60-69	Stage 3
3525	TCGA-CV-7101	HNSC	80	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1999	[Not Available]	-29550	Dead	TUMOR FREE	766	160	[Not Available]	NA	NA	364	[Not Available]	1	160	0	160	0	720	0	160	81.34	0.44	>=80	Stage 2
3526	TCGA-CV-7102	HNSC	76	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-27805	Dead	TUMOR FREE	766	56	[Not Available]	NA	NA	364	Complete Remission/Response	1	56	0	56	0	720	0	56	76.28	0.15	70-79	Stage 4
3527	TCGA-CV-7103	HNSC	49	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2000	[Not Available]	-18219	Dead	WITH TUMOR	766	1591	[Not Available]	NA	NA	364	[Not Available]	1	1591	1	1591	0	720	1	1591	54.24	4.36	40-49	Stage 4
3528	TCGA-CV-7104	HNSC	61	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2000	[Not Available]	-22349	Dead	TUMOR FREE	766	393	[Not Available]	NA	NA	364	Complete Remission/Response	1	393	0	393	0	720	0	393	62.26	1.08	60-69	Stage 4
3529	TCGA-CV-7177	HNSC	82	FEMALE	WHITE	Stage II	Stage I	Head & Neck Squamous Cell Carcinoma	G2	1999	[Not Available]	-30180	Dead	WITH TUMOR	766	663	[Not Available]	NA	NA	364	[Not Available]	1	663	1	663	0	720	1	663	84.44	1.82	>=80	Stage 2
3530	TCGA-CV-7178	HNSC	64	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-23430	Dead	WITH TUMOR	766	2166	[Not Available]	NA	NA	364	[Not Available]	1	2166	1	2166	0	720	1	2166	70.08	5.93	60-69	Stage 4
3531	TCGA-CV-7180	HNSC	34	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1996	[Not Available]	-12523	Dead	WITH TUMOR	766	327	[Not Available]	NA	NA	364	[Not Available]	1	327	1	327	0	720	1	327	35.18	0.9	30-39	Stage 2
3532	TCGA-CV-7183	HNSC	53	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2002	[Not Available]	-19358	Alive	TUMOR FREE	3981	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3981	0	3981	0	3981	0	3981	63.9	10.9	50-59	Stage 2
3533	TCGA-CV-7235	HNSC	67	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2007	[Not Available]	-24800	Alive	TUMOR FREE	2347	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2347	0	2347	0	2347	0	2347	74.32	6.43	60-69	Stage 2
3534	TCGA-CV-7236	HNSC	77	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007	[Not Available]	-28250	Dead	TUMOR FREE	766	144	[Not Available]	NA	NA	364	[Not Available]	1	144	0	144	0	720	0	144	77.74	0.39	70-79	Stage 4
3535	TCGA-CV-7238	HNSC	69	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-25471	Alive	TUMOR FREE	2727	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2727	0	2727	0	2727	0	2727	77.2	7.47	60-69	Stage 2
3536	TCGA-CV-7242	HNSC	60	FEMALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-22136	Alive	TUMOR FREE	1095	548	[Not Available]	NA	NA	364	[Not Available]	0	1095	0	1095	0	720	0	1095	63.6	3	60-69	Stage 2
3537	TCGA-CV-7243	HNSC	50	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-18466	Alive	TUMOR FREE	954	548	[Not Available]	NA	NA	364	[Not Available]	0	954	0	954	0	720	0	954	53.17	2.61	50-59	Stage 3
3538	TCGA-CV-7245	HNSC	62	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-22646	Alive	TUMOR FREE	797	548	[Not Available]	NA	NA	364	[Not Available]	0	797	0	797	0	720	0	797	64.18	2.18	60-69	Stage 4
3539	TCGA-CV-7247	HNSC	55	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1995	[Not Available]	-20433	Dead	WITH TUMOR	766	577	[Not Available]	NA	NA	364	[Not Available]	1	577	1	577	0	720	1	577	57.52	1.58	50-59	Stage 3
3540	TCGA-CV-7248	HNSC	63	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2001	[Not Available]	-23082	Dead	TUMOR FREE	766	521	[Not Available]	NA	NA	364	[Not Available]	1	521	0	521	0	720	0	521	64.62	1.43	60-69	Stage 4
3541	TCGA-CV-7250	HNSC	64	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2000	[Not Available]	-23489	Dead	TUMOR FREE	766	2900	[Not Available]	Distant Metastasis	Distant Metastasis	111	Complete Remission/Response	1	2900	0	2900	0	720	1	111	72.25	7.94	60-69	Stage 4
3542	TCGA-CV-7252	HNSC	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1994	[Not Available]	-22934	Dead	WITH TUMOR	766	151	[Not Available]	NA	NA	364	Progressive Disease	1	151	1	151	0	720	1	151	63.2	0.41	60-69	Stage 4
3543	TCGA-CV-7253	HNSC	58	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1993	[Not Available]	-21473	Dead	WITH TUMOR	766	361	[Not Available]	NA	NA	364	Partial Remission/Response	1	361	1	361	0	720	1	361	59.78	0.99	50-59	Stage 4
3544	TCGA-CV-7254	HNSC	55	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	1996	[Not Available]	-20306	Dead	WITH TUMOR	766	1459	[Not Available]	NA	NA	364	[Not Available]	1	1459	1	1459	0	720	1	1459	59.59	3.99	50-59	Stage 2
3545	TCGA-CV-7255	HNSC	32	FEMALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1995	[Not Available]	-11931	Dead	WITH TUMOR	766	64	[Not Available]	NA	NA	364	Complete Remission/Response	1	64	1	64	0	720	1	64	32.84	0.18	30-39	Stage 4
3546	TCGA-CV-7261	HNSC	57	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-20992	Alive	TUMOR FREE	1512	548	[Not Available]	NA	NA	364	[Not Available]	0	1512	0	1512	0	720	0	1512	61.61	4.14	50-59	Stage 4
3547	TCGA-CV-7263	HNSC	64	MALE	BLACK OR AFRICAN AMERICAN	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	1997	[Not Available]	-23513	Dead	WITH TUMOR	766	560	[Not Available]	NA	NA	364	[Not Available]	1	560	1	560	0	720	1	560	65.91	1.53	60-69	Stage 2
3548	TCGA-CV-7406	HNSC	49	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	GX	1999	[Not Available]	-18250	Dead	TUMOR FREE	766	1748	[Not Available]	NA	NA	364	[Not Available]	1	1748	0	1748	0	720	0	1748	54.75	4.79	40-49	Stage 2
3549	TCGA-CV-7407	HNSC	67	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1992	[Not Available]	-24475	Dead	TUMOR FREE	766	1081	[Not Available]	NA	NA	364	[Not Available]	1	1081	0	1081	0	720	0	1081	69.97	2.96	60-69	Stage 2
3550	TCGA-CV-7409	HNSC	43	MALE	BLACK OR AFRICAN AMERICAN	Stage IVB	Stage IVB	Head & Neck Squamous Cell Carcinoma	G3	1994	[Not Available]	-15888	Dead	TUMOR FREE	766	543	[Not Available]	NA	NA	364	Complete Remission/Response	1	543	0	543	0	720	0	543	44.99	1.49	40-49	Stage 4
3551	TCGA-CV-7410	HNSC	61	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	GX	1993	[Not Available]	-22302	Dead	WITH TUMOR	766	6417	[Not Available]	NA	NA	364	[Not Available]	1	6417	1	6417	0	720	1	6417	78.63	17.57	60-69	Stage 3
3552	TCGA-CV-7411	HNSC	64	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	1994	[Not Available]	-23696	Dead	TUMOR FREE	766	2717	[Not Available]	NA	NA	364	[Not Available]	1	2717	0	2717	0	720	0	2717	72.31	7.44	60-69	Stage 4
3553	TCGA-CV-7413	HNSC	74	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1995	[Not Available]	-27231	Dead	TUMOR FREE	766	294	[Not Available]	NA	NA	364	Complete Remission/Response	1	294	0	294	0	294	0	294	75.36	0.8	70-79	Stage 2
3554	TCGA-CV-7414	HNSC	78	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1995	[Not Available]	-28603	Dead	TUMOR FREE	766	14	[Not Available]	NA	NA	364	Complete Remission/Response	1	14	0	14	0	720	0	14	78.35	0.04	70-79	Stage 4
3555	TCGA-CV-7415	HNSC	60	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1995	[Not Available]	-22062	Dead	WITH TUMOR	766	695	[Not Available]	NA	NA	364	[Not Available]	1	695	1	695	0	720	1	695	62.31	1.9	60-69	Stage 4
3556	TCGA-CV-7416	HNSC	29	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	1994	[Not Available]	-10936	Dead	TUMOR FREE	766	763	[Not Available]	NA	NA	364	[Not Available]	1	763	0	763	0	720	0	763	32.03	2.09	18-29	Stage 4
3557	TCGA-CV-7418	HNSC	62	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1996	[Not Available]	-22805	Dead	TUMOR FREE	766	789	[Not Available]	Locoregional Recurrence	Hypopharynx	494	Complete Remission/Response	1	789	0	789	0	720	1	494	64.6	2.16	60-69	Stage 4
3558	TCGA-CV-7421	HNSC	76	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1997	[Not Available]	-27961	Dead	TUMOR FREE	766	2	[Not Available]	NA	NA	364	[Not Available]	1	2	0	2	0	720	0	2	76.56	0.01	70-79	Stage 4
3559	TCGA-CV-7422	HNSC	60	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	1997	[Not Available]	-22098	Dead	WITH TUMOR	766	1037	[Not Available]	Locoregional Recurrence	Larynx	733	Complete Remission/Response	1	1037	1	1037	0	720	1	733	63.34	2.84	60-69	Stage 4
3560	TCGA-CV-7423	HNSC	65	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	1997	[Not Available]	-24071	Dead	TUMOR FREE	766	3059	[Not Available]	NA	NA	364	[Not Available]	1	3059	0	3059	0	720	0	3059	74.28	8.38	60-69	Stage 2
3561	TCGA-CV-7424	HNSC	67	MALE	ASIAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1997	[Not Available]	-24775	Dead	WITH TUMOR	766	453	[Not Available]	NA	NA	364	[Not Available]	1	453	1	453	0	720	1	453	69.07	1.24	60-69	Stage 4
3562	TCGA-CV-7425	HNSC	77	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2000	[Not Available]	-28368	Dead	WITH TUMOR	766	1718	[Not Available]	NA	NA	364	[Not Available]	1	1718	1	1718	0	720	1	1718	82.37	4.7	70-79	Stage 3
3563	TCGA-CV-7427	HNSC	73	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	1997	[Not Available]	-26975	Dead	TUMOR FREE	766	4760	[Not Available]	Locoregional Recurrence	Oral Cavity	3282	Complete Remission/Response	1	4760	0	4760	1	3282	1	3282	86.89	13.03	70-79	Stage 2
3564	TCGA-CV-7428	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1998	[Not Available]	-17429	Dead	WITH TUMOR	766	1671	[Not Available]	NA	NA	364	[Not Available]	1	1671	1	1671	0	720	1	1671	52.29	4.57	40-49	Stage 4
3565	TCGA-CV-7429	HNSC	55	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	1998	[Not Available]	-20188	Dead	WITH TUMOR	766	107	[Not Available]	NA	NA	364	Partial Remission/Response	1	107	1	107	0	720	1	107	55.56	0.29	50-59	Stage 4
3566	TCGA-CV-7430	HNSC	56	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1996	[Not Available]	-20763	Dead	WITH TUMOR	766	495	[Not Available]	NA	NA	364	[Not Available]	1	495	1	495	0	720	1	495	58.2	1.36	50-59	Stage 4
3567	TCGA-CV-7432	HNSC	79	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G1	1998	[Not Available]	-28875	Dead	WITH TUMOR	766	2570	[Not Available]	NA	NA	364	Complete Remission/Response	1	2570	1	2570	0	720	1	2570	86.09	7.04	70-79	Stage 2
3568	TCGA-CV-7433	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	1999	[Not Available]	-18004	Dead	WITH TUMOR	766	601	[Not Available]	Distant Metastasis	Distant Metastasis	445	Progressive Disease	1	601	1	601	0	720	1	445	50.94	1.65	40-49	Stage 4
3569	TCGA-CV-7434	HNSC	64	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	[Not Available]	-23465	Dead	TUMOR FREE	766	218	[Not Available]	NA	NA	364	Complete Remission/Response	1	218	0	218	0	720	0	218	64.84	0.6	60-69	Stage 4
3570	TCGA-CV-7435	HNSC	57	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1999	[Not Available]	-21049	Dead	TUMOR FREE	766	4680	[Not Available]	NA	NA	364	Complete Remission/Response	1	4680	0	4680	0	720	0	4680	70.44	12.81	50-59	Stage 4
3571	TCGA-CV-7437	HNSC	77	MALE	[Not Available]	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	GX	1996	[Not Available]	-28221	Dead	WITH TUMOR	766	506	[Not Available]	NA	NA	364	[Not Available]	1	506	1	506	0	720	1	506	78.65	1.39	70-79	Stage 2
3572	TCGA-CV-7438	HNSC	87	FEMALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-32021	Dead	WITH TUMOR	766	194	[Not Available]	NA	NA	364	[Not Available]	1	194	1	194	0	720	1	194	88.2	0.53	>=80	Stage 1
3573	TCGA-CV-7440	HNSC	38	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	GX	2000	[Not Available]	-13992	Dead	TUMOR FREE	766	675	[Not Available]	NA	NA	364	[Not Available]	1	675	0	675	0	720	0	675	40.16	1.85	30-39	Stage 2
3574	TCGA-CV-7446	HNSC	66	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1998	[Not Available]	-24170	Dead	WITH TUMOR	766	1093	[Not Available]	NA	NA	364	[Not Available]	1	1093	1	1093	0	720	1	1093	69.17	2.99	60-69	Stage 4
3575	TCGA-CV-7568	HNSC	48	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	1995	[Not Available]	-17670	Dead	TUMOR FREE	766	927	[Not Available]	NA	NA	364	[Not Available]	1	927	0	927	0	720	0	927	50.92	2.54	40-49	Stage 4
3576	TCGA-CV-A45O	HNSC	57	MALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1994	[Not Available]	-20868	Alive	TUMOR FREE	851	548	[Not Available]	NA	NA	364	[Not Applicable]	0	851	0	851	0	720	0	851	59.46	2.33	50-59	other
3577	TCGA-CV-A45P	HNSC	82	FEMALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G2	1998	[Not Available]	-30297	Alive	WITH TUMOR	639	548	[Not Available]	Locoregional Recurrence	Oral Cavity	639	Complete Remission/Response	0	639	0	639	1	639	1	639	84.7	1.75	>=80	Stage 1
3578	TCGA-CV-A45Q	HNSC	69	FEMALE	WHITE	[Not Available]	Stage IVC	Head & Neck Squamous Cell Carcinoma	G1	1995	[Not Available]	-25379	Dead	TUMOR FREE	766	5152	[Not Available]	NA	NA	364	Complete Remission/Response	1	5152	0	5152	0	720	0	5152	83.59	14.11	60-69	other
3579	TCGA-CV-A45R	HNSC	46	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	1997	[Not Available]	-17125	Alive	TUMOR FREE	5480	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	5480	0	5480	0	5480	0	5480	61.89	15	40-49	Stage 3
3580	TCGA-CV-A45T	HNSC	64	FEMALE	WHITE	[Discrepancy]	Stage II	Head & Neck Squamous Cell Carcinoma	G3	1998	[Not Available]	-23452	Dead	TUMOR FREE	766	4856	[Not Available]	NA	NA	364	[Not Available]	1	4856	0	4856	0	720	0	4856	77.5	13.3	60-69	Stage 2
3581	TCGA-CV-A45U	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	1999	[Not Available]	-21746	Dead	WITH TUMOR	766	1079	[Not Available]	NA	Distant Metastasis	1064	Complete Remission/Response	1	1079	1	1079	0	720	1	1064	62.49	2.95	50-59	Stage 4
3582	TCGA-CV-A45V	HNSC	87	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	1999	[Not Available]	-31936	Dead	TUMOR FREE	766	32	[Not Available]	NA	NA	364	[Not Available]	1	32	0	32	0	720	0	32	87.52	0.09	>=80	Stage 4
3583	TCGA-CV-A45W	HNSC	75	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	1999	[Not Available]	-27743	Dead	TUMOR FREE	766	1398	[Not Available]	NA	NA	364	[Not Available]	1	1398	0	1398	0	720	0	1398	79.78	3.83	70-79	Stage 2
3584	TCGA-CV-A45X	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2000	[Not Available]	-17464	Dead	TUMOR FREE	766	198	[Not Available]	NA	NA	364	Complete Remission/Response	1	198	0	198	0	720	0	198	48.36	0.54	40-49	Stage 4
3585	TCGA-CV-A45Y	HNSC	61	MALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-22442	Dead	TUMOR FREE	766	2703	[Not Available]	NA	NA	2318	Complete Remission/Response	1	2703	0	2703	0	720	1	2318	68.84	7.4	60-69	Stage 4
3586	TCGA-CV-A45Z	HNSC	75	MALE	WHITE	[Discrepancy]	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2000	[Not Available]	-27397	Dead	WITH TUMOR	766	1466	[Not Available]	NA	NA	364	[Not Available]	1	1466	1	1466	0	720	1	1466	79.02	4.01	70-79	Stage 2
3587	TCGA-CV-A460	HNSC	72	MALE	WHITE	[Discrepancy]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2001	[Not Available]	-26539	Dead	[Discrepancy]	766	1838	[Not Available]	New Primary Tumor	NA	1425	Complete Remission/Response	1	1838	0	1838	0	720	1	1425	77.69	5.03	70-79	other
3588	TCGA-CV-A461	HNSC	65	MALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2004	[Not Available]	-23955	Dead	TUMOR FREE	766	2064	[Not Available]	NA	NA	364	Complete Remission/Response	1	2064	0	2064	0	2064	0	2064	71.24	5.65	60-69	other
3589	TCGA-CV-A463	HNSC	82	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-30095	Dead	TUMOR FREE	766	23	[Not Available]	NA	NA	364	Complete Remission/Response	1	23	0	23	0	720	0	23	82.46	0.06	>=80	Stage 4
3590	TCGA-CV-A464	HNSC	48	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-17669	Alive	TUMOR FREE	1722	548	[Not Available]	Locoregional Disease	NA	28	Complete Remission/Response	0	1722	0	1722	0	720	1	28	53.09	4.71	40-49	Stage 3
3591	TCGA-CV-A465	HNSC	24	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2008	[Not Available]	-9015	Dead	TUMOR FREE	766	215	[Not Available]	NA	NA	364	Complete Remission/Response	1	215	0	215	0	215	0	215	25.27	0.59	18-29	Stage 3
3592	TCGA-CV-A468	HNSC	42	MALE	[Not Available]	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2001	[Not Available]	-15372	Dead	TUMOR FREE	766	464	[Not Available]	NA	NA	364	Complete Remission/Response	1	464	0	464	0	720	0	464	43.36	1.27	40-49	Stage 4
3593	TCGA-CV-A6JD	HNSC	82	FEMALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	[Not Available]	-29988	Dead	TUMOR FREE	766	182	[Not Available]	NA	NA	364	Complete Remission/Response	1	182	0	182	0	720	0	182	82.6	0.5	>=80	other
3594	TCGA-CV-A6JE	HNSC	78	MALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-28658	Alive	TUMOR FREE	1075	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1075	0	1075	0	1075	0	1075	81.4	2.94	70-79	Stage 2
3595	TCGA-CV-A6JM	HNSC	85	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-31147	Dead	TUMOR FREE	766	194	[Not Available]	Locoregional Recurrence	Oropharynx	107	Complete Remission/Response	1	194	0	194	0	720	1	107	85.81	0.53	>=80	other
3596	TCGA-CV-A6JN	HNSC	53	MALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-19635	Alive	TUMOR FREE	906	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	906	0	906	0	906	0	906	56.24	2.48	50-59	Stage 2
3597	TCGA-CV-A6JO	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-25377	Dead	WITH TUMOR	766	197	[Not Available]	NA	Oral Cavity	127	Progressive Disease	1	197	1	197	0	720	1	127	70.02	0.54	60-69	Stage 4
3598	TCGA-CV-A6JT	HNSC	65	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-23806	Alive	TUMOR FREE	852	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	852	0	852	0	852	0	852	67.51	2.33	60-69	Stage 2
3599	TCGA-CV-A6JU	HNSC	61	FEMALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-22591	Alive	TUMOR FREE	110	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	110	0	110	0	720	0	110	62.15	0.3	60-69	Stage 4
3600	TCGA-CV-A6JY	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-25321	Alive	TUMOR FREE	646	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	646	0	646	0	720	0	646	71.09	1.77	60-69	Stage 4
3601	TCGA-CV-A6JZ	HNSC	68	MALE	WHITE	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-25182	Alive	WITH TUMOR	714	548	[Not Available]	Locoregional Recurrence	Oral Cavity	393	Complete Remission/Response	0	714	0	714	0	720	1	393	70.9	1.95	60-69	Stage 2
3602	TCGA-CV-A6K0	HNSC	58	MALE	WHITE	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-21488	Alive	TUMOR FREE	606	548	[Not Available]	NA	Cervical Lymph Nodes	146	Complete Remission/Response	0	606	0	606	1	146	1	146	60.49	1.66	50-59	Stage 1
3603	TCGA-CV-A6K1	HNSC	65	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-23848	Alive	TUMOR FREE	685	548	[Not Available]	New Primary Tumor	Oral Cavity	401	Complete Remission/Response	0	685	0	685	0	720	1	401	67.17	1.88	60-69	Stage 4
3604	TCGA-CV-A6K2	HNSC	79	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-29114	Dead	WITH TUMOR	766	317	[Not Available]	Locoregional Recurrence	NA	134	Progressive Disease	1	317	1	317	0	720	1	134	80.58	0.87	70-79	Stage 4
3605	TCGA-CX-7082	HNSC	82	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-30174	Dead	TUMOR FREE	766	11	[Not Available]	NA	NA	364	Complete Remission/Response	1	11	0	11	0	720	0	11	82.64	0.03	>=80	Stage 4
3606	TCGA-CX-7085	HNSC	77	FEMALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-28221	Alive	WITH TUMOR	321	548	[Not Available]	Locoregional Recurrence	Oropharynx	92	Complete Remission/Response	0	321	0	321	1	92	1	92	78.14	0.88	70-79	Stage 1
3607	TCGA-CX-7086	HNSC	53	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-19434	Alive	TUMOR FREE	573	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	573	0	573	0	720	0	573	54.78	1.57	50-59	Stage 3
3608	TCGA-CX-7219	HNSC	47	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-17222	Alive	TUMOR FREE	1045	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1045	0	1045	0	720	0	1045	50.01	2.86	40-49	Stage 4
3609	TCGA-CX-A4AQ	HNSC	56	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-20709	Alive	TUMOR FREE	1555	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1555	0	1555	0	720	0	1555	60.96	4.26	50-59	Stage 4
3610	TCGA-D6-6515	HNSC	82	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-30099	Dead	TUMOR FREE	766	403	[Not Available]	NA	Cervical Lymph Nodes	195	Complete Remission/Response	1	403	0	403	1	195	1	195	83.51	1.1	>=80	Stage 2
3611	TCGA-D6-6516	HNSC	69	MALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-25242	Alive	TUMOR FREE	773	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	773	0	773	0	773	0	773	71.23	2.12	60-69	Stage 1
3612	TCGA-D6-6517	HNSC	59	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-21791	Alive	WITH TUMOR	292	548	[Not Available]	NA	Distant Metastasis	161	Progressive Disease	0	292	0	292	0	720	1	161	60.46	0.8	50-59	Stage 3
3613	TCGA-D6-6823	HNSC	50	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-18611	Alive	TUMOR FREE	701	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	701	0	701	0	701	0	701	52.87	1.92	50-59	Stage 2
3614	TCGA-D6-6824	HNSC	61	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-22633	Alive	TUMOR FREE	77	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	77	0	77	0	720	0	77	62.18	0.21	60-69	Stage 4
3615	TCGA-D6-6825	HNSC	73	MALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-26976	Alive	TUMOR FREE	491	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	491	0	491	0	491	0	491	75.2	1.34	70-79	Stage 1
3616	TCGA-D6-6826	HNSC	64	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-23722	Dead	TUMOR FREE	766	348	[Not Available]	NA	NA	364	Complete Remission/Response	1	348	0	348	0	720	0	348	65.9	0.95	60-69	Stage 4
3617	TCGA-D6-6827	HNSC	55	FEMALE	WHITE	Stage I	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-20175	Alive	TUMOR FREE	568	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	568	0	568	0	568	0	568	56.79	1.56	50-59	Stage 1
3618	TCGA-D6-8568	HNSC	62	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-22796	Alive	TUMOR FREE	759	548	[Not Available]	NA	NA	364	Stable Disease	0	759	0	759	0	720	0	759	64.49	2.08	60-69	Stage 2
3619	TCGA-D6-8569	HNSC	52	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-19212	Alive	TUMOR FREE	770	548	[Not Available]	NA	NA	364	Stable Disease	0	770	0	770	0	720	0	770	54.71	2.11	50-59	Stage 2
3620	TCGA-D6-A4Z9	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-21659	Alive	TUMOR FREE	539	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	539	0	539	0	720	0	539	60.77	1.48	50-59	Stage 4
3621	TCGA-D6-A4ZB	HNSC	61	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-22455	Alive	TUMOR FREE	376	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	376	0	376	0	376	0	376	62.51	1.03	60-69	Stage 3
3622	TCGA-D6-A6EK	HNSC	67	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-24558	Alive	TUMOR FREE	875	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	875	0	875	0	720	0	875	69.63	2.4	60-69	Stage 3
3623	TCGA-D6-A6EM	HNSC	65	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-23865	Alive	WITH TUMOR	232	548	[Not Available]	NA	Oral Cavity	232	Complete Remission/Response	0	232	0	232	1	232	1	232	65.97	0.64	60-69	Stage 3
3624	TCGA-D6-A6EN	HNSC	71	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-26294	Alive	TUMOR FREE	687	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	687	0	687	0	687	0	687	73.87	1.88	70-79	Stage 3
3625	TCGA-D6-A6EO	HNSC	44	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-16185	Alive	TUMOR FREE	759	548	[Not Available]	NA	NA	364	Stable Disease	0	759	0	759	0	720	0	759	46.39	2.08	40-49	Stage 4
3626	TCGA-D6-A6EP	HNSC	62	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-22674	Alive	TUMOR FREE	424	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	424	0	424	0	424	0	424	63.24	1.16	60-69	Stage 3
3627	TCGA-D6-A6EQ	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-20876	Alive	TUMOR FREE	368	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	368	0	368	0	720	0	368	58.16	1.01	50-59	Stage 4
3628	TCGA-D6-A6ES	HNSC	50	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-18408	Alive	TUMOR FREE	389	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	389	0	389	0	720	0	389	51.46	1.07	50-59	Stage 4
3629	TCGA-D6-A74Q	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-24702	Alive	TUMOR FREE	710	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	710	0	710	0	720	0	710	69.57	1.94	60-69	Stage 4
3630	TCGA-DQ-5624	HNSC	43	FEMALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-15867	Alive	TUMOR FREE	1778	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1778	0	1778	0	720	0	1778	48.31	4.87	40-49	other
3631	TCGA-DQ-5625	HNSC	52	FEMALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-19211	Dead	TUMOR FREE	766	1133	[Not Available]	NA	Oral Cavity	1058	Complete Remission/Response	1	1133	0	1133	1	1058	1	1058	55.7	3.1	50-59	Stage 2
3632	TCGA-DQ-5629	HNSC	64	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-23550	Dead	TUMOR FREE	766	941	[Not Available]	NA	NA	364	Complete Remission/Response	1	941	0	941	0	720	0	941	67.05	2.58	60-69	other
3633	TCGA-DQ-5630	HNSC	73	MALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-26855	Alive	TUMOR FREE	1030	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1030	0	1030	0	1030	0	1030	76.34	2.82	70-79	other
3634	TCGA-DQ-5631	HNSC	52	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2009	[Not Available]	-19172	Dead	WITH TUMOR	548	548	[Not Available]	NA	Distant Metastasis	447	Complete Remission/Response	1	548	1	548	0	720	1	447	53.99	1.5	50-59	other
3635	TCGA-DQ-7588	HNSC	66	MALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-24106	Dead	WITH TUMOR	766	427	[Not Available]	NA	Oral Cavity	79	Persistent Disease	1	427	1	427	0	720	1	79	67.17	1.17	60-69	other
3636	TCGA-DQ-7589	HNSC	70	MALE	WHITE	[Not Available]	Stage IVC	Head & Neck Squamous Cell Carcinoma	G4	2010	[Not Available]	-25606	Alive	TUMOR FREE	1409	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1409	0	1409	0	720	0	1409	73.96	3.86	70-79	other
3637	TCGA-DQ-7590	HNSC	51	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G4	2010	[Not Available]	-18718	Alive	TUMOR FREE	1413	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1413	0	1413	0	720	0	1413	55.12	3.87	50-59	other
3638	TCGA-DQ-7591	HNSC	62	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G4	2011	[Not Available]	-22798	Alive	TUMOR FREE	622	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	622	0	622	0	720	0	622	64.12	1.7	60-69	other
3639	TCGA-DQ-7592	HNSC	57	MALE	AMERICAN INDIAN OR ALASKA NATIVE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-21041	Alive	TUMOR FREE	1143	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1143	0	1143	0	720	0	1143	60.74	3.13	50-59	other
3640	TCGA-DQ-7593	HNSC	58	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G4	2011	[Not Available]	-21439	Alive	TUMOR FREE	1224	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1224	0	1224	0	720	0	1224	62.05	3.35	50-59	other
3641	TCGA-DQ-7594	HNSC	47	MALE	WHITE	[Not Available]	Stage IVB	Head & Neck Squamous Cell Carcinoma	G4	2011	[Not Available]	-17471	Alive	TUMOR FREE	1218	548	[Not Available]	New Primary Tumor	Oral Cavity	1084	Complete Remission/Response	0	1218	0	1218	0	720	1	1084	51.17	3.33	40-49	other
3642	TCGA-DQ-7595	HNSC	53	MALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-19530	Alive	TUMOR FREE	1190	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1190	0	1190	0	1190	0	1190	56.73	3.26	50-59	Stage 2
3643	TCGA-DQ-7596	HNSC	48	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G4	2011	[Not Available]	-17846	Alive	TUMOR FREE	1265	548	[Not Available]	NA	Cervical Lymph Nodes	137	Persistent Disease	0	1265	0	1265	0	720	1	137	52.32	3.46	40-49	other
3644	TCGA-F7-7848	HNSC	47	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-17251	Alive	TUMOR FREE	1131	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1131	0	1131	0	720	0	1131	50.33	3.1	40-49	Stage 4
3645	TCGA-F7-8298	HNSC	58	MALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-21445	Alive	TUMOR FREE	995	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	995	0	995	0	995	0	995	61.44	2.72	50-59	Stage 1
3646	TCGA-F7-8489	HNSC	48	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-17873	Alive	TUMOR FREE	658	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	658	0	658	0	658	0	658	50.74	1.8	40-49	Stage 2
3647	TCGA-F7-A50G	HNSC	66	MALE	WHITE	Stage III	[Not Available]	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-24285	Alive	TUMOR FREE	616	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	616	0	616	0	616	0	616	68.18	1.69	60-69	Stage 3
3648	TCGA-F7-A50I	HNSC	72	MALE	WHITE	Stage IVA	[Not Available]	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-26373	Alive	TUMOR FREE	92	548	[Not Available]	NA	NA	364	[Not Available]	0	92	0	92	0	720	0	92	72.46	0.25	70-79	Stage 4
3649	TCGA-F7-A50J	HNSC	67	FEMALE	WHITE	Stage III	[Not Available]	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-24758	Alive	TUMOR FREE	947	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	947	0	947	0	947	0	947	70.38	2.59	60-69	Stage 3
3650	TCGA-F7-A61S	HNSC	62	MALE	WHITE	Stage III	[Not Available]	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-22655	Alive	TUMOR FREE	576	548	[Not Available]	Locoregional Recurrence	Cervical Lymph Nodes	213	Complete Remission/Response	0	576	0	576	1	213	1	213	63.6	1.58	60-69	Stage 3
3651	TCGA-F7-A61V	HNSC	54	MALE	WHITE	Stage II	[Not Available]	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-19857	Alive	TUMOR FREE	759	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	759	0	759	0	759	0	759	56.44	2.08	50-59	Stage 2
3652	TCGA-F7-A61W	HNSC	51	MALE	ASIAN	Stage IVA	[Not Available]	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-18879	Alive	TUMOR FREE	14	548	[Not Available]	NA	NA	364	[Unknown]	0	14	0	14	0	720	0	14	51.73	0.04	50-59	Stage 4
3653	TCGA-F7-A620	HNSC	47	MALE	WHITE	Stage III	[Not Available]	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-17475	Alive	TUMOR FREE	543	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	543	0	543	0	543	0	543	49.33	1.49	40-49	Stage 3
3654	TCGA-F7-A622	HNSC	75	MALE	WHITE	Stage III	[Not Available]	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-27456	Dead	WITH TUMOR	766	359	[Not Available]	NA	NA	364	Complete Remission/Response	1	359	1	359	0	720	1	359	76.15	0.98	70-79	Stage 3
3655	TCGA-F7-A623	HNSC	70	MALE	WHITE	Stage IVA	[Not Available]	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-25592	Alive	TUMOR FREE	616	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	616	0	616	0	720	0	616	71.75	1.69	70-79	Stage 4
3656	TCGA-F7-A624	HNSC	73	MALE	WHITE	Stage II	[Not Available]	Head & Neck Squamous Cell Carcinoma	G3	2012	[Not Available]	-26667	Alive	TUMOR FREE	378	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	378	0	378	0	378	0	378	74.05	1.03	70-79	Stage 2
3657	TCGA-H7-7774	HNSC	75	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-27519	Alive	TUMOR FREE	407	548	[Not Available]	New Primary Tumor	Oral Cavity	252	Complete Remission/Response	0	407	0	407	0	720	1	252	76.46	1.11	70-79	Stage 4
3658	TCGA-H7-8501	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2012	[Not Available]	-19808	Alive	TUMOR FREE	461	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	461	0	461	0	720	0	461	55.49	1.26	50-59	Stage 4
3659	TCGA-H7-8502	HNSC	50	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-18286	Alive	TUMOR FREE	458	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	458	0	458	0	720	0	458	51.32	1.25	50-59	Stage 4
3660	TCGA-H7-A6C4	HNSC	35	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-13137	Alive	TUMOR FREE	414	548	[Not Available]	Locoregional Recurrence	Distant Metastasis	235	Complete Remission/Response	0	414	0	414	0	720	1	235	37.1	1.13	30-39	Stage 4
3661	TCGA-H7-A6C5	HNSC	65	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-23808	Alive	TUMOR FREE	642	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	642	0	642	0	642	0	642	66.94	1.76	60-69	Stage 2
3662	TCGA-H7-A76A	HNSC	57	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-20946	Alive	TUMOR FREE	637	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	637	0	637	0	720	0	637	59.09	1.74	50-59	other
3663	TCGA-HD-7229	HNSC	60	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-22076	Alive	WITH TUMOR	1027	548	[Not Available]	Locoregional Recurrence	Larynx	162	Progressive Disease	0	1027	0	1027	0	720	1	162	63.25	2.81	60-69	Stage 4
3664	TCGA-HD-7753	HNSC	62	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-22774	Alive	TUMOR FREE	866	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	866	0	866	0	866	0	866	64.72	2.37	60-69	Stage 1
3665	TCGA-HD-7754	HNSC	69	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-25365	Alive	TUMOR FREE	783	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	783	0	783	0	720	0	783	71.59	2.14	60-69	Stage 4
3666	TCGA-HD-7831	HNSC	74	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-27334	Alive	WITH TUMOR	667	548	[Not Available]	Distant Metastasis	Distant Metastasis	667	Complete Remission/Response	0	667	0	667	0	720	1	667	76.66	1.83	70-79	Stage 4
3667	TCGA-HD-7832	HNSC	52	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-19192	Alive	TUMOR FREE	836	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	836	0	836	0	720	0	836	54.83	2.29	50-59	Stage 4
3668	TCGA-HD-7917	HNSC	62	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-22979	Dead	TUMOR FREE	766	836	[Not Available]	NA	NA	364	Complete Remission/Response	1	836	0	836	0	836	0	836	65.2	2.29	60-69	Stage 2
3669	TCGA-HD-8224	HNSC	63	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-23069	Dead	WITH TUMOR	766	446	[Not Available]	Distant Metastasis	Distant Metastasis	171	Progressive Disease	1	446	1	446	0	720	1	171	64.38	1.22	60-69	Stage 4
3670	TCGA-HD-8314	HNSC	58	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma Basaloid Type	G4	2012	[Not Available]	-21517	Alive	TUMOR FREE	670	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	670	0	670	0	670	0	670	60.74	1.83	50-59	Stage 3
3671	TCGA-HD-8634	HNSC	51	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-18718	Dead	TUMOR FREE	766	385	[Not Available]	NA	NA	364	Complete Remission/Response	1	385	0	385	0	385	0	385	52.3	1.05	50-59	Stage 1
3672	TCGA-HD-8635	HNSC	61	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-22340	Alive	TUMOR FREE	695	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	695	0	695	0	695	0	695	63.07	1.9	60-69	Stage 3
3673	TCGA-HD-A4C1	HNSC	41	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-15096	Alive	TUMOR FREE	11	548	[Not Available]	NA	NA	364	[Not Applicable]	0	11	0	11	0	720	0	11	41.36	0.03	40-49	Stage 4
3674	TCGA-HD-A633	HNSC	74	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-27057	Alive	WITH TUMOR	421	548	[Not Available]	Locoregional Recurrence	Oral Cavity	419	Complete Remission/Response	0	421	0	421	0	720	1	419	75.23	1.15	70-79	Stage 4
3675	TCGA-HD-A634	HNSC	56	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-20810	Dead	WITH TUMOR	766	130	[Not Available]	NA	NA	364	[Unknown]	1	130	1	130	0	720	1	130	57.33	0.36	50-59	Stage 4
3676	TCGA-HD-A6HZ	HNSC	79	FEMALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-29045	Alive	TUMOR FREE	111	548	[Not Available]	NA	NA	364	[Unknown]	0	111	0	111	0	720	0	111	79.82	0.3	70-79	Stage 3
3677	TCGA-HD-A6I0	HNSC	56	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2013	[Not Available]	-20491	Alive	TUMOR FREE	210	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	210	0	210	0	720	0	210	56.68	0.57	50-59	Stage 4
3678	TCGA-HL-7533	HNSC	65	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-23950	Alive	TUMOR FREE	1057	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1057	0	1057	0	720	0	1057	68.47	2.89	60-69	other
3679	TCGA-IQ-7630	HNSC	49	MALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2011	[Not Available]	-18131	Alive	TUMOR FREE	485	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	485	0	485	0	485	0	485	50.97	1.33	40-49	Stage 2
3680	TCGA-IQ-7631	HNSC	60	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-22151	Alive	TUMOR FREE	1172	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1172	0	1172	0	1172	0	1172	63.85	3.21	60-69	Stage 2
3681	TCGA-IQ-7632	HNSC	68	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-24986	Alive	TUMOR FREE	441	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	441	0	441	0	720	0	441	69.62	1.21	60-69	Stage 4
3682	TCGA-IQ-A61E	HNSC	55	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-20417	Alive	TUMOR FREE	1147	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1147	0	1147	0	1147	0	1147	59.04	3.14	50-59	Stage 3
3683	TCGA-IQ-A61G	HNSC	57	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-21066	Alive	WITH TUMOR	360	548	[Not Available]	NA	Oral Cavity	249	Progressive Disease	0	360	0	360	0	720	1	249	58.66	0.99	50-59	Stage 4
3684	TCGA-IQ-A61H	HNSC	76	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-27990	Alive	TUMOR FREE	1138	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1138	0	1138	0	1138	0	1138	79.75	3.12	70-79	Stage 2
3685	TCGA-IQ-A61I	HNSC	63	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	[Not Available]	-23035	Dead	TUMOR FREE	766	2	[Not Available]	NA	NA	364	Complete Remission/Response	1	2	0	2	0	720	0	2	63.07	0.01	60-69	Stage 4
3686	TCGA-IQ-A61J	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-19913	Alive	TUMOR FREE	1021	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1021	0	1021	0	720	0	1021	57.31	2.8	50-59	Stage 4
3687	TCGA-IQ-A61K	HNSC	70	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-25697	Dead	TUMOR FREE	766	161	[Not Available]	NA	NA	364	[Not Applicable]	1	161	0	161	0	720	0	161	70.8	0.44	70-79	Stage 4
3688	TCGA-IQ-A61L	HNSC	72	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-26506	Alive	WITH TUMOR	416	548	[Not Available]	Locoregional Recurrence	Oral Cavity	156	Progressive Disease	0	416	0	416	0	720	1	156	73.71	1.14	70-79	Stage 2
3689	TCGA-IQ-A61O	HNSC	43	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma, Spindle Cell Variant	GX	2012	[Not Available]	-15920	Dead	TUMOR FREE	766	421	[Not Available]	NA	NA	364	Complete Remission/Response	1	421	0	421	0	720	0	421	44.74	1.15	40-49	Stage 4
3690	TCGA-IQ-A6SG	HNSC	61	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-22529	Alive	TUMOR FREE	579	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	579	0	579	0	579	0	579	63.27	1.59	60-69	Stage 3
3691	TCGA-IQ-A6SH	HNSC	55	MALE	BLACK OR AFRICAN AMERICAN	Stage III	Stage IVC	Head & Neck Squamous Cell Carcinoma	G1	2013	[Not Available]	-20109	Alive	TUMOR FREE	471	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	471	0	471	0	720	0	471	56.34	1.29	50-59	Stage 3
3692	TCGA-KU-A66S	HNSC	69	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma Basaloid Type	G2	2012	[Not Available]	-25454	Dead	WITH TUMOR	766	406	[Not Available]	Distant Metastasis	Distant Metastasis	389	Complete Remission/Response	1	406	1	406	1	389	1	389	70.8	1.11	60-69	Stage 3
3693	TCGA-KU-A66T	HNSC	53	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-19405	Alive	TUMOR FREE	552	548	[Not Available]	Locoregional Recurrence	Oral Cavity	552	Complete Remission/Response	0	552	0	552	0	720	1	552	54.64	1.51	50-59	Stage 4
3694	TCGA-KU-A6H7	HNSC	55	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-20314	Alive	TUMOR FREE	586	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	586	0	586	0	720	0	586	57.22	1.6	50-59	Stage 4
3695	TCGA-KU-A6H8	HNSC	41	MALE	WHITE	Stage IVA	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-15066	Dead	WITH TUMOR	766	327	[Not Available]	Locoregional Recurrence	Oral Cavity	110	Progressive Disease	1	327	1	327	0	720	1	110	42.14	0.9	40-49	Stage 4
3696	TCGA-MT-A51W	HNSC	52	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-19098	Alive	TUMOR FREE	437	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	437	0	437	0	437	0	437	53.48	1.2	50-59	Stage 1
3697	TCGA-MT-A51X	HNSC	30	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-10976	Alive	TUMOR FREE	242	548	[Not Available]	NA	NA	364	[Unknown]	0	242	0	242	0	720	0	242	30.71	0.66	30-39	Stage 4
3698	TCGA-MT-A67A	HNSC	85	FEMALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-31161	Alive	TUMOR FREE	914	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	914	0	914	0	914	0	914	87.82	2.5	>=80	Stage 1
3699	TCGA-MT-A67D	HNSC	55	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-20386	Alive	TUMOR FREE	56	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	56	0	56	0	56	0	56	55.97	0.15	50-59	Stage 2
3700	TCGA-MT-A67F	HNSC	60	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-22057	Alive	TUMOR FREE	384	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	384	0	384	0	720	0	384	61.44	1.05	60-69	Stage 4
3701	TCGA-MT-A67G	HNSC	53	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-19394	Alive	[Discrepancy]	190	548	[Not Available]	NA	NA	364	[Unknown]	0	190	0	190	0	720	0	190	53.62	0.52	50-59	Stage 4
3702	TCGA-MT-A7BN	HNSC	74	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-27162	Alive	WITH TUMOR	469	548	[Not Available]	Distant Metastasis	Distant Metastasis	179	Progressive Disease	0	469	0	469	0	720	1	179	75.65	1.28	70-79	Stage 4
3703	TCGA-MZ-A5BI	HNSC	53	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	[Not Available]	2008	[Not Available]	-19500	Dead	TUMOR FREE	766	217	[Not Available]	NA	NA	364	Complete Remission/Response	1	217	0	217	0	720	0	217	53.98	0.59	50-59	other
3704	TCGA-MZ-A6I9	HNSC	68	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-24939	Dead	WITH TUMOR	766	489	[Not Available]	Distant Metastasis	Distant Metastasis	246	[Not Applicable]	1	489	1	489	0	720	1	246	69.62	1.34	60-69	other
3705	TCGA-MZ-A7D7	HNSC	51	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	[Not Available]	2013	[Not Available]	-18974	Alive	WITH TUMOR	547	548	[Not Available]	Distant Metastasis	Distant Metastasis	339	Complete Remission/Response	0	547	0	547	0	720	1	339	53.45	1.5	50-59	Stage 4
3706	TCGA-P3-A5Q5	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2004	[Not Available]	-19728	Alive	TUMOR FREE	910	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	910	0	910	0	720	0	910	56.5	2.49	50-59	Stage 4
3707	TCGA-P3-A5Q6	HNSC	49	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G3	2005	[Not Available]	-17917	Dead	WITH TUMOR	766	480	[Not Available]	NA	Distant Metastasis	280	Complete Remission/Response	1	480	1	480	0	720	1	280	50.37	1.31	40-49	Stage 4
3708	TCGA-P3-A5QA	HNSC	41	MALE	[Unknown]	Stage I	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2008	[Not Available]	-15125	Alive	TUMOR FREE	2182	548	[Not Available]	Locoregional Disease	Oral Cavity	1601	Complete Remission/Response	0	2182	0	2182	1	1601	1	1601	47.38	5.97	40-49	Stage 1
3709	TCGA-P3-A5QE	HNSC	49	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma Basaloid Type	G2	2009	[Not Available]	-18002	Alive	TUMOR FREE	1559	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1559	0	1559	0	1559	0	1559	53.56	4.27	40-49	Stage 3
3710	TCGA-P3-A5QF	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-18035	Dead	WITH TUMOR	766	330	[Not Available]	NA	Distant Metastasis	140	[Unknown]	1	330	1	330	0	720	1	140	50.28	0.9	40-49	Stage 4
3711	TCGA-P3-A6SW	HNSC	50	MALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2005	[Not Available]	-18536	Alive	TUMOR FREE	1120	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1120	0	1120	0	720	0	1120	53.82	3.07	50-59	Stage 4
3712	TCGA-P3-A6SX	HNSC	67	MALE	WHITE	Stage III	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2005	[Not Available]	-24715	Dead	TUMOR FREE	766	1430	[Not Available]	NA	NA	364	Complete Remission/Response	1	1430	0	1430	0	720	0	1430	71.58	3.92	60-69	Stage 3
3713	TCGA-P3-A6T0	HNSC	47	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2007	[Not Available]	-17259	Alive	TUMOR FREE	578	548	[Not Available]	Locoregional Disease	Oral Cavity	365	Complete Remission/Response	0	578	0	578	0	720	1	365	48.84	1.58	40-49	Stage 4
3714	TCGA-P3-A6T2	HNSC	45	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-16588	Alive	TUMOR FREE	2298	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2298	0	2298	0	720	0	2298	51.71	6.29	40-49	Stage 4
3715	TCGA-P3-A6T3	HNSC	49	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-18143	Dead	WITH TUMOR	766	577	[Not Available]	Distant Metastasis	Distant Metastasis	242	Complete Remission/Response	1	577	1	577	0	720	1	242	51.25	1.58	40-49	Stage 4
3716	TCGA-P3-A6T4	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-20027	Dead	WITH TUMOR	766	62	[Not Available]	NA	NA	364	Progressive Disease	1	62	1	62	0	720	1	62	55	0.17	50-59	Stage 4
3717	TCGA-P3-A6T5	HNSC	79	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-28977	Dead	WITH TUMOR	766	882	[Not Available]	Locoregional Disease	Oral Cavity	335	Complete Remission/Response	1	882	1	882	0	720	1	335	81.75	2.41	70-79	Stage 4
3718	TCGA-P3-A6T6	HNSC	53	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2009	[Not Available]	-19694	Dead	WITH TUMOR	766	395	[Not Available]	Distant Metastasis	Distant Metastasis	273	Complete Remission/Response	1	395	1	395	0	720	1	273	55	1.08	50-59	Stage 4
3719	TCGA-P3-A6T7	HNSC	55	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-20301	Dead	TUMOR FREE	766	487	[Not Available]	NA	NA	364	Complete Remission/Response	1	487	0	487	0	720	0	487	56.91	1.33	50-59	Stage 4
3720	TCGA-P3-A6T8	HNSC	54	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2010	[Not Available]	-19754	Alive	TUMOR FREE	400	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	400	0	400	0	720	0	400	55.18	1.1	50-59	Stage 4
3721	TCGA-QK-A64Z	HNSC	79	FEMALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-29037	Dead	WITH TUMOR	766	641	[Not Available]	Locoregional Recurrence	Cervical Lymph Nodes	553	Progressive Disease	1	641	1	641	0	720	1	553	81.25	1.75	70-79	Stage 4
3722	TCGA-QK-A652	HNSC	60	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-22023	Alive	TUMOR FREE	645	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	645	0	645	0	645	0	645	62.06	1.77	60-69	Stage 3
3723	TCGA-QK-A6IF	HNSC	61	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013	[Not Available]	-22463	Alive	TUMOR FREE	704	548	[Not Available]	Distant Metastasis	Distant Metastasis	502	Complete Remission/Response	0	704	0	704	0	720	1	502	63.43	1.93	60-69	other
3724	TCGA-QK-A6IG	HNSC	69	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-25334	Dead	WITH TUMOR	766	222	[Not Available]	Locoregional Disease	Cervical Lymph Nodes	142	Progressive Disease	1	222	1	222	0	720	1	142	69.97	0.61	60-69	Stage 3
3725	TCGA-QK-A6IH	HNSC	65	FEMALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-23936	Alive	WITH TUMOR	653	548	[Not Available]	NA	Distant Metastasis	228	Progressive Disease	0	653	0	653	0	720	1	228	67.32	1.79	60-69	Stage 4
3726	TCGA-QK-A6II	HNSC	52	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-19113	Dead	WITH TUMOR	766	284	[Not Available]	Locoregional Recurrence	Cervical Lymph Nodes	176	Progressive Disease	1	284	1	284	0	720	1	176	53.11	0.78	50-59	Stage 4
3727	TCGA-QK-A6IJ	HNSC	71	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-25966	Alive	TUMOR FREE	387	548	[Not Available]	NA	NA	364	[Unknown]	0	387	0	387	0	720	0	387	72.15	1.06	70-79	Stage 3
3728	TCGA-QK-A6V9	HNSC	56	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-20461	Alive	TUMOR FREE	833	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	833	0	833	0	833	0	833	58.3	2.28	50-59	Stage 2
3729	TCGA-QK-A6VB	HNSC	66	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-24144	Alive	TUMOR FREE	641	548	[Not Available]	New Primary Tumor	NA	613	Complete Remission/Response	0	641	0	641	0	720	1	613	67.86	1.75	60-69	Stage 4
3730	TCGA-QK-A6VC	HNSC	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-22865	Alive	TUMOR FREE	600	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	600	0	600	0	720	0	600	64.24	1.64	60-69	Stage 4
3731	TCGA-QK-A8Z7	HNSC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	[Not Available]	2013	[Not Available]	-21711	Alive	TUMOR FREE	392	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	392	0	392	0	720	0	392	60.51	1.07	50-59	Stage 4
3732	TCGA-QK-A8Z8	HNSC	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVC	Stage IVC	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-22107	Dead	WITH TUMOR	766	171	[Not Available]	NA	NA	364	[Unknown]	1	171	1	171	0	720	1	171	60.99	0.47	60-69	Stage 4
3733	TCGA-QK-A8Z9	HNSC	56	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-20471	Dead	WITH TUMOR	766	449	[Not Available]	Distant Metastasis	Distant Metastasis	205	Complete Remission/Response	1	449	1	449	0	720	1	205	57.28	1.23	50-59	Stage 4
3734	TCGA-QK-A8ZA	HNSC	60	MALE	BLACK OR AFRICAN AMERICAN	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-21979	Dead	TUMOR FREE	766	371	[Not Available]	NA	NA	364	Complete Remission/Response	1	371	0	371	0	720	0	371	61.19	1.02	60-69	other
3735	TCGA-QK-A8ZB	HNSC	68	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-25192	Alive	TUMOR FREE	542	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	542	0	542	0	720	0	542	70.46	1.48	60-69	Stage 4
3736	TCGA-QK-AA3J	HNSC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2013	[Not Available]	-25469	Alive	TUMOR FREE	466	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	466	0	466	0	466	0	466	71.01	1.28	60-69	Stage 1
3737	TCGA-QK-AA3K	HNSC	60	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-22093	Alive	TUMOR FREE	253	548	[Not Available]	NA	NA	364	[Unknown]	0	253	0	253	0	720	0	253	61.18	0.69	60-69	Stage 4
3738	TCGA-RS-A6TO	HNSC	82	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-30104	Dead	WITH TUMOR	766	387	[Not Available]	Locoregional Recurrence	Oral Cavity	338	Complete Remission/Response	1	387	1	387	0	720	1	338	83.48	1.06	>=80	Stage 4
3739	TCGA-RS-A6TP	HNSC	58	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-21393	Alive	TUMOR FREE	516	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	516	0	516	0	516	0	516	59.98	1.41	50-59	Stage 2
3740	TCGA-T2-A6WX	HNSC	73	FEMALE	WHITE	[Not Available]	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2010	[Not Available]	-27005	Dead	WITH TUMOR	766	209	[Not Available]	NA	NA	364	Progressive Disease	1	209	1	209	0	720	1	209	74.51	0.57	70-79	other
3741	TCGA-T2-A6WZ	HNSC	53	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-19397	Dead	WITH TUMOR	766	484	[Not Available]	Distant Metastasis	Distant Metastasis	229	Stable Disease	1	484	1	484	0	720	1	229	54.43	1.33	50-59	other
3742	TCGA-T2-A6X0	HNSC	49	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-18114	Alive	TUMOR FREE	216	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	216	0	216	0	720	0	216	50.18	0.59	40-49	other
3743	TCGA-T2-A6X2	HNSC	82	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2011	[Not Available]	-30013	Alive	TUMOR FREE	987	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	987	0	987	0	987	0	987	84.87	2.7	>=80	Stage 3
3744	TCGA-T3-A92M	HNSC	52	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-19247	Alive	WITH TUMOR	417	548	[Not Available]	Distant Metastasis	Distant Metastasis	417	[Unknown]	0	417	0	417	0	720	1	417	53.84	1.14	50-59	Stage 4
3745	TCGA-T3-A92N	HNSC	79	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVC	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-28879	Dead	WITH TUMOR	766	95	[Not Available]	Distant Metastasis	Distant Metastasis	46	Progressive Disease	1	95	1	95	0	720	1	46	79.33	0.26	70-79	Stage 4
3746	TCGA-TN-A7HI	HNSC	56	MALE	WHITE	Stage IVA	Stage I	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-20666	Alive	TUMOR FREE	412	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	412	0	412	0	720	0	412	57.71	1.13	50-59	Stage 4
3747	TCGA-TN-A7HJ	HNSC	51	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-18809	Alive	TUMOR FREE	403	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	403	0	403	0	720	0	403	52.6	1.1	50-59	Stage 4
3748	TCGA-TN-A7HL	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-21731	Alive	TUMOR FREE	619	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	619	0	619	0	720	0	619	61.19	1.69	50-59	Stage 4
3749	TCGA-UF-A718	HNSC	62	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-22836	Alive	TUMOR FREE	1971	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1971	0	1971	0	720	0	1971	67.92	5.4	60-69	Stage 4
3750	TCGA-UF-A719	HNSC	54	MALE	[Unknown]	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2009	[Not Available]	-19797	Alive	TUMOR FREE	1663	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1663	0	1663	0	1663	0	1663	58.75	4.55	50-59	Stage 2
3751	TCGA-UF-A71A	HNSC	67	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2009	[Not Available]	-24623	Dead	WITH TUMOR	766	86	[Not Available]	NA	NA	364	Complete Remission/Response	1	86	1	86	0	720	1	86	67.65	0.24	60-69	Stage 4
3752	TCGA-UF-A71B	HNSC	50	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-18404	Alive	TUMOR FREE	1506	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1506	0	1506	0	720	0	1506	54.51	4.12	50-59	Stage 4
3753	TCGA-UF-A71D	HNSC	54	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-19747	Alive	TUMOR FREE	1461	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1461	0	1461	0	720	0	1461	58.06	4	50-59	Stage 4
3754	TCGA-UF-A71E	HNSC	63	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2010	[Not Available]	-23071	Dead	TUMOR FREE	766	1504	[Not Available]	NA	NA	364	Complete Remission/Response	1	1504	0	1504	0	720	0	1504	67.28	4.12	60-69	Stage 4
3755	TCGA-UF-A7J9	HNSC	75	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-27459	Alive	TUMOR FREE	1358	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1358	0	1358	0	720	0	1358	78.9	3.72	70-79	Stage 4
3756	TCGA-UF-A7JA	HNSC	66	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2008	[Not Available]	-24121	Alive	TUMOR FREE	2265	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2265	0	2265	0	720	0	2265	72.24	6.2	60-69	Stage 4
3757	TCGA-UF-A7JC	HNSC	42	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-15452	Dead	WITH TUMOR	766	546	[Not Available]	NA	Oral Cavity	229	Complete Remission/Response	1	546	1	546	0	720	1	229	43.8	1.49	40-49	Stage 4
3758	TCGA-UF-A7JD	HNSC	71	MALE	[Unknown]	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2012	[Not Available]	-26101	Dead	TUMOR FREE	766	739	[Not Available]	NA	NA	364	Complete Remission/Response	1	739	0	739	0	720	0	739	73.48	2.02	70-79	Stage 4
3759	TCGA-UF-A7JF	HNSC	80	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-29468	Alive	TUMOR FREE	1686	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1686	0	1686	0	720	0	1686	85.3	4.62	>=80	Stage 4
3760	TCGA-UF-A7JH	HNSC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2012	[Not Available]	-21558	Alive	TUMOR FREE	896	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	896	0	896	0	720	0	896	61.48	2.45	50-59	Stage 4
3761	TCGA-UF-A7JJ	HNSC	68	MALE	[Unknown]	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2013	[Not Available]	-25201	Alive	TUMOR FREE	549	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	549	0	549	0	720	0	549	70.5	1.5	60-69	Stage 4
3762	TCGA-UF-A7JK	HNSC	59	MALE	[Unknown]	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010	[Not Available]	-21696	Dead	WITH TUMOR	766	424	[Not Available]	NA	Larynx	341	Complete Remission/Response	1	424	1	424	0	720	1	341	60.56	1.16	50-59	Stage 4
3763	TCGA-UF-A7JO	HNSC	79	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2009	[Not Available]	-28951	Dead	WITH TUMOR	766	631	[Not Available]	Locoregional Disease	Oral Cavity	525	Complete Remission/Response	1	631	1	631	0	720	1	525	80.99	1.73	70-79	Stage 4
3764	TCGA-UF-A7JS	HNSC	59	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-21676	Dead	WITH TUMOR	766	680	[Not Available]	Locoregional Recurrence	Cervical Lymph Nodes	519	Complete Remission/Response	1	680	1	680	0	720	1	519	61.21	1.86	50-59	Stage 4
3765	TCGA-UF-A7JT	HNSC	72	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2009	[Not Available]	-26375	Dead	WITH TUMOR	766	993	[Not Available]	NA	NA	718	Complete Remission/Response	1	993	1	993	0	720	1	718	74.93	2.72	70-79	Stage 4
3766	TCGA-UF-A7JV	HNSC	62	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011	[Not Available]	-22985	Dead	WITH TUMOR	766	90	[Not Available]	NA	Oropharynx	55	Complete Remission/Response	1	90	1	90	0	720	1	55	63.18	0.25	60-69	Stage 4
3767	TCGA-UP-A6WW	HNSC	58	MALE	WHITE	[Not Available]	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013	[Not Available]	-21427	Alive	TUMOR FREE	518	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	518	0	518	0	720	0	518	60.08	1.42	50-59	other
3768	TCGA-WA-A7GZ	HNSC	58	MALE	WHITE	[Not Available]	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012	[Not Available]	-21207	Dead	TUMOR FREE	766	625	[Not Available]	NA	NA	364	Complete Remission/Response	1	625	0	625	0	625	0	625	59.77	1.71	50-59	Stage 2
3769	TCGA-WA-A7H4	HNSC	69	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2013	[Not Available]	-25363	Alive	TUMOR FREE	443	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	443	0	443	0	443	0	443	70.65	1.21	60-69	Stage 2
3883	TCGA-3Z-A93Z	KIRC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2013	[Not Available]	-25205	Alive	TUMOR FREE	385	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	385	0	385	0	385	0	385	70.06	1.05	60-69	Stage 1
3884	TCGA-6D-AA2E	KIRC	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2013	[Not Available]	-25043	Alive	TUMOR FREE	362	548	[Not Available]	NA	NA	364	[Unknown]	0	362	0	362	0	720	0	362	69.56	0.99	60-69	Stage 1
3885	TCGA-A3-3306	KIRC	67	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-24569	Alive	TUMOR FREE	1120	548	[Not Available]	NA	NA	364	[Not Available]	0	1120	0	1120	0	720	0	1120	70.33	3.07	60-69	Stage 1
3886	TCGA-A3-3307	KIRC	66	MALE	[Not Available]	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-24315	Alive	WITH TUMOR	1436	548	[Not Available]	NA	NA	364	[Not Available]	0	1436	0	1436	0	720	0	1436	70.5	3.93	60-69	Stage 3
3887	TCGA-A3-3308	KIRC	77	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-28287	Alive	TUMOR FREE	16	548	[Not Available]	NA	NA	364	[Not Available]	0	16	0	16	0	720	0	16	77.49	0.04	70-79	Stage 3
3888	TCGA-A3-3311	KIRC	57	MALE	[Not Available]	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-21183	Dead	TUMOR FREE	766	1191	[Not Available]	NA	NA	364	[Not Available]	1	1191	0	1191	0	720	0	1191	61.26	3.26	50-59	Stage 1
3889	TCGA-A3-3313	KIRC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-21556	Dead	TUMOR FREE	735	735	[Not Available]	NA	NA	364	[Not Available]	1	735	0	735	0	720	0	735	61.03	2.01	50-59	Stage 1
3890	TCGA-A3-3316	KIRC	57	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-20931	Alive	TUMOR FREE	1493	548	[Not Available]	NA	NA	364	[Not Available]	0	1493	0	1493	0	720	0	1493	61.39	4.09	50-59	Stage 2
3891	TCGA-A3-3317	KIRC	67	MALE	[Not Available]	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-24803	Alive	TUMOR FREE	1491	548	[Not Available]	NA	NA	560	[Not Available]	0	1491	0	1491	0	720	1	560	71.99	4.08	60-69	Stage 2
3892	TCGA-A3-3319	KIRC	70	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-25699	Alive	TUMOR FREE	1130	548	[Not Available]	NA	NA	364	[Not Available]	0	1130	0	1130	0	720	0	1130	73.45	3.09	70-79	Stage 1
3893	TCGA-A3-3320	KIRC	52	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2005	[Not Available]	-19138	Alive	TUMOR FREE	1508	548	[Not Available]	NA	NA	364	[Not Available]	0	1508	0	1508	0	720	0	1508	56.53	4.13	50-59	Stage 1
3894	TCGA-A3-3322	KIRC	51	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-18754	Alive	TUMOR FREE	1478	548	[Not Available]	NA	NA	364	[Not Available]	0	1478	0	1478	0	720	0	1478	55.39	4.05	50-59	Stage 1
3895	TCGA-A3-3323	KIRC	53	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2006	[Not Available]	-19456	Alive	TUMOR FREE	1106	548	[Not Available]	NA	NA	364	[Not Available]	0	1106	0	1106	0	720	0	1106	56.3	3.03	50-59	Stage 1
3896	TCGA-A3-3324	KIRC	51	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-18843	Alive	TUMOR FREE	1186	548	[Not Available]	NA	NA	364	[Not Available]	0	1186	0	1186	0	720	0	1186	54.84	3.25	50-59	Stage 1
3897	TCGA-A3-3325	KIRC	52	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-19126	Dead	TUMOR FREE	766	1170	[Not Available]	NA	NA	364	Partial Remission/Response	1	1170	0	1170	0	720	0	1170	55.57	3.2	50-59	Stage 1
3898	TCGA-A3-3326	KIRC	47	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2006	[Not Available]	-17285	Alive	TUMOR FREE	1137	548	[Not Available]	NA	NA	364	[Not Available]	0	1137	0	1137	0	720	0	1137	50.44	3.11	40-49	Stage 1
3899	TCGA-A3-3328	KIRC	79	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-29168	Alive	TUMOR FREE	1385	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1385	0	1385	0	1385	0	1385	83.65	3.79	70-79	Stage 1
3900	TCGA-A3-3329	KIRC	75	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-27650	Alive	TUMOR FREE	1624	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1624	0	1624	0	1624	0	1624	80.15	4.45	70-79	Stage 1
3901	TCGA-A3-3331	KIRC	86	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-31615	Alive	TUMOR FREE	1485	548	[Not Available]	NA	NA	364	[Not Available]	0	1485	0	1485	0	720	0	1485	90.62	4.07	>=80	Stage 1
3902	TCGA-A3-3335	KIRC	41	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-15250	Alive	TUMOR FREE	1886	548	[Not Available]	NA	NA	1098	Complete Remission/Response	0	1886	0	1886	1	1098	1	1098	46.92	5.16	40-49	Stage 2
3903	TCGA-A3-3336	KIRC	75	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-27538	Alive	WITH TUMOR	1043	548	[Not Available]	NA	NA	364	[Not Available]	0	1043	0	1043	0	720	0	1043	78.25	2.86	70-79	Stage 1
3904	TCGA-A3-3343	KIRC	79	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-28930	Alive	TUMOR FREE	945	548	[Not Available]	NA	NA	364	[Not Available]	0	945	0	945	0	720	0	945	81.79	2.59	70-79	Stage 2
3905	TCGA-A3-3346	KIRC	68	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-25118	Dead	WITH TUMOR	766	137	[Not Available]	NA	NA	114	Progressive Disease	1	137	1	137	0	720	1	114	69.14	0.38	60-69	Stage 1
3906	TCGA-A3-3347	KIRC	76	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-27966	Dead	WITH TUMOR	766	1610	[Not Available]	NA	NA	610	[Not Available]	1	1610	1	1610	0	720	1	610	80.97	4.41	70-79	Stage 3
3907	TCGA-A3-3349	KIRC	34	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-12431	Alive	TUMOR FREE	1385	548	[Not Available]	NA	NA	364	[Not Available]	0	1385	0	1385	0	720	0	1385	37.83	3.79	30-39	Stage 1
3908	TCGA-A3-3351	KIRC	42	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-15562	Alive	TUMOR FREE	910	548	[Not Available]	NA	NA	364	[Not Available]	0	910	0	910	0	720	0	910	45.1	2.49	40-49	Stage 2
3909	TCGA-A3-3352	KIRC	74	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-22222	Dead	TUMOR FREE	766	561	[Not Available]	NA	NA	364	Complete Remission/Response	1	561	0	561	0	561	0	561	62.38	1.54	70-79	Stage 3
3910	TCGA-A3-3357	KIRC	62	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-22825	Alive	TUMOR FREE	2688	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2688	0	2688	0	2688	0	2688	69.85	7.36	60-69	Stage 2
3911	TCGA-A3-3358	KIRC	57	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-21087	Alive	TUMOR FREE	1307	548	[Not Available]	NA	NA	364	[Not Available]	0	1307	0	1307	0	720	0	1307	61.31	3.58	50-59	Stage 1
3912	TCGA-A3-3359	KIRC	82	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-30269	Alive	TUMOR FREE	2504	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2504	0	2504	0	2504	0	2504	89.73	6.86	>=80	Stage 1
3913	TCGA-A3-3362	KIRC	60	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-21988	Alive	TUMOR FREE	1559	548	[Not Available]	NA	NA	364	[Not Available]	0	1559	0	1559	0	720	0	1559	64.47	4.27	60-69	Stage 1
3914	TCGA-A3-3363	KIRC	50	MALE	ASIAN	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-18596	Alive	TUMOR FREE	319	548	[Not Available]	NA	NA	364	[Not Available]	0	319	0	319	0	720	0	319	51.79	0.87	50-59	Stage 2
3915	TCGA-A3-3365	KIRC	46	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-16915	Alive	TUMOR FREE	873	548	[Not Available]	NA	NA	364	[Not Available]	0	873	0	873	0	720	0	873	48.7	2.39	40-49	Stage 1
3916	TCGA-A3-3367	KIRC	72	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-26489	Alive	TUMOR FREE	2270	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2270	0	2270	0	2270	0	2270	78.74	6.21	70-79	Stage 1
3917	TCGA-A3-3370	KIRC	48	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-17621	Alive	TUMOR FREE	2274	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2274	0	2274	0	2274	0	2274	54.47	6.23	40-49	Stage 1
3918	TCGA-A3-3372	KIRC	64	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-23528	Alive	TUMOR FREE	735	548	[Not Available]	NA	NA	364	[Not Available]	0	735	0	735	0	720	0	735	66.43	2.01	60-69	Stage 3
3919	TCGA-A3-3373	KIRC	54	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-19964	Alive	TUMOR FREE	1621	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1621	0	1621	0	1621	0	1621	59.1	4.44	50-59	Stage 1
3920	TCGA-A3-3374	KIRC	51	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-18890	Alive	TUMOR FREE	1314	548	[Not Available]	NA	NA	364	[Not Available]	0	1314	0	1314	0	720	0	1314	55.32	3.6	50-59	Stage 1
3921	TCGA-A3-3376	KIRC	51	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-18954	Dead	TUMOR FREE	766	1696	[Not Available]	NA	NA	364	Complete Remission/Response	1	1696	0	1696	0	1696	0	1696	56.54	4.64	50-59	Stage 1
3922	TCGA-A3-3378	KIRC	60	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-22090	Alive	TUMOR FREE	630	548	[Not Available]	NA	NA	364	[Not Available]	0	630	0	630	0	720	0	630	62.2	1.72	60-69	Stage 1
3923	TCGA-A3-3380	KIRC	54	MALE	[Not Available]	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-19828	Alive	TUMOR FREE	567	548	[Not Available]	NA	NA	364	[Not Available]	0	567	0	567	0	720	0	567	55.84	1.55	50-59	Stage 1
3924	TCGA-A3-3382	KIRC	69	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-25207	Alive	WITH TUMOR	574	548	[Not Available]	NA	NA	514	[Not Available]	0	574	0	574	0	720	1	514	70.58	1.57	60-69	Stage 1
3925	TCGA-A3-3383	KIRC	52	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-19324	Alive	TUMOR FREE	861	548	[Not Available]	NA	NA	364	[Not Available]	0	861	0	861	0	720	0	861	55.26	2.36	50-59	Stage 1
3926	TCGA-A3-3385	KIRC	46	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-17114	Alive	TUMOR FREE	1993	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1993	0	1993	0	1993	0	1993	52.31	5.46	40-49	Stage 1
3927	TCGA-A3-3387	KIRC	49	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-17920	Alive	TUMOR FREE	617	548	[Not Available]	NA	NA	364	[Not Available]	0	617	0	617	0	720	0	617	50.75	1.69	40-49	Stage 1
3928	TCGA-A3-A6NI	KIRC	47	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2011	[Not Available]	-17190	Alive	TUMOR FREE	1018	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1018	0	1018	0	1018	0	1018	49.85	2.79	40-49	Stage 1
3929	TCGA-A3-A6NJ	KIRC	57	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2012	[Not Available]	-20918	Alive	TUMOR FREE	468	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	468	0	468	0	468	0	468	58.55	1.28	50-59	Stage 1
3930	TCGA-A3-A6NL	KIRC	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2012	[Not Available]	-17952	Alive	TUMOR FREE	689	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	689	0	689	0	689	0	689	51.04	1.89	40-49	Stage 1
3931	TCGA-A3-A6NN	KIRC	78	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2012	[Not Available]	-28689	Alive	TUMOR FREE	3	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3	0	3	0	3	0	3	78.55	0.01	70-79	Stage 1
3932	TCGA-A3-A8CQ	KIRC	59	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2011	[Not Available]	-21572	Alive	TUMOR FREE	3	548	[Not Available]	NA	NA	364	[Unknown]	0	3	0	3	0	720	0	3	59.07	0.01	50-59	Stage 1
3933	TCGA-A3-A8OU	KIRC	74	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2011	[Not Available]	-27377	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	0	0	0	0	0	0	0	74.95	0	70-79	Stage 1
3934	TCGA-A3-A8OV	KIRC	75	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2011	[Not Available]	-27526	Alive	TUMOR FREE	340	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	340	0	340	0	340	0	340	76.29	0.93	70-79	Stage 1
3935	TCGA-A3-A8OW	KIRC	37	MALE	BLACK OR AFRICAN AMERICAN	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2011	[Not Available]	-13546	Alive	TUMOR FREE	323	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	323	0	323	0	323	0	323	37.97	0.88	30-39	Stage 3
3936	TCGA-A3-A8OX	KIRC	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2012	[Not Available]	-23998	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	0	0	0	0	0	0	0	65.7	0	60-69	Stage 1
3937	TCGA-AK-3425	KIRC	68	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2000	[Not Available]	-24912	Alive	TUMOR FREE	3343	548	[Not Available]	NA	NA	364	[Not Available]	0	3343	0	3343	0	720	0	3343	77.36	9.15	60-69	Stage 1
3938	TCGA-AK-3426	KIRC	37	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-13770	Dead	WITH TUMOR	766	885	[Not Available]	NA	NA	256	[Not Available]	1	885	1	885	0	720	1	256	40.12	2.42	30-39	Stage 3
3939	TCGA-AK-3427	KIRC	65	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	GX	2004	[Not Available]	-24067	Alive	TUMOR FREE	3583	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3583	0	3583	0	3583	0	3583	75.7	9.81	60-69	Stage 1
3940	TCGA-AK-3428	KIRC	62	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-22653	Alive	TUMOR FREE	3728	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3728	0	3728	0	3728	0	3728	72.23	10.21	60-69	Stage 3
3941	TCGA-AK-3429	KIRC	54	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-19849	Alive	TUMOR FREE	3328	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3328	0	3328	0	3328	0	3328	63.46	9.11	50-59	Stage 2
3942	TCGA-AK-3430	KIRC	61	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-22612	Dead	TUMOR FREE	766	480	[Not Available]	NA	NA	364	[Not Available]	1	480	0	480	0	720	0	480	63.22	1.31	60-69	Stage 3
3943	TCGA-AK-3431	KIRC	62	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-22852	Dead	TUMOR FREE	766	2241	[Not Available]	NA	NA	364	Complete Remission/Response	1	2241	0	2241	0	2241	0	2241	68.7	6.14	60-69	Stage 2
3944	TCGA-AK-3433	KIRC	48	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	GX	2004	[Not Available]	-17853	Alive	TUMOR FREE	3409	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3409	0	3409	0	3409	0	3409	58.21	9.33	40-49	Stage 2
3945	TCGA-AK-3434	KIRC	72	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-26490	Alive	WITH TUMOR	2087	548	[Not Available]	NA	NA	1640	[Not Available]	0	2087	0	2087	0	720	1	1640	78.24	5.71	70-79	Stage 1
3946	TCGA-AK-3436	KIRC	40	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-14842	Alive	TUMOR FREE	3331	548	[Not Available]	NA	NA	1189	Progressive Disease	0	3331	0	3331	0	720	1	1189	49.75	9.12	40-49	Stage 4
3947	TCGA-AK-3440	KIRC	58	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-21337	Alive	TUMOR FREE	2865	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2865	0	2865	0	2865	0	2865	66.26	7.84	50-59	Stage 1
3948	TCGA-AK-3443	KIRC	45	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	GX	2006	[Not Available]	-16578	Alive	TUMOR FREE	1423	548	[Not Available]	NA	NA	364	[Not Available]	0	1423	0	1423	0	720	0	1423	49.28	3.9	40-49	Stage 2
3949	TCGA-AK-3444	KIRC	80	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-29497	Alive	TUMOR FREE	1471	548	[Not Available]	NA	NA	364	[Not Available]	0	1471	0	1471	0	720	0	1471	84.79	4.03	>=80	Stage 1
3950	TCGA-AK-3445	KIRC	69	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-25494	Alive	TUMOR FREE	2392	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2392	0	2392	0	2392	0	2392	76.35	6.55	60-69	Stage 3
3951	TCGA-AK-3447	KIRC	83	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-30676	Alive	TUMOR FREE	1217	548	[Not Available]	NA	NA	364	[Not Available]	0	1217	0	1217	0	720	0	1217	87.32	3.33	>=80	Stage 2
3952	TCGA-AK-3450	KIRC	85	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-31364	Alive	TUMOR FREE	1779	548	[Not Available]	NA	NA	364	[Not Available]	0	1779	0	1779	0	720	0	1779	90.74	4.87	>=80	Stage 1
3953	TCGA-AK-3451	KIRC	48	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-17859	Alive	TUMOR FREE	2868	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2868	0	2868	0	2868	0	2868	56.75	7.85	40-49	Stage 2
3954	TCGA-AK-3453	KIRC	58	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-21271	Alive	TUMOR FREE	2531	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2531	0	2531	0	2531	0	2531	65.17	6.93	50-59	Stage 2
3955	TCGA-AK-3454	KIRC	84	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-30862	Alive	TUMOR FREE	874	548	[Not Available]	NA	NA	364	[Not Available]	0	874	0	874	0	720	0	874	86.89	2.39	>=80	Stage 1
3956	TCGA-AK-3455	KIRC	71	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-26221	Dead	TUMOR FREE	766	683	[Not Available]	NA	NA	364	[Not Available]	1	683	0	683	0	720	0	683	73.66	1.87	70-79	Stage 3
3957	TCGA-AK-3456	KIRC	48	MALE	BLACK OR AFRICAN AMERICAN	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-17821	Alive	TUMOR FREE	1143	548	[Not Available]	NA	NA	364	[Not Available]	0	1143	0	1143	0	720	0	1143	51.92	3.13	40-49	Stage 2
3958	TCGA-AK-3458	KIRC	48	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-17557	Alive	TUMOR FREE	1168	548	[Not Available]	NA	NA	364	[Not Available]	0	1168	0	1168	0	720	0	1168	51.27	3.2	40-49	Stage 1
3959	TCGA-AK-3460	KIRC	58	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-21281	Alive	TUMOR FREE	2508	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2508	0	2508	0	2508	0	2508	65.13	6.87	50-59	Stage 1
3960	TCGA-AK-3461	KIRC	72	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-26464	Alive	TUMOR FREE	2217	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2217	0	2217	0	2217	0	2217	78.52	6.07	70-79	Stage 1
3961	TCGA-AK-3465	KIRC	71	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	GX	2008	[Not Available]	-26232	Alive	TUMOR FREE	369	548	[Not Available]	NA	NA	364	[Not Available]	0	369	0	369	0	720	0	369	72.83	1.01	70-79	Stage 1
3962	TCGA-AS-3777	KIRC	63	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	[Not Available]	2009	[Not Available]	-23039	Alive	TUMOR FREE	1238	548	[Not Available]	NA	NA	364	[Unknown]	0	1238	0	1238	0	720	0	1238	66.47	3.39	60-69	Stage 1
3963	TCGA-AS-3778	KIRC	35	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2010	[Not Available]	-12937	Alive	TUMOR FREE	43	548	[Not Available]	NA	NA	364	[Unknown]	0	43	0	43	0	720	0	43	35.54	0.12	30-39	Stage 1
3964	TCGA-B0-4688	KIRC	46	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2008	[Not Available]	-16804	Dead	WITH TUMOR	766	101	[Not Available]	NA	NA	364	[Not Available]	1	101	1	101	0	720	1	101	46.28	0.28	40-49	Stage 4
3965	TCGA-B0-4690	KIRC	65	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-23985	Dead	WITH TUMOR	766	43	[Not Available]	NA	NA	364	[Not Available]	1	43	1	43	0	720	1	43	65.79	0.12	60-69	Stage 4
3966	TCGA-B0-4691	KIRC	55	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2009	[Not Available]	-20176	Dead	WITH TUMOR	766	139	[Not Available]	NA	NA	364	[Not Available]	1	139	1	139	0	720	1	139	55.62	0.38	50-59	Stage 4
3967	TCGA-B0-4693	KIRC	72	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2009	[Not Available]	-26659	Dead	TUMOR FREE	766	77	[Not Available]	NA	NA	364	[Not Available]	1	77	0	77	0	720	0	77	73.2	0.21	70-79	Stage 3
3968	TCGA-B0-4694	KIRC	72	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2009	[Not Available]	-26582	Dead	TUMOR FREE	766	106	[Not Available]	NA	NA	364	[Not Available]	1	106	0	106	0	720	0	106	73.07	0.29	70-79	Stage 3
3969	TCGA-B0-4696	KIRC	58	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2001	[Not Available]	-21317	Dead	WITH TUMOR	766	866	[Not Available]	NA	NA	794	[Not Available]	1	866	1	866	0	720	1	794	60.73	2.37	50-59	Stage 3
3970	TCGA-B0-4697	KIRC	46	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2003	[Not Available]	-16844	Dead	WITH TUMOR	766	578	[Not Available]	NA	NA	364	[Not Available]	1	578	1	578	0	720	1	578	47.7	1.58	40-49	Stage 4
3971	TCGA-B0-4698	KIRC	75	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2003	[Not Available]	-27417	Dead	WITH TUMOR	766	42	[Not Available]	NA	NA	364	[Not Available]	1	42	1	42	0	720	1	42	75.18	0.11	70-79	Stage 4
3972	TCGA-B0-4699	KIRC	74	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-27225	Dead	[Discrepancy]	766	110	[Not Available]	NA	NA	364	[Not Available]	1	110	0	110	0	720	0	110	74.84	0.3	70-79	Stage 4
3973	TCGA-B0-4700	KIRC	60	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-22034	Dead	WITH TUMOR	766	1980	[Not Available]	NA	NA	364	[Not Available]	1	1980	1	1980	0	720	1	1980	65.75	5.42	60-69	Stage 4
3974	TCGA-B0-4701	KIRC	66	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-24232	Dead	WITH TUMOR	766	238	[Not Available]	NA	NA	364	[Not Available]	1	238	1	238	0	720	1	238	67	0.65	60-69	Stage 4
3975	TCGA-B0-4703	KIRC	51	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-18921	Dead	WITH TUMOR	766	182	[Not Available]	NA	NA	364	[Not Available]	1	182	1	182	0	720	1	182	52.3	0.5	50-59	Stage 4
3976	TCGA-B0-4706	KIRC	61	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-22331	Dead	TUMOR FREE	26	65	[Not Available]	NA	NA	364	[Not Available]	1	65	0	65	0	720	0	65	61.32	0.18	60-69	Stage 3
3977	TCGA-B0-4707	KIRC	63	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2008	[Not Available]	-23322	Dead	WITH TUMOR	766	600	[Not Available]	NA	NA	364	[Not Available]	1	600	1	600	0	720	1	600	65.49	1.64	60-69	Stage 3
3978	TCGA-B0-4710	KIRC	75	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-27396	Alive	TUMOR FREE	1755	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1755	0	1755	0	1755	0	1755	79.81	4.8	70-79	Stage 3
3979	TCGA-B0-4712	KIRC	76	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-28095	Dead	WITH TUMOR	766	1337	[Not Available]	NA	NA	364	[Not Available]	1	1337	1	1337	0	720	1	1337	80.58	3.66	70-79	Stage 4
3980	TCGA-B0-4713	KIRC	76	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-27899	Dead	WITH TUMOR	766	202	[Not Available]	NA	NA	364	[Not Available]	1	202	1	202	0	720	1	202	76.94	0.55	70-79	Stage 3
3981	TCGA-B0-4714	KIRC	81	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-29873	Dead	WITH TUMOR	766	99	[Not Available]	NA	NA	364	[Not Available]	1	99	1	99	0	720	1	99	82.06	0.27	>=80	Stage 4
3982	TCGA-B0-4718	KIRC	57	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-20910	Alive	WITH TUMOR	1778	548	[Not Available]	NA	NA	768	Progressive Disease	0	1778	0	1778	0	720	1	768	62.12	4.87	50-59	Stage 3
3983	TCGA-B0-4810	KIRC	47	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2001	[Not Available]	-17402	Dead	WITH TUMOR	766	478	[Not Available]	NA	NA	205	[Not Available]	1	478	1	478	0	720	1	205	48.95	1.31	40-49	Stage 3
3984	TCGA-B0-4811	KIRC	48	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2001	[Not Available]	-17792	Dead	WITH TUMOR	766	1417	[Not Available]	NA	NA	458	[Not Available]	1	1417	1	1417	0	720	1	458	52.59	3.88	40-49	Stage 3
3985	TCGA-B0-4813	KIRC	68	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2001	[Not Available]	-25018	Dead	TUMOR FREE	18	18	[Not Available]	NA	NA	364	[Not Available]	1	18	0	18	0	720	0	18	68.54	0.05	60-69	Stage 3
3986	TCGA-B0-4814	KIRC	58	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2001	[Not Available]	-21374	Dead	WITH TUMOR	766	168	[Not Available]	NA	NA	364	[Not Available]	1	168	1	168	0	720	1	168	58.98	0.46	50-59	Stage 4
3987	TCGA-B0-4815	KIRC	65	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2001	[Not Available]	-23873	Dead	WITH TUMOR	766	1588	[Not Available]	NA	NA	364	[Not Available]	1	1588	1	1588	0	720	1	1588	69.71	4.35	60-69	Stage 3
3988	TCGA-B0-4816	KIRC	49	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-18133	Dead	WITH TUMOR	766	1371	[Not Available]	NA	NA	364	[Not Available]	1	1371	1	1371	0	720	1	1371	53.4	3.75	40-49	Stage 2
3989	TCGA-B0-4817	KIRC	81	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-29873	Dead	TUMOR FREE	766	1019	[Not Available]	NA	NA	364	[Not Available]	1	1019	0	1019	0	720	0	1019	84.58	2.79	>=80	Stage 3
3990	TCGA-B0-4818	KIRC	68	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-24853	Dead	WITH TUMOR	766	510	[Not Available]	NA	NA	127	[Not Available]	1	510	1	510	0	720	1	127	69.44	1.4	60-69	Stage 2
3991	TCGA-B0-4819	KIRC	60	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2002	[Not Available]	-22220	Dead	TUMOR FREE	183	183	[Not Available]	NA	NA	364	[Not Available]	1	183	0	183	0	720	0	183	61.34	0.5	60-69	Stage 4
3992	TCGA-B0-4821	KIRC	68	FEMALE	ASIAN	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-25013	Dead	WITH TUMOR	766	1230	[Not Available]	NA	NA	364	[Not Available]	1	1230	1	1230	0	720	1	1230	71.85	3.37	60-69	Stage 3
3993	TCGA-B0-4822	KIRC	78	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2002	[Not Available]	-28774	Dead	WITH TUMOR	766	1111	[Not Available]	NA	NA	364	[Not Available]	1	1111	1	1111	0	720	1	1111	81.82	3.04	70-79	Stage 2
3994	TCGA-B0-4823	KIRC	88	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-32290	Dead	TUMOR FREE	766	454	[Not Available]	NA	NA	364	[Not Available]	1	454	0	454	0	720	0	454	89.65	1.24	>=80	Stage 1
3995	TCGA-B0-4824	KIRC	49	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-18132	Dead	TUMOR FREE	766	1657	[Not Available]	NA	NA	364	[Not Available]	1	1657	0	1657	0	720	0	1657	54.18	4.54	40-49	Stage 1
3996	TCGA-B0-4827	KIRC	77	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2002	[Not Available]	-28467	Dead	WITH TUMOR	766	885	[Not Available]	NA	NA	668	[Not Available]	1	885	1	885	0	720	1	668	80.36	2.42	70-79	Stage 3
3997	TCGA-B0-4828	KIRC	79	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-28948	Dead	WITH TUMOR	766	307	[Not Available]	NA	NA	364	[Not Available]	1	307	1	307	0	720	1	307	80.1	0.84	70-79	Stage 4
3998	TCGA-B0-4833	KIRC	82	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-30190	Dead	WITH TUMOR	766	2386	[Not Available]	NA	NA	364	[Not Available]	1	2386	1	2386	0	720	1	2386	89.19	6.53	>=80	Stage 1
3999	TCGA-B0-4834	KIRC	49	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-18224	Dead	TUMOR FREE	766	2090	[Not Available]	NA	NA	364	[Not Available]	1	2090	0	2090	0	720	0	2090	55.62	5.72	40-49	Stage 1
4000	TCGA-B0-4836	KIRC	61	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-22488	Dead	WITH TUMOR	766	1238	[Not Available]	NA	NA	364	[Not Available]	1	1238	1	1238	0	720	1	1238	64.96	3.39	60-69	Stage 4
4001	TCGA-B0-4837	KIRC	63	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-23129	Dead	WITH TUMOR	766	1378	[Not Available]	NA	NA	1208	[Not Available]	1	1378	1	1378	0	720	1	1208	67.1	3.77	60-69	Stage 1
4002	TCGA-B0-4838	KIRC	69	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-25268	Dead	TUMOR FREE	766	834	[Not Available]	NA	NA	364	[Not Available]	1	834	0	834	0	720	0	834	71.46	2.28	60-69	Stage 1
4003	TCGA-B0-4839	KIRC	80	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-29380	Dead	TUMOR FREE	766	1639	[Not Available]	NA	NA	364	[Not Available]	1	1639	0	1639	0	720	0	1639	84.93	4.49	>=80	Stage 1
4004	TCGA-B0-4841	KIRC	63	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-23097	Dead	WITH TUMOR	766	204	[Not Available]	NA	NA	108	[Not Available]	1	204	1	204	0	720	1	108	63.79	0.56	60-69	Stage 4
4005	TCGA-B0-4842	KIRC	73	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-27019	Dead	WITH TUMOR	766	1724	[Not Available]	NA	NA	250	[Not Available]	1	1724	1	1724	0	720	1	250	78.69	4.72	70-79	Stage 3
4006	TCGA-B0-4843	KIRC	57	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-21088	Dead	WITH TUMOR	766	320	[Not Available]	NA	NA	364	[Not Available]	1	320	1	320	0	720	1	320	58.61	0.88	50-59	Stage 3
4007	TCGA-B0-4844	KIRC	60	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-22220	Dead	WITH TUMOR	766	313	[Not Available]	NA	NA	62	[Not Available]	1	313	1	313	0	720	1	62	61.69	0.86	60-69	Stage 4
4008	TCGA-B0-4845	KIRC	70	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-25582	Dead	WITH TUMOR	766	1986	[Not Available]	NA	NA	748	[Not Available]	1	1986	1	1986	0	720	1	748	75.48	5.44	70-79	Stage 4
4009	TCGA-B0-4846	KIRC	52	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-19139	Dead	WITH TUMOR	766	1200	[Not Available]	NA	NA	163	[Not Available]	1	1200	1	1200	0	720	1	163	55.69	3.29	50-59	Stage 4
4010	TCGA-B0-4847	KIRC	60	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-22147	Dead	[Discrepancy]	766	793	[Not Available]	NA	NA	364	[Not Available]	1	793	0	793	0	720	0	793	62.81	2.17	60-69	Stage 4
4011	TCGA-B0-4848	KIRC	54	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-19892	Dead	WITH TUMOR	766	883	[Not Available]	NA	NA	494	[Not Available]	1	883	1	883	0	720	1	494	56.88	2.42	50-59	Stage 3
4012	TCGA-B0-4849	KIRC	51	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-18843	Dead	WITH TUMOR	766	69	[Not Available]	NA	NA	4	[Not Available]	1	69	1	69	0	720	1	4	51.78	0.19	50-59	Stage 3
4013	TCGA-B0-4852	KIRC	78	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-28552	Dead	WITH TUMOR	766	1121	[Not Available]	NA	NA	860	[Not Available]	1	1121	1	1121	0	720	1	860	81.24	3.07	70-79	Stage 2
4014	TCGA-B0-4945	KIRC	75	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-27523	Dead	TUMOR FREE	766	2145	[Not Available]	NA	NA	364	[Not Available]	1	2145	0	2145	0	720	0	2145	81.23	5.87	70-79	Stage 1
4015	TCGA-B0-5075	KIRC	77	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-28205	Dead	TUMOR FREE	766	637	[Not Available]	NA	NA	364	[Not Available]	1	637	0	637	0	720	0	637	78.97	1.74	70-79	Stage 3
4016	TCGA-B0-5077	KIRC	77	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-28405	Dead	TUMOR FREE	766	1317	[Not Available]	NA	NA	364	[Not Available]	1	1317	0	1317	0	720	0	1317	81.37	3.61	70-79	Stage 1
4017	TCGA-B0-5080	KIRC	63	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-23052	Dead	WITH TUMOR	766	342	[Not Available]	NA	NA	103	[Not Available]	1	342	1	342	0	720	1	103	64.05	0.94	60-69	Stage 4
4018	TCGA-B0-5081	KIRC	79	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-29219	Dead	WITH TUMOR	766	362	[Not Available]	NA	NA	213	[Not Available]	1	362	1	362	0	720	1	213	80.99	0.99	70-79	Stage 3
4019	TCGA-B0-5083	KIRC	63	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-23034	Dead	WITH TUMOR	766	1045	[Not Available]	NA	NA	364	[Not Available]	1	1045	1	1045	0	720	1	1045	65.92	2.86	60-69	Stage 1
4020	TCGA-B0-5084	KIRC	33	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-12219	Dead	WITH TUMOR	766	222	[Not Available]	NA	NA	65	[Not Available]	1	222	1	222	0	720	1	65	34.06	0.61	30-39	Stage 4
4021	TCGA-B0-5085	KIRC	76	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-27793	Dead	TUMOR FREE	766	770	[Not Available]	NA	NA	364	[Not Available]	1	770	0	770	0	720	0	770	78.2	2.11	70-79	Stage 3
4022	TCGA-B0-5088	KIRC	53	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-19677	Dead	TUMOR FREE	766	563	[Not Available]	NA	NA	364	[Not Available]	1	563	0	563	0	720	0	563	55.41	1.54	50-59	Stage 1
4023	TCGA-B0-5092	KIRC	53	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-19611	Dead	WITH TUMOR	766	459	[Not Available]	NA	NA	364	[Not Available]	1	459	1	459	0	720	1	459	54.95	1.26	50-59	Stage 4
4024	TCGA-B0-5094	KIRC	62	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-22965	Dead	WITH TUMOR	766	333	[Not Available]	NA	NA	75	[Not Available]	1	333	1	333	0	720	1	75	63.79	0.91	60-69	Stage 4
4025	TCGA-B0-5095	KIRC	81	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-29921	Dead	TUMOR FREE	766	245	[Not Available]	NA	NA	364	[Not Available]	1	245	0	245	0	720	0	245	82.59	0.67	>=80	Stage 3
4026	TCGA-B0-5096	KIRC	72	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	GX	1998	[Not Available]	-26574	Dead	TUMOR FREE	766	68	[Not Available]	NA	NA	364	[Not Available]	1	68	0	68	0	720	0	68	72.94	0.19	70-79	Stage 3
4027	TCGA-B0-5097	KIRC	59	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-21852	Alive	WITH TUMOR	665	548	[Not Available]	NA	NA	359	[Not Available]	0	665	0	665	0	720	1	359	61.65	1.82	50-59	Stage 3
4028	TCGA-B0-5098	KIRC	53	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	1998	[Not Available]	-19620	Dead	[Discrepancy]	766	1584	[Not Available]	NA	NA	364	[Not Available]	1	1584	0	1584	0	720	0	1584	58.05	4.34	50-59	Stage 1
4029	TCGA-B0-5099	KIRC	88	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-32364	Dead	[Discrepancy]	766	485	[Not Available]	NA	NA	364	[Not Available]	1	485	0	485	0	720	0	485	89.94	1.33	>=80	Stage 3
4030	TCGA-B0-5100	KIRC	72	MALE	BLACK OR AFRICAN AMERICAN	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	1998	[Not Available]	-26478	Dead	WITH TUMOR	766	1913	[Not Available]	NA	NA	1426	[Not Available]	1	1913	1	1913	0	720	1	1426	77.73	5.24	70-79	Stage 3
4031	TCGA-B0-5102	KIRC	74	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	1999	[Not Available]	-27152	Dead	[Discrepancy]	766	2764	[Not Available]	NA	NA	2734	[Not Available]	1	2764	0	2764	0	720	1	2734	81.91	7.57	70-79	Stage 1
4032	TCGA-B0-5104	KIRC	90	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-32873	Dead	TUMOR FREE	766	2752	[Not Available]	NA	NA	364	[Not Available]	1	2752	0	2752	0	720	0	2752	97.54	7.53	>=80	Stage 1
4033	TCGA-B0-5106	KIRC	64	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-23547	Dead	TUMOR FREE	766	1598	[Not Available]	NA	NA	364	[Not Available]	1	1598	0	1598	0	720	0	1598	68.84	4.38	60-69	Stage 1
4034	TCGA-B0-5107	KIRC	65	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-23929	Dead	WITH TUMOR	766	927	[Not Available]	NA	NA	549	[Not Available]	1	927	1	927	0	720	1	549	68.05	2.54	60-69	Stage 4
4035	TCGA-B0-5108	KIRC	54	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2009	[Not Available]	-19932	Alive	TUMOR FREE	1782	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1782	0	1782	0	1782	0	1782	59.45	4.88	50-59	Stage 3
4036	TCGA-B0-5109	KIRC	69	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2009	[Not Available]	-25428	Dead	WITH TUMOR	766	587	[Not Available]	NA	NA	70	[Not Available]	1	587	1	587	0	720	1	70	71.23	1.61	60-69	Stage 3
4037	TCGA-B0-5110	KIRC	71	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2009	[Not Available]	-25976	Alive	TUMOR FREE	2009	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2009	0	2009	0	2009	0	2009	76.62	5.5	70-79	Stage 1
4038	TCGA-B0-5113	KIRC	69	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-25369	Alive	TUMOR FREE	1175	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1175	0	1175	0	1175	0	1175	72.67	3.22	60-69	Stage 3
4039	TCGA-B0-5115	KIRC	43	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2009	[Not Available]	-15935	Alive	WITH TUMOR	1604	548	[Not Available]	NA	NA	75	Progressive Disease	0	1604	0	1604	0	720	1	75	48.02	4.39	40-49	Stage 4
4040	TCGA-B0-5116	KIRC	52	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-19352	Alive	WITH TUMOR	1274	548	[Not Available]	NA	NA	1129	Complete Remission/Response	0	1274	0	1274	1	1129	1	1129	56.47	3.49	50-59	Stage 3
4041	TCGA-B0-5117	KIRC	40	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-14612	Alive	TUMOR FREE	1608	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1608	0	1608	0	1608	0	1608	44.41	4.4	40-49	Stage 1
4042	TCGA-B0-5119	KIRC	61	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-22607	Alive	TUMOR FREE	1552	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1552	0	1552	0	1552	0	1552	66.14	4.25	60-69	Stage 1
4043	TCGA-B0-5120	KIRC	72	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-26559	Alive	TUMOR FREE	1169	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1169	0	1169	0	1169	0	1169	75.92	3.2	70-79	Stage 1
4044	TCGA-B0-5121	KIRC	56	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-20635	Alive	TUMOR FREE	1485	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1485	0	1485	0	1485	0	1485	60.56	4.07	50-59	Stage 1
4045	TCGA-B0-5399	KIRC	46	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-17145	Alive	TUMOR FREE	1411	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1411	0	1411	0	1411	0	1411	50.8	3.86	40-49	Stage 1
4046	TCGA-B0-5400	KIRC	59	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2008	[Not Available]	-21819	Alive	TUMOR FREE	1733	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1733	0	1733	0	1733	0	1733	64.48	4.74	50-59	Stage 3
4047	TCGA-B0-5402	KIRC	64	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2010	[Not Available]	-23477	Alive	WITH TUMOR	1290	548	[Not Available]	NA	NA	444	Progressive Disease	0	1290	0	1290	0	720	1	444	67.81	3.53	60-69	Stage 4
4048	TCGA-B0-5690	KIRC	53	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2004	[Not Available]	-19685	Alive	WITH TUMOR	3392	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	3392	0	3392	0	720	0	3392	63.18	9.29	50-59	Stage 1
4049	TCGA-B0-5691	KIRC	66	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-24120	Alive	WITH TUMOR	3431	548	[Not Available]	NA	NA	3250	[Not Available]	0	3431	0	3431	0	720	1	3250	75.43	9.39	60-69	Stage 1
4050	TCGA-B0-5692	KIRC	66	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-24140	Alive	TUMOR FREE	3944	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3944	0	3944	0	3944	0	3944	76.89	10.8	60-69	Stage 3
4051	TCGA-B0-5693	KIRC	47	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-17177	Alive	TUMOR FREE	4074	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	4074	0	4074	0	4074	0	4074	58.18	11.15	40-49	Stage 1
4052	TCGA-B0-5694	KIRC	71	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-26060	Dead	WITH TUMOR	766	480	[Not Available]	NA	NA	288	[Not Available]	1	480	1	480	0	720	1	288	72.66	1.31	70-79	Stage 3
4053	TCGA-B0-5695	KIRC	61	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-22320	Alive	TUMOR FREE	2150	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2150	0	2150	0	2150	0	2150	67	5.89	60-69	Stage 1
4054	TCGA-B0-5696	KIRC	69	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-25552	Alive	WITH TUMOR	2609	548	[Not Available]	NA	NA	1717	Complete Remission/Response	0	2609	0	2609	1	1717	1	1717	77.1	7.14	60-69	Stage 3
4055	TCGA-B0-5697	KIRC	50	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-18486	Alive	TUMOR FREE	2630	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2630	0	2630	0	2630	0	2630	57.81	7.2	50-59	Stage 1
4056	TCGA-B0-5698	KIRC	77	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-28438	Alive	TUMOR FREE	3631	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3631	0	3631	0	3631	0	3631	87.8	9.94	70-79	Stage 1
4057	TCGA-B0-5699	KIRC	53	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-19647	Alive	TUMOR FREE	3841	548	[Not Available]	NA	NA	94	Complete Remission/Response	0	3841	0	3841	1	94	1	94	64.31	10.52	50-59	Stage 1
4058	TCGA-B0-5700	KIRC	77	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2009	[Not Available]	-28184	Alive	TUMOR FREE	1790	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1790	0	1790	0	1790	0	1790	82.06	4.9	70-79	Stage 1
4059	TCGA-B0-5701	KIRC	65	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-23915	Alive	TUMOR FREE	2461	548	[Not Available]	NA	NA	224	Complete Remission/Response	0	2461	0	2461	1	224	1	224	72.21	6.74	60-69	Stage 3
4060	TCGA-B0-5702	KIRC	71	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-26186	Alive	TUMOR FREE	2172	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2172	0	2172	0	2172	0	2172	77.64	5.95	70-79	Stage 1
4061	TCGA-B0-5703	KIRC	73	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2009	[Not Available]	-26897	Alive	TUMOR FREE	2246	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2246	0	2246	0	2246	0	2246	79.79	6.15	70-79	Stage 1
4062	TCGA-B0-5705	KIRC	65	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-23746	Alive	TUMOR FREE	4537	548	[Not Available]	NA	NA	842	Complete Remission/Response	0	4537	0	4537	1	842	1	842	77.43	12.42	60-69	Stage 1
4063	TCGA-B0-5706	KIRC	45	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-16442	Alive	TUMOR FREE	3205	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3205	0	3205	0	3205	0	3205	53.79	8.77	40-49	Stage 2
4064	TCGA-B0-5707	KIRC	39	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-14598	Alive	TUMOR FREE	3744	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3744	0	3744	0	3744	0	3744	50.22	10.25	30-39	Stage 1
4065	TCGA-B0-5709	KIRC	62	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-22843	Alive	TUMOR FREE	3974	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3974	0	3974	0	3974	0	3974	73.42	10.88	60-69	Stage 3
4066	TCGA-B0-5710	KIRC	57	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-21168	Alive	WITH TUMOR	2430	548	[Not Available]	NA	NA	1441	Progressive Disease	0	2430	0	2430	0	720	1	1441	64.61	6.65	50-59	Stage 1
4067	TCGA-B0-5711	KIRC	50	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-18444	Alive	WITH TUMOR	3989	548	[Not Available]	NA	NA	3766	Complete Remission/Response	0	3989	0	3989	1	3766	1	3766	61.42	10.92	50-59	Stage 3
4068	TCGA-B0-5712	KIRC	68	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-24988	Alive	WITH TUMOR	2722	548	[Not Available]	NA	NA	725	[Not Available]	0	2722	0	2722	0	720	1	725	75.87	7.45	60-69	Stage 4
4069	TCGA-B0-5713	KIRC	75	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-27644	Alive	TUMOR FREE	2782	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2782	0	2782	0	2782	0	2782	83.3	7.62	70-79	Stage 3
4070	TCGA-B0-5812	KIRC	53	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-19600	Alive	TUMOR FREE	3834	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3834	0	3834	0	3834	0	3834	64.16	10.5	50-59	Stage 1
4071	TCGA-B2-3923	KIRC	59	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-21793	Alive	TUMOR FREE	992	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	992	0	992	0	992	0	992	62.38	2.72	50-59	Stage 2
4072	TCGA-B2-3924	KIRC	73	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-26846	Alive	TUMOR FREE	1092	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1092	0	1092	0	1092	0	1092	76.49	2.99	70-79	Stage 1
4073	TCGA-B2-4098	KIRC	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-26606	Dead	TUMOR FREE	766	51	[Not Available]	NA	NA	364	[Not Available]	1	51	0	51	0	720	0	51	72.98	0.14	70-79	Stage 1
4074	TCGA-B2-4099	KIRC	83	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-30355	Alive	TUMOR FREE	972	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	972	0	972	0	972	0	972	85.77	2.66	>=80	Stage 1
4075	TCGA-B2-4101	KIRC	52	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-19059	Alive	TUMOR FREE	648	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	648	0	648	0	648	0	648	53.95	1.77	50-59	Stage 2
4076	TCGA-B2-4102	KIRC	61	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-22492	Alive	TUMOR FREE	952	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	952	0	952	0	952	0	952	64.19	2.61	60-69	Stage 1
4077	TCGA-B2-5633	KIRC	56	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-20493	Alive	TUMOR FREE	963	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	963	0	963	0	963	0	963	58.74	2.64	50-59	Stage 1
4078	TCGA-B2-5635	KIRC	74	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-27183	Alive	TUMOR FREE	755	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	755	0	755	0	755	0	755	76.49	2.07	70-79	Stage 1
4079	TCGA-B2-5636	KIRC	79	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-28901	Alive	TUMOR FREE	919	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	919	0	919	0	919	0	919	81.64	2.52	70-79	Stage 1
4080	TCGA-B2-5639	KIRC	46	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-17045	Dead	WITH TUMOR	766	1003	[Not Available]	NA	NA	163	Progressive Disease	1	1003	1	1003	0	720	1	163	49.41	2.75	40-49	Stage 4
4081	TCGA-B2-5641	KIRC	79	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-28953	Alive	TUMOR FREE	656	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	656	0	656	0	656	0	656	81.07	1.8	70-79	Stage 1
4082	TCGA-B2-A4SR	KIRC	61	MALE	BLACK OR AFRICAN AMERICAN	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	[Not Available]	2012	[Not Available]	-22637	Alive	TUMOR FREE	507	548	[Not Available]	NA	NA	266	Complete Remission/Response	0	507	0	507	1	266	1	266	63.36	1.39	60-69	Stage 2
4083	TCGA-B4-5377	KIRC	68	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-25115	Alive	TUMOR FREE	365	548	[Not Available]	NA	NA	364	[Not Applicable]	0	365	0	365	0	720	0	365	69.76	1	60-69	Stage 4
4084	TCGA-B4-5378	KIRC	62	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-22980	Alive	TUMOR FREE	175	548	[Not Available]	NA	NA	364	[Not Applicable]	0	175	0	175	0	720	0	175	63.39	0.48	60-69	Stage 1
4085	TCGA-B4-5832	KIRC	65	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-23806	Alive	TUMOR FREE	155	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	155	0	155	0	155	0	155	65.6	0.42	60-69	Stage 3
4086	TCGA-B4-5834	KIRC	59	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2010	[Not Available]	-21713	Alive	TUMOR FREE	38	548	[Not Available]	NA	NA	364	[Not Applicable]	0	38	0	38	0	720	0	38	59.55	0.1	50-59	Stage 1
4087	TCGA-B4-5835	KIRC	64	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-23408	Alive	TUMOR FREE	16	548	[Not Available]	NA	NA	364	[Not Applicable]	0	16	0	16	0	720	0	16	64.13	0.04	60-69	Stage 1
4088	TCGA-B4-5836	KIRC	61	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-22341	Alive	TUMOR FREE	141	548	[Not Available]	NA	NA	364	[Not Applicable]	0	141	0	141	0	720	0	141	61.55	0.39	60-69	Stage 1
4089	TCGA-B4-5838	KIRC	52	MALE	WHITE	[Discrepancy]	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-19242	Alive	WITH TUMOR	166	548	[Not Available]	NA	NA	364	[Not Applicable]	0	166	0	166	0	720	0	166	53.14	0.45	50-59	other
4090	TCGA-B4-5843	KIRC	45	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-16779	Alive	TUMOR FREE	11	548	[Not Available]	NA	NA	364	[Not Applicable]	0	11	0	11	0	720	0	11	45.97	0.03	40-49	Stage 1
4091	TCGA-B4-5844	KIRC	61	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2010	[Not Available]	-22409	Alive	TUMOR FREE	7	548	[Not Available]	NA	NA	364	[Unknown]	0	7	0	7	0	720	0	7	61.37	0.02	60-69	Stage 2
4092	TCGA-B8-4143	KIRC	66	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-24132	Dead	WITH TUMOR	766	709	[Not Available]	NA	NA	364	[Not Available]	1	709	1	709	0	720	1	709	68.01	1.94	60-69	Stage 4
4093	TCGA-B8-4146	KIRC	41	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2009	[Not Available]	-15063	Alive	TUMOR FREE	511	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	511	0	511	0	511	0	511	42.64	1.4	40-49	Stage 1
4094	TCGA-B8-4148	KIRC	63	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2009	[Not Available]	-23062	Alive	TUMOR FREE	1520	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1520	0	1520	0	1520	0	1520	67.3	4.16	60-69	Stage 1
4095	TCGA-B8-4151	KIRC	51	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2009	[Not Available]	-18760	Alive	TUMOR FREE	1299	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1299	0	1299	0	1299	0	1299	54.92	3.56	50-59	Stage 3
4096	TCGA-B8-4153	KIRC	74	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-27031	Alive	WITH TUMOR	762	548	[Not Available]	NA	NA	223	[Not Available]	0	762	0	762	0	720	1	223	76.09	2.09	70-79	Stage 3
4097	TCGA-B8-4154	KIRC	73	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-26882	Alive	TUMOR FREE	1380	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1380	0	1380	0	1380	0	1380	77.38	3.78	70-79	Stage 1
4098	TCGA-B8-4619	KIRC	58	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-21206	Alive	TUMOR FREE	523	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	523	0	523	0	523	0	523	59.49	1.43	50-59	Stage 1
4099	TCGA-B8-4620	KIRC	70	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-25786	Alive	WITH TUMOR	777	548	[Not Available]	NA	NA	604	Complete Remission/Response	0	777	0	777	1	604	1	604	72.73	2.13	70-79	Stage 3
4100	TCGA-B8-4621	KIRC	63	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-23176	Alive	TUMOR FREE	788	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	788	0	788	0	788	0	788	65.61	2.16	60-69	Stage 1
4101	TCGA-B8-4622	KIRC	57	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-21135	Alive	WITH TUMOR	1525	548	[Not Available]	NA	NA	1227	Complete Remission/Response	0	1525	0	1525	0	720	1	1227	62.04	4.18	50-59	Stage 4
4102	TCGA-B8-5158	KIRC	56	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2010	[Not Available]	-20764	Alive	TUMOR FREE	1218	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1218	0	1218	0	1218	0	1218	60.18	3.33	50-59	Stage 3
4103	TCGA-B8-5159	KIRC	61	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-22462	Alive	TUMOR FREE	722	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	722	0	722	0	722	0	722	63.47	1.98	60-69	Stage 1
4104	TCGA-B8-5162	KIRC	62	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-23008	Alive	TUMOR FREE	36	548	[Not Available]	NA	NA	364	[Not Available]	0	36	0	36	0	720	0	36	63.09	0.1	60-69	Stage 2
4105	TCGA-B8-5163	KIRC	63	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-23293	Alive	TUMOR FREE	822	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	822	0	822	0	822	0	822	66.02	2.25	60-69	Stage 3
4106	TCGA-B8-5164	KIRC	65	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-23863	Alive	TUMOR FREE	26	548	[Not Available]	NA	NA	364	[Not Available]	0	26	0	26	0	720	0	26	65.4	0.07	60-69	Stage 3
4107	TCGA-B8-5165	KIRC	43	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-15898	Alive	TUMOR FREE	737	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	737	0	737	0	737	0	737	45.54	2.02	40-49	Stage 1
4108	TCGA-B8-5545	KIRC	42	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-15376	Alive	TUMOR FREE	1525	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1525	0	1525	0	1525	0	1525	46.27	4.18	40-49	Stage 1
4109	TCGA-B8-5546	KIRC	38	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-14113	Alive	TUMOR FREE	505	548	[Not Available]	NA	NA	364	[Not Available]	0	505	0	505	0	720	0	505	40.02	1.38	30-39	Stage 1
4110	TCGA-B8-5549	KIRC	53	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-19561	Alive	TUMOR FREE	194	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	194	0	194	0	194	0	194	54.09	0.53	50-59	Stage 1
4111	TCGA-B8-5550	KIRC	71	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-25937	Alive	WITH TUMOR	1476	548	[Not Available]	NA	NA	694	Complete Remission/Response	0	1476	0	1476	1	694	1	694	75.05	4.04	70-79	Stage 3
4112	TCGA-B8-5551	KIRC	65	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-23976	Alive	TUMOR FREE	16	548	[Not Available]	NA	NA	364	[Not Available]	0	16	0	16	0	720	0	16	65.69	0.04	60-69	Stage 1
4113	TCGA-B8-5552	KIRC	41	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-15219	Alive	TUMOR FREE	1046	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1046	0	1046	0	1046	0	1046	44.53	2.86	40-49	Stage 1
4114	TCGA-B8-5553	KIRC	67	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-24729	Alive	TUMOR FREE	435	548	[Not Available]	NA	NA	364	[Not Available]	0	435	0	435	0	720	0	435	68.9	1.19	60-69	Stage 1
4115	TCGA-B8-A54D	KIRC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2011	[Not Available]	-25429	Alive	TUMOR FREE	830	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	830	0	830	0	830	0	830	71.89	2.27	60-69	Stage 3
4116	TCGA-B8-A54E	KIRC	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2011	[Not Available]	-22900	Alive	TUMOR FREE	909	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	909	0	909	0	909	0	909	65.19	2.49	60-69	Stage 1
4117	TCGA-B8-A54F	KIRC	49	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2012	[Not Available]	-18028	Alive	TUMOR FREE	519	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	519	0	519	0	519	0	519	50.78	1.42	40-49	Stage 1
4118	TCGA-B8-A54G	KIRC	50	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2012	[Not Available]	-18612	Alive	TUMOR FREE	53	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	53	0	53	0	53	0	53	51.1	0.15	50-59	Stage 1
4119	TCGA-B8-A54H	KIRC	69	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2012	[Not Available]	-25243	Alive	TUMOR FREE	256	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	256	0	256	0	256	0	256	69.81	0.7	60-69	Stage 2
4120	TCGA-B8-A54I	KIRC	48	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2012	[Not Available]	-17722	Alive	TUMOR FREE	150	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	150	0	150	0	150	0	150	48.93	0.41	40-49	Stage 1
4121	TCGA-B8-A54J	KIRC	60	MALE	BLACK OR AFRICAN AMERICAN	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2012	[Not Available]	-22071	Alive	TUMOR FREE	528	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	528	0	528	0	528	0	528	61.87	1.45	60-69	Stage 2
4122	TCGA-B8-A54K	KIRC	61	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2012	[Not Available]	-22627	Alive	TUMOR FREE	469	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	469	0	469	0	469	0	469	63.23	1.28	60-69	Stage 1
4123	TCGA-B8-A7U6	KIRC	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2013	[Not Available]	-19803	Alive	TUMOR FREE	495	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	495	0	495	0	495	0	495	55.57	1.36	50-59	Stage 1
4124	TCGA-B8-A8YJ	KIRC	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2013	[Not Available]	-21994	Alive	TUMOR FREE	431	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	431	0	431	0	431	0	431	61.4	1.18	60-69	Stage 1
4125	TCGA-BP-4158	KIRC	69	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2001	[Not Available]	-25210	Alive	TUMOR FREE	3377	548	[Not Available]	NA	NA	364	[Not Available]	0	3377	0	3377	0	720	0	3377	78.27	9.25	60-69	Stage 1
4126	TCGA-BP-4159	KIRC	70	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-25677	Dead	WITH TUMOR	766	2601	[Not Available]	NA	NA	2352	[Not Available]	1	2601	1	2601	0	720	1	2352	77.42	7.12	70-79	Stage 1
4127	TCGA-BP-4160	KIRC	67	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-24720	Alive	TUMOR FREE	2881	548	[Not Available]	NA	NA	364	[Not Available]	0	2881	0	2881	0	720	0	2881	75.57	7.89	60-69	Stage 3
4128	TCGA-BP-4161	KIRC	74	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-27119	Alive	WITH TUMOR	2746	548	[Not Available]	NA	NA	2685	[Not Available]	0	2746	0	2746	0	720	1	2685	81.77	7.52	70-79	Stage 1
4129	TCGA-BP-4162	KIRC	65	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-23966	Alive	TUMOR FREE	3074	548	[Not Available]	NA	NA	364	[Not Available]	0	3074	0	3074	0	720	0	3074	74.03	8.42	60-69	Stage 1
4130	TCGA-BP-4163	KIRC	60	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-21980	Alive	TUMOR FREE	2839	548	[Not Available]	NA	NA	364	[Not Available]	0	2839	0	2839	0	720	0	2839	67.95	7.77	60-69	Stage 3
4131	TCGA-BP-4164	KIRC	51	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-18898	Dead	TUMOR FREE	766	992	[Not Available]	NA	NA	364	[Not Available]	1	992	0	992	0	720	0	992	54.46	2.72	50-59	Stage 3
4132	TCGA-BP-4165	KIRC	64	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2002	[Not Available]	-23685	Alive	WITH TUMOR	3037	548	[Not Available]	NA	NA	1049	[Not Available]	0	3037	0	3037	0	720	1	1049	73.16	8.31	60-69	Stage 1
4133	TCGA-BP-4166	KIRC	69	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-25300	Alive	TUMOR FREE	13	548	[Not Available]	NA	NA	364	[Not Available]	0	13	0	13	0	720	0	13	69.3	0.04	60-69	Stage 3
4134	TCGA-BP-4167	KIRC	59	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-21901	Alive	TUMOR FREE	2718	548	[Not Available]	NA	NA	364	[Not Available]	0	2718	0	2718	0	720	0	2718	67.4	7.44	50-59	Stage 3
4135	TCGA-BP-4169	KIRC	76	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-27778	Dead	WITH TUMOR	766	701	[Not Available]	NA	NA	78	[Not Available]	1	701	1	701	0	720	1	78	77.97	1.92	70-79	Stage 2
4136	TCGA-BP-4170	KIRC	72	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-26596	Dead	TUMOR FREE	766	2343	[Not Available]	NA	NA	364	[Not Available]	1	2343	0	2343	0	720	0	2343	79.23	6.41	70-79	Stage 1
4137	TCGA-BP-4173	KIRC	47	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-17449	Alive	TUMOR FREE	1893	548	[Not Available]	NA	NA	364	[Not Available]	0	1893	0	1893	0	720	0	1893	52.96	5.18	40-49	Stage 2
4138	TCGA-BP-4174	KIRC	49	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-18054	Alive	TUMOR FREE	1879	548	[Not Available]	NA	NA	364	[Not Available]	0	1879	0	1879	0	720	0	1879	54.57	5.14	40-49	Stage 2
4139	TCGA-BP-4176	KIRC	64	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-23609	Alive	TUMOR FREE	1955	548	[Not Available]	NA	NA	364	[Not Available]	0	1955	0	1955	0	720	0	1955	69.99	5.35	60-69	Stage 1
4140	TCGA-BP-4177	KIRC	65	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-23955	Alive	TUMOR FREE	1670	548	[Not Available]	NA	NA	364	[Not Available]	0	1670	0	1670	0	720	0	1670	70.16	4.57	60-69	Stage 1
4141	TCGA-BP-4325	KIRC	64	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2001	[Not Available]	-23588	Alive	TUMOR FREE	2964	548	[Not Available]	NA	NA	364	[Not Available]	0	2964	0	2964	0	720	0	2964	72.7	8.11	60-69	Stage 1
4142	TCGA-BP-4326	KIRC	53	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-19376	Dead	WITH TUMOR	766	1625	[Not Available]	NA	NA	958	[Not Available]	1	1625	1	1625	0	720	1	958	57.5	4.45	50-59	Stage 1
4143	TCGA-BP-4327	KIRC	75	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-27556	Dead	TUMOR FREE	766	109	[Not Available]	NA	NA	364	[Not Available]	1	109	0	109	0	720	0	109	75.74	0.3	70-79	Stage 2
4144	TCGA-BP-4329	KIRC	75	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-27699	Dead	WITH TUMOR	766	845	[Not Available]	NA	NA	134	[Not Available]	1	845	1	845	0	720	1	134	78.15	2.31	70-79	Stage 3
4145	TCGA-BP-4330	KIRC	60	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-22239	Alive	TUMOR FREE	1888	548	[Not Available]	NA	NA	364	[Not Available]	0	1888	0	1888	0	720	0	1888	66.06	5.17	60-69	Stage 3
4146	TCGA-BP-4331	KIRC	52	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-19022	Dead	TUMOR FREE	766	2454	[Not Available]	NA	NA	364	[Not Available]	1	2454	0	2454	0	720	0	2454	58.8	6.72	50-59	Stage 1
4147	TCGA-BP-4332	KIRC	36	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-13404	Alive	TUMOR FREE	1133	548	[Not Available]	NA	NA	364	[Not Available]	0	1133	0	1133	0	720	0	1133	39.8	3.1	30-39	Stage 3
4148	TCGA-BP-4334	KIRC	56	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-20609	Dead	WITH TUMOR	766	645	[Not Available]	NA	NA	442	[Not Available]	1	645	1	645	0	720	1	442	58.19	1.77	50-59	Stage 3
4149	TCGA-BP-4335	KIRC	65	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-23860	Dead	WITH TUMOR	766	475	[Not Available]	NA	NA	160	[Not Available]	1	475	1	475	0	720	1	160	66.63	1.3	60-69	Stage 4
4150	TCGA-BP-4337	KIRC	76	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2003	[Not Available]	-27906	Dead	TUMOR FREE	766	2	[Not Available]	NA	NA	364	[Not Available]	1	2	0	2	0	720	0	2	76.41	0.01	70-79	Stage 3
4151	TCGA-BP-4338	KIRC	43	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-15891	Alive	WITH TUMOR	2859	548	[Not Available]	NA	NA	1757	[Not Available]	0	2859	0	2859	0	720	1	1757	51.33	7.83	40-49	Stage 1
4152	TCGA-BP-4340	KIRC	70	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-25752	Dead	TUMOR FREE	766	562	[Not Available]	NA	NA	364	[Not Available]	1	562	0	562	0	720	0	562	72.04	1.54	70-79	Stage 1
4153	TCGA-BP-4341	KIRC	67	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-24727	Dead	WITH TUMOR	766	1589	[Not Available]	NA	NA	364	[Not Available]	1	1589	1	1589	0	720	1	1589	72.05	4.35	60-69	Stage 3
4154	TCGA-BP-4342	KIRC	79	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-29032	Dead	WITH TUMOR	766	2256	[Not Available]	NA	NA	240	[Not Available]	1	2256	1	2256	0	720	1	240	85.66	6.18	70-79	Stage 2
4155	TCGA-BP-4343	KIRC	64	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-23498	Dead	WITH TUMOR	766	1912	[Not Available]	NA	NA	330	[Not Available]	1	1912	1	1912	0	720	1	330	69.57	5.23	60-69	Stage 3
4156	TCGA-BP-4344	KIRC	75	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-27561	Alive	TUMOR FREE	1666	548	[Not Available]	NA	NA	364	[Not Available]	0	1666	0	1666	0	720	0	1666	80.02	4.56	70-79	Stage 1
4157	TCGA-BP-4345	KIRC	62	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-22879	Alive	TUMOR FREE	1516	548	[Not Available]	NA	NA	364	[Not Available]	0	1516	0	1516	0	720	0	1516	66.79	4.15	60-69	Stage 3
4158	TCGA-BP-4346	KIRC	57	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-21057	Dead	TUMOR FREE	766	1493	[Not Available]	NA	NA	364	[Not Available]	1	1493	0	1493	0	720	0	1493	61.74	4.09	50-59	Stage 3
4159	TCGA-BP-4347	KIRC	74	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-27146	Alive	TUMOR FREE	1367	548	[Not Available]	NA	NA	364	[Not Available]	0	1367	0	1367	0	720	0	1367	78.06	3.74	70-79	Stage 3
4160	TCGA-BP-4349	KIRC	68	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-24853	Alive	TUMOR FREE	372	548	[Not Available]	NA	NA	364	[Not Available]	0	372	0	372	0	720	0	372	69.06	1.02	60-69	Stage 1
4161	TCGA-BP-4351	KIRC	51	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-18662	Alive	WITH TUMOR	970	548	[Not Available]	NA	NA	873	[Not Available]	0	970	0	970	0	720	1	873	53.75	2.66	50-59	Stage 3
4162	TCGA-BP-4352	KIRC	74	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-27253	Dead	WITH TUMOR	766	344	[Not Available]	NA	NA	13	[Not Available]	1	344	1	344	0	720	1	13	75.56	0.94	70-79	Stage 4
4163	TCGA-BP-4353	KIRC	61	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-22415	Dead	TUMOR FREE	766	375	[Not Available]	NA	NA	364	[Not Available]	1	375	0	375	0	720	0	375	62.4	1.03	60-69	Stage 1
4164	TCGA-BP-4354	KIRC	40	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-14973	Dead	WITH TUMOR	766	1034	[Not Available]	NA	NA	685	[Not Available]	1	1034	1	1034	0	720	1	685	43.82	2.83	40-49	Stage 4
4165	TCGA-BP-4355	KIRC	59	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2008	[Not Available]	-21642	Dead	TUMOR FREE	766	953	[Not Available]	NA	NA	364	[Not Available]	1	953	0	953	0	720	0	953	61.86	2.61	50-59	Stage 3
4166	TCGA-BP-4756	KIRC	62	FEMALE	ASIAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-23001	Alive	TUMOR FREE	374	548	[Not Available]	NA	NA	364	[Not Available]	0	374	0	374	0	720	0	374	64	1.02	60-69	Stage 1
4167	TCGA-BP-4758	KIRC	40	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-14824	Alive	TUMOR FREE	2208	548	[Not Available]	NA	NA	364	[Not Available]	0	2208	0	2208	0	720	0	2208	46.63	6.05	40-49	Stage 1
4168	TCGA-BP-4759	KIRC	50	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-18569	Alive	TUMOR FREE	2372	548	[Not Available]	NA	NA	364	[Not Available]	0	2372	0	2372	0	720	0	2372	57.33	6.49	50-59	Stage 1
4169	TCGA-BP-4760	KIRC	69	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-25268	Alive	WITH TUMOR	2361	548	[Not Available]	NA	NA	1457	[Not Available]	0	2361	0	2361	0	720	1	1457	75.64	6.46	60-69	Stage 1
4170	TCGA-BP-4761	KIRC	57	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-21019	Alive	TUMOR FREE	182	548	[Not Available]	NA	NA	364	[Not Available]	0	182	0	182	0	720	0	182	58.05	0.5	50-59	Stage 3
4171	TCGA-BP-4762	KIRC	42	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-15358	Dead	TUMOR FREE	766	1343	[Not Available]	NA	NA	364	[Not Available]	1	1343	0	1343	0	720	0	1343	45.72	3.68	40-49	Stage 1
4172	TCGA-BP-4763	KIRC	79	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-29150	Dead	TUMOR FREE	766	1270	[Not Available]	NA	NA	364	[Not Available]	1	1270	0	1270	0	720	0	1270	83.29	3.48	70-79	Stage 1
4173	TCGA-BP-4765	KIRC	43	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-15814	Alive	TUMOR FREE	2184	548	[Not Available]	NA	NA	364	[Not Available]	0	2184	0	2184	0	720	0	2184	49.28	5.98	40-49	Stage 1
4174	TCGA-BP-4766	KIRC	43	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-15799	Alive	TUMOR FREE	1462	548	[Not Available]	NA	NA	364	[Not Available]	0	1462	0	1462	0	720	0	1462	47.26	4	40-49	Stage 1
4175	TCGA-BP-4768	KIRC	72	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-26474	Alive	TUMOR FREE	400	548	[Not Available]	NA	NA	364	[Not Available]	0	400	0	400	0	720	0	400	73.58	1.1	70-79	Stage 1
4176	TCGA-BP-4769	KIRC	63	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-23190	Alive	TUMOR FREE	1876	548	[Not Available]	NA	NA	364	[Not Available]	0	1876	0	1876	0	720	0	1876	68.63	5.14	60-69	Stage 1
4177	TCGA-BP-4770	KIRC	73	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-26824	Dead	WITH TUMOR	766	329	[Not Available]	NA	NA	169	[Not Available]	1	329	1	329	0	720	1	169	74.34	0.9	70-79	Stage 4
4178	TCGA-BP-4771	KIRC	62	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-22771	Dead	WITH TUMOR	766	162	[Not Available]	NA	NA	23	[Not Available]	1	162	1	162	0	720	1	23	62.79	0.44	60-69	Stage 4
4179	TCGA-BP-4774	KIRC	57	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-20827	Alive	TUMOR FREE	1885	548	[Not Available]	NA	NA	364	[Not Available]	0	1885	0	1885	0	720	0	1885	62.18	5.16	50-59	Stage 1
4180	TCGA-BP-4775	KIRC	55	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-20369	Alive	[Discrepancy]	1843	548	[Not Available]	NA	NA	364	[Not Available]	0	1843	0	1843	0	720	0	1843	60.81	5.05	50-59	Stage 1
4181	TCGA-BP-4776	KIRC	52	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-19143	Alive	TUMOR FREE	411	548	[Not Available]	NA	NA	364	[Not Available]	0	411	0	411	0	720	0	411	53.54	1.13	50-59	Stage 1
4182	TCGA-BP-4777	KIRC	46	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-17133	Alive	TUMOR FREE	1731	548	[Not Available]	NA	NA	364	[Not Available]	0	1731	0	1731	0	720	0	1731	51.65	4.74	40-49	Stage 1
4183	TCGA-BP-4781	KIRC	78	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-28701	Alive	TUMOR FREE	2080	548	[Not Available]	NA	NA	364	[Not Available]	0	2080	0	2080	0	720	0	2080	84.27	5.69	70-79	Stage 1
4184	TCGA-BP-4782	KIRC	55	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-20102	Alive	[Discrepancy]	354	548	[Not Available]	NA	NA	364	[Not Available]	0	354	0	354	0	720	0	354	56.01	0.97	50-59	Stage 1
4185	TCGA-BP-4784	KIRC	67	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-24603	Alive	TUMOR FREE	1854	548	[Not Available]	NA	NA	364	[Not Available]	0	1854	0	1854	0	720	0	1854	72.44	5.08	60-69	Stage 1
4186	TCGA-BP-4787	KIRC	59	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-21697	Dead	WITH TUMOR	766	480	[Not Available]	NA	NA	259	[Not Available]	1	480	1	480	0	720	1	259	60.72	1.31	50-59	Stage 4
4187	TCGA-BP-4789	KIRC	48	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-17540	Alive	TUMOR FREE	1489	548	[Not Available]	NA	NA	364	[Not Available]	0	1489	0	1489	0	720	0	1489	52.1	4.08	40-49	Stage 1
4188	TCGA-BP-4790	KIRC	76	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-28076	Dead	TUMOR FREE	766	1111	[Not Available]	NA	NA	364	[Not Available]	1	1111	0	1111	0	720	0	1111	79.91	3.04	70-79	Stage 1
4189	TCGA-BP-4795	KIRC	74	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-27162	Alive	TUMOR FREE	620	548	[Not Available]	NA	NA	364	[Not Available]	0	620	0	620	0	720	0	620	76.06	1.7	70-79	Stage 1
4190	TCGA-BP-4797	KIRC	34	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-12508	Alive	TUMOR FREE	1107	548	[Not Available]	NA	NA	364	[Not Available]	0	1107	0	1107	0	720	0	1107	37.28	3.03	30-39	Stage 3
4191	TCGA-BP-4798	KIRC	74	MALE	WHITE	[Discrepancy]	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-27335	Dead	WITH TUMOR	766	334	[Not Available]	NA	NA	364	[Not Available]	1	334	1	334	0	720	1	334	75.75	0.91	70-79	other
4192	TCGA-BP-4799	KIRC	70	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-25842	Dead	WITH TUMOR	766	1133	[Not Available]	NA	NA	352	[Not Available]	1	1133	1	1133	0	720	1	352	73.85	3.1	70-79	Stage 3
4193	TCGA-BP-4801	KIRC	57	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-20825	Alive	TUMOR FREE	1124	548	[Not Available]	NA	NA	364	[Not Available]	0	1124	0	1124	0	720	0	1124	60.09	3.08	50-59	Stage 1
4194	TCGA-BP-4803	KIRC	79	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-28934	Alive	TUMOR FREE	204	548	[Not Available]	NA	NA	364	[Not Available]	0	204	0	204	0	720	0	204	79.78	0.56	70-79	Stage 3
4195	TCGA-BP-4804	KIRC	59	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-21727	Alive	WITH TUMOR	1459	548	[Not Available]	NA	NA	295	[Not Available]	0	1459	0	1459	0	720	1	295	63.48	3.99	50-59	Stage 1
4196	TCGA-BP-4807	KIRC	42	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-15360	Alive	TUMOR FREE	211	548	[Not Available]	NA	NA	364	[Not Available]	0	211	0	211	0	720	0	211	42.63	0.58	40-49	Stage 1
4197	TCGA-BP-4959	KIRC	49	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-17968	Alive	TUMOR FREE	2660	548	[Not Available]	NA	NA	364	[Not Available]	0	2660	0	2660	0	720	0	2660	56.48	7.28	40-49	Stage 1
4198	TCGA-BP-4960	KIRC	46	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-17099	Alive	TUMOR FREE	2172	548	[Not Available]	NA	NA	364	[Not Available]	0	2172	0	2172	0	720	0	2172	52.76	5.95	40-49	Stage 2
4199	TCGA-BP-4961	KIRC	47	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-17284	Alive	TUMOR FREE	1935	548	[Not Available]	NA	NA	364	[Not Available]	0	1935	0	1935	0	720	0	1935	52.62	5.3	40-49	Stage 1
4200	TCGA-BP-4962	KIRC	58	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-21255	Alive	TUMOR FREE	1785	548	[Not Available]	NA	NA	364	[Not Available]	0	1785	0	1785	0	720	0	1785	63.08	4.89	50-59	Stage 2
4201	TCGA-BP-4963	KIRC	63	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-23373	Alive	TUMOR FREE	1834	548	[Not Available]	NA	NA	364	[Not Available]	0	1834	0	1834	0	720	0	1834	69.01	5.02	60-69	Stage 1
4202	TCGA-BP-4964	KIRC	54	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-20084	Alive	TUMOR FREE	1862	548	[Not Available]	NA	NA	364	[Not Available]	0	1862	0	1862	0	720	0	1862	60.08	5.1	50-59	Stage 1
4203	TCGA-BP-4965	KIRC	46	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-16992	Alive	TUMOR FREE	1871	548	[Not Available]	NA	NA	364	[Not Available]	0	1871	0	1871	0	720	0	1871	51.64	5.12	40-49	Stage 1
4204	TCGA-BP-4967	KIRC	76	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-27857	Alive	TUMOR FREE	205	548	[Not Available]	NA	NA	364	[Not Available]	0	205	0	205	0	720	0	205	76.83	0.56	70-79	Stage 3
4205	TCGA-BP-4968	KIRC	40	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-14651	Alive	TUMOR FREE	1746	548	[Not Available]	NA	NA	364	[Not Available]	0	1746	0	1746	0	720	0	1746	44.89	4.78	40-49	Stage 1
4206	TCGA-BP-4969	KIRC	63	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-23216	Alive	TUMOR FREE	1794	548	[Not Available]	NA	NA	364	[Not Available]	0	1794	0	1794	0	720	0	1794	68.47	4.91	60-69	Stage 1
4207	TCGA-BP-4970	KIRC	44	MALE	ASIAN	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-16228	Alive	TUMOR FREE	433	548	[Not Available]	NA	NA	364	[Not Available]	0	433	0	433	0	720	0	433	45.62	1.19	40-49	Stage 3
4208	TCGA-BP-4971	KIRC	40	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-14675	Alive	TUMOR FREE	1487	548	[Not Available]	NA	NA	364	[Not Available]	0	1487	0	1487	0	720	0	1487	44.25	4.07	40-49	Stage 3
4209	TCGA-BP-4972	KIRC	43	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-16038	Alive	TUMOR FREE	1502	548	[Not Available]	NA	NA	364	[Not Available]	0	1502	0	1502	0	720	0	1502	48.02	4.11	40-49	Stage 3
4210	TCGA-BP-4973	KIRC	47	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-17461	Alive	TUMOR FREE	1384	548	[Not Available]	NA	NA	364	[Not Available]	0	1384	0	1384	0	720	0	1384	51.59	3.79	40-49	Stage 3
4211	TCGA-BP-4974	KIRC	58	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-21310	Dead	WITH TUMOR	766	211	[Not Available]	NA	NA	35	[Not Available]	1	211	1	211	0	720	1	35	58.92	0.58	50-59	Stage 4
4212	TCGA-BP-4975	KIRC	40	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-14710	Alive	TUMOR FREE	1433	548	[Not Available]	NA	NA	364	[Not Available]	0	1433	0	1433	0	720	0	1433	44.2	3.92	40-49	Stage 1
4213	TCGA-BP-4976	KIRC	77	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-28380	Alive	TUMOR FREE	1632	548	[Not Available]	NA	NA	364	[Not Available]	0	1632	0	1632	0	720	0	1632	82.17	4.47	70-79	Stage 1
4214	TCGA-BP-4977	KIRC	57	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-20950	Alive	TUMOR FREE	454	548	[Not Available]	NA	NA	364	[Not Available]	0	454	0	454	0	720	0	454	58.6	1.24	50-59	Stage 1
4215	TCGA-BP-4981	KIRC	75	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-27676	Dead	TUMOR FREE	766	1097	[Not Available]	NA	NA	364	[Not Available]	1	1097	0	1097	0	720	0	1097	78.78	3	70-79	Stage 3
4216	TCGA-BP-4982	KIRC	42	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-15451	Alive	TUMOR FREE	1014	548	[Not Available]	NA	NA	364	[Not Available]	0	1014	0	1014	0	720	0	1014	45.08	2.78	40-49	Stage 1
4217	TCGA-BP-4983	KIRC	67	FEMALE	ASIAN	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-24558	Alive	TUMOR FREE	1413	548	[Not Available]	NA	NA	364	[Not Available]	0	1413	0	1413	0	720	0	1413	71.1	3.87	60-69	Stage 3
4218	TCGA-BP-4985	KIRC	72	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-26611	Dead	WITH TUMOR	766	952	[Not Available]	NA	NA	205	[Not Available]	1	952	1	952	0	720	1	205	75.46	2.61	70-79	Stage 3
4219	TCGA-BP-4986	KIRC	75	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-27612	Alive	TUMOR FREE	785	548	[Not Available]	NA	NA	364	[Not Available]	0	785	0	785	0	720	0	785	77.75	2.15	70-79	Stage 1
4220	TCGA-BP-4987	KIRC	41	FEMALE	ASIAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-15041	Alive	TUMOR FREE	1124	548	[Not Available]	NA	NA	364	[Not Available]	0	1124	0	1124	0	720	0	1124	44.26	3.08	40-49	Stage 1
4221	TCGA-BP-4988	KIRC	72	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-26576	Dead	TUMOR FREE	766	828	[Not Available]	NA	NA	364	[Not Available]	1	828	0	828	0	720	0	828	75.03	2.27	70-79	Stage 1
4222	TCGA-BP-4989	KIRC	58	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-21382	Alive	TUMOR FREE	118	548	[Not Available]	NA	NA	364	[Not Available]	0	118	0	118	0	720	0	118	58.86	0.32	50-59	Stage 3
4223	TCGA-BP-4991	KIRC	54	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-19739	Alive	TUMOR FREE	1413	548	[Not Available]	NA	NA	364	[Not Available]	0	1413	0	1413	0	720	0	1413	57.91	3.87	50-59	Stage 1
4224	TCGA-BP-4992	KIRC	66	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-24438	Alive	TUMOR FREE	501	548	[Not Available]	NA	NA	364	[Not Available]	0	501	0	501	0	720	0	501	68.28	1.37	60-69	Stage 1
4225	TCGA-BP-4993	KIRC	58	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-21407	Alive	TUMOR FREE	177	548	[Not Available]	NA	NA	364	[Not Available]	0	177	0	177	0	720	0	177	59.09	0.48	50-59	Stage 1
4226	TCGA-BP-4994	KIRC	54	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-19946	Alive	TUMOR FREE	1308	548	[Not Available]	NA	NA	364	[Not Available]	0	1308	0	1308	0	720	0	1308	58.19	3.58	50-59	Stage 1
4227	TCGA-BP-4995	KIRC	68	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-24850	Alive	TUMOR FREE	1371	548	[Not Available]	NA	NA	364	[Not Available]	0	1371	0	1371	0	720	0	1371	71.79	3.75	60-69	Stage 1
4228	TCGA-BP-4998	KIRC	49	MALE	ASIAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-17997	Alive	TUMOR FREE	932	548	[Not Available]	NA	NA	364	[Not Available]	0	932	0	932	0	720	0	932	51.82	2.55	40-49	Stage 1
4229	TCGA-BP-4999	KIRC	56	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-20518	Alive	TUMOR FREE	1266	548	[Not Available]	NA	NA	364	[Not Available]	0	1266	0	1266	0	720	0	1266	59.64	3.47	50-59	Stage 1
4230	TCGA-BP-5000	KIRC	40	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-14868	Alive	TUMOR FREE	563	548	[Not Available]	NA	NA	364	[Not Available]	0	563	0	563	0	720	0	563	42.25	1.54	40-49	Stage 1
4231	TCGA-BP-5001	KIRC	43	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-15858	Alive	TUMOR FREE	1177	548	[Not Available]	NA	NA	364	[Not Available]	0	1177	0	1177	0	720	0	1177	46.64	3.22	40-49	Stage 1
4232	TCGA-BP-5004	KIRC	53	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-19383	Alive	TUMOR FREE	1126	548	[Not Available]	NA	NA	364	[Not Available]	0	1126	0	1126	0	720	0	1126	56.15	3.08	50-59	Stage 1
4233	TCGA-BP-5006	KIRC	61	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-22324	Alive	TUMOR FREE	840	548	[Not Available]	NA	NA	364	[Not Available]	0	840	0	840	0	720	0	840	63.42	2.3	60-69	Stage 1
4234	TCGA-BP-5007	KIRC	45	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-16793	Alive	TUMOR FREE	1140	548	[Not Available]	NA	NA	364	[Not Available]	0	1140	0	1140	0	720	0	1140	49.1	3.12	40-49	Stage 2
4235	TCGA-BP-5008	KIRC	46	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-17008	Alive	TUMOR FREE	1071	548	[Not Available]	NA	NA	364	[Not Available]	0	1071	0	1071	0	720	0	1071	49.5	2.93	40-49	Stage 1
4236	TCGA-BP-5009	KIRC	52	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-19052	Dead	WITH TUMOR	766	1092	[Not Available]	NA	NA	324	[Not Available]	1	1092	1	1092	0	720	1	324	55.15	2.99	50-59	Stage 1
4237	TCGA-BP-5010	KIRC	63	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-23130	Dead	WITH TUMOR	766	878	[Not Available]	NA	NA	582	[Not Available]	1	878	1	878	0	720	1	582	65.73	2.4	60-69	Stage 3
4238	TCGA-BP-5168	KIRC	75	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2002	[Not Available]	-27692	Dead	TUMOR FREE	766	1463	[Not Available]	NA	NA	364	[Not Available]	1	1463	0	1463	0	720	0	1463	79.82	4.01	70-79	Stage 1
4239	TCGA-BP-5169	KIRC	70	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-25615	Alive	TUMOR FREE	193	548	[Not Available]	NA	NA	364	[Not Available]	0	193	0	193	0	720	0	193	70.66	0.53	70-79	Stage 1
4240	TCGA-BP-5170	KIRC	55	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-20229	Alive	TUMOR FREE	2412	548	[Not Available]	NA	NA	364	[Not Available]	0	2412	0	2412	0	720	0	2412	61.99	6.6	50-59	Stage 1
4241	TCGA-BP-5173	KIRC	75	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-27436	Dead	TUMOR FREE	766	62	[Not Available]	NA	NA	364	[Not Available]	1	62	0	62	0	720	0	62	75.29	0.17	70-79	Stage 1
4242	TCGA-BP-5174	KIRC	45	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-16693	Alive	TUMOR FREE	2257	548	[Not Available]	NA	NA	364	[Not Available]	0	2257	0	2257	0	720	0	2257	51.88	6.18	40-49	Stage 1
4243	TCGA-BP-5175	KIRC	60	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-21949	Alive	TUMOR FREE	932	548	[Not Available]	NA	NA	364	[Not Available]	0	932	0	932	0	720	0	932	62.64	2.55	60-69	Stage 1
4244	TCGA-BP-5176	KIRC	78	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-28727	Dead	TUMOR FREE	766	1590	[Not Available]	NA	NA	364	[Not Available]	1	1590	0	1590	0	720	0	1590	83	4.35	70-79	Stage 1
4245	TCGA-BP-5177	KIRC	46	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-17147	Alive	TUMOR FREE	293	548	[Not Available]	NA	NA	364	[Not Available]	0	293	0	293	0	720	0	293	47.75	0.8	40-49	Stage 1
4246	TCGA-BP-5178	KIRC	71	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-26070	Dead	WITH TUMOR	766	1912	[Not Available]	NA	NA	396	[Not Available]	1	1912	1	1912	0	720	1	396	76.61	5.23	70-79	Stage 4
4247	TCGA-BP-5180	KIRC	53	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-19413	Alive	TUMOR FREE	2263	548	[Not Available]	NA	NA	364	[Not Available]	0	2263	0	2263	0	720	0	2263	59.35	6.2	50-59	Stage 1
4248	TCGA-BP-5181	KIRC	58	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-21514	Alive	TUMOR FREE	1495	548	[Not Available]	NA	NA	364	[Not Available]	0	1495	0	1495	0	720	0	1495	63	4.09	50-59	Stage 1
4249	TCGA-BP-5182	KIRC	56	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-20597	Alive	TUMOR FREE	1165	548	[Not Available]	NA	NA	364	[Not Available]	0	1165	0	1165	0	720	0	1165	59.58	3.19	50-59	Stage 1
4250	TCGA-BP-5183	KIRC	57	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-20881	Alive	TUMOR FREE	1291	548	[Not Available]	NA	NA	485	[Not Available]	0	1291	0	1291	0	720	1	485	60.7	3.53	50-59	Stage 3
4251	TCGA-BP-5184	KIRC	54	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-19746	Alive	TUMOR FREE	1133	548	[Not Available]	NA	NA	364	[Not Available]	0	1133	0	1133	0	720	0	1133	57.16	3.1	50-59	Stage 1
4252	TCGA-BP-5185	KIRC	56	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-20470	Alive	WITH TUMOR	1132	548	[Not Available]	NA	NA	736	[Not Available]	0	1132	0	1132	0	720	1	736	59.14	3.1	50-59	Stage 1
4253	TCGA-BP-5186	KIRC	50	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-18348	Alive	TUMOR FREE	693	548	[Not Available]	NA	NA	364	[Not Available]	0	693	0	693	0	720	0	693	52.13	1.9	50-59	Stage 1
4254	TCGA-BP-5187	KIRC	54	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-19999	Alive	TUMOR FREE	406	548	[Not Available]	NA	NA	364	[Not Available]	0	406	0	406	0	720	0	406	55.87	1.11	50-59	Stage 1
4255	TCGA-BP-5189	KIRC	60	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-22156	Dead	WITH TUMOR	766	822	[Not Available]	NA	NA	634	[Not Available]	1	822	1	822	0	720	1	634	62.91	2.25	60-69	Stage 1
4256	TCGA-BP-5190	KIRC	61	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-22285	Alive	TUMOR FREE	1011	548	[Not Available]	NA	NA	364	[Not Available]	0	1011	0	1011	0	720	0	1011	63.78	2.77	60-69	Stage 1
4257	TCGA-BP-5191	KIRC	79	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-29207	Alive	TUMOR FREE	967	548	[Not Available]	NA	NA	364	[Not Available]	0	967	0	967	0	720	0	967	82.61	2.65	70-79	Stage 3
4258	TCGA-BP-5192	KIRC	59	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-21891	Alive	TUMOR FREE	714	548	[Not Available]	NA	NA	364	[Not Available]	0	714	0	714	0	720	0	714	61.89	1.95	50-59	Stage 1
4259	TCGA-BP-5194	KIRC	39	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-14551	Alive	TUMOR FREE	408	548	[Not Available]	NA	NA	364	[Not Available]	0	408	0	408	0	720	0	408	40.96	1.12	30-39	Stage 1
4260	TCGA-BP-5195	KIRC	75	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-27547	Alive	TUMOR FREE	749	548	[Not Available]	NA	NA	364	[Not Available]	0	749	0	749	0	720	0	749	77.47	2.05	70-79	Stage 1
4261	TCGA-BP-5196	KIRC	53	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-19719	Alive	TUMOR FREE	1018	548	[Not Available]	NA	NA	364	[Not Available]	0	1018	0	1018	0	720	0	1018	56.77	2.79	50-59	Stage 1
4262	TCGA-BP-5198	KIRC	72	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-26360	Alive	TUMOR FREE	603	548	[Not Available]	NA	NA	364	[Not Available]	0	603	0	603	0	720	0	603	73.82	1.65	70-79	Stage 3
4263	TCGA-BP-5199	KIRC	58	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-21256	Alive	TUMOR FREE	1355	548	[Not Available]	NA	NA	364	[Not Available]	0	1355	0	1355	0	720	0	1355	61.91	3.71	50-59	Stage 2
4264	TCGA-BP-5200	KIRC	44	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2008	[Not Available]	-16197	Alive	TUMOR FREE	1063	548	[Not Available]	NA	NA	364	[Not Available]	0	1063	0	1063	0	720	0	1063	47.26	2.91	40-49	Stage 2
4265	TCGA-BP-5201	KIRC	63	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2008	[Not Available]	-23125	Alive	WITH TUMOR	951	548	[Not Available]	NA	NA	-19	[Not Available]	0	951	0	951	0	720	1	564	65.92	2.6	60-69	Stage 4
4266	TCGA-BP-5202	KIRC	75	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-27556	Alive	TUMOR FREE	29	548	[Not Available]	NA	NA	364	[Not Available]	0	29	0	29	0	720	0	29	75.52	0.08	70-79	Stage 3
4267	TCGA-CJ-4634	KIRC	60	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-22155	Alive	TUMOR FREE	3498	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3498	0	3498	0	3498	0	3498	70.23	9.58	60-69	Stage 1
4268	TCGA-CJ-4635	KIRC	48	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-17620	Alive	TUMOR FREE	1416	548	[Not Available]	NA	NA	364	[Not Available]	0	1416	0	1416	0	720	0	1416	52.12	3.88	40-49	Stage 1
4269	TCGA-CJ-4636	KIRC	51	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-18878	Alive	TUMOR FREE	1924	548	[Not Available]	NA	NA	364	[Not Available]	0	1924	0	1924	0	720	0	1924	56.95	5.27	50-59	Stage 3
4270	TCGA-CJ-4637	KIRC	52	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-19101	Dead	WITH TUMOR	766	2227	[Not Available]	NA	NA	1821	[Not Available]	1	2227	1	2227	0	720	1	1821	58.39	6.1	50-59	Stage 4
4271	TCGA-CJ-4638	KIRC	46	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-17110	Dead	WITH TUMOR	766	431	[Not Available]	NA	NA	70	[Not Available]	1	431	1	431	0	720	1	70	48.02	1.18	40-49	Stage 4
4272	TCGA-CJ-4639	KIRC	49	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-18066	Alive	TUMOR FREE	3229	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3229	0	3229	0	3229	0	3229	58.3	8.84	40-49	Stage 2
4273	TCGA-CJ-4640	KIRC	49	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-18178	Alive	TUMOR FREE	3480	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3480	0	3480	0	3480	0	3480	59.3	9.53	40-49	Stage 3
4274	TCGA-CJ-4641	KIRC	55	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-20410	Dead	WITH TUMOR	766	1661	[Not Available]	NA	NA	-359	[Not Available]	1	1661	1	1661	0	720	1	564	60.43	4.55	50-59	Stage 4
4275	TCGA-CJ-4642	KIRC	47	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-17367	Alive	TUMOR FREE	3205	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3205	0	3205	0	3205	0	3205	56.32	8.77	40-49	Stage 2
4276	TCGA-CJ-4643	KIRC	67	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-24477	Alive	TUMOR FREE	1793	548	[Not Available]	NA	NA	364	[Not Available]	0	1793	0	1793	0	720	0	1793	71.92	4.91	60-69	Stage 2
4277	TCGA-CJ-4644	KIRC	48	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-17882	Dead	WITH TUMOR	766	336	[Not Available]	NA	NA	93	[Not Available]	1	336	1	336	0	720	1	93	49.88	0.92	40-49	Stage 4
4278	TCGA-CJ-4868	KIRC	42	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-15601	Dead	WITH TUMOR	646	646	[Not Available]	NA	NA	37	[Not Available]	1	646	1	646	0	720	1	37	44.48	1.77	40-49	Stage 4
4279	TCGA-CJ-4869	KIRC	49	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-17923	Alive	WITH TUMOR	2554	548	[Not Available]	NA	NA	1754	[Not Available]	0	2554	0	2554	0	720	1	1754	56.06	6.99	40-49	Stage 3
4280	TCGA-CJ-4870	KIRC	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-21340	Alive	TUMOR FREE	1498	548	[Not Available]	NA	NA	364	[Not Available]	0	1498	0	1498	0	720	0	1498	62.53	4.1	50-59	Stage 3
4281	TCGA-CJ-4871	KIRC	63	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-23195	Alive	TUMOR FREE	2423	548	[Not Available]	NA	NA	169	[Not Available]	0	2423	0	2423	0	720	1	169	70.14	6.63	60-69	Stage 4
4282	TCGA-CJ-4872	KIRC	51	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-18862	Alive	TUMOR FREE	1435	548	[Not Available]	NA	NA	364	[Not Available]	0	1435	0	1435	0	720	0	1435	55.57	3.93	50-59	Stage 1
4283	TCGA-CJ-4873	KIRC	85	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-31096	Alive	TUMOR FREE	2259	548	[Not Available]	NA	NA	364	[Not Available]	0	2259	0	2259	0	720	0	2259	91.32	6.18	>=80	Stage 3
4284	TCGA-CJ-4874	KIRC	73	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-26761	Alive	TUMOR FREE	2283	548	[Not Available]	NA	NA	364	[Not Available]	0	2283	0	2283	0	720	0	2283	79.52	6.25	70-79	Stage 1
4285	TCGA-CJ-4875	KIRC	67	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-24510	Dead	WITH TUMOR	766	3554	[Not Available]	NA	NA	531	Complete Remission/Response	1	3554	1	3554	0	720	1	531	76.84	9.73	60-69	Stage 4
4286	TCGA-CJ-4876	KIRC	57	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-20993	Alive	TUMOR FREE	1955	548	[Not Available]	NA	NA	364	[Not Available]	0	1955	0	1955	0	720	0	1955	62.83	5.35	50-59	Stage 2
4287	TCGA-CJ-4878	KIRC	71	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-26224	Alive	TUMOR FREE	2186	548	[Not Available]	NA	NA	364	[Not Available]	0	2186	0	2186	0	720	0	2186	77.78	5.98	70-79	Stage 3
4288	TCGA-CJ-4881	KIRC	41	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-15197	Alive	WITH TUMOR	2014	548	[Not Available]	NA	NA	1881	[Not Available]	0	2014	0	2014	0	720	1	1881	47.12	5.51	40-49	Stage 3
4289	TCGA-CJ-4882	KIRC	57	MALE	BLACK OR AFRICAN AMERICAN	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-21074	Alive	TUMOR FREE	1883	548	[Not Available]	NA	NA	364	[Not Available]	0	1883	0	1883	0	720	0	1883	62.85	5.16	50-59	Stage 3
4290	TCGA-CJ-4884	KIRC	72	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-26475	Alive	TUMOR FREE	1759	548	[Not Available]	NA	NA	364	[Not Available]	0	1759	0	1759	0	720	0	1759	77.3	4.82	70-79	Stage 3
4291	TCGA-CJ-4885	KIRC	64	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-23437	Alive	TUMOR FREE	3451	548	[Not Available]	NA	NA	2041	Complete Remission/Response	0	3451	0	3451	0	720	1	2041	73.62	9.45	60-69	Stage 4
4292	TCGA-CJ-4886	KIRC	42	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-15698	Alive	TUMOR FREE	1952	548	[Not Available]	NA	NA	364	[Not Available]	0	1952	0	1952	0	720	0	1952	48.32	5.34	40-49	Stage 1
4293	TCGA-CJ-4887	KIRC	48	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-17611	Dead	WITH TUMOR	766	932	[Not Available]	NA	NA	322	[Not Available]	1	932	1	932	0	720	1	322	50.77	2.55	40-49	Stage 4
4294	TCGA-CJ-4888	KIRC	59	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-21701	Dead	WITH TUMOR	766	1567	[Not Available]	NA	NA	608	[Not Available]	1	1567	1	1567	0	720	1	608	63.7	4.29	50-59	Stage 4
4295	TCGA-CJ-4889	KIRC	63	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-23051	Alive	TUMOR FREE	1946	548	[Not Available]	NA	NA	364	[Not Available]	0	1946	0	1946	0	720	0	1946	68.44	5.33	60-69	Stage 1
4296	TCGA-CJ-4890	KIRC	72	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-26604	Alive	TUMOR FREE	3519	548	[Not Available]	NA	NA	70	Progressive Disease	0	3519	0	3519	0	720	1	70	82.47	9.63	70-79	Stage 4
4297	TCGA-CJ-4891	KIRC	57	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-21059	Dead	TUMOR FREE	766	819	[Not Available]	NA	NA	364	[Not Available]	1	819	0	819	0	720	0	819	59.9	2.24	50-59	Stage 3
4298	TCGA-CJ-4892	KIRC	65	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-23764	Alive	TUMOR FREE	1521	548	[Not Available]	NA	NA	364	[Not Available]	0	1521	0	1521	0	720	0	1521	69.23	4.16	60-69	Stage 1
4299	TCGA-CJ-4893	KIRC	76	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-27885	Alive	TUMOR FREE	750	548	[Not Available]	NA	NA	364	[Not Available]	0	750	0	750	0	720	0	750	78.4	2.05	70-79	Stage 1
4300	TCGA-CJ-4894	KIRC	58	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-21524	Dead	WITH TUMOR	841	841	[Not Available]	NA	NA	158	[Not Available]	1	841	1	841	0	720	1	158	61.23	2.3	50-59	Stage 3
4301	TCGA-CJ-4895	KIRC	62	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-22892	Dead	WITH TUMOR	766	1200	[Not Available]	NA	NA	61	[Not Available]	1	1200	1	1200	0	720	1	61	65.96	3.29	60-69	Stage 4
4302	TCGA-CJ-4897	KIRC	79	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-29124	Alive	WITH TUMOR	3341	548	[Not Available]	NA	NA	1423	Complete Remission/Response	0	3341	0	3341	1	1423	1	1423	88.88	9.15	70-79	Stage 3
4303	TCGA-CJ-4899	KIRC	42	MALE	ASIAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-15637	Alive	TUMOR FREE	1528	548	[Not Available]	NA	NA	364	[Not Available]	0	1528	0	1528	0	720	0	1528	47	4.18	40-49	Stage 1
4304	TCGA-CJ-4900	KIRC	69	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-25508	Dead	WITH TUMOR	766	1714	[Not Available]	NA	NA	364	[Not Available]	1	1714	1	1714	0	720	1	1714	74.53	4.69	60-69	Stage 4
4305	TCGA-CJ-4901	KIRC	47	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-17396	Alive	TUMOR FREE	1450	548	[Not Available]	NA	NA	364	[Not Available]	0	1450	0	1450	0	720	0	1450	51.6	3.97	40-49	Stage 3
4306	TCGA-CJ-4902	KIRC	61	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-22424	Alive	TUMOR FREE	1520	548	[Not Available]	NA	NA	364	[Not Available]	0	1520	0	1520	0	720	0	1520	65.56	4.16	60-69	Stage 3
4307	TCGA-CJ-4903	KIRC	50	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-18510	Alive	TUMOR FREE	1560	548	[Not Available]	NA	NA	364	[Not Available]	0	1560	0	1560	0	720	0	1560	54.95	4.27	50-59	Stage 1
4308	TCGA-CJ-4904	KIRC	60	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-22036	Alive	WITH TUMOR	3302	548	[Not Available]	NA	NA	278	Stable Disease	0	3302	0	3302	0	720	1	278	69.37	9.04	60-69	Stage 4
4309	TCGA-CJ-4905	KIRC	62	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-22864	Alive	TUMOR FREE	1496	548	[Not Available]	NA	NA	364	[Not Available]	0	1496	0	1496	0	720	0	1496	66.69	4.1	60-69	Stage 1
4310	TCGA-CJ-4907	KIRC	58	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-21208	Alive	TUMOR FREE	1499	548	[Not Available]	NA	NA	364	[Not Available]	0	1499	0	1499	0	720	0	1499	62.17	4.1	50-59	Stage 3
4311	TCGA-CJ-4908	KIRC	38	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-14226	Alive	TUMOR FREE	1531	548	[Not Available]	NA	NA	364	[Not Available]	0	1531	0	1531	0	720	0	1531	43.14	4.19	30-39	Stage 1
4312	TCGA-CJ-4912	KIRC	61	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-22623	Alive	TUMOR FREE	1657	548	[Not Available]	NA	NA	364	[Not Available]	0	1657	0	1657	0	720	0	1657	66.48	4.54	60-69	Stage 2
4313	TCGA-CJ-4913	KIRC	45	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-16757	Dead	WITH TUMOR	766	1173	[Not Available]	NA	NA	538	[Not Available]	1	1173	1	1173	0	720	1	538	49.09	3.21	40-49	Stage 3
4314	TCGA-CJ-4916	KIRC	69	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-25470	Alive	TUMOR FREE	1373	548	[Not Available]	NA	NA	364	[Not Available]	0	1373	0	1373	0	720	0	1373	73.49	3.76	60-69	Stage 3
4315	TCGA-CJ-4918	KIRC	64	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-23379	Dead	WITH TUMOR	766	93	[Not Available]	NA	NA	33	[Not Available]	1	93	1	93	0	720	1	33	64.26	0.25	60-69	Stage 4
4316	TCGA-CJ-4920	KIRC	64	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-23656	Dead	TUMOR FREE	766	139	[Not Available]	NA	NA	364	[Not Available]	1	139	0	139	0	720	0	139	65.15	0.38	60-69	Stage 1
4317	TCGA-CJ-4923	KIRC	63	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-23353	Dead	WITH TUMOR	766	572	[Not Available]	NA	NA	25	[Not Available]	1	572	1	572	0	720	1	25	65.5	1.57	60-69	Stage 4
4318	TCGA-CJ-5671	KIRC	51	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-18954	Alive	TUMOR FREE	3987	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3987	0	3987	0	3987	0	3987	62.81	10.92	50-59	Stage 1
4319	TCGA-CJ-5672	KIRC	84	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-30900	Dead	TUMOR FREE	766	2190	[Not Available]	NA	NA	364	[Not Available]	1	2190	0	2190	0	720	0	2190	90.6	6	>=80	Stage 1
4320	TCGA-CJ-5675	KIRC	70	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-25617	Alive	WITH TUMOR	3936	548	[Not Available]	NA	NA	900	Complete Remission/Response	0	3936	0	3936	1	900	1	900	80.91	10.78	70-79	Stage 2
4321	TCGA-CJ-5676	KIRC	47	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-17170	Alive	WITH TUMOR	4067	548	[Not Available]	NA	NA	2219	Complete Remission/Response	0	4067	0	4067	1	2219	1	2219	58.14	11.13	40-49	Stage 3
4322	TCGA-CJ-5677	KIRC	54	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-19849	Dead	WITH TUMOR	766	782	[Not Available]	NA	NA	288	[Not Available]	1	782	1	782	0	720	1	288	56.48	2.14	50-59	Stage 4
4323	TCGA-CJ-5678	KIRC	62	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-22944	Dead	WITH TUMOR	766	574	[Not Available]	NA	NA	399	[Not Available]	1	574	1	574	0	720	1	399	64.39	1.57	60-69	Stage 4
4324	TCGA-CJ-5679	KIRC	73	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2003	[Not Available]	-26858	Dead	WITH TUMOR	766	679	[Not Available]	NA	NA	595	[Not Available]	1	679	1	679	0	720	1	595	75.39	1.86	70-79	Stage 3
4325	TCGA-CJ-5680	KIRC	65	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2003	[Not Available]	-23778	Dead	WITH TUMOR	766	768	[Not Available]	NA	NA	153	[Not Available]	1	768	1	768	0	720	1	153	67.2	2.1	60-69	Stage 4
4326	TCGA-CJ-5681	KIRC	44	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-16121	Dead	WITH TUMOR	766	552	[Not Available]	NA	NA	17	[Not Available]	1	552	1	552	0	720	1	17	45.65	1.51	40-49	Stage 4
4327	TCGA-CJ-5682	KIRC	60	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-22244	Alive	WITH TUMOR	3736	548	[Not Available]	NA	NA	55	Stable Disease	0	3736	0	3736	0	720	1	55	71.13	10.23	60-69	Stage 4
4328	TCGA-CJ-5683	KIRC	78	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-28745	Alive	TUMOR FREE	1889	548	[Not Available]	NA	NA	364	[Not Available]	0	1889	0	1889	0	720	0	1889	83.87	5.17	70-79	Stage 1
4329	TCGA-CJ-5684	KIRC	61	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-22561	Alive	TUMOR FREE	2231	548	[Not Available]	NA	NA	364	[Not Available]	0	2231	0	2231	0	720	0	2231	67.88	6.11	60-69	Stage 3
4330	TCGA-CJ-5686	KIRC	59	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-21836	Alive	TUMOR FREE	2038	548	[Not Available]	NA	NA	364	[Not Available]	0	2038	0	2038	0	720	0	2038	65.36	5.58	50-59	Stage 1
4331	TCGA-CJ-5689	KIRC	90	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-32872	Dead	TUMOR FREE	766	1620	[Not Available]	NA	NA	364	[Not Available]	1	1620	0	1620	0	720	0	1620	94.43	4.44	>=80	Stage 1
4332	TCGA-CJ-6027	KIRC	77	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2003	[Not Available]	-28359	Dead	TUMOR FREE	766	3615	[Not Available]	NA	NA	364	Complete Remission/Response	1	3615	0	3615	0	3615	0	3615	87.54	9.9	70-79	Stage 1
4333	TCGA-CJ-6028	KIRC	58	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2003	[Not Available]	-21380	Dead	WITH TUMOR	766	1625	[Not Available]	NA	NA	137	[Not Available]	1	1625	1	1625	0	720	1	137	62.98	4.45	50-59	Stage 4
4334	TCGA-CJ-6030	KIRC	65	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-24096	Dead	TUMOR FREE	766	2299	[Not Available]	NA	NA	364	[Not Available]	1	2299	0	2299	0	720	0	2299	72.27	6.29	60-69	Stage 1
4335	TCGA-CJ-6031	KIRC	54	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-19905	Alive	TUMOR FREE	1906	548	[Not Available]	NA	NA	364	[Not Available]	0	1906	0	1906	0	720	0	1906	59.72	5.22	50-59	Stage 1
4336	TCGA-CJ-6032	KIRC	63	FEMALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-23310	Alive	TUMOR FREE	3639	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3639	0	3639	0	3639	0	3639	73.78	9.96	60-69	Stage 2
4337	TCGA-CJ-6033	KIRC	54	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-19919	Dead	WITH TUMOR	766	224	[Not Available]	NA	NA	144	[Not Available]	1	224	1	224	0	720	1	144	55.15	0.61	50-59	Stage 4
4338	TCGA-CW-5580	KIRC	73	FEMALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-26696	Dead	TUMOR FREE	766	1964	[Not Available]	NA	NA	364	[Not Available]	1	1964	0	1964	0	720	0	1964	78.47	5.38	70-79	Stage 4
4339	TCGA-CW-5581	KIRC	44	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-16195	Alive	TUMOR FREE	2799	548	[Not Available]	NA	NA	364	[Not Available]	0	2799	0	2799	0	720	0	2799	52	7.66	40-49	Stage 1
4340	TCGA-CW-5583	KIRC	51	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-18666	Alive	TUMOR FREE	2489	548	[Not Available]	NA	NA	364	[Not Available]	0	2489	0	2489	0	720	0	2489	57.92	6.81	50-59	Stage 1
4341	TCGA-CW-5584	KIRC	74	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-27352	Dead	TUMOR FREE	766	164	[Not Available]	NA	NA	102	[Not Available]	1	164	0	164	0	720	1	102	75.33	0.45	70-79	Stage 3
4342	TCGA-CW-5585	KIRC	51	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-18898	Alive	WITH TUMOR	2609	548	[Not Available]	NA	NA	364	[Not Available]	0	2609	0	2609	0	720	0	2609	58.88	7.14	50-59	Stage 4
4343	TCGA-CW-5587	KIRC	62	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-22693	Alive	TUMOR FREE	2226	548	[Not Available]	NA	NA	2003	[Not Available]	0	2226	0	2226	0	720	1	2003	68.22	6.09	60-69	Stage 3
4344	TCGA-CW-5588	KIRC	78	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-28714	Alive	TUMOR FREE	2017	548	[Not Available]	NA	NA	364	[Not Available]	0	2017	0	2017	0	720	0	2017	84.14	5.52	70-79	Stage 1
4345	TCGA-CW-5589	KIRC	52	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-19312	Alive	TUMOR FREE	2378	548	[Not Available]	NA	NA	364	[Not Available]	0	2378	0	2378	0	720	0	2378	59.38	6.51	50-59	Stage 1
4346	TCGA-CW-5590	KIRC	51	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2004	[Not Available]	-18905	Dead	TUMOR FREE	766	1075	[Not Available]	NA	NA	672	[Not Available]	1	1075	0	1075	0	720	1	672	54.7	2.94	50-59	Stage 4
4347	TCGA-CW-5591	KIRC	56	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-20712	Alive	WITH TUMOR	2271	548	[Not Available]	NA	NA	364	[Not Available]	0	2271	0	2271	0	720	0	2271	62.92	6.22	50-59	Stage 4
4348	TCGA-CW-6087	KIRC	61	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2003	[Not Available]	-22438	Dead	TUMOR FREE	766	41	[Not Available]	NA	NA	364	[Not Available]	1	41	0	41	0	720	0	41	61.54	0.11	60-69	Stage 4
4349	TCGA-CW-6088	KIRC	60	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2003	[Not Available]	-22020	Alive	TUMOR FREE	3222	548	[Not Available]	NA	NA	364	Stable Disease	0	3222	0	3222	0	720	0	3222	69.11	8.82	60-69	Stage 1
4350	TCGA-CW-6090	KIRC	68	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2003	[Not Available]	-24909	Alive	TUMOR FREE	2552	548	[Not Available]	NA	NA	2780	[Not Available]	0	2552	0	2552	0	720	1	2780	75.18	6.99	60-69	Stage 1
4351	TCGA-CW-6093	KIRC	73	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2004	[Not Available]	-26909	Alive	TUMOR FREE	3146	548	[Not Available]	NA	NA	364	Stable Disease	0	3146	0	3146	0	720	0	3146	82.29	8.61	70-79	Stage 1
4352	TCGA-CW-6096	KIRC	44	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2004	[Not Available]	-16140	Alive	TUMOR FREE	2701	548	[Not Available]	NA	NA	364	Stable Disease	0	2701	0	2701	0	720	0	2701	51.58	7.39	40-49	Stage 1
4353	TCGA-CW-6097	KIRC	32	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2004	[Not Available]	-11701	Dead	WITH TUMOR	766	571	[Not Available]	NA	NA	457	[Not Available]	1	571	1	571	0	720	1	457	33.6	1.56	30-39	Stage 3
4354	TCGA-CZ-4853	KIRC	82	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-30191	Alive	TUMOR FREE	774	548	[Not Available]	NA	NA	364	[Not Available]	0	774	0	774	0	720	0	774	84.78	2.12	>=80	Stage 1
4355	TCGA-CZ-4854	KIRC	68	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-24876	Dead	TUMOR FREE	766	1404	[Not Available]	NA	NA	364	[Not Available]	1	1404	0	1404	0	720	0	1404	71.95	3.84	60-69	Stage 1
4356	TCGA-CZ-4856	KIRC	62	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-22684	Alive	TUMOR FREE	18	548	[Not Available]	NA	NA	364	[Not Available]	0	18	0	18	0	720	0	18	62.15	0.05	60-69	Stage 1
4357	TCGA-CZ-4857	KIRC	56	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-20718	Dead	WITH TUMOR	766	1432	[Not Available]	NA	NA	188	[Not Available]	1	1432	1	1432	0	720	1	188	60.64	3.92	50-59	Stage 4
4358	TCGA-CZ-4858	KIRC	39	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-14343	Dead	WITH TUMOR	766	2105	[Not Available]	NA	NA	597	[Not Available]	1	2105	1	2105	0	720	1	597	45.03	5.76	30-39	Stage 2
4359	TCGA-CZ-4859	KIRC	59	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-21842	Alive	TUMOR FREE	1787	548	[Not Available]	NA	NA	364	[Not Available]	0	1787	0	1787	0	720	0	1787	64.69	4.89	50-59	Stage 1
4360	TCGA-CZ-4860	KIRC	60	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2005	[Not Available]	-22115	Dead	WITH TUMOR	766	206	[Not Available]	NA	NA	364	[Not Available]	1	206	1	206	0	720	1	206	61.11	0.56	60-69	Stage 4
4361	TCGA-CZ-4861	KIRC	63	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-23053	Dead	WITH TUMOR	766	446	[Not Available]	NA	NA	364	[Not Available]	1	446	1	446	0	720	1	446	64.34	1.22	60-69	Stage 2
4362	TCGA-CZ-4862	KIRC	46	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-17077	Alive	[Discrepancy]	3271	548	[Not Available]	NA	NA	364	[Not Available]	0	3271	0	3271	0	720	0	3271	55.71	8.96	40-49	Stage 1
4363	TCGA-CZ-4863	KIRC	51	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-18730	Alive	TUMOR FREE	1928	548	[Not Available]	NA	NA	364	[Not Available]	0	1928	0	1928	0	720	0	1928	56.56	5.28	50-59	Stage 3
4364	TCGA-CZ-4864	KIRC	86	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2002	[Not Available]	-31557	Dead	TUMOR FREE	2830	2830	[Not Available]	NA	NA	364	[Not Available]	1	2830	0	2830	0	720	0	2830	94.15	7.75	>=80	Stage 2
4365	TCGA-CZ-4865	KIRC	70	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-25709	Dead	TUMOR FREE	766	166	[Not Available]	NA	NA	364	[Not Available]	1	166	0	166	0	720	0	166	70.84	0.45	70-79	Stage 1
4366	TCGA-CZ-4866	KIRC	79	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-28878	Alive	WITH TUMOR	3267	548	[Not Available]	NA	NA	364	[Not Available]	0	3267	0	3267	0	720	0	3267	88.01	8.94	70-79	Stage 1
4367	TCGA-CZ-5451	KIRC	74	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-27312	Alive	TUMOR FREE	1929	548	[Not Available]	NA	NA	364	[Not Available]	0	1929	0	1929	0	720	0	1929	80.06	5.28	70-79	Stage 2
4368	TCGA-CZ-5452	KIRC	69	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-25486	Alive	TUMOR FREE	1789	548	[Not Available]	NA	NA	364	[Not Available]	0	1789	0	1789	0	720	0	1789	74.67	4.9	60-69	Stage 2
4369	TCGA-CZ-5453	KIRC	67	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-24640	Dead	TUMOR FREE	766	2419	[Not Available]	NA	NA	364	[Not Available]	1	2419	0	2419	0	720	0	2419	74.08	6.62	60-69	Stage 2
4370	TCGA-CZ-5454	KIRC	63	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-23083	Dead	WITH TUMOR	766	722	[Not Available]	NA	NA	423	[Not Available]	1	722	1	722	0	720	1	423	65.17	1.98	60-69	Stage 4
4371	TCGA-CZ-5455	KIRC	63	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-23150	Dead	WITH TUMOR	766	561	[Not Available]	NA	NA	364	[Not Available]	1	561	1	561	0	720	1	561	64.92	1.54	60-69	Stage 4
4372	TCGA-CZ-5456	KIRC	57	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-21164	Alive	WITH TUMOR	2422	548	[Not Available]	NA	NA	951	[Not Available]	0	2422	0	2422	0	720	1	951	64.57	6.63	50-59	Stage 2
4373	TCGA-CZ-5457	KIRC	62	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-22763	Alive	WITH TUMOR	2754	548	[Not Available]	NA	NA	174	[Not Available]	0	2754	0	2754	0	720	1	174	69.86	7.54	60-69	Stage 3
4374	TCGA-CZ-5458	KIRC	43	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-15790	Alive	TUMOR FREE	2789	548	[Not Available]	NA	NA	364	[Not Available]	0	2789	0	2789	0	720	0	2789	50.87	7.64	40-49	Stage 3
4375	TCGA-CZ-5459	KIRC	63	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-23318	Alive	TUMOR FREE	1683	548	[Not Available]	NA	NA	364	[Not Available]	0	1683	0	1683	0	720	0	1683	68.45	4.61	60-69	Stage 3
4376	TCGA-CZ-5460	KIRC	55	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-20392	Alive	WITH TUMOR	2873	548	[Not Available]	NA	NA	364	[Not Available]	0	2873	0	2873	0	720	0	2873	63.7	7.87	50-59	Stage 4
4377	TCGA-CZ-5461	KIRC	52	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2006	[Not Available]	-19030	Dead	WITH TUMOR	330	330	[Not Available]	NA	NA	48	[Not Available]	1	330	1	330	0	720	1	48	53	0.9	50-59	Stage 4
4378	TCGA-CZ-5462	KIRC	83	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2007	[Not Available]	-30659	Dead	WITH TUMOR	766	311	[Not Available]	NA	NA	364	[Not Available]	1	311	1	311	0	720	1	311	84.79	0.85	>=80	Stage 4
4379	TCGA-CZ-5463	KIRC	76	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-27911	Alive	TUMOR FREE	662	548	[Not Available]	NA	NA	364	[Not Available]	0	662	0	662	0	720	0	662	78.23	1.81	70-79	Stage 2
4380	TCGA-CZ-5464	KIRC	69	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-25463	Alive	TUMOR FREE	2128	548	[Not Available]	NA	NA	364	[Not Available]	0	2128	0	2128	0	720	0	2128	75.54	5.83	60-69	Stage 4
4381	TCGA-CZ-5465	KIRC	76	FEMALE	[Not Available]	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-27838	Dead	TUMOR FREE	766	2564	[Not Available]	NA	NA	364	[Not Available]	1	2564	0	2564	0	720	0	2564	83.24	7.02	70-79	Stage 3
4382	TCGA-CZ-5466	KIRC	67	MALE	[Not Available]	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-24669	Alive	TUMOR FREE	685	548	[Not Available]	NA	NA	364	[Not Available]	0	685	0	685	0	720	0	685	69.42	1.88	60-69	Stage 3
4383	TCGA-CZ-5467	KIRC	86	FEMALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-31473	Dead	WITH TUMOR	766	73	[Not Available]	NA	NA	62	[Not Available]	1	73	1	73	0	720	1	62	86.37	0.2	>=80	Stage 3
4384	TCGA-CZ-5468	KIRC	84	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2007	[Not Available]	-30729	Dead	WITH TUMOR	59	59	[Not Available]	NA	NA	364	[Not Available]	1	59	1	59	0	720	1	59	84.29	0.16	>=80	Stage 4
4385	TCGA-CZ-5469	KIRC	41	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-15242	Dead	WITH TUMOR	766	946	[Not Available]	NA	NA	110	[Not Available]	1	946	1	946	0	720	1	110	44.32	2.59	40-49	Stage 2
4386	TCGA-CZ-5470	KIRC	72	FEMALE	[Not Available]	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-26494	Alive	TUMOR FREE	386	548	[Not Available]	NA	NA	364	[Not Available]	0	386	0	386	0	720	0	386	73.59	1.06	70-79	Stage 2
4387	TCGA-CZ-5982	KIRC	59	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2005	[Not Available]	-21592	Alive	TUMOR FREE	2439	548	[Not Available]	NA	NA	364	[Not Available]	0	2439	0	2439	0	720	0	2439	65.79	6.68	50-59	Stage 1
4388	TCGA-CZ-5984	KIRC	51	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2005	[Not Available]	-18775	Alive	TUMOR FREE	2067	548	[Not Available]	NA	NA	364	[Not Available]	0	2067	0	2067	0	720	0	2067	57.06	5.66	50-59	Stage 1
4389	TCGA-CZ-5985	KIRC	58	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-21242	Alive	TUMOR FREE	1997	548	[Not Available]	NA	NA	364	[Not Available]	0	1997	0	1997	0	720	0	1997	63.62	5.47	50-59	Stage 2
4390	TCGA-CZ-5986	KIRC	61	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2006	[Not Available]	-22456	Alive	TUMOR FREE	373	548	[Not Available]	NA	NA	364	[Not Available]	0	373	0	373	0	720	0	373	62.5	1.02	60-69	Stage 1
4391	TCGA-CZ-5987	KIRC	60	MALE	WHITE	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-21928	Dead	WITH TUMOR	766	445	[Not Available]	NA	NA	377	[Not Available]	1	445	1	445	0	720	1	377	61.25	1.22	60-69	Stage 4
4392	TCGA-CZ-5988	KIRC	38	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-14131	Alive	TUMOR FREE	693	548	[Not Available]	NA	NA	364	[Not Available]	0	693	0	693	0	720	0	693	40.59	1.9	30-39	Stage 1
4393	TCGA-CZ-5989	KIRC	60	MALE	WHITE	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2006	[Not Available]	-22170	Alive	TUMOR FREE	1905	548	[Not Available]	NA	NA	364	[Not Available]	0	1905	0	1905	0	720	0	1905	65.91	5.22	60-69	Stage 2
4394	TCGA-DV-5565	KIRC	59	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-21642	Alive	WITH TUMOR	1329	548	[Not Available]	NA	NA	364	[Not Available]	0	1329	0	1329	0	720	0	1329	62.89	3.64	50-59	Stage 1
4395	TCGA-DV-5566	KIRC	67	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-24717	Alive	WITH TUMOR	1398	548	[Not Available]	NA	NA	364	[Not Available]	0	1398	0	1398	0	720	0	1398	71.5	3.83	60-69	Stage 1
4396	TCGA-DV-5567	KIRC	40	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-14642	Alive	WITH TUMOR	2004	548	[Not Available]	NA	NA	2004	Complete Remission/Response	0	2004	0	2004	1	2004	1	2004	45.57	5.49	40-49	Stage 1
4397	TCGA-DV-5568	KIRC	26	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2009	[Not Available]	-9714	Alive	WITH TUMOR	370	548	[Not Available]	NA	NA	364	[Not Available]	0	370	0	370	0	720	0	370	27.61	1.01	18-29	Stage 1
4398	TCGA-DV-5569	KIRC	29	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2009	[Not Available]	-10698	Alive	TUMOR FREE	355	548	[Not Available]	NA	NA	364	[Not Available]	0	355	0	355	0	720	0	355	30.26	0.97	18-29	Stage 1
4399	TCGA-DV-5573	KIRC	41	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-15264	Alive	WITH TUMOR	1130	548	[Not Available]	NA	NA	364	[Not Available]	0	1130	0	1130	0	720	0	1130	44.88	3.09	40-49	Stage 1
4400	TCGA-DV-5574	KIRC	37	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-13517	Alive	WITH TUMOR	2016	548	[Not Available]	NA	NA	357	Complete Remission/Response	0	2016	0	2016	1	357	1	357	42.53	5.52	30-39	Stage 1
4401	TCGA-DV-5575	KIRC	52	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-19022	Alive	WITH TUMOR	1729	548	[Not Available]	NA	NA	364	[Not Available]	0	1729	0	1729	0	720	0	1729	56.81	4.73	50-59	Stage 1
4402	TCGA-DV-5576	KIRC	55	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2008	[Not Available]	-20310	Dead	WITH TUMOR	766	727	[Not Available]	NA	NA	364	[Not Available]	1	727	1	727	0	720	1	727	57.6	1.99	50-59	Stage 1
4403	TCGA-DV-A4VX	KIRC	59	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2008	[Not Available]	-21670	Dead	WITH TUMOR	766	1626	[Not Available]	NA	NA	364	Progressive Disease	1	1626	1	1626	0	720	1	1626	63.78	4.45	50-59	Stage 4
4404	TCGA-DV-A4VZ	KIRC	53	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2007	[Not Available]	-19560	Alive	TUMOR FREE	365	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	365	0	365	0	365	0	365	54.55	1	50-59	Stage 1
4405	TCGA-DV-A4W0	KIRC	55	MALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-20101	Alive	WITH TUMOR	2470	548	[Not Available]	NA	NA	2008	Stable Disease	0	2470	0	2470	0	720	1	2008	61.8	6.76	50-59	Stage 1
4406	TCGA-EU-5904	KIRC	47	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2009	[Not Available]	-17468	Alive	TUMOR FREE	551	548	[Not Available]	NA	NA	364	[Not Available]	0	551	0	551	0	720	0	551	49.33	1.51	40-49	Stage 1
4407	TCGA-EU-5905	KIRC	67	FEMALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-24475	Alive	TUMOR FREE	119	548	[Not Available]	NA	NA	364	[Not Available]	0	119	0	119	0	720	0	119	67.33	0.33	60-69	Stage 1
4408	TCGA-EU-5906	KIRC	55	MALE	WHITE	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2010	[Not Available]	-20246	Alive	TUMOR FREE	206	548	[Not Available]	NA	NA	364	[Not Available]	0	206	0	206	0	720	0	206	55.99	0.56	50-59	Stage 1
4409	TCGA-EU-5907	KIRC	81	MALE	WHITE	Stage III	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2010	[Not Available]	-29863	Alive	TUMOR FREE	127	548	[Not Available]	NA	NA	364	[Not Available]	0	127	0	127	0	720	0	127	82.11	0.35	>=80	Stage 3
4410	TCGA-G6-A5PC	KIRC	54	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G4	2012	[Not Available]	-20029	Dead	WITH TUMOR	766	242	[Not Available]	NA	NA	364	Progressive Disease	1	242	1	242	0	720	1	242	55.5	0.66	50-59	Stage 4
4411	TCGA-G6-A8L6	KIRC	55	MALE	BLACK OR AFRICAN AMERICAN	Stage IV	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2013	[Not Available]	-20306	Dead	WITH TUMOR	766	313	[Not Available]	NA	NA	304	Progressive Disease	1	313	1	313	0	720	1	304	56.45	0.86	50-59	Stage 4
4412	TCGA-G6-A8L7	KIRC	81	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-29883	Alive	TUMOR FREE	2133	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2133	0	2133	0	2133	0	2133	87.66	5.84	>=80	Stage 1
4413	TCGA-G6-A8L8	KIRC	62	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G3	2008	[Not Available]	-22649	Dead	TUMOR FREE	766	1091	[Not Available]	NA	NA	364	Complete Remission/Response	1	1091	0	1091	0	1091	0	1091	65	2.99	60-69	Stage 1
4414	TCGA-GK-A6C7	KIRC	76	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	[Not Available]	2012	[Not Available]	-28107	Alive	TUMOR FREE	61	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	61	0	61	0	61	0	61	77.12	0.17	70-79	Stage 1
4415	TCGA-MM-A563	KIRC	41	MALE	BLACK OR AFRICAN AMERICAN	[Discrepancy]	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2012	[Not Available]	-15037	Alive	TUMOR FREE	591	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	591	0	591	0	591	0	591	42.79	1.62	40-49	other
4416	TCGA-MM-A564	KIRC	68	MALE	BLACK OR AFRICAN AMERICAN	Stage II	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2012	[Not Available]	-24916	Alive	TUMOR FREE	607	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	607	0	607	0	607	0	607	69.88	1.66	60-69	Stage 2
4417	TCGA-MM-A84U	KIRC	58	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2013	[Not Available]	-21375	Alive	TUMOR FREE	700	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	700	0	700	0	700	0	700	60.44	1.92	50-59	Stage 1
4418	TCGA-MW-A4EC	KIRC	72	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G2	2012	[Not Available]	-26649	Alive	TUMOR FREE	498	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	498	0	498	0	498	0	498	74.32	1.36	70-79	Stage 1
4419	TCGA-T7-A92I	KIRC	47	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	[Not Applicable]	Kidney Clear Cell Renal Carcinoma	G1	2013	[Not Available]	-17331	Alive	TUMOR FREE	356	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	356	0	356	0	356	0	356	48.42	0.97	40-49	Stage 1
6916	TCGA-04-1331	OV	78	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-28848	Dead	WITH TUMOR	1224	1336	[Not Available]	Recurrence	[Not Applicable]	459	Complete Remission/Response	1	1336	1	1336	1	459	1	459	82.64	3.66	70-79	other
6917	TCGA-04-1332	OV	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-25786	Dead	WITH TUMOR	1247	1247	[Not Available]	Recurrence	[Not Applicable]	393	[Not Available]	1	1247	1	1247	0	720	1	393	74.01	3.41	70-79	other
6918	TCGA-04-1335	OV	60	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Serous Cystadenocarcinoma	G2	2005	[Not Available]	-21963	Dead	WITH TUMOR	766	55	[Not Available]	NA	NA	364	[Not Available]	1	55	1	55	0	720	1	55	60.28	0.15	60-69	Stage 1
6919	TCGA-04-1336	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-20271	Alive	TUMOR FREE	1495	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1495	0	1495	0	1495	0	1495	59.59	4.09	50-59	other
6920	TCGA-04-1337	OV	78	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	[Not Available]	-28626	Dead	WITH TUMOR	766	61	[Not Available]	NA	NA	364	[Not Available]	1	61	1	61	0	720	1	61	78.54	0.17	70-79	other
6921	TCGA-04-1338	OV	78	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-28789	Alive	WITH TUMOR	1418	548	[Not Available]	Recurrence	[Not Applicable]	380	[Not Available]	0	1418	0	1418	0	720	1	380	82.7	3.88	70-79	other
6922	TCGA-04-1341	OV	85	FEMALE	WHITE	[Not Applicable]	[Not Available]	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-31215	Alive	TUMOR FREE	33	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	33	0	33	0	33	0	33	85.55	0.09	>=80	other
6923	TCGA-04-1342	OV	80	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	2006	[Not Available]	-29501	Dead	WITH TUMOR	766	563	[Not Available]	NA	NA	364	Progressive Disease	1	563	1	563	0	720	1	563	82.31	1.54	>=80	other
6924	TCGA-04-1343	OV	72	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-26428	Dead	WITH TUMOR	766	361	[Not Available]	NA	NA	364	Progressive Disease	1	361	1	361	0	720	1	361	73.34	0.99	70-79	other
6925	TCGA-04-1346	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-26865	Alive	TUMOR FREE	1993	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1993	0	1993	0	1993	0	1993	79.01	5.46	70-79	other
6926	TCGA-04-1347	OV	81	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-29695	Alive	TUMOR FREE	1919	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1919	0	1919	0	720	0	1919	86.55	5.25	>=80	other
6927	TCGA-04-1348	OV	44	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-16236	Dead	WITH TUMOR	766	1483	[Not Available]	Recurrence	[Not Applicable]	575	Complete Remission/Response	1	1483	1	1483	1	575	1	575	48.51	4.06	40-49	other
6928	TCGA-04-1349	OV	69	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-25213	Dead	WITH TUMOR	766	656	[Not Available]	Recurrence	[Not Applicable]	428	Complete Remission/Response	1	656	1	656	0	720	1	428	70.83	1.8	60-69	other
6929	TCGA-04-1350	OV	46	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-16942	Dead	WITH TUMOR	766	1946	[Not Available]	Recurrence	[Not Applicable]	111	Stable Disease	1	1946	1	1946	0	720	1	111	51.71	5.33	40-49	other
6930	TCGA-04-1351	OV	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-28045	Alive	TUMOR FREE	1991	548	[Not Available]	Recurrence	[Not Applicable]	1658	Complete Remission/Response	0	1991	0	1991	1	1658	1	1658	82.23	5.45	70-79	other
6931	TCGA-04-1353	OV	64	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	[Not Available]	2003	[Not Available]	-23611	Alive	TUMOR FREE	16	548	[Not Available]	NA	NA	364	[Not Available]	0	16	0	16	0	720	0	16	64.69	0.04	60-69	other
6932	TCGA-04-1356	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-22855	Dead	WITH TUMOR	766	1499	[Not Available]	Recurrence	[Not Applicable]	156	Progressive Disease	1	1499	1	1499	0	720	1	156	66.68	4.1	60-69	Stage 2
6933	TCGA-04-1357	OV	52	FEMALE	[Not Available]	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-18999	Alive	TUMOR FREE	766	548	[Not Available]	NA	NA	364	[Not Available]	0	714	0	722	0	720	0	564	54.11	2.1	50-59	other
6934	TCGA-04-1360	OV	65	FEMALE	[Not Available]	[Not Applicable]	Stage IA	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-23993	Alive	TUMOR FREE	766	548	[Not Available]	NA	NA	364	[Not Available]	0	714	0	722	0	720	0	564	67.79	2.1	60-69	Stage 1
6935	TCGA-04-1361	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-20860	Alive	TUMOR FREE	989	548	[Not Available]	Recurrence	[Not Applicable]	927	Stable Disease	0	989	0	989	0	720	1	927	59.82	2.71	50-59	other
6936	TCGA-04-1362	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-21745	Dead	WITH TUMOR	766	1348	[Not Available]	Recurrence	[Not Applicable]	223	[Not Available]	1	1348	1	1348	0	720	1	223	63.23	3.69	50-59	Stage 2
6937	TCGA-04-1364	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-22294	Dead	WITH TUMOR	766	1024	[Not Available]	Recurrence	[Not Applicable]	288	Progressive Disease	1	1024	1	1024	0	720	1	288	63.84	2.8	60-69	other
6938	TCGA-04-1365	OV	87	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-31925	Alive	WITH TUMOR	2329	548	[Not Available]	Recurrence	[Not Applicable]	1328	Complete Remission/Response	0	2329	0	2329	1	1328	1	1328	93.78	6.38	>=80	other
6939	TCGA-04-1367	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-18577	Alive	WITH TUMOR	3145	548	[Not Available]	Progression of Disease	[Not Applicable]	2997	Complete Remission/Response	0	3145	0	3145	1	2997	1	2997	59.47	8.61	50-59	other
6940	TCGA-04-1369	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-19571	Dead	WITH TUMOR	766	642	[Not Available]	Progression of Disease	[Not Applicable]	315	[Not Available]	1	642	1	642	0	720	1	315	55.34	1.76	50-59	other
6941	TCGA-04-1370	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-19329	Alive	TUMOR FREE	1824	548	[Not Available]	NA	NA	364	[Not Available]	0	1824	0	1824	0	720	0	1824	57.91	4.99	50-59	other
6942	TCGA-04-1371	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-21243	Alive	TUMOR FREE	2506	548	[Not Available]	NA	NA	364	[Not Available]	0	2506	0	2506	0	720	0	2506	65.02	6.86	50-59	other
6943	TCGA-04-1514	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-16725	Dead	TUMOR FREE	766	1720	[Not Available]	Recurrence	[Not Applicable]	1221	Complete Remission/Response	1	1720	0	1720	1	1221	1	1221	50.5	4.71	40-49	other
6944	TCGA-04-1516	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-17768	Alive	TUMOR FREE	1265	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1265	0	1265	0	1265	0	1265	52.11	3.46	40-49	Stage 1
6945	TCGA-04-1517	OV	79	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-29045	Dead	WITH TUMOR	766	608	[Not Available]	Recurrence	[Not Applicable]	349	Complete Remission/Response	1	608	1	608	1	349	1	349	81.19	1.66	70-79	other
6946	TCGA-04-1519	OV	48	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-17671	Alive	TUMOR FREE	24	548	[Not Available]	NA	NA	364	[Unknown]	0	24	0	24	0	720	0	24	48.45	0.07	40-49	other
6947	TCGA-04-1525	OV	47	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-17469	Dead	WITH TUMOR	1167	1167	[Not Available]	Recurrence	[Not Applicable]	213	Complete Remission/Response	1	1167	1	1167	1	213	1	213	51.02	3.2	40-49	other
6948	TCGA-04-1530	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	[Not Available]	-25013	Dead	WITH TUMOR	766	3622	[Not Available]	Recurrence	[Not Applicable]	350	Complete Remission/Response	1	3622	1	3622	1	350	1	350	78.4	9.92	60-69	other
6949	TCGA-04-1536	OV	60	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-21939	Dead	WITH TUMOR	766	885	[Not Available]	Recurrence	[Not Applicable]	498	[Not Available]	1	885	1	885	0	720	1	498	62.49	2.42	60-69	other
6950	TCGA-04-1542	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G2	2001	[Not Available]	-19263	Dead	WITH TUMOR	766	2561	[Not Available]	Recurrence	[Not Applicable]	1020	Complete Remission/Response	1	2561	1	2561	1	1020	1	1020	59.75	7.01	50-59	other
6951	TCGA-04-1638	OV	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-20987	Dead	TUMOR FREE	766	1686	[Not Available]	Recurrence	[Not Applicable]	298	[Not Available]	1	1686	0	1686	0	720	1	298	62.08	4.62	50-59	other
6952	TCGA-04-1644	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-17725	Dead	WITH TUMOR	766	1487	[Not Available]	Progression of Disease	[Not Applicable]	634	Partial Remission/Response	1	1487	1	1487	0	720	1	634	52.6	4.07	40-49	other
6953	TCGA-04-1646	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-22207	Dead	WITH TUMOR	766	848	[Not Available]	Recurrence	[Not Applicable]	508	[Not Available]	1	848	1	848	0	720	1	508	63.12	2.32	60-69	other
6954	TCGA-04-1648	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-21113	Dead	TUMOR FREE	766	871	[Not Available]	Recurrence	[Not Applicable]	412	[Not Available]	1	871	0	871	0	720	1	412	60.19	2.38	50-59	other
6955	TCGA-04-1649	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-27165	Alive	TUMOR FREE	1966	548	[Not Available]	Recurrence	[Not Applicable]	1672	[Not Available]	0	1966	0	1966	0	720	1	1672	79.76	5.38	70-79	other
6956	TCGA-04-1651	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-19628	Dead	TUMOR FREE	766	1102	[Not Available]	Recurrence	[Not Applicable]	990	[Not Available]	1	1102	0	1102	0	720	1	990	56.76	3.02	50-59	other
6957	TCGA-04-1652	OV	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-28101	Dead	WITH TUMOR	766	969	[Not Available]	Recurrence	[Not Applicable]	880	Complete Remission/Response	1	969	1	969	1	880	1	880	79.59	2.65	70-79	other
6958	TCGA-04-1654	OV	69	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	1999	[Not Available]	-25387	Dead	TUMOR FREE	766	1451	[Not Available]	Recurrence	[Not Applicable]	808	[Not Available]	1	1451	0	1451	0	720	1	808	73.48	3.97	60-69	other
6959	TCGA-04-1655	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G2	1999	[Not Available]	-17988	Dead	TUMOR FREE	766	1380	[Not Available]	Recurrence	[Not Applicable]	819	[Not Available]	1	1380	0	1380	0	720	1	819	53.03	3.78	40-49	other
6960	TCGA-09-0364	OV	80	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-29262	Dead	WITH TUMOR	766	887	[Not Available]	Recurrence	[Not Applicable]	395	Complete Remission/Response	1	887	1	887	1	395	1	395	82.54	2.43	>=80	Stage 2
6961	TCGA-09-0365	OV	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-25703	Dead	WITH TUMOR	766	288	[Not Available]	Recurrence	[Not Applicable]	251	Complete Remission/Response	1	288	1	288	1	251	1	251	71.16	0.79	70-79	other
6962	TCGA-09-0366	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-20440	Dead	WITH TUMOR	766	1757	[Not Available]	Recurrence	[Not Applicable]	190	Stable Disease	1	1757	1	1757	0	720	1	190	60.77	4.81	50-59	other
6963	TCGA-09-0367	OV	67	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-24473	Dead	WITH TUMOR	766	547	[Not Available]	NA	NA	364	Progressive Disease	1	547	1	547	0	720	1	547	68.5	1.5	60-69	other
6964	TCGA-09-0369	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-20705	Dead	WITH TUMOR	766	1082	[Not Available]	Recurrence	[Not Applicable]	274	Complete Remission/Response	1	1082	1	1082	1	274	1	274	59.65	2.96	50-59	other
6965	TCGA-09-1659	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-18733	Dead	WITH TUMOR	766	304	[Not Available]	NA	NA	364	Stable Disease	1	304	1	304	0	720	1	304	52.12	0.83	50-59	other
6966	TCGA-09-1661	OV	75	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-27486	Dead	WITH TUMOR	766	1169	[Not Available]	NA	NA	364	Stable Disease	1	1169	1	1169	0	720	1	1169	78.45	3.2	70-79	other
6967	TCGA-09-1662	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-21246	Dead	WITH TUMOR	766	2717	[Not Available]	Recurrence	[Not Applicable]	1046	Complete Remission/Response	1	2717	1	2717	0	720	1	1046	65.61	7.44	50-59	other
6968	TCGA-09-1664	OV	37	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G1	2002	[Not Available]	-13739	Dead	TUMOR FREE	766	2279	[Not Available]	NA	NA	364	Complete Remission/Response	1	2279	0	2279	0	2279	0	2279	43.85	6.24	30-39	other
6969	TCGA-09-1665	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2002	[Not Available]	-27010	Dead	WITH TUMOR	766	1266	[Not Available]	Recurrence	[Not Applicable]	468	Complete Remission/Response	1	1266	1	1266	1	468	1	468	77.42	3.47	70-79	other
6970	TCGA-09-1666	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-21066	Alive	WITH TUMOR	1752	548	[Not Available]	Recurrence	[Not Applicable]	480	Complete Remission/Response	0	1752	0	1752	1	480	1	480	62.47	4.8	50-59	other
6971	TCGA-09-1667	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-22306	Alive	WITH TUMOR	1882	548	[Not Available]	Recurrence	[Not Applicable]	460	Complete Remission/Response	0	1882	0	1882	1	460	1	460	66.22	5.15	60-69	Stage 2
6972	TCGA-09-1668	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-20972	Alive	WITH TUMOR	1684	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1684	0	1684	0	1684	0	1684	62.03	4.61	50-59	other
6973	TCGA-09-1669	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-20052	Alive	WITH TUMOR	928	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	928	0	928	0	928	0	928	57.44	2.54	50-59	other
6974	TCGA-09-1670	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-21147	Alive	WITH TUMOR	547	548	[Not Available]	Recurrence	[Not Applicable]	547	Complete Remission/Response	0	547	0	547	1	547	1	547	59.39	1.5	50-59	other
6975	TCGA-09-1672	OV	78	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G1	2008	[Not Available]	-28556	Alive	TUMOR FREE	178	548	[Not Available]	NA	NA	364	[Not Available]	0	178	0	178	0	720	0	178	78.67	0.49	70-79	other
6976	TCGA-09-1673	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-18599	Alive	WITH TUMOR	92	548	[Not Available]	NA	NA	364	[Not Available]	0	92	0	92	0	720	0	92	51.17	0.25	50-59	other
6977	TCGA-09-1674	OV	79	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-28878	Alive	WITH TUMOR	260	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	260	0	260	0	260	0	260	79.78	0.71	70-79	other
6978	TCGA-09-1675	OV	50	FEMALE	[Not Available]	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G2	2001	[Not Available]	-18596	Alive	TUMOR FREE	2967	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2967	0	2967	0	2967	0	2967	59.04	8.12	50-59	Stage 1
6979	TCGA-09-2043	OV	69	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-25480	Alive	TUMOR FREE	188	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	188	0	188	0	188	0	188	70.28	0.51	60-69	Stage 1
6980	TCGA-09-2044	OV	77	FEMALE	ASIAN	[Not Applicable]	Stage IIB	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-28231	Alive	TUMOR FREE	186	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	186	0	186	0	186	0	186	77.8	0.51	70-79	Stage 2
6981	TCGA-09-2045	OV	50	FEMALE	ASIAN	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	1996	[Not Available]	-18285	Dead	WITH TUMOR	766	1069	[Not Available]	Recurrence	[Not Applicable]	631	Stable Disease	1	1069	1	1069	0	720	1	631	52.99	2.93	50-59	other
6982	TCGA-09-2048	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-23043	Dead	WITH TUMOR	766	138	[Not Available]	NA	NA	364	Stable Disease	1	138	1	138	0	720	1	138	63.47	0.38	60-69	other
6983	TCGA-09-2049	OV	64	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-23410	Alive	WITH TUMOR	3419	548	[Not Available]	Recurrence	[Not Applicable]	953	Complete Remission/Response	0	3419	0	3419	1	953	1	953	73.45	9.36	60-69	other
6984	TCGA-09-2050	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIA	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-23987	Alive	TUMOR FREE	2163	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2163	0	2163	0	2163	0	2163	71.59	5.92	60-69	Stage 2
6985	TCGA-09-2051	OV	42	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-15650	Alive	TUMOR FREE	1919	548	[Not Available]	Recurrence	[Not Applicable]	583	Complete Remission/Response	0	1919	0	1919	1	583	1	583	48.1	5.25	40-49	other
6986	TCGA-09-2053	OV	72	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-26433	Alive	TUMOR FREE	1209	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1209	0	1209	0	1209	0	1209	75.68	3.31	70-79	other
6987	TCGA-09-2054	OV	58	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-21285	Dead	WITH TUMOR	637	637	[Not Available]	NA	NA	364	Progressive Disease	1	637	1	637	0	720	1	637	60.02	1.74	50-59	other
6988	TCGA-09-2055	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-17545	Alive	TUMOR FREE	819	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	819	0	819	0	819	0	819	50.28	2.24	40-49	Stage 1
6989	TCGA-09-2056	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-22864	Alive	TUMOR FREE	379	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	379	0	379	0	379	0	379	63.64	1.04	60-69	other
6990	TCGA-10-0925	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G1	2000	[Not Available]	-21498	Dead	WITH TUMOR	1652	1652	[Not Available]	Recurrence	[Not Applicable]	558	Partial Remission/Response	1	1652	1	1652	0	720	1	558	63.38	4.52	50-59	other
6991	TCGA-10-0926	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-23307	Dead	WITH TUMOR	788	788	[Not Available]	Recurrence	[Not Applicable]	287	Complete Remission/Response	1	788	1	788	1	287	1	287	65.97	2.16	60-69	other
6992	TCGA-10-0927	OV	65	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2000	[Not Available]	-23982	Dead	WITH TUMOR	2478	2490	[Not Available]	Recurrence	[Not Applicable]	1001	Complete Remission/Response	1	2490	1	2490	1	1001	1	1001	72.48	6.82	60-69	other
6993	TCGA-10-0928	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-26066	Dead	WITH TUMOR	563	563	[Not Available]	NA	NA	364	[Not Available]	1	563	1	563	0	720	1	563	72.91	1.54	70-79	other
6994	TCGA-10-0930	OV	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-25737	Dead	WITH TUMOR	1011	1040	[Not Available]	Recurrence	[Not Applicable]	680	Complete Remission/Response	1	1040	1	1040	1	680	1	680	73.31	2.85	70-79	other
6995	TCGA-10-0931	OV	44	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-16262	Dead	WITH TUMOR	982	1000	[Not Available]	Recurrence	[Not Applicable]	300	Complete Remission/Response	1	1000	1	1000	1	300	1	300	47.26	2.74	40-49	other
6996	TCGA-10-0933	OV	77	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-28433	Dead	WITH TUMOR	356	446	[Not Available]	Recurrence	[Not Applicable]	356	Complete Remission/Response	1	446	1	446	1	356	1	356	79.07	1.22	70-79	other
6997	TCGA-10-0934	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-18602	Dead	WITH TUMOR	119	204	[Not Available]	Recurrence	[Not Applicable]	111	Progressive Disease	1	204	1	204	0	720	1	111	51.49	0.56	50-59	other
6998	TCGA-10-0935	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-25098	Dead	WITH TUMOR	1078	1078	[Not Available]	NA	NA	364	[Not Available]	1	1078	1	1078	0	720	1	1078	71.67	2.95	60-69	other
6999	TCGA-10-0936	OV	69	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-25454	Dead	WITH TUMOR	1089	1123	[Not Available]	NA	NA	364	Partial Remission/Response	1	1123	1	1123	0	720	1	1123	72.76	3.07	60-69	other
7000	TCGA-10-0937	OV	44	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-16222	Dead	WITH TUMOR	460	608	[Not Available]	Recurrence	[Not Applicable]	235	Complete Remission/Response	1	608	1	608	1	235	1	235	46.08	1.66	40-49	other
7001	TCGA-10-0938	OV	80	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-29558	Dead	WITH TUMOR	604	636	[Not Available]	Progression of Disease	[Not Applicable]	362	Progressive Disease	1	636	1	636	0	720	1	362	82.67	1.74	>=80	other
7002	TCGA-13-0714	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-20109	Dead	WITH TUMOR	189	189	[Not Available]	Progression of Disease	[Not Applicable]	110	Progressive Disease	1	189	1	189	0	720	1	110	55.57	0.52	50-59	other
7003	TCGA-13-0717	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-20042	Dead	WITH TUMOR	748	748	[Not Available]	Recurrence	[Not Applicable]	294	Complete Remission/Response	1	748	1	748	1	294	1	294	56.92	2.05	50-59	other
7004	TCGA-13-0720	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-17799	Dead	WITH TUMOR	1355	1355	[Not Available]	Recurrence	[Not Applicable]	292	Complete Remission/Response	1	1355	1	1355	1	292	1	292	52.44	3.71	40-49	other
7005	TCGA-13-0723	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-23094	Dead	WITH TUMOR	1204	1204	[Not Available]	Progression of Disease	[Not Applicable]	210	Progressive Disease	1	1204	1	1204	0	720	1	210	66.52	3.3	60-69	other
7006	TCGA-13-0724	OV	72	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-26342	Dead	WITH TUMOR	83	83	[Not Available]	Progression of Disease	[Not Applicable]	83	Progressive Disease	1	83	1	83	0	720	1	83	72.35	0.23	70-79	other
7007	TCGA-13-0725	OV	44	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-16086	Dead	WITH TUMOR	377	377	[Not Available]	Recurrence	[Not Applicable]	190	Complete Remission/Response	1	377	1	377	1	190	1	190	45.07	1.03	40-49	other
7008	TCGA-13-0726	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	GX	2002	[Not Available]	-20134	Dead	WITH TUMOR	946	949	[Not Available]	Recurrence	[Not Applicable]	392	Complete Remission/Response	1	949	1	949	1	392	1	392	57.72	2.6	50-59	other
7009	TCGA-13-0727	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-26185	Dead	WITH TUMOR	462	462	[Not Available]	Recurrence	[Not Applicable]	253	Complete Remission/Response	1	462	1	462	1	253	1	253	72.96	1.26	70-79	other
7010	TCGA-13-0730	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-26086	Dead	TUMOR FREE	766	542	[Not Available]	NA	NA	364	[Unknown]	1	542	0	542	0	720	0	542	72.9	1.48	70-79	other
7011	TCGA-13-0751	OV	44	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	GX	1999	[Not Available]	-16304	Dead	WITH TUMOR	1678	1678	[Not Available]	Recurrence	[Not Applicable]	653	Complete Remission/Response	1	1678	1	1678	1	653	1	653	49.23	4.59	40-49	other
7012	TCGA-13-0755	OV	75	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-27438	Dead	WITH TUMOR	76	76	[Not Available]	Progression of Disease	[Not Applicable]	34	Progressive Disease	1	76	1	76	0	720	1	34	75.33	0.21	70-79	other
7013	TCGA-13-0757	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-25999	Dead	WITH TUMOR	340	340	[Not Available]	Recurrence	[Not Applicable]	293	Complete Remission/Response	1	340	1	340	1	293	1	293	72.11	0.93	70-79	other
7014	TCGA-13-0758	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-22088	Dead	WITH TUMOR	346	346	[Not Available]	Progression of Disease	[Not Applicable]	212	Partial Remission/Response	1	346	1	346	0	720	1	212	61.42	0.95	60-69	other
7015	TCGA-13-0760	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-23036	Dead	TUMOR FREE	351	351	[Not Available]	NA	NA	364	[Not Available]	1	351	0	351	0	720	0	351	64.03	0.96	60-69	other
7016	TCGA-13-0761	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-18697	Dead	WITH TUMOR	766	1156	[Not Available]	Recurrence	[Not Applicable]	424	Complete Remission/Response	1	1156	1	1156	0	720	1	424	54.35	3.16	50-59	other
7017	TCGA-13-0762	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-23960	Alive	WITH TUMOR	3400	548	[Not Available]	NA	[Not Applicable]	1003	Complete Remission/Response	0	3400	0	3400	1	1003	1	1003	74.91	9.31	60-69	other
7018	TCGA-13-0764	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-22965	Dead	WITH TUMOR	766	1881	[Not Available]	Recurrence	[Not Applicable]	272	Partial Remission/Response	1	1881	1	1881	0	720	1	272	68.02	5.15	60-69	other
7019	TCGA-13-0765	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-18574	Dead	WITH TUMOR	766	1389	[Not Available]	Recurrence	[Not Applicable]	668	Complete Remission/Response	1	1389	1	1389	1	668	1	668	54.66	3.8	50-59	other
7020	TCGA-13-0766	OV	42	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-15571	Dead	WITH TUMOR	766	1725	[Not Available]	Recurrence	[Not Applicable]	628	Complete Remission/Response	1	1725	1	1725	1	628	1	628	47.35	4.72	40-49	other
7021	TCGA-13-0768	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-26999	Dead	WITH TUMOR	766	1784	[Not Available]	NA	[Not Applicable]	398	Complete Remission/Response	1	1784	1	1784	1	398	1	398	78.8	4.88	70-79	other
7022	TCGA-13-0791	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-21380	Dead	WITH TUMOR	766	1224	[Not Available]	Recurrence	[Not Applicable]	281	Complete Remission/Response	1	1224	1	1224	1	281	1	281	61.89	3.35	50-59	other
7023	TCGA-13-0792	OV	40	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-14729	Alive	WITH TUMOR	3602	548	[Not Available]	Recurrence	[Not Applicable]	816	Complete Remission/Response	0	3602	0	3602	1	816	1	816	50.19	9.86	40-49	other
7024	TCGA-13-0793	OV	40	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-14708	Alive	WITH TUMOR	3263	548	[Not Available]	Recurrence	[Not Applicable]	351	Complete Remission/Response	0	3263	0	3263	0	720	1	351	49.2	8.93	40-49	other
7025	TCGA-13-0794	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-21945	Dead	WITH TUMOR	766	1919	[Not Available]	Recurrence	[Not Applicable]	845	Complete Remission/Response	1	1919	1	1919	1	845	1	845	65.34	5.25	60-69	other
7026	TCGA-13-0795	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-24403	Dead	WITH TUMOR	766	619	[Not Available]	Recurrence	[Not Applicable]	325	Complete Remission/Response	1	619	1	619	1	325	1	325	68.51	1.69	60-69	other
7027	TCGA-13-0797	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-18051	Alive	WITH TUMOR	2121	548	[Not Available]	NA	[Not Applicable]	525	Complete Remission/Response	0	2121	0	2121	1	525	1	525	55.23	5.81	40-49	other
7028	TCGA-13-0799	OV	44	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-16171	Alive	TUMOR FREE	2535	548	[Not Available]	NA	[Not Applicable]	1262	Complete Remission/Response	0	2535	0	2535	1	1262	1	1262	51.21	6.94	40-49	other
7029	TCGA-13-0800	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-19087	Alive	TUMOR FREE	2661	548	[Not Available]	NA	[Not Applicable]	1396	Complete Remission/Response	0	2661	0	2661	1	1396	1	1396	59.54	7.29	50-59	other
7030	TCGA-13-0801	OV	46	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-16812	Dead	WITH TUMOR	766	1399	[Not Available]	NA	[Not Applicable]	345	Complete Remission/Response	1	1399	1	1399	1	345	1	345	49.86	3.83	40-49	other
7031	TCGA-13-0802	OV	79	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-29075	Dead	WITH TUMOR	766	1552	[Not Available]	NA	[Not Applicable]	510	Complete Remission/Response	1	1552	1	1552	1	510	1	510	83.85	4.25	70-79	other
7032	TCGA-13-0803	OV	81	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-29685	Dead	WITH TUMOR	1334	1334	[Not Available]	Recurrence	[Not Applicable]	337	Complete Remission/Response	1	1334	1	1334	1	337	1	337	84.93	3.65	>=80	other
7033	TCGA-13-0804	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-27021	Dead	WITH TUMOR	1073	1073	[Not Available]	Recurrence	[Not Applicable]	329	Complete Remission/Response	1	1073	1	1073	1	329	1	329	76.92	2.94	70-79	other
7034	TCGA-13-0805	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-21014	Dead	WITH TUMOR	1073	1074	[Not Available]	Progression of Disease	[Not Applicable]	177	Progressive Disease	1	1074	1	1074	0	720	1	177	60.47	2.94	50-59	other
7035	TCGA-13-0807	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-19890	Dead	TUMOR FREE	414	414	[Not Available]	NA	NA	364	[Not Available]	1	414	0	414	0	720	0	414	55.59	1.13	50-59	other
7036	TCGA-13-0883	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-22395	Dead	WITH TUMOR	2097	2097	[Not Available]	Recurrence	[Not Applicable]	819	Complete Remission/Response	1	2097	1	2097	1	819	1	819	67.06	5.74	60-69	other
7037	TCGA-13-0884	OV	39	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-14538	Dead	WITH TUMOR	3260	3260	[Not Available]	Recurrence	[Not Applicable]	1251	Complete Remission/Response	1	3260	1	3260	1	1251	1	1251	48.73	8.93	30-39	other
7038	TCGA-13-0885	OV	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-25763	Alive	TUMOR FREE	3388	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3388	0	3388	0	3388	0	3388	79.81	9.28	70-79	other
7039	TCGA-13-0886	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-24724	Alive	TUMOR FREE	4665	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	4665	0	4665	0	4665	0	4665	80.46	12.77	60-69	other
7040	TCGA-13-0887	OV	42	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-15669	Dead	WITH TUMOR	2028	2028	[Not Available]	Recurrence	[Not Applicable]	514	Complete Remission/Response	1	2028	1	2028	1	514	1	514	48.45	5.55	40-49	other
7041	TCGA-13-0888	OV	78	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-28498	Dead	TUMOR FREE	766	2811	[Not Available]	NA	NA	364	[Discrepancy]	1	2811	0	2811	0	720	0	2811	85.72	7.7	70-79	other
7042	TCGA-13-0889	OV	75	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	GX	2003	[Not Available]	-27674	Dead	TUMOR FREE	766	2894	[Not Available]	NA	NA	364	Complete Remission/Response	1	2894	0	2894	0	720	0	2894	83.69	7.92	70-79	other
7043	TCGA-13-0890	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-20770	Alive	TUMOR FREE	4424	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	4424	0	4424	0	4424	0	4424	68.98	12.11	50-59	other
7044	TCGA-13-0891	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-26886	Dead	WITH TUMOR	766	3128	[Not Available]	Recurrence	[Not Applicable]	762	Complete Remission/Response	1	3128	1	3128	0	720	1	762	82.17	8.56	70-79	other
7045	TCGA-13-0893	OV	48	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-17573	Dead	WITH TUMOR	1319	1319	[Not Available]	Recurrence	[Not Applicable]	461	Partial Remission/Response	1	1319	1	1319	0	720	1	461	51.72	3.61	40-49	other
7046	TCGA-13-0894	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-19466	Dead	WITH TUMOR	1509	1509	[Not Available]	Recurrence	[Not Applicable]	565	Complete Remission/Response	1	1509	1	1509	1	565	1	565	57.43	4.13	50-59	other
7047	TCGA-13-0897	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-19894	Dead	WITH TUMOR	766	2182	[Not Available]	Recurrence	[Not Applicable]	554	Complete Remission/Response	1	2182	1	2182	1	554	1	554	60.44	5.97	50-59	other
7048	TCGA-13-0899	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-22031	Dead	WITH TUMOR	766	2012	[Not Available]	Recurrence	[Not Applicable]	547	Complete Remission/Response	1	2012	1	2012	1	547	1	547	65.83	5.51	60-69	other
7049	TCGA-13-0900	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-21698	Alive	TUMOR FREE	4077	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	4077	0	4077	0	4077	0	4077	70.57	11.16	50-59	other
7050	TCGA-13-0901	OV	41	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-15333	Alive	WITH TUMOR	589	548	[Not Available]	Recurrence	[Not Applicable]	390	Complete Remission/Response	0	589	0	589	1	390	1	390	43.59	1.61	40-49	other
7051	TCGA-13-0903	OV	42	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-15705	Alive	TUMOR FREE	3887	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3887	0	3887	0	720	0	3887	53.64	10.64	40-49	other
7052	TCGA-13-0904	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-23278	Dead	WITH TUMOR	766	1532	[Not Available]	Progression of Disease	[Not Applicable]	330	Partial Remission/Response	1	1532	1	1532	0	720	1	330	67.93	4.19	60-69	other
7053	TCGA-13-0905	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-18757	Alive	WITH TUMOR	3746	548	[Not Available]	NA	[Not Applicable]	1535	Complete Remission/Response	0	3746	0	3746	1	1535	1	1535	61.61	10.26	50-59	other
7054	TCGA-13-0906	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-18383	Alive	TUMOR FREE	3619	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3619	0	3619	0	3619	0	3619	60.24	9.91	50-59	other
7055	TCGA-13-0908	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-21422	Dead	WITH TUMOR	766	1843	[Not Available]	Recurrence	[Not Applicable]	552	Complete Remission/Response	1	1843	1	1843	0	720	1	552	63.7	5.05	50-59	other
7056	TCGA-13-0910	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-21473	Alive	WITH TUMOR	3548	548	[Not Available]	NA	[Not Applicable]	1212	Complete Remission/Response	0	3548	0	3548	1	1212	1	1212	68.5	9.71	50-59	other
7057	TCGA-13-0911	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-20276	Dead	WITH TUMOR	766	1355	[Not Available]	Progression of Disease	[Not Applicable]	279	Partial Remission/Response	1	1355	1	1355	0	720	1	279	59.22	3.71	50-59	other
7058	TCGA-13-0912	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-21427	Dead	WITH TUMOR	766	1145	[Not Available]	Recurrence	[Not Applicable]	469	Complete Remission/Response	1	1145	1	1145	1	469	1	469	61.8	3.13	50-59	other
7059	TCGA-13-0913	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-19573	Alive	WITH TUMOR	3325	548	[Not Available]	Recurrence	[Not Applicable]	871	Complete Remission/Response	0	3325	0	3325	1	871	1	871	62.69	9.1	50-59	other
7060	TCGA-13-0916	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-18189	Alive	TUMOR FREE	1785	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1785	0	1785	0	1785	0	1785	54.69	4.89	40-49	other
7061	TCGA-13-0919	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-19337	Alive	TUMOR FREE	2571	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2571	0	2571	0	2571	0	2571	59.98	7.04	50-59	other
7062	TCGA-13-0920	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-24064	Dead	WITH TUMOR	766	1484	[Not Available]	Recurrence	[Not Applicable]	297	Complete Remission/Response	1	1484	1	1484	1	297	1	297	69.95	4.06	60-69	other
7063	TCGA-13-0921	OV	72	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-26606	Dead	TUMOR FREE	766	1483	[Not Available]	NA	NA	364	Complete Remission/Response	1	1483	0	1483	0	1483	0	1483	76.9	4.06	70-79	other
7064	TCGA-13-0923	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-27081	Alive	TUMOR FREE	2547	548	[Not Available]	NA	[Not Applicable]	1719	Complete Remission/Response	0	2547	0	2547	1	1719	1	1719	81.12	6.97	70-79	other
7065	TCGA-13-0924	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-16670	Alive	WITH TUMOR	2614	548	[Not Available]	NA	[Not Applicable]	962	Complete Remission/Response	0	2614	0	2614	0	720	1	962	52.8	7.16	40-49	other
7066	TCGA-13-1403	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-17697	Dead	WITH TUMOR	766	2345	[Not Available]	NA	[Not Applicable]	418	Complete Remission/Response	1	2345	1	2345	1	418	1	418	54.87	6.42	40-49	other
7067	TCGA-13-1404	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-17784	Alive	WITH TUMOR	2469	548	[Not Available]	NA	[Not Applicable]	1581	Complete Remission/Response	0	2469	0	2469	1	1581	1	1581	55.45	6.76	40-49	other
7068	TCGA-13-1405	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-18218	Dead	WITH TUMOR	766	868	[Not Available]	NA	[Not Applicable]	228	Complete Remission/Response	1	868	1	868	0	720	1	228	52.25	2.38	40-49	other
7069	TCGA-13-1407	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-18896	Alive	WITH TUMOR	2534	548	[Not Available]	NA	[Not Applicable]	1333	Complete Remission/Response	0	2534	0	2534	1	1333	1	1333	58.67	6.94	50-59	other
7070	TCGA-13-1408	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-21635	Dead	WITH TUMOR	766	1680	[Not Available]	NA	[Not Applicable]	765	Partial Remission/Response	1	1680	1	1680	0	720	1	765	63.83	4.6	50-59	other
7071	TCGA-13-1409	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-26836	Dead	WITH TUMOR	766	1742	[Not Available]	NA	[Not Applicable]	690	[Not Available]	1	1742	1	1742	0	720	1	690	78.24	4.77	70-79	other
7072	TCGA-13-1410	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	GX	2008	[Not Available]	-20950	Alive	WITH TUMOR	2464	548	[Not Available]	NA	[Not Applicable]	319	Complete Remission/Response	0	2464	0	2464	0	720	1	319	64.1	6.75	50-59	other
7073	TCGA-13-1411	OV	81	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-29874	Dead	WITH TUMOR	766	531	[Not Available]	NA	[Not Applicable]	238	Partial Remission/Response	1	531	1	531	0	720	1	238	83.24	1.45	>=80	other
7074	TCGA-13-1412	OV	41	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-15119	Dead	WITH TUMOR	766	984	[Not Available]	NA	[Not Applicable]	409	Complete Remission/Response	1	984	1	984	0	720	1	409	44.09	2.69	40-49	other
7075	TCGA-13-1477	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	2000	[Not Available]	-18111	Dead	WITH TUMOR	1662	1662	[Not Available]	Progression of Disease	[Not Applicable]	235	Progressive Disease	1	1662	1	1662	0	720	1	235	54.14	4.55	40-49	other
7076	TCGA-13-1481	OV	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2000	[Not Available]	-27898	Dead	TUMOR FREE	2648	2648	[Not Available]	NA	NA	364	Complete Remission/Response	1	2648	0	2648	0	2648	0	2648	83.63	7.25	70-79	other
7077	TCGA-13-1482	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	2000	[Not Available]	-19178	Dead	WITH TUMOR	1877	1877	[Not Available]	Recurrence	[Not Applicable]	602	Partial Remission/Response	1	1877	1	1877	0	720	1	602	57.65	5.14	50-59	other
7078	TCGA-13-1483	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-22342	Dead	WITH TUMOR	895	895	[Not Available]	Recurrence	[Not Applicable]	297	Partial Remission/Response	1	895	1	895	0	720	1	297	63.62	2.45	60-69	other
7079	TCGA-13-1484	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-22698	Dead	WITH TUMOR	766	3785	[Not Available]	Recurrence	[Not Applicable]	497	Complete Remission/Response	1	3785	1	3785	1	497	1	497	72.51	10.36	60-69	other
7080	TCGA-13-1485	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	2001	[Not Available]	-17642	Dead	WITH TUMOR	629	629	[Not Available]	Progression of Disease	[Not Applicable]	170	Partial Remission/Response	1	629	1	629	0	720	1	170	50.02	1.72	40-49	other
7081	TCGA-13-1487	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	GX	2002	[Not Available]	-27176	Dead	WITH TUMOR	681	681	[Not Available]	Recurrence	[Not Applicable]	412	Complete Remission/Response	1	681	1	681	0	720	1	412	76.27	1.86	70-79	other
7082	TCGA-13-1488	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-21726	Dead	WITH TUMOR	2154	2154	[Not Available]	Recurrence	[Not Applicable]	351	Complete Remission/Response	1	2154	1	2154	0	720	1	351	65.38	5.9	50-59	other
7083	TCGA-13-1489	OV	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2002	[Not Available]	-25768	Dead	TUMOR FREE	766	2553	[Not Available]	Recurrence	[Not Applicable]	806	Complete Remission/Response	1	2553	0	2553	1	806	1	806	77.54	6.99	70-79	other
7084	TCGA-13-1491	OV	55	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-20262	Dead	WITH TUMOR	1595	1595	[Not Available]	Recurrence	[Not Applicable]	508	Partial Remission/Response	1	1595	1	1595	0	720	1	508	59.84	4.37	50-59	other
7085	TCGA-13-1492	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-24332	Dead	TUMOR FREE	766	3819	[Not Available]	NA	NA	364	Complete Remission/Response	1	3819	0	3819	0	3819	0	3819	77.07	10.46	60-69	other
7086	TCGA-13-1494	OV	43	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-15993	Dead	WITH TUMOR	766	2856	[Not Available]	Recurrence	[Not Applicable]	693	Complete Remission/Response	1	2856	1	2856	0	720	1	693	51.61	7.82	40-49	other
7087	TCGA-13-1495	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-22046	Dead	WITH TUMOR	766	2749	[Not Available]	Recurrence	[Not Applicable]	977	Complete Remission/Response	1	2749	1	2749	1	977	1	977	67.89	7.53	60-69	other
7088	TCGA-13-1496	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-23993	Dead	TUMOR FREE	129	129	[Not Available]	NA	NA	364	[Not Available]	1	129	0	129	0	720	0	129	66.04	0.35	60-69	other
7089	TCGA-13-1497	OV	47	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-17528	Alive	TUMOR FREE	3871	548	[Not Available]	Recurrence	[Not Applicable]	813	Complete Remission/Response	0	3871	0	3871	1	813	1	813	58.59	10.6	40-49	other
7090	TCGA-13-1498	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-26820	Dead	WITH TUMOR	766	2012	[Not Available]	Progression of Disease	[Not Applicable]	534	Partial Remission/Response	1	2012	1	2012	0	720	1	534	78.94	5.51	70-79	other
7091	TCGA-13-1499	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-20668	Alive	WITH TUMOR	3500	548	[Not Available]	Recurrence	[Not Applicable]	583	Complete Remission/Response	0	3500	0	3500	1	583	1	583	66.17	9.58	50-59	other
7092	TCGA-13-1500	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-26172	Dead	WITH TUMOR	425	425	[Not Available]	Recurrence	[Not Applicable]	253	Partial Remission/Response	1	425	1	425	0	720	1	253	72.82	1.16	70-79	other
7093	TCGA-13-1501	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-18393	Dead	WITH TUMOR	766	1314	[Not Available]	Progression of Disease	[Not Applicable]	392	Partial Remission/Response	1	1314	1	1314	0	720	1	392	53.95	3.6	50-59	other
7094	TCGA-13-1504	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-25008	Dead	WITH TUMOR	766	1059	[Not Available]	NA	[Not Applicable]	548	Complete Remission/Response	1	1059	1	1059	1	548	1	548	71.37	2.9	60-69	other
7095	TCGA-13-1505	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-23238	Alive	WITH TUMOR	1998	548	[Not Available]	NA	[Not Applicable]	1561	Complete Remission/Response	0	1998	0	1998	1	1561	1	1561	69.09	5.47	60-69	other
7096	TCGA-13-1506	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-16734	Dead	WITH TUMOR	766	1039	[Not Available]	NA	[Not Applicable]	666	Complete Remission/Response	1	1039	1	1039	1	666	1	666	48.66	2.84	40-49	other
7097	TCGA-13-1507	OV	77	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-28445	Dead	WITH TUMOR	766	1993	[Not Available]	NA	[Not Applicable]	324	Complete Remission/Response	1	1993	1	1993	1	324	1	324	83.33	5.46	70-79	other
7098	TCGA-13-1509	OV	64	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-23481	Alive	WITH TUMOR	2438	548	[Not Available]	NA	[Not Applicable]	578	Complete Remission/Response	0	2438	0	2438	0	720	1	578	70.96	6.67	60-69	other
7099	TCGA-13-1510	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-22708	Dead	WITH TUMOR	766	1359	[Not Available]	NA	[Not Applicable]	1189	[Not Available]	1	1359	1	1359	0	720	1	1189	65.89	3.72	60-69	other
7100	TCGA-13-1511	OV	52	FEMALE	ASIAN	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-19258	Dead	WITH TUMOR	766	1650	[Not Available]	NA	[Not Applicable]	459	Partial Remission/Response	1	1650	1	1650	0	720	1	459	57.24	4.52	50-59	other
7101	TCGA-13-1512	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-18134	Alive	WITH TUMOR	442	548	[Not Available]	NA	[Not Applicable]	427	[Not Available]	0	442	0	442	0	720	1	427	50.86	1.21	40-49	other
7102	TCGA-13-1817	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-20771	Dead	WITH TUMOR	1024	1024	[Not Available]	Recurrence	[Not Applicable]	541	Partial Remission/Response	1	1024	1	1024	0	720	1	541	59.67	2.8	50-59	other
7103	TCGA-13-1819	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-21635	Dead	WITH TUMOR	766	2025	[Not Available]	Recurrence	[Not Applicable]	429	Complete Remission/Response	1	2025	1	2025	1	429	1	429	64.78	5.54	50-59	Stage 2
7104	TCGA-13-2057	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-21554	Alive	WITH TUMOR	2434	548	[Not Available]	NA	[Not Applicable]	897	Complete Remission/Response	0	2434	0	2434	1	897	1	897	65.68	6.66	50-59	other
7105	TCGA-13-2059	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-18449	Alive	WITH TUMOR	2387	548	[Not Available]	NA	[Not Applicable]	1005	Complete Remission/Response	0	2387	0	2387	1	1005	1	1005	57.05	6.54	50-59	other
7106	TCGA-13-2060	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-18635	Alive	WITH TUMOR	2369	548	[Not Available]	NA	[Not Applicable]	1475	Complete Remission/Response	0	2369	0	2369	0	720	1	1475	57.51	6.49	50-59	other
7107	TCGA-13-2061	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-21543	Alive	TUMOR FREE	2339	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2339	0	2339	0	2339	0	2339	65.39	6.4	50-59	other
7108	TCGA-13-2065	OV	71	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-25973	Alive	WITH TUMOR	1993	548	[Not Available]	NA	[Not Applicable]	946	Complete Remission/Response	0	1993	0	1993	1	946	1	946	76.57	5.46	70-79	other
7109	TCGA-13-2066	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-18170	Dead	WITH TUMOR	766	2133	[Not Available]	NA	[Not Applicable]	1028	Complete Remission/Response	1	2133	1	2133	0	720	1	1028	55.59	5.84	40-49	other
7110	TCGA-13-2071	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-23367	Dead	WITH TUMOR	766	773	[Not Available]	NA	[Not Applicable]	322	Complete Remission/Response	1	773	1	773	0	720	1	322	66.09	2.12	60-69	other
7111	TCGA-13-A5FT	OV	67	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-24743	Alive	TUMOR FREE	2143	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2143	0	2143	0	2143	0	2143	73.61	5.87	60-69	other
7112	TCGA-13-A5FU	OV	60	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-22256	Dead	WITH TUMOR	766	256	[Not Available]	NA	NA	364	Partial Remission/Response	1	256	1	256	0	720	1	256	61.63	0.7	60-69	other
7113	TCGA-20-0987	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-22287	Dead	WITH TUMOR	766	701	[Not Available]	Recurrence	[Not Applicable]	442	[Not Available]	1	701	1	701	0	720	1	442	62.94	1.92	60-69	other
7114	TCGA-20-0990	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-27170	Alive	WITH TUMOR	789	548	[Not Available]	Recurrence	[Not Applicable]	871	[Not Available]	0	789	0	789	0	720	1	871	76.55	2.16	70-79	other
7115	TCGA-20-0991	OV	78	FEMALE	WHITE	[Not Applicable]	Stage IIB	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-28694	Alive	TUMOR FREE	797	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	797	0	797	0	797	0	797	80.74	2.18	70-79	Stage 2
7116	TCGA-20-0996	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2001	[Not Available]	-21572	Alive	WITH TUMOR	2196	548	[Not Available]	NA	NA	364	[Not Available]	0	2196	0	2196	0	720	0	2196	65.07	6.01	50-59	other
7117	TCGA-20-1682	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	GX	2007	[Not Available]	-20583	Alive	TUMOR FREE	837	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	837	0	837	0	837	0	837	58.64	2.29	50-59	other
7118	TCGA-20-1683	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-24006	Alive	TUMOR FREE	772	548	[Not Available]	Recurrence	[Not Applicable]	618	Stable Disease	0	772	0	772	0	720	1	618	67.84	2.11	60-69	other
7119	TCGA-20-1684	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-18755	Alive	TUMOR FREE	581	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	581	0	581	0	581	0	581	52.94	1.59	50-59	other
7120	TCGA-20-1685	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-16745	Alive	TUMOR FREE	508	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	508	0	508	0	508	0	508	47.24	1.39	40-49	other
7121	TCGA-20-1686	OV	75	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-27588	Alive	TUMOR FREE	89	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	89	0	89	0	89	0	89	75.78	0.24	70-79	other
7122	TCGA-20-1687	OV	46	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-16961	Alive	TUMOR FREE	81	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	81	0	81	0	720	0	81	46.66	0.22	40-49	other
7123	TCGA-23-1021	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-16484	Dead	WITH TUMOR	1446	1446	[Not Available]	NA	NA	364	Partial Remission/Response	1	1446	1	1446	0	720	1	1446	49.09	3.96	40-49	other
7124	TCGA-23-1022	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-24798	Dead	WITH TUMOR	766	1511	[Not Available]	Recurrence	[Not Applicable]	450	Complete Remission/Response	1	1511	1	1511	1	450	1	450	72.03	4.14	60-69	other
7125	TCGA-23-1023	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-23826	Alive	WITH TUMOR	1233	548	[Not Available]	Recurrence	[Not Applicable]	490	Complete Remission/Response	0	1233	0	1233	1	490	1	490	68.61	3.38	60-69	other
7126	TCGA-23-1024	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-19052	Alive	TUMOR FREE	468	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	468	0	468	0	720	0	468	53.44	1.28	50-59	other
7127	TCGA-23-1026	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-16442	Alive	WITH TUMOR	816	548	[Not Available]	Recurrence	[Not Applicable]	797	Complete Remission/Response	0	816	0	816	1	797	1	797	47.25	2.23	40-49	other
7128	TCGA-23-1027	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-17588	Dead	TUMOR FREE	966	976	[Not Available]	Recurrence	[Not Applicable]	114	Progressive Disease	1	976	0	976	0	720	1	114	50.83	2.67	40-49	other
7129	TCGA-23-1028	OV	43	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-16018	Alive	WITH TUMOR	1503	548	[Not Available]	Recurrence	[Not Applicable]	133	Complete Remission/Response	0	1503	0	1503	1	133	1	133	47.97	4.11	40-49	other
7130	TCGA-23-1029	OV	46	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-16889	Alive	TUMOR FREE	268	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	268	0	268	0	268	0	268	46.97	0.73	40-49	other
7131	TCGA-23-1030	OV	64	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-23416	Alive	TUMOR FREE	886	548	[Not Available]	Recurrence	[Not Applicable]	544	Complete Remission/Response	0	886	0	886	1	544	1	544	66.54	2.43	60-69	other
7132	TCGA-23-1031	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-22225	Dead	WITH TUMOR	575	575	[Not Available]	NA	NA	364	Partial Remission/Response	1	575	1	575	0	720	1	575	62.42	1.57	60-69	other
7133	TCGA-23-1032	OV	73	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-26715	Dead	WITH TUMOR	68	84	[Not Available]	NA	NA	364	[Not Available]	1	84	1	84	0	720	1	84	73.37	0.23	70-79	other
7134	TCGA-23-1107	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-21561	Dead	WITH TUMOR	9	9	[Not Available]	NA	NA	364	[Not Available]	1	9	1	9	0	720	1	9	59.06	0.02	50-59	other
7135	TCGA-23-1109	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-23002	Dead	WITH TUMOR	1562	1562	[Not Available]	Recurrence	[Not Applicable]	987	Partial Remission/Response	1	1562	1	1562	0	720	1	987	67.25	4.28	60-69	other
7136	TCGA-23-1110	OV	42	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-15383	Alive	TUMOR FREE	1658	548	[Not Available]	Recurrence	[Not Applicable]	326	Complete Remission/Response	0	1658	0	1658	1	326	1	326	46.66	4.54	40-49	other
7137	TCGA-23-1111	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-23171	Alive	TUMOR FREE	98	548	[Not Available]	NA	NA	364	[Not Available]	0	98	0	98	0	720	0	98	63.71	0.27	60-69	other
7138	TCGA-23-1113	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-17791	Dead	WITH TUMOR	766	949	[Not Available]	NA	NA	364	Partial Remission/Response	1	949	1	949	0	720	1	949	51.31	2.6	40-49	other
7139	TCGA-23-1114	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-20409	Dead	WITH TUMOR	2089	2089	[Not Available]	Recurrence	[Not Applicable]	634	Complete Remission/Response	1	2089	1	2089	1	634	1	634	61.6	5.72	50-59	other
7140	TCGA-23-1116	OV	83	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-30464	Dead	WITH TUMOR	766	592	[Not Available]	Recurrence	[Not Applicable]	286	Complete Remission/Response	1	592	1	592	1	286	1	286	85.03	1.62	>=80	other
7141	TCGA-23-1117	OV	42	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-15690	Dead	WITH TUMOR	766	1013	[Not Available]	Recurrence	[Not Applicable]	418	Complete Remission/Response	1	1013	1	1013	1	418	1	418	45.73	2.77	40-49	other
7142	TCGA-23-1118	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-16471	Alive	TUMOR FREE	2616	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2616	0	2616	0	2616	0	2616	52.26	7.16	40-49	other
7143	TCGA-23-1119	OV	64	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-23686	Alive	TUMOR FREE	3953	548	[Not Available]	Recurrence	[Not Applicable]	3378	Complete Remission/Response	0	3953	0	3953	1	3378	1	3378	75.67	10.82	60-69	other
7144	TCGA-23-1120	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-22148	Alive	TUMOR FREE	130	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	130	0	130	0	130	0	130	60.99	0.36	60-69	other
7145	TCGA-23-1121	OV	51	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-18983	Alive	TUMOR FREE	194	548	[Not Available]	NA	NA	364	[Not Available]	0	194	0	194	0	720	0	194	52.5	0.53	50-59	other
7146	TCGA-23-1122	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-19537	Dead	WITH TUMOR	766	1189	[Not Available]	Recurrence	[Not Applicable]	447	Complete Remission/Response	1	1189	1	1189	1	447	1	447	56.74	3.26	50-59	other
7147	TCGA-23-1123	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-21552	Dead	WITH TUMOR	766	1018	[Not Available]	NA	NA	364	Progressive Disease	1	1018	1	1018	0	720	1	1018	61.79	2.79	50-59	other
7148	TCGA-23-1124	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-23005	Dead	WITH TUMOR	766	1768	[Not Available]	Recurrence	[Not Applicable]	641	Complete Remission/Response	1	1768	1	1768	1	641	1	641	67.82	4.84	60-69	other
7149	TCGA-23-1809	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-23111	Alive	TUMOR FREE	16	548	[Not Available]	NA	NA	364	[Not Available]	0	16	0	16	0	720	0	16	63.32	0.04	60-69	Stage 2
7150	TCGA-23-2072	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-21523	Dead	WITH TUMOR	766	759	[Not Available]	Recurrence	[Not Applicable]	476	Complete Remission/Response	1	759	1	759	0	720	1	476	61	2.08	50-59	other
7151	TCGA-23-2077	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-16552	Alive	TUMOR FREE	3525	548	[Not Available]	Recurrence	[Not Applicable]	1232	Complete Remission/Response	0	3525	0	3525	1	1232	1	1232	54.97	9.65	40-49	other
7152	TCGA-23-2078	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-24223	Alive	TUMOR FREE	2661	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2661	0	2661	0	2661	0	2661	73.6	7.29	60-69	other
7153	TCGA-23-2079	OV	46	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-17122	Alive	TUMOR FREE	2788	548	[Not Available]	Recurrence	[Not Applicable]	283	Complete Remission/Response	0	2788	0	2788	1	283	1	283	54.51	7.63	40-49	other
7154	TCGA-23-2081	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-18162	Dead	WITH TUMOR	766	2342	[Not Available]	NA	NA	364	Progressive Disease	1	2342	1	2342	0	720	1	2342	56.14	6.41	40-49	other
7155	TCGA-23-2084	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-16493	Dead	WITH TUMOR	766	1516	[Not Available]	Recurrence	[Not Applicable]	619	Complete Remission/Response	1	1516	1	1516	0	720	1	619	49.31	4.15	40-49	other
7156	TCGA-23-2641	OV	85	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-31232	Alive	TUMOR FREE	84	548	[Not Available]	NA	NA	364	[Not Available]	0	84	0	84	0	720	0	84	85.74	0.23	>=80	other
7157	TCGA-23-2643	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-27093	Alive	TUMOR FREE	143	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	143	0	143	0	143	0	143	74.57	0.39	70-79	other
7158	TCGA-23-2645	OV	54	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-19758	Alive	TUMOR FREE	137	548	[Not Available]	NA	NA	364	[Not Available]	0	137	0	137	0	720	0	137	54.47	0.38	50-59	other
7159	TCGA-23-2647	OV	49	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-18205	Alive	TUMOR FREE	135	548	[Not Available]	NA	NA	364	[Not Available]	0	135	0	135	0	720	0	135	50.21	0.37	40-49	other
7160	TCGA-23-2649	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-22210	Alive	TUMOR FREE	116	548	[Not Available]	NA	NA	364	[Not Available]	0	116	0	116	0	720	0	116	61.13	0.32	60-69	other
7161	TCGA-24-0966	OV	78	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-28529	Alive	WITH TUMOR	232	548	[Not Available]	NA	NA	364	Stable Disease	0	232	0	232	0	720	0	232	78.74	0.64	70-79	other
7162	TCGA-24-0968	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-21664	Dead	WITH TUMOR	598	548	[Not Available]	NA	NA	364	Partial Remission/Response	1	714	1	722	0	720	1	564	60.81	1.5	50-59	other
7163	TCGA-24-0970	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-23276	Dead	WITH TUMOR	354	354	[Not Available]	Recurrence	[Not Applicable]	280	Partial Remission/Response	1	354	1	354	0	720	1	280	64.7	0.97	60-69	other
7164	TCGA-24-0975	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-21417	Dead	WITH TUMOR	663	663	[Not Available]	NA	NA	364	Partial Remission/Response	1	663	1	663	0	720	1	663	60.45	1.82	50-59	other
7165	TCGA-24-0979	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-19595	Dead	WITH TUMOR	1264	1264	[Not Available]	Recurrence	[Not Applicable]	428	Complete Remission/Response	1	1264	1	1264	0	720	1	428	57.11	3.46	50-59	other
7166	TCGA-24-0980	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-19579	Dead	WITH TUMOR	233	233	[Not Available]	Recurrence	[Not Applicable]	145	Progressive Disease	1	233	1	233	0	720	1	145	54.24	0.64	50-59	other
7167	TCGA-24-0982	OV	77	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-28201	Dead	WITH TUMOR	679	679	[Not Available]	Recurrence	[Not Applicable]	153	Complete Remission/Response	1	679	1	679	1	153	1	153	79.07	1.86	70-79	other
7168	TCGA-24-1103	OV	50	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-18583	Dead	WITH TUMOR	1646	1646	[Not Available]	Recurrence	[Not Applicable]	678	Complete Remission/Response	1	1646	1	1646	1	678	1	678	55.38	4.51	50-59	other
7169	TCGA-24-1104	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-20527	Dead	WITH TUMOR	1933	1933	[Not Available]	Recurrence	[Not Applicable]	959	Complete Remission/Response	1	1933	1	1933	0	720	1	959	61.49	5.29	50-59	other
7170	TCGA-24-1105	OV	36	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-13187	Dead	WITH TUMOR	1442	1442	[Not Available]	Recurrence	[Not Applicable]	470	Complete Remission/Response	1	1442	1	1442	1	470	1	470	40.05	3.95	30-39	other
7171	TCGA-24-1413	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-18846	Alive	TUMOR FREE	192	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	192	0	192	0	192	0	192	52.12	0.53	50-59	other
7172	TCGA-24-1416	OV	34	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-12772	Alive	TUMOR FREE	194	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	194	0	194	0	720	0	194	35.5	0.53	30-39	other
7173	TCGA-24-1417	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-19775	Alive	TUMOR FREE	238	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	238	0	238	0	720	0	238	54.79	0.65	50-59	other
7174	TCGA-24-1418	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-24842	Alive	TUMOR FREE	243	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	243	0	243	0	243	0	243	68.68	0.67	60-69	other
7175	TCGA-24-1419	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-22659	Alive	TUMOR FREE	239	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	239	0	239	0	239	0	239	62.69	0.65	60-69	other
7176	TCGA-24-1422	OV	82	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-30234	Dead	TUMOR FREE	23	23	[Not Available]	NA	NA	364	[Not Available]	1	23	0	23	0	720	0	23	82.84	0.06	>=80	other
7177	TCGA-24-1423	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-22281	Alive	TUMOR FREE	190	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	190	0	190	0	190	0	190	61.52	0.52	60-69	other
7178	TCGA-24-1424	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-24545	Alive	TUMOR FREE	183	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	183	0	183	0	183	0	183	67.7	0.5	60-69	other
7179	TCGA-24-1425	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-16764	Alive	TUMOR FREE	181	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	181	0	181	0	181	0	181	46.39	0.5	40-49	other
7180	TCGA-24-1426	OV	43	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-15949	Alive	TUMOR FREE	163	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	163	0	163	0	163	0	163	44.11	0.45	40-49	other
7181	TCGA-24-1427	OV	58	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-21423	Alive	WITH TUMOR	147	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	147	0	147	0	720	0	147	59.06	0.4	50-59	other
7182	TCGA-24-1428	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-18306	Alive	WITH TUMOR	529	548	[Not Available]	Recurrence	[Not Applicable]	448	Complete Remission/Response	0	529	0	529	1	448	1	448	51.57	1.45	50-59	other
7183	TCGA-24-1430	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-24939	Dead	WITH TUMOR	863	863	[Not Available]	Recurrence	[Not Applicable]	449	Complete Remission/Response	1	863	1	863	1	449	1	449	70.64	2.36	60-69	other
7184	TCGA-24-1431	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-24758	Dead	WITH TUMOR	583	567	[Not Available]	Recurrence	[Not Applicable]	199	[Not Available]	1	567	1	567	0	720	1	199	69.34	1.55	60-69	other
7185	TCGA-24-1434	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-21810	Dead	WITH TUMOR	568	568	[Not Available]	Recurrence	[Not Applicable]	337	Partial Remission/Response	1	568	1	568	0	720	1	337	61.27	1.56	50-59	other
7186	TCGA-24-1435	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-21107	Dead	WITH TUMOR	1324	1324	[Not Available]	Recurrence	[Not Applicable]	505	Complete Remission/Response	1	1324	1	1324	1	505	1	505	61.41	3.62	50-59	other
7187	TCGA-24-1436	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-20881	Dead	WITH TUMOR	260	260	[Not Available]	NA	NA	364	Partial Remission/Response	1	260	1	260	0	720	1	260	57.88	0.71	50-59	other
7188	TCGA-24-1463	OV	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-25734	Dead	WITH TUMOR	2218	2218	[Not Available]	Recurrence	[Not Applicable]	971	Complete Remission/Response	1	2218	1	2218	1	971	1	971	76.53	6.07	70-79	other
7189	TCGA-24-1464	OV	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-25874	Dead	WITH TUMOR	379	379	[Not Available]	Recurrence	[Not Applicable]	323	[Not Available]	1	379	1	379	0	720	1	323	71.88	1.04	70-79	other
7190	TCGA-24-1466	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-27307	Dead	WITH TUMOR	1373	1373	[Not Available]	Recurrence	[Not Applicable]	491	Complete Remission/Response	1	1373	1	1373	1	491	1	491	78.52	3.76	70-79	other
7191	TCGA-24-1467	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-18652	Dead	WITH TUMOR	3224	3224	[Not Available]	Recurrence	[Not Applicable]	1253	Complete Remission/Response	1	3224	1	3224	1	1253	1	1253	59.89	8.83	50-59	other
7192	TCGA-24-1469	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-25937	Alive	TUMOR FREE	277	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	277	0	277	0	277	0	277	71.77	0.76	70-79	other
7193	TCGA-24-1470	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-20007	Alive	TUMOR FREE	105	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	105	0	105	0	105	0	105	55.06	0.29	50-59	other
7194	TCGA-24-1471	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-22081	Alive	TUMOR FREE	36	548	[Not Available]	NA	NA	364	[Not Available]	0	36	0	36	0	720	0	36	60.55	0.1	60-69	other
7195	TCGA-24-1474	OV	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-20902	Dead	WITH TUMOR	676	676	[Not Available]	Recurrence	[Not Applicable]	332	Partial Remission/Response	1	676	1	676	0	720	1	332	59.08	1.85	50-59	other
7196	TCGA-24-1544	OV	71	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-26141	Dead	WITH TUMOR	820	820	[Not Available]	Progression of Disease	[Not Applicable]	643	Partial Remission/Response	1	820	1	820	0	720	1	643	73.82	2.25	70-79	other
7197	TCGA-24-1545	OV	69	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-25460	Dead	WITH TUMOR	1746	1746	[Not Available]	Recurrence	[Not Applicable]	861	Complete Remission/Response	1	1746	1	1746	1	861	1	861	74.49	4.78	60-69	other
7198	TCGA-24-1546	OV	46	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-17130	Dead	TUMOR FREE	1955	1955	[Not Available]	NA	NA	364	[Not Available]	1	1955	0	1955	0	720	0	1955	52.25	5.35	40-49	other
7199	TCGA-24-1548	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-20945	Dead	WITH TUMOR	493	493	[Not Available]	Recurrence	[Not Applicable]	207	Complete Remission/Response	1	493	1	493	1	207	1	207	58.69	1.35	50-59	other
7200	TCGA-24-1549	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-21432	Dead	WITH TUMOR	1721	1721	[Not Available]	Recurrence	[Not Applicable]	1042	Complete Remission/Response	1	1721	1	1721	1	1042	1	1042	63.39	4.71	50-59	other
7201	TCGA-24-1550	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-18049	Dead	WITH TUMOR	1249	1249	[Not Available]	Recurrence	[Not Applicable]	892	Complete Remission/Response	1	1249	1	1249	1	892	1	892	52.84	3.42	40-49	other
7202	TCGA-24-1551	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-19661	Dead	WITH TUMOR	1579	1579	[Not Available]	Recurrence	[Not Applicable]	764	Complete Remission/Response	1	1579	1	1579	1	764	1	764	58.15	4.32	50-59	other
7203	TCGA-24-1552	OV	77	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-28129	Dead	WITH TUMOR	1259	1259	[Not Available]	Recurrence	[Not Applicable]	403	Complete Remission/Response	1	1259	1	1259	1	403	1	403	80.46	3.45	70-79	other
7204	TCGA-24-1553	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-19393	Dead	WITH TUMOR	1767	1767	[Not Available]	Recurrence	[Not Applicable]	553	Complete Remission/Response	1	1767	1	1767	1	553	1	553	57.93	4.84	50-59	other
7205	TCGA-24-1555	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-18404	Dead	WITH TUMOR	2692	2692	[Not Available]	Recurrence	[Not Applicable]	1577	Complete Remission/Response	1	2692	1	2692	1	1577	1	1577	57.76	7.37	50-59	other
7206	TCGA-24-1556	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIB	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-18517	Dead	WITH TUMOR	2148	2148	[Not Available]	Recurrence	[Not Applicable]	539	Complete Remission/Response	1	2148	1	2148	1	539	1	539	56.58	5.88	50-59	Stage 2
7207	TCGA-24-1557	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-17943	Dead	WITH TUMOR	1213	1213	[Not Available]	Progression of Disease	[Not Applicable]	447	Partial Remission/Response	1	1213	1	1213	0	720	1	447	52.45	3.32	40-49	other
7208	TCGA-24-1558	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-27004	Dead	WITH TUMOR	594	594	[Not Available]	Recurrence	[Not Applicable]	273	Partial Remission/Response	1	594	1	594	0	720	1	273	75.56	1.63	70-79	other
7209	TCGA-24-1560	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G4	1999	[Not Available]	-18671	Dead	WITH TUMOR	1341	1341	[Not Available]	Recurrence	[Not Applicable]	143	Complete Remission/Response	1	1341	1	1341	1	143	1	143	54.79	3.67	50-59	other
7210	TCGA-24-1562	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-24747	Dead	WITH TUMOR	1384	1384	[Not Available]	Recurrence	[Not Applicable]	229	Complete Remission/Response	1	1384	1	1384	1	229	1	229	71.54	3.79	60-69	other
7211	TCGA-24-1563	OV	66	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-24274	Dead	WITH TUMOR	1451	1451	[Not Available]	Recurrence	[Not Applicable]	396	Complete Remission/Response	1	1451	1	1451	1	396	1	396	70.43	3.97	60-69	other
7212	TCGA-24-1564	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-24668	Dead	WITH TUMOR	787	787	[Not Available]	Recurrence	[Not Applicable]	221	Complete Remission/Response	1	787	1	787	1	221	1	221	69.69	2.15	60-69	other
7213	TCGA-24-1565	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-27048	Dead	WITH TUMOR	312	312	[Not Available]	Recurrence	[Not Applicable]	145	Partial Remission/Response	1	312	1	312	0	720	1	145	74.91	0.85	70-79	other
7214	TCGA-24-1567	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-19843	Dead	WITH TUMOR	524	524	[Not Available]	Recurrence	[Not Applicable]	319	[Not Available]	1	524	1	524	0	720	1	319	55.76	1.43	50-59	other
7215	TCGA-24-1603	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	1996	[Not Available]	-19681	Dead	WITH TUMOR	2742	2742	[Not Available]	Recurrence	[Not Applicable]	992	Complete Remission/Response	1	2742	1	2742	1	992	1	992	61.39	7.51	50-59	other
7216	TCGA-24-1604	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1996	[Not Available]	-24471	Dead	WITH TUMOR	2688	2688	[Not Available]	NA	NA	364	Complete Remission/Response	1	2688	1	2688	0	720	1	2688	74.36	7.36	60-69	other
7217	TCGA-24-1614	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-20993	Dead	WITH TUMOR	1470	1470	[Not Available]	Recurrence	[Not Applicable]	644	Complete Remission/Response	1	1470	1	1470	1	644	1	644	61.5	4.02	50-59	other
7218	TCGA-24-1616	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-20785	Dead	WITH TUMOR	1163	1163	[Not Available]	Recurrence	[Not Applicable]	405	Complete Remission/Response	1	1163	1	1163	1	405	1	405	60.09	3.18	50-59	other
7219	TCGA-24-1842	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-18227	Alive	TUMOR FREE	253	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	253	0	253	0	253	0	253	50.6	0.69	40-49	other
7220	TCGA-24-1843	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-24469	Alive	TUMOR FREE	106	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	106	0	106	0	106	0	106	67.28	0.29	60-69	other
7221	TCGA-24-1844	OV	64	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-23542	Alive	TUMOR FREE	113	548	[Not Available]	NA	NA	364	[Not Available]	0	113	0	113	0	720	0	113	64.76	0.31	60-69	other
7222	TCGA-24-1845	OV	42	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-15599	Alive	TUMOR FREE	116	548	[Not Available]	NA	NA	364	[Not Available]	0	116	0	116	0	720	0	116	43.03	0.32	40-49	other
7223	TCGA-24-1846	OV	45	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-16534	Alive	TUMOR FREE	133	548	[Not Available]	NA	NA	364	[Not Available]	0	133	0	133	0	720	0	133	45.63	0.36	40-49	other
7224	TCGA-24-1847	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-16529	Alive	TUMOR FREE	343	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	343	0	343	0	720	0	343	46.19	0.94	40-49	other
7225	TCGA-24-1849	OV	80	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-29555	Alive	TUMOR FREE	176	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	176	0	176	0	176	0	176	81.4	0.48	>=80	other
7226	TCGA-24-1850	OV	72	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-26369	Alive	TUMOR FREE	168	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	168	0	168	0	168	0	168	72.65	0.46	70-79	other
7227	TCGA-24-1852	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-20390	Dead	WITH TUMOR	2201	2201	[Not Available]	Recurrence	[Not Applicable]	1009	Complete Remission/Response	1	2201	1	2201	1	1009	1	1009	61.85	6.03	50-59	other
7228	TCGA-24-1920	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-27042	Alive	TUMOR FREE	298	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	298	0	298	0	298	0	298	74.85	0.82	70-79	other
7229	TCGA-24-1923	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-18628	Dead	WITH TUMOR	690	690	[Not Available]	Recurrence	[Not Applicable]	343	Complete Remission/Response	1	690	1	690	1	343	1	343	52.89	1.89	50-59	other
7230	TCGA-24-1924	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-23801	Dead	WITH TUMOR	919	919	[Not Available]	Recurrence	[Not Applicable]	320	Complete Remission/Response	1	919	1	919	1	320	1	320	67.68	2.52	60-69	other
7231	TCGA-24-1927	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-21719	Dead	WITH TUMOR	500	500	[Not Available]	Recurrence	[Not Applicable]	290	Complete Remission/Response	1	500	1	500	1	290	1	290	60.83	1.37	50-59	other
7232	TCGA-24-1928	OV	77	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-28126	Dead	WITH TUMOR	336	336	[Not Available]	Recurrence	[Not Applicable]	70	Progressive Disease	1	336	1	336	0	720	1	70	77.92	0.92	70-79	other
7233	TCGA-24-1930	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-19387	Dead	WITH TUMOR	2467	2467	[Not Available]	Recurrence	[Not Applicable]	544	Complete Remission/Response	1	2467	1	2467	1	544	1	544	59.83	6.75	50-59	other
7234	TCGA-24-2019	OV	46	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-17009	Alive	TUMOR FREE	148	548	[Not Available]	NA	NA	364	[Not Available]	0	148	0	148	0	720	0	148	46.97	0.41	40-49	other
7235	TCGA-24-2020	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	[Not Available]	-24682	Dead	WITH TUMOR	4624	4624	[Not Available]	Recurrence	[Not Applicable]	723	Complete Remission/Response	1	4624	1	4624	1	723	1	723	80.24	12.66	60-69	other
7236	TCGA-24-2023	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous Cystadenocarcinoma	G3	1994	[Not Available]	-19901	Dead	WITH TUMOR	1364	1364	[Not Available]	Recurrence	[Not Applicable]	1069	Complete Remission/Response	1	1364	1	1364	1	1069	1	1069	58.22	3.73	50-59	other
7237	TCGA-24-2024	OV	72	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	[Not Available]	-26476	Dead	WITH TUMOR	1769	1769	[Not Available]	Recurrence	[Not Applicable]	421	Complete Remission/Response	1	1769	1	1769	1	421	1	421	77.33	4.84	70-79	other
7238	TCGA-24-2026	OV	79	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	[Not Available]	-29050	Dead	TUMOR FREE	1059	1059	[Not Available]	NA	NA	364	[Not Available]	1	1059	0	1059	0	720	0	1059	82.43	2.9	70-79	other
7239	TCGA-24-2027	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	1995	[Not Available]	-18835	Dead	WITH TUMOR	3337	3337	[Not Available]	Recurrence	[Not Applicable]	617	Complete Remission/Response	1	3337	1	3337	0	720	1	617	60.7	9.14	50-59	other
7240	TCGA-24-2029	OV	75	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	[Not Available]	-27527	Dead	WITH TUMOR	439	439	[Not Available]	Recurrence	[Not Applicable]	372	Complete Remission/Response	1	439	1	439	1	372	1	372	76.57	1.2	70-79	other
7241	TCGA-24-2030	OV	87	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	[Not Available]	-31900	Dead	WITH TUMOR	1641	1701	[Not Available]	Recurrence	[Not Applicable]	646	Complete Remission/Response	1	1701	1	1701	1	646	1	646	91.99	4.66	>=80	other
7242	TCGA-24-2033	OV	87	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	[Not Available]	-31977	Dead	WITH TUMOR	562	562	[Not Available]	Recurrence	[Not Applicable]	351	Partial Remission/Response	1	562	1	562	0	720	1	351	89.09	1.54	>=80	other
7243	TCGA-24-2035	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1996	[Not Available]	-23855	Dead	WITH TUMOR	857	857	[Not Available]	Recurrence	[Not Applicable]	287	Partial Remission/Response	1	857	1	857	0	720	1	287	67.66	2.35	60-69	other
7244	TCGA-24-2036	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous Cystadenocarcinoma	G3	1996	[Not Available]	-18582	Dead	WITH TUMOR	1947	1947	[Not Available]	Recurrence	[Not Applicable]	914	Complete Remission/Response	1	1947	1	1947	1	914	1	914	56.21	5.33	50-59	other
7245	TCGA-24-2038	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous Cystadenocarcinoma	GB	2000	[Not Available]	-24957	Dead	WITH TUMOR	1354	1354	[Not Available]	Recurrence	[Not Applicable]	1169	Complete Remission/Response	1	1354	1	1354	1	1169	1	1169	72.04	3.71	60-69	other
7246	TCGA-24-2254	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-24407	Dead	WITH TUMOR	1736	1736	[Not Available]	Recurrence	[Not Applicable]	606	Complete Remission/Response	1	1736	1	1736	1	606	1	606	71.58	4.75	60-69	other
7247	TCGA-24-2260	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	1992	[Not Available]	-27112	Dead	WITH TUMOR	1100	1100	[Not Available]	Recurrence	[Not Applicable]	667	Complete Remission/Response	1	1100	1	1100	1	667	1	667	77.24	3.01	70-79	other
7248	TCGA-24-2261	OV	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1992	[Not Available]	-27897	Dead	WITH TUMOR	24	24	[Not Available]	NA	NA	364	[Not Available]	1	24	1	24	0	720	1	24	76.44	0.07	70-79	other
7249	TCGA-24-2262	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1992	[Not Available]	-20861	Dead	WITH TUMOR	11	11	[Not Available]	NA	NA	364	[Not Available]	1	11	1	11	0	720	1	11	57.14	0.03	50-59	other
7250	TCGA-24-2267	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIB	Serous Cystadenocarcinoma	G3	1993	[Not Available]	-21293	Dead	WITH TUMOR	1446	1446	[Not Available]	Recurrence	[Not Applicable]	512	Complete Remission/Response	1	1446	1	1446	1	512	1	512	62.26	3.96	50-59	Stage 2
7251	TCGA-24-2271	OV	55	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-20399	Dead	WITH TUMOR	962	962	[Not Available]	Recurrence	[Not Applicable]	827	[Not Available]	1	962	1	962	0	720	1	827	58.48	2.63	50-59	other
7252	TCGA-24-2280	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-27356	Alive	WITH TUMOR	2143	548	[Not Available]	Recurrence	[Not Applicable]	535	Complete Remission/Response	0	2143	0	2143	1	535	1	535	80.76	5.87	70-79	other
7253	TCGA-24-2281	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IIA	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-25019	Alive	TUMOR FREE	1357	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1357	0	1357	0	1357	0	1357	72.21	3.72	60-69	Stage 2
7254	TCGA-24-2288	OV	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-25831	Dead	WITH TUMOR	25	25	[Not Available]	NA	NA	364	[Not Available]	1	25	1	25	0	720	1	25	70.79	0.07	70-79	other
7255	TCGA-24-2289	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-25191	Dead	WITH TUMOR	2049	2049	[Not Available]	Recurrence	[Not Applicable]	568	Complete Remission/Response	1	2049	1	2049	0	720	1	568	74.58	5.61	60-69	other
7256	TCGA-24-2290	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1997	[Not Available]	-20530	Dead	WITH TUMOR	1102	1102	[Not Available]	Recurrence	[Not Applicable]	324	Complete Remission/Response	1	1102	1	1102	1	324	1	324	59.23	3.02	50-59	other
7257	TCGA-24-2293	OV	47	FEMALE	WHITE	[Not Applicable]	[Not Available]	Serous Cystadenocarcinoma	G3	1995	[Not Available]	-17235	Dead	TUMOR FREE	506	506	[Not Available]	NA	NA	364	Partial Remission/Response	1	506	0	506	0	720	0	506	48.57	1.39	40-49	other
7258	TCGA-24-2295	OV	69	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1995	[Not Available]	-25416	Dead	WITH TUMOR	1007	1007	[Not Available]	Recurrence	[Not Applicable]	281	Complete Remission/Response	1	1007	1	1007	1	281	1	281	72.34	2.76	60-69	other
7259	TCGA-24-2297	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1993	[Not Available]	-20487	Dead	TUMOR FREE	1699	1699	[Not Available]	NA	NA	364	Complete Remission/Response	1	1699	0	1699	0	1699	0	1699	60.74	4.65	50-59	other
7260	TCGA-24-2298	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1993	[Not Available]	-20453	Dead	WITH TUMOR	1620	1620	[Not Available]	Recurrence	[Not Applicable]	469	Complete Remission/Response	1	1620	1	1620	1	469	1	469	60.43	4.44	50-59	other
7261	TCGA-25-1312	OV	69	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-25537	Dead	TUMOR FREE	31	31	[Not Available]	NA	NA	364	[Not Available]	1	31	0	31	0	720	0	31	70	0.08	60-69	other
7262	TCGA-25-1313	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-22982	Dead	WITH TUMOR	820	820	[Not Available]	Recurrence	[Not Applicable]	394	Complete Remission/Response	1	820	1	820	0	720	1	394	65.17	2.25	60-69	other
7263	TCGA-25-1314	OV	42	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-15462	Dead	WITH TUMOR	974	1004	[Not Available]	Progression of Disease	[Not Applicable]	274	Partial Remission/Response	1	1004	1	1004	0	720	1	274	45.08	2.75	40-49	other
7264	TCGA-25-1315	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-18263	Dead	WITH TUMOR	1553	1583	[Not Available]	Progression of Disease	[Not Applicable]	153	Partial Remission/Response	1	1583	1	1583	0	720	1	153	54.34	4.33	50-59	other
7265	TCGA-25-1316	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-20331	Dead	WITH TUMOR	1126	1279	[Not Available]	Progression of Disease	[Not Applicable]	276	Progressive Disease	1	1279	1	1279	0	720	1	276	59.16	3.5	50-59	other
7266	TCGA-25-1317	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-24199	Dead	TUMOR FREE	766	61	[Not Available]	NA	NA	364	[Not Available]	1	61	0	61	0	720	0	61	66.42	0.17	60-69	other
7267	TCGA-25-1318	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-19755	Dead	WITH TUMOR	1064	1064	[Not Available]	Recurrence	[Not Applicable]	185	Partial Remission/Response	1	1064	1	1064	0	720	1	185	57	2.91	50-59	other
7268	TCGA-25-1319	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-26786	Dead	TUMOR FREE	1977	1977	[Not Available]	Recurrence	[Not Applicable]	730	[Not Available]	1	1977	0	1977	0	720	1	730	78.75	5.41	70-79	other
7269	TCGA-25-1320	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-24018	Dead	WITH TUMOR	1124	1155	[Not Available]	Recurrence	[Not Applicable]	424	Progressive Disease	1	1155	1	1155	0	720	1	424	68.92	3.16	60-69	other
7270	TCGA-25-1321	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-23987	Dead	WITH TUMOR	1033	1033	[Not Available]	Recurrence	[Not Applicable]	454	Complete Remission/Response	1	1033	1	1033	1	454	1	454	68.5	2.83	60-69	other
7271	TCGA-25-1322	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-22646	Dead	WITH TUMOR	91	91	[Not Available]	NA	NA	364	[Not Available]	1	91	1	91	0	720	1	91	62.25	0.25	60-69	other
7272	TCGA-25-1323	OV	72	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-26602	Dead	WITH TUMOR	365	395	[Not Available]	Progression of Disease	[Not Applicable]	365	Complete Remission/Response	1	395	1	395	1	365	1	365	73.91	1.08	70-79	other
7273	TCGA-25-1324	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-27090	Dead	TUMOR FREE	1035	1035	[Not Available]	NA	NA	364	[Not Available]	1	1035	0	1035	0	720	0	1035	77	2.83	70-79	other
7274	TCGA-25-1325	OV	77	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-28183	Dead	TUMOR FREE	976	976	[Not Available]	NA	NA	364	[Not Available]	1	976	0	976	0	720	0	976	79.83	2.67	70-79	other
7275	TCGA-25-1326	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-22339	Dead	WITH TUMOR	945	1249	[Not Available]	Recurrence	[Not Applicable]	396	Partial Remission/Response	1	1249	1	1249	0	720	1	396	64.58	3.42	60-69	other
7276	TCGA-25-1328	OV	38	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-13911	Dead	WITH TUMOR	1979	2009	[Not Available]	Recurrence	[Not Applicable]	244	Partial Remission/Response	1	2009	1	2009	0	720	1	244	43.59	5.5	30-39	other
7277	TCGA-25-1329	OV	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-28093	Dead	TUMOR FREE	90	457	[Not Available]	NA	NA	364	[Not Available]	1	457	0	457	0	720	0	457	78.17	1.25	70-79	other
7278	TCGA-25-1623	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-26060	Dead	WITH TUMOR	565	565	[Not Available]	Recurrence	[Not Applicable]	342	Complete Remission/Response	1	565	1	565	0	720	1	342	72.9	1.55	70-79	other
7279	TCGA-25-1625	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-24298	Dead	WITH TUMOR	548	840	[Not Available]	Recurrence	[Not Applicable]	526	Stable Disease	1	840	1	840	0	720	1	526	68.82	2.3	60-69	other
7280	TCGA-25-1626	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-23932	Dead	WITH TUMOR	481	518	[Not Available]	Recurrence	[Not Applicable]	318	Partial Remission/Response	1	518	1	518	0	720	1	318	66.94	1.42	60-69	other
7281	TCGA-25-1627	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-26784	Dead	TUMOR FREE	11	394	[Not Available]	NA	NA	364	[Not Available]	1	394	0	394	0	720	0	394	74.41	1.08	70-79	other
7282	TCGA-25-1628	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-24488	Dead	WITH TUMOR	627	627	[Not Available]	Recurrence	[Not Applicable]	287	Stable Disease	1	627	1	627	0	720	1	287	68.76	1.72	60-69	other
7283	TCGA-25-1630	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-27006	Dead	TUMOR FREE	239	1162	[Not Available]	NA	NA	364	Complete Remission/Response	1	1162	0	1162	0	1162	0	1162	77.12	3.18	70-79	other
7284	TCGA-25-1631	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-26687	Dead	TUMOR FREE	9	9	[Not Available]	NA	NA	364	[Not Available]	1	9	0	9	0	720	0	9	73.09	0.02	70-79	other
7285	TCGA-25-1632	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-24993	Dead	WITH TUMOR	1732	1799	[Not Available]	Recurrence	[Not Applicable]	537	Complete Remission/Response	1	1799	1	1799	0	720	1	537	73.35	4.93	60-69	other
7286	TCGA-25-1633	OV	64	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-23407	Dead	WITH TUMOR	1843	1891	[Not Available]	Recurrence	[Not Applicable]	616	Complete Remission/Response	1	1891	1	1891	1	616	1	616	69.26	5.18	60-69	other
7287	TCGA-25-1634	OV	75	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-27749	Dead	WITH TUMOR	1081	1091	[Not Available]	Recurrence	[Not Applicable]	380	Complete Remission/Response	1	1091	1	1091	1	380	1	380	78.96	2.99	70-79	other
7288	TCGA-25-1635	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-26200	Dead	WITH TUMOR	1558	1583	[Not Available]	Recurrence	[Not Applicable]	614	Complete Remission/Response	1	1583	1	1583	1	614	1	614	76.07	4.33	70-79	other
7289	TCGA-25-1870	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	[Not Available]	-21550	Dead	WITH TUMOR	455	455	[Not Available]	Recurrence	[Not Applicable]	243	Partial Remission/Response	1	455	1	455	0	720	1	243	60.25	1.25	50-59	other
7290	TCGA-25-1871	OV	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1993	[Not Available]	-25627	Dead	WITH TUMOR	760	760	[Not Available]	Recurrence	[Not Applicable]	230	Progressive Disease	1	760	1	760	0	720	1	230	72.24	2.08	70-79	other
7291	TCGA-25-1877	OV	81	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1993	[Not Available]	-29615	Dead	WITH TUMOR	549	730	[Not Available]	Recurrence	[Not Applicable]	549	Complete Remission/Response	1	730	1	730	1	549	1	549	83.08	2	>=80	other
7292	TCGA-25-1878	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	[Not Available]	-22035	Dead	WITH TUMOR	2587	2587	[Not Available]	Recurrence	[Not Applicable]	971	Complete Remission/Response	1	2587	1	2587	1	971	1	971	67.41	7.08	60-69	other
7293	TCGA-25-2042	OV	60	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-22127	Dead	WITH TUMOR	396	396	[Not Available]	NA	NA	364	Progressive Disease	1	396	1	396	0	720	1	396	61.66	1.08	60-69	other
7294	TCGA-25-2390	OV	80	FEMALE	[Not Available]	[Not Applicable]	[Not Available]	Serous Cystadenocarcinoma	[Not Available]	2003	[Not Available]	-29257	Alive	TUMOR FREE	766	548	[Not Available]	NA	NA	364	[Not Available]	0	714	0	722	0	720	0	564	82.2	2.1	>=80	other
7295	TCGA-25-2391	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-20939	Dead	TUMOR FREE	1492	1492	[Not Available]	NA	NA	364	Complete Remission/Response	1	1492	0	1492	0	1492	0	1492	61.41	4.08	50-59	other
7296	TCGA-25-2392	OV	75	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-27667	Dead	TUMOR FREE	31	31	[Not Available]	NA	NA	364	[Not Available]	1	31	0	31	0	720	0	31	75.83	0.08	70-79	other
7297	TCGA-25-2393	OV	81	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-29585	Dead	WITH TUMOR	1157	1157	[Not Available]	Recurrence	[Not Applicable]	305	Partial Remission/Response	1	1157	1	1157	0	720	1	305	84.17	3.17	>=80	other
7298	TCGA-25-2396	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-26145	Dead	TUMOR FREE	92	92	[Not Available]	NA	NA	364	[Not Available]	1	92	0	92	0	720	0	92	71.83	0.25	70-79	other
7299	TCGA-25-2397	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-21581	Dead	TUMOR FREE	365	365	[Not Available]	NA	NA	364	[Not Available]	1	365	0	365	0	720	0	365	60.08	1	50-59	other
7300	TCGA-25-2398	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-26267	Dead	WITH TUMOR	1369	1369	[Not Available]	Recurrence	[Not Applicable]	577	Complete Remission/Response	1	1369	1	1369	1	577	1	577	75.66	3.75	70-79	other
7301	TCGA-25-2399	OV	80	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-29373	Dead	WITH TUMOR	608	608	[Not Available]	Recurrence	[Not Applicable]	243	Partial Remission/Response	1	608	1	608	0	720	1	243	82.08	1.66	>=80	other
7302	TCGA-25-2400	OV	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-27789	Dead	WITH TUMOR	1278	1278	[Not Available]	Recurrence	[Not Applicable]	577	Complete Remission/Response	1	1278	1	1278	1	577	1	577	79.58	3.5	70-79	other
7303	TCGA-25-2401	OV	64	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-23711	Dead	TUMOR FREE	90	90	[Not Available]	NA	NA	364	[Not Available]	1	90	0	90	0	720	0	90	65.16	0.25	60-69	other
7304	TCGA-25-2404	OV	38	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-14184	Dead	WITH TUMOR	883	883	[Not Available]	Recurrence	[Not Applicable]	426	Complete Remission/Response	1	883	1	883	1	426	1	426	41.25	2.42	30-39	other
7305	TCGA-25-2408	OV	37	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	2005	[Not Available]	-13606	Dead	WITH TUMOR	943	943	[Not Available]	Recurrence	[Not Applicable]	334	Partial Remission/Response	1	943	1	943	0	720	1	334	39.83	2.58	30-39	other
7306	TCGA-25-2409	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-26267	Dead	WITH TUMOR	821	821	[Not Available]	Recurrence	[Not Applicable]	304	Complete Remission/Response	1	821	1	821	0	720	1	304	74.16	2.25	70-79	other
7307	TCGA-29-1688	OV	39	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	1992	[Not Available]	-14574	Dead	WITH TUMOR	2400	2400	[Not Available]	Recurrence	[Not Applicable]	184	Stable Disease	1	2400	1	2400	0	720	1	184	46.47	6.57	30-39	other
7308	TCGA-29-1690	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	1993	[Not Available]	-24319	Dead	WITH TUMOR	1360	1448	[Not Available]	NA	NA	364	[Not Available]	1	1448	1	1448	0	720	1	1448	70.55	3.96	60-69	other
7309	TCGA-29-1691	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	1995	[Not Available]	-18664	Dead	WITH TUMOR	1435	1470	[Not Available]	Recurrence	[Not Applicable]	613	Complete Remission/Response	1	1470	1	1470	1	613	1	613	55.12	4.02	50-59	other
7310	TCGA-29-1692	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	1997	[Not Available]	-21193	Dead	WITH TUMOR	2872	2872	[Not Available]	Recurrence	[Not Applicable]	544	Complete Remission/Response	1	2872	1	2872	1	544	1	544	65.89	7.86	50-59	other
7311	TCGA-29-1693	OV	72	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-26300	Alive	WITH TUMOR	3096	548	[Not Available]	Recurrence	[Not Applicable]	694	Complete Remission/Response	0	3096	0	3096	1	694	1	694	80.48	8.48	70-79	other
7312	TCGA-29-1694	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	GX	2002	[Not Available]	-16523	Dead	WITH TUMOR	766	1187	[Not Available]	NA	NA	364	Stable Disease	1	1187	1	1187	0	720	1	1187	48.49	3.25	40-49	other
7313	TCGA-29-1695	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-22895	Dead	TUMOR FREE	24	1229	[Not Available]	NA	NA	364	[Not Available]	1	1229	0	1229	0	720	0	1229	66.05	3.36	60-69	other
7314	TCGA-29-1696	OV	43	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-15818	Dead	WITH TUMOR	1025	1032	[Not Available]	Recurrence	[Not Applicable]	342	Partial Remission/Response	1	1032	1	1032	0	720	1	342	46.13	2.83	40-49	other
7315	TCGA-29-1697	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-22933	Dead	WITH TUMOR	949	949	[Not Available]	Recurrence	[Not Applicable]	500	Complete Remission/Response	1	949	1	949	1	500	1	500	65.39	2.6	60-69	other
7316	TCGA-29-1698	OV	53	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-19611	Alive	WITH TUMOR	2078	548	[Not Available]	Recurrence	[Not Applicable]	181	Complete Remission/Response	0	2078	0	2078	1	181	1	181	59.38	5.69	50-59	other
7317	TCGA-29-1699	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-21130	Dead	TUMOR FREE	16	1106	[Not Available]	NA	NA	364	[Not Available]	1	1106	0	1106	0	720	0	1106	60.88	3.03	50-59	other
7318	TCGA-29-1701	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-20737	Dead	WITH TUMOR	514	515	[Not Available]	Recurrence	[Not Applicable]	298	Partial Remission/Response	1	515	1	515	0	720	1	298	58.18	1.41	50-59	other
7319	TCGA-29-1702	OV	84	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-30910	Dead	WITH TUMOR	568	728	[Not Available]	Recurrence	[Not Applicable]	286	Complete Remission/Response	1	728	1	728	1	286	1	286	86.62	1.99	>=80	other
7320	TCGA-29-1703	OV	56	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	[Not Available]	-20622	Dead	WITH TUMOR	1815	1815	[Not Available]	Recurrence	[Not Applicable]	324	Complete Remission/Response	1	1815	1	1815	1	324	1	324	61.43	4.97	50-59	other
7321	TCGA-29-1704	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-22511	Alive	WITH TUMOR	1587	548	[Not Available]	Recurrence	[Not Applicable]	568	Complete Remission/Response	0	1587	0	1587	1	568	1	568	65.98	4.34	60-69	other
7322	TCGA-29-1705	OV	47	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	[Not Available]	-17530	Dead	WITH TUMOR	555	555	[Not Available]	Recurrence	[Not Applicable]	283	Complete Remission/Response	1	555	1	555	1	283	1	283	49.51	1.52	40-49	other
7323	TCGA-29-1707	OV	41	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-15017	Alive	TUMOR FREE	1277	548	[Not Available]	Recurrence	[Not Applicable]	1201	Complete Remission/Response	0	1277	0	1277	1	1201	1	1201	44.61	3.5	40-49	Stage 2
7324	TCGA-29-1710	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2006	[Not Available]	-19969	Dead	WITH TUMOR	889	951	[Not Available]	Recurrence	[Not Applicable]	315	Partial Remission/Response	1	951	1	951	0	720	1	315	57.28	2.6	50-59	other
7325	TCGA-29-1711	OV	45	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2006	[Not Available]	-16485	Alive	TUMOR FREE	1053	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1053	0	1053	0	1053	0	1053	48.02	2.88	40-49	other
7326	TCGA-29-1761	OV	80	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-29337	Dead	WITH TUMOR	517	528	[Not Available]	NA	NA	364	Stable Disease	1	528	1	528	0	720	1	528	81.77	1.45	>=80	other
7327	TCGA-29-1762	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	1998	[Not Available]	-21879	Dead	WITH TUMOR	2606	2634	[Not Available]	Recurrence	[Not Applicable]	1375	Complete Remission/Response	1	2634	1	2634	0	720	1	1375	67.11	7.21	50-59	other
7328	TCGA-29-1763	OV	43	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-16021	Alive	WITH TUMOR	2032	548	[Not Available]	Recurrence	[Not Applicable]	428	Complete Remission/Response	0	2032	0	2032	1	428	1	428	49.43	5.56	40-49	Stage 2
7329	TCGA-29-1764	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-18012	Alive	WITH TUMOR	1914	548	[Not Available]	Recurrence	[Not Applicable]	792	Complete Remission/Response	0	1914	0	1914	1	792	1	792	54.55	5.24	40-49	other
7330	TCGA-29-1766	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2006	[Not Available]	-27359	Dead	WITH TUMOR	1190	1199	[Not Available]	Recurrence	[Not Applicable]	672	Progressive Disease	1	1199	1	1199	0	720	1	672	78.19	3.28	70-79	other
7331	TCGA-29-1768	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-18396	Dead	WITH TUMOR	950	952	[Not Available]	Recurrence	[Not Applicable]	547	Stable Disease	1	952	1	952	0	720	1	547	52.97	2.61	50-59	other
7332	TCGA-29-1769	OV	40	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-14754	Alive	TUMOR FREE	699	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	699	0	699	0	699	0	699	42.31	1.91	40-49	other
7333	TCGA-29-1770	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2007	[Not Available]	-20015	Alive	WITH TUMOR	741	548	[Not Available]	Recurrence	[Not Applicable]	377	Complete Remission/Response	0	741	0	741	1	377	1	377	56.83	2.03	50-59	other
7334	TCGA-29-1771	OV	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2007	[Not Available]	-28093	Alive	WITH TUMOR	686	548	[Not Available]	Recurrence	[Not Applicable]	595	Complete Remission/Response	0	686	0	686	1	595	1	595	78.79	1.88	70-79	other
7335	TCGA-29-1774	OV	82	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-29991	Alive	WITH TUMOR	527	548	[Not Available]	Recurrence	[Not Applicable]	234	Progressive Disease	0	527	0	527	0	720	1	234	83.55	1.44	>=80	other
7336	TCGA-29-1775	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2008	[Not Available]	-18943	Alive	WITH TUMOR	376	548	[Not Available]	Recurrence	[Not Applicable]	341	Complete Remission/Response	0	376	0	376	1	341	1	341	52.89	1.03	50-59	other
7337	TCGA-29-1776	OV	63	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-23016	Alive	WITH TUMOR	360	548	[Not Available]	NA	NA	364	Stable Disease	0	360	0	360	0	720	0	360	64	0.99	60-69	other
7338	TCGA-29-1777	OV	47	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2008	[Not Available]	-17356	Alive	WITH TUMOR	374	548	[Not Available]	NA	NA	364	Progressive Disease	0	374	0	374	0	720	0	374	48.54	1.02	40-49	other
7339	TCGA-29-1778	OV	77	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-28147	Alive	TUMOR FREE	454	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	454	0	454	0	454	0	454	78.31	1.24	70-79	other
7340	TCGA-29-1781	OV	69	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-25404	Alive	TUMOR FREE	255	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	255	0	255	0	255	0	255	70.25	0.7	60-69	other
7341	TCGA-29-1783	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-21284	Alive	TUMOR FREE	220	548	[Not Available]	NA	NA	364	[Not Available]	0	220	0	220	0	720	0	220	58.87	0.6	50-59	other
7342	TCGA-29-1784	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-20210	Alive	TUMOR FREE	163	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	163	0	163	0	163	0	163	55.78	0.45	50-59	other
7343	TCGA-29-1785	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-20417	Dead	TUMOR FREE	1053	1104	[Not Available]	Recurrence	[Not Applicable]	473	Complete Remission/Response	1	1104	0	1104	1	473	1	473	58.92	3.02	50-59	other
7344	TCGA-29-2414	OV	75	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	1998	[Not Available]	-27417	Dead	WITH TUMOR	2621	2621	[Not Available]	Recurrence	[Not Applicable]	552	Complete Remission/Response	1	2621	1	2621	1	552	1	552	82.24	7.18	70-79	other
7345	TCGA-29-2425	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-22089	Alive	TUMOR FREE	1977	548	[Not Available]	Progression of Disease	[Not Applicable]	1577	Complete Remission/Response	0	1977	0	1977	1	1577	1	1577	65.89	5.41	60-69	other
7346	TCGA-29-2427	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-21940	Alive	WITH TUMOR	1900	548	[Not Available]	Recurrence	[Not Applicable]	1582	Complete Remission/Response	0	1900	0	1900	1	1582	1	1582	65.27	5.2	60-69	other
7347	TCGA-29-2428	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-21392	Alive	TUMOR FREE	1372	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1372	0	1372	0	1372	0	1372	62.32	3.76	50-59	other
7348	TCGA-29-2429	OV	79	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-29156	Dead	WITH TUMOR	766	421	[Not Available]	NA	NA	364	[Unknown]	1	421	1	421	0	720	1	421	80.98	1.15	70-79	other
7349	TCGA-29-2431	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2006	[Not Available]	-21833	Alive	WITH TUMOR	1285	548	[Not Available]	Recurrence	[Not Applicable]	960	Complete Remission/Response	0	1285	0	1285	1	960	1	960	63.29	3.52	50-59	other
7350	TCGA-29-2432	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-22605	Dead	WITH TUMOR	360	653	[Not Available]	Recurrence	[Not Applicable]	174	Progressive Disease	1	653	1	653	0	720	1	174	63.68	1.79	60-69	other
7351	TCGA-29-2433	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-22315	Alive	TUMOR FREE	620	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	620	0	620	0	620	0	620	62.79	1.7	60-69	other
7352	TCGA-29-2434	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-18997	Alive	TUMOR FREE	349	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	349	0	349	0	349	0	349	52.97	0.96	50-59	other
7353	TCGA-29-2435	OV	78	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-28779	Alive	TUMOR FREE	34	548	[Not Available]	NA	NA	364	[Not Available]	0	34	0	34	0	720	0	34	78.89	0.09	70-79	other
7354	TCGA-29-2436	OV	36	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2009	[Not Available]	-13346	Alive	TUMOR FREE	297	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	297	0	297	0	297	0	297	37.35	0.81	30-39	other
7355	TCGA-29-A5NZ	OV	66	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2011	[Not Available]	-24161	Dead	WITH TUMOR	766	1088	[Not Available]	Recurrence	[Not Applicable]	358	Complete Remission/Response	1	1088	1	1088	1	358	1	358	69.13	2.98	60-69	other
7356	TCGA-30-1714	OV	68	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-25032	Dead	WITH TUMOR	1158	1158	[Not Available]	Recurrence	[Not Applicable]	241	Complete Remission/Response	1	1158	1	1158	0	720	1	241	71.7	3.17	60-69	other
7357	TCGA-30-1718	OV	44	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-16400	Dead	WITH TUMOR	1579	1579	[Not Available]	Recurrence	[Not Applicable]	896	[Not Available]	1	1579	1	1579	0	720	1	896	49.22	4.32	40-49	other
7358	TCGA-30-1853	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2000	[Not Available]	-21404	Dead	WITH TUMOR	1103	1103	[Not Available]	Recurrence	[Not Applicable]	634	Complete Remission/Response	1	1103	1	1103	1	634	1	634	61.62	3.02	50-59	other
7359	TCGA-30-1855	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-22394	Dead	WITH TUMOR	75	75	[Not Available]	NA	NA	364	[Not Available]	1	75	1	75	0	720	1	75	61.52	0.21	60-69	other
7360	TCGA-30-1856	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-20626	Dead	WITH TUMOR	477	477	[Not Available]	Recurrence	[Not Applicable]	220	Partial Remission/Response	1	477	1	477	0	720	1	220	57.78	1.31	50-59	other
7361	TCGA-30-1857	OV	64	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-23689	Dead	WITH TUMOR	8	8	[Not Available]	NA	NA	364	[Not Available]	1	8	1	8	0	720	1	8	64.88	0.02	60-69	other
7362	TCGA-30-1859	OV	56	FEMALE	WHITE	[Not Applicable]	[Not Available]	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-20498	Dead	WITH TUMOR	1463	1463	[Not Available]	NA	NA	364	Partial Remission/Response	1	1463	1	1463	0	720	1	1463	60.13	4.01	50-59	other
7363	TCGA-30-1860	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-21406	Dead	WITH TUMOR	1366	1366	[Not Available]	Recurrence	[Not Applicable]	397	Complete Remission/Response	1	1366	1	1366	1	397	1	397	62.35	3.74	50-59	other
7364	TCGA-30-1861	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-27103	Dead	TUMOR FREE	1058	1058	[Not Available]	NA	NA	364	[Not Available]	1	1058	0	1058	0	720	0	1058	77.1	2.9	70-79	other
7365	TCGA-30-1862	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-23895	Dead	WITH TUMOR	186	186	[Not Available]	NA	NA	364	[Not Available]	1	186	1	186	0	720	1	186	65.93	0.51	60-69	other
7366	TCGA-30-1866	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-22562	Dead	WITH TUMOR	1114	1114	[Not Available]	Recurrence	[Not Applicable]	285	Complete Remission/Response	1	1114	1	1114	0	720	1	285	64.82	3.05	60-69	other
7367	TCGA-30-1867	OV	46	FEMALE	[Not Available]	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	GX	2004	[Not Available]	-17159	Dead	WITH TUMOR	37	37	[Not Available]	NA	NA	364	[Not Available]	1	37	1	37	0	720	1	37	47.08	0.1	40-49	other
7368	TCGA-30-1869	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-18398	Dead	WITH TUMOR	1563	1563	[Not Available]	Recurrence	[Not Applicable]	767	Complete Remission/Response	1	1563	1	1563	0	720	1	767	54.65	4.28	50-59	other
7369	TCGA-30-1880	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2001	[Not Available]	-20525	Dead	WITH TUMOR	1751	1751	[Not Available]	Recurrence	[Not Applicable]	348	Partial Remission/Response	1	1751	1	1751	0	720	1	348	60.99	4.79	50-59	other
7370	TCGA-30-1887	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	[Not Available]	-24495	Dead	WITH TUMOR	738	738	[Not Available]	NA	NA	364	Partial Remission/Response	1	738	1	738	0	720	1	738	69.08	2.02	60-69	other
7371	TCGA-30-1891	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-22344	Dead	WITH TUMOR	914	914	[Not Available]	Recurrence	[Not Applicable]	181	Partial Remission/Response	1	914	1	914	0	720	1	181	63.68	2.5	60-69	other
7372	TCGA-30-1892	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-19256	Dead	WITH TUMOR	1484	1484	[Not Available]	Recurrence	[Not Applicable]	253	Complete Remission/Response	1	1484	1	1484	1	253	1	253	56.78	4.06	50-59	other
7373	TCGA-31-1944	OV	47	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-17207	Alive	WITH TUMOR	1386	548	[Not Available]	Recurrence	[Not Applicable]	678	Complete Remission/Response	0	1386	0	1386	1	678	1	678	50.9	3.79	40-49	other
7374	TCGA-31-1946	OV	30	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-11146	Alive	WITH TUMOR	918	548	[Not Available]	Recurrence	[Not Applicable]	664	[Not Available]	0	918	0	918	0	720	1	664	33.03	2.51	30-39	other
7375	TCGA-31-1950	OV	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2007	[Not Available]	-28100	Alive	WITH TUMOR	571	548	[Not Available]	Recurrence	[Not Applicable]	349	Partial Remission/Response	0	571	0	571	0	720	1	349	78.5	1.56	70-79	other
7376	TCGA-31-1951	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-21352	Alive	WITH TUMOR	684	548	[Not Available]	Recurrence	[Not Applicable]	659	[Not Available]	0	684	0	684	0	720	1	659	60.33	1.87	50-59	other
7377	TCGA-31-1953	OV	52	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-19064	Alive	WITH TUMOR	204	548	[Not Available]	Recurrence	[Not Applicable]	70	Progressive Disease	0	204	0	204	0	720	1	70	52.75	0.56	50-59	other
7378	TCGA-31-1955	OV	43	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-15926	Alive	WITH TUMOR	1293	548	[Not Available]	Recurrence	[Not Applicable]	918	[Not Available]	0	1293	0	1293	0	720	1	918	47.14	3.54	40-49	other
7379	TCGA-31-1956	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-22100	Alive	WITH TUMOR	1342	548	[Not Available]	NA	NA	364	[Not Available]	0	1342	0	1342	0	720	0	1342	64.18	3.67	60-69	other
7380	TCGA-31-1959	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	2009	[Not Available]	-18247	Alive	WITH TUMOR	67	548	[Not Available]	NA	NA	364	[Not Available]	0	67	0	67	0	720	0	67	50.14	0.18	40-49	other
7381	TCGA-36-1568	OV	52	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-19311	Alive	WITH TUMOR	875	548	[Not Available]	Recurrence	[Not Applicable]	548	Partial Remission/Response	0	875	0	875	0	720	1	548	55.27	2.4	50-59	other
7382	TCGA-36-1569	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-19151	Alive	TUMOR FREE	885	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	885	0	885	0	720	0	885	54.86	2.42	50-59	other
7383	TCGA-36-1570	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-17956	Alive	WITH TUMOR	655	548	[Not Available]	Recurrence	[Not Applicable]	375	Partial Remission/Response	0	655	0	655	0	720	1	375	50.95	1.79	40-49	other
7384	TCGA-36-1571	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-19608	Dead	WITH TUMOR	695	695	[Not Available]	Recurrence	[Not Applicable]	375	Complete Remission/Response	1	695	1	695	1	375	1	375	55.59	1.9	50-59	other
7385	TCGA-36-1574	OV	48	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-17847	Alive	WITH TUMOR	686	548	[Not Available]	Recurrence	[Not Applicable]	648	Complete Remission/Response	0	686	0	686	1	648	1	648	50.74	1.88	40-49	other
7386	TCGA-36-1575	OV	83	FEMALE	[Not Available]	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-30592	Alive	TUMOR FREE	260	548	[Not Available]	NA	NA	364	[Not Available]	0	260	0	260	0	720	0	260	84.47	0.71	>=80	other
7387	TCGA-36-1576	OV	76	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-27778	Alive	WITH TUMOR	915	548	[Not Available]	Recurrence	[Not Applicable]	817	Complete Remission/Response	0	915	0	915	1	817	1	817	78.56	2.51	70-79	other
7388	TCGA-36-1577	OV	43	FEMALE	ASIAN	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G2	2007	[Not Available]	-15804	Alive	TUMOR FREE	783	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	783	0	783	0	783	0	783	45.41	2.14	40-49	Stage 2
7389	TCGA-36-1578	OV	63	FEMALE	ASIAN	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-23329	Alive	WITH TUMOR	847	548	[Not Available]	Recurrence	[Not Applicable]	310	[Not Available]	0	847	0	847	0	720	1	310	66.19	2.32	60-69	other
7390	TCGA-36-1580	OV	82	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-29992	Dead	WITH TUMOR	737	737	[Not Available]	Recurrence	[Not Applicable]	440	[Not Available]	1	737	1	737	0	720	1	440	84.13	2.02	>=80	other
7391	TCGA-36-1581	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-23272	Alive	WITH TUMOR	751	548	[Not Available]	Recurrence	[Not Applicable]	702	Complete Remission/Response	0	751	0	751	1	702	1	702	65.77	2.06	60-69	Stage 2
7392	TCGA-36-2529	OV	71	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-26092	Alive	WITH TUMOR	1066	548	[Not Available]	Recurrence	[Not Applicable]	567	Complete Remission/Response	0	1066	0	1066	1	567	1	567	74.35	2.92	70-79	other
7393	TCGA-36-2530	OV	38	FEMALE	ASIAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-13885	Alive	WITH TUMOR	1004	548	[Not Available]	Recurrence	[Not Applicable]	630	Complete Remission/Response	0	1004	0	1004	1	630	1	630	40.76	2.75	30-39	other
7394	TCGA-36-2532	OV	61	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-22333	Alive	WITH TUMOR	897	548	[Not Available]	NA	NA	364	[Not Available]	0	897	0	897	0	720	0	897	63.6	2.46	60-69	other
7395	TCGA-36-2533	OV	55	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-20187	Alive	TUMOR FREE	0	548	[Not Available]	NA	NA	364	[Not Available]	0	714	0	722	0	720	0	564	55.27	0	50-59	other
7396	TCGA-36-2534	OV	72	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-26621	Alive	WITH TUMOR	907	548	[Not Available]	Progression of Disease	[Not Applicable]	383	Partial Remission/Response	0	907	0	907	0	720	1	383	75.37	2.48	70-79	other
7397	TCGA-36-2537	OV	39	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-14595	Alive	WITH TUMOR	788	548	[Not Available]	Progression of Disease	[Not Applicable]	431	Partial Remission/Response	0	788	0	788	0	720	1	431	42.12	2.16	30-39	other
7398	TCGA-36-2538	OV	37	FEMALE	[Not Available]	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-13681	Alive	WITH TUMOR	763	548	[Not Available]	Recurrence	[Not Applicable]	523	Complete Remission/Response	0	763	0	763	1	523	1	523	39.55	2.09	30-39	other
7399	TCGA-36-2540	OV	26	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G1	2008	[Not Available]	-9760	Alive	WITH TUMOR	724	548	[Not Available]	Recurrence	[Not Applicable]	665	Complete Remission/Response	0	724	0	724	1	665	1	665	28.7	1.98	18-29	other
7400	TCGA-36-2542	OV	59	FEMALE	ASIAN	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-21902	Alive	TUMOR FREE	657	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	657	0	657	0	657	0	657	61.76	1.8	50-59	other
7401	TCGA-36-2543	OV	85	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-31211	Dead	WITH TUMOR	68	68	[Not Available]	Progression of Disease	[Not Applicable]	27	Progressive Disease	1	68	1	68	0	720	1	27	85.64	0.19	>=80	other
7402	TCGA-36-2544	OV	58	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-21384	Alive	WITH TUMOR	638	548	[Not Available]	Progression of Disease	[Not Applicable]	325	Partial Remission/Response	0	638	0	638	0	720	1	325	60.29	1.75	50-59	other
7403	TCGA-36-2545	OV	42	FEMALE	[Not Available]	[Not Applicable]	Stage IIIA	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-15444	Alive	TUMOR FREE	557	548	[Not Available]	NA	NA	364	[Not Available]	0	557	0	557	0	720	0	557	43.81	1.52	40-49	other
7404	TCGA-36-2547	OV	64	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-23706	Alive	TUMOR FREE	624	548	[Not Available]	NA	NA	364	[Not Available]	0	624	0	624	0	720	0	624	66.61	1.71	60-69	other
7405	TCGA-36-2548	OV	57	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-20897	Alive	WITH TUMOR	431	548	[Not Available]	Recurrence	[Not Applicable]	395	[Not Available]	0	431	0	431	0	720	1	395	58.39	1.18	50-59	other
7406	TCGA-36-2549	OV	54	FEMALE	[Not Available]	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-20076	Alive	TUMOR FREE	184	548	[Not Available]	NA	NA	364	[Not Available]	0	184	0	184	0	720	0	184	55.47	0.5	50-59	Stage 2
7407	TCGA-36-2551	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-21045	Alive	WITH TUMOR	492	548	[Not Available]	Recurrence	[Not Applicable]	338	Complete Remission/Response	0	492	0	492	1	338	1	338	58.97	1.35	50-59	other
7408	TCGA-36-2552	OV	64	FEMALE	[Not Available]	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-23379	Alive	TUMOR FREE	349	548	[Not Available]	NA	NA	364	[Not Available]	0	349	0	349	0	720	0	349	64.96	0.96	60-69	Stage 2
7409	TCGA-3P-A9WA	OV	55	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIB	Serous Cystadenocarcinoma	G3	2013	[Not Available]	-20211	Alive	TUMOR FREE	420	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	420	0	420	0	420	0	420	56.48	1.15	50-59	Stage 2
7410	TCGA-42-2582	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-17961	Dead	WITH TUMOR	766	1447	[Not Available]	Recurrence	[Not Applicable]	616	Stable Disease	1	1447	1	1447	0	720	1	616	53.14	3.96	40-49	other
7411	TCGA-42-2587	OV	75	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-27510	Alive	TUMOR FREE	722	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	722	0	722	0	722	0	722	77.3	1.98	70-79	other
7412	TCGA-42-2588	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-22377	Dead	WITH TUMOR	766	880	[Not Available]	Progression of Disease	[Not Applicable]	112	Progressive Disease	1	880	1	880	0	720	1	112	63.67	2.41	60-69	other
7413	TCGA-42-2589	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-19852	Alive	WITH TUMOR	1278	548	[Not Available]	Recurrence	[Not Applicable]	364	Complete Remission/Response	0	1278	0	1278	1	364	1	364	57.85	3.5	50-59	other
7414	TCGA-42-2590	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G2	2009	[Not Available]	-20965	Dead	WITH TUMOR	766	317	[Not Available]	Progression of Disease	[Not Applicable]	226	Progressive Disease	1	317	1	317	0	720	1	226	58.27	0.87	50-59	other
7415	TCGA-42-2591	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	GX	2009	[Not Available]	-18654	Alive	TUMOR FREE	1240	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1240	0	1240	0	1240	0	1240	54.47	3.39	50-59	other
7416	TCGA-42-2593	OV	67	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-24823	Dead	WITH TUMOR	766	45	[Not Available]	NA	NA	364	[Not Applicable]	1	45	1	45	0	720	1	45	68.08	0.12	60-69	other
7417	TCGA-57-1582	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-22222	Dead	WITH TUMOR	731	731	[Not Available]	NA	NA	364	Progressive Disease	1	731	1	731	0	720	1	731	62.84	2	50-59	other
7418	TCGA-57-1583	OV	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-21167	Dead	WITH TUMOR	346	346	[Not Available]	NA	NA	364	[Not Available]	1	346	1	346	0	720	1	346	58.9	0.95	50-59	other
7419	TCGA-57-1584	OV	47	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-17263	Alive	WITH TUMOR	643	548	[Not Available]	Recurrence	[Not Applicable]	530	[Not Available]	0	643	0	643	0	720	1	530	49.02	1.76	40-49	other
7420	TCGA-57-1585	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-20862	Dead	WITH TUMOR	53	53	[Not Available]	NA	NA	364	Progressive Disease	1	53	1	53	0	720	1	53	57.26	0.15	50-59	other
7421	TCGA-57-1586	OV	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-24304	Alive	WITH TUMOR	679	548	[Not Available]	Recurrence	[Not Applicable]	259	[Not Available]	0	679	0	679	0	720	1	259	68.4	1.86	60-69	other
7422	TCGA-57-1992	OV	62	FEMALE	[Not Available]	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-22222	Alive	TUMOR FREE	882	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	882	0	882	0	882	0	882	63.26	2.41	60-69	Stage 1
7423	TCGA-57-1993	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-20498	Alive	TUMOR FREE	763	548	[Not Available]	NA	NA	364	[Not Available]	0	763	0	763	0	720	0	763	58.21	2.09	50-59	other
7424	TCGA-57-1994	OV	63	FEMALE	WHITE	[Not Applicable]	[Not Available]	Serous Cystadenocarcinoma	[Not Available]	2004	[Not Available]	-23062	Alive	TUMOR FREE	761	548	[Not Available]	NA	NA	364	[Not Available]	0	761	0	761	0	720	0	761	65.22	2.08	60-69	other
7425	TCGA-59-2348	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1994	[Not Available]	-22222	Alive	TUMOR FREE	5481	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	5481	0	5481	0	5481	0	5481	75.85	15.01	50-59	other
7426	TCGA-59-2349	OV	71	FEMALE	[Not Available]	[Not Applicable]	Stage IA	Serous Cystadenocarcinoma	G3	1994	[Not Available]	-22222	Dead	TUMOR FREE	766	2437	[Not Available]	NA	NA	364	Complete Remission/Response	1	2437	0	2437	0	2437	0	2437	67.51	6.67	70-79	Stage 1
7427	TCGA-59-2350	OV	44	FEMALE	[Not Available]	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	1995	[Not Available]	-22222	Dead	WITH TUMOR	766	679	[Not Available]	Progression of Disease	[Not Applicable]	211	Partial Remission/Response	1	679	1	679	0	720	1	211	62.7	1.86	40-49	other
7428	TCGA-59-2351	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-22222	Alive	TUMOR FREE	3532	548	[Not Available]	Progression of Disease	[Not Applicable]	2139	Complete Remission/Response	0	3532	0	3532	1	2139	1	2139	70.51	9.67	50-59	other
7429	TCGA-59-2352	OV	78	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-22222	Dead	WITH TUMOR	766	286	[Not Available]	NA	NA	364	[Not Available]	1	286	1	286	0	720	1	286	61.62	0.78	70-79	other
7430	TCGA-59-2354	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-22222	Dead	WITH TUMOR	766	1046	[Not Available]	Progression of Disease	[Not Applicable]	462	Stable Disease	1	1046	1	1046	0	720	1	462	63.7	2.86	60-69	other
7431	TCGA-59-2355	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-22222	Dead	WITH TUMOR	766	65	[Not Available]	NA	NA	364	[Not Available]	1	65	1	65	0	720	1	65	61.02	0.18	50-59	other
7432	TCGA-59-2363	OV	40	FEMALE	ASIAN	[Not Applicable]	Stage IIIA	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-22222	Alive	TUMOR FREE	165	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	165	0	165	0	165	0	165	61.29	0.45	40-49	other
7433	TCGA-59-2372	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2005	[Not Available]	-22222	Dead	TUMOR FREE	766	1363	[Not Available]	NA	NA	364	[Not Available]	1	1363	0	1363	0	720	0	1363	64.57	3.73	70-79	other
7434	TCGA-59-A5PD	OV	55	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G3	2011	[Not Available]	-20263	Dead	WITH TUMOR	766	624	[Not Available]	Recurrence	[Not Applicable]	145	Complete Remission/Response	1	624	1	624	1	145	1	145	57.19	1.71	50-59	Stage 1
7435	TCGA-5X-AA5U	OV	61	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	GX	2013	[Not Available]	-22438	Alive	TUMOR FREE	361	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	361	0	361	0	361	0	361	62.42	0.99	60-69	Stage 2
7436	TCGA-61-1721	OV	38	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G1	2008	[Not Available]	-13894	Alive	TUMOR FREE	338	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	338	0	338	0	720	0	338	38.97	0.93	30-39	other
7437	TCGA-61-1722	OV	89	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-32853	Alive	WITH TUMOR	246	548	[Not Available]	NA	NA	364	Stable Disease	0	246	0	246	0	720	0	246	90.62	0.67	>=80	Stage 1
7438	TCGA-61-1724	OV	47	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-17168	Dead	WITH TUMOR	637	637	[Not Available]	NA	NA	364	Progressive Disease	1	637	1	637	0	720	1	637	48.75	1.74	40-49	other
7439	TCGA-61-1725	OV	40	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-14782	Alive	WITH TUMOR	956	548	[Not Available]	Recurrence	[Not Applicable]	844	Stable Disease	0	956	0	956	0	720	1	844	43.09	2.62	40-49	other
7440	TCGA-61-1727	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-27203	Alive	TUMOR FREE	564	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	564	0	564	0	564	0	564	76.02	1.54	70-79	Stage 1
7441	TCGA-61-1728	OV	59	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-21582	Alive	TUMOR FREE	848	548	[Not Available]	Recurrence	[Not Applicable]	533	Complete Remission/Response	0	848	0	848	0	720	1	533	61.41	2.32	50-59	other
7442	TCGA-61-1730	OV	78	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-28508	Dead	WITH TUMOR	132	132	[Not Available]	NA	NA	364	[Not Available]	1	132	1	132	0	720	1	132	78.41	0.36	70-79	Stage 1
7443	TCGA-61-1733	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-26180	Alive	WITH TUMOR	967	548	[Not Available]	Recurrence	[Not Applicable]	175	Stable Disease	0	967	0	967	0	720	1	175	74.32	2.65	70-79	other
7444	TCGA-61-1734	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-19026	Alive	TUMOR FREE	866	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	866	0	866	0	866	0	866	54.46	2.37	50-59	Stage 1
7445	TCGA-61-1736	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-16613	Dead	WITH TUMOR	1484	1484	[Not Available]	Recurrence	[Not Applicable]	764	Complete Remission/Response	1	1484	1	1484	1	764	1	764	49.55	4.06	40-49	other
7446	TCGA-61-1737	OV	42	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-15515	Alive	TUMOR FREE	1364	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1364	0	1364	0	720	0	1364	46.21	3.73	40-49	other
7447	TCGA-61-1738	OV	60	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-21965	Dead	WITH TUMOR	1089	1089	[Not Available]	Recurrence	[Not Applicable]	276	Progressive Disease	1	1089	1	1089	0	720	1	276	63.12	2.98	60-69	other
7448	TCGA-61-1740	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-26169	Dead	WITH TUMOR	74	74	[Not Available]	NA	NA	364	Progressive Disease	1	74	1	74	0	720	1	74	71.85	0.2	70-79	other
7449	TCGA-61-1741	OV	76	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-27762	Dead	WITH TUMOR	1024	1024	[Not Available]	Recurrence	[Not Applicable]	488	Complete Remission/Response	1	1024	1	1024	1	488	1	488	78.81	2.8	70-79	other
7450	TCGA-61-1743	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G2	2004	[Not Available]	-19365	Dead	WITH TUMOR	1329	1329	[Not Available]	Recurrence	[Not Applicable]	809	Complete Remission/Response	1	1329	1	1329	1	809	1	809	56.66	3.64	50-59	Stage 2
7451	TCGA-61-1895	OV	52	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-19060	Alive	TUMOR FREE	44	548	[Not Available]	NA	NA	364	Stable Disease	0	44	0	44	0	720	0	44	52.3	0.12	50-59	other
7452	TCGA-61-1899	OV	81	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-29692	Alive	TUMOR FREE	256	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	256	0	256	0	256	0	256	81.99	0.7	>=80	other
7453	TCGA-61-1900	OV	51	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-18963	Alive	TUMOR FREE	176	548	[Not Available]	NA	NA	364	Stable Disease	0	176	0	176	0	720	0	176	52.4	0.48	50-59	other
7454	TCGA-61-1901	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-24042	Dead	WITH TUMOR	347	347	[Not Available]	Progression of Disease	[Not Applicable]	329	Stable Disease	1	347	1	347	0	720	1	329	66.77	0.95	60-69	other
7455	TCGA-61-1903	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-20381	Alive	TUMOR FREE	396	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	396	0	396	0	396	0	396	56.88	1.08	50-59	Stage 1
7456	TCGA-61-1904	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-22009	Alive	TUMOR FREE	276	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	276	0	276	0	276	0	276	61.01	0.76	60-69	other
7457	TCGA-61-1906	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-20378	Dead	WITH TUMOR	1038	1038	[Not Available]	Recurrence	[Not Applicable]	236	Complete Remission/Response	1	1038	1	1038	1	236	1	236	58.63	2.84	50-59	other
7458	TCGA-61-1907	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-23204	Alive	WITH TUMOR	952	548	[Not Available]	Recurrence	[Not Applicable]	743	Stable Disease	0	952	0	952	0	720	1	743	66.14	2.61	60-69	other
7459	TCGA-61-1910	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-20779	Alive	TUMOR FREE	1127	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1127	0	1127	0	1127	0	1127	59.98	3.09	50-59	Stage 2
7460	TCGA-61-1911	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIA	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-20144	Alive	WITH TUMOR	1293	548	[Not Available]	Recurrence	[Not Applicable]	844	Complete Remission/Response	0	1293	0	1293	1	844	1	844	58.69	3.54	50-59	Stage 2
7461	TCGA-61-1913	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-17575	Alive	TUMOR FREE	1488	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1488	0	1488	0	1488	0	1488	52.19	4.07	40-49	other
7462	TCGA-61-1914	OV	65	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-23850	Alive	WITH TUMOR	1722	548	[Not Available]	Recurrence	[Not Applicable]	1674	Complete Remission/Response	0	1722	0	1722	1	1674	1	1674	70.01	4.71	60-69	other
7463	TCGA-61-1915	OV	50	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-18424	Alive	TUMOR FREE	2061	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2061	0	2061	0	2061	0	2061	56.08	5.64	50-59	Stage 2
7464	TCGA-61-1916	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2002	[Not Available]	-19463	Dead	TUMOR FREE	475	475	[Not Available]	Recurrence	[Not Applicable]	326	[Not Available]	1	475	0	475	0	720	1	326	54.59	1.3	50-59	other
7465	TCGA-61-1917	OV	60	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-21972	Dead	TUMOR FREE	1321	1321	[Not Available]	NA	NA	364	Complete Remission/Response	1	1321	0	1321	0	1321	0	1321	63.77	3.62	60-69	other
7466	TCGA-61-1918	OV	45	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-16689	Dead	WITH TUMOR	479	479	[Not Available]	Recurrence	[Not Applicable]	413	Complete Remission/Response	1	479	1	479	0	720	1	413	47	1.31	40-49	other
7467	TCGA-61-1919	OV	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2001	[Not Available]	-21199	Dead	TUMOR FREE	1161	1161	[Not Available]	Recurrence	[Not Applicable]	439	Complete Remission/Response	1	1161	0	1161	1	439	1	439	61.22	3.18	50-59	other
7468	TCGA-61-1995	OV	43	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-16016	Alive	WITH TUMOR	61	548	[Not Available]	NA	NA	364	Stable Disease	0	61	0	61	0	720	0	61	44.02	0.17	40-49	other
7469	TCGA-61-1998	OV	48	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-17855	Alive	WITH TUMOR	168	548	[Not Available]	NA	NA	364	[Not Available]	0	168	0	168	0	720	0	168	49.34	0.46	40-49	other
7470	TCGA-61-2000	OV	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-24723	Alive	WITH TUMOR	441	548	[Not Available]	Recurrence	[Not Applicable]	339	Stable Disease	0	441	0	441	0	720	1	339	68.9	1.21	60-69	other
7471	TCGA-61-2002	OV	46	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-17115	Alive	WITH TUMOR	547	548	[Not Available]	NA	NA	364	Progressive Disease	0	547	0	547	0	720	0	547	48.36	1.5	40-49	other
7472	TCGA-61-2003	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2008	[Not Available]	-19605	Alive	WITH TUMOR	122	548	[Not Available]	NA	NA	364	Progressive Disease	0	122	0	122	0	720	0	122	54.01	0.33	50-59	other
7473	TCGA-61-2008	OV	40	FEMALE	ASIAN	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G2	2007	[Not Available]	-14791	Alive	WITH TUMOR	932	548	[Not Available]	Recurrence	[Not Applicable]	818	Complete Remission/Response	0	932	0	932	1	818	1	818	43.05	2.55	40-49	Stage 2
7474	TCGA-61-2009	OV	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-23772	Alive	WITH TUMOR	1212	548	[Not Available]	Recurrence	[Not Applicable]	101	Complete Remission/Response	0	1212	0	1212	1	101	1	101	68.4	3.32	60-69	other
7475	TCGA-61-2012	OV	81	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G2	2006	[Not Available]	-29830	Alive	TUMOR FREE	932	548	[Not Available]	NA	NA	364	[Not Available]	0	932	0	932	0	720	0	932	84.22	2.55	>=80	Stage 2
7476	TCGA-61-2016	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2006	[Not Available]	-18788	Dead	WITH TUMOR	766	36	[Not Available]	NA	NA	364	Progressive Disease	1	36	1	36	0	720	1	36	51.54	0.1	50-59	other
7477	TCGA-61-2017	OV	64	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G1	2005	[Not Available]	-23509	Alive	WITH TUMOR	1398	548	[Not Available]	Recurrence	[Not Applicable]	1006	Complete Remission/Response	0	1398	0	1398	1	1006	1	1006	68.19	3.83	60-69	other
7478	TCGA-61-2018	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G3	2005	[Not Available]	-22929	Alive	TUMOR FREE	1381	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1381	0	1381	0	1381	0	1381	66.56	3.78	60-69	Stage 1
7479	TCGA-61-2087	OV	49	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-18182	Alive	TUMOR FREE	146	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	146	0	146	0	146	0	146	50.18	0.4	40-49	Stage 1
7480	TCGA-61-2088	OV	51	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2009	[Not Available]	-18770	Alive	TUMOR FREE	145	548	[Not Available]	NA	NA	364	[Not Available]	0	145	0	145	0	720	0	145	51.79	0.4	50-59	other
7481	TCGA-61-2092	OV	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2004	[Not Available]	-21072	Alive	TUMOR FREE	1573	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1573	0	1573	0	1573	0	1573	62	4.31	50-59	other
7482	TCGA-61-2094	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2003	[Not Available]	-23273	Alive	TUMOR FREE	2182	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2182	0	2182	0	2182	0	2182	69.69	5.97	60-69	other
7483	TCGA-61-2095	OV	54	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-19797	Dead	WITH TUMOR	766	1875	[Not Available]	Recurrence	[Not Applicable]	445	Complete Remission/Response	1	1875	1	1875	1	445	1	445	59.33	5.13	50-59	other
7484	TCGA-61-2096	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-20663	Alive	TUMOR FREE	1776	548	[Not Available]	Recurrence	[Not Applicable]	421	Progressive Disease	0	1776	0	1776	0	720	1	421	61.43	4.86	50-59	Stage 1
7485	TCGA-61-2097	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-25961	Alive	TUMOR FREE	1844	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1844	0	1844	0	1844	0	1844	76.13	5.05	70-79	Stage 2
7486	TCGA-61-2098	OV	62	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-22876	Alive	TUMOR FREE	1993	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1993	0	1993	0	1993	0	1993	68.09	5.46	60-69	other
7487	TCGA-61-2101	OV	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G2	1999	[Not Available]	-20287	Dead	WITH TUMOR	766	1688	[Not Available]	NA	NA	364	Partial Remission/Response	1	1688	1	1688	0	720	1	1688	60.16	4.62	50-59	other
7488	TCGA-61-2102	OV	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-27256	Dead	WITH TUMOR	197	197	[Not Available]	NA	NA	364	[Not Available]	1	197	1	197	0	720	1	197	75.16	0.54	70-79	other
7489	TCGA-61-2104	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G2	2003	[Not Available]	-19432	Alive	TUMOR FREE	2338	548	[Not Available]	Recurrence	[Not Applicable]	1680	Complete Remission/Response	0	2338	0	2338	1	1680	1	1680	59.6	6.4	50-59	Stage 2
7490	TCGA-61-2109	OV	40	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-14900	Dead	WITH TUMOR	629	629	[Not Available]	Recurrence	[Not Applicable]	465	[Not Available]	1	629	1	629	0	720	1	465	42.52	1.72	40-49	other
7491	TCGA-61-2110	OV	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	[Not Available]	1998	[Not Available]	-20718	Dead	WITH TUMOR	1354	1354	[Not Available]	Recurrence	[Not Applicable]	213	Progressive Disease	1	1354	1	1354	0	720	1	213	60.43	3.71	50-59	other
7492	TCGA-61-2111	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-22517	Alive	WITH TUMOR	3825	548	[Not Available]	Recurrence	[Not Applicable]	2205	Complete Remission/Response	0	3825	0	3825	0	720	1	2205	72.12	10.47	60-69	other
7493	TCGA-61-2113	OV	53	FEMALE	WHITE	[Not Applicable]	Stage IIC	Serous Cystadenocarcinoma	G3	1999	[Not Available]	-19722	Dead	TUMOR FREE	676	676	[Not Available]	Recurrence	[Not Applicable]	291	[Not Available]	1	676	0	676	0	720	1	291	55.85	1.85	50-59	Stage 2
7494	TCGA-61-2610	OV	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-22481	Dead	WITH TUMOR	1579	1579	[Not Available]	Recurrence	[Not Applicable]	524	Stable Disease	1	1579	1	1579	0	720	1	524	65.87	4.32	60-69	other
7495	TCGA-61-2611	OV	40	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2008	[Not Available]	-14782	Dead	WITH TUMOR	483	483	[Not Available]	Recurrence	[Not Applicable]	383	Complete Remission/Response	1	483	1	483	1	383	1	383	41.79	1.32	40-49	other
7496	TCGA-61-2612	OV	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2002	[Not Available]	-23074	Dead	WITH TUMOR	193	193	[Not Available]	Recurrence	[Not Applicable]	179	Stable Disease	1	193	1	193	0	720	1	179	63.7	0.53	60-69	other
7497	TCGA-61-2613	OV	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	1998	[Not Available]	-26779	Dead	WITH TUMOR	945	945	[Not Available]	Recurrence	[Not Applicable]	358	Stable Disease	1	945	1	945	0	720	1	358	75.9	2.59	70-79	other
7498	TCGA-61-2614	OV	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2007	[Not Available]	-26142	Dead	WITH TUMOR	262	262	[Not Available]	Recurrence	[Not Applicable]	38	Stable Disease	1	262	1	262	0	720	1	38	72.29	0.72	70-79	other
7499	TCGA-OY-A56P	OV	48	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIB	Serous Cystadenocarcinoma	G3	2010	[Not Available]	-17580	Alive	WITH TUMOR	1207	548	[Not Available]	Recurrence	[Not Applicable]	794	Complete Remission/Response	0	1207	0	1207	1	794	1	794	51.44	3.3	40-49	other
7500	TCGA-OY-A56Q	OV	78	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIA	Serous Cystadenocarcinoma	G3	2012	[Not Available]	-28623	Alive	TUMOR FREE	576	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	576	0	576	0	576	0	576	79.94	1.58	70-79	Stage 2
7501	TCGA-VG-A8LO	OV	55	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IV	Serous Cystadenocarcinoma	GB	2013	[Not Available]	-20274	Dead	WITH TUMOR	766	24	[Not Available]	NA	NA	364	[Not Applicable]	1	24	1	24	0	720	1	24	55.57	0.07	50-59	other
7502	TCGA-WR-A838	OV	72	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous Cystadenocarcinoma	G3	2013	[Not Available]	-26418	Dead	WITH TUMOR	766	304	[Not Available]	Progression of Disease	[Not Applicable]	245	Progressive Disease	1	304	1	304	0	720	1	245	73.16	0.83	70-79	other
10476	TCGA-2E-A9G8	UCEC	59	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage III	Endometrioid endometrial adenocarcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	1249	548	[Not Available]	Locoregional Recurrence	Other, specify	335	Progressive Disease	0	1249	0	1249	0	720	1	335	64.26	3.42	50-59	other
10477	TCGA-4E-A92E	UCEC	54	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage I	Endometrioid endometrial adenocarcinoma	G1	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19818	Alive	TUMOR FREE	13	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	13	0	13	0	13	0	13	54.29	0.04	50-59	Stage 1
10478	TCGA-5B-A90C	UCEC	69	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25518	Alive	TUMOR FREE	1202	548	[Not Available]	Locoregional Recurrence	Other, specify	517	[Not Available]	0	1202	0	1202	0	720	1	517	73.16	3.29	60-69	Stage 1
10479	TCGA-5S-A9Q8	UCEC	51	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2013	[Unknown]	-18785	Alive	TUMOR FREE	313	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	313	0	313	0	313	0	313	52.29	0.86	50-59	other
10480	TCGA-A5-A0G1	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	1996	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24477	Dead	TUMOR FREE	766	3251	[Not Available]	NA	NA	364	Complete Remission/Response	1	3251	0	3251	0	3251	0	3251	75.92	8.9	60-69	Stage 1
10481	TCGA-A5-A0G2	UCEC	57	FEMALE	ASIAN	[Not Applicable]	Stage IIIB	Serous endometrial adenocarcinoma	G3	1997	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20953	Alive	WITH TUMOR	4549	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	4549	0	4549	0	4549	0	4549	69.82	12.45	50-59	other
10482	TCGA-A5-A0G3	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22421	Alive	WITH TUMOR	1428	548	[Not Available]	NA	NA	795	Complete Remission/Response	0	1428	0	1428	1	795	1	795	65.3	3.91	60-69	other
10483	TCGA-A5-A0G5	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26827	Alive	TUMOR FREE	1126	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1126	0	1126	0	1126	0	1126	76.53	3.08	70-79	Stage 1
10484	TCGA-A5-A0G9	UCEC	79	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29122	Alive	TUMOR FREE	2540	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2540	0	2540	0	2540	0	2540	86.69	6.95	70-79	Stage 1
10485	TCGA-A5-A0GA	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24659	Dead	WITH TUMOR	766	543	[Not Available]	NA	NA	364	Partial Remission/Response	1	543	1	543	0	720	1	543	69	1.49	60-69	other
10486	TCGA-A5-A0GB	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23883	Alive	TUMOR FREE	997	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	997	0	997	0	997	0	997	68.12	2.73	60-69	Stage 1
10487	TCGA-A5-A0GD	UCEC	75	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	1999	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27399	Dead	TUMOR FREE	766	3423	[Not Available]	NA	NA	364	Complete Remission/Response	1	3423	0	3423	0	3423	0	3423	84.39	9.37	70-79	Stage 1
10488	TCGA-A5-A0GE	UCEC	38	FEMALE	ASIAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2002	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14170	Alive	TUMOR FREE	3205	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3205	0	3205	0	3205	0	3205	47.57	8.77	30-39	Stage 1
10489	TCGA-A5-A0GG	UCEC	76	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27809	Alive	TUMOR FREE	3762	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3762	0	3762	0	3762	0	3762	86.44	10.3	70-79	Stage 1
10490	TCGA-A5-A0GH	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21090	Alive	TUMOR FREE	2254	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2254	0	2254	0	2254	0	2254	63.91	6.17	50-59	Stage 1
10491	TCGA-A5-A0GI	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23195	Alive	TUMOR FREE	2682	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2682	0	2682	0	2682	0	2682	70.85	7.34	60-69	Stage 1
10492	TCGA-A5-A0GJ	UCEC	44	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16421	Alive	TUMOR FREE	2000	548	[Not Available]	NA	NA	12	Complete Remission/Response	0	2000	0	2000	1	12	1	12	50.43	5.48	40-49	Stage 1
10493	TCGA-A5-A0GM	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19452	Alive	TUMOR FREE	1841	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1841	0	1841	0	1841	0	1841	58.3	5.04	50-59	Stage 1
10494	TCGA-A5-A0GN	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24020	Alive	TUMOR FREE	1841	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1841	0	1841	0	1841	0	1841	70.8	5.04	60-69	Stage 1
10495	TCGA-A5-A0GP	UCEC	58	FEMALE	ASIAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21365	Alive	TUMOR FREE	1416	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1416	0	1416	0	1416	0	1416	62.37	3.88	50-59	Stage 1
10496	TCGA-A5-A0GQ	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28078	Alive	TUMOR FREE	2247	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2247	0	2247	0	2247	0	2247	83.03	6.15	70-79	Stage 1
10497	TCGA-A5-A0GR	UCEC	69	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25353	Alive	TUMOR FREE	1120	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1120	0	1120	0	1120	0	1120	72.48	3.07	60-69	Stage 1
10498	TCGA-A5-A0GU	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21192	Alive	TUMOR FREE	860	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	860	0	860	0	860	0	860	60.38	2.35	50-59	Stage 1
10499	TCGA-A5-A0GV	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24540	Alive	TUMOR FREE	1643	548	[Not Available]	NA	NA	304	Complete Remission/Response	0	1643	0	1643	1	304	1	304	71.69	4.5	60-69	Stage 1
10500	TCGA-A5-A0GW	UCEC	46	FEMALE	ASIAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17092	Alive	TUMOR FREE	706	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	706	0	706	0	706	0	706	48.73	1.93	40-49	Stage 1
10501	TCGA-A5-A0GX	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19625	Alive	TUMOR FREE	2088	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2088	0	2088	0	2088	0	2088	59.45	5.72	50-59	Stage 1
10502	TCGA-A5-A0R6	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23449	Alive	TUMOR FREE	1153	548	[Not Available]	New Primary Tumor	Other, specify	961	Complete Remission/Response	0	1153	0	1153	0	1153	1	961	67.36	3.16	60-69	other
10503	TCGA-A5-A0R7	UCEC	55	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20250	Alive	TUMOR FREE	535	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	535	0	535	0	535	0	535	56.91	1.46	50-59	Stage 1
10504	TCGA-A5-A0R8	UCEC	81	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29777	Alive	TUMOR FREE	596	548	[Not Available]	NA	NA	42	Complete Remission/Response	0	596	0	596	1	42	1	42	83.16	1.63	>=80	Stage 1
10505	TCGA-A5-A0R9	UCEC	51	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18982	Alive	TUMOR FREE	749	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	749	0	749	0	749	0	749	54.02	2.05	50-59	Stage 1
10506	TCGA-A5-A0RA	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25060	Alive	TUMOR FREE	884	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	884	0	884	0	884	0	884	71.03	2.42	60-69	Stage 1
10507	TCGA-A5-A0VO	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23547	Dead	TUMOR FREE	766	875	[Not Available]	NA	NA	364	Complete Remission/Response	1	875	0	875	0	875	0	875	66.86	2.4	60-69	Stage 1
10508	TCGA-A5-A0VP	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27335	Alive	TUMOR FREE	1288	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1288	0	1288	0	1288	0	1288	78.37	3.53	70-79	Stage 1
10509	TCGA-A5-A0VQ	UCEC	62	FEMALE	[Not Available]	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22995	Alive	TUMOR FREE	485	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	485	0	485	0	485	0	485	64.28	1.33	60-69	Stage 1
10510	TCGA-A5-A1OF	UCEC	47	FEMALE	[Not Available]	[Not Applicable]	Stage IA	Mixed serous and endometrioid	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17308	Alive	TUMOR FREE	973	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	973	0	973	0	973	0	973	50.05	2.66	40-49	Stage 1
10511	TCGA-A5-A1OG	UCEC	65	FEMALE	ASIAN	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23956	Dead	WITH TUMOR	766	973	[Not Available]	Metastatic	Lung	337	Complete Remission/Response	1	973	1	973	1	337	1	337	68.25	2.66	60-69	other
10512	TCGA-A5-A1OH	UCEC	86	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31451	Alive	TUMOR FREE	1105	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1105	0	1105	0	1105	0	1105	89.13	3.03	>=80	other
10513	TCGA-A5-A1OJ	UCEC	31	FEMALE	ASIAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11635	Alive	TUMOR FREE	1006	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1006	0	1006	0	1006	0	1006	34.61	2.75	30-39	Stage 1
10514	TCGA-A5-A1OK	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23179	Alive	TUMOR FREE	917	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	917	0	917	0	917	0	917	65.97	2.51	60-69	other
10515	TCGA-A5-A2K2	UCEC	77	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28456	Alive	TUMOR FREE	3595	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3595	0	3595	0	3595	0	3595	87.75	9.84	70-79	Stage 1
10516	TCGA-A5-A2K3	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24907	Alive	TUMOR FREE	2012	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2012	0	2012	0	2012	0	2012	73.7	5.51	60-69	Stage 1
10517	TCGA-A5-A2K4	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25270	Dead	WITH TUMOR	766	871	[Not Available]	Metastatic	Other, specify	528	Complete Remission/Response	1	871	1	871	1	528	1	528	71.57	2.38	60-69	other
10518	TCGA-A5-A2K5	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28057	Alive	TUMOR FREE	752	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	752	0	752	0	752	0	752	78.87	2.06	70-79	Stage 1
10519	TCGA-A5-A2K7	UCEC	41	FEMALE	[Not Available]	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14980	Alive	TUMOR FREE	1063	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1063	0	1063	0	1063	0	1063	43.92	2.91	40-49	Stage 2
10520	TCGA-A5-A3LO	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23401	Alive	TUMOR FREE	776	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	776	0	776	0	776	0	776	66.19	2.12	60-69	Stage 1
10521	TCGA-A5-A3LP	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27131	Alive	TUMOR FREE	455	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	455	0	455	0	455	0	455	75.53	1.25	70-79	Stage 1
10522	TCGA-A5-A7WJ	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23723	Alive	TUMOR FREE	341	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	341	0	341	0	341	0	341	65.88	0.93	60-69	Stage 1
10523	TCGA-A5-A7WK	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Mixed serous and endometrioid	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26044	Alive	WITH TUMOR	560	548	[Not Available]	Locoregional Recurrence	Other, specify	350	Complete Remission/Response	0	560	0	560	1	350	1	350	72.84	1.53	70-79	Stage 1
10524	TCGA-A5-AB3J	UCEC	52	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G2	2013	Peri (6-12 months since last menstrual period)	-19020	Alive	TUMOR FREE	512	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	512	0	512	0	512	0	512	53.48	1.4	50-59	Stage 2
10525	TCGA-AJ-A23M	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage II	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22430	Dead	WITH TUMOR	766	616	[Not Available]	Locoregional Recurrence	Other, specify	516	Stable Disease	1	616	1	616	0	720	1	516	63.1	1.69	60-69	Stage 2
10526	TCGA-AJ-A23N	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25772	Dead	WITH TUMOR	766	439	[Not Available]	NA	NA	364	Progressive Disease	1	439	1	439	0	720	1	439	71.76	1.2	70-79	other
10527	TCGA-AJ-A23O	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25433	Dead	TUMOR FREE	766	312	[Not Available]	NA	NA	364	[Not Available]	1	312	0	312	0	720	0	312	70.49	0.85	60-69	Stage 1
10528	TCGA-AJ-A2QK	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23945	Alive	WITH TUMOR	643	548	[Not Available]	Distant Metastasis	Liver	606	Complete Remission/Response	0	643	0	643	1	606	1	606	67.32	1.76	60-69	Stage 1
10529	TCGA-AJ-A2QL	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22057	Alive	TUMOR FREE	602	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	602	0	602	0	602	0	602	62.04	1.65	60-69	other
10530	TCGA-AJ-A2QM	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage II	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24776	Alive	TUMOR FREE	894	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	894	0	894	0	894	0	894	70.28	2.45	60-69	Stage 2
10531	TCGA-AJ-A2QN	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21915	Alive	TUMOR FREE	1069	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1069	0	1069	0	1069	0	1069	62.93	2.93	60-69	Stage 2
10532	TCGA-AJ-A2QO	UCEC	85	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31222	Dead	TUMOR FREE	766	1045	[Not Available]	NA	NA	364	Complete Remission/Response	1	1045	0	1045	0	1045	0	1045	88.34	2.86	>=80	Stage 1
10533	TCGA-AJ-A3BD	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20998	Alive	TUMOR FREE	1039	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1039	0	1039	0	1039	0	1039	60.33	2.84	50-59	other
10534	TCGA-AJ-A3BF	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23906	Alive	TUMOR FREE	551	548	[Not Available]	Locoregional Recurrence	Other, specify	384	Complete Remission/Response	0	551	0	551	1	384	1	384	66.96	1.51	60-69	other
10535	TCGA-AJ-A3BG	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IA	Mixed serous and endometrioid	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23861	Alive	WITH TUMOR	550	548	[Not Available]	Locoregional Recurrence	Other, specify	480	Complete Remission/Response	0	550	0	550	1	480	1	480	66.83	1.51	60-69	Stage 1
10536	TCGA-AJ-A3BH	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	766	548	[Not Available]	NA	NA	364	[Not Available]	0	714	0	722	0	720	0	564	62.94	2.1	60-69	Stage 1
10537	TCGA-AJ-A3BI	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24623	Alive	TUMOR FREE	575	548	[Not Available]	Locoregional Recurrence	Other, specify	373	[Not Available]	0	575	0	575	0	720	1	373	68.99	1.57	60-69	Stage 1
10538	TCGA-AJ-A3BK	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24943	Alive	TUMOR FREE	1031	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1031	0	1031	0	1031	0	1031	71.11	2.82	60-69	Stage 1
10539	TCGA-AJ-A3EJ	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IIIC2	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27317	Dead	WITH TUMOR	766	50	[Not Available]	NA	NA	364	[Not Available]	1	50	1	50	0	720	1	50	74.93	0.14	70-79	other
10540	TCGA-AJ-A3EK	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Peri (6-12 months since last menstrual period)	-19609	Alive	TUMOR FREE	446	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	446	0	446	0	446	0	446	54.91	1.22	50-59	Stage 1
10541	TCGA-AJ-A3EL	UCEC	47	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17442	Alive	TUMOR FREE	684	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	684	0	684	0	684	0	684	49.63	1.87	40-49	Stage 1
10542	TCGA-AJ-A3EM	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25557	Alive	TUMOR FREE	677	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	677	0	677	0	677	0	677	71.82	1.85	60-69	Stage 1
10543	TCGA-AJ-A3I9	UCEC	52	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19139	Dead	WITH TUMOR	766	519	[Not Available]	Distant Metastasis	Bone	370	Complete Remission/Response	1	519	1	519	1	370	1	370	53.82	1.42	50-59	Stage 2
10544	TCGA-AJ-A3IA	UCEC	77	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28470	Alive	TUMOR FREE	633	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	633	0	633	0	633	0	633	79.68	1.73	70-79	Stage 1
10545	TCGA-AJ-A3NC	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23353	Alive	TUMOR FREE	1125	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1125	0	1125	0	1125	0	1125	67.02	3.08	60-69	Stage 1
10546	TCGA-AJ-A3NE	UCEC	46	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16957	Alive	TUMOR FREE	628	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	628	0	628	0	628	0	628	48.15	1.72	40-49	Stage 1
10547	TCGA-AJ-A3NF	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22210	Alive	TUMOR FREE	645	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	645	0	645	0	645	0	645	62.57	1.77	60-69	other
10548	TCGA-AJ-A3NG	UCEC	83	FEMALE	WHITE	[Not Applicable]	Stage II	Mixed serous and endometrioid	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30351	Alive	TUMOR FREE	475	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	475	0	475	0	475	0	475	84.4	1.3	>=80	Stage 2
10549	TCGA-AJ-A3NH	UCEC	90	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32871	Dead	TUMOR FREE	766	310	[Not Available]	NA	NA	364	Complete Remission/Response	1	310	0	310	0	310	0	310	90.84	0.85	>=80	Stage 1
10550	TCGA-AJ-A3OJ	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2011	Indeterminate (neither Pre or Postmenopausal)	-19826	Alive	TUMOR FREE	467	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	467	0	467	0	467	0	467	55.56	1.28	50-59	Stage 2
10551	TCGA-AJ-A3OK	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26851	Alive	TUMOR FREE	485	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	485	0	485	0	485	0	485	74.84	1.33	70-79	Stage 1
10552	TCGA-AJ-A3OL	UCEC	55	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20115	Dead	WITH TUMOR	766	449	[Not Available]	Distant Metastasis	Other, specify	424	Complete Remission/Response	1	449	1	449	1	424	1	424	56.3	1.23	50-59	other
10553	TCGA-AJ-A3QS	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21162	Alive	TUMOR FREE	513	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	513	0	513	0	513	0	513	59.34	1.4	50-59	other
10554	TCGA-AJ-A3TW	UCEC	78	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28559	Alive	TUMOR FREE	513	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	513	0	513	0	513	0	513	79.59	1.4	70-79	Stage 1
10555	TCGA-AJ-A4ZG	UCEC	53	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2012	[Unknown]	-19492	Alive	TUMOR FREE	498	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	498	0	498	0	720	0	498	54.73	1.36	50-59	other
10556	TCGA-AJ-A5DV	UCEC	65	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23892	Alive	TUMOR FREE	679	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	679	0	679	0	679	0	679	67.27	1.86	60-69	Stage 1
10557	TCGA-AJ-A5DW	UCEC	56	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20711	Alive	TUMOR FREE	390	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	390	0	390	0	390	0	390	57.77	1.07	50-59	Stage 1
10558	TCGA-AJ-A6NU	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23498	Alive	TUMOR FREE	632	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	632	0	632	0	632	0	632	66.06	1.73	60-69	Stage 2
10559	TCGA-AJ-A8CT	UCEC	58	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21515	Alive	TUMOR FREE	82	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	82	0	82	0	82	0	82	59.13	0.22	50-59	Stage 1
10560	TCGA-AJ-A8CV	UCEC	58	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21336	Alive	TUMOR FREE	1068	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1068	0	1068	0	1068	0	1068	61.34	2.92	50-59	Stage 1
10561	TCGA-AJ-A8CW	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23554	Alive	TUMOR FREE	4	548	[Not Available]	NA	NA	364	[Unknown]	0	4	0	4	0	720	0	4	64.5	0.01	60-69	Stage 1
10562	TCGA-AP-A051	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25269	Alive	TUMOR FREE	3948	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3948	0	3948	0	3948	0	3948	79.99	10.81	60-69	Stage 1
10563	TCGA-AP-A052	UCEC	59	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21721	Dead	WITH TUMOR	766	669	[Not Available]	NA	NA	394	Complete Remission/Response	1	669	1	669	0	720	1	394	61.3	1.83	50-59	other
10564	TCGA-AP-A053	UCEC	90	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872	Dead	TUMOR FREE	766	3365	[Not Available]	NA	NA	364	Complete Remission/Response	1	3365	0	3365	0	3365	0	3365	99.21	9.21	>=80	Stage 1
10565	TCGA-AP-A054	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23404	Dead	WITH TUMOR	766	709	[Not Available]	NA	NA	566	Complete Remission/Response	1	709	1	709	1	566	1	566	66.02	1.94	60-69	other
10566	TCGA-AP-A056	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23707	Alive	TUMOR FREE	2618	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2618	0	2618	0	2618	0	2618	72.07	7.17	60-69	Stage 2
10567	TCGA-AP-A059	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25311	Alive	TUMOR FREE	1461	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1461	0	1461	0	1461	0	1461	73.3	4	60-69	Stage 1
10568	TCGA-AP-A05A	UCEC	81	FEMALE	WHITE	[Not Applicable]	Stage II	Serous endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29914	Dead	TUMOR FREE	766	1944	[Not Available]	NA	NA	364	Complete Remission/Response	1	1944	0	1944	0	1944	0	1944	87.22	5.32	>=80	Stage 2
10569	TCGA-AP-A05D	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24597	Alive	TUMOR FREE	1758	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1758	0	1758	0	1758	0	1758	72.16	4.81	60-69	other
10570	TCGA-AP-A05H	UCEC	75	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27744	Alive	TUMOR FREE	1385	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1385	0	1385	0	1385	0	1385	79.75	3.79	70-79	Stage 1
10571	TCGA-AP-A05J	UCEC	66	FEMALE	WHITE	[Not Applicable]	Stage II	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24119	Alive	TUMOR FREE	1122	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1122	0	1122	0	1122	0	1122	69.11	3.07	60-69	Stage 2
10572	TCGA-AP-A05N	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-21254	Dead	TUMOR FREE	766	726	[Not Available]	NA	NA	364	Complete Remission/Response	1	726	0	726	0	726	0	726	60.18	1.99	50-59	Stage 1
10573	TCGA-AP-A05O	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24978	Alive	TUMOR FREE	384	548	[Not Available]	NA	NA	340	Complete Remission/Response	0	384	0	384	1	340	1	340	69.44	1.05	60-69	Stage 1
10574	TCGA-AP-A05P	UCEC	54	FEMALE	ASIAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20017	Alive	TUMOR FREE	636	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	636	0	636	0	636	0	636	56.54	1.74	50-59	Stage 1
10575	TCGA-AP-A0L8	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2000	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25733	Dead	WITH TUMOR	766	1484	[Not Available]	NA	NA	1453	Complete Remission/Response	1	1484	1	1484	1	1453	1	1453	74.52	4.06	70-79	other
10576	TCGA-AP-A0L9	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26185	Alive	TUMOR FREE	3815	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3815	0	3815	0	3815	0	3815	82.14	10.44	70-79	Stage 1
10577	TCGA-AP-A0LD	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23216	Alive	TUMOR FREE	3589	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3589	0	3589	0	3589	0	3589	73.39	9.83	60-69	Stage 1
10578	TCGA-AP-A0LE	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20967	Alive	TUMOR FREE	3357	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3357	0	3357	0	3357	0	3357	66.6	9.19	50-59	Stage 1
10579	TCGA-AP-A0LF	UCEC	82	FEMALE	WHITE	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30027	Alive	WITH TUMOR	2859	548	[Not Available]	NA	NA	364	[Not Applicable]	0	2859	0	2859	0	720	0	2859	90.04	7.83	>=80	other
10580	TCGA-AP-A0LG	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20047	Alive	TUMOR FREE	2015	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2015	0	2015	0	2015	0	2015	60.4	5.52	50-59	Stage 1
10581	TCGA-AP-A0LH	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IA	Mixed serous and endometrioid	G3	2002	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22169	Dead	WITH TUMOR	766	1106	[Not Available]	NA	NA	302	Complete Remission/Response	1	1106	1	1106	1	302	1	302	63.72	3.03	60-69	Stage 1
10582	TCGA-AP-A0LI	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24573	Alive	TUMOR FREE	2972	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2972	0	2972	0	2972	0	2972	75.41	8.14	60-69	other
10583	TCGA-AP-A0LJ	UCEC	42	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15577	Alive	TUMOR FREE	1421	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1421	0	1421	0	1421	0	1421	46.54	3.89	40-49	Stage 1
10584	TCGA-AP-A0LL	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20700	Alive	TUMOR FREE	2554	548	[Not Available]	NA	NA	790	Complete Remission/Response	0	2554	0	2554	1	790	1	790	63.67	6.99	50-59	Stage 1
10585	TCGA-AP-A0LM	UCEC	33	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2004	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12309	Alive	TUMOR FREE	825	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	825	0	825	0	825	0	825	35.96	2.26	30-39	other
10586	TCGA-AP-A0LN	UCEC	56	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20704	Alive	TUMOR FREE	2510	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2510	0	2510	0	2510	0	2510	63.56	6.87	50-59	Stage 1
10587	TCGA-AP-A0LO	UCEC	45	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16493	Dead	WITH TUMOR	766	1016	[Not Available]	NA	NA	516	Complete Remission/Response	1	1016	1	1016	1	516	1	516	47.94	2.78	40-49	Stage 1
10588	TCGA-AP-A0LP	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27898	Alive	TUMOR FREE	1875	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1875	0	1875	0	1875	0	1875	81.51	5.13	70-79	Stage 1
10589	TCGA-AP-A0LQ	UCEC	59	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21629	Alive	TUMOR FREE	2457	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2457	0	2457	0	2457	0	2457	65.94	6.73	50-59	Stage 1
10590	TCGA-AP-A0LS	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23126	Alive	TUMOR FREE	2904	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2904	0	2904	0	2904	0	2904	71.27	7.95	60-69	Stage 1
10591	TCGA-AP-A0LT	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21107	Alive	TUMOR FREE	1497	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1497	0	1497	0	1497	0	1497	61.89	4.1	50-59	Stage 2
10592	TCGA-AP-A0LV	UCEC	39	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14556	Alive	TUMOR FREE	763	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	763	0	763	0	763	0	763	41.94	2.09	30-39	Stage 1
10593	TCGA-AP-A1DH	UCEC	62	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22652	Alive	TUMOR FREE	2180	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2180	0	2180	0	2180	0	2180	67.99	5.97	60-69	Stage 1
10594	TCGA-AP-A1DK	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19509	Alive	TUMOR FREE	2767	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2767	0	2767	0	2767	0	2767	60.99	7.58	50-59	Stage 1
10595	TCGA-AP-A1DM	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22239	Alive	TUMOR FREE	1700	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1700	0	1700	0	1700	0	1700	65.54	4.65	60-69	Stage 1
10596	TCGA-AP-A1DO	UCEC	62	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22787	Alive	TUMOR FREE	952	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	952	0	952	0	952	0	952	64.99	2.61	60-69	Stage 1
10597	TCGA-AP-A1DP	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25601	Dead	WITH TUMOR	766	1081	[Not Available]	Metastatic	Other, specify	831	Complete Remission/Response	1	1081	1	1081	1	831	1	831	73.05	2.96	70-79	Stage 1
10598	TCGA-AP-A1DQ	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Serous endometrial adenocarcinoma	High Grade	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27815	Dead	WITH TUMOR	766	1423	[Not Available]	Metastatic	Other, specify	905	Complete Remission/Response	1	1423	1	1423	1	905	1	905	80.05	3.9	70-79	other
10599	TCGA-AP-A1DR	UCEC	59	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21904	Alive	TUMOR FREE	1495	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1495	0	1495	0	1495	0	1495	64.06	4.09	50-59	other
10600	TCGA-AP-A1DV	UCEC	59	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21901	Alive	TUMOR FREE	204	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	204	0	204	0	204	0	204	60.52	0.56	50-59	Stage 2
10601	TCGA-AP-A1E0	UCEC	40	FEMALE	WHITE	[Not Applicable]	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G2	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14653	Alive	TUMOR FREE	1832	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1832	0	1832	0	1832	0	1832	45.13	5.02	40-49	other
10602	TCGA-AP-A1E1	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27072	Alive	TUMOR FREE	1395	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1395	0	1395	0	1395	0	1395	77.94	3.82	70-79	Stage 1
10603	TCGA-AP-A1E3	UCEC	45	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16544	Alive	WITH TUMOR	847	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	847	0	847	0	720	0	847	47.61	2.32	40-49	other
10604	TCGA-AP-A1E4	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19814	Alive	WITH TUMOR	1555	548	[Not Available]	Metastatic	Other, specify	158	Progressive Disease	0	1555	0	1555	0	720	1	158	58.51	4.26	50-59	Stage 1
10605	TCGA-AP-A3K1	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20594	Dead	WITH TUMOR	766	666	[Not Available]	Locoregional Recurrence	Other, specify	198	Progressive Disease	1	666	1	666	0	720	1	198	58.21	1.82	50-59	other
10606	TCGA-AP-A5FX	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC1	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25063	Dead	WITH TUMOR	766	1099	[Not Available]	Locoregional Recurrence	Other, specify	407	Complete Remission/Response	1	1099	1	1099	1	407	1	407	71.63	3.01	60-69	other
10607	TCGA-AW-A1PO	UCEC	66	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24225	Alive	TUMOR FREE	17	548	[Not Available]	NA	NA	364	[Not Available]	0	17	0	17	0	720	0	17	66.37	0.05	60-69	other
10608	TCGA-AX-A05S	UCEC	81	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29928	Dead	WITH TUMOR	766	413	[Not Available]	NA	NA	338	Progressive Disease	1	413	1	413	0	720	1	338	83.07	1.13	>=80	other
10609	TCGA-AX-A05T	UCEC	82	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30137	Alive	TUMOR FREE	1010	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1010	0	1010	0	1010	0	1010	85.28	2.77	>=80	Stage 1
10610	TCGA-AX-A05U	UCEC	56	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20533	Alive	TUMOR FREE	903	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	903	0	903	0	903	0	903	58.69	2.47	50-59	Stage 1
10611	TCGA-AX-A05W	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IIB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22200	Alive	TUMOR FREE	2450	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2450	0	2450	0	2450	0	2450	67.49	6.71	60-69	Stage 2
10612	TCGA-AX-A05Y	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20904	Alive	TUMOR FREE	2684	548	[Not Available]	NA	NA	194	Complete Remission/Response	0	2684	0	2684	1	194	1	194	64.58	7.35	50-59	Stage 1
10613	TCGA-AX-A05Z	UCEC	37	FEMALE	[Not Available]	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2006	Indeterminate (neither Pre or Postmenopausal)	-13529	Alive	TUMOR FREE	2175	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2175	0	2175	0	2175	0	2175	43	5.95	30-39	other
10614	TCGA-AX-A060	UCEC	77	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28472	Alive	TUMOR FREE	1075	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1075	0	1075	0	1075	0	1075	80.9	2.94	70-79	Stage 1
10615	TCGA-AX-A062	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2005	Indeterminate (neither Pre or Postmenopausal)	-19643	Alive	TUMOR FREE	1399	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1399	0	1399	0	1399	0	1399	57.61	3.83	50-59	Stage 1
10616	TCGA-AX-A063	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23045	Alive	TUMOR FREE	2417	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2417	0	2417	0	2417	0	2417	69.71	6.62	60-69	Stage 1
10617	TCGA-AX-A064	UCEC	81	FEMALE	WHITE	[Not Applicable]	Stage IIA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29625	Alive	TUMOR FREE	1517	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1517	0	1517	0	1517	0	1517	85.26	4.15	>=80	Stage 2
10618	TCGA-AX-A06B	UCEC	72	FEMALE	WHITE	[Not Applicable]	Stage IIA	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26348	Alive	TUMOR FREE	2058	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2058	0	2058	0	2058	0	2058	77.77	5.63	70-79	Stage 2
10619	TCGA-AX-A06D	UCEC	82	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30024	Dead	WITH TUMOR	766	373	[Not Available]	NA	NA	253	Progressive Disease	1	373	1	373	0	720	1	253	83.22	1.02	>=80	other
10620	TCGA-AX-A06F	UCEC	59	FEMALE	WHITE	[Not Applicable]	Stage IVA	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21624	Alive	TUMOR FREE	1748	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1748	0	1748	0	720	0	1748	63.99	4.79	50-59	other
10621	TCGA-AX-A06H	UCEC	60	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22270	Alive	WITH TUMOR	833	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	833	0	833	0	833	0	833	63.25	2.28	60-69	other
10622	TCGA-AX-A06J	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26000	Alive	TUMOR FREE	913	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	913	0	913	0	913	0	913	73.68	2.5	70-79	Stage 1
10623	TCGA-AX-A06L	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23294	Alive	TUMOR FREE	1845	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1845	0	1845	0	1845	0	1845	68.83	5.05	60-69	Stage 1
10624	TCGA-AX-A0IS	UCEC	52	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19173	Dead	WITH TUMOR	766	1858	[Not Available]	NA	NA	448	Complete Remission/Response	1	1858	1	1858	1	448	1	448	57.58	5.09	50-59	Stage 1
10625	TCGA-AX-A0IU	UCEC	79	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29063	Alive	TUMOR FREE	1087	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1087	0	1087	0	1087	0	1087	82.55	2.98	70-79	other
10626	TCGA-AX-A0IW	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24488	Alive	TUMOR FREE	1149	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1149	0	1149	0	1149	0	1149	70.19	3.15	60-69	other
10627	TCGA-AX-A0IZ	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19364	Alive	TUMOR FREE	1333	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1333	0	1333	0	1333	0	1333	56.67	3.65	50-59	Stage 1
10628	TCGA-AX-A0J0	UCEC	47	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-17466	Alive	TUMOR FREE	1220	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1220	0	1220	0	1220	0	1220	51.16	3.34	40-49	Stage 1
10629	TCGA-AX-A0J1	UCEC	80	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29501	Alive	TUMOR FREE	2354	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2354	0	2354	0	2354	0	2354	87.21	6.44	>=80	Stage 1
10630	TCGA-AX-A1C4	UCEC	52	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Indeterminate (neither Pre or Postmenopausal)	-19209	Alive	TUMOR FREE	404	548	[Not Available]	NA	NA	364	[Not Applicable]	0	404	0	404	0	720	0	404	53.7	1.11	50-59	Stage 1
10631	TCGA-AX-A1C5	UCEC	47	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2009	Indeterminate (neither Pre or Postmenopausal)	-17383	Alive	WITH TUMOR	1001	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1001	0	1001	0	1001	0	1001	50.33	2.74	40-49	other
10632	TCGA-AX-A1C7	UCEC	77	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28198	Alive	TUMOR FREE	1054	548	[Not Available]	NA	NA	390	[Not Applicable]	0	1054	0	1054	0	720	1	390	80.09	2.89	70-79	Stage 1
10633	TCGA-AX-A1C8	UCEC	77	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28452	Alive	TUMOR FREE	776	548	[Not Available]	NA	NA	364	[Not Applicable]	0	776	0	776	0	720	0	776	80.02	2.12	70-79	other
10634	TCGA-AX-A1C9	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26903	Alive	TUMOR FREE	802	548	[Not Available]	NA	NA	364	[Not Applicable]	0	802	0	802	0	720	0	802	75.85	2.2	70-79	Stage 1
10635	TCGA-AX-A1CA	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2009	[Not Available]	-25817	Alive	TUMOR FREE	974	548	[Not Available]	NA	NA	364	[Not Applicable]	0	974	0	974	0	720	0	974	73.35	2.67	70-79	Stage 1
10636	TCGA-AX-A1CC	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23795	Alive	TUMOR FREE	788	548	[Not Available]	NA	NA	364	[Not Applicable]	0	788	0	788	0	720	0	788	67.3	2.16	60-69	Stage 1
10637	TCGA-AX-A1CE	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21969	Alive	TUMOR FREE	1037	548	[Not Available]	NA	NA	364	[Not Applicable]	0	1037	0	1037	0	720	0	1037	62.99	2.84	60-69	Stage 1
10638	TCGA-AX-A1CF	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2004	[Not Available]	-25300	Alive	WITH TUMOR	2337	548	[Not Available]	NA	NA	875	Progressive Disease	0	2337	0	2337	0	720	1	875	75.67	6.4	60-69	other
10639	TCGA-AX-A1CI	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22582	Alive	TUMOR FREE	2600	548	[Not Available]	NA	NA	364	[Not Available]	0	2600	0	2600	0	720	0	2600	68.94	7.12	60-69	Stage 1
10640	TCGA-AX-A1CJ	UCEC	59	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2006	Indeterminate (neither Pre or Postmenopausal)	-21655	Alive	TUMOR FREE	2233	548	[Not Available]	NA	NA	364	[Not Available]	0	2233	0	2233	0	720	0	2233	65.4	6.11	50-59	Stage 1
10641	TCGA-AX-A1CK	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21200	Alive	WITH TUMOR	2441	548	[Not Available]	NA	NA	364	[Not Available]	0	2441	0	2441	0	720	0	2441	64.73	6.68	50-59	Stage 1
10642	TCGA-AX-A1CN	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage IIB	Endometrioid endometrial adenocarcinoma	G3	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19860	Alive	WITH TUMOR	1143	548	[Not Available]	New Primary Tumor	Lung	1105	[Not Available]	0	1143	0	1143	0	720	1	1105	57.5	3.13	50-59	Stage 2
10643	TCGA-AX-A1CP	UCEC	84	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30737	Alive	TUMOR FREE	1107	548	[Not Available]	NA	NA	722	[Not Available]	0	1107	0	1107	0	720	1	722	87.18	3.03	>=80	Stage 1
10644	TCGA-AX-A1CR	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IIB	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25812	Alive	TUMOR FREE	701	548	[Not Available]	NA	NA	364	[Not Available]	0	701	0	701	0	720	0	701	72.59	1.92	70-79	Stage 2
10645	TCGA-AX-A2H2	UCEC	86	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIA	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31524	Dead	TUMOR FREE	766	145	[Not Available]	NA	NA	364	Complete Remission/Response	1	145	0	145	0	145	0	145	86.7	0.4	>=80	Stage 2
10646	TCGA-AX-A2H4	UCEC	66	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24234	Dead	WITH TUMOR	766	916	[Not Available]	Locoregional Disease	Other, specify	520	Complete Remission/Response	1	916	1	916	1	520	1	520	68.86	2.51	60-69	other
10647	TCGA-AX-A2H5	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2005	[Not Available]	-24757	Alive	TUMOR FREE	2167	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2167	0	2167	0	2167	0	2167	73.71	5.93	60-69	other
10648	TCGA-AX-A2H7	UCEC	87	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2008	[Not Available]	-32100	Dead	WITH TUMOR	766	1241	[Not Available]	Metastatic	Lung	684	Complete Remission/Response	1	1241	1	1241	1	684	1	684	91.28	3.4	>=80	Stage 1
10649	TCGA-AX-A2H8	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23448	Alive	TUMOR FREE	1861	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1861	0	1861	0	1861	0	1861	69.29	5.1	60-69	Stage 1
10650	TCGA-AX-A2HA	UCEC	35	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2005	[Not Available]	-13142	Alive	TUMOR FREE	2475	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2475	0	2475	0	2475	0	2475	42.76	6.78	30-39	Stage 1
10651	TCGA-AX-A2HC	UCEC	53	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2006	[Not Available]	-19485	Alive	WITH TUMOR	1044	548	[Not Available]	Metastatic	Other, specify	756	Complete Remission/Response	0	1044	0	1044	1	756	1	756	56.21	2.86	50-59	other
10652	TCGA-AX-A2HD	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2008	[Not Available]	-25499	Alive	WITH TUMOR	1414	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	1414	0	1414	0	720	0	1414	73.68	3.87	60-69	other
10653	TCGA-AX-A2HF	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24689	Alive	WITH TUMOR	848	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	848	0	848	0	848	0	848	69.92	2.32	60-69	Stage 1
10654	TCGA-AX-A2HG	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20771	Alive	TUMOR FREE	1163	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1163	0	1163	0	1163	0	1163	60.05	3.18	50-59	Stage 1
10655	TCGA-AX-A2HH	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	[Not Available]	-21924	Alive	WITH TUMOR	540	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	540	0	540	0	720	0	540	61.5	1.48	60-69	Stage 1
10656	TCGA-AX-A2HJ	UCEC	35	FEMALE	ASIAN	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	[Not Available]	-13112	Alive	TUMOR FREE	935	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	935	0	935	0	935	0	935	38.46	2.56	30-39	Stage 1
10657	TCGA-AX-A2HK	UCEC	77	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28316	Dead	WITH TUMOR	766	90	[Not Available]	NA	NA	364	Complete Remission/Response	1	90	1	90	0	720	1	90	77.77	0.25	70-79	other
10658	TCGA-AX-A2IN	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23275	Dead	WITH TUMOR	766	947	[Not Available]	New Primary Tumor	Other, specify	257	[Not Available]	1	947	1	947	0	720	1	257	66.32	2.59	60-69	Stage 1
10659	TCGA-AX-A2IO	UCEC	83	FEMALE	WHITE	[Not Applicable]	Stage IIA	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30539	Alive	TUMOR FREE	1975	548	[Not Available]	NA	NA	364	[Not Available]	0	1975	0	1975	0	720	0	1975	89.02	5.41	>=80	Stage 2
10660	TCGA-AX-A3FS	UCEC	82	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30102	Alive	TUMOR FREE	7	548	[Not Available]	NA	NA	364	[Not Available]	0	7	0	7	0	720	0	7	82.43	0.02	>=80	Stage 1
10661	TCGA-AX-A3FT	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23543	Alive	TUMOR FREE	6	548	[Not Available]	NA	NA	364	[Not Available]	0	6	0	6	0	720	0	6	64.47	0.02	60-69	Stage 1
10662	TCGA-AX-A3FV	UCEC	62	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2009	[Not Available]	-22752	Alive	TUMOR FREE	-6	548	[Not Available]	NA	NA	364	[Not Available]	0	0	0	0	0	720	0	0	62.28	-0.02	60-69	other
10663	TCGA-AX-A3FW	UCEC	66	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24419	Alive	TUMOR FREE	17	548	[Not Available]	NA	NA	364	[Not Available]	0	17	0	17	0	720	0	17	66.9	0.05	60-69	Stage 1
10664	TCGA-AX-A3FX	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IIB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25260	Dead	TUMOR FREE	766	1333	[Not Available]	Locoregional Recurrence	Other, specify	938	[Not Available]	1	1333	0	1333	0	720	1	938	72.81	3.65	60-69	Stage 2
10665	TCGA-AX-A3FZ	UCEC	33	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Endometrioid endometrial adenocarcinoma	G3	2010	[Not Available]	-12331	Alive	TUMOR FREE	6	548	[Not Available]	NA	NA	364	[Not Available]	0	6	0	6	0	720	0	6	33.78	0.02	30-39	other
10666	TCGA-AX-A3G1	UCEC	84	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31037	Dead	TUMOR FREE	766	624	[Not Available]	NA	NA	364	[Not Available]	1	624	0	624	0	720	0	624	86.68	1.71	>=80	Stage 1
10667	TCGA-AX-A3G3	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21308	Alive	TUMOR FREE	42	548	[Not Available]	NA	NA	364	[Not Available]	0	42	0	42	0	720	0	42	58.45	0.11	50-59	other
10668	TCGA-AX-A3G4	UCEC	60	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22099	Alive	TUMOR FREE	9	548	[Not Available]	NA	NA	364	[Not Available]	0	9	0	9	0	720	0	9	60.53	0.02	60-69	other
10669	TCGA-AX-A3G6	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G2	2010	[Not Available]	-24681	Alive	TUMOR FREE	8	548	[Not Available]	NA	NA	364	[Not Available]	0	8	0	8	0	720	0	8	67.59	0.02	60-69	Stage 1
10670	TCGA-AX-A3G7	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2010	[Not Available]	-26187	Alive	TUMOR FREE	9	548	[Not Available]	NA	NA	364	[Not Available]	0	9	0	9	0	720	0	9	71.72	0.02	70-79	other
10671	TCGA-AX-A3G8	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27899	Alive	TUMOR FREE	36	548	[Not Available]	NA	NA	364	[Not Available]	0	36	0	36	0	720	0	36	76.48	0.1	70-79	Stage 1
10672	TCGA-AX-A3G9	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2010	[Not Available]	-23361	Alive	TUMOR FREE	558	548	[Not Available]	NA	NA	364	[Not Available]	0	558	0	558	0	720	0	558	65.49	1.53	60-69	other
10673	TCGA-AX-A3GB	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26724	Alive	TUMOR FREE	440	548	[Not Available]	NA	NA	364	[Not Available]	0	440	0	440	0	720	0	440	74.37	1.2	70-79	Stage 1
10674	TCGA-AX-A3GI	UCEC	66	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2011	[Not Available]	-24388	Alive	TUMOR FREE	12	548	[Not Available]	NA	NA	364	[Not Available]	0	12	0	12	0	720	0	12	66.8	0.03	60-69	other
10675	TCGA-B5-A0JN	UCEC	84	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30933	Alive	TUMOR FREE	2445	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2445	0	2445	0	720	0	2445	91.38	6.69	>=80	other
10676	TCGA-B5-A0JR	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26814	Alive	TUMOR FREE	1731	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1731	0	1731	0	1731	0	1731	78.15	4.74	70-79	Stage 1
10677	TCGA-B5-A0JS	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19995	Alive	TUMOR FREE	2627	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2627	0	2627	0	2627	0	2627	61.94	7.19	50-59	Stage 1
10678	TCGA-B5-A0JT	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23041	Alive	TUMOR FREE	1682	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1682	0	1682	0	1682	0	1682	67.69	4.61	60-69	other
10679	TCGA-B5-A0JU	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21159	Alive	TUMOR FREE	1802	548	[Not Available]	NA	NA	364	[Not Available]	0	1802	0	1802	0	720	0	1802	62.86	4.93	50-59	Stage 1
10680	TCGA-B5-A0JV	UCEC	63	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23295	Alive	TUMOR FREE	2616	548	[Not Available]	Locoregional Disease	Other, specify	698	Complete Remission/Response	0	2616	0	2616	1	698	1	698	70.94	7.16	60-69	Stage 1
10681	TCGA-B5-A0JX	UCEC	62	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22834	Alive	TUMOR FREE	1787	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1787	0	1787	0	1787	0	1787	67.41	4.89	60-69	Stage 1
10682	TCGA-B5-A0JY	UCEC	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18475	Alive	TUMOR FREE	2107	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2107	0	2107	0	2107	0	2107	56.35	5.77	50-59	other
10683	TCGA-B5-A0JZ	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22106	Alive	TUMOR FREE	2173	548	[Not Available]	Metastatic	Other, specify	356	Progressive Disease	0	2173	0	2173	0	720	1	356	66.47	5.95	60-69	other
10684	TCGA-B5-A0K0	UCEC	48	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Indeterminate (neither Pre or Postmenopausal)	-17810	Alive	TUMOR FREE	1478	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1478	0	1478	0	1478	0	1478	52.81	4.05	40-49	Stage 1
10685	TCGA-B5-A0K1	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25291	Alive	TUMOR FREE	1110	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1110	0	1110	0	1110	0	1110	72.28	3.04	60-69	Stage 1
10686	TCGA-B5-A0K2	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Indeterminate (neither Pre or Postmenopausal)	-20080	Alive	TUMOR FREE	2209	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2209	0	2209	0	2209	0	2209	61.02	6.05	50-59	other
10687	TCGA-B5-A0K3	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22664	Dead	WITH TUMOR	766	830	[Not Available]	Locoregional Disease	Other, specify	256	[Not Available]	1	830	1	830	0	720	1	256	64.32	2.27	60-69	Stage 1
10688	TCGA-B5-A0K4	UCEC	51	FEMALE	[Not Available]	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18631	Alive	TUMOR FREE	1757	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1757	0	1757	0	1757	0	1757	55.82	4.81	50-59	Stage 1
10689	TCGA-B5-A0K6	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21515	Alive	TUMOR FREE	1953	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1953	0	1953	0	1953	0	1953	64.25	5.35	50-59	Stage 1
10690	TCGA-B5-A0K7	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23429	Alive	TUMOR FREE	1933	548	[Not Available]	Metastatic	Other, specify	322	Complete Remission/Response	0	1933	0	1933	1	322	1	322	69.44	5.29	60-69	Stage 1
10691	TCGA-B5-A0K8	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25992	Alive	TUMOR FREE	847	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	847	0	847	0	847	0	847	73.48	2.32	70-79	Stage 1
10692	TCGA-B5-A0K9	UCEC	88	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32289	Dead	TUMOR FREE	766	409	[Not Available]	NA	NA	364	Complete Remission/Response	1	409	0	409	0	409	0	409	89.52	1.12	>=80	Stage 2
10693	TCGA-B5-A0KB	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22669	Alive	WITH TUMOR	824	548	[Not Available]	Locoregional Disease	Other, specify	689	Complete Remission/Response	0	824	0	824	1	689	1	689	64.32	2.26	60-69	Stage 1
10694	TCGA-B5-A11E	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Peri (6-12 months since last menstrual period)	-19458	Alive	TUMOR FREE	1820	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1820	0	1820	0	1820	0	1820	58.26	4.98	50-59	Stage 1
10695	TCGA-B5-A11F	UCEC	55	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20171	Alive	TUMOR FREE	5651	548	[Not Available]	Metastatic	Bone	1610	Complete Remission/Response	0	5651	0	5651	1	1610	1	1610	70.7	15.47	50-59	Stage 1
10696	TCGA-B5-A11G	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2001	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25995	Alive	TUMOR FREE	3448	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3448	0	3448	0	3448	0	3448	80.61	9.44	70-79	Stage 1
10697	TCGA-B5-A11H	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24556	Alive	TUMOR FREE	2687	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2687	0	2687	0	2687	0	2687	74.59	7.36	60-69	other
10698	TCGA-B5-A11I	UCEC	65	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23857	Alive	TUMOR FREE	2303	548	[Not Available]	Metastatic	Lung	705	Complete Remission/Response	0	2303	0	2303	0	720	1	705	71.62	6.31	60-69	other
10699	TCGA-B5-A11J	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23485	Alive	TUMOR FREE	1656	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1656	0	1656	0	1656	0	1656	68.83	4.53	60-69	Stage 1
10700	TCGA-B5-A11L	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26120	Dead	TUMOR FREE	766	2240	[Not Available]	Locoregional Recurrence	Other, specify	131	Complete Remission/Response	1	2240	0	2240	1	131	1	131	77.65	6.13	70-79	Stage 1
10701	TCGA-B5-A11M	UCEC	43	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16063	Alive	TUMOR FREE	1362	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1362	0	1362	0	1362	0	1362	47.71	3.73	40-49	Stage 1
10702	TCGA-B5-A11N	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25442	Alive	TUMOR FREE	1876	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1876	0	1876	0	1876	0	1876	74.79	5.14	60-69	Stage 1
10703	TCGA-B5-A11O	UCEC	62	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22720	Alive	TUMOR FREE	2609	548	[Not Available]	New Primary Tumor	Other, specify	1924	Complete Remission/Response	0	2609	0	2609	0	2609	1	1924	69.35	7.14	60-69	Stage 1
10704	TCGA-B5-A11P	UCEC	87	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32047	Alive	TUMOR FREE	1583	548	[Not Available]	NA	NA	364	[Not Available]	0	1583	0	1583	0	720	0	1583	92.07	4.33	>=80	Stage 1
10705	TCGA-B5-A11Q	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23538	Alive	TUMOR FREE	976	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	976	0	976	0	976	0	976	67.12	2.67	60-69	other
10706	TCGA-B5-A11R	UCEC	51	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18878	Alive	TUMOR FREE	2349	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2349	0	2349	0	2349	0	2349	58.12	6.43	50-59	Stage 2
10707	TCGA-B5-A11S	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23085	Alive	TUMOR FREE	2229	548	[Not Available]	New Primary Tumor	Other, specify	41	Complete Remission/Response	0	2229	0	2229	0	2229	1	41	69.31	6.1	60-69	Stage 1
10708	TCGA-B5-A11U	UCEC	74	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27160	Alive	TUMOR FREE	509	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	509	0	509	0	720	0	509	75.75	1.39	70-79	other
10709	TCGA-B5-A11V	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23630	Alive	TUMOR FREE	595	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	595	0	595	0	595	0	595	66.32	1.63	60-69	Stage 1
10710	TCGA-B5-A11W	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22365	Alive	TUMOR FREE	593	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	593	0	593	0	593	0	593	62.86	1.62	60-69	Stage 1
10711	TCGA-B5-A11X	UCEC	66	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24217	Alive	TUMOR FREE	596	548	[Not Available]	Metastatic	Other, specify	397	[Not Available]	0	596	0	596	0	720	1	397	67.93	1.63	60-69	other
10712	TCGA-B5-A11Y	UCEC	59	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21860	Alive	TUMOR FREE	560	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	560	0	560	0	560	0	560	61.38	1.53	50-59	Stage 1
10713	TCGA-B5-A11Z	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22505	Alive	TUMOR FREE	528	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	528	0	528	0	528	0	528	63.06	1.45	60-69	Stage 1
10714	TCGA-B5-A121	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21018	Alive	TUMOR FREE	504	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	504	0	504	0	504	0	504	58.92	1.38	50-59	other
10715	TCGA-B5-A1MR	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	1995	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24017	Alive	TUMOR FREE	6859	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	6859	0	6859	0	6859	0	6859	84.53	18.78	60-69	other
10716	TCGA-B5-A1MS	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22068	Dead	WITH TUMOR	766	3112	[Not Available]	Locoregional Recurrence	Other, specify	2706	Partial Remission/Response	1	3112	1	3112	0	720	1	2706	68.94	8.52	60-69	Stage 1
10717	TCGA-B5-A1MU	UCEC	79	FEMALE	WHITE	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29027	Dead	WITH TUMOR	766	1548	[Not Available]	New Primary Tumor	Other, specify	1365	Complete Remission/Response	1	1548	1	1548	0	720	1	1365	83.71	4.24	70-79	other
10718	TCGA-B5-A1MV	UCEC	84	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30926	Alive	TUMOR FREE	1565	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1565	0	1565	0	1565	0	1565	88.96	4.28	>=80	Stage 1
10719	TCGA-B5-A1MW	UCEC	55	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20183	Alive	TUMOR FREE	447	548	[Not Available]	Locoregional Disease	Other, specify	311	Complete Remission/Response	0	447	0	447	1	311	1	311	56.48	1.22	50-59	Stage 1
10720	TCGA-B5-A1MX	UCEC	47	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17320	Alive	TUMOR FREE	1473	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1473	0	1473	0	1473	0	1473	51.45	4.03	40-49	Stage 1
10721	TCGA-B5-A1MY	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22805	Dead	WITH TUMOR	766	361	[Not Available]	Locoregional Disease	Other, specify	333	[Not Available]	1	361	1	361	0	720	1	333	63.43	0.99	60-69	other
10722	TCGA-B5-A1MZ	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Indeterminate (neither Pre or Postmenopausal)	-19955	Alive	TUMOR FREE	1598	548	[Not Available]	Locoregional Recurrence	Other, specify	613	Complete Remission/Response	0	1598	0	1598	1	613	1	613	59.01	4.38	50-59	Stage 1
10723	TCGA-B5-A1N2	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25612	Dead	WITH TUMOR	766	954	[Not Available]	Distant Metastasis	Brain	804	Complete Remission/Response	1	954	1	954	1	804	1	804	72.73	2.61	70-79	other
10724	TCGA-B5-A3F9	UCEC	56	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20523	Alive	TUMOR FREE	4155	548	[Not Available]	NA	NA	364	[Not Available]	0	4155	0	4155	0	720	0	4155	67.56	11.38	50-59	Stage 1
10725	TCGA-B5-A3FA	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26850	Alive	TUMOR FREE	2929	548	[Not Available]	NA	NA	364	[Not Available]	0	2929	0	2929	0	720	0	2929	81.53	8.02	70-79	Stage 1
10726	TCGA-B5-A3FB	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26779	Alive	TUMOR FREE	2844	548	[Not Available]	NA	NA	364	[Not Available]	0	2844	0	2844	0	720	0	2844	81.1	7.79	70-79	Stage 1
10727	TCGA-B5-A3FC	UCEC	53	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19422	Alive	TUMOR FREE	2185	548	[Not Available]	NA	NA	364	[Not Available]	0	2185	0	2185	0	720	0	2185	59.16	5.98	50-59	Stage 2
10728	TCGA-B5-A3FD	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Indeterminate (neither Pre or Postmenopausal)	-25813	Dead	TUMOR FREE	766	1197	[Not Available]	Locoregional Recurrence	Other, specify	562	[Not Available]	1	1197	0	1197	0	720	1	562	73.95	3.28	70-79	Stage 1
10729	TCGA-B5-A3FH	UCEC	74	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27221	Alive	TUMOR FREE	841	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	841	0	841	0	841	0	841	76.83	2.3	70-79	Stage 1
10730	TCGA-B5-A3S1	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26031	Alive	WITH TUMOR	902	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	902	0	902	0	902	0	902	73.74	2.47	70-79	other
10731	TCGA-B5-A5OC	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIB	Endometrioid endometrial adenocarcinoma	G3	2011	[Not Available]	-26109	Alive	TUMOR FREE	1249	548	[Not Available]	NA	NA	364	[Not Available]	0	1249	0	1249	0	720	0	1249	74.9	3.42	70-79	other
10732	TCGA-B5-A5OD	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2011	[Not Available]	-24775	Alive	TUMOR FREE	1038	548	[Not Available]	NA	NA	364	[Not Available]	0	1038	0	1038	0	720	0	1038	70.67	2.84	60-69	other
10733	TCGA-B5-A5OE	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2011	[Not Available]	-24905	Alive	TUMOR FREE	1063	548	[Not Available]	NA	NA	364	[Not Available]	0	1063	0	1063	0	720	0	1063	71.1	2.91	60-69	other
10734	TCGA-BG-A0LW	UCEC	47	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Indeterminate (neither Pre or Postmenopausal)	-17369	Alive	TUMOR FREE	566	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	566	0	566	0	566	0	566	49.1	1.55	40-49	Stage 1
10735	TCGA-BG-A0LX	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20928	Alive	TUMOR FREE	614	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	614	0	614	0	614	0	614	58.98	1.68	50-59	Stage 1
10736	TCGA-BG-A0M0	UCEC	66	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24427	Alive	TUMOR FREE	588	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	588	0	588	0	588	0	588	68.49	1.61	60-69	Stage 1
10737	TCGA-BG-A0M2	UCEC	62	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22822	Alive	TUMOR FREE	637	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	637	0	637	0	637	0	637	64.23	1.74	60-69	Stage 1
10738	TCGA-BG-A0M3	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27183	Alive	TUMOR FREE	1071	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1071	0	1071	0	1071	0	1071	77.36	2.93	70-79	Stage 1
10739	TCGA-BG-A0M4	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22090	Alive	TUMOR FREE	2167	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2167	0	2167	0	2167	0	2167	66.41	5.93	60-69	Stage 1
10740	TCGA-BG-A0M6	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26666	Dead	TUMOR FREE	766	671	[Not Available]	NA	NA	364	Complete Remission/Response	1	671	0	671	0	671	0	671	74.84	1.84	70-79	other
10741	TCGA-BG-A0M7	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22096	Alive	TUMOR FREE	1937	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1937	0	1937	0	1937	0	1937	65.8	5.3	60-69	other
10742	TCGA-BG-A0M8	UCEC	50	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2008	Indeterminate (neither Pre or Postmenopausal)	-18308	Alive	TUMOR FREE	2020	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2020	0	2020	0	2020	0	2020	55.66	5.53	50-59	Stage 1
10743	TCGA-BG-A0M9	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26708	Alive	TUMOR FREE	2270	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2270	0	2270	0	2270	0	2270	79.34	6.21	70-79	Stage 1
10744	TCGA-BG-A0MA	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22036	Dead	WITH TUMOR	766	326	[Not Available]	Metastatic	Bone	70	Progressive Disease	1	326	1	326	0	720	1	70	61.22	0.89	60-69	Stage 1
10745	TCGA-BG-A0MC	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27136	Alive	TUMOR FREE	1263	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1263	0	1263	0	1263	0	1263	77.75	3.46	70-79	Stage 1
10746	TCGA-BG-A0MG	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26957	Alive	TUMOR FREE	1477	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1477	0	1477	0	1477	0	1477	77.85	4.04	70-79	Stage 1
10747	TCGA-BG-A0MH	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22475	Alive	TUMOR FREE	1930	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1930	0	1930	0	1930	0	1930	66.82	5.28	60-69	Stage 1
10748	TCGA-BG-A0MI	UCEC	83	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30334	Dead	TUMOR FREE	766	714	[Not Available]	NA	NA	364	[Not Available]	1	714	0	714	0	720	0	714	85	1.95	>=80	Stage 1
10749	TCGA-BG-A0MK	UCEC	52	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIB	Endometrioid endometrial adenocarcinoma	G3	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19034	Dead	WITH TUMOR	766	1317	[Not Available]	NA	NA	364	Progressive Disease	1	1317	1	1317	0	720	1	1317	55.72	3.61	50-59	Stage 2
10750	TCGA-BG-A0MO	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23287	Alive	TUMOR FREE	1309	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1309	0	1309	0	1309	0	1309	67.34	3.58	60-69	Stage 1
10751	TCGA-BG-A0MQ	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26284	Alive	WITH TUMOR	1817	548	[Not Available]	NA	NA	364	Stable Disease	0	1817	0	1817	0	720	0	1817	76.94	4.97	70-79	Stage 1
10752	TCGA-BG-A0MS	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19547	Alive	TUMOR FREE	1882	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1882	0	1882	0	1882	0	1882	58.67	5.15	50-59	other
10753	TCGA-BG-A0MT	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23574	Alive	TUMOR FREE	644	548	[Not Available]	Locoregional Disease	Other, specify	565	Partial Remission/Response	0	644	0	644	0	720	1	565	66.31	1.76	60-69	Stage 1
10754	TCGA-BG-A0MU	UCEC	78	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28621	Alive	TUMOR FREE	617	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	617	0	617	0	617	0	617	80.05	1.69	70-79	other
10755	TCGA-BG-A0RY	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24952	Alive	TUMOR FREE	469	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	469	0	469	0	469	0	469	69.6	1.28	60-69	Stage 1
10756	TCGA-BG-A0VT	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20602	Alive	TUMOR FREE	1568	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1568	0	1568	0	1568	0	1568	60.7	4.29	50-59	other
10757	TCGA-BG-A0VV	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19581	Alive	TUMOR FREE	1553	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1553	0	1553	0	1553	0	1553	57.86	4.25	50-59	Stage 1
10758	TCGA-BG-A0VW	UCEC	77	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28383	Alive	TUMOR FREE	1582	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1582	0	1582	0	1582	0	1582	82.04	4.33	70-79	Stage 1
10759	TCGA-BG-A0VX	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21425	Alive	TUMOR FREE	1043	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1043	0	1043	0	1043	0	1043	61.51	2.86	50-59	Stage 1
10760	TCGA-BG-A0VZ	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21414	Alive	TUMOR FREE	1601	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1601	0	1601	0	1601	0	1601	63.01	4.38	50-59	other
10761	TCGA-BG-A0W1	UCEC	89	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G2	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32750	Alive	TUMOR FREE	1607	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1607	0	1607	0	1607	0	1607	94.06	4.4	>=80	Stage 2
10762	TCGA-BG-A0W2	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20998	Alive	TUMOR FREE	1721	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1721	0	1721	0	1721	0	1721	62.2	4.71	50-59	Stage 1
10763	TCGA-BG-A0YU	UCEC	37	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13644	Alive	TUMOR FREE	451	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	451	0	451	0	451	0	451	38.59	1.23	30-39	Stage 1
10764	TCGA-BG-A0YV	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24567	Alive	TUMOR FREE	382	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	382	0	382	0	382	0	382	68.31	1.05	60-69	other
10765	TCGA-BG-A186	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2010	[Not Available]	-22370	Alive	TUMOR FREE	419	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	419	0	419	0	419	0	419	62.39	1.15	60-69	other
10766	TCGA-BG-A187	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	[Not Available]	-24099	Alive	TUMOR FREE	448	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	448	0	448	0	448	0	448	67.21	1.23	60-69	Stage 1
10767	TCGA-BG-A18A	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27086	Alive	TUMOR FREE	426	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	426	0	426	0	426	0	426	75.32	1.17	70-79	Stage 1
10768	TCGA-BG-A18B	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage I	Endometrioid endometrial adenocarcinoma	G2	2010	Peri (6-12 months since last menstrual period)	-19550	Alive	TUMOR FREE	470	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	470	0	470	0	470	0	470	54.81	1.29	50-59	Stage 1
10769	TCGA-BG-A18C	UCEC	72	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	[Not Available]	-26602	Alive	TUMOR FREE	470	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	470	0	470	0	470	0	470	74.12	1.29	70-79	Stage 1
10770	TCGA-BG-A220	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	[Not Available]	-25346	Alive	TUMOR FREE	434	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	434	0	434	0	434	0	434	70.58	1.19	60-69	Stage 1
10771	TCGA-BG-A221	UCEC	84	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30960	Alive	TUMOR FREE	55	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	55	0	55	0	55	0	55	84.91	0.15	>=80	Stage 1
10772	TCGA-BG-A222	UCEC	49	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	[Not Available]	-18220	Alive	TUMOR FREE	291	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	291	0	291	0	291	0	291	50.68	0.8	40-49	Stage 1
10773	TCGA-BG-A2AD	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IIIB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23064	Alive	TUMOR FREE	609	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	609	0	609	0	609	0	609	64.81	1.67	60-69	other
10774	TCGA-BG-A2AE	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Peri (6-12 months since last menstrual period)	-21069	Alive	TUMOR FREE	721	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	721	0	721	0	721	0	721	59.66	1.97	50-59	Stage 1
10775	TCGA-BG-A2L7	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	[Not Available]	-25091	Alive	TUMOR FREE	612	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	612	0	612	0	612	0	612	70.37	1.68	60-69	Stage 1
10776	TCGA-BG-A3EW	UCEC	62	FEMALE	WHITE	[Not Applicable]	Stage III	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22705	Alive	TUMOR FREE	344	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	344	0	344	0	344	0	344	63.1	0.94	60-69	other
10777	TCGA-BG-A3PP	UCEC	82	FEMALE	WHITE	[Not Applicable]	Stage II	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30227	Alive	WITH TUMOR	681	548	[Not Available]	Locoregional Recurrence	Other, specify	665	Progressive Disease	0	681	0	681	0	720	1	665	84.62	1.86	>=80	Stage 2
10778	TCGA-BK-A0C9	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20876	Alive	TUMOR FREE	1092	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1092	0	1092	0	1092	0	1092	60.15	2.99	50-59	Stage 1
10779	TCGA-BK-A0CA	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22378	Alive	TUMOR FREE	1064	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1064	0	1064	0	1064	0	1064	64.18	2.91	60-69	other
10780	TCGA-BK-A0CB	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21930	Alive	TUMOR FREE	1092	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1092	0	1092	0	1092	0	1092	63.03	2.99	60-69	other
10781	TCGA-BK-A0CC	UCEC	69	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25479	Alive	WITH TUMOR	1067	548	[Not Available]	Locoregional Recurrence	Other, specify	1010	Complete Remission/Response	0	1067	0	1067	1	1010	1	1010	72.68	2.92	60-69	other
10782	TCGA-BK-A139	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27077	Dead	WITH TUMOR	766	943	[Not Available]	Locoregional Recurrence	Other, specify	684	[Discrepancy]	1	943	1	943	0	720	1	684	76.71	2.58	70-79	Stage 1
10783	TCGA-BK-A13B	UCEC	58	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21493	Alive	WITH TUMOR	966	548	[Not Available]	Locoregional Recurrence	Other, specify	760	Complete Remission/Response	0	966	0	966	1	760	1	760	61.49	2.64	50-59	Stage 1
10784	TCGA-BK-A13C	UCEC	47	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Peri (6-12 months since last menstrual period)	-17317	Alive	TUMOR FREE	760	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	760	0	760	0	760	0	760	49.49	2.08	40-49	Stage 1
10785	TCGA-BK-A26L	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26002	Alive	TUMOR FREE	734	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	734	0	734	0	734	0	734	73.2	2.01	70-79	other
10786	TCGA-BK-A4ZD	UCEC	42	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2012	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15536	Alive	TUMOR FREE	506	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	506	0	506	0	506	0	506	43.92	1.39	40-49	Stage 1
10787	TCGA-BK-A56F	UCEC	75	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27523	Alive	TUMOR FREE	401	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	401	0	401	0	401	0	401	76.45	1.1	70-79	Stage 1
10788	TCGA-BK-A6W3	UCEC	34	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G2	2013	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12590	Alive	TUMOR FREE	305	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	305	0	305	0	305	0	305	35.3	0.84	30-39	Stage 2
10789	TCGA-BK-A6W4	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22766	Alive	TUMOR FREE	300	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	300	0	300	0	300	0	300	63.15	0.82	60-69	Stage 1
10790	TCGA-BS-A0T9	UCEC	39	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14253	Dead	WITH TUMOR	766	1428	[Not Available]	NA	NA	634	Complete Remission/Response	1	1428	1	1428	0	720	1	634	42.93	3.91	30-39	other
10791	TCGA-BS-A0TA	UCEC	58	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21505	Dead	WITH TUMOR	766	740	[Not Available]	NA	NA	394	Stable Disease	1	740	1	740	0	720	1	394	60.9	2.03	50-59	other
10792	TCGA-BS-A0TC	UCEC	69	FEMALE	ASIAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25560	Alive	TUMOR FREE	2602	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2602	0	2602	0	2602	0	2602	77.1	7.12	60-69	Stage 1
10793	TCGA-BS-A0TD	UCEC	65	FEMALE	ASIAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23950	Alive	TUMOR FREE	2379	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2379	0	2379	0	2379	0	2379	72.08	6.51	60-69	Stage 1
10794	TCGA-BS-A0TE	UCEC	35	FEMALE	ASIAN	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12983	Dead	WITH TUMOR	766	146	[Not Available]	NA	NA	58	Progressive Disease	1	146	1	146	0	720	1	58	35.95	0.4	30-39	other
10795	TCGA-BS-A0TG	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22043	Alive	WITH TUMOR	2371	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2371	0	2371	0	2371	0	2371	66.84	6.49	60-69	other
10796	TCGA-BS-A0TI	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23705	Alive	TUMOR FREE	1882	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1882	0	1882	0	1882	0	1882	70.05	5.15	60-69	Stage 1
10797	TCGA-BS-A0TJ	UCEC	59	FEMALE	ASIAN	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21663	Alive	TUMOR FREE	2068	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2068	0	2068	0	2068	0	2068	64.97	5.66	50-59	Stage 1
10798	TCGA-BS-A0U5	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27945	Alive	TUMOR FREE	2935	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2935	0	2935	0	2935	0	2935	84.54	8.04	70-79	Stage 1
10799	TCGA-BS-A0U7	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23166	Dead	TUMOR FREE	766	935	[Not Available]	NA	NA	364	Complete Remission/Response	1	935	0	935	0	935	0	935	65.98	2.56	60-69	Stage 1
10800	TCGA-BS-A0U8	UCEC	55	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20402	Alive	TUMOR FREE	2963	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2963	0	2963	0	2963	0	2963	63.97	8.11	50-59	other
10801	TCGA-BS-A0U9	UCEC	59	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IIA	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21580	Alive	TUMOR FREE	2825	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2825	0	2825	0	2825	0	2825	66.82	7.73	50-59	Stage 2
10802	TCGA-BS-A0UA	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24872	Alive	TUMOR FREE	3495	548	[Not Available]	Locoregional Disease	Other, specify	520	Complete Remission/Response	0	3495	0	3495	1	520	1	520	77.66	9.57	60-69	Stage 1
10803	TCGA-BS-A0UF	UCEC	65	FEMALE	ASIAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23771	Alive	TUMOR FREE	2611	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2611	0	2611	0	2611	0	2611	72.23	7.15	60-69	Stage 1
10804	TCGA-BS-A0UJ	UCEC	68	FEMALE	ASIAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2004	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25149	Alive	TUMOR FREE	2506	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2506	0	2506	0	2506	0	2506	75.72	6.86	60-69	Stage 1
10805	TCGA-BS-A0UL	UCEC	54	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2004	Peri (6-12 months since last menstrual period)	-19982	Alive	TUMOR FREE	2481	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2481	0	2481	0	2481	0	2481	61.5	6.79	50-59	Stage 1
10806	TCGA-BS-A0UM	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23400	Alive	WITH TUMOR	2644	548	[Not Available]	Metastatic	Brain	1454	Complete Remission/Response	0	2644	0	2644	1	1454	1	1454	71.3	7.24	60-69	Stage 1
10807	TCGA-BS-A0UT	UCEC	62	FEMALE	ASIAN	[Not Applicable]	Stage IIB	Endometrioid endometrial adenocarcinoma	G2	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22775	Alive	TUMOR FREE	2212	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2212	0	2212	0	2212	0	2212	68.41	6.06	60-69	Stage 2
10808	TCGA-BS-A0UV	UCEC	55	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20266	Alive	TUMOR FREE	2228	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2228	0	2228	0	2228	0	2228	61.59	6.1	50-59	other
10809	TCGA-BS-A0V4	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20777	Alive	TUMOR FREE	1810	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1810	0	1810	0	1810	0	1810	61.84	4.96	50-59	Stage 1
10810	TCGA-BS-A0V6	UCEC	55	FEMALE	ASIAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20369	Alive	TUMOR FREE	2725	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2725	0	2725	0	2725	0	2725	63.23	7.46	50-59	Stage 1
10811	TCGA-BS-A0V7	UCEC	48	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17810	Alive	TUMOR FREE	1934	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1934	0	1934	0	1934	0	1934	54.06	5.3	40-49	Stage 1
10812	TCGA-BS-A0V8	UCEC	68	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	[Not Applicable]	Stage IIB	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24981	Alive	TUMOR FREE	2544	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2544	0	2544	0	2544	0	2544	75.36	6.97	60-69	Stage 2
10813	TCGA-BS-A0VI	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IIB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21198	Alive	TUMOR FREE	2646	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2646	0	2646	0	2646	0	2646	65.28	7.24	50-59	Stage 2
10814	TCGA-BS-A0WQ	UCEC	55	FEMALE	ASIAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20131	Alive	TUMOR FREE	2022	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2022	0	2022	0	2022	0	2022	60.65	5.54	50-59	Stage 1
10815	TCGA-D1-A0ZN	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Peri (6-12 months since last menstrual period)	-22026	Alive	TUMOR FREE	512	548	[Not Available]	New Primary Tumor	Other, specify	448	Complete Remission/Response	0	512	0	512	0	512	1	448	61.71	1.4	60-69	Stage 1
10816	TCGA-D1-A0ZO	UCEC	75	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27482	Alive	TUMOR FREE	602	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	602	0	602	0	602	0	602	76.89	1.65	70-79	Stage 1
10817	TCGA-D1-A0ZP	UCEC	59	FEMALE	WHITE	[Not Applicable]	Stage IVA	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21581	Alive	TUMOR FREE	911	548	[Not Available]	Locoregional Disease	Other, specify	629	Complete Remission/Response	0	911	0	911	0	720	1	629	61.58	2.49	50-59	other
10818	TCGA-D1-A0ZQ	UCEC	90	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32873	Alive	TUMOR FREE	260	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	260	0	260	0	260	0	260	90.71	0.71	>=80	Stage 1
10819	TCGA-D1-A0ZR	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Indeterminate (neither Pre or Postmenopausal)	-21157	Alive	TUMOR FREE	17	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	17	0	17	0	17	0	17	57.97	0.05	50-59	Stage 1
10820	TCGA-D1-A0ZS	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19821	Alive	TUMOR FREE	148	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	148	0	148	0	148	0	148	54.67	0.41	50-59	Stage 1
10821	TCGA-D1-A0ZU	UCEC	34	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12458	Alive	TUMOR FREE	872	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	872	0	872	0	872	0	872	36.5	2.39	30-39	Stage 1
10822	TCGA-D1-A0ZV	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21374	Alive	TUMOR FREE	728	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	728	0	728	0	728	0	728	60.51	1.99	50-59	Stage 1
10823	TCGA-D1-A0ZZ	UCEC	80	FEMALE	WHITE	[Not Applicable]	Stage IB	Mixed serous and endometrioid	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29420	Alive	TUMOR FREE	686	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	686	0	686	0	686	0	686	82.43	1.88	>=80	Stage 1
10824	TCGA-D1-A101	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22078	Alive	TUMOR FREE	53	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	53	0	53	0	53	0	53	60.59	0.15	60-69	Stage 1
10825	TCGA-D1-A102	UCEC	49	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Peri (6-12 months since last menstrual period)	-17991	Alive	TUMOR FREE	135	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	135	0	135	0	135	0	135	49.63	0.37	40-49	Stage 1
10826	TCGA-D1-A103	UCEC	87	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31841	Alive	TUMOR FREE	669	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	669	0	669	0	669	0	669	89.01	1.83	>=80	Stage 1
10827	TCGA-D1-A15V	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24886	Alive	TUMOR FREE	1201	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1201	0	1201	0	1201	0	1201	71.42	3.29	60-69	Stage 1
10828	TCGA-D1-A15W	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21545	Alive	TUMOR FREE	915	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	915	0	915	0	915	0	915	61.49	2.51	50-59	other
10829	TCGA-D1-A15X	UCEC	45	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	High Grade	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16532	Alive	TUMOR FREE	909	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	909	0	909	0	909	0	909	47.75	2.49	40-49	Stage 1
10830	TCGA-D1-A15Z	UCEC	72	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26638	Dead	TUMOR FREE	766	58	[Not Available]	NA	NA	364	Complete Remission/Response	1	58	0	58	0	58	0	58	73.09	0.16	70-79	Stage 1
10831	TCGA-D1-A160	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25673	Alive	TUMOR FREE	112	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	112	0	112	0	112	0	112	70.6	0.31	70-79	Stage 1
10832	TCGA-D1-A161	UCEC	78	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28695	Alive	TUMOR FREE	892	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	892	0	892	0	892	0	892	81	2.44	70-79	Stage 1
10833	TCGA-D1-A162	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25543	Alive	TUMOR FREE	1145	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1145	0	1145	0	1145	0	1145	73.07	3.13	60-69	Stage 1
10834	TCGA-D1-A163	UCEC	50	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G2	2008	Peri (6-12 months since last menstrual period)	-18604	Alive	TUMOR FREE	991	548	[Not Available]	Metastatic	Other, specify	223	Complete Remission/Response	0	991	0	991	1	223	1	223	53.65	2.71	50-59	other
10835	TCGA-D1-A165	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23526	Alive	TUMOR FREE	20	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	20	0	20	0	20	0	20	64.47	0.05	60-69	other
10836	TCGA-D1-A167	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25575	Alive	TUMOR FREE	478	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	478	0	478	0	478	0	478	71.33	1.31	70-79	Stage 1
10837	TCGA-D1-A168	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24586	Alive	TUMOR FREE	1098	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1098	0	1098	0	1098	0	1098	70.32	3.01	60-69	Stage 1
10838	TCGA-D1-A169	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IV	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23238	Alive	WITH TUMOR	1135	548	[Not Available]	Metastatic	Other, specify	519	Complete Remission/Response	0	1135	0	1135	0	720	1	519	66.73	3.11	60-69	other
10839	TCGA-D1-A16B	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23450	Alive	TUMOR FREE	1106	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1106	0	1106	0	1106	0	1106	67.23	3.03	60-69	Stage 1
10840	TCGA-D1-A16D	UCEC	49	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G2	2008	Peri (6-12 months since last menstrual period)	-17933	Alive	TUMOR FREE	1141	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1141	0	1141	0	1141	0	1141	52.22	3.12	40-49	Stage 1
10841	TCGA-D1-A16E	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26859	Alive	TUMOR FREE	1119	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1119	0	1119	0	1119	0	1119	76.6	3.06	70-79	Stage 1
10842	TCGA-D1-A16F	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22242	Alive	TUMOR FREE	80	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	80	0	80	0	80	0	80	61.11	0.22	60-69	Stage 1
10843	TCGA-D1-A16G	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous endometrial adenocarcinoma	High Grade	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27065	Dead	WITH TUMOR	766	834	[Not Available]	Locoregional Disease	Other, specify	642	Complete Remission/Response	1	834	1	834	0	720	1	642	76.38	2.28	70-79	other
10844	TCGA-D1-A16I	UCEC	62	FEMALE	WHITE	[Not Applicable]	Stage IC	Serous endometrial adenocarcinoma	High Grade	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22836	Dead	TUMOR FREE	766	350	[Not Available]	NA	NA	364	Complete Remission/Response	1	350	0	350	0	350	0	350	63.48	0.96	60-69	Stage 1
10845	TCGA-D1-A16J	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IIB	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22319	Alive	TUMOR FREE	910	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	910	0	910	0	910	0	910	63.6	2.49	60-69	Stage 2
10846	TCGA-D1-A16N	UCEC	51	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2009	Peri (6-12 months since last menstrual period)	-18787	Alive	TUMOR FREE	945	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	945	0	945	0	945	0	945	54.02	2.59	50-59	other
10847	TCGA-D1-A16O	UCEC	44	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16114	Alive	TUMOR FREE	1023	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1023	0	1023	0	1023	0	1023	46.92	2.8	40-49	Stage 1
10848	TCGA-D1-A16Q	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19873	Alive	TUMOR FREE	324	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	324	0	324	0	324	0	324	55.3	0.89	50-59	Stage 2
10849	TCGA-D1-A16R	UCEC	39	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Indeterminate (neither Pre or Postmenopausal)	-14465	Alive	TUMOR FREE	21	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	21	0	21	0	21	0	21	39.66	0.06	30-39	Stage 1
10850	TCGA-D1-A16S	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25690	Alive	TUMOR FREE	568	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	568	0	568	0	568	0	568	71.89	1.56	70-79	other
10851	TCGA-D1-A16V	UCEC	78	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28635	Dead	TUMOR FREE	766	120	[Not Available]	NA	NA	364	Complete Remission/Response	1	120	0	120	0	120	0	120	78.73	0.33	70-79	other
10852	TCGA-D1-A16X	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19799	Alive	TUMOR FREE	111	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	111	0	111	0	111	0	111	54.51	0.3	50-59	Stage 1
10853	TCGA-D1-A16Y	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20455	Alive	TUMOR FREE	532	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	532	0	532	0	532	0	532	57.46	1.46	50-59	Stage 1
10854	TCGA-D1-A174	UCEC	51	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Indeterminate (neither Pre or Postmenopausal)	-18702	Alive	TUMOR FREE	594	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	594	0	594	0	594	0	594	52.83	1.63	50-59	Stage 1
10855	TCGA-D1-A175	UCEC	48	FEMALE	WHITE	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	Indeterminate (neither Pre or Postmenopausal)	-17802	Alive	TUMOR FREE	202	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	202	0	202	0	202	0	202	49.29	0.55	40-49	Stage 1
10856	TCGA-D1-A176	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24521	Alive	TUMOR FREE	917	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	917	0	917	0	917	0	917	69.65	2.51	60-69	Stage 1
10857	TCGA-D1-A177	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25602	Alive	TUMOR FREE	548	548	[Not Available]	Locoregional Disease	Other, specify	347	Complete Remission/Response	0	548	0	548	1	347	1	347	71.59	1.5	70-79	Stage 1
10858	TCGA-D1-A179	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28037	Dead	WITH TUMOR	766	448	[Not Available]	Metastatic	Lung	427	Complete Remission/Response	1	448	1	448	1	427	1	427	77.99	1.23	70-79	other
10859	TCGA-D1-A17A	UCEC	59	FEMALE	WHITE	[Not Applicable]	Stage IIA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21560	Alive	TUMOR FREE	48	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	48	0	48	0	48	0	48	59.16	0.13	50-59	Stage 2
10860	TCGA-D1-A17B	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25504	Alive	TUMOR FREE	213	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	213	0	213	0	213	0	213	70.41	0.58	60-69	Stage 1
10861	TCGA-D1-A17C	UCEC	78	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28571	Alive	TUMOR FREE	30	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	30	0	30	0	30	0	30	78.31	0.08	70-79	Stage 1
10862	TCGA-D1-A17D	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21441	Alive	TUMOR FREE	926	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	926	0	926	0	926	0	926	61.24	2.54	50-59	Stage 1
10863	TCGA-D1-A17F	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25116	Alive	TUMOR FREE	39	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	39	0	39	0	39	0	39	68.87	0.11	60-69	Stage 1
10864	TCGA-D1-A17H	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22389	Alive	TUMOR FREE	852	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	852	0	852	0	852	0	852	63.63	2.33	60-69	Stage 1
10865	TCGA-D1-A17K	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27283	Alive	TUMOR FREE	854	548	[Not Available]	Locoregional Disease	Other, specify	815	Complete Remission/Response	0	854	0	854	1	815	1	815	77.03	2.34	70-79	Stage 1
10866	TCGA-D1-A17L	UCEC	81	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29899	Alive	TUMOR FREE	802	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	802	0	802	0	802	0	802	84.05	2.2	>=80	Stage 1
10867	TCGA-D1-A17M	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20685	Alive	TUMOR FREE	311	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	311	0	311	0	311	0	311	57.48	0.85	50-59	Stage 2
10868	TCGA-D1-A17N	UCEC	46	FEMALE	[Not Available]	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Peri (6-12 months since last menstrual period)	-17045	Alive	TUMOR FREE	46	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	46	0	46	0	46	0	46	46.79	0.13	40-49	Stage 1
10869	TCGA-D1-A17Q	UCEC	54	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Peri (6-12 months since last menstrual period)	-20015	Alive	TUMOR FREE	54	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	54	0	54	0	54	0	54	54.95	0.15	50-59	Stage 1
10870	TCGA-D1-A17R	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-21382	Dead	TUMOR FREE	766	339	[Not Available]	NA	NA	364	Complete Remission/Response	1	339	0	339	0	339	0	339	59.47	0.93	50-59	Stage 1
10871	TCGA-D1-A17S	UCEC	59	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21794	Alive	TUMOR FREE	739	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	739	0	739	0	739	0	739	61.69	2.02	50-59	Stage 1
10872	TCGA-D1-A17T	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24652	Alive	TUMOR FREE	71	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	71	0	71	0	71	0	71	67.69	0.19	60-69	Stage 1
10873	TCGA-D1-A17U	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19544	Alive	TUMOR FREE	697	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	697	0	697	0	697	0	697	55.42	1.91	50-59	other
10874	TCGA-D1-A1NS	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19638	Alive	TUMOR FREE	43	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	43	0	43	0	43	0	43	53.88	0.12	50-59	Stage 1
10875	TCGA-D1-A1NU	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27272	Alive	TUMOR FREE	402	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	402	0	402	0	402	0	402	75.77	1.1	70-79	Stage 1
10876	TCGA-D1-A1NW	UCEC	72	FEMALE	WHITE	[Not Applicable]	Stage IVB	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26556	Alive	TUMOR FREE	22	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	22	0	22	0	720	0	22	72.77	0.06	70-79	other
10877	TCGA-D1-A1NX	UCEC	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24441	Alive	WITH TUMOR	555	548	[Not Available]	Metastatic	Other, specify	476	Complete Remission/Response	0	555	0	555	1	476	1	476	68.44	1.52	60-69	other
10878	TCGA-D1-A1NY	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24683	Alive	TUMOR FREE	513	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	513	0	513	0	513	0	513	68.98	1.4	60-69	Stage 1
10879	TCGA-D1-A1NZ	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22027	Alive	TUMOR FREE	548	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	548	0	548	0	548	0	548	61.81	1.5	60-69	Stage 1
10880	TCGA-D1-A1O0	UCEC	77	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28162	Alive	TUMOR FREE	63	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	63	0	63	0	63	0	63	77.28	0.17	70-79	Stage 1
10881	TCGA-D1-A1O5	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22580	Alive	TUMOR FREE	458	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	458	0	458	0	458	0	458	63.07	1.25	60-69	Stage 1
10882	TCGA-D1-A1O7	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22037	Alive	TUMOR FREE	32	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	32	0	32	0	32	0	32	60.42	0.09	60-69	Stage 1
10883	TCGA-D1-A1O8	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25789	Dead	TUMOR FREE	766	120	[Not Available]	NA	NA	364	Complete Remission/Response	1	120	0	120	0	120	0	120	70.93	0.33	70-79	other
10884	TCGA-D1-A2G0	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IB	Mixed serous and endometrioid	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25573	Alive	TUMOR FREE	1484	548	[Not Available]	NA	NA	364	[Not Available]	0	1484	0	1484	0	720	0	1484	74.08	4.06	70-79	Stage 1
10885	TCGA-D1-A2G5	UCEC	50	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18322	Alive	WITH TUMOR	1455	548	[Not Available]	Distant Metastasis	Other, specify	1122	Complete Remission/Response	0	1455	0	1455	1	1122	1	1122	54.15	3.98	50-59	Stage 1
10886	TCGA-D1-A2G6	UCEC	53	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19547	Dead	WITH TUMOR	766	258	[Not Available]	NA	NA	364	[Not Available]	1	258	1	258	0	720	1	258	54.22	0.71	50-59	other
10887	TCGA-D1-A2G7	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2007	Peri (6-12 months since last menstrual period)	-23913	Dead	TUMOR FREE	766	1793	[Not Available]	NA	NA	364	Complete Remission/Response	1	1793	0	1793	0	1793	0	1793	70.38	4.91	60-69	Stage 1
10888	TCGA-D1-A3DA	UCEC	77	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28142	Alive	TUMOR FREE	483	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	483	0	483	0	483	0	483	78.37	1.32	70-79	other
10889	TCGA-D1-A3DG	UCEC	81	FEMALE	WHITE	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29771	Dead	TUMOR FREE	766	130	[Not Available]	NA	NA	364	[Not Available]	1	130	0	130	0	720	0	130	81.86	0.36	>=80	other
10890	TCGA-D1-A3DH	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25935	Alive	TUMOR FREE	573	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	573	0	573	0	573	0	573	72.57	1.57	70-79	Stage 1
10891	TCGA-D1-A3JP	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22538	Alive	TUMOR FREE	515	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	515	0	515	0	720	0	515	63.12	1.41	60-69	Stage 1
10892	TCGA-D1-A3JQ	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22297	Alive	TUMOR FREE	526	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	526	0	526	0	526	0	526	62.49	1.44	60-69	other
10893	TCGA-DF-A2KN	UCEC	60	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	67	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	67	0	67	0	67	0	67	61.02	0.18	60-69	Stage 1
10894	TCGA-DF-A2KR	UCEC	84	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31007	Alive	TUMOR FREE	2178	548	[Not Available]	New Primary Tumor	Lung	2113	Complete Remission/Response	0	2178	0	2178	0	2178	1	2113	90.86	5.96	>=80	other
10895	TCGA-DF-A2KS	UCEC	69	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25313	Alive	TUMOR FREE	3318	548	[Not Available]	New Primary Tumor	Other, specify	2277	Complete Remission/Response	0	3318	0	3318	0	3318	1	2277	78.39	9.08	60-69	Stage 1
10896	TCGA-DF-A2KU	UCEC	60	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22222	Alive	TUMOR FREE	3067	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	3067	0	3067	0	3067	0	3067	69.24	8.4	60-69	Stage 1
10897	TCGA-DF-A2KV	UCEC	55	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20160	Alive	TUMOR FREE	2717	548	[Not Available]	NA	NA	364	[Not Available]	0	2717	0	2717	0	720	0	2717	62.63	7.44	50-59	Stage 1
10898	TCGA-DF-A2KY	UCEC	49	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IVA	Endometrioid endometrial adenocarcinoma	G3	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18086	Alive	WITH TUMOR	332	548	[Not Available]	NA	NA	364	[Not Available]	0	332	0	332	0	720	0	332	50.43	0.91	40-49	other
10899	TCGA-DF-A2KZ	UCEC	87	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31973	Alive	TUMOR FREE	826	548	[Not Available]	NA	NA	364	[Not Available]	0	826	0	826	0	720	0	826	89.8	2.26	>=80	Stage 1
10900	TCGA-DF-A2L0	UCEC	60	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22200	Dead	WITH TUMOR	766	788	[Not Available]	Distant Metastasis	Other, specify	523	Complete Remission/Response	1	788	1	788	1	523	1	523	62.94	2.16	60-69	other
10901	TCGA-DI-A0WH	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	[Not Available]	-23692	Alive	TUMOR FREE	496	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	496	0	496	0	496	0	496	66.22	1.36	60-69	Stage 1
10902	TCGA-DI-A1BU	UCEC	55	FEMALE	WHITE	[Not Applicable]	Stage IIB	Mixed serous and endometrioid	G3	2008	[Not Available]	-20114	Alive	TUMOR FREE	1195	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1195	0	1195	0	1195	0	1195	58.34	3.27	50-59	Stage 2
10903	TCGA-DI-A1BY	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IIB	Endometrioid endometrial adenocarcinoma	G2	2008	[Not Available]	-23113	Alive	TUMOR FREE	1114	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1114	0	1114	0	1114	0	1114	66.33	3.05	60-69	Stage 2
10904	TCGA-DI-A1C3	UCEC	38	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2008	[Not Available]	-13885	Alive	TUMOR FREE	739	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	739	0	739	0	739	0	739	40.04	2.02	30-39	Stage 1
10905	TCGA-DI-A1NN	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23026	Alive	WITH TUMOR	1076	548	[Not Available]	Metastatic	Other, specify	1023	Complete Remission/Response	0	1076	0	1076	1	1023	1	1023	65.99	2.95	60-69	other
10906	TCGA-DI-A1NO	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24996	Dead	WITH TUMOR	766	285	[Not Available]	NA	NA	364	Complete Remission/Response	1	285	1	285	0	720	1	285	69.22	0.78	60-69	other
10907	TCGA-DI-A2QT	UCEC	51	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	[Not Applicable]	Stage IIIC	Serous endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18835	Dead	WITH TUMOR	766	377	[Not Available]	NA	NA	364	[Not Available]	1	377	1	377	0	720	1	377	52.6	1.03	50-59	other
10908	TCGA-DI-A2QU	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24488	Dead	WITH TUMOR	766	946	[Not Available]	NA	NA	364	[Not Available]	1	946	1	946	0	720	1	946	69.63	2.59	60-69	other
10909	TCGA-DI-A2QY	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IIB	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23398	Dead	TUMOR FREE	766	3349	[Not Available]	NA	NA	364	Complete Remission/Response	1	3349	0	3349	0	3349	0	3349	73.23	9.17	60-69	Stage 2
10910	TCGA-E6-A1LX	UCEC	40	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14731	Alive	TUMOR FREE	711	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	711	0	711	0	711	0	711	42.28	1.95	40-49	Stage 1
10911	TCGA-E6-A1LZ	UCEC	76	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2007	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28054	Alive	TUMOR FREE	2406	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2406	0	2406	0	2406	0	2406	83.39	6.59	70-79	Stage 1
10912	TCGA-E6-A1M0	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20629	Alive	TUMOR FREE	1793	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1793	0	1793	0	1793	0	1793	61.39	4.91	50-59	other
10913	TCGA-E6-A2P8	UCEC	53	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IV	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19448	Dead	WITH TUMOR	766	72	[Not Available]	Metastatic	Lung	60	Progressive Disease	1	72	1	72	0	720	1	60	53.44	0.2	50-59	other
10914	TCGA-E6-A2P9	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24088	Alive	TUMOR FREE	1386	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1386	0	1386	0	1386	0	1386	69.74	3.79	60-69	Stage 1
10915	TCGA-E6-A8L9	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22333	Alive	TUMOR FREE	1013	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1013	0	1013	0	1013	0	1013	63.92	2.77	60-69	Stage 1
10916	TCGA-EC-A1NJ	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27002	Alive	TUMOR FREE	488	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	488	0	488	0	488	0	488	75.26	1.34	70-79	Stage 1
10917	TCGA-EC-A1QX	UCEC	71	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26259	Alive	TUMOR FREE	224	548	[Not Available]	NA	NA	219	Progressive Disease	0	224	0	224	0	720	1	219	72.51	0.61	70-79	Stage 1
10918	TCGA-EC-A24G	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2011	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-20857	Alive	TUMOR FREE	511	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	511	0	511	0	511	0	511	58.5	1.4	50-59	Stage 2
10919	TCGA-EO-A1Y5	UCEC	63	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23251	Alive	TUMOR FREE	332	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	332	0	332	0	332	0	332	64.57	0.91	60-69	other
10920	TCGA-EO-A1Y7	UCEC	65	FEMALE	[Not Available]	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24085	Alive	WITH TUMOR	1495	548	[Not Available]	Distant Metastasis	Lung	880	Progressive Disease	0	1495	0	1495	0	720	1	880	70.03	4.09	60-69	Stage 1
10921	TCGA-EO-A1Y8	UCEC	87	FEMALE	[Not Available]	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31971	Alive	TUMOR FREE	1147	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1147	0	1147	0	1147	0	1147	90.67	3.14	>=80	Stage 1
10922	TCGA-EO-A22R	UCEC	56	FEMALE	[Not Available]	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20604	Alive	TUMOR FREE	1878	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1878	0	1878	0	1878	0	1878	61.55	5.14	50-59	Stage 1
10923	TCGA-EO-A22S	UCEC	58	FEMALE	[Not Available]	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21328	Alive	TUMOR FREE	1872	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1872	0	1872	0	1872	0	1872	63.52	5.13	50-59	Stage 1
10924	TCGA-EO-A22T	UCEC	56	FEMALE	ASIAN	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20608	Alive	TUMOR FREE	2035	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2035	0	2035	0	2035	0	2035	61.99	5.57	50-59	Stage 2
10925	TCGA-EO-A22U	UCEC	83	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30557	Alive	TUMOR FREE	1407	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1407	0	1407	0	1407	0	1407	87.51	3.85	>=80	Stage 1
10926	TCGA-EO-A22X	UCEC	36	FEMALE	[Not Available]	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2008	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13245	Alive	TUMOR FREE	1752	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1752	0	1752	0	1752	0	1752	41.06	4.8	30-39	other
10927	TCGA-EO-A22Y	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25127	Alive	TUMOR FREE	1567	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1567	0	1567	0	1567	0	1567	73.08	4.29	60-69	Stage 1
10928	TCGA-EO-A2CG	UCEC	69	FEMALE	ASIAN	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25279	Alive	TUMOR FREE	1564	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1564	0	1564	0	1564	0	1564	73.49	4.28	60-69	Stage 1
10929	TCGA-EO-A2CH	UCEC	73	FEMALE	[Not Available]	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26966	Dead	WITH TUMOR	766	590	[Not Available]	Metastatic	Liver	304	Progressive Disease	1	590	1	590	0	720	1	304	75.44	1.62	70-79	other
10930	TCGA-EO-A3AS	UCEC	86	FEMALE	[Not Available]	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31450	Alive	TUMOR FREE	1046	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1046	0	1046	0	1046	0	1046	88.97	2.86	>=80	Stage 1
10931	TCGA-EO-A3AU	UCEC	72	FEMALE	[Not Available]	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26406	Alive	TUMOR FREE	1543	548	[Not Available]	New Primary Tumor	Lung	1178	Complete Remission/Response	0	1543	0	1543	0	1543	1	1178	76.52	4.22	70-79	Stage 2
10932	TCGA-EO-A3AV	UCEC	51	FEMALE	[Not Available]	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2010	Peri (6-12 months since last menstrual period)	-18713	Alive	TUMOR FREE	1069	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1069	0	1069	0	1069	0	1069	54.16	2.93	50-59	other
10933	TCGA-EO-A3AY	UCEC	58	FEMALE	[Not Available]	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21291	Alive	WITH TUMOR	1158	548	[Not Available]	Locoregional Recurrence	Other, specify	1163	Complete Remission/Response	0	1158	0	1158	1	1163	1	1163	61.46	3.17	50-59	Stage 1
10934	TCGA-EO-A3AZ	UCEC	80	FEMALE	[Not Available]	[Not Applicable]	Stage IB	Mixed serous and endometrioid	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29234	Alive	TUMOR FREE	826	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	826	0	826	0	826	0	826	82.3	2.26	>=80	Stage 1
10935	TCGA-EO-A3B0	UCEC	43	FEMALE	ASIAN	[Not Applicable]	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2011	Indeterminate (neither Pre or Postmenopausal)	-15954	Alive	TUMOR FREE	1412	548	[Not Available]	NA	NA	364	[Discrepancy]	0	1412	0	1412	0	720	0	1412	47.55	3.87	40-49	other
10936	TCGA-EO-A3B1	UCEC	63	FEMALE	[Not Available]	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23162	Alive	TUMOR FREE	820	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	820	0	820	0	820	0	820	65.66	2.25	60-69	Stage 1
10937	TCGA-EO-A3KU	UCEC	68	FEMALE	[Not Available]	[Not Applicable]	Stage II	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25116	Alive	TUMOR FREE	677	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	677	0	677	0	677	0	677	70.62	1.85	60-69	Stage 2
10938	TCGA-EO-A3KW	UCEC	72	FEMALE	[Not Available]	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26492	Alive	TUMOR FREE	497	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	497	0	497	0	497	0	497	73.89	1.36	70-79	Stage 1
10939	TCGA-EO-A3KX	UCEC	80	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29260	Alive	TUMOR FREE	1170	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1170	0	1170	0	1170	0	1170	83.31	3.2	>=80	Stage 1
10940	TCGA-EO-A3L0	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28003	Alive	TUMOR FREE	1554	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1554	0	1554	0	1554	0	1554	80.92	4.25	70-79	Stage 1
10941	TCGA-EY-A1G7	UCEC	86	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G2	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31603	Dead	WITH TUMOR	766	189	[Not Available]	NA	NA	95	Complete Remission/Response	1	189	1	189	1	95	1	95	87.04	0.52	>=80	Stage 2
10942	TCGA-EY-A1G8	UCEC	83	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30517	Dead	TUMOR FREE	766	456	[Not Available]	NA	NA	364	Complete Remission/Response	1	456	0	456	0	456	0	456	84.8	1.25	>=80	Stage 1
10943	TCGA-EY-A1GC	UCEC	62	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22656	Alive	TUMOR FREE	1647	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1647	0	1647	0	1647	0	1647	66.54	4.51	60-69	Stage 1
10944	TCGA-EY-A1GD	UCEC	51	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18638	Alive	TUMOR FREE	1639	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1639	0	1639	0	1639	0	1639	55.52	4.49	50-59	Stage 1
10945	TCGA-EY-A1GE	UCEC	67	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24667	Alive	TUMOR FREE	741	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	741	0	741	0	741	0	741	69.56	2.03	60-69	Stage 1
10946	TCGA-EY-A1GF	UCEC	75	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27450	Alive	TUMOR FREE	826	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	826	0	826	0	826	0	826	77.42	2.26	70-79	Stage 1
10947	TCGA-EY-A1GH	UCEC	70	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25802	Alive	TUMOR FREE	710	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	710	0	710	0	710	0	710	72.59	1.94	70-79	Stage 1
10948	TCGA-EY-A1GI	UCEC	52	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-19117	Alive	TUMOR FREE	710	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	710	0	710	0	710	0	710	54.28	1.94	50-59	Stage 1
10949	TCGA-EY-A1GJ	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26715	Alive	TUMOR FREE	727	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	727	0	727	0	727	0	727	75.13	1.99	70-79	Stage 1
10950	TCGA-EY-A1GK	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27127	Alive	TUMOR FREE	693	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	693	0	693	0	693	0	693	76.17	1.9	70-79	Stage 1
10951	TCGA-EY-A1GL	UCEC	51	FEMALE	WHITE	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18761	Alive	TUMOR FREE	1014	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1014	0	1014	0	1014	0	1014	54.14	2.78	50-59	Stage 2
10952	TCGA-EY-A1GM	UCEC	60	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIA	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22010	Dead	WITH TUMOR	766	995	[Not Available]	Locoregional Recurrence	NA	791	Complete Remission/Response	1	995	1	995	1	791	1	791	62.98	2.72	60-69	other
10953	TCGA-EY-A1GO	UCEC	65	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23853	Alive	WITH TUMOR	586	548	[Not Available]	Metastatic	Lung	517	Complete Remission/Response	0	586	0	586	1	517	1	517	66.91	1.6	60-69	other
10954	TCGA-EY-A1GP	UCEC	54	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20011	Alive	TUMOR FREE	573	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	573	0	573	0	573	0	573	56.36	1.57	50-59	Stage 1
10955	TCGA-EY-A1GQ	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27905	Alive	WITH TUMOR	544	548	[Not Available]	Metastatic	Other, specify	334	Complete Remission/Response	0	544	0	544	1	334	1	334	77.89	1.49	70-79	Stage 1
10956	TCGA-EY-A1GR	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24784	Alive	TUMOR FREE	536	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	536	0	536	0	536	0	536	69.32	1.47	60-69	Stage 1
10957	TCGA-EY-A1GS	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26012	Dead	WITH TUMOR	766	670	[Not Available]	NA	NA	364	Stable Disease	1	670	1	670	0	720	1	670	73.05	1.83	70-79	other
10958	TCGA-EY-A1GT	UCEC	68	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25151	Alive	TUMOR FREE	490	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	490	0	490	0	490	0	490	70.2	1.34	60-69	other
10959	TCGA-EY-A1GU	UCEC	66	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24304	Dead	TUMOR FREE	766	997	[Not Available]	NA	NA	364	Complete Remission/Response	1	997	0	997	0	997	0	997	69.27	2.73	60-69	Stage 1
10960	TCGA-EY-A1GV	UCEC	75	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Mixed serous and endometrioid	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27581	Alive	TUMOR FREE	481	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	481	0	481	0	481	0	481	76.83	1.32	70-79	other
10961	TCGA-EY-A1GW	UCEC	73	FEMALE	WHITE	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26979	Dead	WITH TUMOR	766	337	[Not Available]	Metastatic	Liver	190	Progressive Disease	1	337	1	337	0	720	1	190	74.79	0.92	70-79	other
10962	TCGA-EY-A1GX	UCEC	76	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27962	Dead	TUMOR FREE	766	1127	[Not Available]	Locoregional Recurrence	Other, specify	743	Complete Remission/Response	1	1127	0	1127	1	743	1	743	79.64	3.09	70-79	other
10963	TCGA-EY-A1H0	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G2	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20937	Alive	WITH TUMOR	588	548	[Not Available]	NA	NA	364	Partial Remission/Response	0	588	0	588	0	720	0	588	58.93	1.61	50-59	other
10964	TCGA-EY-A210	UCEC	82	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Mixed serous and endometrioid	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30095	Alive	TUMOR FREE	383	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	383	0	383	0	383	0	383	83.44	1.05	>=80	other
10965	TCGA-EY-A212	UCEC	83	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30680	Dead	WITH TUMOR	766	310	[Not Available]	NA	NA	364	Partial Remission/Response	1	310	1	310	0	720	1	310	84.85	0.85	>=80	other
10966	TCGA-EY-A214	UCEC	66	FEMALE	WHITE	[Not Applicable]	Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24136	Alive	TUMOR FREE	438	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	438	0	438	0	438	0	438	67.28	1.2	60-69	other
10967	TCGA-EY-A215	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22076	Alive	TUMOR FREE	574	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	574	0	574	0	574	0	574	62.01	1.57	60-69	Stage 1
10968	TCGA-EY-A2OM	UCEC	55	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20398	Alive	TUMOR FREE	694	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	694	0	694	0	694	0	694	57.75	1.9	50-59	Stage 1
10969	TCGA-EY-A2ON	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22624	Dead	WITH TUMOR	766	610	[Not Available]	NA	NA	226	Progressive Disease	1	610	1	610	0	720	1	226	63.61	1.67	60-69	other
10970	TCGA-EY-A2OO	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage IB	Mixed serous and endometrioid	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20797	Alive	TUMOR FREE	1392	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1392	0	1392	0	1392	0	1392	60.75	3.81	50-59	Stage 1
10971	TCGA-EY-A2OP	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23090	Alive	TUMOR FREE	944	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	944	0	944	0	944	0	944	65.8	2.58	60-69	Stage 1
10972	TCGA-EY-A2OQ	UCEC	61	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22309	Alive	TUMOR FREE	885	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	885	0	885	0	885	0	885	63.5	2.42	60-69	Stage 1
10973	TCGA-EY-A3L3	UCEC	82	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30138	Alive	TUMOR FREE	832	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	832	0	832	0	832	0	832	84.79	2.28	>=80	Stage 1
10974	TCGA-EY-A3QX	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23663	Dead	WITH TUMOR	766	989	[Not Available]	Locoregional Recurrence	Other, specify	896	Complete Remission/Response	1	989	1	989	0	720	1	896	67.49	2.71	60-69	other
10975	TCGA-EY-A4KR	UCEC	56	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20669	Dead	WITH TUMOR	766	346	[Not Available]	NA	NA	364	Progressive Disease	1	346	1	346	0	720	1	346	57.54	0.95	50-59	other
10976	TCGA-EY-A547	UCEC	75	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27686	Alive	TUMOR FREE	545	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	545	0	545	0	545	0	545	77.29	1.49	70-79	Stage 1
10977	TCGA-EY-A548	UCEC	83	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30544	Alive	TUMOR FREE	430	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	430	0	430	0	430	0	430	84.8	1.18	>=80	Stage 1
10978	TCGA-EY-A549	UCEC	78	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28570	Alive	TUMOR FREE	605	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	605	0	605	0	605	0	605	79.88	1.66	70-79	Stage 1
10979	TCGA-EY-A54A	UCEC	67	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC2	Endometrioid endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24822	Alive	TUMOR FREE	447	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	447	0	447	0	447	0	447	69.18	1.22	60-69	other
10980	TCGA-EY-A5W2	UCEC	72	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26498	Alive	TUMOR FREE	516	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	516	0	516	0	516	0	516	73.96	1.41	70-79	Stage 1
10981	TCGA-EY-A72D	UCEC	87	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31818	Alive	TUMOR FREE	179	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	179	0	179	0	179	0	179	87.6	0.49	>=80	Stage 2
10982	TCGA-FI-A2CX	UCEC	82	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30224	Alive	TUMOR FREE	2031	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2031	0	2031	0	2031	0	2031	88.31	5.56	>=80	Stage 1
10983	TCGA-FI-A2CY	UCEC	60	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Mixed serous and endometrioid	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22098	Alive	TUMOR FREE	2080	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2080	0	2080	0	2080	0	2080	66.2	5.69	60-69	Stage 1
10984	TCGA-FI-A2D0	UCEC	55	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2008	Peri (6-12 months since last menstrual period)	-20393	Alive	TUMOR FREE	1213	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1213	0	1213	0	1213	0	1213	59.15	3.32	50-59	Stage 1
10985	TCGA-FI-A2D2	UCEC	66	FEMALE	WHITE	[Not Applicable]	Stage IB	Mixed serous and endometrioid	G3	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24260	Dead	WITH TUMOR	766	2352	[Not Available]	Locoregional Recurrence	Lung	1917	Complete Remission/Response	1	2352	1	2352	1	1917	1	1917	72.86	6.44	60-69	Stage 1
10986	TCGA-FI-A2D4	UCEC	44	FEMALE	WHITE	[Not Applicable]	Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2009	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16163	Dead	WITH TUMOR	766	243	[Not Available]	NA	NA	364	Partial Remission/Response	1	243	1	243	0	720	1	243	44.92	0.67	40-49	other
10987	TCGA-FI-A2D5	UCEC	56	FEMALE	WHITE	[Not Applicable]	Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20666	Dead	WITH TUMOR	766	421	[Not Available]	Metastatic	Other, specify	280	Partial Remission/Response	1	421	1	421	0	720	1	280	57.73	1.15	50-59	other
10988	TCGA-FI-A2D6	UCEC	74	FEMALE	WHITE	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27060	Dead	TUMOR FREE	766	767	[Not Available]	NA	NA	364	Complete Remission/Response	1	767	0	767	0	767	0	767	76.19	2.1	70-79	Stage 1
10989	TCGA-FI-A2EU	UCEC	68	FEMALE	[Not Available]	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24837	Alive	TUMOR FREE	2941	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2941	0	2941	0	2941	0	2941	76.05	8.05	60-69	Stage 1
10990	TCGA-FI-A2EW	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIB	Serous endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26267	Alive	WITH TUMOR	1795	548	[Not Available]	Metastatic	Liver	1169	Complete Remission/Response	0	1795	0	1795	1	1169	1	1169	76.83	4.91	70-79	Stage 2
10991	TCGA-FI-A2EX	UCEC	58	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2005	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21489	Alive	WITH TUMOR	284	548	[Not Available]	Metastatic	NA	213	Complete Remission/Response	0	284	0	284	1	213	1	213	59.61	0.78	50-59	other
10992	TCGA-FI-A2EY	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23042	Dead	TUMOR FREE	766	880	[Not Available]	New Primary Tumor	Lung	577	Complete Remission/Response	1	880	0	880	0	880	1	577	65.49	2.41	60-69	other
10993	TCGA-FI-A2F4	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23621	Alive	TUMOR FREE	2230	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2230	0	2230	0	2230	0	2230	70.78	6.11	60-69	Stage 1
10994	TCGA-FI-A2F8	UCEC	64	FEMALE	WHITE	[Not Applicable]	Stage II	Serous endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23649	Alive	WITH TUMOR	933	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	933	0	933	0	933	0	933	67.3	2.55	60-69	Stage 2
10995	TCGA-FI-A2F9	UCEC	79	FEMALE	WHITE	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G3	2009	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28886	Alive	TUMOR FREE	1803	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1803	0	1803	0	1803	0	1803	84.02	4.94	70-79	Stage 1
10996	TCGA-FI-A3PV	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	High Grade	2003	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24898	Dead	WITH TUMOR	766	1249	[Not Available]	NA	NA	364	[Not Available]	1	1249	1	1249	0	720	1	1249	71.59	3.42	60-69	Stage 1
10997	TCGA-FI-A3PX	UCEC	57	FEMALE	WHITE	[Not Applicable]	Stage IIIC2	Serous endometrial adenocarcinoma	High Grade	2008	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21063	Alive	TUMOR FREE	2384	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	2384	0	2384	0	2384	0	2384	64.19	6.53	50-59	other
10998	TCGA-H5-A2HR	UCEC	71	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25986	Alive	TUMOR FREE	53	548	[Not Available]	NA	NA	364	[Not Available]	0	53	0	53	0	720	0	53	71.29	0.15	70-79	Stage 1
10999	TCGA-JU-AAVI	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIC1	Serous endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22289	Dead	WITH TUMOR	766	540	[Not Available]	Distant Metastasis	Other, specify	505	Complete Remission/Response	1	540	1	540	1	505	1	505	62.5	1.48	60-69	other
11000	TCGA-K6-A3WQ	UCEC	60	FEMALE	WHITE	[Not Applicable]	Stage IVB	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22092	Dead	WITH TUMOR	766	427	[Not Available]	Locoregional Recurrence	Other, specify	351	[Not Available]	1	427	1	427	0	720	1	351	61.65	1.17	60-69	other
11001	TCGA-KJ-A3U4	UCEC	55	FEMALE	WHITE	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G1	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20392	Alive	TUMOR FREE	1095	548	[Not Available]	Locoregional Recurrence	Other, specify	306	[Discrepancy]	0	1095	0	1095	0	720	1	306	58.83	3	50-59	Stage 1
11002	TCGA-KP-A3VZ	UCEC	69	FEMALE	WHITE	[Not Applicable]	Stage IV	Serous endometrial adenocarcinoma	High Grade	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25366	Alive	WITH TUMOR	722	548	[Not Available]	NA	NA	364	[Not Available]	0	722	0	722	0	720	0	722	71.43	1.98	60-69	other
11003	TCGA-KP-A3W0	UCEC	72	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26378	Alive	TUMOR FREE	404	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	404	0	404	0	404	0	404	73.33	1.11	70-79	Stage 1
11004	TCGA-KP-A3W1	UCEC	76	FEMALE	[Not Evaluated]	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27902	Alive	TUMOR FREE	288	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	288	0	288	0	288	0	288	77.18	0.79	70-79	Stage 1
11005	TCGA-KP-A3W3	UCEC	72	FEMALE	WHITE	[Not Applicable]	Stage IB	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26310	Alive	WITH TUMOR	794	548	[Not Available]	Distant Metastasis	Liver	661	Complete Remission/Response	0	794	0	794	1	661	1	661	74.21	2.17	70-79	Stage 1
11006	TCGA-KP-A3W4	UCEC	63	FEMALE	WHITE	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23200	Dead	WITH TUMOR	766	554	[Not Available]	Distant Metastasis	Liver	321	Partial Remission/Response	1	554	1	554	0	720	1	321	65.03	1.52	60-69	other
11007	TCGA-PG-A5BC	UCEC	72	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage II	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26436	Alive	TUMOR FREE	707	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	707	0	707	0	707	0	707	74.31	1.94	70-79	Stage 2
11008	TCGA-PG-A6IB	UCEC	68	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24969	Alive	TUMOR FREE	648	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	648	0	648	0	648	0	648	70.14	1.77	60-69	Stage 1
11009	TCGA-PG-A7D5	UCEC	62	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2011	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23006	Alive	TUMOR FREE	1177	548	[Not Available]	NA	NA	364	Stable Disease	0	1177	0	1177	0	720	0	1177	66.21	3.22	60-69	Stage 1
11010	TCGA-PG-A914	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26992	Alive	TUMOR FREE	687	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	687	0	687	0	687	0	687	75.78	1.88	70-79	Stage 1
11011	TCGA-PG-A915	UCEC	60	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Serous endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22119	Alive	TUMOR FREE	249	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	249	0	249	0	249	0	249	61.24	0.68	60-69	Stage 1
11012	TCGA-PG-A916	UCEC	70	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage I	Endometrioid endometrial adenocarcinoma	G2	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25617	Alive	TUMOR FREE	522	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	522	0	522	0	522	0	522	71.56	1.43	70-79	Stage 1
11013	TCGA-PG-A917	UCEC	74	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IA	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27104	Alive	TUMOR FREE	212	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	212	0	212	0	212	0	212	74.79	0.58	70-79	Stage 1
11014	TCGA-QF-A5YS	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage II	Mixed serous and endometrioid	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20841	Alive	TUMOR FREE	689	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	689	0	689	0	689	0	689	58.95	1.89	50-59	Stage 2
11015	TCGA-QF-A5YT	UCEC	57	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage II	Endometrioid endometrial adenocarcinoma	G1	2010	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20981	Alive	TUMOR FREE	1215	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	1215	0	1215	0	1215	0	1215	60.77	3.33	50-59	Stage 2
11016	TCGA-QS-A5YQ	UCEC	55	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIA	Endometrioid endometrial adenocarcinoma	G1	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20425	Alive	TUMOR FREE	759	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	759	0	759	0	759	0	759	58	2.08	50-59	other
11017	TCGA-QS-A5YR	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIB	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22372	Alive	WITH TUMOR	719	548	[Not Available]	NA	NA	364	Stable Disease	0	719	0	719	0	720	0	719	63.22	1.97	60-69	other
11018	TCGA-QS-A744	UCEC	86	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIB	Endometrioid endometrial adenocarcinoma	G2	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31520	Alive	TUMOR FREE	451	548	[Not Available]	NA	NA	364	[Not Applicable]	0	451	0	451	0	720	0	451	87.53	1.23	>=80	other
11019	TCGA-QS-A8F1	UCEC	85	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IIIA	Serous endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31386	Dead	WITH TUMOR	766	135	[Not Available]	NA	NA	364	Progressive Disease	1	135	1	135	0	720	1	135	86.3	0.37	>=80	other
11020	TCGA-SJ-A6ZI	UCEC	64	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G1	2013	[Unknown]	-23653	Alive	TUMOR FREE	631	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	631	0	631	0	631	0	631	66.49	1.73	60-69	Stage 1
11021	TCGA-SJ-A6ZJ	UCEC	61	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G2	2012	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22597	Alive	TUMOR FREE	556	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	556	0	556	0	556	0	556	63.39	1.52	60-69	Stage 1
11022	TCGA-SL-A6J9	UCEC	73	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26701	Alive	TUMOR FREE	2	548	[Not Available]	NA	NA	364	[Unknown]	0	2	0	2	0	720	0	2	73.11	0.01	70-79	Stage 1
11023	TCGA-SL-A6JA	UCEC	77	FEMALE	BLACK OR AFRICAN AMERICAN	[Not Applicable]	Stage IB	Endometrioid endometrial adenocarcinoma	G3	2013	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28401	Alive	TUMOR FREE	7	548	[Not Available]	NA	NA	364	Complete Remission/Response	0	7	0	7	0	7	0	7	77.78	0.02	70-79	Stage 1
